1998”N“x –k—¢‘åŠwˆãŠw•”E‘åŠw•a‰@Œ¤‹†‹ÆÑW(HTML”Å)


i’FŒ´–{‚ÅŒäŠm”F‰º‚³‚¢ take@bme.ahs.kitasato-u.ac.jpj



<<01 ‰ð–UŠw>>

1. mŒ´’˜n Two novel testicular serine proteases, TESP1 and TESP2, are present in the mouse sperm acrosome. Kohno, N.CYamagata, K.CYamada, S.CKashiwabara, S.i’}”g‘åjCŽðˆäNOi‰ðjCBaba, T.i’}”g‘åj: Biochem. Biophys. Res. Commun., 245: 658`665, 1998.

2. mŒ´’˜n Exocytosis-removal cycle of single secretory granules visualized by confocal laser microscopy. £ì²‹vi‰ðj: Bioimages, 5(4): 153`155, 1997.

3. mŒ´’˜n Different effects of prolonged isocapnic hypoxia on the carotid body and the glomus cells in the wall of the common carotid artery of the chicken. ‹T“c•‡ŽqCŽO‰Y³–¾C—Ñ“c‰Ã˜Yi‰ðj: Brain Res., 805(1-2): 191`206, 1998.

4. mŒ´’˜n Substance P- and CGRP-immunoreactive fibers in the chicken carotid bodies after nodose ganglionectomy and midcervical vagotomy. ‹T“c•‡Žqi‰ðj: Brain Res., 807(1-2): 246`249, 1998.

5. mŒ´’˜n Molecular cloning and characterization of meichroacidin (Male meiotic metaphase chromosome-associated acidic protein). Tsuchida, J.CNishina, Y.CWakabayashi, N.CNozaki, M.iã‘åjCŽðˆäNOi‰ðjCNishimune, Y.iã‘åj: Dev. Biol., 197: 67`76, 1998.

6. mŒ´’˜n Laminin ƒ¿1 chain G domain peptide, RKRLQVQLSIRT, inhibits epithelial branching morphogenesis of cultured embryonic mouse submandibular gland. –å’J—Tˆêi‰ðjCNomizu, M.iNIHjCSorokin, L.iUniv. Erlangen-NurembergjCŽR‰È³•½i‰ðjCYamada, Y.iNIHj: Dev. Dyn., 212: 394`402, 1998.

7. mŒ´’˜n Human salivary gland parenchymal cells seen by SEM from the cytoplasmic side using a new osmium maceration method. Riva, A.CLoffredo, F.iUniv. CagliarijC£ì²‹vi‰ðjCCongiu, T.CTesta Riva, F.iUniv. Cagliarij: Eur. J. Morphol., 36(Suppl.): 35`40, 1998.

8. mŒ´’˜n Cytoskeletal regulation of human salivary secretion studied by high resolution electron microscopy and confocal laser microscopy. £ì²‹vi‰ðjCTesta Riva, A.CLoffredo, F.CCongiu, T.iUniv. CagliarijCŽR‰È³•½i‰ðjCRiva, F.iUniv. Cagliarij: Eur. J. Morphol., 36(Suppl.): 41`45, 1998.

9. mŒ´’˜n Apical vesicles bearing inositol 1,4,5-trisphosphate receptors in the Ca2+ initiation site of ductal epithelium of submandibular gland. Yamamoto-Hino, M.CMiyawaki, A.i“Œ‘åjC£ì²‹vCˆÀ’B‰hŽ¡˜YCŽR‰È³•½i‰ðjCFujimoto, T.iŒQ‘åjCSugiyama, T.CFuruichi, T.CHasegawa, M.i‹¦˜a”­yjCMikoshiba, K.i“Œ‘åj: J. Cell Biol., 141: 135`142, 1998.

10. mŒ´’˜n Laminin 5 can promote assembly of the lamina densa in the skin equivalent model. Tsunenage, M.iŽ‘¶“°jCˆÀ’B‰hŽ¡˜Yi‰ðjCAmano, S.iŽ‘¶“°jCBurgeson, R.E.iMasachusetts General HospitaljC¼ŽR•q•viŽ‘¶“°j: Matrix Biol., 17: 603`613, 1998.

11. m€Œ´’˜n Ž©—¥_Œoƒjƒ…[ƒƒ“‚ð‚ß‚®‚é×–EŠOƒ}ƒgƒŠƒbƒNƒX: ‹@”\•ªŽq”­Œ»‚É‹y‚Ú‚·×–EŠOŠÂ‹«‚Ì–ðŠ„. ˆÀ’B‰hŽ¡˜Yi‰ðjC—é–ØL‰piˆã—Éq¶jC‘vŽž‰hCŽRš “OiŽO•H‰»Šw¶–½jCŽR–{•q•¶i‰¡•lŽs‘åj: Ž©—¥_Œo, 35(3): 301`306, 1998.

12. mŒ¤‹†•ñi•¶•”Èjn ‰º‚‘Ì—²‹N•”‚æ‚蕪”傳‚ê‚éƒzƒ‹ƒ‚ƒ“‚Ì“¯’è‚Æ‚»‚Ì‹@”\‚̉ð–¾. ‹T“c•‡ŽqCŽO‰Y³–¾i‰ðj. Œ¤‹†•ñ‘, 1998.

13. mŒ¤‹†•ñi•¶•”Èjn ŠíŠ¯Œ`¬‚ÉŠÖ—^‚·‚郉ƒ~ƒjƒ“‹@”\ƒhƒƒCƒ“‚̃XƒNƒŠ[ƒjƒ“ƒO‚Æ‚»‚ê‚ç‚Ì‹@”\‚ÌŒ¤‹†. –å’J—Tˆêi‰ðj: •½¬10”N“x‰ÈŠwŒ¤‹†”ï•â•‹àŽÀÑ•ñ‘, 1998.

14. mŠwp‘n i•ª’SŽ·•Mj “dŽqŒ°”÷‹¾Šî‘b‹Zp‚Ɖž—p1998; ˆãŠw¥¶•¨Šw—̈æ‚É‚¨‚¯‚é‘–¸Œ^ƒvƒ[ƒuŒ°”÷‹¾‚ÌŒ»ó‚Æ‚»‚̉”\«|“Á‚É×–E‚Ì’´”÷\‘¢‚ÌŠÏŽ@‚Æ‘gD‰»Šw–@‚ւ̉ž—p|, p.140`144, ŽR‰È³•½i‰ðj. •ÒW ‘æ‚X‰ñ“dŒ°ƒTƒ}[ƒXƒN[ƒ‹ŽÀsˆÏˆõ‰ïC ŠwÛŠé‰æ, “Œ‹ž, 98.07.29”­s.

15. mŠwp‘n i•ª’SŽ·•Mj ×–E‹@”\‚Æ‘ãŽÓƒ}ƒbƒv, ‡U. ×–E‚Ì“®“I‹@”\; ×–EŠOƒ}ƒgƒŠƒbƒNƒX, p.28`36, ‘å˜a‰ë”Vi“Œ—ˆã‘åjC…–ìˆêæi“Œ‘åjCˆÀ’B‰hŽ¡˜Yi‰ðjC’†—¢_ˆêC¡‘º•Û’‰C—Ñ—˜•Fi“Œ‘åj. •ÒW ¼’ˑהüi_ŒË‘åjC “Œ‹ž‰»Šw“¯l, “Œ‹ž, 98.10.19”­s.

16. mŠwp‘n i•ª’SŽ·•Mj Šâ”guÀ: Œ»‘ãˆãŠw‚ÌŠî‘b|l‘̂̂Ȃ肽‚¿|; Á‰»Ší, p.13`33, £ì²‹vi‰ðj. •ÒW âˆäŒš—Yi‡“V“°‘åjC²“¡’B•vi“ŒˆãŽ•‘åjC Šâ”g‘“X, “Œ‹ž, 98.10.00”­s.

17. mŠwp‘n i•ª’SŽ·•Mj Frontiers of Oral Biology, Vol. 10, Glandular Mechanisms of Salivary Secretion; The dynamics of exocytosis of preformed secretory granules from acini in rat salivary glands, p.89`100, £ì²‹vCŽR‰È³•½i‰ðj. •ÒW Garrett, J.R., Ekstrom, J., Anderson, L.C.iKing's CollegejC Karger, Basel, 98.00.00”­s.

18. mŠwp‘n i•ª’SŽ·•Mj ƒJƒ‹ƒVƒgƒjƒ“|Šî‘b‚Æ—Õ°; ƒJƒ‹ƒVƒgƒjƒ“‚Ì“à•ª”åŠíŠ¯|Œ`‘Ô‚¨‚æ‚Ñ‘gDŠw“IŒ¤‹†, p.72`77, ‹T“c•‡Žqi‰ðj. •ÒW ŽR–{ˆí—YC‚‹´’¼”VC•ÒC ƒ‰ƒCƒtƒTƒCƒGƒ“ƒXC“Œ‹žC98.10.30”­s.

19. m‹³‰È‘n i•ª’SŽ·•Mj •W€×–E¶•¨Šw; ¬–E‘Ì, p.64`77, ŽR‰È³•½i‰ðj. •ÒW Îìt—¥iŒQ‘åjC‹ß“¡®•i“Œ–k‘åjCŽÄ“c—mŽO˜Yi‹ã‘åjC ˆãŠw‘‰@, “Œ‹ž, 99.01.10”­s.

20. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj l‚Ì‚©‚炾‚Æ•a‹C‚ÌŽ–“T; l‘Ì‚ð–hŒä‚·‚é‚à‚Ì, ‚©‚炾‚ð“®‚©‚·, «‚ÆĶŽY, p.47`64, ÷–ØW•Fi‰ðj. •ÒW ŽR“ທYi“Œ‘åjC•ÒC V¯o”ÅŽÐC“Œ‹žC98.06.15”­s.

21. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ÒWj BCJA‚Ì–{: —¯ŠwŒoŒ±ŽÒ‚ªŒê‚é‰p‘‚ÌŠw–â‚ƶŠˆ; •ÒW ’†‘º‚‰“iɪ‘åjC£ì²‹vi–k—¢‘åjC •—lŽÐ, “Œ‹ž, 98.05.15”­s.

22. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ª’SŽ·•Mj Microscopy Image Analysis and 3D Reconstruction CD-ROM, Vol.1; Exocytosis in living salivary glands, £ì²‹vi‰ðjCOno, M.i‰¡•lŽs‘åj. •ÒW Pawley, J.W., Robinson, J.P.(Purdue Univ.)C Purdue University, USA, 98.12.00”­s.

23. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Three-dimensional dynamics of the Golgi apparatus in mitotic parotid acinar cells as analyzed by computer graphics of cytochemically-marked serial sections. ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: 5th Joint Meeting, The Japan Society of Histochemistry and Cytochemistry and the Histochemical Society i98.07.26j, San Diego, USA, Abstracts, A15, 1998.

24. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Development of the rat conduction system as determined by Leu-7(HNK-1) immunohistochemistry and computer graphics reconstruction. ÂŽR’¼‘Pi‹~–½jC‰Í–쌒C˜aò“OC‹g“cTC—é–ØŒ[‰îi“àjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jCŽR‰È³•½i‰ðj: 6th World Congress on Heart Failure-Mechanisms and Management i98.05.19j, ƒWƒ…ƒl[ƒu, J. Heart Failure, 5(1): 56, 1998.

25. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Serous and mucous granule exocytosis in living salivary glands. £ì²‹vi‰ðj: 76th General Session and Exhibition of the IADR i98.06.26j, ƒj[ƒX, J. Dent. Res., 77: 905, 1998.

26. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Strong inhibitory effect of type ‡X collagen fibrils on bovine aortic endothelial cell growth. Z“c–õOCYamato, M.CMizuno, K.CˆÀ’B‰hŽ¡˜Yi‰ðjCSakurai, Y.COkano, T.C—Ñ—˜•F: 3rd Congress of the Asian-Pacific Organization for Cell Biology i98.08.26j, ‘åã, Cell Struct. Funct., 23(Suppl.): 83, 1998.

27. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j A peptide sequence from the laminin ƒ¿1 chain amino-terminal globular domain required for organ development. –å’J—TˆêCŽR‰È³•½i‰ðjCKuratomi, Y.CNomizu, M.CYamada, Y.iNIHj: Gordon Conference on Basement Membrane i98.06.07`13j, New Hampshire, Abstracts, 1998.

28. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Laminin 5 can promote assembly of the lamina densa in the skin equivalent model. ˆÀ’B‰hŽ¡˜Yi‰ðjCí’·½CAmano, S.CBurgeson, R.E.CNishiyama, T.: Gordon Conference on Basement Membrane i98.06.07j, New Hampshire, Abstracts, p.6, 1998.

29. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Distributional changes of Golgi-related proteins in the disorganized Golgi apparatus of the rat parotid acinar cells. ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: 5th Joint Meeting, The Japan Society of Histochemistry and Cytochemistry and the Histochemical Society i98.07.23j, San Diego, USA, Abstracts, A23, 1998.

30. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Co-localization of laminin-5 and HD1 in the developing submandibular gland duct. –å’J—TˆêCŽR‰È³•½i‰ðj: 3rd Congress of the Asian-Pacific Organization for Cell Biology i98.08.26j, ‘åã, Abstracts, p.126, 1998.

31. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Okadaic acid induces disruption of the Golgi stack in rat parotid acinar cells by the accumulation of ƒÀ-COP-coated vesicles and abnormal transport of a trans-Golgi membrane protein. ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: 100th Anniversary Conference Golgi Complex: State of the Art 100 Years after Camillo Golgi's Discovery i98.09.19j, Pavia, Italy, Abstract Book, p.130, 1998.

32. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Relationship between amylase secretion and fluid secretion in the isolated perfused parotid gland of the rat. ‘ºã­—²i¶—Œ¤jC‹g‘ºŒ[ˆêi–k‘åjC£ì²‹vi‰ðj: Gordon Research Conferences "Salivary Gland & Saliva" i99.02.25j, California, USA.

33. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŽhŒƒ“`“±Œn‚Ì”­¶‚Æ‚»‚Ì‹NŒ¹|ƒ‰ƒbƒg‘ÙŽe³íS‚¨‚æ‚ÑŠïŒ`S‚Å‚ÌŒŸ“¢|. ÂŽR’¼‘Pi‹~–½jC‰Í–쌒C˜aò“Oi“àjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jCŽR‰È³•½i‰ðj: ‘æ34‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï i98.07.22j, “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽ, 14(2): 168, 1998.

34. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹¤Å“_ƒŒ[ƒU[Œ°”÷‹¾‚É‚æ‚é’Pˆêè÷—±‚ÌŠJŒû•ª”å‰ß’ö‚Ì“®“I‰ðÍ|¶—E¶‰»Šw“I‰ðÍ‚Æ‚ÌÚ“_|. £ì²‹vi‰ðjC‹g‘ºŒ[ˆêi–k‘åjC‘ºã­—²i¶—Œ¤j: “ú–{“dŽqŒ°”÷‹¾Šw‰ï‘æ43‰ñƒVƒ“ƒ|ƒWƒEƒ€ i98.10.30j, ç—t, ƒVƒ“ƒ|ƒWƒEƒ€˜_•¶W, p.189`192, 1998.

35. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj •ªŽq‚©‚ç×–E, ‚»‚µ‚Ä‘ŸŠí‚Ö: ƒŠƒAƒ‹ƒ^ƒCƒ€‹¤Å“_ƒŒ[ƒU[Œ°”÷‹¾‚ª‚Ý‚¹‚éƒ~ƒŠ•b‚̶–½Œ»Û. £ì²‹vi‰ðj: ‘æ21‰ñ“ú–{•ªŽq¶•¨Šw‰ïƒoƒCƒIƒeƒNƒmƒƒW[ƒZƒ~ƒi[ i98.12.18j, ‰¡•l, —\eW, p.165, 1998.

36. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒSƒ‹ƒW‘w”‚̕ö‰ó‚É”º‚¤ƒÀ-COP‚Ì•ª•z•Ï“®i‡U). ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: ‘æ103‰ñ“ú–{‰ð–UŠw‰ï‘S‘ŠwpW‰ï i98.04.01j, ‘åã, ‰ð–UŠwŽGŽ, 73(4): 404, 1998.

37. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒŠƒ“Ž_‰»-’EƒŠƒ“Ž_‰»”½‰ž‚ÆŠJŒû•ª”å. £ì²‹vi‰ðj: ‘æ103‰ñ“ú–{‰ð–UŠw‰ï‘S‘ŠwpW‰ï i98.04.01j, ‘åã, ‰ð–UŠwŽGŽ, 73(4): 405, 1998.

38. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«’áŽ_‘f‰º‚É‚¨‚¯‚éƒjƒƒgƒŠŒz“®–¬¬‘Ì‚ÆŒŒŠÇ•Ç‚É•ª•z‚·‚éƒOƒƒ€ƒX×–E|”½‰ž‚͈قȂé. ‹T“c•‡ŽqCŽO‰Y³–¾i‰ðjC—Ñ“c‰Ã˜YiŽY‹Æˆã‘åj: ‘æ103‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i98.04.01j, ‘åã, ‰ð–UŠwŽGŽ, 73(4): 412, 1998.

39. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ä\¬‚µ‚½³í‚¨‚æ‚ѕψÙiƒ¿1-519, Arg¨Cys)‡UŒ^ƒRƒ‰[ƒQƒ“–ÔüˆÛ‚Ì”÷׌`‘Ô. ˆÀ’B‰hŽ¡˜Yi‰ðj: ‘æ103‰ñ“ú–{‰ð–UŠw‰ï‘S‘ŠwpW‰ï i98.04.01j, ‘åã, —\eW, p.129, 1998.

40. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œ´ŽqŠÔ—ÍŒ°”÷‹¾‚Å‘gD‰»Šw‚ðs‚¤ã‚Å‚Ì”–â‘è. Ÿ–”CiŒ`‘ÔŒnjC“¡–{˜aCŽR‰È³•½i‰ðj: ‘æ54‰ñ“ú–{“dŽqŒ°”÷‹¾Šw‰ï i98.05.14j, å‘ä, “dŽqŒ°”÷‹¾, 33(Supp.): 115, 1999.

41. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒZƒ‹ƒgƒŠ×–E‚ÌŽOŽŸŒ³“IŠÏŽ@i‡U) ŒŒ‰t|¸‘ƒŠÖ–å. ’†–{’¼i‰ðj: “ú–{”­¶¶•¨Šw‰ï i98.05.30j, ŒF–{, —vŽ|W, p.182, 1998.

42. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽOŽŸŒ³ƒfƒWƒ^ƒCƒU‚É‚æ‚éäCœœ^‹È‚Ì’è—ʉ»‚ÌŽŽ‚Ý. ÷–ØW•Fi‰ðj: ‘æ52‰ñ“ú–{l—ÞŠw‰ï i98.09.12j, –kŠC“¹.

43. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j MRI‚É‚æ‚鶑̊ç–Ê–jœ•”‚ÌŒ`‘Ô(3). ’r“c•qŽqi‰ðjC’†‘ºŒ³Mi’†‘ºƒNƒŠƒjƒbƒNj: ‘æ52‰ñ“ú–{l—ÞŠw‰ï‘å‰ï i98.09.13j, –kŠC“¹, —\eW, p.37, 1998.

44. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¨‚‚̶‰E·‚ÌŒ¤‹†‚ƃCƒ„ƒŠƒ“ƒO‚ÌŠJ”­‚ɂ‚¢‚Ä. ’r“c•qŽqi‰ðjC’†‘ºŒ³Mi’†‘ºƒNƒŠƒjƒbƒNj: ‘æ3‰ñ“ú–{ŠçŠw‰ï‘å‰ï i98.10.04j, ‘åã, —\eW, p.33, 1998.

45. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‡UŒ^ƒRƒ‰[ƒQƒ“‚R–{½‚点‚ñ—̈æ‚ÌĉÌ. …–ìˆêæC’†—¢_ˆêi“Œ‘åjCˆÀ’B‰hŽ¡˜Yi‰ðjCŸ–”CiŒ`‘ÔŒnjC—Ñ—˜•Fi“Œ‘åj: ‘æ71‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i98.10.15j, –¼ŒÃ‰®, ¶‰»Šw, 70(8): 893, 1998.

46. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘Á‰t‘B‚ÌŠJŒû•ª”å‚Ì“®“I’²ß‹@\: ƒCƒ[ƒWƒ“ƒO‚ƃJƒ‰ƒ€–@‚É‚æ‚é‰ðÍ. £ì²‹vi‰ðjC‹g‘ºŒ[ˆêi–k‘åj: ‘æ40‰ñŽ•‰ÈŠî‘bˆãŠw‰ïŠwp‘å‰ï i98.10.18j, ˆ¤’m, Ž•‰ÈŠî‘bˆãŠw‰ïŽGŽ, 40(•â): 380, 1998.

47. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒAƒ“ƒLƒŠƒ“ƒŠƒs[ƒg‚ðŽ‚ÂV‹Kƒ^ƒ“ƒpƒNŽ¿V-1‚Ì”|—{‹Ø‚É‚¨‚¯‚é”­Œ». ŒÃì—DŽqi“ŒˆãŽ•‘åjC—é–ØL‰piˆã—Éq¶Šw•”jC“¡è_li“ŒˆãŽ•‘åjCˆÀ’B‰hŽ¡˜Yi‰ðjCΓcs’miŽO•H¶–½‰ÈŒ¤jC…àV‰p—mi“ŒˆãŽ•‘åjCŽRš “O iŽO•H¶–½‰ÈŒ¤jC¬—Ñ‚‹`i“ŒˆãŽ•‘åj: ‘æ21‰ñ“ú–{_Œo‰ÈŠwE‘æ41‰ñ“ú–{_Œo‰»Šw‡“¯‘å‰ï i98.10.23j, “Œ‹ž, ´˜^W, p.410, 1998.

48. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Morphology of zygomatic region in the living analyzed by MRI (3). ’r“c•qŽqi‰ðjC’†‘ºŒ³Mi’†‘ºƒNƒŠƒjƒbƒNj: Anthropological Sience, 106(2): 158, 1998.

49. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘Á‰t‘B”­¶‰ß’ö‚Å‚Ì“±ŠÇã”çŠî’ꑤזE–Œ‚Ì“ÁŽê‰». –å’J—TˆêCŽR‰È³•½i‰ðj: ‘æ103‰ñ“ú–{‰ð–UŠw‰ï‘S‘ŠwpW‰ï i98.04.01j, ‘åã, ‰ð–UŠwŽGŽ, 73(4): 422, 1998.

50. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒjƒƒgƒŠ‚b×–E‚Ì”|—{‚Æ_Œoƒyƒvƒ`ƒh‚̉ðÍ. ŽO‰Y³–¾C‹T“c•‡Žqi‰ðj: ‘æ104‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i99.03.29j, ŽO‘é, ‰ð–UŠwŽGŽ, 74(1): 72, 1999.

51. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —¼‘¤«‚É, ŠOŒz“®–¬‚ÌŒ`¬•s‘S‚ðŽ¦‚·Œz“®–¬Œn‚Ì”jŠi—á‚ɂ‚¢‚Ä. ‘ºãŒöŽC‹T“c•‡Žqi‰ðj: “ú–{‰ð–UŠw‰ï‘æ86‰ñŠÖ“Œ’n•û‰ï i98.10.17j, “Œ‹ž, ‰ð–UŠwŽGŽ, 74(2): 243, 1999.

52. mŒ¤‹†‰ïi‘Ûjn iƒ[ƒNƒVƒ‡ƒbƒvj Functional morphology of salivary secretion: new insights into granule docking, priming and triggering shown by confocal microscopy, TEM and SEM. £ì²‹vi‰ðjCLoffredo, F.CRiva, A.iUniv. CagliarijC‹g‘ºŒ[ˆêi–k‘åjC‘ºã­—²i¶—Œ¤j: 1st Meeting for International Collaborative Research Project "Coupling Mechanisms of Fluid Secretion and Exocytosis" i99.01.12j, ‰ªè.

53. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ƒRƒ‰[ƒQƒ“×üˆÛ‚ÌŒ`¬‚Æ‚»‚̧Œä. ˆÀ’B‰hŽ¡˜Yi‰ðj: ‘æ49‰ñˆã—p‚•ªŽqŒ¤‹†‰ï i98.12.16j, “Œ‹ž, —\eW, p.1`4, 1998.

54. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ž©—¥_Œo|Œn“”­¶‚©‚çlH•›t‘Ž¿‚Ü‚Å|. ˆÀ’B‰hŽ¡˜Yi‰ðj: ‘æ‚V‰ñŽO–ج•v‹L”OƒVƒ“ƒ|ƒWƒEƒ€ i98.07.17j, “Œ‹ž, —\eW, p.8, 1998.

55. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j PC12×–E‚Ì‹@”\”­Œ»‚É‹y‚Ú‚·‡WŒ^ƒRƒ‰[ƒQƒ“‚Ì–ðŠ„. ˆÀ’B‰hŽ¡˜Yi‰ðjC‘vŽž‰hCŽRš “OiŽO•H‰»Šw¶–½jCŽR–{•q•¶i‰¡•lŽs‘åjCL£ŽuOC’†—¢_ˆêC—Ñ—˜•Fi“Œ‘åj: ‘æ45‰ñƒ}ƒgƒŠƒbƒNƒXŒ¤‹†‰ï i98.04.30j, H“c, ‘å‰ï´˜^W, p.53`54, 1998.

56. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠíŠ¯Œ`¬‚ÉŠÖ‚í‚郉ƒ~ƒjƒ“‚P—R—ˆ‚̃yƒvƒ`ƒh. –å’J—Tˆêi‰ðjC–ì…Šî‹`C‘q•x—Eˆê˜YCŽR“c‹g•FiNIHjCŽR‰È³•½i‰ðj: ‘æ45‰ñƒ}ƒgƒŠƒbƒNƒXŒ¤‹†‰ï‘å‰ï i98.05.01j, H“c, ´˜^W, p.61`62, 1998.

57. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ˆâ“`«˜ËŽòÇ/bó‘B‹@”\’ቺǃ‰ƒbƒgrdw‚ÌŠ{‰º‘B×–E‚ÌŒ`‘ÔE•ªŽqˆÙí. £ì²‹vCŽðˆäNOCŽR‰È³•½i‰ðjC‘åγ“¹C‘O“c’‰Œvi—Šw•”jC¼–Šr”ViRIŒnjCŒÃŠÚêˆêiŽÀ“®j: ‘æ12‰ñ‘Á‰t‘B’k˜b‰ï i98.10.18j, ˆ¤’m.

58. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j SPM‚É‚æ‚éÔŒŒ‹…–Œ‚Ì\‘¢‰ðÍ. Ÿ–”CiŒ`‘ÔŒnjCŽR‰È³•½i‰ðj: “ú–{“dŽqŒ°”÷‹¾Šw‰ï¢¶•¨ŽŽ—¿‰ðÍ‚Ì‚½‚ß‚Ì‘–¸ƒvƒ[ƒuŒ°”÷‹¾–@Œ¤‹†•”‰ï£ i98.12.06j, VŠƒ.


<<02 ¶—Šw>>

59. mŒ´’˜n Substance P- and calcitonin gene-related peptide-containing nerve fibers in the nasal mucosa of chronically hypoxic rats. ¼“cGŽ÷C“ú‰º•”’CŽOi‰¡•lŽs‘åjC—Ñ“c‰Ã˜NiŽY‹Æˆã‘åjCŒÃ쎠i‰¡•lŽs‘åjCìã—Ïi¶—jC’|’†•q•¶C’ÏŽçi‰¡•lŽs‘åj: Brain Res. Bull., 45(6): 563`569, 1998.

60. mŒ´’˜n Changes in the distribution of nitric oxide synthase immunoreactive nerve fibers in the chronically hypoxic rat carotid body. “ú‰º•”’CŽOC¼“cGŽ÷i‰¡•lŽs‘åjCŒ´“c—SŽ¡C—Ñ“c‰Ã˜NiŽY‹Æˆã‘åjCŒÜ–ì—R‰À—i“àjCìã—Ïi¶—jC’|’†•q•¶i‰¡•lŽs‘åj: Brain Res., 795(1-2): 292`296, 1998.

61. mŒ´’˜n Hypoxic adaptation of the peptidergic innervation in the rat carotid body. “ú‰º•”’CŽOi‰¡•lŽs‘åjC—Ñ“c‰Ã˜NiŽY‹Æˆã‘åjC¼“cGŽ÷i‰¡•lŽs‘åjCŒÜ–ì—R‰À—i“àjCPowell F.L.CEllisman M.H.iUCSAjCìã—Ïi¶—jC’|’†•q•¶i‰¡•lŽs‘åj: Brain Res., 806(2): 165`174, 1998.

62. mŒ´’˜n Transient appearance of substance P-like immunoreactivity in the granular convoluted tubules of the male mouse submandibular gland; light - and electron - microscopic studies. “ú‰º•”’CŽOC¼“cGŽ÷i‰¡•lŽs‘åjCŒÜ–ì—R‰À—i“àjCŒIŒ´Ž—Ri–@ˆãjCìã—Ïi¶—jC’|’†•q•¶i‰¡•lŽs‘åj: Cell Tissue Res., 292(1): 177`180, 1998.

63. mŒ´’˜n Distribution of VIP receptors in the human submandibular gland: an immunohistochemical study. “ú‰º•”’CŽOC¼“cGŽ÷i‰¡•lŽs‘åjCŒÜ–ì—R‰À—i“àjCìã—Ïi¶—jCŒIŒ´Ž—Ri–@ˆãjC’ÏŽçC’|’†•q•¶i‰¡•lŽs‘åj: Histol. Histopathol., 13(2): 373`378, 1998.

64. mŒ´’˜n Immunohistochemical localization of regulatory neuropeptides in human circum vallate papillae. “ú‰º•”’CŽOC¼“cGŽ÷i‰¡•lŽs‘åjCŒÜ–ì—R‰À—i“àjCŒÃ쎠i‰¡•lŽs‘åjC”ä—¯ŠÔO”üCìã—Ïi¶—jC’ÏŽçC’|’†•q•¶i‰¡•lŽs‘åj: J. Anat., 192: 557`564, 1998.

65. mŒ´’˜n Simple fluctuation of Ca2+ elicits the complex circadian dynamics of cyclic AMP and cyclic GMP in Paramecium. ’·’J쌚Ž¡i‰@ˆã—ÃŒn¥¶—jC‹e’n_li“úˆã‘åjCÎè–ζi“Œ–k‘åjCTamura, A.i…ŽYŠw•”jC’ËŒ´•Û‘åi“Œ–k‘åjCNakaoka Y.iã‘åjCŠâˆä‰hˆêC²“¡“oŽu˜Yi‰@ˆã—ÃŒnj: J. Cell Sci., 112(2): 201`207, 1999.

66. mŒ´’˜n Principles of Electron Spectroscopic Imaging (ESI) in Hard Tissue Biology. “ñdì–LC–î–ì”üÉCã–쳎÷COno, M.CKozuka, Y.C–îŒû»iˆã—Éq¶jC²“¡—º•½i¶—jCSuzuki, Y.iƒTƒ“ƒXƒ^[jCTakagi, T.i“ŒˆãŽ•‘åjCNagai, N.i‰ª‘åjC–iÞ—¿‰»ŠwŒ¤jCŠÖ’J‰Á’qŽqi–òŠw•”j: J. Hard Tissue Biol., 7(1): 1`10, 1998.

67. mŒ´’˜n Extracellular potassium rapidly inhibits axonal transport of particles in cultured mouse dorsal root ganglion neurites. ”ä—¯ŠÔO”üi¶—jC¼“c‘•ci¶•¨•¨—ŒnjC•Ð‘q—²i¶—jC“ú‰º•”’CŽOC’|’†•q•¶i‰¡•lŽs‘åjCìã—Ïi¶—j: J. Neurobiol., 38: 225`233, 1999.

68. mŒ´’˜n Renal compensation for body water loss during dehydration in neonatal rats. ˆÀ¼®•FC‰ÍŒ´Ž‰ëi¶—j: Jpn. J. Physiol., 48(3): 181`187, 1998.

69. mŒ´’˜n ”A‘f—A‘—‘Ì. ò“c‚¢‚Ô‚«i“àjC‰ÍŒ´Ž‰ëi¶—j: t‚Æ“§Í, 45(—Õ‘): 257`260, 1998.

70. mŒ´’˜n ”ñ‘I‘ð«—zƒCƒIƒ“ƒ`ƒƒƒlƒ‹. ‰ÍŒ´Ž‰ëi¶—j: t‚Æ“§Í, 45(—Õ‘): 270`274, 1998.

71. m€Œ´’˜n Molecular Machineries of the Neonatal Rat Kidney against Osmotic Stress. ‰ÍŒ´Ž‰ëCˆÀ¼®•Fi¶—jCò“c‚¢‚Ô‚«i“àj: Elsevier Science B.V., p.151`158, 1998.

72. m€Œ´’˜n Renal Compensation for Body Water Loss during Dehydration in Neonatal Rats. ˆÀ¼®•FC‰ÍŒ´Ž‰ëi¶—j: Nagano Symposium on Sports Scinces, p.392`396, 1998.

73. mŒ¤‹†•ñiŒú¶Èjn “`’B•¨Ž¿‚É‚æ‚鎲õ—A‘—‚Ì’²ß‹@\. ìã—ÏC”ä—¯ŠÔO”üi¶—j: ‹ØˆÞk«‘¤õd‰»Ç‚̬ˆö‚Æ•a‘Ô‚ÉŠÖ‚·‚錤‹†”Ç•½¬10”N“xŒ¤‹†•ñ‘, p.23, 1999.

74. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ƒGƒ“ƒgƒƒs[’~Ï’x‰„‹@\‚ÆŽ©ŒÈ‘gD‰»‚É‚æ‚鶑̂̎žŠÔ’˜”­Œ»‹@\. ’·’J쌚Ž¡i¶—j: ‰ªè‘—§‹¤“¯Œ¤‹†‹@\Šî‘b¶•¨ŠwŒ¤‹†Š‹¤“¯Œ¤‹†•ñ‘, 6: 103, 1998.

75. m‘àn Ž²õ—A‘—‚Ì‘ª’è. ”ä—¯ŠÔO”üC•Ð‘q—²Cìã—Ïi¶—j: Brain and Nerve, 50(8): 703`710, 1998.

76. m‘àn Axoplasmic transport and its signal transduction mechanism. ’|’†•q•¶i‰¡•lŽs‘åjCìã—Ïi¶—jC–x‰p–¾C‹´–{—eŽqi‰¡•lŽs‘åjC”ä—¯ŠÔO”üi¶—jC“ú‰º•”’CŽOi‰¡•lŽs‘åj: Jpn. J. Physiol., 48(6): 413`420, 1998.

77. m‘àn ”A‘f. ‰ÍŒ´Ž‰ëi¶—jCò“c‚¢‚Ô‚«i“àj: t‘Ÿ, 21(1): 2`6, 1998.

78. m‘àn Ž²õ—A‘—‚Ì‘ª’è–@. ”ä—¯ŠÔO”üC•Ð‘q—²Cìã—Ïi¶—j: ”]‚̉Ȋw, 20(9): 1017`1021, 1998.

79. muÀn ‚¨‘Š–oƒ‰ƒŠƒeƒB. ‰ÍŒ´Ž‰ëi¶—j: t‘Ÿ, 20(4): 218`218, 1998.

80. muÀn Š©i’ . ‰ÍŒ´Ž‰ëi¶—j: t‘Ÿ, 21(1): 61`61, 1998.

81. mŠwp‘n i•ª’SŽ·•Mj ŒõƒVƒOƒiƒ‹ƒgƒ‰ƒ“ƒXƒ_ƒNƒVƒ‡ƒ“; ƒ]ƒEƒŠƒ€ƒV‚ÌŒõ‰ž“š‚Æs“®‚ÌŠT“úƒŠƒYƒ€, p.122`127, ’·’J쌚Ž¡i¶—jCÎè–ζC’ËŒ´•Û•vi“Œ–k‘åj. •ÒW ˜@À‹ÂŽki‰¡•lŽs‘åjC–Ø‘º¬“¹i“s˜Vl‘‡Œ¤jC“¿‰iŽj¶iã‘åjC•ÒC ƒVƒ…ƒvƒŠƒ“ƒK[¥ƒtƒFƒAƒ‰[ƒN, “Œ‹ž, 99.04.02”­s.

82. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Urea inhibits hypertonicity-induced expression of urea transporter (UT1)mRNA in cultured rat kidney IMCD cells. ò“c‚¢‚Ô‚«i“àjCˆÀ¼®•Fi¶—jC¬‹v•Û–ƒŽqCXŒû¹•FC¬—Ñ–Li“àjC‰ÍŒ´Ž‰ëi¶—j: ‘æ31‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i98.10.25`28j, Philadelphia, J. Am. Soc. Nephrol., 9: 20, 1998.

83. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Expression of neurotrophins and their receptors in alve olar macrophages (AM) and the lung. HŽRŽuDi“àjC‰±ì’¼ŽiC“ú‰º•”’CŽOi‰¡•lŽs‘åjCìã—Ïi¶—jC¬—ÑO—Si“àjC’|’†•q•¶i‘ŽmŠÚ‘åjC•x“c—FKi“àj: ALA/ATS Int. Conference i98.04.00j, Chicago, USA.

84. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Changes in the distribution of neuropeptid-containing nerve fibers in the chronically hypoxic rat carotid body. “ú‰º•”’CŽOi‰¡•lŽs‘åjC—Ñ“c‰Ã˜NiŽY‹Æˆã‘åjCŒÜ–ì—R‰À—i“àjC¼“cGŽ÷C”ö–ì M.i‰¡•lŽs‘åjCPowell, F.L.CEllisman, M.HiUCSAjCìã—Ïi¶—jC’|’†•q•¶i‘ŽmŠÚ‘åj: 5th Joint Meeting of Histochemistry and Cytochemistryi‘æ5‰ñ“ú•Ä‡“¯‘gD×–E‰»Šw‰ï‹cj i98.07.23`26j, San Diego.

85. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The effect of vasopression (AVP) and hypertonicty on mRNA expression of a basolateral Na/K/2Cl isoform (rNKCC1) in cultured rat kidney IMCD cells. ˆÀ¼®•Fi¶—jCò“c‚¢‚Ô‚«C¬‹v•Û–ƒŽqi“àjC‰ÍŒ´Ž‰ëi¶—j: ‘æ31‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i98.10.25`28j, Philadelphia, J. Am. Soc. Nephrol., 9: 30, 1998.

86. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Extracellular potassium inhibits axonal transport in cultured mouse dorsal root ganglion cells. ”ä—¯ŠÔO”üC•Ð‘q—²i¶—jC¼“c‘•ci¶•¨•¨—ŒnjC“ú‰º•”’CŽOC’|’†•q•¶i‰¡•lŽs‘åjCìã—Ïi¶—j: 28th Annual Meeting, Society for Neuroscience i98.11.12j, ƒƒXƒAƒ“ƒWƒFƒ‹ƒX, Abstracts, 24(2): 2014, 1998.

87. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Cellular and subcellular localization of ATP sensitive potassium channel subunit (Kir6.1) in rat brain. Zhou, M.i“ŒŠC‘åjCˆÀ¼®•Fi¶—jCTanaka, O.CSekiguchi, M.i“ŒŠC‘åjCò“c‚¢‚Ô‚«i“àjCInoue, T.i“ŒŠC‘åjC‰ÍŒ´Ž‰ëi¶—j: 3rd Conference on ABC Proteins and Ion Channels-From Geneto Disease i99.03.12`13j, ‹ž“s, ƒvƒƒOƒ‰ƒ€, p.5, 1999.

88. mŠw‰ïi‘S‘jn i“Á•Êu‰‰j Ž²õ—A‘—‚Ì’²ß‹@˜. ìã—Ïi¶—j: ‘æ9‰ñ“ú–{––½_ŒoŒ¤‹†‰ïŠwpW‰ï i98.08.22j, “Œ‹ž.

89. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’Pƒ‚©‚ç•¡ŽG‚Ö‚ÌŽžŠÔ‚Ì–î. ’·’J쌚Ž¡i¶—j: ‘æ20‰ñ“ú–{‘n‘¢Šw‰ï i98.10.31j, ‘Š–ÍŒ´, ˜_•¶W, p.12, 1998.

90. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j t‘Ž¿W‡ŠÇ‚Ì–Œ—A‘—‘Ì‚Ì‚Z“§ˆ³‰º‚É‚¨‚¯‚é”­Œ»’²ßCaƒVƒOƒiƒ‹. ‰ÍŒ´Ž‰ëCˆÀ¼®•Fi¶—jCò“c‚¢‚Ô‚«CXŒû¹•Fi“àj: ‘æ20‰ñ¶‘Ì–Œ‚Æ–ò•¨‚Ì‘ŠŒÝì—pƒVƒ“ƒ|ƒWƒEƒ€ i98.11.18`19j, •xŽR, u‰‰—vŽ|W, p.139`142, 1998.

91. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝ”S–Œ‚É‚¨‚¯‚éƒyƒvƒ`ƒh«_ŒoüˆÛ‚Ì’è—Ê“IŒŸ“¢. ŒÜ–ì—R‰À—i“àjC“ú‰º•”’CŽOC¼“cGŽ÷i‰¡•lŽs‘åjCìã—Ïi¶—jCâˆä•¶•Fi“àjC’|’†•q•¶i‘ŽmŠÚ‘åj: ‘æ103‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i98.04.01j, ‘åã, ‰ð–UŠwŽGŽ, 73: 424, 1998.

92. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’Pƒ‚ÈCa2+U“®‚ªD‚è‚È‚·×–E“àŠT“úŽž‹óƒ_ƒCƒiƒ~ƒNƒX. ’·’J쌚Ž¡i¶—jC‹e’n_li“úˆã‘åjCÎè–ζi“Œ–k‘åjCŠâˆä‰hˆêi‰@ˆã—ÃŒnj: ‘æ21‰ñ“ú–{_Œo‰ÈŠw‘æ41‰ñ“ú–{_Œo‰»Šw‡“¯‘å‰ï i98.09.23j, “Œ‹ž, ´˜^W, p.397, 1998.

93. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒj—‘‚É‚¨‚¯‚é•\‘wƒAƒNƒ`ƒ“\‘¢‚ÌŒ`¬‰ß’ö‚̉ðÍ. ²“¡ßŽqi“ŒH‘åjC²“¡—º•½i¶—jC•lŒûK‹vi“ŒH‘åj: ‘æ7‰ñ“ú–{ƒoƒCƒIƒCƒ[ƒWƒ“ƒOŠw‰ï i98.10.20j, •l¼, ƒoƒCƒIƒCƒ[ƒWƒ“ƒO, 7(3): 91, 1998.

94. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠT“úƒŠƒYƒ€‚̉·“x•âž«‚É‚¨‚¯‚éATP‹y‚Ñ×–E“àî•ñ“`’B‚Ì–ðŠ„. Îè–ζi“Œ–k‘åjC’·’J쌚Ž¡i¶—jC’ËŒ´•Û•vi“Œ–k‘åjCŠâˆä‰hˆêi‘åŠw‰@j: “ú–{ŽžŠÔ¶•¨Šw‰ï i98.11.14j, •Ÿ‰ª, ‘æ5‰ñ“ú–{ŽžŠÔ¶•¨Šw‰ï‰ïŽ, 4(2): 111, 1998.

95. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”|—{t‘Ž¿“à‘wW‡ŠÇ×–E‚Å‚Ì”A‘f—A‘—‘Ì(rUT1)ˆâ“`Žq‚Ì”­Œ»’²ß. ò“c‚¢‚Ô‚«i“àjCˆÀ¼®•Fi¶—jCXŒû¹•FC¬‹v•Û–ƒŽqi“àjC‰ÍŒ´Ž‰ëi¶—j: ‘æ76‰ñ“ú–{¶—Šw‰ï i99.03.28`30j, ’·è, —\eW, p.252, 1999.

96. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚Z“§ˆ³‚Å—U“±‚³‚ê‚郉ƒbƒgt‘Ž¿“à‘wW‡ŠÇ‚ÌNa+/H+—A‘—‘Ì. XŒû¹•FCò“c‚¢‚Ô‚«C¬‹v•Û–ƒŽqi“àjCˆÀ¼®•FC‰ÍŒ´Ž‰ëi¶—j: ‘æ76‰ñ“ú–{¶—Šw‰ï i99.03.28`30j, ’·è, —\eW, p.253, 1999.

97. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«’áŽ_‘f‰º‚̃‰ƒbƒgŒz“®–¬¬‘Ì‚É‚¨‚¯‚éƒyƒvƒ`ƒh«_ŒoŽx”z‚̇‰ž. —Ñ“c‰Ã˜NiŽY‹Æˆã‘åjC“ú‰º•”’CŽOi‰¡•lŽs‘åjCŒ´ŒûŒjiŽY‹Æˆã‘åjCìã—Ïi¶—jC’|’†•q•¶i‰¡•lŽs‘åj: ‘æ76‰ñ“ú–{¶—Šw‰ï‘å‰ï i99.03.29j, ’·è, —\eW, p.351, 1999.

98. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Hypertonicity-induced expression of a basolateral Na+-K+-2Cl-cotransporter (rBSC2) mRNA in rat kidney inner medullary collecting duct (IMCD) cells. ŽáV‰pŽjiˆãŠw•”Šw¶jCˆÀ¼®•Fi¶—jCò“c‚¢‚Ô‚«C¬‹v•Û–ƒŽqi“àjC‰ÍŒ´Ž‰ëi¶—j: ‘æ75‰ñ“ú–{¶—Šw‰ï i98.03.27`29j, ‹à‘ò, Jpn. J. Physiol., 48(Suppl.): 87, 1998.

99. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Differential time-dependent changes of urea cotransporter (rUT1) mRNA in cultred rat kidney inner medullary collecting duct (IMCD) cells incubated in hypertonic medium. ò“c‚¢‚Ô‚«i“àjCˆÀ¼®•Fi¶—jC¬‹v•Û–ƒŽqi“àjC‰ÍŒ´Ž‰ëi¶—j: ‘æ75‰ñ“ú–{¶—Šw‰ï i98.03.27`29j, ‹à‘ò, Jpn. J. Physiol., 48(Suppl.): 87, 1998.

100. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Expression of basolateral Na+-K+-2Cl-cotransporter in the rat kidney during dehydration. ˆÀ¼®•Fi¶—jCò“c‚¢‚Ô‚«C¬‹v•Û–ƒŽqi“àjC‰ÍŒ´Ž‰ëi¶—j: ‘æ75‰ñ“ú–{¶—Šw‰ï i98.03.27`29j, ‹à‘ò, Jpn. J. Physiol., 48(Suppl.): 87, 1998.

101. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Auditory structures in the budgerigar (Melopsittacus undulatus). ²“¡—º•½i¶—jC“¡Œ´GŽqi“ú–{—Žq‘åjCŽRèŽÌ•viŠò•Œ‘åj: ‘æ75‰ñ“ú–{¶—Šw‰ï i98.03.28j, ‹à‘ò, Jpn. J. Physiol., 48(Suppl.): 141, 1998.

102. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒg—LŠs“û“ª‚É‚¨‚¯‚éƒyƒvƒ`ƒh«_ŒoüˆÛ‚Ì•ª•z. ìã—Ïi¶—jC¼“cGŽ÷i‰¡•lŽs‘åjCŒÜ–ì—R‰À—i“àjC“ú‰º•”’CŽOi‰¡•lŽs‘åjC’|’†•q•¶i‘ŽmŠÚ‘åj: ‘æ103‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i98.04.01j, ‘åã, ‰ð–UŠwŽGŽ, 73: 422, 1998.

103. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒgŠ{‰º‘B‚É‚¨‚¯‚éVIPƒŠƒZƒvƒ^[‚Ì•ª•z. “ú‰º•”’CŽOi‰¡•lŽs‘åjCŒÜ–ì—R‰À—i“àjC¼“cGŽ÷i‰¡•lŽs‘åjCìã—Ïi¶—jC’|’†•q•¶i‘ŽmŠÚ‘åj: ‘æ103‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i98.04.01j, ‘åã, ‰ð–UŠwŽGŽ, 73: 423, 1998.

104. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –«’áŽ_‘f󋵉º‚̃‰ƒbƒg•@”S–Œ‚É‚¨‚¯‚éƒyƒvƒ`ƒh«_ŒoŽx”z. ¼“cGŽ÷C“ú‰º•”’CŽOi‰¡•lŽs‘åjC—Ñ“c‰Ã˜NiŽY‹Æˆã‘åjCìã—Ïi¶—jC’|’†•q•¶i‘ŽmŠÚ‘åj: ‘æ103‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i98.04.01j, ‘åã, ‰ð–UŠwŽGŽ, 73: 425, 1998.

105. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j V¶Ž™Šúƒ‰ƒbƒgt‚É‚¨‚¯‚é”A‘f—A‘—‘ÌiUT1, UT2, UT3) mRNA‚Ì”­Œ»‚Ì”­’B‹y‚Ñ’E…ŽhŒƒ‚Ö‚Ì”½‰ž. ò“c‚¢‚Ô‚«i“àjCˆÀ¼®•Fi¶—jC¬‹v•Û–ƒŽqC¬—Ñ–Li“àjC–‹`’‰iˆã—Éq¶jC‰ÍŒ´Ž‰ëi¶—j: ‘æ41‰ñ“ú–{t‘ŸŠw‰ïŠwp‘å‰ï i98.05.11`12j, “Œ‹ž, Jpn. J. Nephrol., 40: 211, 1998.

106. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j t”玿W‡ŠÇ(CCD)‚É‚¨‚¯‚éATPŠ´Žó«K+ƒ`ƒƒƒlƒ‹ƒTƒuƒ†ƒjƒbƒg(Kir6.1)‚̃~ƒlƒ‰ƒ‹ƒRƒ‹ƒ`ƒRƒCƒhˆË‘¶«”­Œ». ˆÀ¼®•Fi¶—jCò“c‚¢‚Ô‚«i“àjC¬¼NGi¹˜H‰Á•a‰@jC¬‹v•Û–ƒŽqC¬—Ñ–Li“àjC–‹`’‰iˆã—Éq¶jC‰ÍŒ´Ž‰ëi¶—j: ‘æ41‰ñ“ú–{t‘ŸŠw‰ï i98.05.11`12j, “Œ‹ž, Jpn. J. Nephrology, 40: 209, 1998.

107. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒZƒLƒZƒCƒCƒ“ƒR(Melopsittacus undulatus)‚Ì’®ŠoŠÖ˜A”]_ŒoŠji‡Uj: ZENKƒ^ƒ“ƒpƒNŽ¿‚̖Ɖu‘gD‰»Šw‚Æ2-deoxyglucose‚É‚æ‚é’Tõ. ²“¡—º•½i¶—jCŽO“‡Ø•äŽqC“¡Œ´GŽqi“ú—‘åjCŽRèŽÌ•viŠò•Œ‘åj: ‘æ9‰ñ“ú–{”äŠr¶—¶‰»Šw‰ï i98.07.11j, ç—t, Jpn. Comp. Physiol. Biol., “ú–{”äŠr¶—¶‰»Šw‰ï‘æ9‰ñ‘å‰ï—\eW, p.50, 1998.

108. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Prostaglandin E2‚ÌCAMP/protein kinase AƒJƒXƒP[ƒh‚ð‰î‚·‚鎲õ—A‘—Cüì—p. ”ä—¯ŠÔO”üC•Ð‘q—²i¶—jC¼“c‘•ci¶•¨•¨—ŒnjC“ú‰º•”’CŽOi‰¡•lŽs‘åjCŠÛŽRGi–ƒjC’|’†•q•¶i‘ŽmŠÚ‘åjCŠO{”ü•vi–ƒjCìã—Ïi¶—j: ‘æ21‰ñ“ú–{_Œo‰ÈŠw‘æ41‰ñ“ú–{_Œo‰»Šw‡“¯‘å‰ï i98.09.23j, “Œ‹ž, ´˜^W, p.372, 1998.

109. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒgŠî’ꑤŒ^Na/K/2Cl‹¤—A‘—‘Ì(rNKCC1)‚Ì’P—£‚Æt‘Ž¿“à‘wW‡ŠÇ×–E‚Å‚Ì‚‰t•‰‰×Œã‚̈â“`Žq”­Œ»—U“±. ˆÀ¼®•Fi¶—jCò“c‚¢‚Ô‚«i“àjC‰ÍŒ´Ž‰ëi¶—j: ‘æ21‰ñ“ú–{•ªŽq¶•¨Šw‰ï i98.12.16`19j, ‰¡•l, u‰‰—vŽ|W, p.117, 1998.

110. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Š´Šo_Œo‚ÌŽ²õ—A‘—‚ɑ΂·‚é×–EŠOATP‚Ì‘£i«Cü. âŠÔ—æŽqC”ä—¯ŠÔO”üC•Ð‘q—²i¶—jC¼“c‘•ci¶•¨•¨—ŒnjC“‡“cƒˆêiˆã—Éq¶jC’|’†•q•¶i‘ŽmŠÚ‘åjCìã—Ïi¶—j: ‘æ76‰ñ“ú–{¶—Šw‰ï‘å‰ï i99.03.28j, ’·è, —\eW, p.125, 1999.

111. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Š´Šoƒjƒ…[ƒƒ“‚É‚¨‚¯‚éƒyƒ“ƒgƒoƒ‹ƒrƒ^[ƒ‹‚ÌŽ²õ—A‘——}§ì—p. ŠÛŽRGi–ƒjC”ä—¯ŠÔO”üC•Ð‘q—²i¶—jC¼“c‘•ci¶•¨•¨—ŒnjCŠO{”ü•vi–ƒjCìã—Ïi¶—j: ‘æ76‰ñ“ú–{¶—Šw‰ï‘å‰ï i99.03.28j, ’·è, —\eW, p.125, 1999.

112. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚’£‰t•‰‰×Œã‚Ì•ª”åŒ^Na/K/2Cl‹¤—A‘—‘Ì(rNKCC1)”­Œ»—Ê‚ÌŒoŽž“I•Ï‰». ˆÀ¼®•Fi¶—jCò“c‚¢‚Ô‚«CXŒû¹•FC¬‹v•Û–ƒŽqi“àjC‰ÍŒ´Ž‰ëi¶—j: ‘æ76‰ñ“ú–{¶—Šw‰ï i99.03.28`30j, ’·è, —\eW, p.278, 1999.

113. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ}ƒEƒXŠ{‰º‘Bè÷—±«–c‘å•”‚É‚¨‚¯‚éƒTƒuƒXƒ^ƒ“ƒX‚o‚Ì‹ÇÝ. ¼“cGŽ÷C“ú‰º•”’CŽOi‰¡•lŽs‘åjCŒÜ–ì—R‰À—i“àjCìã—Ïi¶—jC’|’†•q•¶i‘ŽmŠÚ‘åj: ‘æ104‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i99.03.29`31j, “Œ‹ž, ‰ð–UŠwŽGŽ, 74: 117, 1999.

114. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –«’áŽ_‘f󋵉º‚̃‰ƒbƒgA“ª‚É‚¨‚¯‚éƒyƒvƒ`ƒh«_ŒoŽx”z. ‹g“c‚ŽjC¼“cGŽ÷C“ú‰º•”’CŽOi‰¡•lŽs‘åjCŒÜ–ì—R‰À—i“àjC—Ñ“c‰Ã˜NiŽY‹Æˆã‘åjCìã—Ïi¶—jC’|’†•q•¶i‘ŽmŠÚ‘åj: ‘æ104‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i99.03.29`31j, “Œ‹ž, ‰ð–UŠwŽGŽ, 74: 139, 1999.

115. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒgŒz“®–¬¬‘Ì‚É‚¨‚¯‚éƒyƒvƒ`ƒh«_ŒoŽx”z‚Ì–«’áŽ_‘f󋵂ւ̓K‰ž. “ú‰º•”’CŽOi‰¡•lŽs‘åjC—Ñ“c‰Ã˜NiŽY‹Æˆã‘åjC¼“cGŽ÷i‰¡•lŽs‘åjCìã—Ïi¶—jC’|’†•q•¶i‘ŽmŠÚ‘åj: ‘æ104‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i99.03.29`31j, “Œ‹ž, ‰ð–UŠwŽGŽ, 74: 139, 1999.

116. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –«’áŽ_‘f󋵉º‚̃‰ƒbƒgŒz“®–¬¬‘Ì‚É‚¨‚¯‚éNOS–Ɖu—z«üˆÛ‚Ì•ª•z. ŒÜ–ì—R‰À—i“àjC“ú‰º•”’CŽOi‰¡•lŽs‘åjC—Ñ“c‰Ã˜NiŽY‹Æˆã‘åjC¼“cGŽ÷i‰¡•lŽs‘åjCìã—Ïi¶—jC’|’†•q•¶i‘ŽmŠÚ‘åj: ‘æ104‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i99.03.29`31j, “Œ‹ž, ‰ð–UŠwŽGŽ, 74: 139, 1999.

117. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒOƒ‹ƒJƒSƒ“‚ÌŽ²õ“à—A‘—‚ɑ΂·‚éŒø‰Ê. “©—zC–x‰p–¾i‰¡•lŽs‘åjCìã—Ïi¶—jC‰Á”Z³lC‹´–{—eŽqC’|’†•q•¶CÎì‹`Oi‰¡•lŽs‘åj: ‘æ76‰ñ“ú–{¶—Šw‰ï‘å‰ï i99.03.29j, ’·è, —\eW, p.265, 1999.

118. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž²õ—A‘—‚ɑ΂·‚éprogesterone‚Ì‘¬‚â‚©‚È—}§ì—p. ”ä—¯ŠÔO”üC•Ð‘q—²i¶—jC¼“c‘•ci¶•¨•¨—ŒnjC”~’ÃŒ’‘¾˜Yi¶—jC“‡“cƒˆêiˆã—Éq¶jC’|’†•q•¶i‘ŽmŠÚ‘åjCìã—Ïi¶—j: ‘æ76‰ñ“ú–{¶—Šw‰ï‘å‰ï i99.03.29j, ’·è, —\eW, p.267, 1999.

119. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÝ“à•ª”å×–E‚É‚¨‚¯‚éŠJŒû•úo‚Ì’²ß‹@˜i‡Uj. •Ð‘q—²C”ä—¯ŠÔO”üCìã—Ïi¶—j: ‘æ76‰ñ“ú–{¶—Šw‰ï‘å‰ï i99.03.29j, ’·è, —\eW, p.267, 1999.

120. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒgŒz“®–¬¬‘Ì‚É•ª•z‚·‚éNOSŠÜ—LüˆÛ‚Ì–ðŠ„. “ú‰º•”’CŽOi‰¡•lŽs‘åjCŒ´“c—S_CCŒ´ŒûŒjC—Ñ“c‰Ã˜NiŽY‹Æˆã‘åjCìã—Ïi¶—jC’|’†•q•¶i‰¡•lŽs‘åj: ‘æ76‰ñ“ú–{¶—Šw‰ï‘å‰ï i99.03.29j, ’·è, —\eW, p.300, 1999.

121. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –«’áŽ_‘f󋵉º‚̃‰ƒbƒgŒz“®–¬¬‘Ì‚É‚¨‚¯‚éNOS–Ɖu—z«üˆÛ‚Ì•ª•z. ŒÜ–ì—R‰À—i“àjC“ú‰º•”’CŽOi‰¡•lŽs‘åjC—Ñ“c‰Ã˜NiŽY‹Æˆã‘åjC¼“cGŽ÷i‰¡•lŽs‘åjCìã—ÏC’|’†•q•¶i¶—j: ‘æ104‰ñ“ú–{‰ð–UŠw‰ï‘‰ï‘S‘ŠwpW‰ï i99.03.31j, “Œ‹ž, Acta Anat. Nippon, 74(1): 139, 1999.

122. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j V¶Ž™ƒ‰ƒbƒgt”A׊ǂɂ¨‚¯‚éNa+ˆË‘¶«/ƒOƒ‹ƒR[ƒX—A‘—‘Ì‚Ì”­Œ». ¬‹v•Û–ƒŽqi“àjCˆÀ¼®•Fi¶—jCò“c‚¢‚Ô‚«i“àjC–‹`’‰iˆã—Éq¶jC‰ÍŒ´Ž‰ëi¶—j: ‘æ‚V‰ñ”­ˆçtŒ¤‹†‰ï i98.05.13j, “Œ‹ž, ´˜^W, p.14, 1998.

123. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‚Z“§ˆ³‚É‚æ‚è—U“±‚³‚ê‚ét‘Ž¿“à‘wW‡ŠÇ‚Ì–Œ—A‘—‘ÌNKCC1. ˆÀ¼®•Fi¶—jCò“c‚¢‚Ô‚«C¬‹v•Û–ƒŽqi“àjC‰ÍŒ´Ž‰ëi¶—j: ‘æ4‰ñ•ªŽqt‘ŸŒ¤‹†‰ï i98.09.5`6j, ‘åã, ´˜^W, p.4, 1998.

124. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‚Z“§ˆ³ŠÂ‹«‰º‚É‚¨‚¯‚é”|—{t‘Ž¿“à‘wW‡ŠÇ×–E‚ÌCaƒVƒOƒiƒ‹. XŒû¹•FCò“c‚¢‚Ô‚«i“àjCˆÀ¼®•FC‰ÍŒ´Ž‰ëi¶—j: •½¬10”N“x¶—Œ¤‹†‰ï(×–E‹@”\§Œä‚ƃJƒ‹ƒVƒEƒ€ƒVƒOƒiƒ‹) i98.11.12`13j, “Œ‰ªè, ƒvƒƒOƒ‰ƒ€, p.2, 1998.

125. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝ“à•ª”医ۂ̉Ž‹‰». •Ð‘q—²C”ä—¯ŠÔO”üCìã—Ïi¶—j: ¶—ŠwŒ¤‹†ŠŒ¤‹†‰ïuÁ‰»ŠÇ‹@”\v i98.12.11j, ‰ªè, ƒvƒƒOƒ‰ƒ€.

126. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj ¶‘Ì‚É‚¨‚¯‚é‹É¬ƒGƒ“ƒgƒƒs[¶¬‚ÆŽžŠÔ’˜. ’·’J쌚Ž¡i¶—j: ‘‡Œ¤‹†‘åŠw‰@‘åŠw¥ƒOƒ‹[ƒvŒ¤‹†uV•ª–ì‚ÌŠJ‘ñv|¶‘Ì‚ÌŽžŠÔ’˜”­Œ»‹@\ i99.01.06j.


<<03 ¶‰»Šw>>

127. mŒ´’˜n Purification of NADH-cytochrome B5 reductase from pig testis microsomes by isoelectric focusing. ŒK“c³Li¶‰»jC˜@Œ©‰p¢i¶•¨•¨—‰»jC–qƒiŠñjCŒÃ£—TŽqi¶‰»Œnj: Biochemical Archives, 14: 247`257, 1998.

128. mŒ´’˜n A two-step purification of cytochrome P-450 from pig testis by cholesterol affinity column chromatography. ŒK“c³Li¶‰»jC–qƒiŠñjC˜@Œ©‰p¢i¶•¨•¨—‰»j: Biochemical Archives, 14: 307`317, 1998.

129. mŒ´’˜n Purification of cytochrome P-450 from pig testis microsomes by hydrophobic chromatography and isoelectric focusing. ŒK“c³Li¶‰»jC–qƒiŠñjC˜@Œ©‰p¢i¶•¨•¨—‰»j: Biochemical Archives, 15: 31`43, 1999.

130. mŒ´’˜n Serum and antral gastrin levels in fed and fasted rats; Relation to aging. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC–ì––‰Ê—Ñi϶‰ï’†‰›•a‰@jC‹{‘òŽµ˜YCª–{“TŽqi“dŒ°ƒZƒ“ƒ^[jC–x“c‹±Žqi¶‰»j: Comp. Biochem. Physiol., 121A: 223`228, 1998.

131. mŒ´’˜n Comparison of four monoclonal antibodies reacting with gastric gland mucous cell-derived mucins of rat and frog. ŒIŒ´½iŠÖ“Œ‰»ŠwjCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC‘¾“c_—ÇCŸŽR“wiM‘åjC’†–ì—Ï‘¾iŠÖ“Œ‰»ŠwjC“à“¡³‹KiŠOjC–x“c‹±Žqi¶‰»j: Comp. Biochem. Physiol., 121B: 315`321, 1998.

132. mŒ´’˜n Distinct effects of tetragastrin in rat gastroduodenal mucosa on mucin content and mucosal protective action against histamine-induced injury. ¬Žº—Tˆêi“àjCÎŒ´˜a•Fiˆã—Éq¶jC¬“‡—m“ñC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: Dig. Dis. Sci., 43(5): 1050`1056, 1998.

133. mŒ´’˜n Age-related stimulation by tetragastrin of gastric mucin biosynthesis in rat. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC“ú‰º•”’CŽOi‰¡•lŽs‘åjCìã—Ïi¶—jC–x“c‹±Žqi¶‰»j: Eur. J. Pharmacol., 366: 87`92, 1999.

134. mŒ´’˜n Inhibition of helicobacter pylori sialic acid-specific haemagglutination by human gastrointestinal mucins and milk glycoproteins. Hirmo, S.CKelm, S.CIwersen, M.iUniv. KieljC–x“c‹±ŽqCŒÜäzsMi¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jCSuguri, T.CMorita, M.iáˆó“û‹ÆjCWadstrom, T.CSchauer, R.iUniv. Kielj: FEMS Immunol. Med. Microbiol., 20: 275`281, 1998.

135. mŒ´’˜n Three-dimensional structure of a glycosphingolipid having a novel carbohydrate linkage, GalƒÀ1-4 (Fucƒ¿1-3) GlcƒÀ1-3GalƒÀ, determined by theoretical calculations. ìã~iO‘O‘åjCìã‘×i–ƒ•z‘åjC’†‘º˜a¶C¬“ˆ‹vŽqi¶‰»jCˆÉ“¡³‰piO‘O‘åjC‹Êˆä—mˆêi¶‰»j: Glycoconj. J., 15: 107`113, 1998.

136. mŒ´’˜n New monoclonal antibodies against gastric gland mucous cell-type mucins: A comparative immunohitochemical study. ‘¾“c_—ÇC’†ŽR~C•S£³MiMB‘åjCŒIŒ´½iŠÖ“Œ‰»ŠwjCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC–x“c‹±Žqi¶‰»j: Histochem. Cell Biol., 110: 113`119, 1998.

137. mŒ´’˜n Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to the analysis of glycopeptide-containing multiple O-linked oligosaccharides. Šâ£m—Ei¶‰»jC“c’†“ÖŽuiˆ®‰»¬jC”äŠé”\”ViŠÅŒìŠw•”jC¬‹v•Û“§i“àjCŽPˆèŽqi¶‰»jC‹ÑŒËžŠ“ñiˆ®‰»¬jC¬—Ñ–Li“àjC–x“c‹±Žqi¶‰»j: J. Chromatogr. B, 709: 145`149, 1998.

138. mŒ´’˜n Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion. Šâ£m—Ei¶‰»jC“c’†“ÖŽuiˆ®‰»¬jC”äŠé”\”ViŠÅŒìŠw•”jC¬‹v•Û“§C²–ì—²i“àjCŽPˆèŽqi¶‰»jCŒËŠÀˆêEiˆ®‰»¬jC¬—Ñ–Li“àjC–x“c‹±Žq i¶‰»j: J. Chromatogr. B, 724: 1`7, 1999.

139. mŒ´’˜n Screening and fermentation of endo-ƒ¿-N-acetylgalactosaminidase S, a mucin-hydrolyzing enzyme from streptomyces acting on the galNAc-O-ser(Thr) linkage. “c’†–F•C‚‹´—mŽqC‘呺’qi–kŒ¤jCŽPˆèŽqCŠâ£m—EC–x“c‹±Žqi¶‰»j: J. Ferment. Bioengin., 85(4): 381`387, 1998.

140. mŒ´’˜n Histochemical reactivity of normal, metaplastic, and neoplastic tissues to ƒ¿-linked N-acetylglucosamine residue-specific monoclonal antibody HIK1083. ’†‘º’¼C‘¾“c_—ÇCŸŽR“wCÔ¼‘׎ŸiMB‘åjCÎŒ´˜a•Fiˆã—Éq¶Šw•”jCŒIŒ´½iŠÖ“Œ‰»ŠwjC–x“c‹±Žqi¶‰»j: J. Histochem. Cytochem., 46(7): 793`801, 1998.

141. mŒ´’˜n ‘å’°ƒ€ƒ`ƒ“‚Ì—Ê“I•Ï‰»‚©‚ç‚Ý‚½ƒ‰ƒbƒgŽÀŒ±’×ᇫ‘å’°‰Š‚ÌŒŸ“¢|DSS‘å’°‰Š‚ÆNEM‘å’°‰Š‚Æ‚Ì”äŠrŒŸ“¢|. ’†–ìŽj˜Yi“àjC¬Œ´ii¶‰»jC‹v•Û“c•q•Fi•£–ì•Ó‘‡•a‰@jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: Jpn. J. Gastroenterol., “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95(6): 513`523, 1998.

142. mŒ´’˜n Purification of NADPH-cytochrome P-450 reductase from pig testis microsomes by isoelectric focusing in an immobiline pH gradient. ŒK“c³Li¶‰»jC˜@Œ©‰p¢i¶•¨•¨—‰»jCŒÃ£—TŽqi¶‰»Œnj: Kitasato Med., 28(4): 345`351, 1998.

143. mŒ´’˜n Effects of acid secretagogues or HCl on rat gastric mucins. ‘å씎”Vi“àjC¬Œ´ii¶‰»jC’†–ìŽj˜YC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: Kitasato Med., 28(5): 415`420, 1998.

144. mŒ´’˜n Effects of 2-[(2-dimethylaminobenzyl) sulfinyl] benzimidazole, the proton-pump inhibitor, on rat gastric mucins with HCl-ethanol-induced gastric damage. ’†–ìŽj˜Yi“àjC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: Kitasato Med., 28(5): 428`434, 1998.

145. mŒ´’˜n Effect of roxatidine bismuth citrate (MX1) against acetylsalicylic acid - and indomethacin-induced gastric mucosal damage in rats. Marazova, K.CKlouchek, E.CPopov, A.CIvanov. Ch.CKrushkov, T.iBulgaria Med.jCŽs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC–x“c‹±Žqi¶‰»j: Methods Find. Exp. Clin. Pharmacol., 20(8): 667`672, 1998.

146. mŒ´’˜n Purification of cytochrome b5 from pig testis microsomes by isoelectric focusing in an immobiline pH gradient. ŒK“c³Li¶‰»jC˜@Œ©‰p¢i¶•¨•¨—‰»jCŒÃ£—TŽqi¶‰»Œnj: Protein Expr. Purif., 12: 420`424, 1998.

147. mŒ´’˜n ‰–Ž_ƒƒLƒTƒ`ƒWƒ“ƒAƒZƒ^[ƒg‚̃‰ƒbƒgˆÝ”S‰t•ª”呉Áì—p. ‚‹´LsC—é–ØOKCr–ؽˆêC¬ì‚¿‚³‚ÆC‹{àVŽ•Fi’é‘‘ŸŠíjCŽs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC–x“c‹±Žqi¶‰»j: –ò—‚ÆŽ¡—Ã, 26(10): 1701`1704, 1998.

148. m€Œ´’˜n Anti-GM2 antibodies in Guillain-Barre syndrome with acute cytomegalovirus infection. ’†‘º˜a¶i¶‰»jC“ü]KŽqi“àjC‹à‘ò’¼”üi¶‰»ŒnjCÄ“¡–L˜ai“àjC‹Êˆä—mˆêi¶‰»j: Ann. N.Y. Acad. Sci., 845: 423`424, 1998.

149. m€Œ´’˜n Monoclonal antibody directed to glycosphingolipid SEGLx isolated from spirometra erinaceieuropaei. ¬“ˆ‹vŽqi¶‰»jC–ö‘ò—ºCìã‘×i–ƒ•z‘åjC’†‘ºŒ’‚`iŠñjC’†‘º˜a¶i¶‰»jC“à“c–¾•FC‘º“c‹`•Fi–ƒ•z‘åjC‹Êˆä—mˆêi¶‰»j: ICOPA ‡\ 9th International Congress of Parasitology, p.1149`1152, 1998.

150. m€Œ´’˜n ƒKƒXƒgƒŠƒ“Žó—e‘ÌhRÜL-365,260‚̃‰ƒbƒgˆÝ”S‰t‘ãŽÓ‚ɑ΂·‚é‰e‹¿. ¬Žº—TˆêC¼Œ³Ž›Ž—çi“àjCÎŒ´˜a•Fiˆã—Éq¶jCŽs쑸•¶C–x“c‹±Žqi¶‰»j: Progress in Medicine, 18(8): 2119`2124, 1998.

151. m€Œ´’˜n ’×ᇫ‘å’°‰Š‚ð—p‚¢‚½”t×–E‚ÌŒ¸­‚ƃ€ƒ`ƒ“‚ÉŠÖ‚·‚錟“¢. ’†–ìŽj˜Yi“àjC¬Œ´ii¶‰»jC‹v•Û“c•q•FC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: Therapeutic Research, 19(12): 3885`3887, 1998.

152. m€Œ´’˜n RˆÝƒ€ƒ`ƒ“’PƒNƒ[ƒ“R‘Ì‚ð—p‚¢‚½ƒ‰ƒbƒgˆÝ”S–Œ’†ƒ€ƒ`ƒ“ŠÜ—Ê‘ª’è‚ÌŽŽ‚Ý. ŒIŒ´½iŠÖ“Œ‰»ŠwjCÎŒ´˜a•Fiˆã—Éq¶Šw•”jCŽs쑸•¶CŒÜäzsMC–x“c‹±Žqi¶‰»j: Therapeutic Research, 19(Suppl.1): 67`69, 1998.

153. m€Œ´’˜n N-ƒGƒ`ƒ‹ƒ}ƒŒƒCƒ~ƒh(NEM)—U”­‘å’°‰Š‚É‚¨‚¯‚é‘å’°ƒ€ƒ`ƒ“‚ÌŒŸ“¢|DSS—U”­‘å’°‰Šƒ‚ƒfƒ‹‚Æ‚Ì”äŠr|. ’†–ìŽj˜Yi“àjC¬Œ´ii¶‰»jC‹v•Û“c•q•FC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: Ulcer Research, 25(2): 198`208, 1998.

154. m€Œ´’˜n ˆÝ”S‰tƒQƒ‹‘w‚ð\¬‚·‚郀ƒ`ƒ““œ½‚ÌŒŸ“¢|‘Á‰tƒ€ƒ`ƒ“‚ÌŠÖ—^|. ¬•½‹v³CŽ­Ž™“‡³–LCΈä–M—Yi–òŠwjCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC–x“c‹±Žqi¶‰»j: Ulcer Research, 25(2): 97`101, 1998.

155. m€Œ´’˜n ‰Æ“e‘å’°ƒ€ƒ`ƒ“Ž©ŒÈ–Ɖu‚É‚æ‚é‘å’°”S–ŒŠQ. ¬Œ´ii¶‰»jCŒÜ\—’³LC’†–ìŽj˜YC‹v•Û“c•q•Fi“àjC–x“c‹±Žqi¶‰»j: Á‰»ŠÇ‚ƖƉu, 34: 95`97, 1997.

156. mŒ¤‹†•ñi•¶•”Èjn Endo-GalNAcase-S‚ÌŒø—¦“IŽY¶‚Ì‚½‚ß‚ÌStreptomyces sp. OH-11242‚Ì”|—{ðŒ‚ÌŒŸ“¢. –x“c‹±ŽqCŠâ£m—ECŽPˆèŽqi¶‰»j: •¶•”ȉȊwŒ¤‹†”ï•â•‹àŠî”ÕŒ¤‹†(A)¢ƒGƒ“ƒhŒ^ƒOƒŠƒRƒVƒ_[ƒ[‚Ì“ÁˆÙ“I‚ÈŠˆ«‚ð—˜—p‚µ‚½V‚µ‚¢“œ½HŠw“IŒ¤‹†‚Ì“WŠJ£ ‘æ‚Q‰ñŒöŠJƒVƒ“ƒ|ƒWƒEƒ€u‰‰—vŽ|W, p.7, 1998.

157. mŒ¤‹†•ñiŒú¶Èjn TNF‚̈â“`ŽqŒ‡‘¹ƒ}ƒEƒX‚Ö‚ÌCJDˆöŽqÚŽíŽÀŒ±|TNFƒ¿‚Í“`’B«ŠC–Èó”]Ç‚Ì•K{ˆöŽq‚Å‚Í‚È‚¢. ‹Êˆä—mˆêi¶‰»jCùŒ´•Žui”÷jC¬“ˆ‹vŽqC’†‘º˜a¶i¶‰»jC‘ê—´—YC“cŒû•¶Íiˆã—Éq¶jC‘å’J‹`•vCŽO‰Y’å‘¥i¸j: u’x”­«ƒEƒCƒ‹ƒXŠ´õv’²¸Œ¤‹†”Ç•½¬‚X”N“xŒ¤‹†•ñ‘, p.61`68, 1998.

158. m‘àn ˆÝ”S‰t‚̕ω»‚ƈݔS–Œ•a•Ï. ÎŒ´˜a•Fiˆã—Éq¶Šw•”jCŒÜäzsMi¶‰»j: ˆãŠw‚Ì‚ ‚ä‚Ý, 186(9): 562`566, 1998.

159. mŠwp‘n i‹¤’˜j ˆÝ”S‰t‚Ì–£—Í‚ð’T‚é. –x“c‹±Žqi¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”j. ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 99.02.25”­s.

160. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Gangliosides of lungfish brain. ’†‘º˜a¶i¶‰»jCˆÀ“úÍi”]ŠOjC“à“c–¾•Fi–ƒ•z‘åjC¬“ˆ‹vŽqC‹Êˆä—mˆêi¶‰»j: 12th General Meeting of the European Society for Neurochemistry i10.07.22j, ƒTƒ“ƒNƒgƒyƒeƒ‹ƒuƒ‹ƒO, J. Neurochem., 71(Suppl.): 1998.

161. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Establishment of a monoclonal antibody directed to a glycosphingolipid SEGLx isolated from Spirometra erinaceieuropae. –ö‘ò—ºi–ƒ•z‘åjC¬“ˆ‹vŽqi¶‰»jCìã‘×i–ƒ•z‘åjC’†‘ºŒ’‚`iŠñjC’†‘º˜a¶i¶‰»jC“à“c–¾•FC‘º“c‹`•Fi–ƒ•z‘åjC‹Êˆä—mˆêi¶‰»j: 9th International Congress of Parasitology i10.08.26j, –‹’£, Parasitol. Int., 47(Suppl.): 342, 1998.

162. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Glycosphingolipids in pseudophyllidean tapeworms. “üŽq‰pKC–ö‘ò—ºCìã‘×C“à“c–¾•FC‘º“c‹`•Fi–ƒ•z‘åjC¬“ˆ‹vŽqC’†‘º˜a¶C‹Êˆä—mˆêi¶‰»j: 9th International Congress of Parasitology i10.08.26j, –‹’£, Parasitol. Int., 47(Suppl.): 342, 1998.

163. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Rabbit colonic mucins induced autoantibodies and may cause ulcerative colitis-like mucosal damage. ¬Œ´ii¶‰»jCŒÜ\—’³LC’†–ìŽj˜YC‹v•Û“c•q•Fi“àjC¬ìŽj—mC–x“c‹±Žqi¶‰»j: •Ä‘Á‰»Ší•aŠw‰ï i98.05.16`22j, ƒjƒ…[ƒIƒŠƒ“ƒY, Gastroenterology, 114(4): 1054, 1998.

164. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Measurement of mucin content in human gastric juices and its application to gastroduodenal diseases. ˆÀŠC‹`—jiŽD–y“Œ“¿F‰ï•a‰@jC¼Œ³Ž›Ž—çi“àjCŽs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC–x“c‹±Žqi¶‰»j: 11th World Congress of Gastroenterology i98.09.08j, Vienna, Digestion, 59(Suppl.3): 217, 1998.

165. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effects of ecabet sodium, a novel gastroprotective agent, on mucin biosynthesis in the corpus and antrum of rat stomach. –x“c‹±Žqi¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jCŽs쑸•¶i¶‰»j: 11th World Congress of Gastroenterology i98.09.08j, Vienna, Digestion, 59(Suppl.3): 240, 1998.

166. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Roxatidine-induced stimulation of mucin biosynthesis mediated by nitric oxide is limited to the surface mucus cells of rat gastric oxyntic mucosa. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: 11th World Congress of Gastroenterology i98.09.08j, Vienna, Digestion, 59(Suppl.3): 240, 1998.

167. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Teprenone stimulates the secretion of gastric mucus and accelerates the recovery from aspirin-induced damage in rat gastric mucosa. ÎŒ´˜a•Fiˆã—Éq¶Šw•”jCŽðˆä’C•Fi“àjCŽs쑸•¶i¶‰»jC›’J’ËMŽqi¶‰»ŒnjC–x“c‹±Žqi¶‰»j: 11th World Congress of Gastroenterology i98.09.08j, Vienna, Digestion, 59(Suppl.3): 240, 1998.

168. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Characterization of two individual rat gastric mucin components recognized by monoclonal antibodies RGM21 or HIK1083. ŒÜäzsMi¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jCŒIŒ´½iŠÖ“Œ‰»ŠwjC–x“c‹±Žqi¶‰»j: 11th World Congress of Gastroenterology i98.09.08j, Vienna, Digestion, 59(Suppl.3): 240, 1998.

169. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Aggregated human serum IgA1 induced by sialidase treatment had a lower number of O-linked sugar chains on the hinge portion. Šâ£m—Ei¶‰»jC“c’†~Žuiˆ®‰»¬jC”äŠé”\”ViŠÅŒìŠw•”jC¬‹v•Û“§C²–ì—²i“àjCŽPˆèŽqC‘å‰Í^“ñi¶‰»jCŒËŠÀˆêEiˆ®‰»¬jC¬—Ñ–Li“àjC –x“c‹±Žqi¶‰»j: International Symposium on Sialobiology and Other Novel Forms of Glycosylation (2nd Pan-Pacific Conference) i98.11.12j, ‘ä–k, ‘Û“œŽ¿¶–½‰ÈŠwŒŸ“¢‰ï—vŽ|W, p.2, 1998.

170. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj NGF‚É‚æ‚éPC12×–E_Œo“Ë‹NL’·‚ÉŠÖŒW‚·‚éƒVƒAƒ‹Ž_“]ˆÚy‘f‘jŠQÜ‚Ìì—p‹@\‚ɂ‚¢‚Ä. ¬“ˆ‹vŽqC’†‘º˜a¶i¶‰»jC“à“c–¾•Fi–ƒ•z‘åjCŒÃ£—TŽqi¶‰»ŒnjC‹Êˆä—mˆêi¶‰»j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i10.10.15j, –¼ŒÃ‰®, ¶‰»Šw, 70(8): 716, 1998.

171. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “Á’¥“I‚È“œ½\‘¢‚ð‚à‚“œŽ‰Ž¿spirometoside‚̃}ƒ“ƒ\ƒ“—ô“ªð’ŽSpirometra erinacei‚É‚¨‚¯‚é‹ÇÝ«. “üŽq‰pKC–ö‘ò—ºCìã‘×C“à“c–¾•FC‘º“c‹`•Fi–ƒ•z‘åjC’†‘º˜a¶C¬“ˆ‹vŽqC‹Êˆä—mˆêi¶‰»j: ‘æ40‰ñ“ú–{Ž‰Ž¿¶‰»ŠwŒ¤‹†‰ï¥Œ¤‹†W‰ï i10.07.03j, ‘åã, Ž‰Ž¿¶‰»ŠwŒ¤‹†‰ï, 40: 120`123, 1998.

172. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒsƒŠƒWƒ‹ƒAƒ~ƒm‰»ƒIƒŠƒS“œ‚Ì…—n‰t’†‚É‚¨‚¯‚é—§‘Ì”zÀ‰ðÍ. ŽPˆèŽqCŠâ£m—EC–x“c‹±Žqi¶‰»j: ‘æ47‰ñ“ú–{‰ž—p“œŽ¿‰ÈŠw‰ï i98.10.02j, ŽD–y, ‰ž—p“œŽ¿‰ÈŠw, 45(3): 348, 1998.

173. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒKƒXƒgƒŠƒ“‚̃‰ƒbƒgˆÝ”S‰t‘ãŽÓ‚É‹y‚Ú‚·ì—p‚̉Á—î‚É‚æ‚é•Ï‰». Žs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ40‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i98.10.29j, “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95(‘): 206, 1998.

174. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j DSS‘å’°‰Š‚É‚¨‚¯‚érMuc3‚Ì•Ï“®. ‹v•Û“c•q•Fi“àjC¬Œ´ii¶‰»jC•lèG–¾i¶•¨jC‹Ê–؉p–¾i‰ðjC’†–ìŽj˜YCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: “ú–{ŽÀŒ±’×ᇊw‰ï i98.11.27j, “Œ‹ž, ŽÀŒ±’×á‡, 1998.

175. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j LatimeriaiƒV[ƒ‰ƒJƒ“ƒXj‚̃~ƒGƒŠƒ“PLP/DM20ˆâ“`Žq‚Ì\‘¢. ‰“ŽR—zŽqC‹g“cO”üC¬—Ñ‘fŽqCŒIŒ´³i‘n‰¿‘åjC¬“ˆ‹vŽqC‹Êˆä—mˆêi¶‰»j: ‘æ41‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï i10.09.22j, ‰¡•l, _Œo‰»Šw, 37(3): 418, 1998.

176. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “Á’¥“I‚È“œ½\‘¢‚ð‚à‚“œŽ‰Ž¿spirometosides‚ÌŠeŽíð’Ž‚É‚¨‚¯‚é‹ÇÝ«. “üŽq‰pKC]ŒŽ«ŽjC–ö‘ò—ºCìã‘×C“à“c–¾•FC‘º“c‹`•Fi–ƒ•z‘åjC’†‘º˜a¶C¬“ˆ‹vŽqC‹Êˆä—mˆêi¶‰»j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i10.10.16j, –¼ŒÃ‰®, ¶‰»Šw, 70(8): 920, 1998.

177. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰ZŽÀð’ŽDipylidium caninum‚̃XƒtƒBƒ“ƒS“œŽ‰Ž¿. ]ŒŽ«ŽjC“üŽq‰pKC–ö‘ò—ºCìã‘×C“à“c–¾•FC‘º“c‹`•Fi–ƒ•z‘åjC’†‘º˜a¶C¬“ˆ‹vŽqC‹Êˆä—mˆêi¶‰»j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i10.10.17j, –¼ŒÃ‰®, ¶‰»Šw, 70(8): 1038, 1998.

178. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ|ƒŠƒVƒAƒƒKƒ“ƒOƒŠƒIƒVƒh‚̃VƒAƒ‹Ž_‚ÌCü. ’†‘º˜a¶C¬“ˆ‹vŽqi¶‰»jCŠ}ŠÔŒ’Žki“ŒˆãŽ•‘åjC‹Êˆä—mˆêi¶‰»j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i10.10.17j, –¼ŒÃ‰®, ¶‰»Šw, 70(8): 1039, 1998.

179. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¸‘ƒ‚©‚ç‚Ì“™“d“_“d‹C‰j“®‚É‚æ‚éReductose‚̸»–@. ŒK“c³Li¶‰»j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i10.10.17j, –¼ŒÃ‰®, ¶‰»Šw, 70(8): 1069, 1998.

180. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œ‹‡Œ^“œƒ^ƒ“ƒpƒNŽ¿‚̶—‹@”\‰ð–¾‚Ì‚½‚߂̃sƒŠƒWƒ‹ƒAƒ~ƒm‰»ƒIƒŠƒS“œ½‚Ì…—n‰t’†‚É‚¨‚¯‚é—§‘Ì”zÀ‰ðÍ. ŽPˆèŽqCŠâ£m—EC–x“c‹±Žqi¶‰»j: “ú–{–òŠw‰ï‘æ118‰ñ”N‰ï i98.03.31j, ‹ž“s, —vŽ|W, p.43, 1998.

181. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆêŽ_‰»’‚‘f‡¬y‘f(NOS)‚̈ݔS–Œ“à‚É‚¨‚¯‚é‹Ç݂ƈêŽ_‰»’‚‘f(NO)‚Ì”S‰t‘ãŽÓ‚É‚¨‚¯‚é–ðŠ„‚Ì‰ð–¾. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.04.17j, ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95(‘): 218, 1998.

182. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒgŒŒ´IgA1‚É‚¨‚¯‚éN-ƒOƒŠƒJƒ““œ½‚Ì•”ˆÊ“ÁˆÙ“IƒtƒRƒVƒ‹‰». “c’†~Žuiˆ®‰»¬jCŠâ£m—Ei¶‰»jC”äŠé”\”ViŠÅŒìŠw•”jC¬‹v•Û“§i“àjCŒËŠÀˆêEiˆ®‰»¬jC¬—Ñ–Li“àjC–x“c‹±Žqi¶‰»j: ‘æ20‰ñ“œŽ¿ƒVƒ“ƒ|ƒWƒEƒ€i“ú–{“œŽ¿Šw‰ïj i98.07.16j, ŽD–y, —vŽ|W, p.111, 1998.

183. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒg‚̃Gƒ“ƒeƒƒAƒ|ƒ€ƒ`ƒ“‚ÌŒŸ“¢. ¬Œ´ii¶‰»jC•lèG–¾i¶•¨ŠwjC¬ìŽj—mi¶‰»jC’†–ìŽj˜YC‹v•Û“c•q•Fi“àjC–x“c‹±Žqi¶‰»j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï i98.10.16j, –¼ŒÃ‰®, “ú–{¶‰»Šw, 70(8), 1998.

184. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒKƒXƒgƒŠƒ“‚̃‰ƒbƒgˆÝƒ€ƒ`ƒ“¶‡¬Šˆ«˜´iì—p‚ɑ΂·‚éˆêŽ_‰»’‚‘f(NO)‘ãŽÓŒn‚ÌŠÖ—^. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï i98.10.17j, –¼ŒÃ‰®, “ú–{¶‰»Šw, 70(8): 1033, 1998.

185. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ€ƒ`ƒ“Œ^“œ½ƒRƒA—̈æ‚Ì…—n‰t’†‚É‚¨‚¯‚é—§‘Ì\‘¢. ŽPˆèŽqCŠâ£m—EC–x“c‹±Žqi¶‰»j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï i98.10.17j, –¼ŒÃ‰®, “ú–{¶‰»Šw, 70(8): 1034, 1998.

186. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒgŒŒ´IgA1‚Ìוª‰æ‚ƃqƒ“ƒW•”ˆÊƒ€ƒ`ƒ“Œ^“œ½‚̉ðÍ. Šâ£m—ECŽPˆèŽqC–x“c‹±Žqi¶‰»jC”äŠé”\”ViŠÅŒìŠw•”jC¬‹v•Û“§C¬—Ñ–Li“àjC“c’†~ŽuCŒËŠÀˆêEiˆ®‰»¬j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï i98.10.17j, –¼ŒÃ‰®, “ú–{¶‰»Šw, 70(8): 1037, 1998.

187. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‚ƒmƒNƒ[ƒiƒ‹R‘ÌRGM21‚¨‚æ‚ÑHIK1083‚ð—p‚¢‚Ä–¾‚ç‚©‚Æ‚È‚Á‚½ƒ‰ƒbƒgˆÝ‚Ì•”ˆÊ‚É‚æ‚郀ƒ`ƒ“•ªŽqŽí‚Ì‘Šˆá. ŒÜäzsMi¶‰»jC›’J’ËMŽqi¶‰»ŒnjCÎŒ´˜a•Fiˆã—Éq¶Šw•”jCŒIŒ´½iŠÖ“Œ‰»ŠwjC–x“c‹±Žqi¶‰»j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï i98.10.17j, –¼ŒÃ‰®, “ú–{¶‰»Šw, 70(‘): 1033, 1998.

188. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j CJD‚Ì•a‘Ô”­Œ»‚ÉiNOS‚Í•K—v‚©. ‹Êˆä—mˆêi¶‰»jCùŒ´•Žui”÷jC¬“ˆ‹vŽqC’†‘º˜a¶i¶‰»j: Œú¶È“Á’莾Š³’x”­«ƒEƒCƒ‹ƒXŠ´õ’²¸Œ¤‹†”Ç i11.01.18j, “Œ‹ž, •½¬10”N“x”ljï‹cƒvƒƒOƒ‰ƒ€, p.10, 1999

189. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝƒ€ƒ`ƒ“¶‡¬‚ɑ΂·‚éƒqƒXƒ^ƒ~ƒ“‚ƃKƒXƒgƒŠƒ“‚Ìì—p‚Ì”äŠrŒŸ“¢. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ18‰ñƒqƒXƒ^ƒ~ƒ“ƒŒƒZƒvƒ^[Œ¤‹†‰ï i98.07.24j, ‹ž“s, ´˜^W, p.56`57, 1998.

190. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝ”S–Œ‚É‚¨‚¯‚éƒKƒXƒgƒŠƒ“‚̃€ƒ`ƒ“¶‡¬‚ɑ΂·‚éì—p|ì—p‹@\‚̉𖾂ƉÁ—î‚É‚æ‚é•Ï‰»‚ɂ‚¢‚Ä|. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC—Ñ“c_–¾i“àjC–x“c‹±Žqi¶‰»j: ‘æ17‰ñCytoprotectionŒ¤‹†‰ï i99.02.05j, ‹ž“s, ´˜^W, p.15, 1999.

191. m“Á‹–n RƒqƒgˆÝƒ€ƒ`ƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì(H.10-134272). ŒIŒ´½iŠÖ“Œ‰»ŠwjCÎŒ´˜a•Fiˆã—Éq¶Šw•”jC–x“c‹±Žqi¶‰»jC‰ªˆÀŒMi•a—jC“àŽRG”üiŠÖ“Œ‰»Šwj.


<<05 –ò—Šw>>

192. mŒ´’˜n Evidence for a role of kallikrein-kinin system in patients with shock after blunt trauma. ™–{Ÿ•FC•½“cŒõ”Ži‹~–½jC”n“ˆ³—²CŽ­ŽæMi–ò—jC‘å˜a“c—²i‹~–½j: Am. J. Physiol., 274(R-43): 1556`1560, 1998.

193. mŒ´’˜n Crucial suppressive role of renal kallikrein-kinin system in development of salt-sensitive hypertension. Ž­ŽæMC”n“ˆ³—²C—Ñòi–ò—j: Biol. Res., 31: 143`149, 1998.

194. mŒ´’˜n Reduction of sodium deoxycholic acid-induced scratching behaviour by bradykinin B2 receptor antagonists. —ÑòC”n“ˆ³—²i–ò—j: Br. J. Pharmacol., 126(1): 197`204, 1999.

195. mŒ´’˜n Effect of prolonged administration of a urinary kininase inhibitor, ebelactone B, on the development of deoxycorticosterone acetate-salt hypertension in rats. ˆÉ“¡_Žki“àjC”n“ˆ³—²i–ò—jC’†“ˆ^ˆêi“àjC—Ñòi–ò—jC˜aò“Oi“àjCŽ­ŽæMi–ò—j: Br. J. Pharmacol., 126(3): 613`620, 1998.

196. mŒ´’˜n Purification and amino acid sequence of halystase from snake vnom of Agkistrondon halys blomhoffi, a serine protease that cleaves specifically fibrinogen and kininogen. ¼ˆä‘¾‰qi“¡“c•Û‰q‘åjC÷ˆä‰Ã•FC“¡‘º‹g”Ži“Þ—ÇŒ§—§ˆã‘åjC—Ñòi–ò—jC‘åÎKŽqi–òŠw•”jC—é–Ø­”üC•lŽq“ñŽ¡CŽR–{‹`MCŽRè~ŽqC–؉º”ü’q ŽqCç’JWˆêi“¡“c•Û‰q‘åj: Eur. J. Biochem., 252(3): 569`575, 1998.

197. mŒ´’˜n Possible background mechanisms of the effectiveness of cyclooxygenase-2 inhibitors in the treatment of rheumatoid arthritis. Ž­ŽæMC”n“ˆ³—²i–ò—jCŒ´“c–FÆiˆã—Éq¶Šw•”j: Inflamm. Res., 47(Suppl. 2): 107`111, 1998.

198. mŒ´’˜n Effects of a neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats. ’†“ˆ^ˆêi“àjC”n“ˆ³—²i–ò—jCˆÉ“¡_Žki“àjC—Ñòi–ò—jC–‹`’‰iˆã—Éq¶jCŽ­ŽæMi–ò—j: Int. J. Tissue React., 20(2): 45`56, 1998.

199. mŒ´’˜n Functional b1-integrins release the suppression of fibronectin matrix assembly by vitronectin. Zhang, Q.CSakai, T.CNowlen, J.(Univ. Wisconsin)C—Ñòi–ò—jCFssler, R.(Lund Univ.)CMosher, D.F.(Univ. Wisconsin): J. Biol. Chem., 274(1): 368`375, 1999.

200. mŒ´’˜n Differing profiles of prostaglandin formation inhibition between selective prostaglandin H synthase-2 inhibitors and conventional NSAIDs in inflammatory and non-inflammatory sites of the rat. Œ´“c–FÆiˆã—Éq¶Šw•”jC쑺“¹ŽqC”¨’†Œöi–ò—jCÄ“¡^ŠóC‰¬–ìŽO’qŽqi¶•¨‰»ŠwŒnjC‘å–ì—²i“àjC‰¬–ìŒjŽqCQiusheng Yangi–ò—j: Prostaglandins & Other Lipid Mediators, 55: 345`358, 1998.

201. mŒ´’˜n Age trends in circadian characteristic of heart rate and heart rate variability in health. Cornelissen, G.CHalberg, G.COtsuka, K.CWatanabe, Y.CŒF’J—YŽ¡i–ò—jCUezono, K.CKawasaki, T.CWeber M.CDrayer, J.I.M.CSiegelova, J.: Scripta Media(BRNO), 71(4): 191`198, 1998.

202. mŒ´’˜n Chronobiologic optimization of exercise physiology and practice guided by heart rate variability. Weydahl, A.CCornelissen, G.CHalberg, F.CSiegelova, J.CŒF’J—YŽ¡i–ò—jCOtsuka, K.: Scripta Media(BRNO), 71(4): 215`230, 1998.

203. mŒ´’˜n VGCPŽ{sŒã‚ÌŽ¡Œ±ŽÀŽ{‚ÉŠÖ‚·‚é‰Û‘è. ‰¡“cTˆêi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jCŒF’J—YŽ¡i–ò—jC‘ºèŒõ–Mi¸jC‘ò“cŽÀ‰ÔC•ŽR­ˆêC–îŒã˜a•vi–òÜ•”j: ŒŽŠ§–òŽ–, 40(13): 151`157, 1998.

204. mŒ´’˜n Mizolastine (MKC-431)‚Ì‚—îŽÒ‚É‚¨‚¯‚é–ò•¨“®‘Ô. ŒF’J—YŽ¡i–ò—jC‰¡“cTˆêi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jCˆä‘òŽu–¼–ìi¸jC“¡“c•üŒbi–ò—jC‘ò“cŽÀ‰Ôi–òÜ•”jC‘ºèŒõ–Mi¸jC’†ˆäŒbŽqC_”gˆŸ–îŽq: —Õ°–ò—, 29(4): 699`705, 1998.

205. m€Œ´’˜i‰p•¶jn Fleeting "Monitor-" or "Grief-Associated" blood pressure disorders: MESOR-hypertension and circadian hyperamplitudetension. Burchell, H.CCornelissen, G.CHalberg, F.CHalpin, C.CŒF’J—YŽ¡i–ò—jCOtsuka, K.CWatanabe, Y.CZaslavskaya, R.: Supercomputing Institure, p.186, 1998.

206. m€Œ´’˜n Capsaicin-induced microvascular changes in rat stomach; Role of calcitonin gene-related peptide (CGRP) and substance P-. ²”ŒˆÐ’jC‘å–ì—²C–pŸtC—ÑO”üC¼Œ³Ž›Ž—çi“àjC”n“ˆ³—²CŽ­ŽæMi–ò—j: Microcirculation Annual, 14: 109`110, 1998.

207. m€Œ´’˜n ƒJƒvƒTƒCƒVƒ“‚É‚æ‚éˆÝ”S–Œ”÷¬zŠÂ‚Ì”½‰ž|ƒTƒuƒXƒ^ƒ“ƒX‚o‚ÆCGRP‚Ì–ðŠ„|. ²”ŒˆÐ’jC‘å–ì—²C–pŸtC—ÑO”üC¼ŽR˜a’jC¼Œ³Ž›Ž—çi“àjC”n“ˆ³—²CŽ­ŽæMi–ò—j: Ulcer Research, 25: 109`111, 1998.

208. m€Œ´’˜n ‚’£H‰–…‚É‚æ‚éƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ‚Ì—}§|“àˆö«CGRP‚ÌŠÖ—^|. –pŸtC‘å–ì—²C²”ŒˆÐ’jC—ÑO”üC¼ŽR˜a’jC¼Œ³Ž›Ž—çi“àjC”n“ˆ³—²CŽ­ŽæMi–ò—j: Ulcer Research, 25: 112`114, 1998.

209. m€Œ´’˜n ƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ”­¶‚Ì•a‘Ô|‘ˆ«ˆöŽq‚Æ‚µ‚Ä‚ÌŒŒ¬”‹ÃW|. ‘å–ì—²i“àjC”n“ˆ³—²C—ÑòCŽ­ŽæMi–ò—j–pŸtC²”ŒˆÐ’jC—ÑO”üC¼Œ³Ž›Ž—çi“àj: Ulcer Research, 25: 1`5, 1998.

210. m€Œ´’˜n ƒLƒjƒm[ƒQƒ“‚Ì•ª”åáŠQ‚Æbulk flow. —Ñòi–ò—j: ¶‰»Šw, 70(7): 553`557, 1998.

211. m€Œ´’˜n pŒãŠÌáŠQ”­Œ»‚ÉŠÖ—^‚·‚éˆöŽq‚Ìtree-based model‚É‚æ‚é’Tõ“IŒŸ“¢. ŒF’J—YŽ¡i–ò—jC‰¡“cTˆêi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jC‘ò“cŽÀ‰Ôi–òÜjC“¡“c•üŒbC”n“ˆ³—²i–ò—jC”ö’¹Ÿ–çC“uLKCˆÉ“¡’¼ŽqC•ŽR­ˆêC–îŒã˜a•v i–òÜ•”jC‘åγ•½C’ÖLŒv: –ò܉uŠw, 3(Suppl.): 48`49, 1998.

212. m€Œ´’˜n ƒAƒZƒ`ƒ‹ƒRƒŠƒ“ƒGƒXƒeƒ‰[ƒ[‘jŠQ–ò, ƒCƒsƒ_ƒNƒŠƒ“‚Ì‚—îŽÒ‚É‚¨‚¯‚é–ò•¨“®‘Ô. ŒF’J—YŽ¡i–ò—jC‰¡“cTˆêi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jCˆä‘òŽu–¼–ìi¸jC“¡“c•üŒbi–ò—jC‘ò“cŽÀ‰Ôi–òÜ•”jC‘ºèŒõ–Mi¸j: —Õ°–ò—, 29(1,2): 253`254, 1998.

213. m€Œ´’˜n ŒŒ“œ~‰º–òMKC-542‚Ì‚—îŽÒ‚É‚¨‚¯‚é–ò•¨“®‘Ô‚Æ–ò—ÍŠw. ‰¡“cTˆêi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jCŒF’J—YŽ¡i–ò—jCˆä‘òŽu–¼–ìi¸jC“¡“c•üŒbi–ò—jC‘ò“cŽÀ‰Ôi–òÜ•”jC‘ºèŒõ–Mi¸jC’†ˆäŒbŽqi—Õ°–ò—j: —Õ°–ò—, 30(1): 269`270, 1999.

214. m€Œ´’˜n 19-Nortestosterone—U“±‘Ì‚É‚¨‚¯‚錎ŒoŽüŠú‚É‚æ‚é–ò•¨“®‘Ԃւ̉e‹¿. ‘ò“cŽÀ‰Ôi–òÜ•”jCŒF’J—YŽ¡i–ò—jC‰¡“cTˆêi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jC“¡“c•üŒbi–ò—jCˆä‘òŽu–¼–ìC‘ºèŒõ–Mi¸j: —Õ°–ò—, 30(1): 271`272, 1999.

215. mÇ—á•ñn The effect of interferon on circadian rhythm of heart rate variability in a patient with acute hepatitis C; A case report. ŒF’J—YŽ¡C”n“ˆ³—²i–ò—j: Clin. Pharmacol. Ther., 8(5): 105`109, 1998.

216. m‘àn Œü¸_–ò. ŒF’J—YŽ¡i–ò—jC΋½‰ªƒi¸j: ˆã–òƒWƒƒ[ƒiƒ‹, 34(11): 85`89, 1998.

217. m‘àn ¶‘Ì“àƒLƒjƒ“—V—£‚̃Cƒ“ƒWƒP[ƒ^[. ”n“ˆ³—²i–ò—j: ‰ŠÇ‚ƖƉu, 6: 471`482, 1998.

218. m‘àn ˆÝ”S–Œ”÷¬zŠÂ–hŒä‚ƃjƒ…[ƒƒyƒvƒ`ƒh‚Ì–ðŠ„. ‘å–ì—²i“àjCŽ­ŽæMC”n“ˆ³—²i–ò—jC¼Œ³Ž›Ž—çi“àj: ŒŒŠÇ‚Æ“à”ç, 8: 464`471, 1998.

219. m‘àn ƒrƒ^ƒ~ƒ“‚b¥‚d‰»‡•¨EPC-K1Œø‰Ê. ŒI—Ñ‹`˜aC”n“ˆ³—²i–ò—j: “ú–{ˆãŽ–V•ñ, (3886): 117, 1998.

220. m‘àn ¸_‰È—̈æ‚É‚¨‚¯‚鎞ŠÔ–ò—Šw. ŒF’J—YŽ¡i–ò—j: —Õ°¸_–ò—, 2(3): 255`262, 1999.

221. mŠwp‘n i•ª’SŽ·•Mj Aggressology and Reticuloendothelial System; 1. Stress and microcirculation, different response of arterioles and venules in rat gastric mucosal microcirculation to endothelin-1 and endothelin-3, p.58`67, ‘å–ì—²i“àjCŽ­ŽæMC”n“ˆ³—²i–ò—jC—ÑO”üC¼Œ³Ž›Ž—çi“àj. •ÒW “y‰®‰ëtiŒc‘åjC•ÒC “ú–{ˆãŠwŠÙC“Œ‹žC98.00.00”­s.

222. mŠwp‘n i•ª’SŽ·•Mj Aggressology and Reticuloendothelial System; 1. Stress and microcirculation, direct observation of microcirculation of the basal region of rat gastric mucosa, p.50`57, ‘å–ì—²i“àjCŽ­ŽæMi–ò—jC¼ŽR˜a’jC¼Œ³Ž›Ž—çi“àj. •ÒW “y‰®‰ëtiŒc‘åjC•ÒC “ú–{ˆãŠwŠÙC“Œ‹žC98.00.00”­s.

223. mŠwp‘n i•ª’SŽ·•Mj Microcirculatory Aspect of Asian Traditional Medicine; Microcirculatory mechanism of preventive effect of capsaicin on the ethanol-induced gastric mucosal injury in rats, p.3`9, Ž­ŽæMi–ò—jC‘å–ì—²C—ÑO”üC–pŸtC²”ŒˆÐ’ji“àjC”n“ˆ³—²i–ò—j. •ÒW Niimi, H.CPatumraj, S.CTigno, X.T.CXiu, R.C•ÒC Monduzzi, Bologna, 98.00.00”­s.

224. mŠwp‘n i•ª’SŽ·•Mj Ž¾Š³‚©‚ç‚Ý‚½—Õ°–ò—Šw; zŠÂŠí5. ‚Ž‰ŒŒÇ, p.141`149, ŒF’J—YŽ¡i–ò—j. •ÒW ‘å‹´‹žˆêC“¡‘ºº•vC•ÒC –òŽ–Žž•ñŽÐ, “Œ‹ž, 99.00.00”­s.

225. mŠwp‘n i•ª’SŽ·•Mj Aggressology and Reticuloendothelial System; 1. Stress and microcirculation: Pivital role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship, p.3`36, Ž­ŽæMC”n“ˆ³—²i–ò—j. •ÒW “y‰®‰ëtiŒc‘åjC•ÒC “ú–{ˆãŠwŠÙ, “Œ‹ž, 98.00.00”­s.

226. mŠwp‘n i•ª’SŽ·•Mj Aggressology and Reticuloendothelial System; 1. Stress and microcirculation: Five steps on leukocyte extravasation in the microcirculation by chemoattractants, p.37`43, ¬“c—²Ž¡iŽRŒ`‘åjCŽ­ŽæMC”¨’†Œöi–ò—jCŽR‰È³•½i‰ðj. •ÒW “y‰®‰ëtiŒc‘åjC•ÒC “ú–{ˆãŠwŠÙ, “Œ‹ž, 98.00.00”­s.

227. mŠwp‘n i•ª’SŽ·•Mj Aggressology and Reticuloendothelial System; 1. Stress and microcirculation: Approaches to the development of novel antihypertensive drugs, p.68`75, ”n“ˆ³—²CŽ­ŽæMi–ò—j. •ÒW “y‰®‰ëtiŒc‘åjC•ÒC “ú–{ˆãŠwŠÙ, “Œ‹ž, 98.00.00”­s.

228. mŠwp‘n i•ª’SŽ·•Mj Annual Review, t‘Ÿ1999; t‚É‚¨‚¯‚éCOX-2‚Ì”­Œ»•ª•z‚ƈӋ`, p.18`25, ”n“ˆ³—²i–ò—j. ’†ŠOˆãŠwŽÐ, “Œ‹ž, 99.00.00”­s.

229. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Facilitation of renal kallikrein kinin system prevents the development of hypertension by inhibiting sodium retention. ”n“ˆ³—²C—Ñòi–ò—jCˆÉ“¡_Žki“àjCŽ­ŽæMi–ò—j: 15th International Conference on Kinins i98.10.19`24j, “Þ—Ç.

230. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor. rXˆê˜Yi“¡‘ò–ò•ijC—ÑòC”n“ˆ³—²i–ò—j: 15th International Conference on Kinins i98.10.19`24j, “Þ—Ç.

231. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j A secretory mechanism of renal kallikrein by a high potassium ion; a possible involvement of ATP-sensitive potassium channel. —ÑòC“¡“c•üŒbC”n“ˆ³—²CŽ­ŽæMi–ò—j: 15th International Conference on Kinins i98.10.19`24j, “Þ—Ç.

232. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Nonlinear relation of the circadian blood pressure amplitude to cardiovascular disease risk. Comelissen, G.COtsuka, K.CChen, Ch.H.CŒF’J—YŽ¡i–ò—jCWatanabe, Y.CHalberg, F.CSiegelova, J.CDusek, B.: 6th International Fair of Medical Technology and Pharmacy i98.11.04`07j, Bruno.

233. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Reduction in circulatory platelet number by anti-platelet antibody and inhibition of platelet aggregation prevent ethanol-induced mucosal injury in rats. ‘å–ì—²i“àjC”n“ˆ³—²C‰H‘º‘fŽqi–ò—jC²”ŒˆÐ’jC–pŸti“àjC—ÑòCŽ­ŽæMi–ò—jC¼Œ³Ž›Ž—çi“àj: 99th Annual Meeting of the American Gastroenterological Association i98.05.17`20j, New Orleans, Gastroenterology, 114: 246`247, 1998.

234. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Capsaicin prevents ethanol-induced gastric lesion by suppression of constriction of collecting venules in rats: A study using intravital microscopy. ²”ŒˆÐ’jC‘å–ì—²C–pŸtC—ÑO”üC¼Œ³Ž›Ž—çi“àjC”n“ˆ³—²i–ò—jCŽ­ŽæMi–ò—j: 99th Annual Meeting of the American Gastroenterological Association i98.05.17`20j, New Orleans, Gastroenterology, 114: 274, 1998.

235. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Role of endogenous prostaglandin E2 as a modulator of release of calcitonin gene-related peptide to prevent ethanol-induced gastric mucosal injury in rat. –pŸti“àjC”n“ˆ³—²i–ò—jC‘å–ì—²C²”ŒˆÐ’jC—ÑO”üC¼ŽR˜a’ji“àjCŽ­ŽæMi–ò—jC¼Œ³Ž›Ž—çi“àj: 99th Annual Meeting of the American Gastroenterological Association i98.05.17`20j, New Orleans, Gastroenterology, 114: 77, 1998.

236. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Inhibition of kinin degradation on luminal side of renal tubules, but not in circulation, prevents development of hypertension in rats. ”n“ˆ³—²i–ò—jC’†“ˆ^ˆêCˆÉ“¡_Žki“àjC—ÑòCŽ­ŽæMi–ò—j: 17th Scientific Meeting of the International Society of Hypertension i98.06.07`11j, Amsterdam, J. Hypertens., 16(Suppl. 2): 135, 1998.

237. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Preventive effect of a prolonged administration of urinary kininase inhibitor, ebelactone B (EB) on rat DOCA-salt hypertension. ˆÉ“¡_Žki“àjC”n“ˆ³—²i–ò—jC˜aò“Oi“àj: 17th Scientific Meeting of the International Society of Hypertension i98.06.07`11j, Amsterdam, J. Hypertens., 16(Suppl.): 141, 1998.

238. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effects of a neutral endopeptidase inhibitor, BP102, on the development of DOCA-salt hypertension in kininogen deficient rats. ’†“ˆ^ˆêi“àjC”n“ˆ³—²i–ò—jCˆÉ“¡_Žki“àjC—Ñòi–ò—jC–‹`’‰i“àjCŽ­ŽæMi–ò—j: 17th Scientific Meeting of the International Society of Hypertension i98.06.10j, Amsterdam.

239. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j A pharmacological study on post-operative liver dysfunction. ŒF’J—YŽ¡i–ò—jC‰¡“cTˆêi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jC“¡“c•üŒbi–ò—jC”ö’¹Ÿ–çC“uLKC‘ò“cŽÀ‰ÔCˆÉ“¡’¼ŽqC•ŽR­ˆêC›Œ´[LC–îŒã˜a•vi–òÜ •”j: 13th International Congress of Pharmacology i98.07.26`31j, Munchen.

240. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Pharmacokinetics of mizolastine, a novel antiallergic drug, in the elderly. ‰¡“cTˆêi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jCŒF’J—YŽ¡i–ò—jCˆä‘òŽu–¼–ìi¸jC“¡“c•üŒbi–ò—jC‘ò“cŽÀ‰Ôi–òÜ•”jC‘ºèŒõ–Mi¸j: 13th International Congress of Pharmacology i98.07.26`31j, Munchen.

241. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Prevention of the development of DOCA-salt hypertension by prolonged administration of urinary carboxypeptidase Y-like kininase inhibitor ebelactone B (EB) with the increase in urinary kinin excretions. ˆÉ“¡_Žki“àjC”n“ˆ³—²i–ò—jC˜aò“Oi“àj: 13th International Congress of Pharmacology i98.07.26`31j, Munchen, Arch. Pharmacol., 358(Suppl. 2): 15.6, 1998.

242. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Mechanisms for increasing effect on renal kallikrein secretion by a high potassium administration. “¡“c•üŒbCŒF’J—YŽ¡C—ÑòC’r“cN—TC—é–Ø—§‹ICˆî‘º’¼ÆC”n“ˆ³—²i–ò—j: 13th International Congress of Pharmacology i98.07.26`31j, Munchen, Arch. Pharmacol., 358(Suppl. 2): 745, 1998.

243. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Protective action of capsaicin in ethanol-induced rat gastric mucosal injury is not due to released substance P, but to released calcitonin gene-related peptide. —ÑO”üC–pŸtC²”ŒˆÐ’jC‘å–ì—²C¼Œ³Ž›Ž—çi“àjC”n“ˆ³—²CŽ­ŽæMi–ò—j: 11th World Congress of Gastroenterology i98.09.06`11j, Vienna, Austria, Digestion, 59(Suppl.3): 241, 1998.

244. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The effect of a novel 5-HT3 agonist on symptoms of subjects with constipation and their intestinal motilities. “¡“c•üŒbCŒF’J—YŽ¡i–ò—jC‰¡“cTˆêC‘ò“cŽÀ‰Ôi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jC¼Œ³Ž›Ž—çi“àjC‘ºèŒõ–Mi¸jC”n“ˆ³—²i–ò—j: 11th World Congress of Gastroenterology i98.09.06`11j, Vienna, Digestion, 59(Suppl.3): 744, 1998.

245. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Time-dependent prolongation of activated partial theromboplastin time (APTT) after intravenous injection of lipoplysaccharide into rats. ŽRŒûFŽ¡iŠOjC”n“ˆ³—²CŽ­ŽæMi–ò—j: 15th International Conference on Kinins i98.10.19`24j, “Þ—Ç.

246. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Involvement of des-arg9-bradykinin and B1 receptor in rat carrageenin-induced pleurisy. —ÑòC”n“ˆ³—²i–ò—j: 15th International Conference on Kinins i98.10.19`24j, “Þ—Ç.

247. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Bradykinin B2 receptor antagonisits reduces cratching behavior induced by sodium deoxycholic acid. —ÑòC”n“ˆ³—²i–ò—j: 15th International Conference on Kinins i98.10.19`24j, “Þ—Ç.

248. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Synergitic contribution of angiotensin ‡U and kinins to epinephrine-induced pulmonary edema in rats with chronic heart failure. •xŽR”ŽŽji’é‹ž‘åjC”n“ˆ³—²i–ò—j: 15th International Conference on Kinins i98.10.19`24j, “Þ—Ç.

249. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of neutralendopeptidase inhibitor on bradykinin-induced bronchoconstriction. 㞊‹gli‹~–½jC—ÑòC”n“ˆ³—²i–ò—j: 15th International Conference on Kinins i98.10.19`24j, “Þ—Ç.

250. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of a nonpeptide mimic of bradykinin, FR190997 on the size of myocardial infarction after coronary ligation in rats. ˆÉ“¡_Žki“àjC”n“ˆ³—²i–ò—jC˜aò“Oi“àj: 15th International Conference of Kinins i98.10.19`20j, “Þ—Ç, Abstracts, p.5, 1998.

251. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Prevention of the development of DOCA-salt hypertension by prolonged administration of an inhibitor of urinary carboxypeptidase Y-like kininase, ebelactone B (EB) and it's cancellation by HOE140. ˆÉ“¡_Žki“àjC”n“ˆ³—²i–ò—jC˜aò“Oi“àj: 15th International Conference of Kinins i98.10.19`20j, “Þ—Ç, Abstracts, p.6, 1998.

252. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Increase in renal kallikrein secretion by a blockade of a renal ATP-sensitive K+ channels. “¡“c•üŒbC—ÑòCŒF’J—YŽ¡Cˆî‘º’¼ÆC”n“ˆ³—²i–ò—j: 15th International Conference on Kinins i98.10.19`24j, “Þ—Ç, Kinin Abstract Book, p.97, 1998.

253. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j ƒGƒ^ƒm[ƒ‹‚É‚æ‚éˆÝ”S–ŒáŠQ‚Ì”­¶‹@\‚Æ‚»‚Ì—}§: V‚µ‚¢Ž¡—ÖòŠJ”­‚ւ̃Aƒvƒ[ƒ`. ”n“ˆ³—²i–ò—j: “ú–{Á‰»ŠíŠÖ˜AŠw‰ïTŠÔ(DDW-Japan 1998 Yokohama) i98.04.17j, ‰¡•l.

254. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŒŒŠÇV¶‚É‚¨‚¯‚écyclooxygenase (COX)-2‚Ì”­Œ»‚Æ–ðŠ„. ”n“ˆ³—²C”¨’†ŒöC쑺“¹ŽqC—Ñòi–ò—jCŒ´“c–FÆiˆã—Éq¶Šw•”jCŽ­ŽæM: ‘æ18‰ñ“ú–{‰ŠÇŠw‰ï i98.11.21j, “Œ‹ž.

255. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V‚µ‚­”­Œ©‚³‚ꂽ”A’†ƒLƒjƒi[ƒ[‚Ì‘jŠQ‚ÍDOCA-salt‚ŒŒˆ³‚Ì”­Ç‚ð—}§‚·‚é|ƒLƒjƒmƒQƒ“Œ‡‘¹Brown Norway Katholiekƒ‰ƒbƒg‚Å‚ÌŒŸ“¢|. ’†“ˆ^ˆêi“àjC”n“ˆ³—²i–ò—jCˆÉ“¡_Žki“àjC—Ñòi–ò—jC‹àXWC–‹`’‰i“àj: ‘æ71‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï i98.06.06j, •Ÿ‰ª, “ú–{“à•ª”åŠw‰ïŽ, 74(1): 184, 1998.

256. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”ñƒyƒvƒ`ƒh«ƒuƒ‰ƒWƒLƒjƒ“B2Žó—e‘̃Aƒ“ƒ^ƒSƒjƒXƒgFR190997‚Ìin vivo‚É‚¨‚¯‚鉊ǎä‹Nì—p. —ÑòC”n“ˆ³—²i–ò—j: ‘æ19‰ñ“ú–{‰ŠÇŠw‰ï i98.09.03`04j, “Œ‹ž.

257. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒ´V¶‚É‚¨‚¯‚éƒLƒ}[ƒ[‚Ì–ðŠ„: ƒXƒ|ƒ“ƒW”牺ˆÚAƒ‚ƒfƒ‹‚É‚¨‚¯‚鸻ƒLƒ}[ƒ[‹y‚уLƒ}[ƒ[ˆâ“`Žq“±“ü‚ÌŒø‰Ê. ‘º¼—ŽqC—Ñòi–ò—jC•Ð“c~C‰F–ìŒ÷iV“ú–{»ècjC”n“ˆ³—²i–ò—j: ‘æ19‰ñ“ú–{‰ŠÇŠw‰ï i98.09.03`04j, “Œ‹ž.

258. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgEƒJƒ‰ƒQƒjƒ“‹¹–Œ‰ŠŒãŠú‚É‚¨‚¯‚éCOX-2‚Ì–ðŠ„‚Æ‚»‚Ì—U“±ˆöŽq. ”¨’†ŒöC쑺“¹Žqi–ò—jC‰¬–ìŽO’qŽqi¶‰»ŒnjC”n“ˆ³—²i–ò—jCŒ´“c–FÆiˆã—Éq¶Šw•”j: ‘æ19‰ñ“ú–{‰ŠÇŠw‰ï i98.09.03`04j, “Œ‹ž, ´˜^W, p.150, 1998.

259. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«‰ŠÇƒ‚ƒfƒ‹‚É‚¨‚¯‚éƒTƒCƒgƒJƒCƒ“ŽY¶‘jŠQ–òFR167653‚ÌR‰ŠÇì—p. 쑺“¹ŽqC”¨’†Œöi–ò—jC‰¬–ìŽO’qŽqi¶‰»ŒnjCŒ´“c–FÆiˆã—Éq¶Šw•”j: ‘æ19‰ñ“ú–{‰ŠÇŠw‰ï i98.09.03`04j, “Œ‹ž, ´˜^W, p.161, 1998.

260. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚’£H‰–…‚É‚æ‚éƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ‚ɑ΂·‚éƒCƒ“ƒhƒƒ^ƒVƒ“‚ÌŒø‰Ê|“àˆö«CGRP‚ÌŠÖ—^|. –pŸtC—ÑO”üC²”ŒˆÐ’jC‘å–ì—²C¼ŽR˜a’ji“àjC”n“ˆ³—²CŽ­ŽæMi–ò—jC¼Œ³Ž›Ž—çi“àj: ‘æ19‰ñ“ú–{‰ŠÇŠw‰ï i98.09.03`4j, “Œ‹ž, —\eW, p.146, 1998.

261. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”ñƒyƒvƒ`ƒh«ƒuƒ‰ƒWƒLƒjƒ“ƒAƒSƒjƒXƒgFR190997‚Ìד®–¬ƒmƒ‹ƒAƒhƒŒƒiƒŠƒ“Š´Žó«’ቺ‚𔺂¤‚ŒŒˆ³”­¶—}§ì—p. ”n“ˆ³—²C—ÑòC“¡“c•üŒbi–ò—jC‹g•xŒ’ŽuiŠáj: “ú–{‚ŒŒˆ³Šw‰ï‘‰ï i98.09.24`26j, L“‡, ´˜^W, p.41, 1998.

262. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j pŒãŠÌáŠQ”­Œ»‚ÉŠÖ—^‚·‚éˆöŽq‚Ìtree-based model‚É‚æ‚é’Tõ“IŒŸ“¢. ŒF’J—YŽ¡i–ò—jC‰¡“cTˆêi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jC‘ò“cŽÀ‰Ôi–òÜjC“¡“c•üŒbC”n“ˆ³—²i–ò—jC”ö’¹Ÿ–çC“uLKCˆÉ“¡’¼ŽqC•ŽR­ˆêC–îŒã˜a•v i–òÜ•”jC‘åγ•½C’ÖLŒv: ‘æ‚S‰ñ“ú–{–ò܉uŠw‰ïŠwp‘‰ï i98.11.06`07j, “Œ‹ž.

263. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒ“œ~‰º–òMKC-542‚Ì‚—îŽÒ‚É‚¨‚¯‚é–ò•¨“®‘Ô‚Æ–ò—ÍŠw. ‰¡“cTˆêi—Õ°Ž¡Œ±ŠÇ—ƒZƒ“jCŒF’J—YŽ¡i–ò—jCˆä‘òŽu–¼–ìi¸jC“¡“c•üŒbi–ò—jC‘ò“cŽÀ‰Ôi–òÜ•”jC‘ºèŒõ–Mi¸jC’†ˆäŒbŽq: ‘æ19‰ñ“ú–{—Õ°–ò—Šw‰ï i98.11.20`21j, ‘啪.

264. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝ”S–Œ”÷¬zŠÂ‚©‚猩‚½ƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ‚ɑ΂·‚éƒJƒvƒTƒCƒVƒ“‚Ì—}§Œø‰Ê. ²”ŒˆÐ’jC‘å–ì—²C–pŸtC¼Œ³Ž›Ž—çC—ÑO”üC¼ŽR˜a’ji“àjC”n“ˆ³—²CŽ­ŽæMi–ò—j: ‘æ24‰ñ“ú–{”÷¬zŠÂŠw‰ï‘‰ï i99.02.26`27j, “Œ‹ž, —\eW, p.69, 1999.

265. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒJƒŠƒNƒŒƒCƒ“-ƒLƒjƒ“Œn‚̃‰ƒbƒgS‹Ø[Ç‘ƒk¬Œø‰Ê. ˆÉ“¡_Žki“àjC”n“ˆ³—²C—Ñòi–ò—j: “ú–{–ò—Šw‰ï i99.03.22`25j, ŽD–y, Jpn. J. Pharmacol., 79(Suppl. 1): 120, 1999.

266. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚’£H‰–…‚É‚æ‚éƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ‚Ì—}§‹@\|¶‘ÌŒ°”÷‹¾‰º‚Å‚ÌŒŸ“¢|. ²”ŒˆÐ’jC‘å–ì—²C–pŸti“àjC—ÑòC”n“ˆ³—²CŽ­ŽæMi–ò—jC¼Œ³Ž›Ž—çi“àj: ‘æ72‰ñ“ú–{–ò—Šw‰ï”N‰ï i99.03.22`25j, ŽD–y, Jpn. J. Pharmacol., 79(Suppl.1): 53, 1999.

267. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“I2‚É‚æ‚éƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ‚Ì—}§ì—p|“àˆö«—V—£CGRP‚ÌŠÖ—^|. –pŸti“àjC”n“ˆ³—²i–ò—jC‘å–ì—²C²”ŒˆÐ’jC—ÑO”üi“àjC—ÑòCŽ­ŽæMi–ò—jC¼Œ³Ž›Ž—çi“àj: ‘æ72‰ñ“ú–{–ò—Šw‰ï”N‰ï i99.03.22`25j, ŽD–y, Jpn. J. Pharmacol., 79(Suppl.1): 53, 1999.

268. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgEƒJƒ‰ƒQƒjƒ“‹¹–Œ‰ŠŒãŠú‚É‚¨‚¯‚éCOX-2‚ÌTGF-b‚É‚æ‚é—U“±. ”¨’†ŒöC쑺“¹ŽqC”n“ˆ³—²i–ò—jCŒ´“c–FÆiˆã—Éq¶Šw•”j: ‘æ72‰ñ“ú–{–ò—Šw‰ï”N‰ï i99.03.22`25j, ŽD–y, Jpn. J. Pharmacol., 79(Suppl.1): 59, 1999.

269. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgƒJƒ‰ƒQƒjƒ“‹¹–Œ‰Š‚É‚¨‚¯‚éƒTƒCƒgƒJƒCƒ“ŽY¶‘jŠQ–òFR167653‚ÌR‰ŠÇì—p. 쑺“¹ŽqC”¨’†Œöi–ò—jC‰¬–ìŽO’qŽqi¶‰»ŒnjC”n“ˆ³—²i–ò—jC¼”öƒFCŒ´“c–FÆiˆã—Éq¶Šw•”j: ‘æ72‰ñ“ú–{–ò—Šw‰ï”N‰ï i99.03.22`25j, ŽD–y, Jpn. J. Pharmacol., 79(Suppl.1): 59, 1999.

270. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j in vivo‚É‚¨‚¯‚éVEGF‚Ìup-regulation‚ð‰î‚µ‚½Angiotensin ‡U‚É‚æ‚錌ŠÇV¶‘£iì—p‚ÌŒŸ“¢. ‘º¼—Žqi–ò—jC•Ð“c~iV“ú–{»ècjC—Ñòi–ò—jC‰F–ìŒ÷iV“ú–{»ècjC”n“ˆ³—²i–ò—j: ‘æ72‰ñ“ú–{–ò—Šw‰ï”N‰ï i99.03.22`25j, ŽD–y, Jpn. J. Pharmacol., 79(Suppl.1): 79, 1999.

271. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‚ƒ‹ƒ‚ƒbƒg‚Ì‹C“¹‚É‚¨‚¯‚éŒÄ‹CˆêŽ_‰»’‚‘f”­¶‚ƃyƒvƒ`ƒh«_Œo“`’B•¨Ž¿‚ÌŠÖ—^‚ÌŒŸ“¢. ¡è‹M¶C¬—ÑO—SC“c’†’¼•FC–{‘½Œ¤–çC‹v•Û“cŸi“àjC—ÑòC”n“ˆ³—²i–ò—jC•y“c—FKi“àj: ‘æ39‰ñ“ú–{ŒÄ‹zŠíŠw‰ï‘‰ï i99.03.26j, ‰¡•l.

272. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ‚ɑ΂·‚é‚’£H‰–…‚Ì•ÛŒìì—p|“àˆö«CGRP‚ÌŠÖ—^|. –pŸtC—ÑO”üC²”ŒˆÐ’jC‘å–ì—²i“àjC”n“ˆ³—²CŽ­ŽæMi–ò—jC¼ŽR˜a’jC¼Œ³Ž›Ž—çi“àj: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.04.14`17j, ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95(—Õ‘): 193, 1998.

273. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒJƒvƒTƒCƒVƒ“ˆÝ”S–Œ“Š—^Žž‚Ì”S–Œ”÷¬zŠÂ‚Ì”½‰ž‚̉ðÍ|“àˆö«CGRP‚Ì–ðŠ„|. ²”ŒˆÐ’jC‘å–ì—²C–pŸti“àjC”n“ˆ³—²CŽ­ŽæMi–ò—jC—ÑO”üC¼ŽR˜a’jC¼Œ³Ž›Ž—çi“àj: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.04.14`17j, ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95(—Õ‘): 208, 1998.

274. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j tƒJƒŠƒNƒŒƒCƒ“-ƒLƒjƒ“Œn•ŠŠˆ‰»‚É‚æ‚郉ƒbƒgDOCA-H‰–‚ŒŒˆ³‚Ì”­Ç—}§. ˆÉ“¡_Žki“àjC—ÑòC”n“ˆ³—²i–ò—jC˜aò“Oi“àj: “ú–{‚ŒŒˆ³Šw‰ï‘‰ï i98.09.24`26j, L“‡, ´˜^W, p.53, 1998.

275. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j tŒŒŠÇ«‚ŒŒˆ³ƒ‚ƒfƒ‹‚É‚¨‚¯‚éƒVƒNƒƒIƒLƒVƒQƒi[ƒ[-2‘jŠQ–ò‚ÌŒø‰Ê. —ÑòC‰¬–ìŽO’qŽqC”n“ˆ³—²i–ò—j: ‘æ72‰ñ“ú–{–ò—Šw‰ï”N‰ï i99.03.22`25j, ŽD–y, Jpn. J. Pharmacol., 79(Suppl.1): 186, 1999.

276. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –ƒŒƒ‰ƒbƒg‚É‚¨‚¯‚éƒAƒ~ƒƒCƒh‚ÌtƒJƒŠƒNƒŒƒCƒ“•ª”å‘£iì—p. “¡“c•üŒbC—ÑòCˆî‘º’¼ÆCŒF’J—YŽ¡C”n“ˆ³—²i–ò—j: ‘æ72‰ñ“ú–{–ò—Šw‰ï”N‰ï i99.03.22`25j, ŽD–y, Jpn. J. Pharmacol., 79(Suppl.1): 266, 1999.

277. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j LPS—U“±ŠÌáŠQƒ}ƒEƒX, ƒTƒCƒgƒJƒCƒ““Š—^ƒ}ƒEƒXŠÌ’†SÖ¬‚Ö‚Ì”’ŒŒ‹…‚ÌÚ’…‚ÆFR167653‚É‚æ‚é—}§. ¼–{–LCˆÉ“¡‹`–çC‚‹´‹BC²“¡ŒõŽjCŠ`“cÍiŠOjC”n“ˆ³—²i–ò—j: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽGŽ, 100(—Õ‘): 417, 1999.

278. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒŒŠÇV¶‚É‚¨‚¯‚éƒLƒ}[ƒ[‚Ì–ðŠ„; ƒXƒ|ƒ“ƒW”牺ˆÚAƒ‚ƒfƒ‹‚É‚¨‚¯‚鸻ƒLƒ}[ƒ[‹y‚уLƒ}[ƒ[ˆâ“`Žq“±“ü‚ÌŒø‰Ê. ‘º¼—ŽqC—Ñòi–ò—jC•Ð“c~C‰F–ìŒ÷iV“ú–{»ècjC”n“ˆ³—²i–ò—j: ‘æ98‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï i98.06.06j, “Œ‹ž, “ú–{–ò—ŠwŽGŽ, 112(4), 1998.

279. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j LPS—U“±ŠÌáŠQƒ}ƒEƒX‚É‚¨‚¯‚éŠÌ’†SÖ¬‚Ö‚Ì”’ŒŒ‹…‚ÌÚ’…‚ÆFR167653‚É‚æ‚é—}§. ¼–{–LCˆÉ“¡‹`–çC‚‹´‹BC²“¡ŒõŽjCŠ`“cÍiŠOjC”n“ˆ³—²i–ò—j: ‘æ99‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï i98.10.03j, “È–Ø.

280. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j tƒJƒŠƒNƒŒƒCƒ“Œn‚Ì‚ŒŒˆ³”­¶—}§ì—p; ƒLƒjƒmƒQƒ“Œ‡‘¹ƒ‰ƒbƒg‚É‚æ‚錟“¢. ”n“ˆ³—²C—ÑòC“¡“c•üŒbi–ò—jCˆÉ“¡_ŽkC’†“ˆ^ˆêi“àj: ‘æ‚R‰ñ•a‘Ô‚ÆŽ¡—Âɂ¨‚¯‚éƒvƒƒeƒA[ƒ[‚ƃCƒ“ƒqƒrƒ^[Œ¤‹†‰ï i98.08.21j, –¼ŒÃ‰®.

281. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j LPS—U“±ŠÌáŠQƒ}ƒEƒX‚É‚¨‚¯‚éŠÌ’†SÖ¬‚Ö‚Ì”’ŒŒ‹…‚ÌÚ’…‚ÆFR167653‚É‚æ‚é—}§. ¼–{–LCˆÉ“¡‹`–çC‚‹´‹BC²“¡ŒõŽjCŠ`“cÍiŠOjC”n“ˆ³—²i–ò—j: ‘æ‚S‰ñ“ú–{ƒGƒ“ƒhƒgƒLƒVƒ“Œ¤‹†‰ïƒŒ[ƒU[ˆãŠw‰ï‘å‰ï i98.09.25j, “Œ‹ž.

282. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j LPSŠÌáŠQ‚É‚¨‚¯‚éFR167653‚Ì”’ŒŒ‹…—}§Œø‰Ê. ¼–{–LCˆÉ“¡‹`–çC‚‹´‹BC²“¡ŒõŽjCŠ`“cÍiŠOjC”n“ˆ³—²i–ò—j: ‘æ‚S‰ñŠÌzŠÂŒ¤‹†‰ï i99.03.20j, “Œ‹ž.


<<06 ”÷¶•¨Šw>>

283. mŒ´’˜n Characterization of SFO-1, a plasmid-mediated inducible class AƒÀ-lactamasen from Enterobacter cloacae. Matsumoto, Y.Cˆä㼋vi”÷j: Antimicrob. Agents Chemother., 43: 307`313, 1999.

284. mŒ´’˜n The glycoprotein of the carcinoembryonic antigen (CEA) gene family expresed on epithelial keratinocytes in viral warts. ]ì´•¶C–{‘½—R”üC¬–ì—F“¹iŒF–{‘åjC–k—¢‰p˜YC•–س•Fi”÷j: Arch. Dermatol. Res., 290: 453`457, 1998.

285. mŒ´’˜n A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus. Matsuoka, M.CEndou, K.i–kŠC“¹–ò‘åjCKobayashi, H.Cˆä㼋vi”÷j: FEMS Microbiol. Lett., 167: 221`227, 1998.

286. mŒ´’˜n Microbiological characteristic in Japan. ˆä㼋vi”÷j: Haematology, 28: 10`11, 1998.

287. mŒ´’˜n Characterization of a surface membrane molecule expressed by natural killer cells in most inbred mouse strains: monoclonal antibody c9.1 identifies an allelic form of the 2B4 antigen. ‹v•Û“cFˆêi”÷jC‰Á“¡GŽ÷CMuguruma, K.iŽÀ’†Œ¤jC¬ŽR_ˆêiŠñj: Immunology, 96(3): 491`497, 1999.

288. mŒ´’˜n A putative human papillomavirus type 57 new subtype isolated from plantar epidermoid cyst without intracytoplasmic inclusion bodies. –k—¢‰p˜Yi”÷jC]ì´•¶C–{‘½—R”üC¬–ì—F“¹iŒF–{‘åjC…“‡—TCì‡áÁi¹ƒ}ƒŠ‘åj: J. Gen. Virol., 79(8): 1977`1981, 1998.

289. mŒ´’˜n —Õ°Þ—¿•ª—£‹Û‚ÌŠeŽíR‹Û–ò‚ɑ΂·‚銴Žó«ƒT[ƒxƒCƒ‰ƒ“ƒX(‚Q”NŽŸ•ñ). ’–Žë~i‡“V‘åjCˆä㼋vi”÷jC¼–ì•Žui‹ž“s–ò‘åjC“n•Ó’¼Ž÷C㌴M”ViŽD–y‘åjC‹g“c_i•Ÿ“‡ˆã‘åjC¬—Ñ–F•viŒc‘åj: Jpn. J. Antibiot., 51: 47`68, 1998.

290. mŒ´’˜n DNA vaccine against oncogenic hamster cells transformed by HDV 16 E6/E7 oncogenes and the activated ras oncogene. Smahel, M.CSobotkora, E.CVonka, V.CHamsikova, E.CZak, R.iPraha Czeck RepublicjC–k—¢‰p˜Yi”÷jCLudikova, V.: Oncol. Rep., 6(1): 211`215, 1999.

291. mŒ´’˜n Helicobacter pylori‚É‚¨‚¯‚éclarithromycin‘Ï«‹@\‚̉ðÍ|in vitroŒp‘ã”|—{‹Û‚Æ—Õ°•ª—£‹Û‚Ì”äŠr|. ŽG‰êˆÐi”÷jC¬—Ñ“ÐiŽO•Hƒr[ƒV[ƒGƒ‹jC“¡‰ª—˜¶i‘啪‘åjC“ß{ŸC‰ª–{—¹ˆêCˆä㼋vi”÷j: Š´õÇŠw‰ïŽ, 72: 918`923, 1998.

292. mŒ´’˜n Salmonella typhimuvium—R—ˆƒ~ƒjƒZƒ‹‚̖Ɖu‰ž“š—U“±”\; ¶‹ÛƒƒNƒ`ƒ“‚Æ‚µ‚Ẳ”\«‚ɂ‚¢‚Ä. ùŒ´•ŽuCˆä㼋vi”÷jC‹g“cGi“àjC¬¼—mŽqi—\–hˆãŠwŒnj: ŽÀŒ±Š´õƒZƒ~ƒi[‘æ‚V‰ñu‰‰W, 7: 20`25, 1998.

293. mŒ´’˜n ŒoŒûRŒ´ÛŽæƒ}ƒEƒX‚É‚¨‚¯‚é’°ŠÇ‚ÆäB‘Ÿ‚s×–E‚̉ðÍ. ‹Ê“àGˆêi”÷jC²“¡Œ’li“ŒŠC‘åjC”ª‘º•qŽuCã–ììCˆêi“Œ‘åjC“n•ÓŽçC“ú”ä‹I•¶iŒc‘åjCŠ_¶‰€Žqi“ŒŠC‘åj: Á‰»Ší‚ƖƉu, 34: 56`60, 1998.

294. mŒ´’˜n ‘o‹ÉƒCƒIƒ“\‘¢‚ð‚à‚ÂcephemŒn–ò‚Ìclass CŒ^ƒÀ lactamaseŽY¶—Δ^‹Û‚ɑ΂·‚éì—p. ˆä“cFŽui”÷jC‘ ‰€‘ãC•½–앶–çi–¾Ž¡»‰ÙjCˆä㼋vi”÷j: “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46: 479`484, 1998.

295. mŒ´’˜n ŒŒ‰t—R—ˆStaphylococcus aureus‚̶•¨Šw“I«ó‚ÆR‹Û–òŠ´Žó«. ’†èM•FC“à“cˆêOC•½“c‘×—Çi•a‰@jCˆä㼋vi”÷j: “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46: 486`490, 1998.

296. m€Œ´’˜i‰p•¶jn Qunolone resistance in E. coli and Salmonella spp. isolated in Japan. ˆä㼋vC‹v‰ä–¾’jC–k—¢‰p˜YC“ü–ì“cˆê•FCùŒ´•ŽuC‰ª–{—¹ˆêi”÷j: Proceedings of WHO Meeting, p.179`180, 1998.

297. mŒ¤‹†•ñi•¶•”Èjn ƒ|ƒŠƒIƒEƒCƒ‹ƒXƒŒƒZƒvƒ^[“±“üƒ}ƒEƒX‚ð—p‚¢‚½ŒoŒû¶ƒƒNƒ`ƒ“‚ÌŒø‰ÊŒŸ’èŒn‚ÌŠm—§. ‹Ê“àGˆêi”÷j: •¶•”ȉȊwŒ¤‹†•â•‹à(Šî”ÕŒ¤‹†C-2)Œ¤‹†¬‰Ê•ñ‘, 1998.

298. mŒ¤‹†•ñi•¶•”Èjn ESBLŽY¶‹Û‚Ì•ªŽq‰uŠw“I‰ðÍ. ˆä㼋vi”÷j: •½¬9, 10”N“x•¶•”ȉȊwŒ¤‹†•ñ‘, 1998.

299. mŒ¤‹†•ñiŒú¶Èjn ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ŽY¶‹Û‚Ìv‘¬f’f–@‚ÌŠm—§. ˆä㼋vi”÷j: Œú¶ÈV‹»Ä‹»Š´õÇ‚ÉŠÖ‚í‚镽¬10”N“xŒ¤‹†•ñ‘, 1999.

300. m‘àn ESBLs. ‹v‰ä–¾’jCˆä㼋vi”÷j: Medical Technology, 26: 1068`1070, 1998.

301. m‘àn –òÜ‘Ï«‚ÌŒ»ó; ‘˜_‚Æ‚±‚ê‚©‚ç‚Ì“W–]. ˆä㼋vi”÷j: Progress in Medicine, 18: 2609`2612, 1998.

302. m‘àn Why do antimicrobial agents become ineffectual? ˆä㼋vC‹v‰ä–¾’jC“‡“àçŒbŽqC–î–ìŽõˆêC‰ª–{—¹ˆêi”÷j: Yonsei Med. J., 39: 502`513, 1998.

303. m‘àn ˜b‘è‚ÌŠ´õÇESBLs. ˆä㼋vi”÷j: ˆãŠwŒŸ¸, 46: 1660`664, 1997.

304. m‘àn ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[‚Ì“®Œü‚Æ‚»‚Ì‘Îô|ƒOƒ‰ƒ€‰A«ž…‹Û—R—ˆ‚̃À-ƒ‰ƒNƒ^ƒ}[ƒ[Œ™‹C«. ˆä㼋vi”÷j: Š´õÇŒ¤‹†, 28: 1`5, 1998.

305. m‘àn –òÜŠ´Žó«ŽŽŒ±‚Ì‘g‚݇‚킹•û. ‹v‰ä–¾’jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ŒŸ¸‚Æ‹Zp, 26: 1198`1199, 1998.

306. m‘àn R‹Û–ò‘Ï«‚ð‚ß‚®‚Á‚Ä. Šâ–{ˆ¤‹gi“Œ‘åjC•½¼Œ[ˆêi‡“V“°‘åjCˆî¼FŽvi“s˜Vlˆã—ÃZƒ“jCˆä㼋vi”÷j: Ž¡—Êw, 32: 1317`1329, 1998.

307. m‘àn –òÜ‘Ï«‚ðŽw•W‚Æ‚µ‚½‰@“àŠ´õ‚ÌŒ»ó. ˆä㼋vi”÷j: ’üMˆãŠw, 51: 85`94, 1999.

308. m‘àn ‘Ï«‹ÛŠ´õÇ; ESBLŽY¶‹ÛŠ´õÇ. ‰ª–{—¹ˆêCˆä㼋vi”÷j: “ú–{“à‰ÈŠwŽGŽ, 86: 71`77, 1997.

309. m‘àn f’f‚Ìi•à; í—ª“IR‹Û–ò—Ö@‚Ì‚½‚ß‚ÌŠ´Žó«ƒeƒXƒg. ˆä㼋vi”÷j: “ú–{“à‰ÈŠwŽGŽ, 87: 5`10, 1998.

310. m‘àn R‹Û–ò•sŠˆ‰»y‘f‚Ì—Ê“I, Ž¿“I•ÏˆÙ‚É‚æ‚é‘Ï«‹@\. ˆä㼋vC‰ª–{—¹ˆêi”÷j: “ú–{—Õ°, 55: 149`154, 1997.

311. m‘àn ŋ߂̃À-ƒ‰ƒNƒ^ƒ}[ƒ[‚Ì•ª—ނƉuŠw. –î–ìŽõˆêCˆä㼋vi”÷j: —Õ°‚Æ”÷¶•¨, 26: 103`109, 1999.

312. m‘àn AmpCƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ŽY¶‹Û. ‹v‰ä–¾’ji”÷j: —Õ°‚Æ”÷¶•¨, 26: 159`164, 1999.

313. m‘àn ׋ۂ̖òÜ‘Ï«. ˆä㼋vi”÷j: —Õ°”÷¶•¨ŠwŽGŽ, 8: 59`64, 1998.

314. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ”÷¶•¨ŠwŽÀK’ñ—v, ‘æ‚Q”Å; R¶•¨Ž¿‘Ï«‚Ì‘ª’è, p.83`90, ˆä㼋vC‰ª–{—¹ˆêi”÷j. •ÒW “Œ‹ž‘åŠwˆã‰ÈŠwŒ¤‹†ŠŠw—F‰ïC•ÒC ŠÛ‘P, “Œ‹ž, 98.04.20”­s.

315. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj R‹Û–ò“Š—^‚̉Ȋw; ‘Ï«‹Û‚Æ‚»‚Ì‘Îô: ƒOƒ‰ƒ€—z«‹Û, p.254`263, ˆä㼋vC‹v‰ä–¾’ji”÷j. •ÒW ´…Šì”ª˜YC¼–{•¶•vC•ÒC ˆã–òƒWƒƒ[ƒiƒ‹, ‘åã, 98.06.30”­s.

316. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj Ž¡—ÖòƒKƒCƒh; ƒ|ƒŠƒyƒvƒ`ƒhŒnR‹Û, p.600`606, ˆä㼋vC‹v‰ä–¾’jC“‡“àçŒbŽqi”÷j. •ÒW Medical Practice•ÒWˆÏˆõ‰ïC•ÒC •¶Œõ“°, “Œ‹ž, 99.02.10”­s.

317. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j In vitro antibacterial activity of SCH27899 (Ziracin) against gram-positive cocci. ²“¡—Yˆêiˆã—Éq¶Šw•”jC‹v‰ä–¾’jC‰ª–{—¹ˆêCˆä㼋vi”÷j: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy i98.00.00j, San Diego, USA, Abstract, No.E-112, 1998.

318. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The novel ketolide HMR3647 shows high activity against gram-positive cocci. ˆä㼋vi”÷jC²“¡—Yˆêiˆã—Éq¶Šw•”jC‹v‰ä–¾’jC‰ª–{—¹ˆêi”÷j: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy i98.00.00j, San Diego, USA, Abstract, No.E-138, 1998.

319. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j L-84, a new oral carbapenem: in vitro antibacterial activity against clinical isolates of ƒÀ-lactamase producers. ˆä㼋vC‹v‰ä–¾’ji”÷jC²“¡—Yˆêiˆã—Éq¶Šw•”jC‰ª–{—¹ˆêi”÷j: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy i98.00.00j, San Diego, USA, Abstract, No.F-63, 1998.

320. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j A putative HPV57 new subtype isolated from epidermoid cysts. ]ì´•¶iŒF–{‘åjC–k—¢‰p˜Yi”÷jC–{‘½—R”üiŒF–{‘åjCˆä㼋vi”÷jC¬–ì—F“¹iŒF–{‘åj: 17th International Papilloma Virus Conference i99.01.13j, Charleston, SC, USA.

321. mŠw‰ïi‘S‘jn i“Á•Êu‰‰j R‹Û–ò’a¶‚Ì—ðŽj‚Æ‚»‚Ì”­“W. ˆä㼋vi”÷j: ‘æ31‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i98.09.03j, –‹’£.

322. mŠw‰ïi‘S‘jn i“Á•Êu‰‰j Šî‘b׋ۊw‚Ì—§ê‚©‚猩‚½‘Ï«‹ÛoŒ»‚Ì”wŒi. ˆä㼋vi”÷j: ‘æ40‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï i98.11.13j, ‹à‘ò.

323. mŠw‰ïi‘S‘jn i“Á•Êu‰‰j ‰@“à‰˜õ‚ÌŽw•W‚Æ‚µ‚ẴÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ŒŸo‚̈Ӌ`. ˆä㼋vi”÷j: ‘æ10‰ñ—Õ°”÷¶•¨Šw‰ï i99.01.31j, ìè.

324. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j R‹Û–ò‚Ì—\–h“I“Š—^‚ÌŒ÷ß|׋ۊw“I—§ê‚©‚ç‚Ý‚½‘Ï«‹ÛoŒ»‚Ì”wŒi. ˆä㼋vC‰ª–{—¹ˆêi”÷j: ‘æ13‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï i98.00.00j, “Œ‹ž, “ú–{ŠÂ‹«Š´õŠw‰ïŽ, 13: 38, 1998.

325. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒÀ-ƒ‰ƒNƒ^ƒ€–ò‚ð’†S‚Æ‚µ‚Ä; ‚Ç‚¤‚È‚é21¢‹I‚̉Ȋw—Ö@. ˆä㼋vi”÷j: ‘æ72‰ñ“ú–{׋ۊw‰ï‘‰ï i99.03.26j, “Œ‹ž, “ú–{׋ۊwŽGŽ, 54: 83, 1999.

326. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Šî‘b‚©‚猩‚½‘Ï«‹ÛŠ´õÇ. ‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ73‰ñ“ú–{Š´õÇŠw‰ï‘‰ï i99.03.30`31j, “Œ‹ž, Š´õÇŠwŽGŽ, 73: 67, 1999.

327. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒ}ƒEƒXNKƒŒƒZƒvƒ^[C9.1‚Ì«ó. ‹v•Û“cFˆêi”÷jC‰Á“¡GŽ÷iŽÀ’†Œ¤jC¬ŽR_ˆêiŠñj: ‘æ28‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï i98.12.04j, _ŒË, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 28: 356, 1998.

328. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰©FƒuƒhƒE‹…‹Û‚Ì•@o“à•Û—L󋵂̌Ÿ“¢. “‡“àçŒbŽqi”÷jC•½”ö•S‡ŽqiŠÅŒìŠw•”jCˆî–ØŸ‰pC—é–Ø—§rC•Ó–؉€KC‹kéËiŽ¨•@jCˆä㼋vi”÷j: ‘æ13‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï i98.00.00j, “Œ‹ž.

329. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j TCRƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚ð—p‚¢‚½”DP¬—§EˆÛŽ‚ÉŠÖ‚·‚錤‹†i‘æ3•ñ). ‘P•û‹e•vC‘O“c‘åLCŸÀŽqC‹g‘òœAKC¬—Ñ‘PŠ®CŒ©í‘½ŠìŽqC–q–ìP‹vi“ŒŠC‘åjC‹Ê“àGˆêi”÷j: ‘æ50‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï i98.04.20j, å‘ä, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 50(Suppl.): 160, 1998.

330. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j E.faecium‚É‚¨‚¯‚éƒLƒmƒƒ“‚̈ꎟ•W“I•ªŽq. “¡–{Fˆêi‘å“ú–{»–òŒ¤jCŽRŠÝƒˆêi”÷jC¬ŽR“c‹`”ŽC¬Ž›—æŽqC•ž•”GºC’†‘ºMˆêi‘å“ú–{»–òŒ¤jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.04`05j, ˜a‰ÌŽR, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46(Suppl.): 150, 1998.

331. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j E.faecium‚̃Lƒmƒƒ“‚“x‘Ï«Šl“¾‹@\(1) GyrA‚¨‚æ‚ÑParC•ÏˆÙ‚ÌŒŸo. ¬ŽR“c‹`”Ži‘å“ú–{»–òŒ¤jCŽRŠÝƒˆêi”÷jC“¡–{FˆêC¬Ž›—æŽqC•ž•”GºC’†‘ºMˆêi‘å“ú–{»–òŒ¤jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.04`05j, ˜a‰ÌŽR, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46(Suppl.): 152, 1998.

332. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j E.faecium‚̃Lƒmƒƒ“‚“x‘Ï«Šl“¾‹@\(1) ƒLƒmƒƒ“”ro•ÏˆÙŠ”‚ÌŒŸ“¢. ¬Ž›—æŽqi‘å“ú–{»–òŒ¤jCŽRŠÝƒˆêi”÷jCm‰êrKC¬ŽR“c‹`”ŽC“¡–{FˆêC•ž•”GºC’†‘ºMˆêi‘å“ú–{»–òŒ¤jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.04`05j, ˜a‰ÌŽR, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46(Suppl.): 153, 1998.

333. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Klebsiella pneumoniae‚©‚ç‚ÌESBLŽY¶‹Û‚ÌŒŸo‚Æ‚»‚Ì«ó‚ɂ‚¢‚Ä. “ß{”üsi–ì•Ó’n•a‰@jC¬¼—mŽqi—\–hˆãŠwŒnjC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.04`05j, ˜a‰ÌŽR, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46(Suppl.): 157, 1998.

334. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ESBLŽY¶‹Û‚Ì•aŒ´«‚ÉŠÖ‚·‚錤‹†. •€N—Yi’é‹ž‘åjC‰Á“¡~ŽqCˆÉ“¡‹§C“‡–{—SŽqC™ŽR”£C‹{‰º‘ôC¼’J”£C‘ˆä‰³•FC¼‘º[CŽR–{”ü˜aCì㬖éŽqC‹{‘òK‹vC‰ª–{—¹ˆêCˆä㼋v i”÷j: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.04`05j, ˜a‰ÌŽR, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46(Suppl.): 210, 1998.

335. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒƒ^ƒƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ŒŸo–@‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ¬ˆé„i”÷jC²“¡‘וFiº˜a–ò•iŒ¤jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.04`05j, ˜a‰ÌŽR, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46(Suppl.): 85, 1998.

336. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j E.cloacae—R—ˆClass CŒ^ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[‘½—ÊŽY¶•ÏˆÙŠ”‚̈â“`‰ðÍ. ‹v‰ä–¾’jC‰ª–{—¹ˆêC²“¡—DŽqCˆä㼋vi”÷j: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.04`05j, ˜a‰ÌŽR, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46(Suppl.): 86, 1998.

337. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ŒŸ¸—pÜPCase TEST‚Ì–â‘è“_‚Æ‚»‚̉ü—ǂɂ‚¢‚Ä. ‰ª–{—¹ˆêC¬ˆé„C²“¡—DŽqC‹v‰ä–¾’jCˆä㼋vi”÷j: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.04`05j, ˜a‰ÌŽR, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46(Suppl.): 88, 1998.

338. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PCR–@‚É‚æ‚è‚S‹ÛŽí‚©‚瓯ˆê‚ÌESBLŽY¶ˆâ“`Žq‚ðŒŸo‚µ“¾‚½‚PÇ—á. ŽR–{”ü˜ai’é‹ž‘åjCŽR“cç‰eC¼‘º[Cì㬖éŽqC•€N—YC‹{‘òK‹vC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ45‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i98.11.11`13j, ‚’m, —Õ°•a—, 46(Suppl.): 266, 1998.

339. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j E.faecalis‚̃Lƒmƒƒ“‚“x‘Ï«‹@\. “¡–{Fˆêi‘å“ú–{»–òŒ¤jCŽRŠÝƒˆêi”÷jC¬ŽR“c‹`”ŽC¬Ž›—æŽqC•ž•”Gºi‘å“ú–{»–òŒ¤jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ45‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï i98.11.26j, “Œ‹ž, ´˜^W, p.55, 1998.

340. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒvƒ‰ƒXƒ~ƒh«‚Ìclass C type ƒÀ-lactamase‚ðŽY¶‚·‚éE.coli‚ÆK.pneumoniae‚ɂ‚¢‚Ä‚ÌŠî‘b“IŒŸ“¢‚ɂ‚¢‚Ä. ŽR“cç‰eCì㬖éŽqCŽR–{”ü˜aC¼‘º[C¬ò”ŽºC•€N—YC‹{‘òK‹vi’é‹ž‘åjC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ45‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï i98.11.26j, “Œ‹ž, ´˜^W, p.57, 1998.

341. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Serratia marcescens—R—ˆ‚̃Nƒ‰ƒX‚`Œ^‚¨‚æ‚Ñ‚aŒ^ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ŽY¶ƒvƒ‰ƒXƒ~ƒh‚ɂ‚¢‚Ä. –î–ìŽõˆêC‹v‰ä–¾’jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ45‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï i98.11.26j, “Œ‹ž, ´˜^W, p.58, 1998.

342. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j E.cloacae—R—ˆclass CŒ^ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[‘½—ÊŽY¶•ÏˆÙŠ”‚̈â“`‰ðÍ. ‹v‰ä–¾’jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ72‰ñ“ú–{׋ۊw‰ï‘‰ï i99.03.24`26j, “Œ‹ž, “ú–{׋ۊwŽGŽ, 54: 175, 1999.

343. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Serratia marcescens—R—ˆ‚̃Nƒ‰ƒX‚`Œ^‚¨‚æ‚Ñ‚aŒ^ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ŽY¶ƒvƒ‰ƒXƒ~ƒh‚ɂ‚¢‚Ä. –î–ìŽõˆêC‹v‰ä–¾’jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ72‰ñ“ú–{׋ۊw‰ï‘‰ï i99.03.24`26j, “Œ‹ž, “ú–{׋ۊwŽGŽ, 54: 273, 1999.

344. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Salmonella typhimurium—R—ˆƒ~ƒjƒZƒ‹‚ÌŒoŒû¶‹ÛƒƒNƒ`ƒ“‚Æ‚µ‚Ẳ”\«. ùŒ´•ŽuCˆä㼋vi”÷jC¬¼—mŽqi—\–hˆãŠwŒnj: ‘æ71‰ñ“ú–{׋ۊw‰ï‘‰ï i98.04.03j, ¼–{, “ú–{׋ۊwŽGŽ, 53(1): 234, 1998.

345. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŒoŒûRŒ´“Š—^‚ÍIEL‚Æ––½‚s×–E‚ɈقȂ锽‰ž«‚ð—U“±‚·‚é. ‹Ê“àGˆêi”÷jC²“¡Œ’li“ŒŠC‘åjC¬‘òGsiƒcƒ€ƒ‰jC¬ŽR_ˆêiŠñjC’r˜eM’¼iŠÅŒìŠw•”jC”ª‘º•qŽuCã–ììCˆêi“Œ‘åjCŠ_¶‰€Žqi“ŒŠC‘åj: ‘æ28‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï i98.12.03j, _ŒË, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 28: 144, 1998.

346. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Salmonella typhimurium—R—ˆƒ~ƒjƒZƒ‹‚ÌŒoŒû¶‹ÛƒƒNƒ`ƒ“‚Æ‚µ‚Ẳ”\«(2). ùŒ´•ŽuCˆä㼋vi”÷jC¬¼—mŽqi—\–hˆãŠwŒnj: ‘æ72‰ñ“ú–{׋ۊw‰ï‘‰ï i99.03.24`26j, “Œ‹ž, “ú–{׋ۊwŽGŽ, 54(1): 304, 1999.

347. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j VŒ^ƒTƒ‹ƒ‚ƒlƒ‰ƒƒNƒ`ƒ“‚ÌŠJ”­. ùŒ´•Žui”÷j: ‘æ47‰ñ“ú–{Š´õÇŠw“Œ“ú–{’n•û‰ï‘‰ïE‘æ45‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï i98.11.26j, “Œ‹ž, ´˜^W, p.32, 1998.

348. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[‚Ì“®Œü‚Æ‚»‚Ì‘Îô|ƒOƒ‰ƒ€‰A«ž…‹Û‚ð’†S‚É|. ˆä㼋vC‹v‰ä–¾’jC‰ª–{—¹ˆêi”÷j: ‘æ28‰ñŒ™‹C«Š´õÇŒ¤‹†‰ï i98.00.00j, “Œ‹ž, ´˜^W, p.13, 1998.

349. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Serratia marcescens—R—ˆ‚̃Nƒ‰ƒX‚`Œ^‚¨‚æ‚Ñ‚aŒ^ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ŽY¶ƒvƒ‰ƒXƒ~ƒh‚ɂ‚¢‚Ä. –î–ìŽõˆêC‹v‰ä–¾’jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ‚V‰ñ–òÜ‘Ï«ƒVƒ“ƒ|ƒWƒEƒ€ i98.00.00j, “Œ‹ž, ´˜^W, p.10`11, 1998.

350. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j –òÜ‘Ï«‚ðŽw•W‚Æ‚µ‚½‰@“àŠ´õ‚ÌŒ»ó. ˆä㼋vi”÷j: ŠÖ“Œ’üM•a‰@‰@“àŠ´õ‘ÎôˆÏˆõ‰ï i98.04.16j, “Œ‹ž.

351. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j MRSA‚ÌŠî‘b‚ƃeƒCƒRƒvƒ‰ƒjƒ“. ˆä㼋vi”÷j: ‘æ‚Q‰ñˆ¤•QŒ§•a‰@–òÜŽt‰ï“Œ—\Žx•”Œ¤C‰ï i98.06.02j, ¼ŽR.

352. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‘Ï«‹ÛoŒ»‚Ì”wŒi‚ðl‚¦‚é. ˆä㼋vi”÷j: ‘æ3‰ñ–k•”•Ÿ‰ªŠ´õÇŒ¤‹†‰ïŽx•”Œ¤C‰ï i98.09.11j, –k‹ãB.

353. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ˜b‘è‚Ì‘Ï«‹Û. ˆä㼋vi”÷j: •½¬10”N“xŽl‘—Õ°ŒŸ¸‹ZŽt‰ï”÷¶•¨Œ¤C‰ï i98.10.25j, “¿“‡.

354. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Šî‘b׋ۊw“I—§ê‚©‚ç‚Ý‚½‰@“àŠ´õ‚ÌŒ»ó. ˆä㼋vi”÷j: ‘æ‚T‰ñ“ú–{ˆã‰È‘åŠw‰@“àŠ´õ‘Îô i98.11.00j, “Œ‹ž.

355. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j R‹Û–ò‚Æ‘Ï«‹Û‚ÌoŒ». ˆä㼋vi”÷j: ‘æ21‰ñŽ­Ž™“‡Š´õÇŒ¤‹†‰ï i99.02.12j, Ž­Ž™“‡.

356. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j R‹Û–ò‚Æ‘Ï«‹Û‚ÌoŒ». ˆä㼋vi”÷j: ‘æ21‰ñŽ­Ž™“‡Š´õÇŒ¤‹†‰ï i99.02.12j, Ž­Ž™“‡.

357. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒTƒ‹ƒ‚ƒlƒ‰ƒ~ƒjƒZƒ‹‚ÌŒoŒûƒƒNƒ`ƒ“‚Æ‚µ‚Ẳ”\«. ùŒ´•Žui”÷j: ‘æ‚U‰ñ–k—¢”÷¶•¨ƒAƒJƒfƒ~[Œ¤‹†‰ï i99.02.24j, “Œ‹ž.

358. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j VŒ^ƒqƒgƒpƒsƒƒ}ƒEƒCƒ‹ƒX‚Ì’Tõ‚Æ‚»‚̉ðÍ. –k—¢‰p˜Yi”÷jC]ì´•¶iŒF–{‘åjCˆä㼋vi”÷j: ‘æ11‰ñˆâ“`Žq‚Æ‚»‚ÌŽü•Ó i98.08.04j, \˜a“c.


<<07 –ƉuŠw>>

359. m€Œ´’˜n Prolongation effect of FK506 on the survival of 3-day preserved kidney allografts in dogs. “n•”_“ñi–ƉujC^è‹`•FCŠÛŽR–ΑPiŽÀ“®ŒnjC‰““¡’‰—YC¬ŽÄŒ’i”åjC²“¡ŒõŽjCŠ`“cÍiŠOj: Transplant. Proc., 30(7): 3603`3605, 1998.

360. mŒ¤‹†•ñiŒú¶Èjn ‘åŒ^“®•¨iƒCƒkj‚É‚æ‚é–ƉuŠ°—eƒ‚ƒfƒ‹‚ÉŠÖ‚·‚錤‹†. “n•”_“ñi–ƉujC’–ŒÒ—T‹I—mi‹ž‘åj: •½¬9”N“xŒú¶‰ÈŠwŒ¤‹†”ï•â•‹à, –Ɖu¥ƒAƒŒƒ‹ƒM[“™Œ¤‹†Ž–‹Æi‘ŸŠíˆÚA•”–åjŒ¤‹†•ñ‘, p.18`23, 1998.

361. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Trimming of auto-crossreactive antibodies: implications of the cytolytic activity of CD4+ T cells, lpr disease and positive selection. ŽÂŒ´MŒ«i–Ɖuj: ‘æ28‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï i98.12.03j, _ŒË, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ïŠwpW‰ï‹L˜^, 28: 11, 1998.

362. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj Ž€‘ÌtˆÚA‚Ö‰ž—p‰Â”\‚ȬŒ¢‚ðƒ‚ƒfƒ‹‚É‚µ‚½–ƉuŠ°—e‚Ì“±“ü–@. “n•”_“ñC‹àŽq„‹vC‘å’J•¶—Yi–ƉujC‰““¡’‰—Yi”åjC²“¡ŒõŽjiŠOjC^è‹`•FiŽÀ“®Œnj: ‘æ34‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i98.12.01j, “Œ‹ž, “ú–{ˆÚAŠw‰ï‘‰ï, 33(—Õ): 161, 1998.

363. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ¬Œ¢‚ÌtˆÚA‚ðƒ‚ƒfƒ‹‚É‚µ‚½–ƉuŠ°—e“±“ü–@. “n•”_“ñC‘å’J•¶—YC‹àŽq„‹vi–ƉujC‘å‹v•Û‚Ý‚Ç‚èC”Ñ’Ë‚Ý‚³‚ði—\–hˆãŠwŒnjCŽÂŒ´MŒ«i–Ɖuj: ‘æ28‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï i98.12.04j, _ŒË, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ïŠwpW‰ï‹L˜^, 28: 371, 1998.


<<08 •a—Šw>>

364. mŒ´’˜n Detection of K-ras point mutations in the supernatants of peritoneal and pleural effusions for diagnosis complementary to cytologic examination. ŽR‰º˜a–çC‹vêŽ÷CŽÂ“cGi•a‰@•a—jC‚‹´‰fŽqC‰ªˆÀŒMi•a—j: Am. J. Clin. Pathol., 109(6): 704`711, 1998.

365. mŒ´’˜n Active cyclin A-cdkz complex, a possible critical factor for cell proliferation in human primary lung carcinoma. “y‹´—mC‘‘ŽiŒõ•FCÓ¢ˆ®C¬—Ñ^—ŽqCì‹v•ÛˆÀ˜NC‹T’J“Oi•a—j: Am. J. Pathol., 153(9): 863`872, 1998.

366. mŒ´’˜n Tumor extension and cell proliferation in adenocarcinoma of the lung. ‘‘ŽiŒõ•FC“y‹´—mi•a—jCX‰i³“ñ˜Yi“s϶‰ï’†‰›•a‰@jCÓ¢ˆ®C‹T’J“Oi•a—j: Am. J. Pathol., 154(3): 909`918, 1998.

367. mŒ´’˜n Large cell neuroendocrine carcinoma of the lung, a histologic and immunohistochemical study of 22 cases. Ó¢ˆ®C‹T’J“OC‘‘ŽiŒõ•FC“y‹´—mi•a—jC•i“cƒC‹g‘º”Ž–Mi‹¹ŠOj: Am. J. Surg. Pathol., 22(5): 526`537, 1998.

368. mŒ´’˜n Additive effects of medroxyprogesterone acetate and 5-fluorouracil derivative on 7,12-dimethylbenz-[a]anthracene-induced rat mammary tumors. â–{”ECŒ´–ù‹gCMitamura, T.CSassa, S.CKudo, H.CSuzuki, S.CKuwa, K.i“ŒˆãŽ•‘åjC‰ªˆÀŒMi•a—jCShinoda, H.i“ŒˆãŽ•‘åj: Anti-Cancer Drugs, 9: 351`357, 1998.

369. mŒ´’˜n Expression of HuD protein is essential for initial plase of neuronal differentiation in rat pheochromocytoma PC12 cells. “y‹´—mC‘‘ŽiŒõ•FCŽá“c—tŽqC‹T’J“Oi•a—j: Biochem. Biophys. Res. Commun., 244(3): 226`229, 1998.

370. mŒ´’˜n CDK4, a possible critical regulator of apoptosis in rat pheochromocytoma PC12 cells. “y‹´—mC‘‘ŽiŒõ•FC‹T’J“Oi•a—jCKondo, E.i‰ª‘åjCAkiyama, T.i“Œ‘åj: Biochem. Biophys. Res. Commun., 253(3): 609`613, 1998.

371. mŒ´’˜n Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis. ŽOŽ}MC‰ªˆÀŒMi•a—j: Cancer, 83: 111`121, 1998.

372. mŒ´’˜n Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis. ŽOã“N•vC–ö‘òM”Vi•a—jC”nêLsC¬’r·—Yi‹îž•a‰@jC‰ªˆÀŒMi•a—j: Cancer, 85(2): 318`325, 1999.

373. mŒ´’˜n Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma. ŽOŽ}Mi•a—jC‹´‘º”ü‹IiŒ`‘ÔŒnjCŒ´“ÖŽqi“àjC‰ªˆÀŒMi•a—j: Cancer, 85(2): 453`464, 1999.

374. mŒ´’˜n p53 and p21 WAF1 expression in lymphocytic thyroiditis and thyroid tumors. ‰ªˆÀŒMi•a—jCŒY•”“ŒŽ¡iŠOjC¬–ì‘ò—Îi•a—Œ¤C¶jCŽOã“N•vi•a—jC“¡Œ´–rŒ›i“úÔˆã—ÃZƒ“ƒ^[j: Clin. Immunol. Immunopathol., 88(2): 183`191, 1998.

375. mŒ´’˜n Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Vˆä‹g“Ti•a—Œ¤C¶jC‚—œ‹ÏC–k슰iƒwƒLƒXƒgŒ¤jC‰ªˆÀŒMi•a—j: Cytokine, 10(11): 890`896, 1998.

376. mŒ´’˜n Chromogranin B (secretogranin I), a neuroendocrine-regulated secretory protein, is sorted to exocrine secretory granules in transgenic mice. Natori, S.CKing AngusCWeib UrsulaiHeidelberg‘åjCIguchi, H.i‹ãB‚ª‚ñƒZƒ“jC“y‰®giˆã—Éq¶jC‹T’J“Oi•a—jCTakayanagi, R.CNawata, H.i‹ã‘åjCWieland B. HuttneriHeidelberg‘åj: EMBO J., 17(12): 3277`3289, 1998.

377. mŒ´’˜n Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas. ‰ªˆÀŒMCŽO•xO”Vi•a—jCŽR‰º˜a–çi•a‰@•a—jCŽOã“N•vi•a—jC“¡Œ´–rŒ›i“úÔƒZƒ“ƒ^[jC‰Á“¡ŠîMC‰Ÿ‘º[—Yi’¹Žæ‘åj: J. Cancer Res. Clin. Oncol., 124: 444`449, 1998.

378. mŒ´’˜n High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical pictures. Kosugi, S.i‹ž‘åjC²“¡—Yˆêi•a—jCMatsuda, A.i‹ž‘åjC‘åŽR‹XGiŽ™jCFujieda, K.i–k‘åjCInomata, H.i’é‹ž‘åjC‹T’J“Oi•a—jCIsozaki, O.i“Œ—ˆã‘åjCSissy M. JhiangiOhio State Univ.j: J. Clin. Endocrinol. Metab., 83(11): 4123`4129, 1998.

379. mŒ´’˜n Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumors. ŽOŽ}Mi•a—jC‹´‘º”ü‹IiŒ`‘ÔŒnjC’¬“c‘å•ãi•a‰@•a—jC‰ªˆÀŒMi•a—j: J. Pathol., 187: 173`183, 1999.

380. mŒ´’˜n Up-regulation of CD44 variant exon expression in endometrial carcinomas; Analysis of mRNA and protein isoforms, and relation to clinicopathological factors. ŽOŽ}MC‰ªˆÀŒMi•a—j: Jpn. J. Cancer Res., 89: 291`298, 1998.

381. mŒ´’˜n K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination. ŽR‰º˜a–çi•a‰@•a—•”jC–Ø“c–FŽ÷i“àjCŽÂ“cGi•a‰@•a—•”jC–Ø“cŒõLi“àjC‰ªˆÀŒMi•a—j: Jpn. J. Cancer Res., 90: 240`248, 1999.

382. mŒ´’˜n Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Liang ShanCYasushi NakamuraCMisa NakamuraCToyoharu YokoiCMasahiko Tsujimotoi˜a‘åjCRyoichi Arimaiã‘åjC‹T’J“Oi•a—jCKennichi Kakudoi˜a‘åj: Lab. Invest., 78(4): 471`475, 1998.

383. mŒ´’˜n The significance of frequent and independent p53 and bcl-2 expression in large cell neuroendocrine carcinomas of the lung. Ó¢ˆ®C‹T’J“Oi•a—jC•i“cƒC‹g‘º”Ž–Mi‹¹ŠOj: Mod. Pathol., 12(3): 1999.

384. mŒ´’˜n The role of the Epstein-Barr virus in the oncogenesis of EBV(+) gastric carcinomas. ‚–ìN—Yi•a—jC‰Á“¡—miŠàŒ¤jCŽOŽ}Mi•a—jCX–ΘYC‰–“c^”üi“Œ‘åˆã‰ÈŒ¤jC‘“cŒõLi‰¡•lŽs‘åjCŽOã“N•vC‰ªˆÀŒMi•a—j: Virchows Arch., 434: 17`22, 1999.

385. m’Z•ñ¥‘¬•ñn Evaluation of antifungal activity of an antifungal drug by in vitro simulation of in vivo pharmacokinetics of the drug against fungal hyphal growth. ŒàŠî–PC”’‹à‰pŽ÷C¼‰ª‰p–¾CV’ØNCŽR“c‹gi“Œ‹ž”_H‘åjC‘q“c_i“Œ‹žŒ°”÷‹¾‰@jC–]ŒŽ^‹|i–òÜjC‹v•ÄŒõi•a—j: Jpn. J. Med. Mycol., 39(3): 173`178, 1998.

386. mŒ¤‹†•ñi•¶•”Èjn –«bó‘B‰Š‚Ìbó‘B”­Šà‘£iì—p‚É‚¨‚¯‚éƒeƒƒƒA’·¥ƒeƒƒƒ‰[ƒ[Šˆ«‚̉ʂ½‚·–ðŠ„. ‰ªˆÀŒMi•a—j: •½¬9`10”N“x‰ÈŠwŒ¤‹†”ï•â•‹à, Šî”ÕŒ¤‹†(C-2)Œ¤‹†¬‰Ê•ñ‘, 1998.

387. mÇ—á•ñn Sarcomatoid Carcinoma of the Descending Colon. ‘‘ŽiŒõ•FC“y‹´—mCŠâŸºŒ[ˆêCŒK”ö’èmCŽOã“N•vC‹T’J“Oi•a—j: Acta Oncol., 37(7/8): 765`768, 1998.

388. mÇ—á•ñn Neuron-specific enolase-producing epithelioid leiomyosarcoma with gross vascular invasion and intracardiac involvement. “y‹´—mi•a—jC“ß{–ìG“ñC–ìŒû‚Žji®ŠOjC‹T’J“Oi•a—j: Arch. Pathol. Lab. Med., 122(12): 1116`1119, 1998.

389. mÇ—á•ñn A functional thyrotropin- and growth hormone-secreting pituitary adenoma with a ultrastructurally monomorphic feature: A case study. Ozawa, Y.iŒc‘åjC‹T’J“Oi•a—jCKasuga, A.C¬‚•½Ž¡CKanda, N.CMaruyama, H.CSaruta, T.iŒc‘åj: Endocr. J., 45(2): 211`219, 1998.

390. mÇ—á•ñn Immunohistochemical analysis of a case of gastritis cystica profunda associated with carcinoma development. ŽO•xO”VCŠâŸºŒ[ˆêi•a—jC‰J‹{–¾•¶C‹à“cŒå—ÇiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: Scand. J. Gastroenterol., 33: 1226`1229, 1998.

391. mÇ—á•ñn Autoimmune enteropathy with severe atrophic gastritis and colitis in an adult; Proposal of a generalized autoimmune disorder of the alimentary tract. ŽO•xO”Vi•a—jC“c•Ó‘CŒÜ\—’³LCŸ–””º‰hi“àjCVˆäLNC‹e’rŽj˜YiŠOjCŠô¢‹´“Äi“àjC‰ªˆÀŒMi•a—j: Scand. J. Gastroenterol., 33: 716`720, 1998.

392. mÇ—á•ñn Recurrence in meningeal hemangiopericytomas. Hara, M.C–öŒ†CNagashima, G.CWakimoto, H.CŽOã“N•vi•a—jCYamamoto, S.CTamaki, M.CHirakawa, K.i“ŒˆãŽ•‘åj: Surg. Neurol., 50: 586`591, 1998.

393. m‘àn in situ RT-PCR–@. “n•ÓƒC‹T’J“Oi•a—j: ŒŸ¸‚Æ‹Zp, 27(5): 1999.

394. m‘àn Š´õÇÇŒóŒQ‡U; ‡Z.ƒgƒŠƒpƒmƒ\[ƒ}Ç. ‹v•ÄŒõC‚ˆä’qŽqi•a—j: •Êû“ú–{—Õ°—̈æ•ÊÇŒóŒQƒVƒŠ[ƒY, (24): 405`408, 1998.

395. muÀn Ž¾Š³•Ê•a‘Ô¶—‚Æ•a—¥—Õ°ŒŸ¸ˆãŠw[16]ƒAƒgƒs[«”畆‰Š(Atopic Dermatitis AD). ‹v•ÄŒõi•a—jC–]ŒŽ^‹|iç—t‘åj: ŒŽŠ§–òŽ–, 40(12): 93`103, 1998.

396. mŠwp‘n i•ª’SŽ·•Mj ‘å’°‚Ì—Õ°•ªŽq•a—Šw; IBD‚É‚¨‚¯‚é”­Šà‹@\‚ƈâ“`ŽqˆÙí, p.44`50, ‰ªˆÀŒMCŽO•xO”Vi•a—jCVˆäLNiŠOjCŒÜ\—’³Li“àj. •ÒW “¡·F”ŽiàÕ‹¦ˆã‘åjC•ÒC ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹žC98.00.00”­s.

397. mŠwp‘n i•ª’SŽ·•Mj Annual Review ŒÄ‹zŠí1999; Ž¾Š³‚Ì•aˆö‚Æ•a‘Ô 8._Œo“à•ª”啪‰»‚ðŽ¦‚·”xŽîá‡, p.126`132, ‹T’J“Oi•a—j. ’†ŠOˆãŠwŽÐC99.01.20”­s.

398. m‹³‰È‘n i•ª’SŽ·•Mj —Õ°”÷¶•¨Šw; —Õ°^‹ÛŠw‘˜_, p.206`211, ‹v•ÄŒõi•a—jC‘¼5–¼. •ÒW ›–ì„Žji•l¼ˆã‘åjC¼“cM‹`iìèˆã‘åjC•ÒC ˆãŠw‘‰@, “Œ‹žC98.04.15”­s.

399. m‹³‰È‘n i•ª’SŽ·•Mj —Õ°”÷¶•¨Šw; —Õ°^‹ÛŠwŠe˜_, p.213`235, ‹v•ÄŒõi•a—jC‘¼5–¼. •ÒW ›–ì„Žji•l¼ˆã‘åjC¼“cM‹`iìèˆã‘åjC•ÒC ˆãŠw‘‰@, “Œ‹žC98.04.15”­s.

400. m–|–ón i‹¤’˜j Á‰»ŠÇ^‹ÛÇ Siegfried Nolting’˜; ‹v•ÄŒõi•a—jC–å“cŒ\Žqi–¾Ž¡–ò‰È‘åj. ƒƒfƒBƒJƒ‹ƒgƒŠƒrƒ…[ƒ“, “Œ‹žC98.05.30”­s.

401. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Detection of IL-6 mRNA in human tumor cells by in situ reverse transcription-PCR. “n•ÓƒC²“¡—Yˆêi•a—jC“y‰®giˆã—Éq¶jCKobayashi, K.C‹T’J“Oi•a—j: 5th Joint Meeting, Japan Society of Histochemistry and Cytochemistry i98.07.24`26j, San Diego, J. Histochem. Cytochem., 46: 31, 1998.

402. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’_”XŠà‚É‚¨‚¯‚éBcl-2‚Ì”­Œ»‚Æ‚»‚̈Ӌ`‚ɂ‚¢‚Ä. ŽOã“N•vC–ö‘òM”VCŽO•xO”Vi•a—jC”nê—T”VC¬’r·—Yi“s—§‹îž•a‰@jC‰ªˆÀŒMi•a—j: ‘æ87‰ñ“ú–{•a—Šw‰ï‘‰ï i98.04.15j, L“‡, “ú–{•a—Šw‰ï‰ïŽ, 87(1): 396, 1998.

403. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{“à–ŒŠà‚É‚¨‚¯‚éCD44’`”’mRNA‰ßè”­Œ»‚ƈӋ`. ŽOŽ}Mi•a—jC‹´‘º”ü‹IiŒ`‘ÔŒnjC‰ªˆÀŒMi•a—j: ‘æ87‰ñ“ú–{•a—Šw‰ï‘‰ï i98.04.15j, L“‡, “ú–{•a—Šw‰ïŽ, 87(1): 394, 1998.

404. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Independent p53 and Bcl-2 expression in large cell neuroendocrine carcinomas of the lung. Ó¢ˆ®C“y‹´—mC‘‘ŽiŒõ•FC‹T’J“Oi•a—j: ‘æ87‰ñ“ú–{•a—Šw‰ï‘‰ï i98.04.16j, L“‡, “ú–{•a—Šw‰ï‰ïŽ, 87(1): 454`454, 1998.

405. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒg”xŠà‚É‚¨‚¯‚é×–EŽüŠú§ŒäˆöŽqcdk2‚Ì‹@”\. “y‹´—mC‘‘ŽiŒõ•FCÓ¢ˆ®Cì‹v•ÛˆÀ˜NC‹T’J“Oi•a—j: ‘æ87‰ñ“ú–{•a—Šw‰ï‘‰ï i98.04.16j, L“‡, “ú–{•a—Šw‰ï‰ïŽ, 87(1): 460, 1998.

406. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘Šú”x‘BŠà‚Ì‘B‚É‚¨‚¯‚é×–EŽüŠúŠÖ˜A’`”’‚ÌŠÖ—^. ‘‘ŽiŒõ•FC“y‹´—mCÓ¢ˆ®i•a—jCX‰i³“ñ˜Yi“s϶‰ï’†‰›•a‰@jC‹T’J“Oi•a—j: ‘æ87‰ñ“ú–{•a—Šw‰ï‘‰ï i98.04.16j, L“‡, “ú–{•a—Šw‰ï‰ïŽ, 87(1): 460, 1998.

407. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j cyclin D1’`”’‰ßè”­Œ»‚͈݊à‚Ìis‚Æ—\Œã‚É–§Ú‚ÉŠÖ—^‚·‚é. ‚–ìN—YC‰ªˆÀŒMi•a—j: ‘æ87‰ñ“ú–{•a—Šw‰ï‘‰ï i98.04.16j, L“‡, “ú–{•a—Šw‰ï‰ïŽ, 87(1): 466, 1998.

408. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘OcŠu‚É”­¶‚µ‚½d‰»Œ^‘å×–E«ƒŠƒ“ƒpŽî‚Ì‚Q—á. ŠâŸºŒ[ˆêC‰ªˆÀŒMi•a—j: ‘æ87‰ñ“ú–{•a—Šw‰ï‘‰ï i98.04.16j, L“‡, “ú–{•a—Šw‰ï‰ïŽ, 87(1): 476, 1998.

409. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Mixed pituitary adenomas (GH-PRL producing) and ganglioneuroma in the sella turcica: A case report. ‹T’J“Oi•a—jC‰ªGGC¬—шè•vi”]ŠOjC¬‚•½Ž¡iŒc‘åjCì–ìM”VC“¡ˆä´Fi”]ŠOj: 7th International Pituitaty Pathology Club Meeting i98.10.04j, ” ª.

410. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Concept and moleculobiological approach of silent pituitary adenomas. ¬‚•½Ž¡iŒc‘åjC‹T’J“Oi•a—jCŒÃŠø–ÎC¬—шè•vi”]ŠOjC‘å’JŒõOC‰Í£•k: 7th International Pituitaty Pathology Club Meeting i98.10.05j, ” ª.

411. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Hormone-marker profiles and prognosis of 26 large cell neuroendocrine carcinomas of the lung. Ó¢ˆ®C“y‹´—mC‘‘ŽiŒõ•Fi•a—jC•i“cƒC‹g‘º”Ž–Mi‹¹ŠOjC‹T’J“Oi•a—j: ‘æ39‰ñ“ú–{”xŠàŠw‰ï‘‰ï i98.10.30j, ‹à‘ò, ”xŠà, 38(5): 474`474, 1998.

412. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”xŠà‚É‚¨‚¯‚é×–E‘B‚Æcyclin A‚Æ‚ÌŠÖ˜A. ‘‘ŽiŒõ•FC“y‹´—mCÓ¢ˆ®C‹T’J“Oi•a—j: ‘æ39‰ñ“ú–{”xŠàŠw‰ï‘‰ï i98.10.30j, ‹à‘ò, ”xŠà, 38(5): 492, 1998.

413. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j in situ RT-PCR–@‚É‚æ‚éŽîá‡×–E‚ÌInterleukin-6 mRNA‚Ì”­Œ»‚ÌŒŸ“¢. “n•ÓƒC²“¡—Yˆêi•a—jC“y‰®giˆã—Éq¶jC‹T’J“Oi•a—j: ‘æ87‰ñ“ú–{•a—Šw‰ï‘‰ï i98.04.14j, L“‡, “ú–{•a—Šw‰ï‰ïŽ, 87(1): 349, 1998.

414. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žîá‡×–E‚É‚¨‚¯‚éInterleukin-6 mRNA‚Ì×–E“à”­Œ»‚ÌŒŸ“¢. “n•ÓƒC²“¡—Yˆêi•a—jC“y‰®giˆã—Éq¶jC‹T’J“Oi•a—j: ‘æ71‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï i98.06.05j, •Ÿ‰ª, “ú–{“à•ª”åŠw‰ïŽGŽ, 74(1): 200, 1998.

415. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •aŠú‡TŠú”x‘BŠà‚Ì‘B‚É‚¨‚¯‚é×–EŽüŠúŠÖ˜A’`”’‚ÌŠÖ—^. ‘‘ŽiŒõ•FC“y‹´—mCÓ¢ˆ®i•a—jCX‰i³“ñ˜Yi“s϶‰ï’†‰›•a‰@jC‹T’J“Oi•a—j: ‘æ57‰ñ“ú–{ŠàŠw‰ï i98.10.02j, ‰¡•l, ‘‰ï‹LŽ–, p.400, 1998.

416. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”xŠà‚Ì‘B‚É‚¨‚¯‚écdk2‚ÌŠÖ—^. “y‹´—mC‘‘ŽiŒõ•FCÓ¢ˆ®Cì‹v•ÛˆÀ˜NC‹T’J“Oi•a—j: ‘æ57‰ñ“ú–{ŠàŠw‰ï i98.10.02j, ‰¡•l, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.398, 1998.

417. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Intratumoral sarcoid reaction‚𔺂Á‚½‹CŠÇŽxƒJƒ‹ƒ`ƒmƒCƒh‚Ì‚P—á. Ó¢ˆ®C“y‹´—mC‘‘ŽiŒõ•Fi•a—jC•i“cƒC‹g‘º”Ž–Mi‹¹ŠOjC‹T’J“Oi•a—j: ‘æ39‰ñ“ú–{”xŠàŠw‰ï‘‰ï i98.10.29j, ‹à‘ò, ”xŠà, 38(5): 556`556, 1998.

418. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”x‘BŠà‚Æf’f‚³‚ê–UŒŸŒã‚É‹¹‘BŠà‚Æl‚¦‚ç‚ꂽ‚P—á. ‘‘ŽiŒõ•FC“y‹´—mCÓ¢ˆ®i•a—jC–î“ߣM—Yi“àjC‹T’J“Oi•a—j: ‘æ122‰ñ“ú–{”xŠàŠw‰ïŠÖ“Œ•”‰ï i98.07.18j, “Œ‹ž, “ú–{”xŠàŠw‰ïŠÖ“Œ•”‰ï‰ïŽ, p.9, 1998.

419. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹CŠÇŽxo“à”­ˆçŠà“÷Žî‚Ì‚P—á. Ó¢ˆ®C“y‹´—mC‘‘ŽiŒõ•FCŒ´‰p‘¥i•a—jC•i“cƒC‹g‘º”Ž–Mi‹¹ŠOjC‹T’J“Oi•a—j: ‘æ123‰ñ“ú–{”xŠàŠw‰ïŠÖ“Œ•”‰ï i98.12.12j, Š‘ò.

420. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ä”­‚ð‚«‚½‚µ‚½‹¹–ŒŽîᇂ̂PØœ—á. ŠâŸºŒ[ˆêi•a—j: “ú–{•a—Šw‰ïŠÖ“ŒŽx•”‘æ‚R‰ñ•W–{ŒðŒ©‰ï i99.01.23j, “Œ‹ž.

421. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j p‘Of’f‚ª¢“ï‚Å‚ ‚Á‚½‚•ª‰»Œ^Žq‹{Œz•”‘BŠà‚Ì‚P—á. ŠâŸºŒ[ˆêi•a—j: ‘æ‚X‰ñ•wl‰È•a—Œ¤‹†‰ï i98.12.19j, L“‡.

422. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Microangiography. ŽOŽ}Mi•a—j: ‘æ5‰ñŠÌŒŒ—¬“®‘ÔƒCƒ[ƒWŒ¤‹†‰ï i99.02.07j, “Œ‹ž.

423. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “û‘BØœ’f’[‚Ìf’f|•a—ˆã‚Ì—§ê‚©‚ç|. ŠâŸºŒ[ˆêi•a—j: ‘æ15‰ñ_“Þ쌧“û‘Bbó‘BŠO‰ÈŒ¤‹†‰ï i99.03.06j, ‰¡•l.

424. mŠw‰ïŽåÃi‘ÛŠw‰ïjn ‘Û‰º‚‘Ì•a—Œ¤‹†‰ï, ‘æ‚V‰ñ‰ï‹ci98.10.02`07j. ‹T’J“Oi•a—j:


<<09 ‰q¶ŠwEŒöO‰q¶Šw>>

425. mŒ´’˜n Control of pneumoconiosis in Japan. ‘Š‘òDŽ¡i‰qj: Asian Medical Journal, 41(12): 589`596, 1998.

426. mŒ´’˜n Evaluation of passive smoking by measuring urinary trans, transmuconic acid and exhaled carbon monoxide levels. ’JŒûŽu•äCV’Ã’J^li‰qjCˆäã—tŽqi—\–hˆãŠwŒnjC•Ð‹Ë—TŽjC–å˜e•”Žiˆã—Éq¶jC‘Š‘òDŽ¡i‰qj: Industrial Health, 37(1): 88`94, 1999.

427. mŒ´’˜n Change in obstructive pulmonary function as a result of cumulative exposure to welding fumes as determined by magnetopneumography in Japanese are welders. ’†ŠÙr•vi“Œ—ˆã‘åjC‘Š‘òDŽ¡i‰qjC”ªã‹œŽiiº˜aˆã‘åjCZheg Yi-QinC¬’J½i“Œ“d‹@‘åjCΓnOˆêiVƒLƒƒƒ^ƒsƒ‰[ŽO•Hj: Occupational and Environmental Medicine, 55(10): 673`677, 1998.

428. mŒ´’˜n Prognosis of accidental low back pain at work. ŽÂŒ´‘C‰ª“c[ŽjCŒv—Ç“OC‘å˜a“c^‹IŽqCV’Ã’J^lC‘Š‘òDŽ¡i‰qj: Tohoku J. Exp. Med., 186: 291`302, 1998.

429. mŒ´’˜n Magnetometric evaluation for the effect of chrysotile on alveolar macrophages. Œv—Ç“OC‰ª“c[Žji‰qjC•Ð‹Ë—TŽjiˆã—Éq¶jC‘Š‘òDŽ¡i‰qjC‰ªˆÀŒMi•a—jC¬’J½i“Œ“d‹@‘åj: Tohoku J. Exp. Med., 186: 87`98, 1998.

430. m€Œ´’˜n Role of laparoscopic vascular changes in fatty liver; comparative study with instrahepatic microvasculature using experimental model. Š¡•”‚ЂƂÝC‘Š‘òDŽ¡i‰qjCΈäŒö“¹i‘—§“쉡•l•a‰@jC“y‰®‰ëtiŒc‘åj: 20th European Conference on Microcirculation, p.35`39, 1998.

431. m€Œ´’˜n Estimation of exposure to welding fumes using new magnetopneumography. ”ªã‹œŽiiº˜aˆã‘åjC‘Š‘òDŽ¡i‰qjC’†ŠÙr•vi“Œ—ˆã‘åjC¬’J½CZheg Yi-Qini“Œ“d‹@‘åjCΓnOˆêiVƒLƒƒƒ^ƒsƒ‰[ŽO•Hj: Advances in the Prevention of Occupational Respiratory Diseases, p.136`141, 1998.

432. m€Œ´’˜n National survey on classification for surpervision of pneumoconiosis (1). ŽÂŒ´‘C‘Š‘òDŽ¡C’JŒûŽu•äCV’Ã’J^li‰qjC™‰Y—R”üŽqi—\–hˆãŠwŒnjC“n•ÓŒõNC”‘—˜‰hŽqC‚“c™¦i‰qj: Advances in the Prevention of Occupational Respiratory Diseases, p.157`161, 1998.

433. m€Œ´’˜n National survey on classification for surpervision of pneumoconiosis (2). ’JŒûŽu•äC‘Š‘òDŽ¡CV’Ã’J^li‰qjC™‰Y—R”üŽqi—\–hˆãŠwŒnjCŽÂŒ´‘i‰qjC’†‘ºŒ«iˆã—Éq¶jCŒÃ‰Í‘×C‚“c™¦i‰qj: Advances in the Prevention of Occupational Respiratory Diseases, p.162`165, 1998.

434. m€Œ´’˜n Effect of limestone on the alveolar macrophages of hamsters. ™‰Y—R”üŽqi—\–hˆãŠwŒnjCŒv—Ç“OC‘Š‘òDŽ¡C‰ª“c[ŽjC“n•ÓŒõNCŒ´“c‹vi‰qjC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjC¬’J½i“Œ“d‹@‘åj: Advances in the Prevention of Occupational Respiratory Diseases, p.550`554, 1998.

435. m€Œ´’˜n Effect of limestone on the lungs of rabbits. ^‰º‹I”ü‘ãi—\–hˆãŠwŒnjC‰ª“c[ŽjC‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝCŒv—Ç“OC“n•ÓŒõNi‰qjC™‰Y—R”üŽqi—\–hˆãŠwŒnjC¬’J½i“Œ“d‹@‘åj: Advances in the Prevention of Occupational Respiratory Diseases, p.555`560, 1998.

436. m€Œ´’˜n Magnetometric evaluation for toxicity of titanium dioxide to alveolar macrophages. ‰ª“c[ŽjC‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝCŒv—Ç“OCV’Ã’J^lCŽÂŒ´‘i‰qjC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjC¬’J½i“Œ“d‹@‘åj: Advances in the Prevention of Occupational Respiratory Diseases, p.621`625, 1998.

437. m€Œ´’˜n Magnetometric evaluation for the toxicity of silicon carbide whisker to alveolar macrophages in hamsters. Š¡•”‚ЂƂÝC‘Š‘òDŽ¡C‘å˜a“c^‹IŽqCŒv—Ç“OC‰ª“c[Žji‰qjC^‰º‹I”ü‘ãC™‰Y—R”üŽqi—\–hˆãŠwŒnjC¬’J½i“Œ“d‹@‘åj: Advances in the Prevention of Occupational Respiratory Diseases, p.626`630, 1998.

438. m€Œ´’˜n Magnetometric evaluation for the toxicity of chrysotile fibers to alveolar macrophages. Œv—Ç“OC‘Š‘òDŽ¡C‰ª“c[ŽjCŠ¡•”‚ЂƂÝCV’Ã’J^lCŽÂŒ´‘i‰qjC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjC¬’J½i“Œ“d‹@‘åj: Advances in the Prevention of Occupational Respiratory Diseases, p.664`668, 1998.

439. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn _“Þ쌧‰º‚ÌŠeŽíŠé‹Æ‚É‚¨‚¯‚郃“ƒ^ƒ‹ƒwƒ‹ƒX‚Ì•]‰¿•û–@. Š¡•”‚ЂƂÝi‰qjC–쑺r˜Z˜YC–ö‰ºŸ]CŽRŒû‰xŽqC’Ëvˆä—vi_“ÞìŽY‹Æ•ÛŒ’„iƒZƒ“jC‘Š‘òDŽ¡CŽÂŒ´‘i‰qjCˆäã´i“Œ‹žŒxŽ@•a‰@jC‰ª“c[Žj i‰qj: _“Þ쌧ŽY‹Æ•ÛŒ’„iƒZƒ“ƒ^[; ŽY‹Æ•ÛŒ’’²¸Œ¤‹†•ñ‘, p.1`16, 1998.

440. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ƒeƒgƒ‰ƒNƒƒƒGƒ`ƒŒƒ“‚Ì”ro‚É”º‚¤‘å‹C’†ŠgŽU”Z“x•ª•z‚ɂ‚¢‚Ä. –å˜e•”ŽC•Ð‹Ë—TŽjC’‡À­GC²“¡¹Žqiˆã—Éq¶jC‚“c™¦C‘Š‘òDŽ¡i‰qjC’†‘ºŒ«iˆã—Éq¶j: ‘S‘ƒNƒŠ[ƒjƒ“ƒOŠÂ‹«‰q¶“¯‹Æ‘g‡˜A‡‰ï; ƒNƒŠ[ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錤‹†•ñ‘•½¬‚X”N“x, p.10`15, 1998.

441. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ƒNƒŠ[ƒjƒ“ƒOì‹ÆŽÒ‚ÌŽ€ˆö\‘¢‚ÉŠÖ‚·‚é‰uŠw“IŒ¤‹†|’†ŠÔ•ñ|. ’†‘ºŒ«iˆã—Éq¶jC‚“c™¦i‰qjC–å˜e•”Žiˆã—Éq¶jC‘Š‘òDŽ¡CŒ´“c‹vCŠ¡•”‚ЂƂÝCV’Ã’J^li‰qjC—é–Ø–q•Fiˆã—Éq¶j: ‘S‘ƒNƒŠ[ƒjƒ“ƒOŠÂ‹«‰q¶“¯‹Æ‘g‡˜A‡‰ï; ƒNƒŠ[ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錤‹†•ñ‘•½¬‚X”N“x, p.16`21, 1998.

442. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ¶ŠU‚ɂ킽‚錒N‚Ì•ÛŽ‘iŠˆ“®‚Ì‘ÌŒn‰»‚ð‚ß‚´‚µ‚Ä. ¬ò–¾iŽY‹Æˆã‘åjC¬—Ñ“oi‘—§¬Ž™•a‰@jC‚“c™¦C‘Š‘òDŽ¡i‰qjCŒÜ\—’³hiŽ©Ž¡ˆã‘åjC‘å‹v•Û—˜WiŽY‹Æˆã‘åjC™“c”£i‘啪Œ§ˆãŽt‰ïjC•Œ© ŒhŽOi“ú–{ˆãŽt‰ïjC’†ìr’ji–kŠC“¹ˆãŽt‰ïjC¼ˆäˆê˜Yi‰¡•l`–k•ÛŒ’ŠjCX–{Œ“žGiã‘åjC‹g“cŸ”üi¹ƒ}ƒŠˆã‘åj: “ú–{ˆãŽt‰ï‘‡­ôŒ¤‹†‹@\ˆÏ‘õ; ¶ŠU‚ɂ킽‚錒N‚Ì•ÛŽ‘iŠˆ“®‚Ì‘ÌŒn‰»‚ð‚ß‚´‚µ‚Ä, p.1`23, 1998.

443. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ‰»Šw•¨Ž¿‰ß•qó‘Ô‚ÉŠÖ‚·‚é’²¸. ‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝCV’Ã’J^li‰qj: ˜J“­È; •½¬10”N“xЊQ‰ÈŠw‚ÉŠÖ‚·‚éˆÏ‘õŒ¤‹†•ñ‘, p.1`81, 1999.

444. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ƒKƒ‰ƒX‘@ˆÛ“™‚̉uŠw“I’²¸Œ¤‹†‚ÉŠÖ‚·‚éƒf[ƒ^ƒx[ƒX‚Ì쬂¨‚æ‚Ñ—LŠQ«ŽŽŒ±‚Ì‚½‚ß‚Ì•W€‘@ˆÛ‚Ì쬕û–@‚ÌŒ¤‹†ˆÏˆõ‰ï•ñ. ‚“c™¦C‘Š‘òDŽ¡i‰qjC_ŽRé•FiŽYˆãŒ¤jC‚‹´•ÛŽ¡i“ú–{–³‹@jC•x“c‰ësiƒjƒ`ƒAƒXjC¼‘ò‹¤Žii’†‰›˜JЖh‹¦jC“Œ•qºiŽY‹Æˆã‘åjCX‰iŒª“ñ i‘åã•{—§¬l•aƒZƒ“jC–î–ì‰h“ñi’é‹ž‘åjC¡‰–‰®ÍC—é–ØÍ‹Li˜J“­ÈjCH“¡ŒõOCô“cOˆê˜Yi’†‰›˜JЖh‹¦j: ˜J“­È; •½¬‚X”N“xƒKƒ‰ƒX‘@ˆÛ“™‚̉uŠw“I’²¸Œ¤‹†‚ÉŠÖ‚·‚éƒf[ƒ^ƒx[ƒX‚Ì쬂¨‚æ‚Ñ—LŠQ«ŽŽŒ±‚Ì‚½‚ß‚Ì•W€‘@ˆÛ‚Ì쬕û–@‚ÌŒ¤‹†ˆÏˆõ‰ï•ñ‘, p.1`153, 1998.

445. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ƒXƒ`ƒŒƒ“‚Ì_Œo“Å«‚ÉŒW‚í‚é‰uŠw“I’²¸Œ¤‹†ˆÏˆõ‰ï•ñ. ÷ˆäŽ¡•FiŽYˆãŒ¤jC‘Š‘òDŽ¡i‰qjCr‹Lrˆêi“Œ‘åjCˆä㮉pi‹ã‘åjC‘å‹v•Û—˜WiŽY‹Æˆã‘åjC‘å‘O˜aKiŒc‘åjC–k‘º‘ìi‘å“ú–{ƒCƒ“ƒLjC²“¡² •viŽR—œˆã‘åjC¼èGriˆ®‰»¬jC‹{ì@”ViŽYˆãŒ¤jC˜a“cUié‹Êˆã‘åj–q–ì–Γ¿CH“¡ŒõOi’†Ð–h˜J“­‰q¶ŒŸ¸ƒZƒ“jCà_–{˜aFCˆäã—zˆê˜Yi˜J “­ÈjC—é–Ø‹œC‘©“cOˆê˜Yi’†Ð–h˜J“­‰q¶ŒŸ¸ƒZƒ“j: ˜J“­È; •½¬‚X”N“xƒXƒ`ƒŒƒ“‚Ì_Œo“Å«‚ÉŒW‚í‚é‰uŠw“I’²¸Œ¤‹†ˆÏˆõ‰ï•ñ‘, p.1`99, 1998.

446. m‘àn ŽY‹Æˆã‚Æ‚µ‚ÄŠˆ“®‚·‚é‚É‚Í. ‘Š‘òDŽ¡i‰qj: J. Integr. Med., 9(2): 112`115, 1999.

447. m‘àn ‹i‰Œ‚ƈùŽð‚ÆŠà—\–h. ’JŒûŽu•äCŽÂŒ´‘C‘Š‘òDŽ¡i‰qj: Medicina, 35(3): 414`416, 1998.

448. m‘àn ˜J“­‰q¶Šî‘buÀ(10)˜J“­ˆÀ‘SƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg‚Ì‚½‚߂̘J“­‰q¶‚Ì’mŽ¯. ‘å˜a“c^‹IŽqC‘Š‘òDŽ¡i‰qj: ˆÀ‘S‰q¶ƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg, 18(46): 50`53, 1998.

449. m‘àn ‚¶‚ñ”x. ‘Š‘òDŽ¡i‰qj: “ú–{ˆãŽt‰ïŽGŽ, 120(3): 435`439, 1998.

450. m‘àn ì‹ÆŠÖ˜AŽ¾Š³—\–h‚Ì‚½‚ß‚ÌŒ’NŠÇ—(1) ‰Á—î‚Æì‹ÆŠÖ˜AŽ¾Š³. ‘Š‘òDŽ¡i‰qj: ˜J“­‰q¶ŠÇ—, 9(2): 19`25, 1998.

451. m‘àn ì‹ÆŠÖ˜AŽ¾Š³—\–h‚Ì‚½‚ß‚ÌŒ’NŠÇ—(2) Žå‚Èì‹ÆŠÖ˜AŽ¾Š³‚Ì”­¶—vˆö‚ÆŠÇ—. ‘Š‘òDŽ¡i‰qj: ˜J“­‰q¶ŠÇ—, 9(4): 33`37, 1998.

452. m‘àn •a‹x‹Æ“Œv•ñ. V’Ã’J^li‰qj: ˜J–±ˆÀ‘S‰q¶‚©‚È‚ª‚í, 1998(11): 20`23, 1998.

453. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i’P’˜j ˜J“­ˆÀ‘SƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg“™‚Ì‚½‚߂̘J“­‰q¶‚Ì’mŽ¯. ‘Š‘òDŽ¡i‰qj. •ÒW “ú–{˜J“­ˆÀ‘S‰q¶ƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg‰ï•ÒC “ú–{˜J“­ˆÀ‘S‰q¶ƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg‰ï, “Œ‹ž, 98.11.15”­s.

454. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ‹Æ–±ãŽ¾•a‚Ì”F’莑—¿Wi‰ü’ù”Å); ‘å“®–¬‚̉Á—î•Ï‰»‚ÉŠÖ‚·‚é•a—Šw“IŒ¤‹†, p.414`430, ‘Š‘òDŽ¡CV’Ã’J^li‰qj. •ÒW ˜J“­È•ÒC ˜J“­Šî€’²¸‰ï, “Œ‹ž, 98.03.01”­s.

455. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆˆãŽÀ‘HƒKƒCƒh; ŽY‹ÆˆãŠˆ“®‚ÌŠî–{: ŽY‹Æˆã‚ÌE–±‚Æ‚»‚ÌŽÀÛ, p.11`30, ‘Š‘òDŽ¡i‰qj. •ÒW ˜a“cUié‹Êˆã‘åj•ÒC •¶Œõ“°, “Œ‹ž, 98.08.26”­s.

456. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; ƒAƒ‹ƒR[ƒ‹ˆË‘¶Ç, p.8, Š¡•”‚ЂƂÝi‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

457. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; ˆê”ÊŒ’Nf’f, p.16`17, Œv—Ç“Oi‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

458. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; ƒGƒCƒY, p.31`32, Š¡•”‚ЂƂÝi‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

459. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; ‹i‰Œ, p.82`83, ’JŒûŽu•äi‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

460. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; Œ’NŠÇ—, p.113`114, ŽÂŒ´‘i‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

461. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; Œ’N‘Š’k, p.116`117, ŽÂŒ´‘i‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

462. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; ¶ŠˆKŠµ•a, p.269`270, V’Ã’J^li‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

463. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; ¶—“I”N—î, p.274, V’Ã’J^li‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

464. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; WHO, p.292`293, ŽÂŒ´‘i‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

465. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; “ÁŽêŒ’Nf’f, p.314, Œv—Ç“Oi‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

466. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; ”æ˜J, p.351`352, ‘Š‘òDŽ¡i‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

467. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; •s’èD‘i, p.360`361, V’Ã’J^li‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

468. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; ƒvƒ‰ƒCƒ}ƒŠ[ƒPƒA, p.363, ŽÂŒ´‘i‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

469. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; •½‹ÏŽõ–½, p.368`369, V’Ã’J^li‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

470. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; –ò•¨ˆË‘¶, p.392, Š¡•”‚ЂƂÝi‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

471. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ«“T; ˜’É, p.398`399, ‘Š‘òDŽ¡i‰qj. •ÒW ‹TŽR’¼Ki“ú–{˜J“­Œ¤‹†‹@\jC–Ø‘ºŽüi‘ñ‘åjC‚“c™¦i’†Ð–hjC’|“à“o‹K•viˆ¤’m‹³ˆç‘åjC“n•ÓŽOŽ}Žqi’}”g‘åjC•ÒC 쓇‘“X, “Œ‹ž, 99.03.05”­s.

472. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ÒWj Advances in the Prevention of Occupational Respiratory Diseases; •ÒW ç‘ã’JŒcŽOiŒ]”x˜JЕa‰@jCדc—Ti•úŽËü‰e‹¿‹¦‰ïjC‘Š‘òDŽ¡i‰qj•ÒC 98.00.00”­s.

473. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Study design, job stress patterns and implications for policy development. ì㌛liŠò•Œ‘åjCŒ´’J—²ŽjiŽYˆãŒ¤jC¬—ÑÍ—Yiˆ¤’mˆã‘åjCÎ蹕vi‹à‘òˆã‘åjC—Ñ„Žii“ú—§Œ’NŠÇ—ƒZƒ“jC“¡“c’èiŠ ’J‘‡•a‰@jC‘Š‘òDŽ¡ i‰qjC‹{貌áCœA®“TiNKKjC‹´–{C“ñi•xŽmƒ[ƒƒbƒNƒXjCr‹Lrˆêi“Œ‘åj: 4th Conference on Creating Health Workplaces i99.03.12j, Boltimore.

474. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Experience with two major job stress questionnaires: JCQ and NIOSH job stress questionnaire. Œ´’J—²ŽjiŽYˆãŒ¤jCì㌛liŠò•Œ‘åjC¬—ÑÍ—Yiˆ¤’mˆã‘åjCÎ蹕vi‹à‘òˆã‘åjC—Ñ„Žii“ú—§Œ’NŠÇ—ƒZƒ“jC“¡“c’èiŠ ’J‘‡•a‰@jC‘Š‘òDŽ¡ i‰qjC‹{貌áCœA®“TiNKKjC‹´–{C“ñi•xŽmƒ[ƒƒbƒNƒXjCr‹Lrˆêi“Œ‘åj: 4th Conference on Creating Health Workplaces i99.03.12j, Boltimore.

475. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Job stress, depressive symptom and sick absence in Japan. ¬—ÑÍ—Yiˆ¤’mˆã‘åjCì㌛liŠò•Œ‘åjCŒ´’J—²ŽjiŽYˆãŒ¤jCÎ蹕vi‹à‘òˆã‘åjC—Ñ„Žii“ú—§Œ’NŠÇ—ƒZƒ“jC“¡“c’èiŠ ’J‘‡•a‰@jC‘Š‘òDŽ¡ i‰qjC‹{貌áCœA®“TiNKKjC‹´–{C“ñi•xŽmƒ[ƒƒbƒNƒXjCr‹Lrˆêi“Œ‘åj: 4th Conference on Creating Health Workplaces i99.03.12j, Boltimore.

476. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Job stress and coronar heart disease risk factors in Japan. —Ñ„Žii“ú—§Œ’NŠÇ—ƒZƒ“jCì㌛liŠò•Œ‘åjCŒ´’J—²ŽjiŽYˆãŒ¤jC¬—ÑÍ—Yiˆ¤’mˆã‘åjCÎ蹕vi‹à‘òˆã‘åjC“¡“c’èiŠ ’J‘‡•a‰@jC‘Š‘òDŽ¡ i‰qjC‹{貌áCœA®“TiNKKjC‹´–{C“ñi•xŽmƒ[ƒƒbƒNƒXjCr‹Lrˆêi“Œ‘åj: 4th Conference on Creating Health Workplaces i99.03.12j, Boltimore.

477. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j The association between psychosocial job conditions and chronic atrophic gastritis. ‹{貌áC–x]³’mC–‘Œ³•iNKKjCì㌛liŠò•Œ‘åjCŒ´’J—²ŽjiŽYˆãŒ¤jC¬—ÑÍ—Yiˆ¤’mˆã‘åjCÎ蹕vi‹à‘òˆã‘åjC—Ñ„Žii“ú—§Œ’NŠÇ—ƒZ ƒ“jC“¡“c’èiŠ ’J‘‡•a‰@jC‘Š‘òDŽ¡i‰qjCœA®“TiNKKjC‹´–{C“ñi•xŽmƒ[ƒƒbƒNƒXjCr‹Lrˆêi“Œ‘åj: 4th Conference on Creating Health Workplaces i99.03.12j, Boltimore.

478. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Reliability, validity and distribution among occupations of job content questionnaire scales in Japan. ì㌛liŠò•Œ‘åjCŒ´’J—²ŽjiŽYˆãŒ¤jC¬—ÑÍ—Yiˆ¤’mˆã‘åjCÎ蹕vi‹à‘òˆã‘åjC—Ñ„Žii“ú—§Œ’NŠÇ—ƒZƒ“jC“¡“c’èiŠ ’J‘‡•a‰@jC‘Š‘òDŽ¡ i‰qjC‹{貌áCœA®“TiNKKjC‹´–{C“ñi•xŽmƒ[ƒƒbƒNƒXjCr‹Lrˆêi“Œ‘åj: 1st International ICOH Conference on Psychosocial Factors at Work i98.08.24j, ƒfƒ“ƒ}[ƒN, Abstracts, p.69, 1998.

479. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Role of laparoscopic vascular changes in fatty liver; comparative study with instrahepatic microvascular using experimental model. Š¡•”‚ЂƂÝC‘Š‘òDŽ¡i‰qjCΈäŒö“¹i‘—§“쉡•l•a‰@jC“y‰®‰ëtiŒc‘åj: 20th European Conference on Microcirculation i98.08.30j, Paris, Proceedings, p.35`39, 1998.

480. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Historical aspects of control for pneumoconiosis in Japan. ‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝCV’Ã’J^li‰qj: 1st International Conference the History of Occupational and Environmental Prevention i98.10.04j, Italy, Short Paper, p.126, 1998.

481. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‚¶‚ñ”x‘Îô‚Ì•à‚Ý. ‘Š‘òDŽ¡i‰qj: ‘æ71‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï i98.04.23j, ·‰ª, ŽY‹Æ‰q¶ŠwŽGŽ, 40(—Õ‘): 96`97, 1998.

482. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹Î˜JŽÒ‚Ì“Ë‘RŽ€; –UŒŸ‚©‚ç‚Ý‚½Ž€ˆö‚Æ‚»‚Ì”wŒi. ‘å˜a“c^‹IŽqCV’Ã’J^li‰qjC™‰Y—R”üŽqi—\–hˆãŠwŒnjCŒv—Ç“OCŽÂŒ´‘i‰qjC’†‘ºŒ«iˆã—Éq¶jC‘Š‘òDŽ¡i‰qjC˜aò“Oi“àjCŒIŒ´Ž—Ri–@ ˆãj: ‘æ68‰ñ“ú–{‰q¶Šw‰ï‘‰ï i98.03.25j, ‰ªŽR, “ú–{‰q¶ŠwŽGŽ, 53(1): 212, 1998.

483. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚jŒ§‰º‚ÌŠeŽíŠé‹Æ‚É‚¨‚¯‚éƒXƒgƒŒƒX“x‚ɂ‚¢‚Ä. Š¡•”‚ЂƂÝi‰qjC΋´‹vŽqC–ö‰ºŸ]CŽRŒû‰xŽqi_“Þ쌧•ÛŒ’„iƒZƒ“jCŽÂŒ´‘C‰ª“c[Žji‰qjC–쑺r˜Z˜Yi_“ÞìŽY‹Æ•ÛŒ’„iƒZƒ“j: ‘æ71‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï i98.04.22j, ·‰ª, ŽY‹Æ‰q¶ŠwŽGŽ, 40(—Õ‘): 158, 1998.

484. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œ’N‹³ˆçŒ^HRA‚ÌŠJ”­‚ɂ‚¢‚Äi‘æ‚Q•ñ). ˆÉ“Œˆê˜Yi“Œ—ˆã‘åjC‘Š‘òDŽ¡i‰qjC“¡Ž}Œ«°C’r“cŽ‹Ii“Œ‹žŠwŒ|‘åj: ‘æ71‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï i98.04.22j, ·‰ª, ŽY‹Æ‰q¶ŠwŽGŽ, 40(—Õ‘): 246, 1998.

485. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’èŠúŒ’Nf’fŒ‹‰Ê‚©‚ç‚Ý‚½‰^“®ˆ•û. V’Ã’J^lC‘Š‘òDŽ¡C’JŒûŽu•äC‘å˜a“c^‹IŽqC‰ª“c[ŽjCŒv—Ç“OCŽÂŒ´‘CŠ¡•”‚ЂƂÝi‰qjC™‰Y—R”üŽqi—\–hˆãŠwŒnjC’†‘ºŒ«iˆã—Éq¶j: ‘æ71‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï i98.04.22j, ·‰ª, ŽY‹Æ‰q¶ŠwŽGŽ, 40(—Õ‘): 373, 1998.

486. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¥ŠE‘ª’è–@‚É‚æ‚éŽ_‰»ƒ`ƒ^ƒjƒEƒ€‚Ì×–E«áŠQ•]‰¿. ‰ª“c[ŽjCŒv—Ç“OCŠ¡•”‚ЂƂÝCV’Ã’J^lCŽÂŒ´‘i‰qjC^‰º‹I”ü‘ãC™‰Y—R”üŽqCˆäã—tŽqi—\–hˆãŠwŒnjC‘Š‘òDŽ¡i‰qjC¬’J½i“Œ‹ž“d‹@‘åj: ‘æ71‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï i98.04.22j, ·‰ª, ŽY‹Æ‰q¶ŠwŽGŽ, 40(—Õ‘): 442, 1998.

487. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j E‹Æ«ƒXƒgƒŒƒX‚Æ—}‚¤‚ÂÇ󂨂æ‚ÑŽ¾•a‹x‹Æ|E‹Æ«ƒXƒgƒŒƒX‚ÆŒ’NƒRƒz[ƒgŒ¤‹†ƒx[ƒXƒ‰ƒCƒ“ƒf[ƒ^‚̉ðÍ. ì㌛liŠò•Œ‘åjCŒ´’J—²ŽjiŽYˆãŒ¤jC¬—ÑÍ—Yiˆ¤’mˆã‘åjCÎ蹕vi‹à‘òˆã‘åjC—Ñ„Žii“ú—§Œ’NŠÇ—ƒZƒ“jC“¡“c’èiŠ ’J‘‡•a‰@jC‘Š‘òDŽ¡ i‰qjC–‘Œ³•C‹{貌áCœA®“TiNKKjC‰Í–ìŒcŽOi•xŽmƒ[ƒƒbƒNƒXjCr‹Lrˆêi“Œ‘åj: ‘æ71‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï i98.04.22j, ·‰ª, ŽY‹Æ‰q¶ŠwŽGŽ, 40(—Õ‘): 553, 1998.

488. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j NIOHE‹Æ«ƒXƒgƒŒƒX’²¸•[‚¨‚æ‚ÑJCQ‚ÌS—‘ª’èŠw“I•]‰¿. Œ´’J—²ŽjiŽYˆãŒ¤jCŽO–Ø–¾Žqi“Œ‘åjCì㌛liŠò•Œ‘åjC¬—ÑÍ—Yiˆ¤’mˆã‘åjCÎ蹕vi‹à‘òˆã‘åjC—Ñ„Žii“ú—§Œ’NŠÇ—ƒZƒ“jC“¡“c’èiŠ ’J‘ ‡•a‰@jC–‘Œ³•C‹{貌áCœA®“TiNKKjC‘Š‘òDŽ¡i‰qjC‰Í–ìŒcŽOi•xŽmƒ[ƒƒbƒNƒXjCr‹Lrˆêi“Œ‘åj: ‘æ71‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï i98.04.22j, ·‰ª, ŽY‹Æ‰q¶ŠwŽGŽ, 40(—Õ‘): 554, 1998.

489. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’†¬Šé‹Æ‚É‚¨‚¯‚錒Nf’f‚ÉŠÖ‚·‚éˆÓŽ¯’²¸. ŽÂŒ´‘CV’Ã’J^lC‘å˜a“c^‹IŽqi‰qjC™‰Y—R”üŽqi—\–hˆãŠwŒnjC’†‘ºŒ«iˆã—Éq¶jC‘Š‘òDŽ¡i‰qj: ‘æ71‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï i98.04.24j, ·‰ª, ŽY‹Æ‰q¶ŠwŽGŽ, 40(—Õ‘): 648, 1998.

490. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¥ŠE‘ª’è‚É‚æ‚éƒNƒŠƒ\ƒ^ƒCƒ‹‚Ì×–E“Å«•]‰¿. Œv—Ç“OC‰ª“c[ŽjCŠ¡•”‚ЂƂÝCV’Ã’J^lCŽÂŒ´‘C’JŒûŽu•äi‰qjC™‰Y—R”üŽqC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjC‘Š‘òDŽ¡i‰qjC¬’J½i“Œ‹ž“d‹@‘åj: ‘æ71‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï i98.04.24j, ·‰ª, ŽY‹Æ‰q¶ŠwŽGŽ, 40(—Õ‘): 694, 1998.

491. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —L‹@—nÜ‚ðŽg—p‚·‚éˆóüHê‚̈ê‰ü‘PŽ–—á. ‰ª“c[Žji‰qjCˆäã—tŽqi—\–hˆãŠwŒnjCYoung-Chae ChoC‰“æGŽ÷C‹|–ì“ÞŽqCŠ¡•”‚ЂƂÝC‘Š‘òDŽ¡i‰qjC•Ð‹Ë—TŽjC–å˜e•”Žiˆã—Éq¶j: ‘æ7‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï i98.06.11j, ˆ®ì, ´˜^W, p.24, 1998.

492. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚jŒ§‰º‚ÌŠeŽíŠé‹Æ“à˜J“­ŽÒ‚Ì•ø‚¦‚éƒXƒgƒŒƒX“x‚ɂ‚¢‚Ä. Š¡•”‚ЂƂÝC‘Š‘òDŽ¡CŽÂŒ´‘CŒv—Ç“OC‰ª“c[ŽjCV’Ã’J^li‰qjC^‰º‹I”ü‘ãC™‰Y—R”üŽqCˆäã—tŽqi—\–hˆãŠwŒnj: ‘æ7‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï i98.06.11j, ˆ®ì, ´˜^W, p.30, 1998.

493. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠO•Ç“h‘•‚É‚æ‚éƒLƒVƒŒƒ“‚ÌŽº“à‰˜õ. ‰“æGŽ÷i‰qjC•Ð‹Ë—TŽjiˆã—Éq¶jC‰ª“c[Žji‰qjCˆäã—tŽqi—\–hˆãŠwŒnjCYoung-Chae ChoCŠ¡•”‚ЂƂÝC‘Š‘òDŽ¡i‰qjC–å˜e•”Žiˆã—Éq¶j: ‘æ7‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï i98.06.11j, ˆ®ì, ´˜^W, p.37, 1998.

494. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –^Œ§“à‚ÌŠeŽíŠé‹Æ‚É‚¨‚¯‚éƒXƒgƒŒƒX“x‚ɂ‚¢‚Ä|Ž©‹LŽ®’²¸‚æ‚è|. Š¡•”‚ЂƂÝi‰qj: “ú–{ƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ï‘æ31‰ñ‘å‰ï i98.08.01j, å‘ä, ˜_•¶W, p.60, 1998.

495. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹Î˜JŽÒ¢‘ã‚Ì“Ë‘RŽ€; –UŒŸf’f‚ÉŠî‚­”­ÇŽžŠÔ‚Æs“®—lŽ®‚Ì“Á’¥. ‘å˜a“c^‹IŽqi‰qjC’†”¨ˆêC‘ŠèrÆC˜aò“Oi“àjC‘Š‘òDŽ¡i‰qjCŒIŒ´Ž—Ri–@ˆãj: ‘æ46‰ñ“ú–{ЊQˆãŠw‰ï i98.10.15j, –¼ŒÃ‰®, “ú–{ЊQˆãŠw‰ï‰ïŽ, 46(—Õ‘): 162, 1998.

496. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —L‹@—nÜŽg—pHê‚̉ü‘PŽ–—á. Š¡•”‚ЂƂÝC‰“æGŽ÷C‰ª“c[ŽjCŽÂŒ´‘i‰qjCˆäã—tŽqi—\–hˆãŠwŒnjC‘Š‘òDŽ¡i‰qjC•Ð‹Ë—TŽjC–å˜e•”Žiˆã—Éq¶j: ‘æ46‰ñ“ú–{ЊQˆãŠw‰ï i98.10.15j, –¼ŒÃ‰®, “ú–{ЊQˆãŠw‰ï‰ïŽ, 46(—Õ‘): 170, 1998.

497. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠO•Ç“h‘•Œã‚̃LƒVƒŒƒ“‚É‚æ‚鎺“à‰˜õ‚ɂ‚¢‚Ä. Š¡•”‚ЂƂÝC‹|–ì“ÞŽqi‰qjC•Ð‹Ë—TŽjiˆã—Éq¶jCV’Ã’J^lCŒv—Ç“Oi‰qjC™‰Y—R”üŽqi—\–hˆãŠwŒnjC‘Š‘òDŽ¡i‰qjC–å˜e•”Žiˆã—Éq¶j: ‘æ46‰ñ“ú–{ЊQˆãŠw‰ï i98.10.15j, –¼ŒÃ‰®, “ú–{ЊQˆãŠw‰ï‰ïŽ, 46(—Õ‘): 170, 1998.

498. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —«˜J“­ŽÒ‚̃XƒgƒŒƒX‚Æ‚»‚Ì–â‘è“_. ‹|–ì“ÞŽqC‰“æGŽ÷CŠ¡•”‚ЂƂÝC‘Š‘òDŽ¡i‰qjCì㌛liŠò•Œ‘åjCŒ´’J—²ŽjiŽYˆãŒ¤jC¬—ÑÍ—Yiˆ¤’mˆã‘åjC—Ñ„Žii“ú—§Œ’NŠÇ—ƒZƒ“jCÎè ¹•vi‹à‘òˆã‘åjC“¡“c’èiŠ ’J‘‡•a‰@jC‹´–{C“ñC‰Í–ìŒcŽOi•xŽmƒ[ƒƒbƒNƒXjCr‹Lrˆêi“Œ‘åj: ‘æ14‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï i98.11.07j, “Œ‹ž, ƒXƒgƒŒƒX‰ÈŠw, 13(2): 70, 1998.

499. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒNƒŠƒ\ƒ^ƒCƒ‹‚ɑ΂·‚é×–EŽ¥ŠE‘ª’è•]‰¿. Œv—Ç“OC‰ª“c[Žji‰qjC•Ð‹Ë—TŽjiˆã—Éq¶jCˆäã—tŽqi—\–hˆãŠwŒnjCŠ¡•”‚ЂƂÝC‘Š‘òDŽ¡i‰qj: ‘æ69‰ñ“ú–{‰q¶Šw‰ï‘‰ï i99.03.27j, ç—t, “ú–{‰q¶ŠwŽGŽ, 54(1): 170, 1999.

500. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ЊQ«˜’É‚ÌŽóŒãŒo‰ß‚ÌŒŸ“¢. ŽÂŒ´‘C‰ª“c[ŽjCŒv—Ç“OC‘Š‘òDŽ¡i‰qjC’†‘ºŒ«iˆã—Éq¶jCV’Ã’J^li‰qjC™‰Y—R”üŽqi—\–hˆãŠwŒnj: ‘æ69‰ñ“ú–{‰q¶Šw‰ï‘‰ï i99.03.27j, ç—t, “ú–{‰q¶ŠwŽGŽ, 54(1): 211, 1999.

501. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹Î˜JŽÒ‚Ì“Ë‘RŽ€‚Ì“Á’¥; ”­ÇŽžŠÔ‚Æs“®—lŽ®‚©‚ç‚ÌŒŸ“¢. ‘å˜a“c^‹IŽqi‰qjC˜aò“OC‘ŠèrÆC’†”¨ˆêi“àjCV’Ã’J^lC‘Š‘òDŽ¡i‰qjCŒIŒ´Ž—Ri–@ˆãj: ‘æ46‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï i98.09.11j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€, p.328, 1998.

502. mŒ¤‹†‰ïi‘Ûjn iˆê”Êu‰‰j Job stress among women in Japan. ‘Š‘òDŽ¡i‰qj: EU-Japan Collaborative Research Workshop on Job Stress and Health i98.11.05j, “Œ‹ž.

503. mŒ¤‹†‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Magnetometric evaluation for toxicity of chrysotile to alveolar macrophages. ‘Š‘òDŽ¡CŒv—Ç“OC‰ª“c[Žji‰qjC•Ð‹Ë—TŽjiˆã—Éq¶jC‰ªˆÀŒMi•a—jC¬’J½i“Œ‹ž“d‹@‘åj: 14th International Symposium on Cellular Endocrinology i98.09.24j, New York.

504. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Ž¥ŠE‘ª’è‚ð—p‚¢‚½Î–È‚Ì×–E‰e‹¿•]‰¿. Œv—Ç“OC‰ª“c[ŽjC”‘—˜‰hŽqC‘Š‘òDŽ¡i‰qjC¬’J½i“Œ‹ž“d‹@‘åj: ƒ}ƒOƒlƒeƒBƒbƒNƒXŒ¤‹†‰ï i99.03.18j, “Œ‹ž, Œ¤‹†‰ïŽ‘—¿MAG-99-1-25: 7`12, 1999.

505. mŠwpÜi‘“àÜjn ìŒûÜ: Šî‘bˆãŠw‚ÌŒ¤‹†‚ÉêS‚·‚é‚©‚½‚í‚ç_“Þ쌧ˆãŽt‰ï‚̉ïˆõ‚Æ‚µ‚ĈãŠw‹y‚шãp‚ÌŒüã”­“W‚ÉŠñ—^‚µ‚½Œ÷Ñ. ‘Š‘òDŽ¡i‰qj.

506. mŠw‰ïŽåÃi‚»‚Ì‘¼jn ‘æ71‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ïEE‹Æ«ŒÄ‹zŠíŽ¾Š³Œ¤‹†‰ï‰ï’·i98.04.24j, ·‰ª. ‘Š‘òDŽ¡i‰qj.


<<10 –@ˆãŠw>>

507. mŒ´’˜n “û—cŽ™“Ë‘RŽ€ÇŒóŒQ‚É‚¨‚¯‚éŠÌŽ‰–b‰»‚Ìf’f“IˆÓ‹`. ¯ˆä‚Ì‚èŽqCŒÃì—FCŒIŒ´Ž—Ri–@ˆãj: –k—¢ˆãŠw, 28(6): 484`493, 1998.

508. mÇ—á•ñn ‹}«‘å“®–¬‰ð—£‚ɉ–Ž_ƒjƒJƒ‹ƒWƒsƒ“‚ÌŽ‘±“_“HÃ’‚ª—LŒø‚Å‚ ‚Á‚½3Ç—á. ¡ˆäŠ°i–@ˆãjC‘å˜a“c—²i‹~–½j: ƒZƒ‰ƒsƒ…[ƒeƒBƒbƒNƒŠƒT[ƒ`, 20(1): 283`288, 1999.

509. mÇ—á•ñn ‚±‚ñ‚ÈÇ—á, ‚±‚ñ‚ȉ摜|“Á”­«H“¹”j—ô. ¡ˆäŠ°i–@ˆãjC‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 10: 461, 1998.

510. mÇ—á•ñn ƒ‰ƒCÇŒóŒQ‚ª‹^‚í‚ꂽæ“V«•›t”玿‰ßŒ`¬‚̈êÇ—á. ¯ˆä‚Ì‚èŽqCŒÃì—FC¼ˆäG˜aC‰iˆä’q‹IC’†‘º–ΊîC™]G–¾C¡ˆäŠ°i–@ˆãjC“c‹v•ÛŒ›sC‰¡“csŽjC¼‰YM•viŽ™jCŒIŒ´Ž—Ri–@ˆãj: –@ˆãŠw‚ÌŽÀÛ‚ÆŒ¤‹†, 41: 231`237, 1998.

511. mÇ—á•ñn CT‰æ‘œ‚Å—¼‘¤«¬”]oŒŒ‚ª‹^‚í‚ꂽ1–UŒŸ—á. ¼ˆäG˜aC¯ˆä‚Ì‚èŽqC‰iˆä’q‹ICŒÃì—FC’†‘º–ΊîC™]G–¾CŒIŒ´•¶’jC¡ˆäŠ°i–@ˆãjC¼Šª”Ži•újC‰““¡¹Fi”]ŠOjC‘å˜a“c—²i‹~–½j: –@ˆãŠw‚ÌŽÀÛ‚ÆŒ¤‹†, 41: 239`244, 1998.

512. mÇ—á•ñn ƒI[ƒgƒoƒC‚É‚æ‚é“ÁˆÙ‚ÈŒð’ÊŽ–ŒÌŽ€—á. ŒÃì—FC¯ˆä‚Ì‚èŽqC¼ˆäG˜aC‰iˆä’q‹IC™]G–¾C’†‘º–ΊîC¡ˆäŠ°CŒIŒ´Ž—Ri–@ˆãj: –@ˆãŠw‚ÌŽÀÛ‚ÆŒ¤‹†, 41: 245`249, 1998.

513. m‘àn ‹}«‘å“®–¬‰ð—£‚Ì“à‰È“IŽ¡—Ã. ¡ˆäŠ°i–@ˆãjC‘å˜a“c—²i‹~–½j: ICU‚ÆCCU, 23: 23`29, 1999.

514. muÀn –݂Ȃǂ̂̂ǂ̂‚©‚¦. ¡ˆäŠ°i–@ˆãjC‘Š”nˆêˆåi‹~–½j: Medical Practice, 15: 50`52, 1998.

515. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j CPAOA‚̳‘ø‰ð–U‚É‚¨‚¯‚鎀ˆö‹†–¾. ŒIŒ´Ž—RC¯ˆä‚Ì‚èŽqC¼ˆäG˜aC‰iˆä’q‹Ii–@ˆãj: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ïŠwp‘‰ï i98.11.13j, ‚¼, “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 9(9): 391, 1998.

516. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Œo”ç“IS”x•â•(PCPS)‚Ì—Õ°“IŒŸ“¢. ¡ˆäŠ°i–@ˆãjC—Ñ@”Ži‹¹ŠOjCÂŽR’¼‘PC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{ˆãHŠwŽ¡—Êw‰ï‘æ12‰ñŠwp‘å‰ï i99.02.05j, _ŒË.

517. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –@ˆã³‘ø‰ð–U¥ŒŸˆÄ‚É‚¨‚¯‚éƒgƒ‰ƒCƒG[ƒW‚É‚æ‚é–ò•¨ƒXƒNƒŠ[ƒjƒ“ƒO. ™]G–¾C¼ˆäG˜aC¯ˆä‚Ì‚èŽqC’†‘º–ΊîCŒÃì—FC‰iˆä’q‹IC¡ˆäŠ°CŒIŒ´•¶’ji–@ˆãjC—јN´iˆãŠw•”Šw¶jC¬—щpŽ÷C’†ŠÛ®”üiŒ`‘ÔŒnjC’ç–M •Fi¸jCŒIŒ´Ž—Ri–@ˆãj: ‘æ82ŽŸ“ú–@ˆã‘‰ï i98.04.16j, “Œ‹ž, “ú–@ˆãŽ, 52(Suppl.): 72, 1998.

518. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j gŒ³Šm”F‚ð–Ú“I‚Æ‚µ‚½eŽqŠÓ’è—á. ’†‘º–ΊîC¯ˆä‚Ì‚èŽqC‰iˆä’q‹IC¼ˆäG˜aC™]G–¾CŒÃì—FCŒIŒ´Ž—Ri–@ˆãj: “ú–{DNA‘½Œ^Šw‰ï‘æ7‰ñŠwpW‰ï i98.12.03j, ¼–{, ´˜^W, p.22, 1998.

519. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j SIDS‚̬”]¥”]Š²•”‚É‚¨‚¯‚é•a—‘gDŠw“I‚È‚ç‚Ñ‚É‘gDŒv—Ê“IŒ¤‹†. ŒÃì—FC¯ˆä‚Ì‚èŽqC¼ˆäG˜aC‰iˆä’q‹IC’†‘º–ΊîC™]G–¾CŒIŒ´•¶’ji–@ˆãjC’†ŠÛ®”üC¬—щpŽ÷iŒ`‘ÔŒnjC¡ˆäŠ°CŒIŒ´Ž—Ri–@ˆãj: ‘æ82ŽŸ“ú–@ˆã‘‰ï i98.04.16j, “Œ‹ž, “ú–@ˆãŽ, 52(Suppl.): 100, 1998.

520. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “ÁˆÙ‚ÈŒo‰ß‚ð‚Æ‚Á‚½‹}«‘å“®–¬‰ð—£‚̈ê–UŒŸ—á: •a—ŠŒ©‚Æ‘å“®–¬‘¢‰e‚Æ‚Ì”äŠr. ŒÃì—Fi–@ˆãjC‘ºˆä’BÆiŒc‘åjC¯ˆä‚Ì‚èŽqC¡ˆäŠ°C¼ˆäG˜aC‰iˆä’q‹IC’†‘º–ΊîC™]G–¾CŒIŒ´•¶’ji–@ˆãjC—јN´iˆãŠw•”Šw¶jC¬—щpŽ÷ iŒ`‘ÔŒnjCŒIŒ´Ž—Ri–@ˆãj: ‘æ82ŽŸ“ú–@ˆã‘‰ï i98.04.16j, “Œ‹ž, “ú–@ˆãŽ, 52(Suppl.): 99, 1998.

521. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œz•”ŽhØ‘n‚É‚æ‚è‘Œz“®–¬‚É“Ý“I‘¹‚ð‚«‚½‚µ‚½ˆê–UŒŸ—á. ¼ˆäG˜aC¯ˆä‚Ì‚èŽqC‰iˆä’q‹ICŒÃì—FC™]G–¾C’†‘º–ΊîC¡ˆäŠ°CŒIŒ´Ž—Ri–@ˆãj: ‘æ48‰ñ“ú–{–@ˆãŠw‰ï‹ãB’n•û‰ï i98.10.29j, ²‰ê, u‰‰—vŽ|W, p.4, 1998.

522. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j ˆÙ󎀑̂ƖUŒŸƒVƒXƒeƒ€(4): ‚ ‚éS‘Ÿ«“Ë‘RŽ€‚ÉŠÖ‚·‚é–â‘è“_. ‰iˆä’q‹ICŒÃì—FC¯ˆä‚Ì‚èŽqC¼ˆäG˜aC™]G–¾C’†‘º–ΊîCŒIŒ´•¶’jC¡ˆäŠ°CŒIŒ´Ž—Ri–@ˆãj: ‘æ67‰ñ“ú–{–@ˆãŠw‰ïŠÖ“Œ’n•û‰ï i98.10.24j, “Œ‹ž, u‰‰—vŽ|W, p.29, 1998.

523. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j ‰º‘åÖ¬ƒtƒBƒ‹ƒ^[‘•’…Œã‚ɶ‚¶‚½”x“®–¬ŒŒðÇðÇ‚É‚æ‚é“Ë‘RŽ€‚̈ê—á. ‰iˆä’q‹IC¡ˆäŠ°C¯ˆä‚Ì‚èŽqC¼ˆäG˜aC™]G–¾C’†‘º–ΊîCŒÃì—FCŒIŒ´•¶’jCŒIŒ´Ž—Ri–@ˆãj: ‘æ67‰ñ“ú–{–@ˆãŠw‰ïŠÖ“Œ’n•û‰ï i98.10.24j, “Œ‹ž, u‰‰—vŽ|W, p.29, 1998.

524. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “–‰@‚É‚¨‚¯‚éSŒ´«ƒVƒ‡ƒbƒN‚É‚¨‚¯‚éPCPS‰^—p•û–@. ¡ˆäŠ°i–@ˆãjC—Ñ@”Ži‹¹ŠOjCÂŽR’¼‘PC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ9‰ñPCPSiŒo”ç“IS”x•â•jŒ¤‹†‰ï i99.03.03j, ç—t.


<<11 Šñ¶’ŽŠw>>

525. mŒ´’˜n B-cell activation in the mesenteric lymph nodes of resistant BALB/c mice infected with the murine nematode parasite Trichuris muris. ¬ŽR_ˆêiŠñjC‹Ê“àGˆêi”÷jC•x“c³_C–k“ˆ—²iƒeƒ‹ƒ‚jCˆÉ“¡—mˆêiŠñj: Parasitol. Res., 85(3): 194`199, 1999.

526. mŒ´’˜n A preliminary study on susceptibility of mice of various strain to Hymenolepis nana eggs. –qƒCˆÉ“¡—mˆêiŠñj: Tropical Medicine, 40: 45`46, 1998.

527. mŒ´’˜n A simple method for screening of macrofilaricidal compounds; The inhibitory effect of substances on phosphatase activity of adult Dirofilaria immitis. –qƒiŠñjCŒK“c³Li¶‰»jCMitsui, Y.CFujimaki, Y.i’·è‘åjCˆÉ“¡—mˆêiŠñj: Tropical Medicine, 40: 95`97, 1998.

528. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Recombinant cysteine proteinase can activate splenic T cells to produce IL-5 in Spirometra-infected mice. ’†‘ºŒ’‚`iŠñjCŠÇªˆê’jiMB‘åj: ‘æ9‰ñ‘ÛŠñ¶’ŽŠw‰ï i98.08.27j, ç—t, Parasitol. Internat., 47(Suppl.): 60, 1998.

529. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Epidemiological studies on cerebral cysticercosis in Jilin Province, China. ˆÉ“¡—mˆêC–qƒiŠñjCIchikawa, H.i‹à‘òˆã‘åjCDo, J.CZhang, Y.i”’‹‰¶ˆã‘åj: 9th International Congress of Parasitology i98.08.24`28j, ç—t, Parasitol. Internat., 47(Suppl.): 319, 1998.

530. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j A sero-immunological studies on cyslicercosis in Jilin Province of China. Ichikawa, H.i‹à‘òˆã‘åjCˆÉ“¡—mˆêiŠñjCZhang Yongshengi”’‹‰¶ˆã‘åjCZhi-Jieiƒnƒ‹ƒsƒ“ˆã‘åj: 9th International Congress of Parasitology i98.08.24`28j, ç—t, Parasitol. Internat., 47(Suppl.): 363, 1998.

531. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j International cooperative studies on chemotherapy of parasitic diseases with the scientific utilization of traditional medicinal plants. –qƒCˆÉ“¡—mˆêiŠñjCTabaru, Y.iJICAjCTada, I.i‹ã‘åjCAoki, Y.CFujimaki, Y.CMitsui, Y.i’·è‘åjCCaceres, A.iƒOƒ@ƒeƒ}ƒ‰ƒTƒ“ƒJƒ‹ƒƒX‘åjCKofi-Tsekpo, W.M.iƒPƒjƒA’†‰›ˆãŠwŒ¤jCZhang, Y.i”’‹‰¶j: 9th International Congress of Parasitology i98.08.24`28j, ç—t, Parasitol. Internat., 47(Suppl.): 380, 1998.

532. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Nippostrongylus braziliensisŠ´õ‚¨‚æ‚Ñ”rœ‚É”º‚¤ƒ‰ƒbƒg¬’°ƒ€ƒ`ƒ“‚Ì—Ê“IŽ¿“I•Ï“®. ÎŒ´˜a•Fiˆã—Éq¶Šw•”jC’†‘ºŒ’‚`iŠñjC–¼˜as•¶i‹{èˆã‘åj: ‘æ67‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï i98.04.02j, _ŒË, Parasitol. Internat., 47(Suppl.): 43, 1998.

533. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‡¬–ò‚ɑ΂·‚é–òÜ‘Ï«‚ªŒœ”O‚³‚ê‚éŠñ¶’ŽÇ‚̶–ò‚É‚æ‚鎡—ÂɊւ·‚錤‹†. –qƒCˆÉ“¡—mˆêiŠñjC’£‰i¶i’†‘”’‹‰¶ˆã‘åj: “ú–{–òŠw‰ï‘æ118”N‰ï i98.04.02j, ‹ž“s, u‰‰—vŽ|W(3), p.163, 1998.

534. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j CK-1‚É‚æ‚郊ƒ“Ž_‰»‚ð‰î‚µ‚½cyclophilin B (p24)‚ÌŠˆ«’²ß. Žë–ì~C‰ª–ì–ƒˆßŽqC‰H•x‰ëmiˆã—Éq¶jC’†‘ºŒ’‚`iŠñjC“¡Œ´ŽO’m—YC‘å’ÎŒ’‘ iˆã—Éq¶j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i98.10.15j, –¼ŒÃ‰®, ¶‰»Šw, 70(8): 875, 1998.

535. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’†•ÄƒOƒAƒeƒ}ƒ‰‚É‚¨‚¯‚éŠñ¶’ŽÇ‚ÌŽ¡—ÂɗL—p‚È–ò—pA•¨Ž‘Œ¹‚Ì’Tõ. –qƒCˆÉ“¡—mˆêiŠñjCA.ƒJƒZƒŒƒXiƒOƒ@ƒeƒ}ƒ‰, ƒTƒ“ƒJƒ‹ƒƒX‘åjCŽ™“ˆãùi–òŠwj: “ú–{–òŠw‰ï‘æ119”N‰ï i99.03.31j, “¿“‡, u‰‰—vŽ|W(2), p.163, 1999.


<<12 ŽÀŒ±“®•¨Šw>>

536. mŒ´’˜n The role of a new Liquid-solid scintillator, a mixture of DPO, POPOP and Epon 812, for enhancement of autoradiograms with tritium agents. ¼–Šr”ViRIŒnjCŒÃŠÚêˆêiŽÀ“®j: J. Vet. Med. Sci., 60(7): 795`797, 1998.

537. m€Œ´’˜n Analyses of proteins related to the hereditary dwarfism of rdw rat. ‘åX•jiŽO•H‰»Šw¶–½Œ¤jC‘åγ“¹i—Šw•”jCˆêƒm£K‘ãiŽO•H‰»Šw¶–½Œ¤jCŒÃŠÚêˆêiŽÀ“®jC‘O“c’‰Œvi—Šw•”j: J. Protein Chem., 17(6): 518, 1998.

538. m€Œ´’˜n Accumulation of molecular chaperon proteins in the endoplasmic reticulum from the rdw rat thyroid cells with hypothyroidism. ‘åγ“¹C‘O“c’‰Œvi—Šw•”jC‘åX•jCˆêƒm£K‘ãC–p³”üiŽO•H‰»Šw¶–½Œ¤jCŒÃŠÚêˆêiŽÀ“®j: Proc. Japan. Soc. Comp. Endocrinol., 13: 45, 1998.

539. m€Œ´’˜n ˆâ“`«˜ËŽòǃ‰ƒbƒgrdw‚ňÙí‚È‹““®‚ðŽ¦‚·ƒ^ƒ“ƒpƒN. ‘åX•jiŽO•H‰»Šw¶–½Œ¤jC‘åγ“¹i—Šw•”jCˆêƒm£K‘ãC–p³”üiŽO•H‰»Šw¶–½Œ¤jCŒÃŠÚêˆêiŽÀ“®jC‘O“c’‰Œvi—Šw•”j: ¶‰»Šw, 70: 1117, 1998.

540. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Characterization of the rdw rat with hereditary dwarfism/hypothyroidism. ŒÃŠÚêˆêiŽÀ“®j: The 7th International Pituitary Pathology Club Meetingi‘æ7‰ñ‘Û‰º‚‘Ì•a—‰ï‹cj i98.10.05j, ” ª.

541. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Accumulation of stress proteins in thyroid gland of the rdw rat with hypothyroidism. ‘åγ“¹i—Šw•”jC‘åX•jiŽO•H‰»Šw¶–½Œ¤jC‘O“c’‰Œvi—Šw•”jCŒÃŠÚêˆêiŽÀ“®j: The 11th Asia-Oceania Congress of Endocrinology i98.04.12`16j, ŠØ‘, Abstracts, p.275, 1998.

542. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Accumulation of molecular chaperon proteins in the thyroid cells from the rdw rat with hypothyroidism. ‘åγ“¹i—Šw•”jC‘åX•jCˆêƒm£K‘ãiŽO•H‰»Šw¶–½Œ¤jCŒÃŠÚêˆêiŽÀ“®jC‘O“c’‰Œvi—Šw•”j: ‘æ71‰ñ•Ä‘bó‘BŠw‰ï i98.09.18j, •Ä‘ƒIƒŒƒSƒ“Bƒ|[ƒgƒ‰ƒ“ƒh, u‰‰—vŽ|W, p.48, 1998.

543. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ˆâ“`«˜ËŽòǃ‰ƒbƒgrdw‚̃^ƒ“ƒpƒNŽ¿‰ðÍ. ŒÃŠÚêˆêiŽÀ“®j: ‘æ16‰ñ•xŽmƒzƒ‹ƒ‚ƒ“ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX i98.07.17j, ” ª, ´˜^W, p.6, 1998.

544. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j bó‘B‹@”\’ቺǃ‰ƒbƒgrdw‚Ìbó‘B‰ðÍ. ŒÃŠÚêˆêiŽÀ“®jCŽðˆäNOi‰ðj: ‘æ45‰ñ“ú–{ŽÀŒ±“®•¨Šw‰ï‘‰ï i98.05.28j, ¼–{, u‰‰—vŽ|W, p.127, 1998.

545. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j bó‘B‹@”\•s‘Sǃ‰ƒbƒgrdwbó‘B‚É‚¨‚¯‚鬖E‘Ì•ªŽqƒVƒƒƒyƒƒ“‚Ì’~Ï. ‘åγ“¹C‘O“c’‰Œvi—Šw•”jC‘åX•jCˆêƒm£K‘ãC–p³”üiŽO•H‰»Šw¶–½Œ¤jCŒÃŠÚêˆêiŽÀ“®j: ‘æ23‰ñ“ú–{”äŠr“à•ª”åŠw‰ï i98.07.31j, Š˜Î, u‰‰—vŽ|W, p.28, 1998.

546. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’`”’‚Ì”÷—Êv‘¬’Tõ‚Æ\‘¢‰ðÍ; 4.•ªŽqƒVƒƒƒyƒƒ“’`”’Ž¿. ‘åγ“¹i—Šw•”jC‘åX•jCˆêƒm£K‘ãC–p³”üiŽO•H‰»Šw¶–½Œ¤jC‘O“c’‰Œvi—Šw•”jCŒÃŠÚêˆêiŽÀ“®j: ‘æ36‰ñ“ú–{¶•¨•¨—Šw‰ï i98.10.04j, ”Ž‘½, u‰‰—vŽ|W, p.192, 1998.

547. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˜ËŽòǃ‰ƒbƒgŒ´ˆöˆâ“`ŽqÀrdw‚̃‰ƒbƒg‘æ7”ÔõF‘̂ւ̃}ƒbƒsƒ“ƒO. ’š–ÁCˆÀ“c^—C‹{–{’q”üC“AŠŽ‹Ïi–¼ŒÃ‰®Žs‘åjCŒÃŠÚêˆêiŽÀ“®jCˆÀ‹‰@‚Žui–¼ŒÃ‰®Žs‘åj: ‘æ15‰ñ“ú–{Ž¾Š³ƒ‚ƒfƒ‹Šw‰ï‘‰ï i98.11.27j, “Œ‹ž, u‰‰—vŽ|W, p.57, 1998.

548. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒCƒk‚É‚¨‚¯‚鋶Œ¢•aƒEƒCƒ‹ƒX‚ɑ΂·‚éELISAR‘Ì‚Ì•Û—L’²¸. ’r“c’‰¶CâˆäŠwCã°˜aOi“ú‘åjC”¯N—YiŽÀ“®jCˆÉ“¡Ž¡i“®–òŒ¤j: “ú–{bˆãŒöO‰q¶Šw‰ï i99.02.12j, ŽD–y, “ú–{bˆãŒöO‰q¶Šw‰ï´˜^, p.445, 1998.

549. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆâ“`«˜ËŽòÇ¥bó‘B‹@”\’ቺǃ‰ƒbƒgrdw‚̉º‚‘̖Ɖu‘gDŠw“I‰ðÍ. ¼–Šr”ViRIŒnjCŒÃŠÚêˆêiŽÀ“®j: ‘æ126‰ñ“ú–{bˆãŠw‰ï i98.08.23j, ]•Ê, u‰‰—vŽ|W, p.237, 1998.

550. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰Æ“e‚Ì”ñŠJ‹¹“Iƒr[ƒY•ÂÇÄŠÁ—¬–@‚É‚æ‚é“®•¨ƒ‚ƒfƒ‹‚ÆS“d}‚̕ω»‡U. ”¯N—YiŽÀ“®jC’†ŽR–ÎMiŽÀ“®ŒnjC’r“cŒ›ºC‹{Œ´‰p•viˆã—Éq¶Šw•”j: ‘æ15‰ñ“ú–{S“dŠw‰ïŠwpW‰ï i98.10.02j, Ž­Ž™“‡, ´˜^W¥S“d}, 18(5): 735, 1998.

551. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˆâ“`«˜ËŽòÇ/bó‘B‹@”\’ቺǃ‰ƒbƒgrdw‚É‚¨‚¯‚鎾•aŠÖ˜A’`”’Ž¿‚̉ðÍ. ‘åγ“¹C‘O“c’‰Œvi—Šw•”jC‘åX•jiŽO•H‰»Šw¶–½Œ¤jCŒÃŠÚêˆêiŽÀ“®j: ‘æ11‰ñˆâ“`Žq‚Æ‚»‚ÌŽü•ÓŒ¤‹†‰ï i98.08.04j, \˜a“c, u‰‰—vŽ|W, p.7, 1998.


<<13 ¶•¨•¨—‰»Šw>>

552. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ª’SŽ·•Mj ¶‰»ŠwŽ«“T, ‘æ3”Å; ƒJƒ^ƒ‰[ƒ[, ƒyƒ‹ƒIƒLƒVƒ\[ƒ€, ƒyƒ‹ƒIƒLƒVƒ_[ƒ[, ƒ~ƒGƒƒyƒ‹ƒIƒLƒVƒ_[ƒ[, ƒ‰ƒNƒgƒyƒ‹ƒIƒLƒVƒ_[ƒ[, ƒ‰ƒbƒJ[ƒ[, ˜@Œ©‰p¢i¶•¨•¨—‰»j. •ÒW ˆäãŒ\ŽOC‘¼7–¼C•ÒC “Œ‹ž‰»Šw“¯l, “Œ‹žC98.10.08”­s.

553. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘哤ƒ^ƒ“ƒpƒNŽ¿ƒÀ3‚ÌŽ_«ƒGƒ^ƒm[ƒ‹’†‚Å‚Ì\‘¢•Ï‰»‚̉ðÍ. ]‰Ä½C’Ѻ˜aLC“B‹{ÂCX“c—Y•½i•s“ñ»–ûjCŽu‘º—R‹IC˜@Œ©‰p¢i¶•¨•¨—‰»j: ‘æ71‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i98.10.17j, –¼ŒÃ‰®, ¶‰»Šw, 70(8): 1048, 1998.

554. mŒ¤‹†‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j ‘哤ƒ^ƒ“ƒpƒNŽ¿ƒÀ3‚ÌŽ_«ƒGƒ^ƒm[ƒ‹’†‚Å‚Ì\‘¢•Ï‰». ˜@Œ©‰p¢CŽu‘º—R‹Ii¶•¨•¨—‰»jCŒK“c³Li¶‰»jC]‰Ä½C’Ѻ˜aLCX“ca•½C“B‹{Âi•s“ñ»–ûj: ‘æ5‰ñuƒ^ƒ“ƒpƒNŽ¿‚Ì—§‘Ì\‘¢‚Ì\’zŒ´—vƒ[ƒNƒVƒ‡ƒbƒv i98.12.08j, “Œ‹ž, —\eW, p.79, 1998.


<<1401 “à‰ÈŠw‡T>>

555. mŒ´’˜n Endoscopic treatment of early colo-rectal cancer. ŒÜ\—’³LCŸ–””º‰hC¬—Ñ´“TC¼Œ³Ž›Ž—çi“àj: Acta Endoscopica, 28(2): 97`112, 1998.

556. mŒ´’˜n CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. “à“¡‹g—²i“àjCSaito, K.CShiiba, K.i“Œ–k‘åjCOhuchi, A.i“Œ–k˜JÐjC¼Œ³Ž›Ž—çi“àjCNagura, H.COhtani, H.i“Œ–k‘åj: Cancer Res., 58(August 15): 3491`3494, 1998.

557. mŒ´’˜n Markedly elevated cell turnover is characteristic of small, deeply invasive carcinomas of the clorectum. ‚‹´—T”Vi“àjCŽO•xO”Vi•a—jCŒÜ\—’³LCŸ–””º‰hi“àjC‰ªˆÀŒMi•a—j: Cancer, 85(4): 796`802, 1999.

558. mŒ´’˜n Staging of gastric cancer with endoscopic ultrasonography and endoscopic mucosal resection. –Ø“cŒõLC“c•Ó‘C“n•Ó–€–çC‘“ŒŠ²•vC‹ß“¡ˆê‰pCŽR“cŽŠlCâŒû“NÍC¼Œ³Ž›Ž—çi“àj: Endoscopy, 30(Suppl.): 64`68, 1998.

559. mŒ´’˜n Á‰»Ší“àŽ‹‹¾‚ÌôòÁ“Å‚ÉŠÖ‚·‚éŠî‘b“I‚¨‚æ‚Ñ—Õ°“IŒŸ“¢. ²“¡‘˜aŽqCX‰ºkŽ¡CùGsiƒIƒŠƒ“ƒpƒXŒõŠwjC–؉ºç–œŽqi•a‰@jC‘åˆä“c³li“àj: Gastroenterol. Endosc., 40(3): 543`549, 1998.

560. mŒ´’˜n Š×‰šŒ^‘ŠúˆÝŠàZ”͈Íf’f‚É‚¨‚¯‚é“K‰žŒ^‹­’²‚¨‚æ‚ÑIHbFÊ‹­’²•¹—pˆ—‚ÌŒŸ“¢. ŽRãp‚³‚ä‚èC‘åˆä“c³lCŽR“cŽŠlC¼Œ³Ž›Ž—çi“àj: Gastroenterol. Endosc., 40(6): 867`877, 1998.

561. mŒ´’˜n ƒÀ3-adrenergic receptor gene polymorphism is not associated with hypertension in NIDDM patients without nephropathy. ”nêPtC’†“ˆ^ˆêi“àjC–‹`’‰iˆã—Éq¶j: Hormone and Metabolic Research, 30(10): 629`632, 1998.

562. mŒ´’˜n Efficacy of surgery after saccessful chemotherapy for advanced gastric cancer. Seike, K.COhtsu, A.CYoshida, S.CKinoshita, T.COno, M.i‘—§‚ª‚ñƒZƒ“ƒ^[jC¬ò˜aŽO˜Yi“àjCMiyata, Y.i²‹v‘‡•a‰@jCShirao, K.i‘—§‚ª‚ñƒZƒ“jCShimada, Y.CKurihara, M.iº˜a‘åj: Int. J. Clin. Oncol., 3: 159`164, 1998.

563. mŒ´’˜n A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy. “cÈiCŠŽRŒå˜NC…–ì•q”VCŽR‰ºŒSŽiCŽO‰YO”VCŠŒ´„C•ž•”é—TCŽO‘îO–¾C¼‰ª’qŽiC•ºŒÉGKCŠp“ì‘׎uC‹xêˆÐ”VC‰z’qG“TiL“‡‘åjC¼–{‘׎i iŽOŽÄ•a‰@jCˆÀ•”–¾˜NCˆÀ’BŒ£i‘—§‘Š–ÍŒ´•a‰@jC¬–“•¶’jCã–앶ºi“ŒŠC‘åjC›“c•¶•vC‘åŒI–κiº˜a‘åjCŽÄ“c‹v—YC‘•ª–ΔŽi“àj: J. Clin. Gastroenterol., 26(4): 287`291, 1998.

564. mŒ´’˜n A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori. ¬ò˜aŽO˜YC“c•Ó‘C“ú”䌪ˆêC¡òOC‘åˆä“c³lC‰ª•”Ž¡–íC¼Œ³Ž›Ž—çi“àjC‰ªˆÀŒMi•a—j: J. Gastroenterol. Hepatol., 13: 301`304, 1998.

565. mŒ´’˜n Hepatitis G virus infection from needle-stick injuries in hospital employees. a’J–¾—²i“àjC’|“à“ÖŽqi¶‰»ŒnjC÷ˆäŒc‘¢i—ÕŒŸjC¼Œ³Ž›Ž—çi“àj: J. Hosp. Infect., 40: 287`290, 1998.

566. mŒ´’˜n Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer. Ohtani, H.i“Œ–k‘åjC“à“¡‹g—²i“àjCSaito, K.CNagura, H.i“Œ–k‘åj: Lab. Invest., 77(3): 231`241, 1997.

567. mŒ´’˜n Prevalence of hepatitis G virus RNA and anti-E2 in a Japanese haemodialysis population. a’J–¾—²i“àjC’|“à“ÖŽqi¶‰»ŒnjCŠ™“cvŽõC¼Œ³Ž›Ž—çi“àjC¬—Ñ’¼”VC‹g“càˆi‘Š–ÍzŠÂŠíƒNƒŠƒjƒbƒNj: Nephrol. Dial. Transplant., 13: 2033`2036, 1998.

568. mŒ´’˜n ’×ᇌ^’¼’°”S–Œ’EÇŒóŒQ‚Ì“àŽ‹‹¾“IŒo‰ß. ²“c”ü˜aCŒÜ\—’³LC‰¡ŽRŒOC‚‹´—T”VC¬—Ñ´“TCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCŽO•xO”Vi•a—j: Á‰»Ší“àŽ‹‹¾, 10(10): 1295`1301, 1998.

569. mŒ´’˜n ‘å’°—LŒs«ƒ|ƒŠ[ƒv‚Ì“àŽ‹‹¾“I“Eœ‚É‚¨‚¯‚é—¯’uƒXƒlƒA‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ¬—Ñ´“TCŸ–””º‰hC‰¡ŽRŒOC‚‹´—T”VCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 52: 45`48, 1998.

570. mŒ´’˜n ‘ŠúˆÝŠà‚ɑ΂·‚é“àŽ‹‹¾“I”S–ŒØœŒã‚̈âŽc¥Ä”­—á‚ÌŒŸ“¢‚Æ‘Îô. “c•Ó‘i“àjC“ˆ”ömiŠOjC‘“ŒŠ²•vC“n•Ó–€–çC–Ø“c–FŽ÷C–Ø“cŒõLC¬ò˜aŽO˜YCŽO‹´—˜‰·C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOjCŽO•xO”V i•a—j: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 53: 43`47, 1998.

571. mŒ´’˜n EMR‚ÌŽè‹Z‚ƬÑ. ŒÜ\—’³LC¬—Ñ´“TC‚‹´—T”VC‰¡ŽRŒOCŸ–””º‰hi“àj: ‘Šú‘å’°Šà, 2(5): 613`619, 1998.

572. mŒ´’˜n ‹ÇŠˆâŽc‚©‚ç‚Ý‚½“K‰ž‚ÆŒÀŠE; EMR—á‚É‚¨‚¯‚é‹ÇŠˆâŽc‚ÌŒŸ“¢. ŒÜ\—’³LC‰¡ŽRŒOC‚‹´—T”VC¬—Ñ´“TCŸ–””º‰hi“àj: ‘Šú‘å’°Šà, 2(6): 639`645, 1999.

573. mŒ´’˜n “œ”A•a«_ŒoáŠQŠ³ŽÒ‚É‚¨‚¯‚é‘«æäŠÖ߉“®«|•àsŽž‚Ì“®“Ió‘Ô‚Å‚ÌŒŸ“¢|. ‹àXWi“àjC–؎åÅC–‹`’‰iˆã—Éq¶j: “œ”A•a, 41(5): 363`371, 1998.

574. mŒ´’˜n “œ”A•a«_ŒoáŠQŠ³ŽÒ‚É‚¨‚¯‚é‘«’êäEãñ•”ˆ³‘ª’è‚Ɖß舳ŒyŒ¸‚ÌŽŽ‚Ý. ‹àXWi“àjC–؎åÅC–‹`’‰iˆã—Éq¶j: “œ”A•a, 42(3): 201`207, 1999.

575. mŒ´’˜n ‘å’°‘ŠúŠà‚ÌŽ¡—Ö@‘I‘ð‚É‚¨‚¯‚é“àŽ‹‹¾‰º‹Ç’–@‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‚‹´—T”VC¬—Ñ´“TCŸ–””º‰hCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àj: “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 40(4): 651`662, 1998.

576. mŒ´’˜n Šˆ“®ŠúCrohn•a‚ɑ΂·‚é‰h—{—Ö@‚Ì–³ìˆ×”äŠrŽŽŒ±. ¬—Ñ´“TCŸ–””º‰hC‰¡ŽRŒOC‚‹´—T”VCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àj: “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95(11): 1212`1221, 1998.

577. mŒ´’˜n –å–¬ˆ³˜´iÇ‚É‚¨‚¯‚éH“¹Ã–¬áŽd‰»—Ö@‘OŒã‚ÌŒŒ’†‘’_`Ž_’l‚Ì•Ï“®. ‹´‹l´]C‘•ª–ΔŽi“àjCŽÄ“c‹v—Yi‘å“à•a‰@j: –ò—‚ÆŽ¡—Ã, 26(Suppl.2): 105`108, 1998.

578. mŒ´’˜n ‘Šú’¼’°Šà‚ɑ΂·‚é”S–ŒØœp(EMR). ŒÜ\—’³LCŸ–””º‰hC¬—Ñ´“TC‚‹´—T”VC‰¡ŽRŒOi“àj: —Õ°ŠO‰È, 54(4): 407`411, 1998.

579. m€Œ´’˜n “dŽq“àŽ‹‹¾‚É‚æ‚éŒõØ’f–@‚ð—p‚¢‚½—§‘ÌŒv‘ªƒVƒXƒeƒ€. ›–ì‘C‘åˆä“c³lC—Ñ“c_–¾C¡òOC“c•Ó‘C¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj: ˆÝ‚Æ’°, 33(2): 167`173, 1998.

580. m€Œ´’˜n ˆÝŠà‚Ìf’f‚É‚wüŒŸ¸‚Í•s—v‚©|•K{‚Æ‚µ‚È‚¢—§ê‚©‚ç; E‚¢‚ ‚°f’f. ‘åˆä“c³lCˆÀ’BŒ£C“n•Ó–€–çC–Ø“c–FŽ÷C¡òOC“c•Ó‘C–Ø“cŒõLC¬ò˜aŽO˜YCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: ˆÝ‚Æ’°, 33(4): 591`597, 1998.

581. m€Œ´’˜n ’×ᇫ‘å’°‰Š‚É‚Ý‚ç‚ê‚é•~ΗlŠŒ©‚Ì—Õ°•a—Šw“IŒŸ“¢. Ÿ–””º‰hC‰¡ŽRŒOC‚‹´—T”VC¬—Ñ´“TCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC‘å’J„³CˆäŒ´ŒúiŠOjCŽO•xO”Vi•a—j: ˆÝ‚Æ’°, 33(9): 1243`1253, 1998.

582. m€Œ´’˜n Œ´”­«’_`«ŠÌd•Ï‚É‚¨‚¯‚éŠÌ×–EŠà‚̇•¹‚ɂ‚¢‚Äi‘½Ž{Ý‹¤“¯Œ¤‹†j. a’J–¾—²i“àjC“c’†Ž–¾i‰¡•lŽs‘åj: ŠÌ‘Ÿ, 39(8): 600`602, 1998.

583. m€Œ´’˜n ‚bŒ^–«ŠÌ‰Š‚ɑ΂·‚éƒCƒ“ƒ^[ƒtƒFƒƒ“—Ö@‚Ì’·Šú—\Œã‚ÉŠÖ‚·‚錟“¢. “y‹´Œ’Ca’J–¾—²i“àj: ŠÌ‘Ÿ, 39: 787`789, 1998.

584. m€Œ´’˜n ‰ŠÇ«’°Ž¾Š³‚Ì“àŽ‹‹¾“IŒo‰ßŠÏŽ@. ŒÜ\—’³LC¬—Ñ´“TCŸ–””º‰hi“àj: Á‰»Ší“àŽ‹‹¾, 11(2): 308`314, 1999.

585. m€Œ´’˜n “œ”A•a«_ŒoáŠQŠ³ŽÒ‚ÌäEãñ•”‚É‚¨‚¯‚é‘«’ꈳ•]‰¿. ‹àXWC’†“ˆ^ˆêC_N”VC”~‘òTˆêC“Iê´˜aC“¡“c–F–Mi“àjC–‹`’‰C–؎åÅiˆã—Éq¶j: “œ”A•a«‡•¹Ç, 11: 133`138, 1999.

586. m€Œ´’˜n ‰ŠÇ«’°Ž¾Š³‚É‚¨‚¯‚é“àŽ‹‹¾ŒŸ¸‚Ì–ðŠ„. ŒÜ\—’³LCŸ–””º‰hC¬—Ñ´“TC‰¡ŽRŒOC‚‹´—T”VC¼Œ³Ž›Ž—çi“àj: “ú–{‘å’°ŒŸ¸Šw‰ïŽGŽ, 15: 58`60, 1998.

587. m’Z•ñ¥‘¬•ñn ”ñd•Ï«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚éŠÌ“àŽîᎫ•a•Ï‚ÌŒŸ“¢. ’†‘ò‹MGC‘•ª–ΔŽCa’J–¾—²Có–ì˜NC“ú‚‰›C‚“c‰ë”ŽC¼Œ³Ž›Ž—çi“àj: “ú–{–å–¬ˆ³˜´iÇH“¹Ã–¬áŽŠw‰ïŽ, 4: 429, 1998.

588. mÇ—á•ñn An autopsy case of troglitazone - Induced fulminant hepatitis. a’J–¾—²C“n•Ó^²C“¡“c–F–MC¼Œ³Ž›Ž—çi“àjCŒK”ö’èmi•a—jC‚‹´‹v’ji‘Š–Í’†‰›ƒNƒŠƒjƒbƒNjC’|“àŽ¡’ji‘Š–Í–ì•a‰@j: Diabetes Care, 21(12): 2140`2143, 1998.

589. mÇ—á•ñn Hematoma with high oxygen partial pressure resulting from injection sclerotherapy for esophageal varies - Report of a case. ‘ºã‹§li‘ºã‹L”O•a‰@jC¯‰ÁÍŽqC–î–ìtŠCCr–ØŽ”VCOhshima, K.C–î–ì“N˜Yi¼ŽRŽs–¯•a‰@jC‘•ª–ΔŽi“àj: Dig. Endosc., 11(1): 55`61, 1999.

590. mÇ—á•ñn A case of advanced esophageal carcinoma with a prolonged complete response to chemoradiotherapy. ’†–ìŽj˜YC¬ò˜aŽO˜YC“c•Ó‘C’JìˆêŽuCŽRè‚¢‚ÂÝC‹ß“¡ˆê‰pC“n•Ó–€–çC¡òOC–Ø“c–FŽ÷C–Ø“cŒõLC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjC¬—ÑLsC”äŠé ”\Ž÷iŠOj: Kitasato Med., 28(5): 456`460, 1998.

591. mÇ—á•ñn Troglitazone‚É‚æ‚錀NJ̉Š‚Ì‚P—á. “n•Ó^²Ca’J–¾—²i“àj: Minophagen Medical Review, 43(6): 348`349, 1998.

592. mÇ—á•ñn Idiopathic adulthood ductopenia‚ð‹^‚Á‚½‚P—á. a’J–¾—²C’†‘ò‹MGC—¢“¹“N•Fi“àj: Progress in Medicine, 18(4): 857`858, 1998.

593. mÇ—á•ñn ¬’°“àŽ‹‹¾‚Åp‘Of’f‚µ‚½Œ´”­«‹ó’°Šà‚Ì‚P—á. ‰¡ŽRŒOC¬—Ñ´“TCŸ–””º‰hC‚‹´—T”VCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjCΈär–çi“Œ–M‘åj: Progress of Digestive Endoscopy, 51: 96`99, 1998.

594. mÇ—á•ñn BarrettH“¹Œo‰ß’†‚É”­¶‚µ‚½‘Šú‘BŠà‚Ì‚P—á. ‘ºã’C‘å–ì—²C‰º•lF˜YC“c’†”ŽŽuC¼–Ø–ÎŽ÷C‹k“c‹P—Yi“àjC“¿ŽRåC•ÊŠ—²: Progress of Digestive Endoscopy, 52: 106`107, 1998.

595. mÇ—á•ñn ”S–Œ‰ºŽîᇗl‚Ì“÷ŠáŒ`‘Ô‚ð’悵‚½‘å’°isŠà‚Ì‚Q—á. ‚‹´—T”VC¬—Ñ´“TC‰¡ŽRŒOCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: Progress of Digestive Endoscopy, 52: 162`163, 1998.

596. mÇ—á•ñn äXŒ´”­ƒKƒXƒgƒŠƒm[ƒ}‚ÌŠÌ“]ˆÚ‚Æ“ú–{ZŒŒ‹z’ŽÇ‚ð•ê’n‚Æ‚µ‚½ŠÌd•Ï‚É”º‚Á‚½ŠÌ×–EŠà, t×–EŠà‚ð‡•¹‚µ‚½‚P—á. •Ûâ”ü¶i“àjC•“¡M”üC—é–ØO”VCÄ“¡rŽii‘å˜aŽs—§•a‰@jC”½’¬mˆêCŽO—Ö„i“ŒŠC‘åj: Progress of Digestive Endoscopy, 52: 174`175, 1998.

597. mÇ—á•ñn Ç—á‚©‚ç‚Ý‚½“lje‚Æf’f‚ÌŠî‘biCase 26). ¬—Ñ´“TCŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ˆÝ‚Æ’°, 33(6): 904`907, 1998.

598. mÇ—á•ñn ”ÄŒŒ‹…Œ¸­ŒXŒü‚ð’悵•s®–¬S“à–Œ‰Š‚ð”F‚ß‚½¬l”­ÇStill•a‚Ì‚P—á. ‘O“c’å‘¥C•Ûâ”ü¶i“àjCVˆätŽ}i‘å˜aŽs—§•a‰@jC‹ß“¡Œ[•¶i“àj: ŠÖ“ŒƒŠƒEƒ}ƒ`‹»–¡‚ ‚éÇ—á‚Æ‚»‚Ì–â‘è“_, 32: 71`78, 1998.

599. mÇ—á•ñn R’×ᇗÖ@‚É‚æ‚è—ÇD‚ÈŒo‰ß‚ðŽ¦‚µ‚½reactive lymphoid hyperplasia‚Ì‚RÇ—á. ¬¼OˆêC¡‘º´ŽqC‘“c‰p–¾CŽðˆä’C•FCŽl‹{—R”üŽqC“y‹´Œ’C“°X‹»ˆê˜YC²“‡Œh´i‰¡•lŽs–¯•a‰@j: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 53: 150`151, 1998.

600. mÇ—á•ñn •›“û“ªŠ‡–ñ‹ØØŠJp‚ƃXƒeƒ“ƒg‘}“üp‚É‚æ‚鎡—ª—LŒø‚Å‚ ‚Á‚½äXŠÇ”ñ–ü‡‚É‚æ‚éÄ”­«‹}«äX‰Š‚Ì‚P—á. ^‹ÊŽõ”ü¶C“ú”䌪ˆêCŽá—ÑŒ’ŽiC›–ì‘i“àj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 53: 210`211, 1998.

601. mÇ—á•ñn “àŽ‹‹¾‰º‚̶ŒŸ‚É‚æ‚èf’f‚µ“¾‚½‰ñ’°ˆ««ƒŠƒ“ƒpŽî‚Ì‚P—á. ‚’Jˆç’ji“àjCr“cTŽõC—ÑO”üi“àjC—é–ØG–¾C¼‰ªŠ²—YC–kì³–¾C׈ä‰p—YC‘匴‹BCÔ‰H‹v¹i‰¡{‰ê‹¤Ï•a‰@j: “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽ, 40(3): 579`584, 1998.

602. mÇ—á•ñn oŒŒ‚ɑ΂µ‚ăq[ƒ^[ƒvƒ[ƒuŽ~ŒŒ–@‚ª—LŒø‚Å‚ ‚Á‚½•úŽËü«’°‰Š‚Ì‚P—á. ‘ºãK‘¾˜YCΈäŒ\‘¾CˆÀŠC‹`—jCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCŽO•xO”Vi•a—j: “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽ, 40(5): 792`796, 1998.

603. m‘àn tÇŽ¡—ÂÌStrategy. Žç‰®’B”üC–‹`’‰i“àj: BIO Clinica, 14(2): 129`135, 1999.

604. m‘àn “àŽ‹‹¾ŒŸ¸‚É”º‚¤Š´õ. ‘åˆä“c³lCŸ–””º‰hC¼Œ³Ž›Ž—çC–؉ºç–œŽqi“àj: Clin. Eng., 9(10): 945`946, 1998.

605. m‘àn ‘‚¦‘±‚¯‚é“œ”A•a‚Æ‚Í. Žç‰®’B”üC–‹`’‰i“àj: Dental Frontier, 5: 64`66, 1998.

606. m‘àn Á‰»«’×á‡‚Æ“àŽ‹‹¾|f’f¥Ž¡—Ã¥•a‘Ô¶—|. ¼Œ³Ž›Ž—çC‘åˆä“c³li“àj: Gastroenterol. Endosc., 41(1): 3`9, 1999.

607. m‘àn ’°Œ^ƒx[ƒ`ƒFƒbƒg•a‚¨‚æ‚Ñ’Pƒ«’×ᇂɑ΂·‚éÝ‘îŒo’°‰h—{—Ö@‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‚‹´—T”VCŸ–””º‰hC‰¡ŽRŒOC¬—Ñ´“TCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOjC[–xMŽqC–ìŒû‹…Žqi‰h—{j: JJPEN, 20(9): 787`788, 1998.

608. m‘àn ŽOŽŸŒ³’´‰¹”g“àŽ‹‹¾. –Ø“cŒõLC“n•Ó–€–çCr–س—YC‘“ŒŠ²•vC›–ì‘C‰¡ŽRŒOC‹ß“¡ˆê‰pC¬—Ñ´“TCŽR“cŽŠlCâŒû“NÍC–ì“o½C¼Œ³Ž›Ž—çi“àj: Mebio, 15(12): 78`82, 1998.

609. m‘àn Ž©ŒÈ–Ɖu«ŠÌŽ¾Š³‚É‚¨‚¯‚é”­Šà‚Ì–â‘è“_. a’J–¾—²i“àjC“c’†Ž–¾i‰¡•lŽs‘åj: Medicina, 35(1): 108`109, 1998.

610. m‘àn ŠÌ¶ŒŸ. a’J–¾—²i“àj: Medicina, 35(11): 408`409, 1998.

611. m‘àn —lX‚È󋵂Ŋ̎¾Š³‚ð‚Ç‚¤‚Ý‚é‚©; ”D•w‚ÉŠÌ‹@”\ˆÙí‚ð‚Ý‚½‚ç. a’J–¾—²C’†‘ò‹MGC—¢“¹“N•Fi“àj: Medicina, 36(2): 259`261, 1999.

612. m‘àn oŒŒ«’×á‡; “àŽ‹‹¾Ž¡—ÂÌi•à. “c•Ó‘C¡òOCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: Modern Physician, 18(12): 1484`1486, 1998.

613. m‘àn ˆÝŠàEMRŒã‚̈âŽcÄ”­. ¼Œ³Ž›Ž—çi“àj: ˆÝ‚Æ’°, 33(13): 1685`1686, 1998.

614. m‘àn ˆÝŠà‚Ìf’f‚É‚wüŒŸ¸‚Í•s—v‚©|Ž„‚Í‚±‚¤l‚¦‚é|. ¼Œ³Ž›Ž—çi“àj: ˆÝ‚Æ’°, 33(4): 657`657, 1998.

615. m‘àn ‘å’°Ž¾Š³‚Ìf’f‚É’’°‚wüŒŸ¸‚Í•K—v‚©. ŒÜ\—’³Li“àj: ˆÝ‚Æ’°, 33(5): 784, 1998.

616. m‘àn ˆÝ’×ᇥ\“ñŽw’°’×á‡. ¼Œ³Ž›Ž—çi“àj: ˆãŠw‚Æ–òŠw, 40(6): 993`999, 1998.

617. m‘àn Á‰»«’×ᇂ̉uŠw|H. pyloriŠ´õ•p“x‚ðŠÜ‚ß‚Ä|. “c•Ó‘C¼Œ³Ž›Ž—çi“àj: ˆãŠw‚Ì‚ ‚ä‚Ý, 186(9): 509`513, 1998.

618. m‘àn ^‹Û«Šá“à‰Š. “c•Ó‘i“àj: Šà‰»Šw—Ö@Žž‚ÌEmergency, p.163`169, 1998.

619. m‘àn ‹}«ˆÝ”S–Œ•a•Ïi‹}«ˆÝ‰Š, ‹}«ˆÝ’×á‡). “c•Ó‘i“àj: ¡“ú‚ÌŽ¡—ÃŽwj, p.394`395, 1999.

620. m‘àn • ’Éi‹}«• Ç‚Íœ‚­j. ¬—Ñ´“TCŸ–””º‰hCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àj: ŽY•wl‰È‚ÌŽÀÛ, 47(10): 1575`1582, 1998.

621. m‘àn ƒoƒ‹[ƒ“•Âljº‹ts«ŒoÖ¬“IÇðp. ‘•ª–ΔŽi“àjCˆé•”‹`Œ›i•újCŽR‰ª²¢Có–ì˜NC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOj: Žèp, 52(8): 1205`2111, 1998.

622. m‘àn Øœ•s”\isˆÝŠà‚ɑ΂·‚éNeoadjuvant Chemotherapy. ¬ò˜aŽO˜YC“c•Ó‘C‹ß“¡ˆê‰pCŽRè‚¢‚ÂÝC¼Œ³Ž›Ž—çi“àjC‹e’rŽj˜YC¬—ÑLsC”äŠé”\Ž÷iŠOj: Á‰»Ší‰È, 26(2): 173`178, 1998.

623. m‘àn Á‰»ŠíŽ¾Š³‚É‚¨‚¯‚éŒo’°‰h—{–@. Ÿ–””º‰hC¬—Ñ´“TCŒÜ\—’³Li“àjC“‰€”EC[–xMŽqiŠÅŒì•”j: Á‰»ŠíŠO‰ÈNursing, 4(2): 120`216, 1999.

624. m‘àn ˜à; ‚È‚º’¼’°’×ᇂȂ̂©. Ÿ–””º‰hi“àj: Á‰»Ší“àŽ‹‹¾, 10(10): 1252`1252, 1998.

625. m‘àn ˆÝŽîᇂ¨‚æ‚шݑO’ë•”–Ñ׌ŒŠÇŠg’£Ç(GAVE)‚ɑ΂·‚éAPC–@‚É‚æ‚鎡—Ã. “c•Ó‘i“àjC“ˆ”ömiŠOjC–k‘º‹§C“ú‚‰›C‚“c‰ë”ŽCŽRè‚¢‚ÂÝC‘“ŒŠ²•vC“n•Ó–€–çC–Ø“c–FŽ÷C–Ø“cŒõLC¬ò˜aŽO˜YCŽO‹´—˜‰·C‘åˆä“c³lC¼Œ³ Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 10(12): 1603`1608, 1998.

626. m‘àn ”÷¬ˆÝŠà‚̃XƒNƒŠ[ƒjƒ“ƒO; ¸–§f’f‚É‚¨‚¯‚éŠg‘å“àŽ‹‹¾‚Ì—L—p«‚ÆŒÀŠE. ‘åˆä“c³lC¡òOC“n•Ó–€–çC“c•Ó‘C–Ø“cŒõLC¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj: Á‰»Ší“àŽ‹‹¾, 10(6): 760`764, 1998.

627. m‘àn ¬’°ƒ|ƒŠ[ƒv‚ɑ΂·‚ép’†“àŽ‹‹¾“I“Eœ. ¬—Ñ´“TCŸ–””º‰hC—ÀLC‰¡ŽRŒOC‚‹´—T”VCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjCŽO•xO”Vi•a—j: Á‰»Ší“àŽ‹‹¾, 10(9): 1169`1175, 1998.

628. m‘àn H“¹¥ˆÝŽ¾Š³‚ɑ΂·‚éŽOŽŸŒ³’´‰¹”g“àŽ‹‹¾. –Ø“cŒõLC“n•Ó–€–çCr–س—YC‘“ŒŠ²•vC›–ì‘C‰¡ŽRŒOC‹ß“¡ˆê‰pC¬—Ñ´“TCŽR“cŽŠlCâŒû“NÍC–ì“o½C¼Œ³Ž›Ž—çi“àj: Á‰»Ší“àŽ‹‹¾, 11(1): 65`73, 1999.

629. m‘àn ”A’†”÷—ʃAƒ‹ƒuƒ~ƒ“. _N”VC–‹`’‰i“àj: ‘‡—Õ°'98‘Š§, ŒŸ¸ƒf[ƒ^ƒ}ƒjƒ…ƒAƒ‹, p.433`436, 1998.

630. m‘àn “œ‘ãŽÓŒŸ¸ƒOƒ‹ƒR[ƒX. ‹àXWC–‹`’‰i“àj: ‘‡—Õ°, 47(‘Š§): 437`443, 1998.

631. m‘àn ‘’_ŠÇŒ‹Î‚ð‡•¹‚µ‚½’_”X’_Îǂւ̃Aƒvƒ[ƒ`|“àŽ‹‹¾‚Ì—§ê‚©‚ç|. –Ø“cŒõLC‘“ŒŠ²•vC“n•Ó–€–çC–Ø“c–FŽ÷C¡òOC¼Œ³Ž›Ž—çi“àjC¯–ìOŽ÷C“‡“cŒªC‚‹´‹BC‹g“c@‹IiŠOj: ’_‚ÆäX, 19(6): 467`471, 1998.

632. m‘àn Mallory-WeissÇŒóŒQ. “c•Ó‘C¼Œ³Ž›Ž—çi“àj: “ú–{—Õ°, 56(9): 124`127, 1998.

633. m‘àn Á‰»«’×ᇎ¡–ü‚ÌŽ¿‚©‚ç‚Ý‚½H. pyloriœ‹Û—Ö@‚ÌŽ¡—ÃŒø‰Ê. ¡òOC¬ò˜aŽO˜YC’†ˆä‹v—YC“c•Ó‘C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: “ú–{—Õ°, 57(1): 167`172, 1999.

634. m‘àn Á‰»ŠÇoŒŒi“fŒŒ, ‰ºŒŒj. ¡òOC“c•Ó‘CŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: —Õ°ˆã, 24(‘Š§): 1924`1928, 1998.

635. m‘àn ƒqƒXƒ^ƒ~ƒ“Žó—e‘ÌhR–ò(H2RA). ¡òOC‘åˆä“c³lCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: —Õ°Á‰»Ší“à‰È, 13(13): 1843`1848, 1998.

636. m‘àn Total Colonoscopoy|‘}“ü¢“ï—á‚ÌŒ´ˆö‚Æ‰ðŒˆ–@|. ŒÜ\—’³Li“àj: —Õ°Á‰»Ší“à‰È, 14(1): 87`96, 1999.

637. m‘àn “œ”A•a«tÇ‚ÌŽ¡—Ã. Žç‰®’B”üC–‹`’‰i“àj: —Õ°¬l•a, 28: 1434`1437, 1998.

638. muÀn ˆÝŠàEMR‚ÌŠ®‘SØœ‚Ì”»’èŠî€‚ð‹‚ß‚Ä. ¼Œ³Ž›Ž—çi“àjC‰ªèK‹IiŽRŒûŒ§Œú¶˜AŽü“Œ‘‡•a‰@jCˆä“c˜a“¿i’©“ú‘åjCåb“cŒ‰i϶‰ï’†’Õa‰@jC’|‰ºŒö–îi“ŒˆãŽ•‘åjC’|˜—²’jiŠàŒ¤jC•l “c•×iŽÐ‰ï•ÛŒ¯’†‰›‘‡•a‰@jC‰Á“¡—miŠàŒ¤jC‰º“c’‰˜ai‘—§‚ª‚ñƒZƒ“ƒ^[jC–ˆÉ³‹`i‹à‘ò‘åj: ˆÝ‚Æ’°, 33(12): 1640`1658, 1998.

639. muÀn Œ´”­«’_`«ŠÌd•Ï‚É‚¨‚¯‚éŠÌ×–EŠà‚̇•¹. a’J–¾—²i“àj: Ž¡—Êw, 33(3): 335`335, 1999.

640. muÀn ‚±‚ñ‚ÈÇ—á, ‚±‚ñ‚ȉ摜. ¡òOC‘ŠèrÆi“àjC‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 10(12): 1279`1279, 1998.

641. muÀn Á‰»«’×á‡|¡“ú“I‰Û‘è‚Æ–¾“ú‚Ö‚ÌŽwj|. ¼Œ³Ž›Ž—çi“àjC–ØÆ–¾i“ŒŽœˆã‘åjC’†‘òŽO˜Yi“¡“c•ÛŒ’‰q¶‘åjC²“¡MãEi‡‘åj: Á‰»«’×á‡|—Õ°‚ÆŠî‘b|, 17(1): 2`15, 1998.

642. m•ÒWŽÒ‚ւ̎莆i‰p•¶jn Hepatocellular carcinoma arising from primary biliary cirrhosis in Japan. “c’†Ž–¾i‰¡•lŽs‘åjCa’J–¾—²i“àjC“à“¡ŽÀi“s˜Vlˆã—ÃZƒ“ƒ^[jC¬¼’BŽii‘—§‰¡•l•a‰@jCŠÃ–ØGˆêi“ú‘åjCŽÄ“cŽÀiº˜a‘åjC‹{ì_i’é‹ž ‘åj: Am. J. Gastroenterol., 93(7): 1190`1191, 1998.

643. mŠwp‘n i•ª’SŽ·•Mj ‰ŠÇ«’°Ž¾Š³‚Ì—Õ°, f’f‚ÆŽ¡—Â܂Å; Crohn•a‚Ì“àŽ‹‹¾f’f, p.64`70, ŒÜ\—’³LC¬—Ñ´“TCŸ–””º‰hi“àj. •ÒW ’©‘q‹ÏiVŠƒ‘åjC‘½“c³‘åi‹ž“s‚ª‚ñ‹¦‰ïjC•ÒC “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[C“Œ‹žC98.04.15”­s.

644. mŠwp‘n i•ª’SŽ·•Mj ‰ŠÇ«’°Ž¾Š³‚Ì—Õ°|f’f‚©‚玡—Â܂Å|; Crohn•a‚ÌCT, MRf’f, p.57`63, ¬—Ñ´“TCŸ–””º‰hi“àjCˆé•”‹`Œ›i•új. •ÒW ’©‘q‹ÏiVŠƒ‘åjC‘½“c³‘åi‹ž“s‚ª‚ñ‹¦‰ïjC•ÒC “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[C“Œ‹žC98.04.15”­s.

645. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã, ¼Œ³Ž›Ž—çi“àj. •ÒW ‰ª•”Ž¡–íC¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

646. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã, ‚P.H“¹¥ˆÝ¥‘å’°; isH“¹Šà‚Ìf’f, 1: 14`22, ŽO‹´—˜‰·i“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

647. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; ‘ŠúH“¹Šà¥isH“¹Šà‚Ì’´‰¹”g“àŽ‹‹¾f’f, p.22`27, –Ø“cŒõLC‹ß“¡ˆê‰pC–ì“o½i“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

648. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; ‘ŠúˆÝŠà‚Ì“àŽ‹‹¾f’f, p.38`45, ¼Œ³Ž›Ž—çi“àj. •ÒW ‰ª•”Ž¡–íC¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

649. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; ‘ŠúˆÝŠà‚Ì‚wüf’f, p.45`54, ¼Œ³Ž›Ž—çi“àj. •ÒW ‰ª•”Ž¡–íC¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

650. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã, 1.H“¹¥ˆÝ¥‘å’°; ˆÝŠà‚Ì[’B“xf’f, 6: 66`69, ‘åˆä“c³li“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

651. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã, 1.H“¹¥ˆÝ¥‘å’°; ‚wü‚É‚æ‚éˆÝŠà‚Ì[’B“xf’f, p.70`72, ‘åˆä“c³li“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

652. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; ˆÝŠà‚Ì’´‰¹”g“àŽ‹‹¾f’f, p.73`81, –Ø“cŒõLCŽR“cŽŠlCâŒû“NÍi“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

653. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã, 1.H“¹¥ˆÝ¥‘å’°; ‘ŠúˆÝŠà‚ÌZ”͈Íf’f, p.82`89, ‘åˆä“c³li“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

654. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã, 1.H“¹¥ˆÝ¥‘å’°; ˆÝŠà‚̶ŒŸf’f, p.89`92, ‘åˆä“c³li“àjCã™G‰ii•a—j. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

655. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; ¬’°Šà‚̉uŠw, —Õ°Çó, p.104`105, ŒÜ\—’³Li“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

656. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; ¬’°Šà‚Ìf’f, p.106`108, ŒÜ\—’³Li“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

657. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; ¬’°Šà‚ÌŠÓ•Êf’f, p.108`115, ŒÜ\—’³Li“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

658. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; ‘Šú‘å’°Šà‚Ìf’f, p.116`128, ŒÜ\—’³Li“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

659. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã, 1)H“¹¥ˆÝ¥‘å’°; is‘å’°Šà‚Ìf’f, 1: 129`137, ¬—Ñ´“Ti“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

660. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; ‘Šú‘å’°Šà‚Ì[’B“xf’f, p.138`148, ŒÜ\—’³Li“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

661. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã, 1)H“¹¥ˆÝ¥‘å’°; ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é‘å’°Šà‚Ì[’B“xf’f, p.149`152, ¬—Ñ´“Ti“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

662. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; Á‰»ŠÇˆ««ƒŠƒ“ƒpŽî‚Ìf’f, 1: 169`190, Ÿ–””º‰hi“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

663. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; H“¹Šà‚̉»Šw—Ö@, p.200`208, ¬ò˜aŽO˜Yi“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

664. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; ¬’°Šà, ‘å’°ŠàŽ¡—Â̎ÀۂƬÑ, p.230`239, ŒÜ\—’³Li“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

665. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; Á‰»ŠÇˆ««ƒŠƒ“ƒpŽî‚ÌŽ¡—Ã, 1: 250`261, Ÿ–””º‰hi“àj. •ÒW ¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

666. mŠwp‘n i•ª’SŽ·•Mj Á‰»«’×á‡; ‰ŠúŽ¡—Âƈێ—Ö@‚̂Ƃ炦•û, p.45`50, ¼Œ³Ž›Ž—çi“àj. •ÒW 󳔎i–k‘åjC•ÒC “ì]“°C“Œ‹žC98.05.01”­s.

667. mŠwp‘n i•ª’SŽ·•Mj F‘f¥Šg‘å“àŽ‹‹¾‚ÌÅ‘Oü; ‰æ‘œˆ—¥‰æ‘œ‰ðÍ, p.43`48, ¡òOC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj. •ÒW ’O‰HŠ°•¶Cˆä“c˜a“¿C•ÒC “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[C“Œ‹žC98.06.10”­s.

668. mŠwp‘n i•ª’SŽ·•Mj F‘f¥Šg‘å“àŽ‹‹¾‚ÌÅ‘Oü; Šg‘å“àŽ‹‹¾‚É‚æ‚éf’f, p.198`203, ‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj. •ÒW ’O‰HŠ°•¶Cˆä“c˜a“¿C•ÒC “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[C“Œ‹žC98.06.10”­s.

669. mŠwp‘n i•ª’SŽ·•Mj V‰æ‘œf’f‚Ì‚½‚߂̉ð•”}•ˆ|ŠÌ‘Ÿ¥’_“¹¥äX‘Ÿ¥äB‘Ÿ; ‡[. ’´‰¹”g“àŽ‹‹¾‚©‚ç‚Ý‚½’_“¹¥äX‘Ÿ‚̉ð–U, –Ø“cŒõLCŽR“cŽŠlCâŒû“NÍi“àj. •ÒW ¬ìŒ’“ñ•ÒC Medical ViewC99.03.30”­s.

670. mŠwp‘n i•ª’SŽ·•Mj Šà‰»Šw—Ö@Žž‚ÌEmergency; Á‰»ŠíŒnáŠQ‚̑Ήž(‚»‚Ì2), p.75`82, ¬ò˜aŽO˜YC–ì’†”ü˜aC¼Œ³Ž›Ž—çi“àj. •ÒW Ô‘òCŒáié‹Ê‚ª‚ñƒZƒ“ƒ^[jC²X–Øí—Yi“s—§‹îž•a‰@jC¬ò˜aŽO˜Yi“àjC•ÒC æ’[ˆãŠwŽÐC“Œ‹žC98.09.30”­s.

671. mŠwp‘n i•ª’SŽ·•Mj Šà‰»Šw—Ö@Žž‚ÌEmergency; Á‰»ŠíŒnáŠQ‚̑Ήž(‚»‚Ì2), p.83`90, ¡òOC¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj. •ÒW Ô‘òCŒáié‹Ê‚ª‚ñƒZƒ“ƒ^[jC²X–Øí—Yi“s—§‹îž•a‰@jC¬ò˜aŽO˜Yi“àjC•ÒC æ’[ˆãŠwŽÐC“Œ‹žC98.09.30”­s.

672. mŠwp‘n i•ª’SŽ·•Mj Ç—á‚ÉŠw‚ÔŠÌ‘Ÿ•aŠw; ‘å—Ê“fŒŒ‚É‚æ‚èƒVƒ‡ƒbƒN‚Ɋׂé‚àŽ¡—ª‘tŒø‚µ‚½–«t•s‘S‡•¹‚aŒ^ŠÌd•Ï‚Ì‚P—á, p.42`43, ‘•ª–ΔŽi“àj. •ÒW ‰êŒÃáÁi’é‹ž‘åjC—^ŽÅ^iº˜a‘åjC•ÒC V‹»ˆãŠwo”ÅŽÐC“Œ‹žC98.10.01”­s.

673. mŠwp‘n i•ª’SŽ·•Mj Ç—á‚ÉŠw‚ÔŠÌ‘Ÿ•aŠw; ƒXƒeƒ“ƒg—¯’uŠg’£p‚ðs‚Á‚½ŠÌÖ¬•ÂÇ‚Ì‚P—á, p.60`61, ‘ºãK‘¾˜YC‘•ª–ΔŽi“àj. •ÒW ‰êŒÃáÁi’é‹ž‘åjC—^ŽÅ^iº˜a‘åjC•ÒC V‹»ˆãŠwo”ÅŽÐC“Œ‹žC98.10.01”­s.

674. mŠwp‘n i•ª’SŽ·•Mj Ç—á‚ÉŠw‚ÔŠÌ‘Ÿ•aŠw; ˆÙís“®‚ð‚­‚è•Ô‚·Œy“xŠÌáŠQ, p.64`65, a’J–¾—²Có–ì˜Ni“àj. •ÒW ‰êŒÃáÁi’é‹ž‘åjC—^ŽÅ^iº˜a‘åjC•ÒC V‹»ˆãŠwo”ÅŽÐC“Œ‹žC98.10.01”­s.

675. mŠwp‘n i•ª’SŽ·•Mj Ç—á‚ÉŠw‚ÔŠÌ‘Ÿ•aŠw; Lip-PEITŒã100‚©ŒŽ¶‘¶‚µ‚Ä‚¢‚éŠÌŽîá‡(42 mmŒa)‚Ì‚P—á, p.78`79, ‘•ª–ΔŽi“àj. •ÒW ‰êŒÃáÁi’é‹ž‘åjC—^ŽÅ^iº˜a‘åjC•ÒC V‹»ˆãŠwo”ÅŽÐC“Œ‹žC98.10.01”­s.

676. mŠwp‘n i•ª’SŽ·•Mj Ç—á‚ÉŠw‚ÔŠÌ‘Ÿ•aŠw; –òÜ•ž—pŒã‚É‘J‰„‚·‚鉩át‚ð‚«‚½‚µ‚½‚P—á, p.110`111, ‚“c‰ë”ŽCa’J–¾—²i“àj. •ÒW ‰êŒÃáÁi’é‹ž‘åjC—^ŽÅ^iº˜a‘åjC•ÒC V‹»ˆãŠwo”ÅŽÐC“Œ‹žC98.10.01”­s.

677. mŠwp‘n i•ª’SŽ·•Mj Á‰»Ší“àŽ‹‹¾Ž¡—Ã}ƒjƒ…ƒAƒ‹|‰ü’ù‘æ2”Å; Á‰»ŠÇoŒŒ‚ɑ΂·‚鎡—Ã|‹Ç’—Ö@, p.94`98, ‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj. •ÒW “¡“c—Í–çiº˜a‘åjC”äŠé”\Ž÷i–k—¢‘åjC•ÒC “ì]“°C“Œ‹žC98.12.10”­s.

678. mŠwp‘n i•ª’SŽ·•Mj Á‰»Ší“àŽ‹‹¾Ž¡—Ã}ƒjƒ…ƒAƒ‹; ã•”Á‰»ŠÇ‚̃|ƒŠƒyƒNƒgƒ~[, p.32`49, ¼Œ³Ž›Ž—çi“àj. •ÒW “¡“c—Í–çiº˜a‘åjC”äŠé”\Ž÷i–k—¢‘åjC•ÒC “ì]“°C“Œ‹žC98.12.10”­s.

679. mŠwp‘n i•ª’SŽ·•Mj Á‰»Ší“àŽ‹‹¾Ž¡—Ã}ƒjƒ…ƒAƒ‹|‰ü’ù‘æ2”Å; Á‰»ŠÇoŒŒ‚ɑ΂·‚鎡—Ã|‹Ç’—Ö@, p.94`98, ‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj. •ÒW “¡“c—Í–çiº˜a‘åjC”äŠé”\Ž÷i–k—¢‘åjC•ÒC “ì]“°C“Œ‹žC98.12.10”­s.

680. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŽ¾Š³ÅV‚ÌŽ¡—Ã1999-2000; \“ñŽw’°’×á‡, b.ˆÛŽ—Ö@, p.117`120, ŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj. •ÒW ŒË“c„‘¾˜Yi“ŒŽœˆã‘åjC™–ìŒ\‘ i‹ã‘åjC’†‘ºFŽii’é‹ž‘åjC•ÒC “ì]“°C“Œ‹žC98.12.15”­s.

681. mŠwp‘n i•ª’SŽ·•Mj 1999¡“ú‚ÌŽ¡—ÃŽwj; 11.Á‰»ŠíŽ¾Š³|ˆÝ’×ᇥ\“ñŽw’°’×ᇥ•«‡•”’×á‡, p.396`398, ¼Œ³Ž›Ž—çi“àj. •ÒW ‘½‰ê{K’jC”öŒ`‰x˜YC¼Œ³Ž›Ž—çi–k—¢‘åjC‘¼C•ÒC ˆãŠw‘‰@C“Œ‹žC99.01.01”­s.

682. mŠwp‘n i•ª’SŽ·•Mj 1999¡“ú‚ÌŽ¡—ÃŽwj; –å–¬ˆ³˜´iÇiH“¹Ã–¬áŽ‚ðŠÜ‚Þj, p.429`431, ‘•ª–ΔŽi“àj. •ÒW ‘½‰ê{K’jC”öŒ`‰x˜YC¼Œ³Ž›Ž—çi–k—¢‘åjC‘¼C•ÒC ˆãŠw‘‰@C“Œ‹žC99.01.01”­s.

683. mŠwp‘n i•ª’SŽ·•Mj Annual ReviewÁ‰»Ší1999; –«ˆÝ‰Š, p.197`199, ¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj. •ÒW ŒË“c„‘¾˜YC•ÒC ’†ŠOˆãŠwŽÐC“Œ‹žC99.01.20”­s.

684. mŠwp‘n i•ª’SŽ·•Mj Ž¡—ÃgƒsƒbƒNƒX100; –å–¬ˆ³˜´iÇ‚Ì•a‘Ô‚ÆŽ¡—Ã, 81: 235`242, ‚“c‰ë”ŽC‘•ª–ΔŽi“àj. “ìŽR“°C“Œ‹žC99.01.20”­s.

685. mŠwp‘n i•ª’SŽ·•Mj –å–¬ŒŒsƒAƒgƒ‰ƒX; ’ZˆÝÖ¬, p.50`51, ‚“c‰ë”Ži“àj. •ÒW ‘•ª–ΔŽi–k—¢‘åjC¬Œ´Ÿ•qi•Ÿ“‡Œ§—§ˆã‘åjCa’Jii‚‚­‚Αoˆ¤•a‰@jC‹ßX•¶•vi‘‹g•a‰@jC‘º“‡’¼ÆiŒÕƒm–å•a‰@jC¼’J³ˆêiç—t‘åj•ÒC ˆãŠw‘‰@C“Œ‹žC99.03.01”­s.

686. mŠwp‘n i•ª’SŽ·•Mj –å–¬ŒŒsƒAƒgƒ‰ƒX; 2)’ˆÓ‚·‚ׂ«ŒŒs˜H (1)Œz¥˜r“ªÃ–¬”rŒŒ˜H, p.53`54, ‘•ª–ΔŽC“ú‚‰›i“àj. •ÒW ‘•ª–ΔŽi–k—¢‘åjC¬Œ´Ÿ•qi•Ÿ“‡Œ§—§ˆã‘åjCa’Jii‚‚­‚Αoˆ¤•a‰@jC‹ßX•¶•vi‘‹g•a‰@jC‘º“‡’¼ÆiŒÕƒm–å•a‰@jC¼’J³ˆêiç—t‘åj•ÒC ˆãŠw‘‰@C“Œ‹žC99.03.01”­s.

687. mŠwp‘n i•ª’SŽ·•Mj –å–¬ŒŒsƒAƒgƒ‰ƒX; –å–¬|”xÖ¬•«‡Porto-Pulmonary Venous Anastomosis (PPVA), p.56`57, ‘•ª–ΔŽC‘ºã‹§li“àj. •ÒW ‘•ª–ΔŽi–k—¢‘åjC¬Œ´Ÿ•qi•Ÿ“‡Œ§—§ˆã‘åjCa’Jii‚‚­‚Αoˆ¤•a‰@jC‹ßX•¶•vi‘‹g•a‰@jC‘º“‡’¼ÆiŒÕƒm–å•a‰@jC¼’J³ˆêiç—t‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC99.03.01”­s.

688. mŠwp‘n i•ª’SŽ·•Mj –å–¬ŒŒsƒAƒgƒ‰ƒX; H“¹ŠÂóÖ¬, p.62, ‘•ª–ΔŽi“àj. •ÒW ‘•ª–ΔŽi–k—¢‘åjC¬Œ´Ÿ•qi•Ÿ“‡Œ§—§ˆã‘åjCa’Jii‚‚­‚Αoˆ¤•a‰@jC‹ßX•¶•vi‘‹g•a‰@jC‘º“‡’¼ÆiŒÕƒm–å•a‰@jC¼’J³ˆêiç—t‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC99.03.01”­s.

689. mŠwp‘n i•ª’SŽ·•Mj –å–¬ŒŒsƒAƒgƒ‰ƒX; ˆÝtÖ¬ƒVƒƒƒ“ƒg|—‘‘ƒÃ–¬, p.97`98, ‘•ª–ΔŽi“àj. •ÒW ‘•ª–ΔŽi–k—¢‘åjC¬Œ´Ÿ•qi•Ÿ“‡Œ§—§ˆã‘åjCa’Jii‚‚­‚Αoˆ¤•a‰@jC‹ßX•¶•vi‘‹g•a‰@jC‘º“‡’¼ÆiŒÕƒm–å•a‰@jC¼’J³ˆêiç—t‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC99.03.01”­s.

690. mŠwp‘n i•ª’SŽ·•Mj –å–¬ŒŒsƒAƒgƒ‰ƒX; Œo“®–¬«–å–¬‘¢‰e, p.110`122, ‘•ª–ΔŽi“àj. •ÒW ‘•ª–ΔŽi–k—¢‘åjC¬Œ´Ÿ•qi•Ÿ“‡Œ§—§ˆã‘åjCa’Jii‚‚­‚Αoˆ¤•a‰@jC‹ßX•¶•vi‘‹g•a‰@jC‘º“‡’¼ÆiŒÕƒm–å•a‰@jC¼’J³ˆêiç—t‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC99.03.01”­s.

691. mŠwp‘n i•ÒWj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰ÈŽ¡—Ã; •ÒW ‰ª•”Ž¡–íC¼Œ³Ž›Ž—çC’JŒû–ÒCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@C“Œ‹žC98.04.15”­s.

692. mŠwp‘n i•ÒWj Šà‰»Šw—Ö@Žž‚ÌEmergency; •ÒW Ô‘òCŒáié‹Ê‚ª‚ñƒZƒ“ƒ^[jC²X–Øí—Yi“s—§‹îž•a‰@jC¬ò˜aŽO˜Yi“àjC•ÒC æ’[ˆãŠwŽÐC“Œ‹žC98.09.30”­s.

693. mŠwp‘n i•ÒWj 1999¡“ú‚ÌŽ¡—ÃŽwj; •ÒW ‘½‰ê{K’jC”öŒ`‰x˜YC¼Œ³Ž›Ž—çi–k—¢‘åjC‘¼C•ÒC ˆãŠw‘‰@C“Œ‹žC99.01.01”­s.

694. mŠwp‘n i•ÒWj –å–¬ŒŒsƒAƒgƒ‰ƒX; •ÒW ‘•ª–ΔŽi–k—¢‘åjC¬Œ´Ÿ•qi•Ÿ“‡Œ§—§ˆã‘åjCa’Jii‚‚­‚Αoˆ¤•a‰@jC‹ßX•¶•vi‘‹g•a‰@jC‘º“‡’¼ÆiŒÕƒm–å•a‰@jC¼’J³ˆêiç—t‘åj•ÒC ˆãŠw‘‰@C“Œ‹žC99.03.01”­s.

695. m‹³‰È‘n i•ª’SŽ·•Mj “à‰ÈŠw‘‰ü’ù‘æ5”Å; ˆÝ“÷Žî, p.1600`1602, ¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj. •ÒW “‡“cŠ]C•ÒC ’†ŽR‘“XC“Œ‹žC99.03.01”­s.

696. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Á‰»ŠíŽ¾Š³ver.2 - state of arts. ‡T.ˆÝ¥’°; –«Á‰»«’×ᇂ̖ò•¨—Ö@|‹}«Šú‚ÌŽ¡—Âƈێ—Ö@, —£’EŠú, Ä”­—\–h, 1: 356`359, ŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj. •ÒW ‹ÊŒF³‰xi’é‹ž‘åjC–]ŒŽ‰p—²i–h‰qˆã‘åjC•ÒC ˆãŽ•–òo”ÅC“Œ‹žC98.08.20”­s.

697. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Ultracytochemical localization of Ca2+-ATPase in rat gastric mucosa: Special reference to the autonomic nervous and microcirculatory system. ¬¼OˆêC²“‡Œh´C¡‘º´ŽqC‘“c‰p–¾C¼ŽR˜a’jCŽl‹{—R”üŽqCŽðˆä’C•FC“y‹´Œ’i“àjCOda, M.CIshii, H.i‰¡•lŽs—§Žs–¯•a‰@j: 99th Annual Meeting of the American Gastroenterological Association i98.05.16j, U.S.A.

698. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Role of newly experimental echocolonoscope (XCF-UMQ 200) for the diagnosis of colorectal tumor. ¬—Ñ´“TCŸ–””º‰hC‰¡ŽRŒOC“n•Ó–€–çC–Ø“cŒõLCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àj: 11th International Symposium on Endoscopic Ultrasonography i98.01.11j, ‹ž“s.

699. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Prediction of response to 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor (PD-ECGF). ¬ò˜aŽO˜YC“c•Ó‘C‹ß“¡ˆê‰pCŽRè‚¢‚ÂÝC¼Œ³Ž›Ž—çi“àj: •Ä‘ŠàŽ¡—Êw‰ï(ASCO) i98.05.16j, LosAngeles, •Ä‘ŠàŽ¡—Êw‰ï‰ïŽ, 17: 261, 1998.

700. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Late phase ‡U study of S-1, a novel oral fluoropyrimidine derivative, in patients with advanced gastric cancer. Kurihara, M.C¬ò˜aŽO˜Yi“àjCHasegawa, K.CNakano, K.: •Ä‘ŠàŽ¡—Êw‰ï(ASCO) i98.05.16j, LosAngeles, •Ä‘ŠàŽ¡—Êw‰ï‰ïŽ, 17: 261, 1998.

701. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Markedly elevated cell turnover is characteristic of small advanced carcinomas of the colorectum. ‚‹´—T”Vi“àjCŽO•xO”Vi•a—jCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjC‰ªˆÀŒMi•a—j: ‘æ11‰ñ¢ŠEÁ‰»Ší•aŠw‰ï‹c i98.09.08j, ƒI[ƒXƒgƒŠƒA, ƒEƒB[ƒ“.

702. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Efficacy of balloon occuluded retrograde transversus obliteration (BRTO) for solitary gastric varices associated with gastro-renal shunt (GRS). ‘•ª–ΔŽC‚“c‰ë”ŽCó–ì˜NC“ú‚‰›C’†‘ò‹MGCa’J–¾—²C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: 11th World Congress of Gastroenterology i98.09.08j, Vienna, Austria, Digestion, 59(Suppl.3): 336, 1998.

703. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Is surveillance necessary after colonoscopic polypectomy? ŒÜ\—’³LCŸ–””º‰hC¬—Ñ´“TC‚‹´—T‹vC‰¡ŽRŒOC¼Œ³Ž›Ž—çi“àj: 9th World Congress of Digestive Endoscopy i98.09.11j, ƒEƒB[ƒ“iƒI[ƒXƒgƒŠƒAj.

704. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Virological analysis of hepatitis C virus obtained from an agammaglobulinemic patient with chronic hepatitis C. ’†‘ò‹MGC‰Á“¡é”VCInudoh, M.C™ŽR˜a•vCShibuya, S.CKokubu, K.C¼Œ³Ž›Ž—çi“àj: World Congress of Gastroenterology i98.10.16j, Vienna.

705. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Comparative study of endoscopic injection sclerotherapy (EIS) versus endoscopic variceal ligation (EVL) for esophageal varices in patients with tumor thrombosis of portal trunk (VP3) associated with hepatocellular carcinoma (HCC). ‚“c‰ë”ŽC‘•ª–ΔŽCŽR‰ª²¢C“ú‚‰›C–Ø“c–FŽ÷C–Ø“cŒõLC¼Œ³Ž›Ž—çi“àj: Cancer Detection & Prevention i98.10.27j, Nice.

706. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Increased glomerular volume in Japanese NIDDM patients. Žç‰®’B”üCŽç‰®—˜‰ÀC“c’†Œ[Ži‚`C–‹`’‰i“àjCMauer, M.iƒ~ƒlƒ\ƒ^‘åj: ‘æ31‰ñ•Ä‘t‘ŸŠw‰ï i98.10.27j, Philadelphia, JASN, 9: 119, 1998.

707. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical features do not predict whether typical nephropathological changes of diabetes are present in Japanese NIDDM patients. Žç‰®’B”üi“àjCSuzuki, D.i“ŒŠC‘åjCŽç‰®—˜‰ÀC“c’†Œ[Ži‚`C–‹`’‰i“àjCSakai, H.i“ŒŠC‘åjCMauer, M.iƒ~ƒlƒ\ƒ^‘åj: ‘æ31‰ñ•Ä‘t‘ŸŠw‰ï i98.10.27j, Philadelphia, JASN, 9: 120, 1998.

708. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Tubular basement membrane width in Japanese NIDDM patients. Žç‰®’B”üCŽç‰®—˜‰ÀC“c’†Œ[Ži‚`C–‹`’‰i“àjCMauer, M.iƒ~ƒlƒ\ƒ^‘åj: ‘æ31‰ñ•Ä‘t‘ŸŠw‰ï i98.10.27j, Philadelphia, JASN, 9: 120, 1998.

709. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Tubular Basement Menbrane (TBM) with in Japanese Type 2 diabetic patients. “c’†Œ[Ži‚`CŽç‰®’B”üCŽç‰®—˜‰ÀC–‹`’‰Cƒ}ƒCƒPƒ‹ƒ}ƒEƒƒ@[i“àj: ƒAƒƒŠƒJt‘Ÿ•aŠw‰ï i98.10.28j, ƒtƒBƒ‰ƒfƒ‹ƒtƒBƒA.

710. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰ŠÇ«’°Ž¾Š³‚Ìf’fŽ¡—ÂÌV‚µ‚¢“WŠJ. ŒÜ\—’³LCŸ–””º‰hC¬—Ñ´“TC‰¡ŽRŒOC‚‹´—T”Vi“àj: DDW JAPAN 98ƒTƒeƒ‰ƒCƒgƒVƒ“ƒ|ƒWƒEƒ€ i98.04.17j, ‰¡•l.

711. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘å’°Žîᇂɑ΂·‚é“àŽ‹‹¾“I“Eœ‚Ì•]‰¿‚ƃtƒHƒ[ƒAƒbƒv. ŒÜ\—’³LCŸ–””º‰hi“àj: DDW JAPAN 1998 i98.04.17j, ‰¡•l.

712. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘å’°smŠà‚ÌsmZ“x•ª—Þ‚Æ—Õ°“IˆÓ‹`. ¬—Ñ´“TCŸ–””º‰hi“àj: DDW JAPAN 1998 i98.04.17j, ‰¡•l, Gastroenterol. Endosc., 40(Suppl. 1): 360, 1998.

713. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Œ´”­«d‰»«’_ŠÇ‰Š‚Ìf’f‚É‚¨‚¯‚é“àŽ‹‹¾“I‹ts«’_ŠÇ‘¢‰eŠŒ©‚Ì—L—p«. ‘•ª–ΔŽC¼Œ³Ž›Ž—çi“àj: ‘æ34‰ñ“ú–{’_“¹Šw‰ï‘‰ï i98.04.18j, ‰¡•l, ’_“¹, 12(1): 77, 1998.

714. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Helicobacter pyloriŠ´õ‚É‚æ‚éˆÝŠà”­¶‹@˜‚̉ðÍ|ˆÝ”S–Œ×–E“®‘ÔŠàŠÖ˜A’`”’”­Œ»‚ɂ‚¢‚Ä|. “ú”䌪ˆêC¬ò˜aŽO˜YC“c•Ó‘C¡òOC¼Œ³Ž›Ž—çi“àjCŽO•xO”VCŒK”ö’èmC‰ªˆÀŒMi•a—j: ‘æ70‰ñ“ú–{ˆÝŠàŠw‰ï i98.06.20j, “Œ‹ž, ´˜^W, p.7, 1998.

715. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Vp3ŠÌ×–EŠàÇ—á‚ÌH“¹Ã–¬áŽ‚ɑ΂·‚é“àŽ‹‹¾“IŽ¡—Â̌Ÿ“¢`EIS‚ÆEVL‚̑Δä`. ‚“c‰ë”ŽC‘•ª–ΔŽi“àj: ‘æ5‰ñ“ú–{–å–¬ˆ³˜´iÇH“¹Ã–¬áŽŠw‰ï i98.09.03j, •Ÿ‰ª.

716. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒŒ[ƒU[Œõ‚ð‰ž—p‚µ‚½—§‘ÌŒv‘ª. ‘åˆä“c³lC›–ì‘i“àj: ‘æ19‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï i98.09.24j, “Œ‹ž.

717. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j • o‹¾, “àŽ‹‹¾Ž¡—Â̓K‰ž‚ÆŒÀŠE|‘å’°‘ŠúŠà‚ɑ΂·‚é“àŽ‹‹¾Ž¡—Â̓K‰ž‚ÆŒÀŠE. ŒÜ\—’³LCŸ–””º‰hC¬—Ñ´“Ti“àj: ‘æ53‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï i98.10.16j, •Ÿ‰ª.

718. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “«ˆÝ֬ᎂɑ΂·‚鎡—Ãí—ª. ‘•ª–ΔŽC‚“c‰ë”Ži“àj: ‘æ2‰ñŠÌ‘ŸŠw‰ï‘å‰ïƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“ i98.10.16j, ‹à‘ò, ŠÌ‘Ÿ, 39(Suppl.2): 69, 1998.

719. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “–‰@‚É‚¨‚¯‚éŠÌd•Ï‚̬ˆö‚¨‚æ‚Ñ—\Œã‚ÉŠÖ‚·‚錟“¢. “y‹´Œ’C¬¼OˆêCŽðˆä’C•Fi“àj: ‘æ2‰ñŠÌ‘ŸŠw‰ï‘å‰ï i98.10.17j, ‹à‘ò, ŠÌ‘Ÿ, 39(Suppl.2): 100, 1998.

720. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘å’°‘ŠúŠà‚ɑ΂·‚é“àŽ‹‹¾“IŽ¡—Â̓K‰ž‚Æ–â‘è“_. ¬—Ñ´“TCŒÜ\—’³Li“àj: ‘æ40‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i98.10.29j, “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95(—Õ‘): 141, 1998.

721. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ã•”Á‰»ŠÇoŒŒ‚ɑ΂·‚é“àŽ‹‹¾“IŽ~ŒŒ–@‚ÌŒÀŠE|“Á‚ÉŽ~ŒŒ•s”\—á‚ÌŒŸ“¢|. “c•Ó‘C¼Œ³Ž›Ž—çi“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.20j, ‰ªŽR.

722. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Šg‘åŠÏŽ@‚É‚æ‚é”÷¬ˆÝŠà‚̃XƒNƒŠ[ƒjƒ“ƒO. ‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘æ7‰ñƒNƒŠƒjƒJƒ‹ƒrƒfƒIƒtƒH[ƒ‰ƒ€ i99.02.04j, “Œ‹ž.

723. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’´‰¹”g“àŽ‹‹¾ŽOŽŸŒ³‰æ‘œˆ’u‘•’uXEU-IP 2 system‚ÌŽg—pŒoŒ±. “n•Ó–€–çC–Ø“cŒõLi“àj: ‘æ7‰ñƒNƒŠƒjƒJƒ‹ƒrƒfƒIƒtƒH[ƒ‰ƒ€ i99.02.04j, “Œ‹ž.

724. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ã•”Á‰»ŠÇ‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾‚Ì‹ß–¢—ˆ. –Ø“cŒõLC¼Œ³Ž›Ž—çi“àj: ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï i98.04.17j, ‰¡•l, Digest. Endosc..

725. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj H“¹Ã–¬áŽ‚ɑ΂·‚é“àŽ‹‹¾“Id‰»—Ö@; ’·Šú—\Œã‚ÌŒŸ“¢‚©‚çlˆÄ‚µ‚½d‰»ÜŠÉ™’“ü–@‚ÌŽŽ‚Ý. ‚“c‰ë”ŽC‘•ª–ΔŽi“àj: ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.04.18j, ‰¡•l.

726. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‘å’°Šàæi•”ƒ}ƒNƒƒtƒ@[ƒW‚ÆŽîá‡ZCD8—z«‚s×–E‚ÌŠÖ˜A«. “à“¡‹g—²i“àjC‘å’J–¾•vCÄ“¡ˆê–çC”—tŒ’ˆêC–¼‘qGi“Œ–k‘åj: ‘æ57‰ñ“ú–{ŠàŠw‰ï i98.10.01j, ‰¡•l.

727. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj “–‰@‚É‚¨‚¯‚éŠÌd•Ïǂ̬ˆö•ÊŽÀ‘Ô. Ä“¡rŽiCa’J–¾—²i“àj: ‘æ2‰ñŠÌ‘ŸŠw‰ï‘å‰ï i98.10.17j, ‹à‘ò, ŠÌ‘Ÿ, 39(Suppl.2): 100, 1998.

728. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj “àŽ‹‹¾“I”S–ŒØœp‚Ì“K‰žŒˆ’è‚É‚¨‚¯‚é’´‰¹”g“àŽ‹‹¾‚Ìf’f”\‚ÌŒ»ó‚Æ3D-EVS‚Ö‚ÌŠú‘Ò. –Ø“cŒõLC¼Œ³Ž›Ž—çi“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.19j, ‰ªŽR.

729. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj äXŽ¾Š³‚É‚¨‚¯‚éERCP‚Ì—L—p«`ERCP‚ð‘ÎÆ‚Æ‚µ‚Ä`. ”’{‹±ŽqC–Ø“cŒõLi“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.19j, ‰ªŽR.

730. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‰æ‘œ‰ðÍ‚É‚æ‚éˆÝ•a•ÏŠÓ•Êf’f‚ÌŽŽ‚Ý. ’†ˆä‹v—YC‘åˆä“c³li“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.20j, ‰ªŽR, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 40(Suppl.2): 1582, 1998.

731. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒqƒg‘å’°Šà‚ÉZ‚·‚éCD8+‚s×–E‚ÍŠ³ŽÒ‚Ì—\ŒãˆöŽq‚ƂȂ肤‚é. “à“¡‹g—²i“àjC‘å’J–¾•vC–¼‘qGi“Œ–k‘åj: ‘æ28‰ñ“ú–{–ƉuŠw‰ï‘‰ï i98.12.02j, _ŒË, Proc. Jpn. Soc. Immunol., 28(26): 1998.

732. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŒÇ—§«ˆÝ֬ᎂɑ΂·‚éBRTO‚Ì‘Ï—p«. ‘•ª–ΔŽi“àj: ‘æ18‰ñ‰æ‘œˆãŠw‰ï i99.02.12j, “Œ‹ž, “ú–{‰æ‘œˆãŠw‰ïŽGŽ, 17(4): 237, 1999.

733. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Rifampicin‚É‚æ‚éˆÝ”S–ŒáŠQ‚Ì”­¶‹@˜‚ÉŠÖ‚·‚錤‹†|“Á‚É•Ç×–E‚Ì’´”÷Œ`‘Ô‚ð’†S‚Æ‚µ‚Ä|. ¬¼OˆêC²“‡Œh´C¡‘º´ŽqC‘“c‰p–¾C¼ŽR˜a’jCŽl‹{—R”üŽqCŽðˆä’C•FC“y‹´Œ’C‘½“cTˆê˜YCΈäŒö“¹CŠÛŽRŸ–çC‹T’Jé—²CD“c³–çCΈä—T³ i“àj: 1998”N“ú–{Á‰»ŠíŠÖ˜AŠw‰ïTŠÔ i98.04.15j, ‰¡•l.

734. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äXŽîᇫ•a•Ï‚É‚¨‚¯‚é“àŽ‹‹¾‰ºäX‰tÌŽæ–@‚ÌŠJ”­‚ÆäX‰t’†c-ki-rasˆâ“`Žq•ÏˆÙŒŸo–@‚ÌŒŸ“¢. –Ø“c–FŽ÷C–Ø“cŒõLC‘“ŒŠ²•vC“n•Ó–€–çC¡òOC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.04.15j, ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95: 74, 1998.

735. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝŠà‰»Šw—Ö@‚ÌŒ»‹µ‚Æ¡Œã‚Ì“W–]. ¬ò˜aŽO˜Yi“àj: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.04.16j, ‰¡•l.

736. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –å–¬ˆ³˜´iÇ‚É‚¨‚¯‚éPSE‚ÌŒø‰Ê‚ÆŽ¡—ÈӋ`. “ú‚‰›C‘•ª–ΔŽCó–ì˜NC‚“c‰ë”ŽCa’J–¾—²C¼Œ³Ž›Ž—çi“àjC¼‰iŒh“ñCˆé•”‹`Œ›i•új: ‘æ34‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï i98.04.16j, ‰¡•l, —\eW, 39(Suppl.1): 115.

737. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’_”XŽ¾Š³‚É‚¨‚¯‚éMRCP‚Ì—L—p«, ‘æ2•ñ|ERCP‚ð‘ÎÆ‚Æ‚µ‚Ä|. ”’{‹±ŽqC–Ø“cŒõLC¡òOC‘“ŒŠ²•vC“n•Ó–€–çC›–ì‘C–Ø“c–FŽ÷C“c•Ó‘C¬ò˜aŽO˜YCŽO‹´—˜‰·C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjC–k‘º‰ë–çC“‡“cŒªC ‚‹´‹BC‹g“c@‹IiŠOjCˆé•”‹`Œ›i•új: ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.04.18j, ‰¡•l, Gastroenterol. Endosc., 40(Suppl.1): 432, 1998.

738. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽOŽŸŒ³’´‰¹”g“àŽ‹‹¾(EU-IP system)‚ð—p‚¢‚½‘ÌÏ‘ª’è‚Ì—L—p«‚ɂ‚¢‚Ä. “n•Ó–€–çC–Ø“cŒõLC‘“ŒŠ²•vC›–ì‘C‹ß“¡ˆê‰pC¬—Ñ´“TCŽR“cŽŠlCâŒû“NÍC–ì“o½C¼Œ³Ž›Ž—çi“àj: ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.04.18j, ‰¡•l, Gastroenterol. Endosc., 40: 388, 1998.

739. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “œ”A•a«_ŒoáŠQŠ³ŽÒ‚̉ßè‘«’ꈳ‚ɑ΂·‚éƒNƒbƒVƒ‡ƒ“«—ÇD‚ÈŒC‚̈³ŒyŒ¸Œø‰Ê. ‹àXWC’†“ˆ^ˆêC‹´’Ü—m”üC_N”VC”~‘òTˆêC“Iê´˜aC“¡“c–F–Mi“àjC–؎åÅC–‹`’‰iˆã—Éq¶j: ‘æ41‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï i98.05.21j, ˜a‰ÌŽR, “œ”A•a, 41(Suppl.1): 218, 1998.

740. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “d—¬’mŠo臒l(CPT)‚ð—p‚¢‚½“œ”A•a«_ŒoáŠQ‚É‚¨‚¯‚é_ŒoáŠQoŒ»—lŽ®. ”~‘òTˆêC‹àXWC’†“ˆ^ˆêC_N”VC‰œ‰Hr–¾C‚“c“NGC‹´’Ü—m”üC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ41‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï i98.05.21j, ˜a‰ÌŽR, “œ”A•a, 41(Suppl.1): 244, 1998.

741. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 5FU‚ÌBiochemical Modulation‚ÌŽÀÛ. ¬ò˜aŽO˜Yi“àj: ‘æ70‰ñ“ú–{ˆÝŠàŠw‰ï i98.06.20j, “Œ‹ž.

742. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Retzius vein‚ð—L‚·‚é–å–¬ˆ³˜´iÇ‚Ì‚P—á. ‘OìŒö’jC‘ºãK‘¾˜YC²“c”ü˜aC^‹ÊŽõ”ü¶C‘•ª–ΔŽi“àjCŒK”ö’èmC‘å•”½i•a—j: ‘æ5‰ñ“ú–{–å–¬ˆ³˜´iÇH“¹Ã–¬áŽŠw‰ï i98.09.04j, •Ÿ‰ª, “ú–{–å–¬ˆ³˜´iÇH“¹Ã–¬áŽŠw‰ïŽGŽ, 4(2): 157, 1998.

743. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Helicobacter pyloriœ‹Û—Ö@‚É‚æ‚éˆÝMALTƒŠƒ“ƒpŽî‚ƈÝàh–E«ˆÝ‰Š‚ÌtelomeraseŠˆ«‚̕ω». ŽO—Ö˜jC’·”ö‹v”üC‹v•xŽõC’·“ˆ—mŽ¡i“àj: ‘æ57‰ñ“ú–{ŠàŠw‰ï i98.10.01j, ‰¡•l.

744. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j isˆÝŠà‚ð‘ÎÛ‚Æ‚µ‚½S-1ŒãŠú—Õ°‘æ‡U‘ŠŽŽŒ±. ’·’Jì_ˆêC¬ò˜aŽO˜Yi“àjC’†–ìCŽ¡C•½“cŒöˆêCˆ³‰Æd‹IC‰Á“¡rKCH’JŽõˆêC‘]˜a—Z¶C•½¼‹`•¶C‰ºŽRFCˆÀ•WˆêCŽÂˆäŠiC‰ª“c‘בãCˆ»•”Œö œòCŒIŒ´–«iS-1ˆÝŠàŒ¤‹†‰ï‚jƒOƒ‹[ƒvj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.07j, •Ÿ‰ª, ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ïŽGŽ, 33(3): 97, 1998.

745. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Øœ•s”\is¥Ä”­ˆÝŠà‰»Šw—Ö@Ç—á‚Ì’·Šú¬Ñ. ‘åŒK³–¼C‘å’ÓÖC–p¬˜aC‹g“c–κi‘—§‚ª‚ñƒZƒ“ƒ^[jC‹{“c‰À“Tiˆï錧—§’†‰›•a‰@jCŠÖ–ÎŽ÷i²‹v‘‡•a‰@jC”’”ö‘ºC“‡“cˆÀ”Ži‘—§‚ª‚ñƒZƒ“ ƒ^[jC¬ò˜aŽO˜Yi“àjCŒIŒ´–«iº˜a‘åj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.07j, •Ÿ‰ª, —\eW, 33(3): 404, 1998.

746. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Øœ•s”\isˆÝŠà‚ɑ΂·‚éneoadjuvant chemotherapy‚̈Ӌ`‚Æ’·Šú—\Œã. ¬ò˜aŽO˜YC“c•Ó‘C‹ß“¡ˆê‰pCŽRè‚¢‚¸‚ÝC¼Œ³Ž›Ž—çi“àjC“ˆ”ömC”äŠé”\Ž÷iŠOj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.07j, •Ÿ‰ª, —\eW, 33(3): 420, 1998.

747. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “œ”A•a«‘«‰óás‚Ì—\–h‚Æ‘Îôi‘æ5•ñj|‰ß‹Ž20”NŠÔ‚ÉŒoŒ±‚µ‚½“œ”A•a«‰óás“ü‰@Š³ŽÒ88—á‚Ì—Õ°“IŒŸ“¢|. ‹àXWi“àjC–؎åÅiˆã—Éq¶jC–‹`’‰i“àj: ‘æ14‰ñ“ú–{‹`Žˆ‘•‹ïŠw‰ïŠwp‘å‰ï i98.10.09j, ¼ŽR, “ú–{‹`Žˆ‘•‹ïŠw‰ïŽ, 14(“Á•Ê): 142`143, 1998.

748. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œ´”­«’_`«ŠÌd•Ï(PBC)‚É‚¨‚¯‚éTelomeraseŠˆ«. ŽO—Ö˜jCŠOŽR‹v‘¾˜YCiŽm‰iŽqCŽðˆä‘¾˜YCŠ™“cˆêŽõC’|‹g—R‰ÁŽuC“n•Ó—²ŽiC“n•Ó´Ž¡C–{ŠÔ“ñ˜YC–ì“o½C‹àŽR³–¾i“àj: ‘æ47‰ñ‹¤ÏˆãŠw‰ï i98.10.14j, ‹à‘ò.

749. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j BrutonŒ^–³ƒÁ|ƒOƒƒuƒŠƒ“ŒŒÇŠ³ŽÒ‚æ‚蓾‚ç‚ꂽ‚bŒ^ŠÌ‰ŠƒEƒCƒ‹ƒX‚̶•¨Šw“I“Á«‚ÌŒŸ“¢. ’†‘ò‹MGC‰Á“¡é”VC™ŽR˜a•vCa’J–¾—²C‘•ª–ΔŽC¼Œ³Ž›Ž—çi“àj: ‘æ2‰ñŠÌ‘ŸŠw‰ï‘å‰ïƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“ i98.10.16j, ‹à‘ò.

750. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒoƒ‹[ƒ“‰º‹ts«ŒoÖ¬“IÇðp(B-RTO)pŒã‚É‚¨‚¯‚éƒAƒ~ƒmŽ_•‰‰×‚ÌŒŸ“¢`ƒAƒ“ƒ‚ƒjƒA‹y‚уAƒ~ƒmŽ_•ª‰æ‚ð’†S‚É`. ‚“c‰ë”ŽC‘•ª–ΔŽC“ú‚‰›C’†‘ò‹MGCa’J–¾—²i“àj: ‘æ2‰ñŠÌ‘ŸŠw‰ï‘å‰ïƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“ i98.10.17j, ‹à‘ò.

751. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°“àŽ‹‹¾‚É‚æ‚éŒoãè–å“IŒ¸ˆ³ƒ`ƒ…[ƒu‘}“üp‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‹g‘ò”ÉC¬—Ñ´“TC—ÀLC‰¡ŽRŒOC‚‹´—T”VCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOj: ‘æ16‰ñ“ú–{‘å’°ŒŸ¸Šw‰ï‘‰ï i98.10.20j, VŠƒ.

752. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Helicobacter pyloriœ‹Û—Ö@Œã‚̈ÝMACTƒŠƒ“ƒpŽî‚ƈÝàh–E«ˆÝ‰Š‚ÌTelomeraseŠˆ«‚̕ω». ŽO—Ö˜jCŠOŽR‹v‘¾˜YCiŽm‰iŽqCŽðˆä‘¾˜YCŠ™“cˆêŽõC’|‹g—R‰ÁŽuC“n•Ó—²ŽiC“n•Ó´Ž¡C–{ŠÔ“ñ˜YC–ì“o½C‹àŽR³–¾i“àj: ‘æ40‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i98.10.29j, “Œ‹ž.

753. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’_äXŽ¾Š³‚É‚¨‚¯‚éMRCP‚Ì—L—p«‘æ‚Q•ñ`ERCP‚ð‘ÎÆ‚Æ‚µ‚Ä`. ”’{‹±ŽqC–Ø“cŒõLC¡òOC‘“ŒŠ²•vC“n•Ó–€–çC–Ø“c–FŽ÷C“c•Ó‘C¬ò˜aŽO˜YCŽO‹´—˜‰·C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjC–k‘º‰ë–çC“‡“cŒªC‚‹´‹BC ‹g“c@‹IiŠOjCˆé•”‹`Œ›i•új: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.19j, ‰ªŽR.

754. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –³‘¤EERBDƒXƒ‰ƒ“ƒg‚Ì—L—p«‚ÌŒŸ“¢|‘¤E•tERBDƒXƒ‰ƒ“ƒg‚ð‘ÎÛ‚Æ‚µ‚Ä|. ›–ì‘C–Ø“cŒõLi“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.19j, ‰ªŽR, ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï´˜^W, 40: 1488, 1998.

755. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚r󌋒°Ž²”PÇ‚É‚¨‚¯‚é“àŽ‹‹¾“I®•œp‚ÌŒŸ“¢. Žá—ÑŒ’ŽiCŒÜ\—’³LC‰¡ŽRŒOC‚‹´—T”VC¬—Ñ´“TCŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.19j, ‰ªŽR, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 40(—Õ‘2): 1632`1632, 1998.

756. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V‚µ‚¢ŒoŒû“I’_“¹‹¾(XCHF-B36)‚ÌŽg—pŒoŒ±. “n•Ó–€–çC–Ø“cŒõLC’|‘òŽO‘ãŽqCr–س—YC”’{‹±ŽqC‘“ŒŠ²•vC–Ø“c–FŽ÷C¡òOC¼Œ³Ž›Ž—çi“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.20j, ‰ªŽR, Gastroenterol. Endosc., 40: 1674, 1998.

757. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’×ᇥ‹·óŒ^‹•ŒŒ«‘å’°‰Š‚Ì“Á’¥‚ÆŒo‰ß. ‚‹´—T”VCŸ–””º‰hC²“c”ü˜aC—ÀLCŽá—ÑŒ’ŽiC‰¡ŽRŒOC¬—Ñ´“TCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.20j, ‰ªŽR, ´˜^W, 40: 1641, 1998.

758. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V‹­’²ˆ—Žè–@i‰¼Ìj‚Ì—Õ°“I—L—p«‚ÌŒŸ“¢. ¡òOC‘åˆä“c³lC‘“ŒŠ²•vCŽRè‚¢‚ÂÝC“n•Ó–€–çC–Ø“c–FŽ÷C“c•Ó‘C–Ø“cŒõLC¬ò˜aŽO˜YCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.20j, ‰ªŽR, ´˜^W, p.1736`1736, 1998.

759. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘Šú‘å’°Šà‚ɑ΂·‚é”S–ŒØœp(EMR)‚É‚¨‚¯‚éˆâŽcÄ”­‚ÌŒŸ“¢. ‰¡ŽRŒOCŒÜ\—’³LC—ÀLCŽá—ÑŒ’ŽiC‚‹´—T”VC¬—Ñ´“TCŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.20j, ‰ªŽR, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 40(Suppl.2): 1632, 1998.

760. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j BRTO“K‰žŠO‹y‚ÑŒø‰Ê•s—Ç‚Å‚ ‚Á‚½ŒÇ—§«ˆÝ֬ᎂɑ΂·‚éSO-EIS‹y‚ÑBRTOŒãEIS‚ÌŒŸ“¢. ŽR‰ª²¢C‘•ª–ΔŽC‚“c‰ë”ŽCŽRèDŠìC“ú‚‰›Có–ì˜NC’†‘ò‹MGC¡òOC¼Œ³Ž›Ž—çi“àjC¼‰iŒh“ñCˆé•”‹`Œ›i•új: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.20j, ‰ªŽR, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 40(Suppl.2): 1700, 1998.

761. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Š×‰šŒ^‘ŠúˆÝŠà‚ÌZ”͈Íf’f‚ɑ΂·‚éV‚µ‚¢IHbFÊ‹­’²ˆ—‚ÌŒŸ“¢. ŽRè‚¢‚ÂÝC‘åˆä“c³lCŽRãp‚³‚ä‚èC‘“ŒŠ²•vC“n•Ó–€–çC–Ø“c–FŽ÷C¡òOC“c•Ó‘C–Ø“cŒõLC¬ò˜aŽO˜YCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.20j, ‰ªŽR, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 40: 1735, 1998.

762. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒg|Ž_’×á‡C•œ‰ß’ö‚É‚¨‚¯‚é’×ᇎü•Óƒ€ƒ`ƒ“‚Ì“®‘Ԃɂ‚¢‚Ä. —Ñ“c_–¾i“àjCÎŒ´˜a•Fiˆã—Éq¶jC¬“‡—m“ñi“àjC–x“c‹±Žqi¶‰»jC¼Œ³Ž›Ž—çi“àj: ŽÀŒ±’×ᇊw‰ï i98.11.27j, “Œ‹ž.

763. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌd•Ïǂɇ•¹‚µ‚½’¼’°Ã–¬áŽ‚ɑ΂·‚é“àŽ‹‹¾“I’¼’°Ã–¬áŽd‰»—Ö@‚ª—L—p‚Å‚ ‚Á‚½‚Q—á. ’|‘òŽO‘ãŽqC‚“c‰ë”ŽC“ú‚‰›Có–ì˜NC’†‘ò‹MGCa’J–¾—²C‘•ª–ΔŽC¼Œ³Ž›Ž—çi“àj: ‘æ32‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï i98.12.04j, ŽD–y.

764. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Rendu-Osler-Weber•a‚É‚¨‚¯‚éŠÌ•a•Ï‚ÌŒŸ“¢. “n•Ó^²C‚“c‰ë”ŽC“ú‚‰›C’†‘ò‹MGCa’J–¾—²C‘•ª–ΔŽC¼Œ³Ž›Ž—çi“àjCˆé•”‹`Œ›i•új: ‘æ32‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï i98.12.04j, ŽD–y, ŠÌ‘Ÿ, 39(3): 126`126, 1998.

765. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •”•ª“IäB“®–¬Çðp(PSE)‚Ì‘OŒã‚É‚¨‚¯‚éƒgƒƒ“ƒ{ƒzƒCƒGƒ`ƒ“‚Ì•Ï“®‚Æ‚»‚ÌŽ¡—ÃŒø‰Ê‚ɂ‚¢‚Ä. “ú‚‰›C‘•ª–ΔŽC‚“c‰ë”ŽC’†‘ò‹MGCa’J–¾—²C¼Œ³Ž›Ž—çi“àjCˆé•”‹`Œ›i•új: ‘æ32‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï i98.12.04j, ŽD–y, ŠÌ‘Ÿ, 39(3): 139, 1998.

766. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j H. pyloriœ‹ÛŒã‚ÉtelomeraseŠˆ«‚ª’ቺ‚µ‚½ˆÝMALTƒŠƒ“ƒpŽî‚Ì‚P—á. ŽO—Ö˜jCŠOŽR‹v‘¾˜YC’·“ˆ—mŽ¡C‹v•xŽõCŠ™“cˆêŽõCiŽm‰iŽqCŽðˆä‘¾˜YC’|‹g—R‰ÁŽuC“n•Ó—²Žii“àjC“n•Ó´Ž¡i•a—jC–{ŠÔ“ñ˜YC–ì“o½C‹àŽR³–¾ i“àj: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï(DDW-JAPAN) i98.04.15j, ‰¡•l.

767. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’×ᇫ‘å’°‰ŠÇ—á‚É‚¨‚¯‚éŒû‘¤i“W—á‚ÌŒŸ“¢. ‰¡ŽRŒOCŒÜ\—’³LC‚‹´—T”VC¬—Ñ´“TCŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï(DDW-JAPAN) i98.04.15j, ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95(Suppl.): 234, 1998.

768. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒNƒ[ƒ“•a‚Æ”DP‚ɂ‚¢‚Ä‚Ì—Õ°“IŒŸ“¢. ‚‹´—T”VCŸ–””º‰hC‰¡ŽRŒOC¬—Ñ´“TCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC“‡“cMGiŽY•wj: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.04.15j, ‰¡•l, —\eW, p.257, 1998.

769. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j 17Η«‚É”­¶‚µ, ¶ŒŸ‚É‚Ä’E—Ž‚µ‚½ˆÝ‚•ª‰»Œ^‘BŠà‚Ì‚P—á. ΈäŒ\‘¾C‰Í–씎‹vi“àjC¼“ck‘¢C’†ìˆêi’ËvˆäÔ\Žš•a‰@jC¼–{–LCVˆäLNiŠOjC“c•Ó‘CŽO‹´—˜‰·CŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCΈä‰p ºCŽO•xO”Vi•a—j: ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï i98.04.17j, ‰¡•l.

770. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŽŽìŒ^’´‰¹”g“àŽ‹‹¾GF-UMP230‚ÌŽg—pŒoŒ±. ›–ì‘C–Ø“cŒõLC”’{‹±ŽqC‘“ŒŠ²•vC“n•Ó–€–çC‹ß“¡ˆê‰pC¡òOC–Ø“c–FŽ÷C“c•Ó‘C¬ò˜aŽO˜YCŽO‹´—˜‰·C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.04.18j, ‰¡•l, ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï´˜^W, 40: 481, 1998.

771. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”S–Œ–hŒäŒn–òÜ‚ªlH’×ᇎ¡–ü‰ß’ö‚Ì”S–ŒŒŒs“®‘Ô‚É—^‚¦‚é‰e‹¿|pharmacoendoscopy‚É‚æ‚錟“¢|. ¡òOC‘åˆä“c³lC“n•Ó–€–çC‹ß“¡ˆê‰pC–Ø“c–FŽ÷C“c•Ó‘C–Ø“cŒõLC¬ò˜aŽO˜YCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.04.18j, ‰¡•l, ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï´˜^W, p.467`467, 1998.

772. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “àŽ‹‹¾“I“û“ªŠg’£p(EPD)‚ð—p‚¢‚½’_“¹ÓÎp‚Ì—Õ°“IŒŸ“¢. —é–ØG–¾Cr“cTŽõi‰¡{‰ê‹¤Ï•a‰@jC—ÑO”üC‚’Jˆç’jC¬“‡—m“ñC¼‰ªŠ²—YC‘匴‹Bi“àj: ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.04.18j, ‰¡•l, ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï´˜^W, p.479, 1998.

773. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j NIDDMtÇŠe•aŠú‚É‚¨‚¯‚鎅‹…‘̉ßèàh‰ß‚ÆŽ…‹…‘Ìàh‰ß’l‚ÌŒoŽž•Ï‰». _N”VC“Iê´˜aC’†“ˆ^ˆêC‚“c“NGC‹´’Ü—m”üC¬‹v•Û–ƒŽqC”~‘òTˆêC‹àXWC“¡“c–F–MC–‹`’‰i“àj: ‘æ41‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï i98.05.21j, ˜a‰ÌŽR, “œ”A•a, 41(Suppl.1): 273, 1998.

774. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒgŠÌ×–EŠàŠÖ˜AALDH‚̈ꎟ\‘¢‚ɂ‚¢‚Ä. —¢“¹“N•FC’|“à“ÖŽqCa’J–¾—²C’†“‡—mˆêi“àj: “ú–{ƒAƒ‹ƒR[ƒ‹¥–ò•¨ˆãŠw‰ï i98.08.29j, _ŒË, “ú–{ƒAƒ‹ƒR[ƒ‹¥–ò•¨ˆãŠw‰ïŽGŽ, p.502`503, 1998.

775. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒg”x¬×–E‚ª‚ñ×–E‚É‚¨‚¯‚é‘æ‚TõF‘Ì’·˜r‚̃zƒ‚Œ‡Ž¸—̈æ‚̉ðÍ. “c‘ºŒ¤“ñCM‘Žš—mCŽO—Ö˜jCŠÖ’J„’jC‘ºã‘P‘¥i“àj: ‘æ57‰ñ“ú–{ŠàŠw‰ï i98.10.02j, ‰¡•l.

776. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Crohn•a‚Ì• •”CTf’f‚ɂ‚¢‚Ä‚Ì—Õ°“IŒŸ“¢. ‰¡ŽRŒOC¬—Ñ´“TC—ÀLCŽá—ÑŒ’ŽiC‚‹´—T”VCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCˆé•”‹`Œ›i•újCŽO•xO”Vi•a—j: ‘æ85‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.10.29j, “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95(—Õ‘): 300, 1998.

777. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “œ”A•a«‰óás“ü‰@Š³ŽÒ‚Ì—Õ°“I“Á’¥|Ž©Œ±88—á‚ÌŒŸ“¢|. ‹àXWC“yM“c•¶—²C‚“c“NGC’†“ˆ^ˆêC_N”VCŽç‰®’B”üC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ13‰ñ“ú–{“œ”A•a‡•¹ÇŠw‰ï i98.12.04j, –¼ŒÃ‰®, “ú–{“œ”A•a‡•¹ÇŠw‰ï´˜^W, 1(Suppl.1): 68, 1998.

778. mŠw‰ïi‘S‘jn iŒöŠJuÀj ’´‰¹”g“àŽ‹‹¾‹y‚ÑŠÇo“à’´‰¹”gŒŸ¸‚É‚æ‚éf’f. –Ø“cŒõLi“àj: ’´‰¹”gŠw‰ï’´‰¹”gf’f–@uK‰ï i99.02.13j, ‰¡•l.

779. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j ‘å’°u“àŽ‹‹¾Ž¡—Ãv. Ÿ–””º‰hi“àj: ‘æ10‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“ŒƒZƒ~ƒi[ i99.02.14j, “Œ‹ž, —\eW, p.77`81, 1999.

780. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŠúˆÝŠà‚ɑ΂·‚é“àŽ‹‹¾“I”S–ŒØœŒã‚̈âŽc¥Ä”­—á‚ÌŒŸ“¢‚Æ‘Îô. “c•Ó‘i“àjC“ˆ”ömiŠOj: ‘æ66‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.06.12j, “Œ‹ž.

781. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’´‰¹”g“àŽ‹‹¾‰ºúŽh‚Ì“K‰ž. “n•Ó–€–çC–Ø“cŒõLi“àj: ‘æ63‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.12.00j, “Œ‹ž.

782. mŠw‰ïi’n•ûjn iƒ[ƒNƒVƒ‡ƒbƒvj [’B“xf’f‚ÆŽ¡—Õûj‚ð‚ß‚®‚Á‚Ä. Ÿ–””º‰hi“àjC‘º“c—mŽqi“Œ—ˆã‘åjCåMLi“s—§‹îž•a‰@j: ‘æ66‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.06.13j, “Œ‹ž, —\eW, p.3, 1998.

783. mŠw‰ïi’n•ûjn iƒ[ƒNƒVƒ‡ƒbƒvj oŒŒ«’×ᇂɑ΂·‚é“àŽ‹‹¾“IŽ~ŒŒ–@‚ÌŒÀŠE|“Á‚ÉŽ~ŒŒ•s”\—á‚ÌŒŸ“¢‚Æ‚»‚Ì‘Îô|. “c•Ó‘C–k‘º‹§i“àj: ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.11.28j, “Œ‹ž.

784. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘O—§‘B”^ᇂ¨‚æ‚Ñ‘O—§‘B’¼’°á‘‚ðŒ`¬‚µ‚³‚ç‚ɉ»”^«Ò’ʼnŠ‚ð‡•¹‚µ‚½NIDDM‚Ì‚P—á. “c’†Œ[Ži‚`C‹àXWC–‹`’‰i“àj: ‘æ35‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i98.01.24j, ‰¡•l.

785. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Epirubicin‹CŠÇŽx“®–¬“®’Ž¡—ª‘tŒø‚µ‚½Œ´”­«ŠÌŠà‘½”­”x“]ˆÚ‚Ì‚P—á. ‰Á“¡—L‹IC²“‡Œh´C¬¼OˆêC¼ŽR˜a’jC“y‹´Œ’C¡‘º´ŽqC‘“c‰p–¾CŽðˆä’C•FCŽl‹{—R”üŽqi“àjC¬—ÑM—YCŸ–“NŽji‰¡•lŽs—§Žs–¯•a‰@j: ‘æ248‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.02.21j, “Œ‹ž.

786. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j • •”•s’èD‘i‚Å”­Ç‚µ, f’f‚É‹ê—¶‚µ‚½‰»”^«Ò’ʼnŠ‚Ì‚P—á. ŽO—Ö˜jCŠOŽR‹v‘¾˜YCiŽm‰iŽqCŽðˆä‘¾˜YCŠ™“cˆêŽõC’|‹g—R‰ÁŽuC“n•Ó—²ŽiC“n•Ó´Ž¡C–{ŠÔ“ñ˜YC–ì“o½C‹àŽR³–¾i“àj: ‘æ63‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.05.09j, “Œ‹ž.

787. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Chemoradiotherapy‚É‚Ä’·ŠúCR‚ª“¾‚ç‚ꂽH“¹Šà‚Ì‚P—á. ’†–ìŽj˜YC“c•Ó‘C¬ò˜aŽO˜YCŽRè‚¢‚ÂÝC‹ß“¡ˆê‰pC“n•Ó–€–çC¡òOC–Ø“c–FŽ÷C–Ø“cŒõLC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjC¬—ÑLsC”äŠé”\Ž÷ iŠOj: ‘æ249‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.05.16j, ‘å‹{.

788. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠÌˆ««ƒŠƒ“ƒpŽî‚É‚æ‚é•ÂÇ«‰©át‚ð’悵‚½AIDS‚Ì‚P—á. Žðˆä’C•FCŽl‹{—R”üŽqC‘“c‰p–¾C¡‘º´ŽqC“y‹´Œ’C¼ŽR˜a’ji“àjC¬¼OˆêC²“‡Œh´Câ–{Œõ’jC‘ŠŠy—TŽqC’†‘ºé¶i‰¡•lŽs—§Žs–¯•a‰@j: ‘æ249‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.05.16j, ‘å‹{.

789. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “àŽ‹‹¾“I®•œp‹y‚ÑŒ¸ˆ³ƒ`ƒ…[ƒu‚ª—L—p‚Å‚ ‚Á‚½‚r󌋒°Ž²”PÇ‚Ì‚P—á. Žá—ÑŒ’ŽiCŒÜ\—’³LC¬—Ñ´“TC‚‹´—T”VC‰¡ŽRŒOCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjC–ì‘ò’¼ŽjC‘å’J„³iŠOj: ‘æ66‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.06.12j, “Œ‹ž, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 40(12): 2185, 1998, Á‰»Ší“àŽ‹‹¾‚Ìi•à(Progress of Digestive Endoscopy), 53: 239, 1998.

790. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —¯’uƒXƒlƒA‚ð—p‚¢‚ÄØœ‚µ‚½\“ñŽw’°‰ºs‹rƒ|ƒŠ[ƒv‚Ì‚P—á. ¼èGŽ¡C¼‰ªŠ²—YCŒ¢”öŒöŒúiŽ©‰q‘à‰¡{‰ê•a‰@jCr“cTŽõC—ÑO”üC—é–ØG–¾C‚’Jˆç’jC¬“‡—m“ñi“àjC‘匴‹Bi‰¡{‰ê‹¤Ï•a‰@j: ‘æ66‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.06.12j, “Œ‹ž, —\eW, p.51, 1998.

791. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j R’×ᇗÖ@‚É‚æ‚è—ÇD‚ÈŒo‰ß‚ðŽ¦‚µ‚½reactive lymphoid hyperplasia (RLH)‚Ì‚RÇ—á. ¬¼OˆêC¼ŽR˜a’jC“y‹´Œ’C²“‡Œh´C‘“c‰p–¾C¡‘º´ŽqCŽl‹{—R”üŽqCŽðˆä’C•Fi“àj: ‘æ66‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.06.13j, “Œ‹ž.

792. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘’_ŠÇŒ‹Î‚É‚æ‚é’_ŠÇ‰Š‚ðŒ_‹@‚É”­Œ©‚³‚ꂽ’_‚Ì‚¤Šà“÷Žî‚Ì‚P—á. ”’{‹±ŽqC›–ì‘i“àjCˆÀ’BŒ£C–Ø‘º‚“¿C¬“ˆ’B–çC–쑺–¾C’†‘º—zŽqC“n•ÓK•vCˆÀ•”–¾˜Yi‘—§‘Š–ÍŒ´•a‰@j: ‘æ251‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.09.19j, “Œ‹ž.

793. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j • o“à‚Ì”“®–¬‚ÉL”͈͂ɓn‚Á‚ÄŠ®‘S•Âǂ𗈂µ‚½• •”“®–¬ŒŒðÇ‚Ì‚P—á. ‘«—§‘ñ–çC²“‡Œh´C¬¼OˆêC“y‹´Œ’i‰¡•lŽs—§Žs–¯•a‰@jC“°X‹»ˆê˜YC’†ŽRŒOC¡‘º´ŽqC‘“c‰p–¾CŽðˆä’C•FCŽl‹{—R”üŽqC’†‘ºé¶i“àj: ‘æ251‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.09.19j, “Œ‹ž.

794. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j äXƒOƒ‹ƒJƒSƒm[ƒ}‚Ì‚P—á. ¬“‡—m“ñCˆéè“N’jC—ÑO”üC—é–ØG–¾C‚’Jˆç’ji“àjC¼‰ªŠ²—YC‘匴‹Bi‰¡{‰ê‹¤Ï•a‰@j: ‘æ251‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.09.19j, “Œ‹ž, ´˜^W, p.38, 1998.

795. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰æ‘œ“I‚ÉŠÌ“àŽîᎫ•a•Ï‚ª‹^‚í‚ꂽŠÌA-Vshunt‚Ì‚P—á. “n•Ó^²C‚“c‰ë”ŽC“ú‚‰›C’†‘ò‹MGCa’J–¾—²C‘•ª–ΔŽC¼Œ³Ž›Ž—çi“àjC¼‰iŒh“ñCˆé•”‹`Œ›i•új: ‘æ251‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.09.19j, “Œ‹ž, ‘æ251‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï´˜^W, p.26, 1998.

796. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆÝ”S–Œ‰ºŽîᇗl‚ÌŒ`‘Ô‚ð’悵, Œo‰ßŠÏŽ@‚³‚ꂽ‘ŠúˆÝŠà‚Ì‚PŽèp—á. ‹e’nG•FC–Ø“cŒõLC“n•Ó–€–çC–Ø“c–FŽ÷C“c•Ó‘C¬ò˜aŽO˜YC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjC–î–ì„ŽiC“ˆ”ömC”äŠé”\Ž÷iŠOjCŽO•xO”Vi•a—jC“y •û‰pŽji“y•ûƒNƒŠƒjƒbƒNj: ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.11.27j, “Œ‹ž.

797. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j EUS‚ª—L—p‚Å‚ ‚Á‚½ˆÝGastrointestinal Stromal Tumor‚Ì‚Q—á. ‘“c‰p–¾C¡‘º´ŽqCŽðˆä’C•FCŽl‹{—R”üŽqC“y‹´Œ’C“°X‹»ˆê˜Yi“àjC¬¼OˆêC²“‡Œh´C’†‘ºé¶C”–غli‰¡•lŽs—§Žs–¯•a‰@j: ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.11.27j, “Œ‹ž.

798. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹•ŒŒ«‘å’°‰Š‚É‚æ‚鉺sŒ‹’°‹·ó‚ɑ΂µŒo“àŽ‹‹¾“Iƒoƒ‹[ƒ“Šg’£p‚ª—LŒø‚Å‚ ‚Á‚½‚P—á. ˆ¢•”Œ’“ñC‘å–ì—²C…ŒûŸlC‰Í–씎‹vC¼–Ø–ÎŽ÷C‹k“c‹P—Yi“àj: ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.11.28j, “Œ‹ž, —\eW, p.94, 1998.

799. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠÌ×–EŠà‚Æ‘¼‘ŸŠíŠà‚Æ‚Ìd•¡Šà‚Ì—Õ°“IŒŸ“¢. ‹g‘ò”ÉCa’J–¾—²C—¢“¹“N•FC“ú‚‰›C‚“c‰ë”ŽC’†‘ò‹MGC‘•ª–ΔŽC¼Œ³Ž›Ž—çi“àj: ‘æ32‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï i98.12.03j, ŽD–y.

800. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “¯Žž«‚S‘½”­«ˆÝŠà‚Ì‚P—á. •Ûâ”ü¶C”½’¬mˆêCÄ“¡rŽiC•“¡M”üi“àj: ‘æ31‰ñ_“Þ쌧Á‰»Ší•aˆãŠw‰ï‘‰ï i98.12.05j, ìè.

801. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘’_ŠÇ‚¨‚æ‚ÑäXŠÇ“àŒ‹Î‚ðEPBD‚É‚Äœ‹Ž‚µ“¾‚½‚P—á. ŽOˆäN—˜C—ÑO”üC‰Í‘º°MCˆéè“N’jC—é–ØG–¾C‚’Jˆç’jC¬“‡—m“ñC¼‰ªŠ²—YC‘匴‹Bi“àj: ‘æ31‰ñ_“Þ쌧Á‰»Ší•aˆãŠw‰ï‘‰ï i98.12.05j, ìè.

802. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j äXŠà‚É—ÞŽ—‚µ‚½ERD‘œ‚ð’悵‚½Islet Cell Tumor‚Ì‚PØœ—á. ’|‘òŽO‘ãŽqC–Ø“cŒõLC‘“ŒŠ²•vC“n•Ó–€–çC›–ì‘C–Ø“c–FŽ÷C¡òOC“c•Ó‘C¬ò˜aŽO˜YC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjCª–{—S‘¾C“‡“cŒªC‚‹´‹BC ‹g“c@‹IiŠOjCŽO•xO”VCΈä‰pºi•a—j: ‘æ65‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.12.11j, ‰¡•l.

803. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “àŽ‹‹¾“Iƒoƒ‹[ƒ“Šg’£p‚ª’˜Œø‚µ‚½‘ŠúH“¹ƒAƒJƒ‰ƒVƒA‚Ì‚P—á. “c•Ó‘C“n•Ó–€–çC–Ø“c–FŽ÷C–Ø“cŒõLC¬ò˜aŽO˜YCŽO‹´—˜‰·C‘åˆä“c³lC¼Œ³Ž›Ž—çC•Ð“c‰Ä–çCΈäŒ\‘¾CˆÀ’BŒ£i“àj: ‘æ252‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.12.12j, ‰¡•l.

804. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Á‰»ŠíÇó‚ðŒ_‹@‚É”­Œ©‚³‚ꂽŒã• –ŒƒŠƒ“ƒpŠÇŽî‚Ì‚P—á. “°X‹»ˆê˜YC²“‡Œh´C¬¼OˆêC“y‹´Œ’C‘“c‰p–¾C¡‘º´ŽqCŽðˆä’C•FCŽl‹{—R”üŽqi“àjCŽO•Ó‘å‰îC•Ÿ“‡P’jC‹S“ª•¶•FCÎŽR‹ÅC瓇—²ŽiC´…‘å •ãC²–ìm’ji‰¡•lŽs—§Žs–¯•a‰@j: ‘æ252‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.12.12j, ‰¡•l.

805. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Žá”N«–«ŠÖ߃ŠƒEƒ}ƒ`(JRA)‚ƃAƒ~ƒƒCƒh[ƒVƒX‚ð‡•¹‚µ‚½‘å’°Crohn•a‚Ì‚P—á. Žs쇎qC‚‹´—T”VC“’–{‰ÀGC‰¡ŽRŒOC¬—Ñ´“TCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çC“c’†Z–¾C‹ß“¡Œ[•¶i“àj: “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.12.13j, “Œ‹ž.

806. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾(EUS)‚É‚æ‚éˆÝŠà[’B“xf’f‚ɂ‚¢‚Ä. ›–ì‘C–Ø‘º‚“¿C–쑺–¾C—ÀLC¬“ˆ’B–çC’†‘º—zŽqCˆÀ’BŒ£i“àjC“n•”K•vCˆÀ•”–¾˜YC—¼‹{–¾•¶C‹à“cŒå˜YC–å˜eŒ›C‚‹´r‹BCiŠOjCŽO•xO”VCó ”ö•Žmi•a—j: ‘æ15‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i98.12.19j, ‰¡•l, ‘æ15‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï´˜^W, p.9, 1998.

807. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “œ”A•aŠ³ŽÒ‚É‚¨‚¯‚鸖§‘̬•ª•ªÍ‚ƃCƒ“ƒXƒŠƒ“’ïR«. _N”VC“yM“c•¶—²C‚“c“N•FC’†“ˆ^ˆêCŽç‰®’B”üC‹àXWC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ36‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i99.01.23j, ‘å‹{.

808. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j CSII‚Ì—L—p«‚Æ–â‘è“_|“–‰È‚É‚¨‚¯‚éŽg—pŒoŒ±‚©‚ç|. ’†“ˆ^ˆêC‹àXWC“yM“c•¶—²C‚“c“N•FC_N”VCŽç‰®’B”üC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ36‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i99.01.23j, ‘å‹{.

809. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘å’°ƒXƒR[ƒv‘}“ü–@. ŒÜ\—’³Li“àj: ‘æ10‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“ŒƒZƒ~ƒi[ i99.02.14j, “Œ‹ž.

810. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’°dÏÇ‚ðŒ_‹@‚É”­Œ©‚³‚ꂽŽá”N«‰¡sŒ‹’°Šà‚Ì‚P—á. ‹g‘ò”ÉC‰¡ŽRŒOC—ÀLCŽá—ÑŒ’ŽiC‚‹´—T”VC¬—Ñ´“TCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ‘æ253‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i99.02.20j, “Œ‹ž.

811. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠÌMixed carcinoid-adenocarcinoma‚Ì‚P—á. ‹g“cGC“ú‚‰›C‚“c‰ë”ŽC’†‘ò‹MGCa’J–¾—²C‘•ª–ΔŽC¼Œ³Ž›Ž—çi“àjCŒK”ö’èmi•a—j: ‘æ471‰ñ“à‰ÈŠw‰ï’n•û‰ï i99.03.13j, “Œ‹ž.

812. mŠw‰ïi’n•ûjn iŒöŠJuÀj ˆÝ; ’´‰¹”g“àŽ‹‹¾. ŽR“cŽŠli“àj: ‘æ10‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“ŒƒZƒ~ƒi[ i99.02.13j, “Œ‹ž, ŠÖ“ŒƒZƒ~ƒi[ƒeƒLƒXƒg, p.30`34, 1999.

813. mŒ¤‹†‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Staging of gastric cancer with EUS and endoscopic mucosal resection. –Ø“cŒõLi“àj: ‘æ11‰ñ‘ÛEUSƒVƒ“ƒ|ƒWƒEƒ€ i98.01.10j, ‹ž“s, Endoscopy, 30(Suppl.): 64`68, 1998.

814. mŒ¤‹†‰ïi‘Ûjn iŒöŠJuÀj EUS Live demonstration. –Ø“cŒõLi“àj: International Seminor of Therapeutic Endoscopy '98 i98.07.29j, ‰¡•l.

815. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j BRTOŒ¤‹†‰ï‘æ2‰ñƒAƒ“ƒP[ƒg’²¸•ñ. ‘•ª–ΔŽi“àj: ‘æ1‰ñBRTOŒ¤‹†‰ïq–å–¬ˆ³˜´iÇŠw‰ï•’uŒ¤‹†‰ïr i98.09.03j, •Ÿ‰ª.

816. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j ‘å’°ŽîᇫŽ¾Š³‚̃|ƒCƒ“ƒg. ŒÜ\—’³Li“àj: ‘æ983‰ñÅVˆã—ÃZƒ~ƒi[ i98.09.20j, “Œ‹ž.

817. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j NIDDM‚É‚¨‚¯‚é_ŒoüˆÛŒa•ÊáŠQ“x‚Ì“d‹C¶—Šw“I’è—Ê•]‰¿|Current perception threshold‚É‚æ‚錟“¢|. ‹àXWC”~‘òTˆêC’†“ˆ^ˆêC_N”VC‰œ‘ºr–¾C‚“c“NGC‹´’Ü—m”üC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ2‰ñƒVƒ“ƒ|ƒWƒEƒ€“œ”A•aŒ¤‹†‰ï i98.04.04j, “Œ‹ž.

818. mŒ¤‹†‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj NIDDM‚É‚¨‚¯‚é”AƒAƒ‹ƒuƒ~ƒ“”rŸ•—Ê‚Ít‘gD•a•Ï‚ð„‘ª‚·‚é—L—p‚È—Õ°“IŽw•W‚Å‚Í‚È‚¢. Žç‰®’B”üC“c’†Œ[Ži‚`C_N”VC“Iê´˜aC–‹`’‰i“àj: ‘æ10‰ñ“ú–{“œ”A•a«tÇŒ¤‹†‰ï i98.11.14j, “Œ‹ž.

819. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –«“÷‰èŽîÇ‚É‘å’°‚Ì‘½”­c‘–’×ᇂ𕹔­‚µ‚½1Žèp—á. ‚‹´—T”VCŸ–””º‰hC‰¡ŽRŒOC¬—Ñ´“TCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjCˆäŒ´ŒúC‘å’J„³iŠOjCŽO•xO”Vi•a—j: ‘æ5‰ñ“Œ“ú–{IBD•aˆö¥•a‘ÔƒtƒH[ƒ‰ƒ€ i98.00.00j, “Œ‹ž.

820. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j •\–ʊ׉šŒ^‘Šú‘å’°Šà‚Ì—Õ°•a—Šw“IŒŸ“¢. ‚‹´—T”VCŒÜ\—’³LC—ÀLC‰¡ŽRŒOC¬—Ñ´“TCŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ‘æ1‰ñ‘å’°‡Uc•t’uŒ¤‹†‰ï i98.00.00j, ‰ªŽR, ´˜^W, p.1818, 1998.

821. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°‘ŠúŠà‚Ì”N“x•Ê„ˆÚ‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‚‹´—T”VCŒÜ\—’³LC¬—Ñ´“TC‰¡ŽRŒOCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCˆäŒ´ŒúC‘å’J„³iŠOjCŽO•xO”Vi•a—j: ‘æ48‰ñ‘å’°ŠàŒ¤‹†‰ï i98.00.00j, Ž­Ž™“‡, ´˜^W, p.29, 1998.

822. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™‘å’°isŠà‚Ì—Õ°•a—Šw“I‚¨‚æ‚іƉu‘gDŠw“I“Á’¥‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‚‹´—T”Vi“àjCŽO•xO”Vi•a—jCŒÜ\—’³LC¬—Ñ´“TC‰¡ŽRŒOCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjC‰ªˆÀŒMi•a—j: ‘æ49‰ñ‘å’°ŠàŒ¤‹†‰ï i98.00.00j, “Œ‹ž, ´˜^W, p.54, 1998.

823. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j V‚µ‚¢’´‰¹”gŽOŽŸŒ³‰æ‘œˆ—‘•’u(EU-IP system)‚ÌŽg—pŒoŒ±. “n•Ó–€–çC–Ø“cŒõLC‘“ŒŠ²•vC›–ì‘C‹ß“¡ˆê‰pC¬—Ñ´“TCŽR“cŽŠlCâŒû“NÍC–ì“o½C¼Œ³Ž›Ž—çi“àj: ‘æ4‰ñŠÇo“à’´‰¹”g“àŽ‹‹¾Œ¤‹†‰ï i98.02.00j.

824. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒKƒXƒgƒŠƒ“Žó—e‘ÌhRÜL-365, 260‚̃‰ƒbƒgˆÝ”S‰t‘ãŽÓ‚ɑ΂·‚é‰e‹¿. ¬Žº—Tˆêi“àjCÎŒ´˜a•Fiˆã—Éq¶jCŽs쑸•¶i¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ49‰ñƒyƒvƒVƒ“Œ¤‹†‰ï i98.02.20j, “Œ‹ž, Progress in Medicine, 18(8): 2119`2124, 1998.

825. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j \“ñŽw’°Ã–¬áŽ‚Ì‚S—á. ó–ì˜NC‘•ª–ΔŽC‚“c‰ë”ŽC“ú‚‰›C’|‘òŽO‘ãŽqCr–س—YC¼Œ³Ž›Ž—çi“àjC¼‰iŒh“ñCˆé•”‹`Œ›i•újC^‹ÊŽõ”ü¶i“àj: ‘æ7‰ñ“àŽ‹‹¾“IH“¹ˆÝ֬᎑¢‰eŒ¤‹†‰ï i98.04.18j, ‰¡•l.

826. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j V‚µ‚¢ŽOŽŸŒ³’´‰¹”g“àŽ‹‹¾‰æ‘œˆ—‘•’uXEU-IP 2 system‚ÌŽg—pŒoŒ±. “n•Ó–€–çC–Ø“cŒõLC‘“ŒŠ²•vC›–ì‘C‹ß“¡ˆê‰pC¬—Ñ´“TCŽR“cŽŠlCâŒû“NÍC–ì“o½C¼Œ³Ž›Ž—çi“àj: ‘æ1‰ñ’´‰¹”g“àŽ‹‹¾‚Ì‚“xæi‹Zp‚ÌŠJ”­‚Æ•‹y‚ÉŠÖ‚·‚錤‹†‰ï i98.04.20j, ‰¡•l, Gastroenterol. Endosc., 40: 574, 1998.

827. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “œ”A•a«_ŒoáŠQŠ³ŽÒ‚É‚¨‚¯‚é‘«’ꈳ•ª•z‚Æ‘«æäŠÖ߉“®«. ‹àXWi“àj: ‘æ107‰ñ“œ”A•a’k˜b‰ï i98.06.10j, “Œ‹ž.

828. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ’·ŠúŠÔHEN‚ðŒp‘±’†‚Ì”ñ“ÁˆÙ«‘½”­«¬’°’×á‡Ç‚Ì‚P—á. Žá—ÑŒ’ŽiCŸ–””º‰hC—ÀLC‰¡ŽRŒOC‚‹´—T”VC¬—Ñ´“TCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOjC[–xMŽqiŠÅŒì•”jC–ìŒû‹…Žqi‰h—{•”j: ‘æ21‰ñÝ‘îŒo’°‰h—{Œ¤‹†‰ï i98.10.24j, “Œ‹ž.

829. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Ž¼•z–ò‚Ì“\•t‚É‚æ‚è“œ”A•a«‘«”畆’×á‡i‰óásj‚ð”­Ç‚µ‚½NIDDM‚Ì‚Q—á. “yM“c•¶—²C‹àXWCŽç‰®’B”üC‚“c“NGC’†“ˆ^ˆêC_N”VC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ4‰ñ“œ”A•aƒtƒbƒgƒPƒAŒ¤‹†‰ï i98.11.07j, “Œ‹ž.

830. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŽOŽŸŒ³’´‰¹”g“àŽ‹‹¾‰æ‘œˆ—‘•’u‚Ì—L—p«‚Æ–â‘è“_(EV-IP2 system). “n•Ó–€–çC–Ø“cŒõLC’|‘òŽO‘ãŽqCr–س—YC‘“ŒŠ²•vC›–ì‘C‹ß“¡ˆê‰pC¬—Ñ´“TCŽR“cŽŠlCâŒû“NÍC–ì“o½C¼Œ³Ž›Ž—çi“àj: ‘æ2‰ñ’´‰¹”g“àŽ‹‹¾‚Ì‚“xæi‹Zp‚ÌŠJ”­‚Æ•‹y‚ÉŠÖ‚·‚錤‹†‰ï i98.11.20j, ‰ªŽR, Gastroenterological Endoscopy, 40: 1805, 1998.

831. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰EŠÌ“®–¬ƒoƒ‹[ƒ“•ÂljºH“¹Ã–¬áŽd‰»—Ö@‚ðŽ{s‚µ—LŒø‚Å‚ ‚Á‚½‚P—á. “ú‚‰›C‘•ª–ΔŽCŽR‰ª²¢CŽRèDŠìCó–ì˜NC’†‘ò‹MGC‚“c‰ë”ŽCa’J–¾—²C¼Œ³Ž›Ž—çi“àjC‘ëì­˜aC¼‰iŒh“ñCˆé•”‹`Œ›i•új: ‘æ9‰ñEVISŒ¤‹†‰ï i98.11.21j, ‰ªŽR, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 40(Suppl.2): 1794, 1998.

832. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j V‚µ‚¢IHbFÊ‹­’²ˆ—‚É‚æ‚é‘ŠúˆÝŠà‚ÌZ”͈Íf’f. ‹e’nG•FC‘åˆä“c³lCŽRè‚¢‚ÂÝC“n•Ó–€–çC–Ø“c–FŽ÷C¡òOC“c•Ó‘C–Ø“cŒõLC¬ò˜aŽO˜YCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: ‘æ7‰ñƒNƒŠƒjƒJƒ‹ƒrƒfƒIƒtƒH[ƒ‰ƒ€ i99.02.04j, “Œ‹ž.

833. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Nervometer‚ð—p‚¢‚½“œ”A•a«––½_ŒoáŠQ‚Ì•]‰¿. ”~‘òTˆêC‹àXWC“Iê´˜aC“¡“c–F–MC–‹`’‰CÎìŽåÅi“àj: ‘æ1‰ñCPTŒ¤‹†‰ï i99.02.13j, “Œ‹ž.

834. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j isŠÌ×–EŠà‚ɑ΂·‚é“®’¥–å’•¹—p‰»Šw—Ö@‚ÌŒŸ“¢|CDDPŒŒ’†”Z“x‚ð‚Ó‚­‚ß‚Ä|. “ú‚‰›C‘•ª–ΔŽCó–ì˜NC’†‘ò‹MGC‚“c‰ë”ŽCa’J–¾—²C¼Œ³Ž›Ž—çi“àjC¼‰iŒh“ñCˆé•”‹`Œ›i•új: ƒŠƒU[ƒo[Œ¤‹†‰ï i99.02.13j, ɪ.

835. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j isŠÌ×–EŠà‚ɑ΂·‚é“®’¥–å’•¹—p‰»Šw—Ö@‚ÌŒŸ“¢`CDDPŒŒ’†”Z“x‚ð‚Ó‚­‚ß‚Ä`. “ú‚‰›C‘•ª–ΔŽCó–ì˜NC’†‘ò‹MGC‚“c‰ë”ŽCa’J–¾—²C¼Œ³Ž›Ž—çi“àjC¼‰iŒh“ñCˆé•”‹`Œ›i•új: ‘æ34‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï i98.10.15j, ‹à‘ò.

836. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj ƒoƒgƒ‹‘Ζ@: “àŽ‹‹¾Ž¡—Ãversus B-RTO. ‘•ª–ΔŽi“àj: ‘æ4‰ñH•ÛƒJƒ“ƒtƒ@ƒŒƒ“ƒX i98.11.14j, ‹{é.

837. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‰ŠÇ«’°Ž¾Š³‚Ì“àŽ‹‹¾f’f. ŒÜ\—’³Li“àj: ‘æ33‰ñ‹ß‹E’n‹æÁ‰»Ší“àŽ‹‹¾§’k‰ï i98.06.06j, ‘åã.

838. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‚QŒ^“œ”A•a‚É‚¨‚¯‚é“œ”A•a«tÇ‘Šú‚ÌŽ…‹…‘Ì•a•Ï. Žç‰®’B”üi“àj: ‘æ7‰ñŠÖ“ŒtŒ¤‹†‰ï i99.02.20j, “Œ‹ž.

839. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j –å–¬ˆ³˜´iÇ‚ÌV‚½‚ÈŽ¡—Ö@|BRTO, PSE‚È‚Ç‚ðŠÜ‚ß|. ‘•ª–ΔŽi“àj: ‘æ10‰ñ–kŠC“¹–å–¬ˆ³˜´iÇŒ¤‹†‰ï i99.03.06j, ŽD–y.

840. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “àŽ‹‹¾“I֬᎑¢‰e(EVIS)‚Æd‰»—Ö@. ‘•ª–ΔŽi“àj: ‘æ3‰ñ‘q•~SclerotherapyŒ¤‹†‰ï i99.03.25j, ‘q•~.

841. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Á‰»ŠíŽ¾Š³‚Ì•a‘Ô‚ÆŽ¡—Ã|“Á‚Éã•”Á‰»ŠíŽ¾Š³‚ɂ‚¢‚Ä|. ‘åˆä“c³li“àj: ‘æ37‰ñPharmaceutical CareŒ¤‹†‰ï i98.01.18j, ŠC˜V–¼.

842. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‘å’°“àŽ‹‹¾‘}“üŽè‹Z. ŒÜ\—’³Li“àj: ‘æ4‰ñ‹{錧‘å’°“àŽ‹‹¾Žè‹ZŒ¤‹†‰ï i98.04.04j, å‘ä.

843. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‘ŠúˆÝŠà‚Ì“àŽ‹‹¾f’f|“Á‚ɬ‚³‚Ȉ݊à‚ɂ‚¢‚Ä|. ‘åˆä“c³li“àj: ìèˆãŽt‰ï‘æ80‰ñŠO‰Èˆã‰ï i98.04.20j, ‰¡•l.

844. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ”÷¬ˆÝŠà‚Ìf’f|‚wü‚Æ“àŽ‹‹¾‚̑Δä|. ‘åˆä“c³li“àj: ‘Š–ÍŒ´ŽsˆãŽt‰ïˆÝŠàŒŸfŒ¤C‰ï i98.09.16j, ‘Š–ÍŒ´.

845. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Á‰»«’×ᇂ̖ò•¨—Ö@|“Á‚ɃwƒŠƒRƒoƒNƒ^[ƒsƒƒŠ‚ð’†S‚É|. ‘åˆä“c³li“àj: _“Þ쌧•a‰@–òÜŽt‰ïŒ¤C‰ï i99.01.21j, ‰¡•l.

846. mŒ¤‹†‰ïi’n•ûjn iƒ[ƒNƒVƒ‡ƒbƒvj “œ”A•aŠ³ŽÒ‚ÌQDL‚ÌŒüã‚ð–ÚŽw‚µ‚Ä|–âf•[’²¸Œ‹‰ÊiŽ©ŠoÇój‚Æ_ŒoŠw“I—ŠwŠŒ©, ŒŸ¸¬Ñi‘¼ŠoŠŒ©j‚̑Δä|. ‹àXWi“àj: ‘æ2‰ñ_“ÞìARIŒ¤‹†‰ï i99.03.04j, ‰¡•l.

847. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘¢ŒŒ«ƒvƒƒgƒ|ƒ‹ƒtƒBƒŠƒ“Ç‚É”º‚¤ŠÌd•Ï‚̃rƒ^ƒ~ƒ“‚d—Ö@. ¬¼OˆêC¡‘º´ŽqC‘“c‰p–¾C¼ŽR˜a’jCŽl‹{—R”üŽqCŽðˆä’C•FC“y‹´Œ’Cç—t—DŽqC²“‡Œh´i“àj: ‘æ27‰ñ_“ÞìŠÌ’k˜b‰ï i98.01.17j, ‰¡•l.

848. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j bó‘B‹@”\‚̳퉻‚É”º‚Á‚Äbó‘BŽî‚ª”ì‘債‚½‚ÆŽv‚í‚ê‚阴iÇ‚Ì‚P—á. ”óŒûŒö–¾iŒ´‹L”Of—ÊjC_—R‰Á—i“àj: _“Þ쌧“û‘Bbó‘BŠO‰ÈŒ¤‹†‰ï i98.03.07j, ‰¡•l.

849. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j \‘¢‹­’²‚ð—p‚¢‚½‘å’°Ž¾Š³‚̉ð–¾. ¬—Ñ´“Ti“àj: ‘æ8‰ñ_“Þ쌧Á‰»Ší“àŽ‹‹¾§’k‰ï i98.04.04j, ‰¡•l.

850. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒgƒƒOƒmƒ^ƒ]ƒ“iƒmƒXƒJ[ƒ‹j‚É‚æ‚錀NJ̉Š‚Ì‚P—á. “n•Ó^²Ca’J–¾—²i“àj: ‘æ7‰ñ_“Þ쥓Œ‹žŒ€ÇŠÌ‰ŠŽ¡—ÃŒ¤‹†‰ï i98.04.04j, _“Þì.

851. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘å’°Ž¾Š³‚ɑ΂·‚é“àŽ‹‹¾“IŽ~ŒŒ–@. ¬—Ñ´“TCŸ–””º‰hC—ÀLC‰¡ŽRŒOC‚‹´—T”VCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àj: ‘æ22‰ñ_“Þì‘å’°Ž¾Š³Œ¤‹†‰ï i98.06.11j, ‰¡•l.

852. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’°•ÂÇ‚ðŒ_‹@‚Éf’f‚³‚ꂽ¬’°Žîᇂ̂P—á. Žðˆä’C•FCŽl‹{—R”üŽqC‘“c‰p–¾C¡‘º´ŽqC“°X‹»ˆê˜YC“y‹´Œ’i“àjC¬¼OˆêC²“‡Œh´C–Ø‘º‰p–¾C“¡ˆä³ˆêCÎŽR‹ÅC‹S“ª•¶•FC•Ÿ“‡P’jC’†‘ºé¶ i‰¡•lŽs—§Žs–¯•a‰@j: ‘æ43‰ñ_“Þ쌧Á‰»Ší•aŒ¤‹†‰ï i98.06.13j, ‰¡•l.

853. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j •Û‘¶“I‚ÉŽ¡—µ‚¦‚½“àŽ‹‹¾“IŽ¡—Âɂæ‚é‘å’°úE‚Ì‚P—á. ŽO—Ö˜jCŠOŽR‹v‘¾˜YCiŽm‰iŽqCŽðˆä‘¾˜YCŠ™“cˆêŽõC’|‹g—R‰ÁŽuC“n•Ó—²ŽiC–{ŠÔ“ñ˜YC–ì“o½C‹àŽR³–¾i“àj: ‘æ43‰ñ_“Þ쌧Á‰»Ší•aŒ¤‹†‰ï i98.06.13j, ‰¡•l.

854. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠÖß’É‚É”º‚¤ŠÌ‹@”\‘ˆ«‚ðŒJ‚è•Ô‚µ‚½AMA‰A«PBC‚Ì‚P—á. ŽO—Ö˜jCŠOŽR‹v‘¾˜YCiŽm‰iŽqCŠ™“cˆêŽõC‰œ‘ºr–¾C“c•Ó—T–¾C’|‹g—R‰ÁŽui“àjC“n•Ó´Ž¡i•a—jC“n•Ó—²ŽiC–{ŠÔ“ñ˜YC–ì“o½C‹àŽR³–¾i“àj: ‘æ103‰ñŠÌ’_äXŽ¾Š³Œ¤‹†‰ï i98.07.06j, ‰¡•l.

855. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œo”ç“IäX”X–EúŽh‚É‚ÄÇóÁŽ¸‚µ, ”X–E, äX΂àÁŽ¸‚µ‚½‚P—á. ‘å–ì—²C‘O‘ºˆÀ•¶C…ŒûŸlCˆ¢•”Œ’“ñC‰Í–씎‹vC¼–Ø–ÎŽ÷C‹k“c‹P—Yi“àj: ‘æ4‰ñÓìOPEN Conference i98.07.11j, ‘åˆé.

856. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠÖß’É‚É”º‚¤ŠÌ‹@”\‘ˆ«‚ðŒJ‚è•Ô‚µ‚½AMA‰A«PBC‚Ì‚P—á. ŽO—Ö˜jCŠOŽR‹v‘¾˜YCiŽm‰iŽqCŽðˆä‘¾˜YCŠ™“cˆêŽõC’|‹g—R‰ÁŽuC“n•Ó—²Žii“àjC“n•Ó´Ž¡i•a—jC–{ŠÔ“ñ˜YC–ì“o½C‹àŽR³–¾i“àj: ‘æ103‰ñŠÌ’_äXŽ¾Š³Œ¤‹†‰ï i98.07.16j, ‰¡•l.

857. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j –å–¬Çð‚ł݂‚©‚Á‚½ŠÌ×–EŠà. Žs쇎qCa’J–¾—²i“àj: ‘Š–ÍŒ´ƒŠƒo[ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i98.09.21j, ‘Š–ÍŒ´.

858. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j PEIT‚ÆTAE‚Ì•¹—p—á. ‘ºã’C‚“c‰ë”ŽC‘•ª–ΔŽi“àjCˆé•”‹`Œ›i•új: ‘æ3‰ñ_“ÞìŠÌ‚ª‚ñŽ¡—ÃŒ¤‹†‰ï i98.11.10j, ‘Š–ÍŒ´.

859. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’_Δ­ìÇó‚𔺂Á‚½‹}«’_”X‰Š‚Å”­Œ©‚³‚ꂽ’_”XŒz•”Šà‚Ì‚P—á. …ŒûŸlC‘å–ì—²Cˆ¢•”Œ’“ñC‰Í–씎‹vC¼–Ø–ÎŽ÷C‹k“c‹P—YC‹gˆäº•vC‚‹´—B˜Yi“àjC”Ñ”öGC•ÊŠ—²: •½¬10”N“x_“Þì“à‰ÈW’k‰ï i98.11.16j, ‰¡•l.

860. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j äXŽ¾Š³‚É‚¨‚¯‚éäX‰t’†c-ki-rasˆâ“`Žqcodon 12“_“Ë‘R•ÏˆÙ—z«—¦‚ɑ΂·‚é‰Á—î‚̉e‹¿. –Ø“c–FŽ÷C–Ø“cŒõLCr–س—YCŽRèDŠìC’|‘òŽO‘ãŽqC“n•Ó–€–çC‘“ŒŠ²•vC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘æ22‰ñ˜V”NÁ‰»Ší•aŒ¤‹†“¢˜_‰ï i98.12.00j, “Œ‹ž.

861. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‚aŒ^ŠÌ‰ŠƒLƒƒƒŠƒA‚É‚¨‚¯‚éHBsRŒ´ÁŽ¸—á‚Ì—Õ°“IŒŸ“¢. ”’{‹±ŽqC›–ì‘CˆÀ’BŒ£C–Ø‘º‚“¿C¬“ˆ’B–çC–쑺–¾C’†‘º—zŽqC“n•ÓK•vCˆÀ•”–¾˜Yi“àj: _“ÞìÁ‰»Ší•aŒ¤‹†‰ï i99.00.00j, ‰¡•l.

862. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Rendu-Osler-Weber•a‚É‚¨‚¯‚éŠÌ•a•Ï‚ÌŒŸ“¢. “n•Ó^²Ca’J–¾—²C“ú‚‰›C’†‘ò‹MGC‚“c‰ë”ŽC‘•ª–ΔŽC¼Œ³Ž›Ž—çi“àj: ‘æ45‰ñ• o‹¾§˜b‰ï i99.02.18j, “Œ‹ž.

863. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ž©ŒÈ–Ɖu«ŠÌ‰Š‚Ì‹}«‘ˆ«‚µ‚½’j«‚Ì‚P—á. Žs쇎qCa’J–¾—²C’†‘ò‹MGC‘•ª–ΔŽi“àj: ‘æ45‰ñ‰ë–‰€ƒŠƒo[ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX i99.02.18j, “Œ‹ž, V–ò‚ÆŽ¡—Ã.

864. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’°œ“]ˆÚ‚É”º‚¤ŠÌ×–EŠà‚ɑ΂µTAE‚ÆUFT“à•ž‚ª—LŒø‚Å‚ ‚Á‚½ŠÌd•Ï‚Ì‚P—á. ‘ºã’C‘•ª–ΔŽC“ú‚‰›C‚“c‰ë”Ži“àjC¼‰iŒh“ñCˆé•”‹`Œ›i•új: ‘æ4‰ñ_“ÞìŠÌ‚ª‚ñŽ¡—ÃŒ¤‹†‰ï i99.02.23j, ‘Š–ÍŒ´.

865. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j äXŽ¾Š³‚É‚¨‚¯‚éäX‰t’†ˆâ“`ŽqˆÙí‚ÌŒŸ“¢. –Ø“c–FŽ÷C–Ø“cŒõLCr–س—YC’|‘òŽO‘ãŽqCŽRèDŠìC“n•Ó–€–çC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘æ6‰ñ_“ÞìBPƒNƒ‰ƒu i99.03.02j, ‰¡•l.

866. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j f’f‚É‹ê—¶‚µ‚Ä‚¢‚鬂³‚¢ŠÌŽîᎫ•a•Ï‚Ì‚P—á. “cŒ´‹v”üŽqC“ú‚‰›C’†‘ò‹MGC‚“c‰ë”ŽCa’J–¾—²C‘•ª–ΔŽC¼Œ³Ž›Ž—çi“àj: ‘æ21‰ñ_“ÞìŽáŽèŠÌ‘Ÿ•×‹­‰ï i99.03.12j, _“Þì.

867. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ž©ŒÈ–Ɖu«ŠÌ‰Š‚ª‹}«‘ˆ«‚µ‚½’j«‚Ì‚P—á. Žs쇎qCa’J–¾—²i“àj: ‘Š–ÍŒ´ƒŠƒo[ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i99.03.15j, ‘Š–ÍŒ´, ˆãŽt‰ïŽGŽ.

868. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj ’´‰¹”g“àŽ‹‹¾f’f‚ÌŽÀÛ. –Ø“cŒõLi“àj: ‘æ2‰ñ’¹ŽæEUSƒZƒ~ƒi[ i99.03.13j, •ÄŽq.

869. mŠw‰ïŽåÃi‚»‚Ì‘¼jn ‘æ1‰ñB-RTOŒ¤‹†‰ïi98.09.03j, •Ÿ‰ªiŽQ‰ÁŽÒ: 150–¼, “à‰È, ŠO‰È, •úŽËü‰Èˆãj ‘•ª–ΔŽi“àj:


<<1402 “à‰ÈŠw‡U>>

870. mŒ´’˜n Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Yazaki, Y.CIsobe, M.CHiramatsu, S.CMorimoto, S.CHiroe, M.COmichi, C.CNakano, T.CSaeki, M.C˜aò“Oi“àjCSekiguchi, M.: Am. J. Cardiol., 82: 537`540, 1998.

871. mŒ´’˜n Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Okura, Y.CTakeda, K.CHonda, S.CHanawa, H.CWatanabe, H.CKodama, M.iVŠƒ‘åjC˜aò“Oi“àjCAizawa, Y.iVŠƒ‘åjCSeki, S.i–h‰qˆã‘åjCAbo, T.iVŠƒ‘åj: Circ. Res., 82: 1035`1042, 1998.

872. mŒ´’˜n A new scoring system to predict the efficacy of steroid therapy for patients with active myocarditis; A retrospective study. Kodama, M.COkura, Y.CHirono, S.CHanawa, H.COgawa, Y.CItoh, M.C˜aò“Oi“àjC‘Š‘ò‹`–[iVŠƒ‘åj: Jpn. Circ. J., 62(10): 715`720, 1998.

873. mŒ´’˜n Hepatitis C virus infection and heart diseases; A multicenter study in Japan. Matsumori, A.COhashi N.CHasegawa, K.CSasayama, S.CEto, T.CImaizumi, T.C˜aò“Oi“àjCKawamura K.CKawana, M.CKimura, A.CKitabatake, A.CMatsuzaki, M.CNagai, R.CTanaka, H.CHiroe, M.CHori, M.CInoko, H.CSeko, Y.CSekiguchi, M.CShimotohno, K.CSugishita, Y.CTakeda, N.CTakihara, K.CTanaka, M.CTokuhisa, T.CToyo-oka, T.CYokoyama, M.Cand Co-research Workers: Jpn. Circ. J., 62(5): 389`391, 1998.

874. mŒ´’˜n The usefulness of holter monitoring in selection of pharmacological therapy for patients with sustained ventricular tachycardia; Studies in patients with no effective pharmacological therapy determined in the electrophysiologic study. ’ë–ìTˆêCŒÃ“ˆ”ŽŽiCŽí“cGŽiCˆ¢•”WC‘啽WŽii“àjC‘Š‘ò‹`–[iVŠƒ‘åj: Jpn. Circ. J., 62: 347`352, 1998.

875. mŒ´’˜n Doppler echocardiographic method to determine early and rate diastolic filling volume separately; Validation and relationship between filling velocity and volume. •ìMŒåC‘åŒIŽ¡•FCù‰ª‘åŽjC’¬“c—z“ñC’·“c˜a”VC–Øì“c—²ˆêi“àj: Jpn. Heart J., 39(4): 489`501, 1998.

876. mŒ´’˜n Comparison of arrhythmogenicity of atrial pacing at several right atrial pacing sites. Evaluation of canine atrial electrograms during atrial pacing and arrhythmogenicity for atrial fibrillation. ’ë–ìTˆêCŽR‰Y³KC˜h’Ë—²C“c•Ó–õ‹MCŒÃ“ˆ”ŽŽiCŽí“cGŽii“àjC‘Š‘ò‹`–[iVŠƒ‘åj: Pace, 21: 1918`1926, 1998.

877. mŒ´’˜n Œ€ÇŒ^S‹Ø‰Š‚ɑ΂·‚éŒo”ç“IS”x•â•–@. ˜aò“Oi“àjCÂŽR’¼‘Pi‹~–½j: S‘Ÿ, 30(11): 704`706, 1998.

878. m€Œ´’˜i‰p•¶jn Do ketone bodies contribute to protect against damage caused by both myocardial ischemia and reperfusion injury? ²“¡´‹MC‘“c‘ìi“àjCŽR–{aˆê˜Yi‹~–½jC¼ŽRÄ‹vi—Õ•a—jCì’[M–íC˜aò“Oi“àj: Ischemic Heart, 1: 501`509, 1998.

879. mŒ¤‹†•ñiŒú¶Èjn ‘J‰„‰»‚·‚éS‹Ø‰Š‚Æ“Á”­«S‹ØÇ‚ÉŠÖ‚·‚錤‹†. ˜aò“OC‰Í–쌒C‰¡ŽR_”VC—é–ØŒ[‰îi“àjCÂŽR’¼‘Pi‹~–½j: Œú¶È“Á’莾Š³’²¸Œ¤‹†”Ç(Šî”ÕŒ¤‹†•”–å), “Á’莾Š³‚ÉŠÖ‚·‚é”÷¶•¨”Ç•½¬‚X”N“xŒ¤‹†•ñ‘, p.49`52, 1998.

880. mŒ¤‹†•ñiŒú¶Èjn ‘½‘ŸŠíˆÚAƒlƒbƒgƒ[ƒN‚ւ̑Ήž‚ÉŠÖ‚·‚錤‹†; 3. ”]Ž€‚µ‚½ŽÒ‚Ìg‘Ì‚©‚ç‚Ì‘ŸŠí‚Ì“Eo‚ÉŠÖ‚·‚錤‹†. Ž›‰ªŒdi“Œ—ˆã‘åjC–ì–{‹T‹v—Yi‹ã‘åjC™–{šæiã‘åjC_–ì“N•vi“¡“c•ÛŒ’‰q¶‘åjC“‡èCŽŸiˆÇ—Ñ‘åjC‰¡“c—Tsi“úˆã‘åjC¬–ömi“Œ—ˆã‘åjC ¼“côiã‘åjC–k‘º‘yˆê˜Yi‘—§zŠÂŠíƒZƒ“jC“c’†hˆêi‹ž‘åjCì轎¡iMB‘åjC“¡Œ´Œ¤Žiié‹Ê‘åjC˜aò“Oi“àjC‘哇Lˆêi–¼‘åjC—Ñ_CX ’B˜YC¬’†ßŽqCÀŠÔKŽqi“ú–{‘ŸŠíˆÚAƒlƒbƒgƒ[ƒNj: •½¬‚X”N“xŒú¶È‰ÈŠwŒ¤‹†”ï•â•‹à, –Ɖu¥ƒAƒŒƒ‹ƒM[“™Œ¤‹†Ž–‹Æ(‘ŸŠíˆÚA•”–å)Œ¤‹†•ñ‘, p.242`249, 1998.

881. mÇ—á•ñn Iron deposition in myocardium documented on standard computed tomography in cardiac hemochromatosis. ’ë–ìTˆêi“àjC‰¡ŽR‡ŽŸC’ë–ì—TŒbC‘Š‘ò‹`–[iVŠƒ‘åj: Circulation, 97: 2371, 1998.

882. mÇ—á•ñn Sâ|•”’É‚Å”­Ç‚µSƒ^ƒ“ƒ|ƒi[ƒf‚©‚çƒVƒ‡ƒbƒN‚ɊׂÁ‚½‚ª‹Ù‹}Žèp‚É‚æ‚è‹~–½‚³‚ꂽŒŒð•ÂÇŒ^‹}«‘å“®–¬‰ð—£‚Ì‚P—á. ‹g“cTC—é–ØŒ[‰îi“àjCÂŽR’¼‘PC—Ñ@”Ži‹~–½jC¡ˆäŠ°i–@ˆãjC˜aò“Oi“àj: Heart View, 2(5): 613`618, 1998.

883. mÇ—á•ñn ‹}«Šú‚̃Xƒeƒ“ƒg—¯’u‚É‚æ‚è‹~–½‚µ‚¦, NYHA class ‡T‚Å‘Þ‰@‚µ‚½¶Š¥“®–¬ŽåŠ²•”[Ç‚Ì‚P—á. Ä“¡~ŽqC•‘ò—˜˜YC˜aò“Oi“àj: Heart View, 2(7): 830`837, 1998.

884. mÇ—á•ñn A 55-year-old man with chronic pancreatitis complaining of inveterateabdominal pain. ŽRŠÝ‚GC’|“àˆêC‘ŠèrÆi“àjC‹à鳉ÀiŠOjC•½“cŒõ”Ži‹~–½jC˜aò“Oi“àj: J. Cardiol., 33: 37`38, 1999.

885. mÇ—á•ñn AMIŒã‚̃uƒ[ƒAƒEƒgŒ^Ž©—R•Ç”j—ô‚ɑ΂µS–ŒoƒhƒŒƒi[ƒW‹y‚ÑPCPS‚ðì—p‚µªŽ¡p‚ðs‚¦‚½‚P—á. ‘ºˆé’mdi“àjC¡ˆäŠ°i–@ˆãjC—Ñ@”Ži‹~–½jC‹g“cTC—é–ØŒ[‰îi“àjCÂŽR’¼‘PC㞊‹glC•½“cŒõ”ŽC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 19: 182`183, 1998.

886. mÇ—á•ñn Proscillaridin (CaradrinR)’†“Å‚Ì‚P—á. ‚‹´ŠîC’|“c’è¶C‹v•Û‹Mºi´…Œú¶•a‰@jC˜aò“Oi“àj: “ú–{“à‰ÈŠw‰ïŽGŽ, 87(10): 127`128, 1998.

887. m‘àn ECG Exercise Testing: Novel insights. ˜aò“OC“y‰®’¼—²i“àj: 98' AHA Highlights, p.172`175, 1999.

888. m‘àn Šg’£Œ^S‹ØÇ‚Ì•a‘Ô‚ÆŽ¡—Ã|–ò•¨Ž¡—Âð’†S‚Æ‚µ‚Ä|. •ìMŒåC˜aò“Oi“àj: Heart Nursing, 11(10): 86`93, 1998.

889. m‘àn –«S‹Ø‰Š‚ÆS‹ØÇ‚Æ‚ÌŠÖ‚í‚è|‘J‰„‚·‚éS‹Ø‰Š‘œ|. ˜aò“OC•ìMŒåC‰¡ŽR_”Vi“àj: Heart View, 2(6): 656`660, 1998.

890. m‘àn ACE‘jŠQ–ò‚ƃAƒ“ƒWƒIƒeƒ“ƒVƒ“‡UŽó—e‘ÌhR–ò‚Ì‚±‚ê‚©‚ç. ’†”¨ˆêi•a—jC˜aò“Oi“àj: MEDICO, 29(10): 9`12, 1998.

891. m‘àn QT‰„’·‚Æ•s®–¬. ’ë–ìTˆêi“àj: Ther. Res., 20: 204`211, 1999.

892. m‘àn •p–¬«•s®–¬E“´•p”. ’ë–ìTˆêi“àj: ŠÅŒì‹Zp, 45: 36`37, 1999.

893. m‘àn •p–¬«•s®–¬E”­ì«ãŽº•p”. ’ë–ìTˆêi“àj: ŠÅŒì‹Zp, 45: 38`41, 1999.

894. m‘àn •p–¬«•s®–¬ESŽº•p”. ’ë–ìTˆêi“àj: ŠÅŒì‹Zp, 45: 42`45, 1999.

895. m‘àn S‹@”\’ቺ—á‚Å‚ÌRŒŒð—Ö@‚Ì“K‰ž‚ÆŽÀÛ. ¼“cçŠGŽqC˜aò“Oi“àj: ŒÄ‹z‚ÆzŠÂ, 46(8): 751`757, 1998.

896. m‘àn –Ɖu‚ÆS‹ØÇ. ¼“cçŠGŽqC˜aò“Oi“àj: Ž¡—Êw, 32(9): 54`57, 1998.

897. m‘àn ŠeŽí•s®–¬‚ÆR•s®–¬–òES–[ד®. ’ë–ìTˆêi“àj: Ž¡—Öò, 3(4): 92`94, 1998.

898. m‘àn Œ€ÇŒ^S‹Ø‰Š‚ÌŠT”O‚ƉuŠw. ÂŽR’¼‘Pi‹~–½jC˜aò“Oi“àj: zŠÂŠí‰È, 44(5): 409`416, 1998.

899. m‘àn Ž©ŒÈ–Ɖu«S‹ØáŠQ‚ƃTƒCƒgƒJƒCƒ“. ‘å‘q—T“ñC¬‹Ê½C‘Š‘ò‹`–[iVŠƒ‘åjC˜aò“Oi“àj: zŠÂŠí‰È, 44: 522`531, 1998.

900. m‘àn “ú–{zŠÂŠíŠw‰ïS‘ŸˆÚAˆÏˆõ‰ï‚©‚ç‚ÌŒ»ó•ñ. ˜aò“Oi“àj: zŠÂŠíê–åˆã, 6(2): 245`251, 1998.

901. m‘àn SŽº«•s®–¬‚É‚¨‚¯‚éƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“. ’ë–ìTˆêi“àj: “à‰È, 82: 101`106, 1998.

902. m‘àn S‘ŸˆÚA‚Ɠ«S•s‘S. ˜aò“Oi“àj: “ú–{ˆãŽt‰ïŽGŽ, 119(11): 1750`1754, 1998.

903. m‘àn S‘ŸˆÚA‚ð‚Ç‚¤l‚¦‚é‚©. ˜aò“Oi“àj: –ˆ“úƒ‰ƒCƒt, (3ŒŽ†): 89`95, 1999.

904. muÀn ’èŠú“I‰^“®‚Ì—L‰v«‚ɂ‚¢‚Ä. ´…Š®‰xi“àj: Sports Sagamihara, 17: 1998.

905. muÀn Ž¸_‚ÌŠ³ŽÒ‚³‚ñ‚ɑ΂·‚éf’f‚ÆŽ¡—ÂÌi•à|“Á‚É_Œo’²ß«Ž¸_‚ɂ‚¢‚Ä|. ´…Š®‰xi“àj: –k—¢‘åŠw•a‰@ƒjƒ…[ƒYƒŒƒ^[‘‹, 31: 1999.

906. mŠwp‘n i•ª’SŽ·•Mj ‘±S‘Ÿ‘ãŽÓŽÀŒ±–@; NOSmRNA‚̉ðÍ|ribnuclease protein assay‚̉ž—p, p.556`561, ‘å‘q—T“ñiVŠƒ‘åjC˜aò“Oi“àj. ˜Z–@o”ÅŽÐ, “Œ‹ž, 98.11.01”­s.

907. mŠwp‘n i•ª’SŽ·•Mj The Ischemic Heart; Do ketone bodies contribute to protection against damage caused by bothmyocardial ischemia and reperfusion injury? p.501`509, ²“¡´‹MC‘“c‘ìi“àjCŽR–{aˆê˜Yi‹~–½jC¼ŽRÄ‹vi—Õ•a—jCì’[M–íC˜aò“Oi“àj. •ÒW Mochizuki, S.CTakeda, N.i“Œ‹žŽœŒbˆã‘åjCet al.•ÒC Kluwer Academic Publishers, Boston, 98.00.00”­s.

908. m‹³‰È‘n i•ª’SŽ·•Mj “à‰È—Õ°ƒŠƒtƒ@ƒŒƒ“ƒXƒuƒbƒN; S‹ØÇ, S‹Ø‰Š, 2: 200`213, •ìMŒåC˜aò“Oi“àj. •ÒW ¡ˆä_ŽOiŽD–yˆã‘åjC’†Œ´ˆê•Fi“Œ‘åjC–I‰®‡ˆêiˆÇ—Ñ‘åjCŽRŒû“Oi“Œ–M‘åjC•ÒC ’†ŽR‘“X, “Œ‹ž, 98.07.31”­s.

909. m‹³‰È‘n i•ª’SŽ·•Mj Ž¾Š³•ÊÅVˆ•û; Š´õ«S“à–ŒÇ, p.130`131, “y‰®’¼—²C˜aò“Oi“àj. •ÒW –îè‹`—Yi“Œ‘åjCŒË“c„‘¾˜Yi“Œ‹žŽœŒbˆã‘åjC•ÒC ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 98.12.10”­s.

910. m‹³‰È‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj|1999; S‹Ø‰Š, p.367`368, ˜aò“Oi“àj. •ÒW ‘½‰ê{K’ji‘½‰ê{ƒNƒŠƒjƒbƒNjC”öŒ`‰x˜YiŠàŒ¤•t‘®•a‰@jC•ÒC ˆãŠw‘‰@, “Œ‹ž, 99.01.01”­s.

911. m‹³‰È‘n i•ª’SŽ·•Mj Ž¡—Â̂µ‚©‚½; ªŽ¡—Ö@‚ƌƑ§“I—Ö@, p.141`148, ˜aò“Oi“àj. •ÒW “c‘ºN“ñiŽR—œˆã‘åjC•ÒC ˆãŽ•–òo”Å, “Œ‹ž, 99.03.15”­s.

912. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŠO—ˆf—Â̂·‚ׂÄ; Œƒ‚µ‚¢‹¹’É, p.24`27, ’†”¨ˆêi•a—jC˜aò“Oi“àj. ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 99.01.14”­s.

913. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj S‹Ø‚Ì\‘¢‚Æ‘ãŽÓ 1997; Žá”NŽÒ‚¨‚æ‚Ñ‘s”NŽÒ‚Ì“Ë‘RŽ€|–UŒŸ—á‚©‚çŽÀ‘Ô‚ð’T‚é|, p.227`233, ‘ŠèrÆi“àjC’†”¨ˆêi•a—jC‘å˜a“c^‹IŽqi“àjC¯ˆä‚Ì‚èŽqCŒÃì—Fi–@ˆãjCó—˜–õC‘Š”nˆêˆåi‹~–½jCŒIŒ´Ž—Ri–@ˆãjC‘å˜a“c—²i‹~ –½jC˜aò“Oi“àj. •ÒW S‹Ø‘ãŽÓŒ¤‹†‰ïC•ÒC ˜Z–@o”ÅŽÐ, “Œ‹ž, 98.11.01”­s.

914. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Alcoholics' heart and heart diseases. ˜aò“Oi“àj: International Symposium on Heart Disease i98.05.20j, ƒJƒCƒ.

915. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Protective action of Blockade and JTV-519 on SAH heart muscle. ²“¡´‹MC‘“c‘ìi“àjCŽR–{aˆê˜Yi‹~–½jC¼ŽRÄ‹vi—Õ•a—jC‘ºã˜aŽqC–ì“cçtCì’[M–íC²X–Ø‹BC“y‰®’¼—²C˜aò“Oi“àj: 16th International Society for Heart Research i98.05.28j, Rodos, J. Mol. Cell. Cardiol., 30: 9, 1998.

916. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Vanadium augments pump function and energy kinetics in diabetic ret heart. –ì“cçtC‘ºã˜aŽqC‘“c‘ìC²“¡´‹MC‰Í–쌒C‰¡ŽR_”VC“y‰®’¼—²C˜aò“Oi“àj: 16th International Society for Heart Research i98.05.28j, Rodos, J. Mol. Cell. Cardiol., 30: 60, 1998.

917. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Abrupt one day cessation effects of three different antihypertensive agents on blood pressure and autonomic nervous function. ´…Š®‰xC–]ŒŽr’¼C•‘ò—˜˜YC•ìMŒåC‘º¼€C˜Iè‹P•vC˜aò“Oi“àj: 17th Scientific Meeting of the International Society of Hypertension i98.06.11j, Amsterdam, J. Hypertens., 16(Suppl.): 249, 1998.

918. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical outcome of catheter thrombolytic aspiration therapy in patients with acute pulmonary thromboembolism. •½¼T‰EC‰¬Œ´“ÄC–k–ì‹`˜aCˆäŠÖ»ŠGC‘º¼€C˜aò“Oi“àj: 20th Congress of the European Society of Cardiology i98.08.24j, Vienna, Austria, Eur. Heart J., 19(Suppl.): 1998.

919. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j S•s‘S‚Ì•a‘Ô‚©‚玡—ÂÖ. ˜aò“Oi“àj: “ú–{“à‰ÈŠw‰ïŠwpW‰ï‘æ26‰ñ“à‰ÈŠw‚Ì“W–] i98.11.01j, ‰F“s‹{.

920. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«S‹Ø[ÇŽž‚É‚¨‚¯‚éÄŠÁ—¬—Ö@‚Ì•]‰¿. ˆ¢•”˜jC˜aò“Oi“àj: ‘æ46‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï i98.09.13j, “Œ‹ž.

921. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ä•ª‹ÉŒã•s‰ž«(post-repolarization refractoriness)‚Ì’è—Ê“I•]‰¿–@‚ÌŒŸ“¢|ŽÀŒ±Œ¢S–[‚É‚¨‚¯‚élH“I‹·˜H‚Ì“`“±«‚ÌŒŸ“¢|. ’ë–ìTˆêCŽR‰Y³KCŒÃ“ˆ”ŽŽiC˜h’Ë—²i“àjC‘Š‘ò‹`–[iVŠƒ‘åj: ‘æ15‰ñ“ú–{S“dŠw‰ïŠwpW‰ï i98.10.01j, Ž­Ž™“‡, S“d}, 18: 675, 1998.

922. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “d‹C¶—ŒŸ¸ã—LŒø”»’è‚Ì–òÜŽ¡—Ã’†‚É”F‚ß‚ç‚ê‚éSŽº•p”‚ÌÄ”­|—Õ°“IÄ”­‚ð—\’m‚·‚é“d‹C¶—Šw“IŽw•W‚Í‘¶Ý‚·‚é‚©|. ’ë–ìTˆêCŽR‰Y³KCŒÃ“ˆ”ŽŽiCŽí“cGŽiC‘啽WŽiC˜h’Ë—²i“àjC‘Š‘ò‹`–[iVŠƒ‘åj: ‘æ15‰ñ“ú–{S“dŠw‰ïŠwpW‰ï i98.10.01j, Ž­Ž™“‡, S“d}, 18: 723, 1998.

923. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Až‚ÝŒ^œ×“®Ší(ICD)ì“®Žž‚ÉŠ³ŽÒ‘Ì•\–Ê‚ÉoŒ»‚·‚é˜R‚ê“d—¬‚Í‘æŽOŽÒ‚É‚Æ‚Á‚ĈÀ‘S‚©|‹¹•”AžŒ^ICDÇ—á‚É‚¨‚¯‚é—Õ°“IŒŸ“¢|. ’ë–ìTˆêCŽR‰Y³KCŒÃ“ˆ”ŽŽiCŽí“cGŽiC‘啽WŽiC˜h’Ë—²C‘Š‘ò‹`–[i“àj: ‘æ15‰ñ“ú–{S“dŠw‰ïŠwpW‰ï i98.10.01j, Ž­Ž™“‡, S“d}, 18: 726, 1998.

924. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PECAM-1 polymorphism associated with myocardial infarction in Japanese. ù‰ª‘åŽjC’·“c˜a”VC–k–ì‹`˜aC‚‹´ŠîC‘ŠèrÆC•‘ò—˜˜YC•ìMŒåC´…Š®‰xC˜aò“Oi“àjCKimura, A.: Japanese Section of the International Society for Heart Research i98.12.10j, “Œ‹ž, J. Mol. Cell. Cardiol., 30(11): 316, 1998.

925. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j R•s®–¬–ò‚Ì“`“±“râŒø‰Ê‚ÌV‚µ‚¢Žw•W|“râ˜AŒ‹Šú(BCD)‚É‚æ‚éR•s®–¬–òì—p‚Ì•]‰¿|‘æ2•ñ, Ä•ª‹ÉŒã•s‰ž«‚ɑ΂·‚éƒvƒƒJƒCƒ“ƒAƒ~ƒh‚Ìì—p‚ÌŒŸ“¢|. ’ë–ìTˆêC‹g‘ò’¼lCXŒû¹•FC–k–ì‹`˜aC˜aò“Oi“àj: ‘æ63‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï i99.03.27j, “Œ‹ž, Jpn. Circ. J., 63(Suppl.1): 203, 1999.

926. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ä”­«”­ì«S–[ד®‚ɑ΂·‚éƒxƒ‰ƒpƒ~ƒ‹’·Šú“Š—^‚Ì—Õ°“IŒø‰Ê‚ÌŒŸ“¢|’·Šú“I‚È“d‹C“IƒŠƒ‚ƒfƒŠƒ“ƒO‚Í—}§‚³‚ê‚é‚©|. ’ë–ìTˆêC‹g‘ò’¼lCŒ´‰pKCXŒû¹•FC–k–ì‹`˜aC˜aò“Oi“àj: ‘æ63‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï i99.03.27j, “Œ‹ž, Jpn. Circ. J., 63(Suppl.1): 362, 1999.

927. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¶Žº‹@”\’ቺǗá‚ɑ΂·‚éMilrinone‚̈³Žó—e‘Ì”½ŽË‹@”\‚¨‚æ‚ё̉t«ˆöŽq‚Ö‚Ì‹}«Œø‰Ê. ´…Š®‰xC–]ŒŽr’¼Cù‰ª‘åŽjCìŒû’|’jC•‘ò—˜˜YC•ìMŒåC‘º¼€C˜Iè‹P•vC˜aò“Oi“àjC–x’rdŽ¡i•új: ‘æ63‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï i99.03.29j, “Œ‹ž, Jpn. Circ. J., 63(Suppl.1): 376, 1999.

928. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j S‘ŸŽ€‚µ‚½¸_•ª—ô•aŠ³ŽÒ‚ÌS“d}•Ï‰». ’|’[‹ÏC²“¡´‹MC‘ºã˜aŽqC–ì“cçtCŒ¢”öŒöŒúCˆäŠÖ»ŠGC‘“c‘ìC˜aò“Oi“àjCˆÀˆä³C’†“‡ß•vi¸j: ‘æ96‰ñ“ú–{“à‰ÈŠw‰ï i99.03.31j, “Œ‹ž, “ú–{“à‰ÈŠw‰ïŽGŽ, 88(‘): 177, 1999.

929. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹}«”xÇðÇ‚É‚æ‚鎀–S‚ª‰@ŠO”­Ç‚ɔ䂵‰@“à”­Ç‚Å‚—¦‚Å‚ ‚邱‚Ƃɂ‚¢‚Ä‚ÌlŽ@. ‰¬Œ´“ÄC•½¼T‰ECˆäŠÖ»ŠGi“àjC–ìè˜a–çCÎì“NCÔo쌫Ž¡C–k–ì‹`˜aC‰iˆä‡iÀ’ÃŽs—§•a‰@jC‘º¼€C˜aò“Oi“àj: ‘æ95‰ñ“ú–{“à‰ÈŠw‰ïu‰‰‰ï i98.04.11j, •Ÿ‰ª, ´˜^W, p.296, 1998.

930. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j A‚¦ž‚ÝŒ^œ×“®Ší’Ê“dŽž‚Ì‘Ì•\–ʘR‚ê“d—¬‚ÌŒŸ“¢|ŽÀŒ±Œ¢‚É‚¨‚¯‚鑽Ží‘Ì•\–ʉñ˜H“¯Žž‹L˜^‚Å‚ÌŒŸ“¢|. ’ë–ìTˆêCŽR‰Y³KC“cìŽÀCŒÃ“ˆ”ŽŽiCŽí“cGŽiC˜h’Ë—²i“àjC‘Š‘ò‹`–[iVŠƒ‘åj: ‘æ13‰ñ“ú–{S‘Ÿƒy[ƒVƒ“ƒO“d‹C¶—Šw‰ïŠwpW‰ï i98.05.28j, “Œ‹ž, •s®–¬, 14: 235, 1998.

931. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –³ÇŒó«¶Žº‹@”\’ቺǗá‚É‚¨‚¯‚鈳Žó—eŠí”½ŽË‹@”\. ´…Š®‰xC–]ŒŽr’¼C‘ºˆé’mdC‚‹´‚©‚¨‚éC’·“c˜a”VCìŒû’|’jC•‘ò—˜˜YC•ìMŒåC‘º¼€C˜Iè‹P•vC˜aò“Oi“àj: ‘æ46‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï i98.09.10j, “Œ‹ž, J. Cardiol., 32(Suppl.1): 333, 1998.

932. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Pimobendan therapy on cardiopulmonary and arterial baroreceptors in patients with asymptomatic heart failure. ´…Š®‰xC–]ŒŽr’¼CìŒû’|’jC’·“c˜a”VC•‘ò—˜˜YC•ìMŒåC˜Iè‹P•vC˜aò“Oi“àj: ‘æ‚Q‰ñ“ú–{S•s‘SŠw‰ï‘‰ï i98.10.16j, ŽD–y, J. Card. Fail., 4(3): 100, 1998.

933. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Changes in ejection fraction during and after exercise in patients with ischemic heart disease and with dilated cardiomyopathy. –]ŒŽr’¼C´…Š®‰xCìŒû’|’jC‘ºˆé’mdC‚‹´‚©‚¨‚éC’·“c˜a”VC•‘ò—˜˜YC•ìMŒåC‘º¼€C˜Iè‹P•vC˜aò“Oi“àjC–x’rdŽ¡i•új: ‘æ‚Q‰ñ“ú–{S•s‘SŠw‰ï‘‰ï i98.10.16j, ŽD–y, J. Card. Fail., 4(3): 1141, 1998.

934. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ~ˆ³Ü‚ðˆê“ú’†’f‚µ‚½ê‡‚̉e‹¿. –ö–Εvi¶•¨•¨—ŒnjC´…Š®‰xC˜aò“Oi“àj: ‘æ45‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i98.11.11j, ‚’m, —Õ°•a—, 46(•â): 231, 1998.

935. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Cardiac dendritic cells: Immunohistochemical characterization in the human heart with acute myocarditis. ‰¡ŽR_”VC‰Í–쌒C—é–ØŒ[‰îCÂŽR’¼‘PC˜aò“Oi“àjCŒK”ö’èmi•a—jC“à“¡áÁiVŠƒ‘åj: Japanese Section of the International Society for Heart Research i98.12.10j, “Œ‹ž.

936. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹i‰Œ‚ÍŠ¥¹k«‹·SÇ‚ÌŽ¡—ÃŒø‰Ê‚ðŒ¸‚¶‚é. ‰º•lF˜YC‘º“cŽÀC‘DèrˆêC‘ –ìN‘¢i…ŒË϶‰ï•a‰@j: ‘æ63‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï i99.03.29j, “Œ‹ž.

937. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j S‹Ø‰Š‚Ì—Õ°. ˜aò“Oi“àj: “ú–{“à‰ÈŠw‰ïŠÖ“ŒŽx•”ŽåÑæ19‰ñ¶ŠU‹³ˆçu‰‰‰ï i98.12.13j, “Œ‹ž.

938. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j AMIŒã‚̃uƒ[ƒAƒIƒEƒgŒ^Ž©—R•Ç”j—ô‚ɑ΂µS–ŒoƒhƒŒƒi[ƒW‹y‚ÑPCPS‚ðì—p‚µªŽ¡p‚ðs‚¦‚½‚P—á. ‘ºˆé’mdi“àjC¡ˆäŠ°C—Ñ@”Ži‹~–½jC‹g“cTC—é–ØŒ[‰îi“àjCÂŽR’¼‘PC㞊‹glC•½“cŒõ”ŽC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ44‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i98.02.14j, Š‘ò.

939. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”xÇðÇ—á‚Ì•ÂÇŽžÄŠÁ—¬Žž‚Ì”x“®–¬ŒŒ—¬‚ÌŒŸ“¢|Doppler Wire, Pressure Wire‚ð—p‚¢‚Ä|. “ü–ì”üŽ÷i’|“c‘‡•a‰@jCˆ¢•”˜ji“àjCâã‘ñ˜YC“n•Ó—TCŒã“¡Œ«‰xC–ؖF‘¥C“à“¡’¼–ØC–ؖF’¼i’|“c‘‡•a‰@j: ‘æ155‰ñ“ú–{“à‰ÈŠw‰ï“Œ–k’n•û‰ï i98.06.13j, å‘ä.

940. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–Ž{Ý‚É‚¨‚¯‚éGFX stend‘}“ü—á; SAT (Sub-Awte-Thrombosis)Ç—á‚ÌŒŸ“¢. “n•Ó—Ti’|“c‘‡•a‰@jCˆ¢•”˜ji“àjCŒã“¡Œ«‰xC–ؖF‘¥C“à“¡’¼–ØC–ؖF’¼i’|“c‘‡•a‰@j: “ú–{ƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Šw‰ï“Œ–k’n•û‰ï i98.07.13j, ŒSŽR.

941. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒÃŠ¥“®–¬‚ÌPICAŽ¡—Ã’†‚ɶŽåŠ²“®–¬‚Ìspasm‚ð‚«‚½‚µ‚½‚PÇ—á. âã‘ñ˜Yi’|“c‘‡•a‰@jCˆ¢•”˜ji“àjCŒã“¡Œ«‰xC–ؖF’¼i’|“c‘‡•a‰@j: “ú–{ƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Šw‰ï“Œ–k’n•û‰ï i98.07.13j, ŒSŽR.

942. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é‰ß‹Ž‚T”NŠÔ‚ÌSŽ¾Š³‚É‚æ‚é—ˆ‰@ŽžS”x’âŽ~iDOA)‚Ì—Õ°“IŒŸ“¢. ‰º•lF˜YC‘º“cŽÀC‘DèrˆêC‘ –ìN‘¢i“àj: ˆï錧‹~‹}ˆãŠw‰ï i98.09.05j, ˆïé.

943. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œo”ç“IS”x•â•‘•’u(PCPS)ì“®‘OŒã‚ÌCoronary slow wire‚É‚¨‚¯‚銥“®–¬–Ê—¬‘¬‚ÌŒŸ“¢|‹}«S‹Ø‰Š‚É‚æ‚éSŒ´«ƒVƒ‡ƒbƒNÇ—á‚É‚Ä|. ‰F²dCi’|“c‘‡•a‰@jCˆ¢•”˜ji“àjCâã‘ñ˜YC“n•Ó—TCŒã“¡Œ«‘¥C–ؖF‘¥C“à“¡’¼–ØC–ؖF’¼i’|“c‘‡•a‰@j: ‘æ156‰ñ“ú–{“à‰ÈŠw‰ï“Œ–k’n•û‰ï i98.09.12j, ŽRŒ`.

944. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’vŽ€“ISŽº•p”‚Ì”­Ç‚ð’ÇÕ‚Å‚«‚½ƒAƒ‹ƒR[ƒ‹ˆË‘¶Ç‚Ì‚P—á. ‹´–{“ÄCù‰ª‘åŽjC’|‘ºmŽuCŽRŠÝ‚GC’·“c˜a”VC–k–ì‹`˜aC‚‹´ŠîC’ë–ìTˆêC•ìMŒåC˜aò“Oi“àj: “ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï‘æ169‰ñŠwpW‰ï i98.09.12j, ‘å‹{.

945. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j PCPS‰º‚É‚Ädirect PTCA‚ðŽ{s‚µ‹~–½‚µ“¾‚½‰EŠ¥“®–¬•ÂÇ‚ðŠÜ‚Þ‚RŽ}•a‰@. ˆ¢•”˜ji“àj: ‘æ‚R‰ñ“Œ–kSŒŒŠÇ“àƒGƒR[Œ¤‹†‰ï i99.02.06j, å‘ä.

946. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–Ž{Ý‚É‚¨‚¯‚éY stentpŽ{s—á; IVUS(ŒŒŠÇ“à’´‰¹”g)‚ð—p‚¢‚ÄŒŸ“¢‚·‚é. ˆ¢•”˜ji“àjCŒã“¡Œ«‰xCŠ™“c•q˜YC–ؖF‘¥C“à“¡’¼–ØC–ØG’¼i’|“c‘‡•a‰@j: ‘æ127‰ñ“ú–{zŠÂŠíŠw‰ï“Œ–k’n•û‰ï i99.02.13j, å‘ä.

947. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–Ž{Ý‚É‚¨‚¯‚éY stentpŽ{s—á‚ÌŒŸ“¢; Chroma-Flo‚ð—p‚¢‚Ä. ˆ¢•”˜ji“àjCŒã“¡Œ«‰xCç—t‘åC–ؖF‘¥C“à“¡’¼–ØC–ØG’¼i’|“c‘‡•a‰@j: ‘æ127‰ñ“ú–{zŠÂŠíŠw‰ï“Œ–k’n•û‰ï i99.02.13j, å‘ä.

948. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–Ž{Ý‚É‚¨‚¯‚éNir stentŽg—p—á‚Ì•ñ; IVUS(ŒŒŠÇ“à’´‰¹”g)‚ð—p‚¢‚Ä. ˆ¢•”˜ji“àjCŒã“¡Œ«‰xCŠ™“c•q˜YC–ؖF‘¥C“à“¡’¼–ØC–ØG’¼i’|“c‘‡•a‰@j: ‘æ127‰ñ“ú–{zŠÂŠíŠw‰ï“Œ–k’n•û‰ï i99.02.13j, å‘ä.

949. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘å“®–¬•ÙŠÔŒÌáŠQ‚ð’æ‚·‚é’öMechanical Alternans‚ð’˜–¾‚É”F‚ß‚½S•s‘S‚Ì‚PÇ—á. Š™“c•q˜Yi’|“c‘‡•a‰@jCˆ¢•”˜ji“àjCŒã“¡Œ«‰xC–ؖF‘¥C“à“¡’¼–ØC–ØG’¼i’|“c‘‡•a‰@j: ‘æ127‰ñ“ú–{zŠÂŠíŠw‰ï“Œ–k’n•û‰ï i99.02.13j, å‘ä.

950. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j TAE‚ÅŽ¡–ü‚µ‚½‹}«S‹Ø[Ç‚ÌŽ¡—ÃŒo‰ß’†‚É”F‚ß‚ç‚ꂽ‹‘åˆÝ•Ç“àŒŒŽî‚Ì‚P—á. ²–ì—zŽqi“àjC¡òOCÂŽR’¼‘PC¼ŽR¬‘¾˜YC‘ŠèrÆCŒ´‰pKC¼Šª”ŽC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ46‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i99.02.20j, ‰¡•l.

951. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Žq‹{‘B‹ØLJ•¹”DP‚Ì”DP‰Šú‚É”­Ç‚µ‚½‹}«”xŒŒðÇðÇ‚Ì‚P—á. Îì“NC‰¬Œ´“ÄCŒÜ\—’‰Ä•FC—ÑŽ”üC²X–Ø‹BC‹g“cNGC•½¼T‰EC´…_ˆÀiÀ’ÃŽs—§•a‰@j: ‘æ177‰ñ“ú–{“à‰ÈŠw‰ï“ŒŠC’n•û‰ï i99.02.20j, –¼ŒÃ‰®.

952. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’†ˆô“ªŠà“Eop‚¨‚æ‚Ñ•úŽËüŽ¡—ÃŒã‚Ì•p”­‚·‚éŒz“®–¬“´Ž¸_‚Éephedrine‚ª’˜Œø‚µ‚½‚P—á. ’Ì–ì•x‹PC´…Š®‰xCŽRŠÝ‚GC‘ºã˜aŽqC‘ºˆé’mdC–]ŒŽr’¼C•‘ò—˜˜YC•ìMŒåC˜aò“Oi“àj: ‘æ171‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i99.02.20j, “Œ‹ž.

953. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j í—p—ʈȉº‚Ì“Š—^—Ê‚ÅŠÌt‹@”\áŠQ‚ª‚È‚¢‚É‚à‚©‚©‚í‚炸ƒsƒ‹ƒƒm[ƒ‹’†“Å‚ð‚«‚½‚µ‚½‚QÇ—á. Š—“c‡ŽqCù‰ª‘åŽjC–k‘º—zŽqC“’–{‰ÀGCŒ´‰pKC‹g‘ò’¼lCXŒû¹•FC–k–ì‹`˜aC’––”FŒ³C’ë–ìTˆêC˜aò“Oi“àj: ‘æ171‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i99.02.20j, “Œ‹ž.

954. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j S‘Ÿ‚̖Ɖu‰ž“š‚ÉŠÖ‚·‚錤‹†. ˜aò“Oi“àj: ‘æ‚X‰ñS‘Ÿ•aƒtƒH[ƒ‰ƒ€ i98.08.06j, “Œ‹ž.

955. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘J‰„‚·‚éS‹Ø‰Š‚Æ“Á”­«S‹ØÇ‚ÉŠÖ‚·‚錤‹†. ˜aò“Oi“àj: •½¬10”N“x“Á’莾Š³‚ÉŠÖ‚·‚é”÷¶•¨Œ¤‹†”ljï‹c i98.07.03j, “Œ‹ž.

956. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒgS‹Ø‰Š‚É‚¨‚¯‚éS‘ŸŽ÷ó×–E‚ÉŠÖ‚·‚é–Ɖu‘gD“IŒ¤‹†. ‰¡ŽR_”VC‰Í–쌒C¼“cçŠGŽqCÂŽR’¼‘PC—é–ØŒ[‰îC˜aò“Oi“àjCŒK”ö’èmC‹T’J“Oi•a—jC“à“¡^iVŠƒ‘åj: Œú¶È“Á’莾Š³“Á”­«S‹ØÇ’²¸Œ¤‹†”Ç•½¬10”N“x‘æ‚P‰ñ”ljï‹c i98.09.04j, ‹ž“s.

957. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒgS‹Ø‰Š‚ÉoŒ»‚·‚éS‘ŸŽ÷ó×–E‚Ì–ðŠ„‚É‚Â‚¢‚Ä. ‰¡ŽR_”VC‰Í–쌒C¼“cçŠGŽqC—é–ØŒ[‰îCÂŽR’¼‘PC˜aò“Oi“àjCŒK”ö’èmi•a—j: ‘æ20‰ñS‹Ø¶ŒŸŒ¤‹†‰ï i98.10.24j, ·‰ª.

958. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j V‚µ‚¢S‹Ø•ÛŒì–ò(JTV-519)‚Ì–ò—ì—p‚ÌŒŸ“¢|ƒNƒ‚–Œ‰ºoŒŒŒãS•s‘S“®•¨ƒ‚ƒfƒ‹‚É‚æ‚錟“¢|. ì’[M–íC²“¡´‹MC‘“c‘ìC˜aò“Oi“àjC¼ŽRÄ‹vi—Õ•a—jCŽR–{aˆê˜Yi‹~–½j: ‘æ21‰ñS‹Ø‘ãŽÓŒ¤‹†‰ï i98.10.24j, “Œ‹ž.

959. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒgS‹Ø‰Š‚É‚¨‚¯‚éS‘ŸŽ÷ó×–E‚ÉŠÖ‚·‚é–Ɖu‘gD“IŒ¤‹†. ‰¡ŽR_”VC‰Í–쌒C¼“cçŠGŽqC—é–ØŒ[‰îCÂŽR’¼‘PC˜aò“Oi“àjCŒK”ö’èmC‹T’J“Oi•a—jC“à“¡áÁiVŠƒ‘åj: ‘æ21‰ñS‹Ø‘ãŽÓŒ¤‹†‰ï i98.10.25j, “Œ‹ž.

960. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “Á”­«S‹ØÇ‚Ì”­Ç‹@˜‚É‚¨‚¯‚é•aŒ´”÷¶•¨‚ÌŠÖ—^‚ÌŒ¤‹†. ˜aò“OC‰Í–쌒C’|’[‹ÏC¼“cçŠGŽqC‰¡ŽR_”VC—é–ØŒ[‰îC’––”FŒ³CÂŽR’¼‘Pi“àj: •½¬10”N“x“Á’莾Š³‚ÉŠÖ‚·‚é”÷¶•¨Œ¤‹†”ljï‹c i99.01.08j, “Œ‹ž.

961. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j S‘ŸŽ÷ó×–E: ƒ‰ƒbƒgS‹Ø‚ƃqƒgS‹Ø‚̈Ⴂ‚ɂ‚¢‚Ä. ‰¡ŽR_”Vi“àjCŒK”ö’èmi•a—jC¼“cçŠGŽqC’––”FŒ³C—é–ØŒ[‰îC‰Í–쌒CÂŽR’¼‘Pi“àjC‹T’J“Oi•a—jC˜aò“Oi“àj: Œú¶È“Á’莾Š³, “Á”­«S‹ØÇ’²¸Œ¤‹†”Ç•½¬10”N“x‘æ‚Q‰ñ”ljï‹c i99.01.22j, ‹ž“s.

962. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j SˆÚA‚ÌŒ»ó‚Æ“W–]. ˜aò“Oi“àj: ‘æ27‰ñŠò•ŒŒ§“à‰Èˆã‰ïu‰‰‰ï i98.04.05j, Šò•Œ‰H“‡.

963. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j S‹Ø‹•ŒŒ‚Ì–ò•¨—Ö@. ˜aò“Oi“àj: _“Þì•a‰@–òÜŽt‰ï–òŠwŒ¤C‰ï i98.06.13j, ‰¡•l.

964. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Ž©ŒÈ–Ɖu«S‹ØÇ. ˜aò“Oi“àj: ‘æ‚Q‰ñHIJCŒ¤‹†‰ï i99.02.13j, “Œ‹ž.

965. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j “Á”­«S‹ØÇ‚ÌŽ¡—Ãí—ª. ˜aò“Oi“àj: ‘æ15‰ñç—tzŠÂŠí’k˜b‰ï i98.06.26j, ç—t.

966. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j –«S•s‘S‚̒ljÁ—Ö@. ˜aò“Oi“àj: ‘æ1‰ñˆ¤“†zŠÂŠíŒ¤‹†‰ï i98.07.01j, “Œ‹ž.

967. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j –k—¢‘åŠw•a‰@zŠÂŠí“à‰È‚Å‚ÌŽ¡Œ±ƒR[ƒfƒBƒl[ƒ^[Šˆ“®•ñ. ˜aò“Oi“àj: ƒXƒ^ƒfƒBEƒR[ƒfƒBƒl[ƒ^[(SC)‚ÉŠÖ‚·‚錤‹†‰ï i98.07.10j, ‘åã.

968. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Ž©ŒÈ–Ɖu«S‹Ø‰Š. ˜aò“Oi“àj: •½¬10”N“x_ŒË‘åŠwˆãŠw•”‘åŠw‰@“Á•Êu‹` i98.09.03j, _ŒË.

969. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j S‹Ø‰Š‚Ì—Õ°. ˜aò“Oi“àj: ã“s‰êŒSŽsˆãŽt‰ïŠwpu‰‰‰ï i98.11.26j, Ž­À.

970. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j –«S•s‘S‚ð‚ß‚®‚éŋ߂̘b‘è. ˜aò“Oi“àj: ²“nˆãŽt‰ïŠwpu‰‰‰ï i98.12.04j, ²“n.

971. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j –«S•s‘S‚ð‚ß‚®‚éÅV‚̘b‘è. ˜aò“Oi“àj: ‘å˜azŠÂŠí•×‹­‰ï i99.02.22j, ‘å˜a.

972. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘Ò‹@’†‚ÌS‘ŸˆÚAŒó•âŽÒ‚ɂ‚¢‚Ä. ˜aò“Oi“àj: ¢S‘ŸˆÚA‚ð‚à‚Á‚Æ’m‚낤£Žs–¯ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€ i98.10.17j, –¼ŒÃ‰®.

973. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “®–¬ŠÇŠJ‘¶Ç‚Æf’f‚³‚ꂽ“Á”­«”x“®–¬Šg’£Ç‚Ì‚PÇ—á. Œã“¡Œ«‰xi’|“c‘‡•a‰@jCˆ¢•”˜ji“àjC–ؖF‘¥C“à“¡’¼–ØC–ؖF’¼i’|“c‘‡•a‰@j: •Ÿ“‡zŠÂŠí§˜b‰ï i98.06.10j, •Ÿ“‡.

974. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠoÁÜÃ’‚É‚æ‚èŽOë•Ù‚ÉŠ´õ«S“à–Œ‰Š‚ð’悵‚½‚P—á. ¼“cçŠGŽqC‘ºˆé’mdCÄ“¡~ŽqC²X–Ø‹BCXŒû¹•FC’·“c˜a”VC’¬“c—z“ñC˜aò“Oi“àjC¼ŽR¬‘¾˜YCÂŽR’¼‘PC‹g“cTC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC æÒ³Šîi‹¹ŠOj: ‘æ44‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï i98.09.19j, ‰¡•l.

975. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ž¡—â“ï‚Å‚ ‚Á‚½‰EŠ¥“®–¬•ÂÇ‚É‚æ‚é‹}«S‹Ø[Ç‚Ì‚PÇ—á. ˆ¢•”˜ji“àj: ‘æ‚X‰ñ•Ÿ“‡ƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ƒJƒ“ƒtƒ@ƒŒƒ“ƒX(CIC) i98.09.26j, ŒSŽR.

976. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹}«S‹Ø[ÇŽžŒŒð‘œ‚Ì•]‰¿; Chroma-Fla‚ð—p‚¢‚Ä. ˆ¢•”˜ji“àj: ‘æ‚R‰ñ“Œ–kSŒŒŠÇ“àƒGƒR[Œ¤‹†‰ï i99.02.06j, å‘ä.

977. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj zŠÂŠíŽ¾Š³‚É‚¨‚¯‚é‰î“üƒ|ƒCƒ“ƒg. ˜aò“Oi“àj: ‘æ269‰ñVŠƒ–ò‰È‘åŠwƒZƒ~ƒi[ i98.12.03j, VŠƒ.


<<1403 ?? >>

978. mŒ´’˜n Diaphragm function during sighs in awake dogs after laparotomy. •Ð‹Ë“ú²ŽqC•Ð‹Ë^li“àjCKieser, Teresa M.CEaston, Paul A.: Am. J. Respir. Crit. Care Med., 157: 1085`1092, 1998.

979. mŒ´’˜n Regional differences in the distribution of gastrin-, somatostatin-, and serotonin-Immunoreactive basal granulated cells in the rat stomach. ŒÜ–ì—R‰À—Câˆä•¶•Fi“àj: Biomed. Res., 19(2): 101`109, 1998.

980. mŒ´’˜n Topographical distribution of neuropeptide-containing nerve fibers in the rat stomach: A quantitative analysis using antibodies against protein gene product 9.5 and gastric mucins. ŒÜ–ì—R‰À—¢i“àjCŽs쑸•¶C–x“c‹±Žqi¶‰»jC’|’†•q•¶i‰¡•lŽs‘åjCâˆä•¶•Fi“àjC“ú‰º•”’CŽOi‰¡•lŽs‘åj: Biomed. Res., 19(6): 357`368, 1998.

981. mŒ´’˜n Assessing new migraine therapies in Japan. âˆä•¶•FC“y‹´‚©‚¨‚èCŒÜ\—’‹v‰Ài“àj: Cephalalgia, (Suppl.23): 9`14, 1999.

982. mŒ´’˜n Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Ashina, M.CBendtsen, L.CJensen, R.Câˆä•¶•Fi“àj: International Association for the Study of Pain, 79: 201`205, 1999.

983. mŒ´’˜n Prediction of locomotion function a one month after stroke. Matsunaga, A.CKurokawa, Y.C_“c’¼Câˆä•¶•Fi“àj: J. Phys. Ther. Sci., 9: 93`97, 1998.

984. mŒ´’˜n Assessing new migraine therapies in Japan Cephalalgia. âˆä•¶•FC“y‹´‚©‚¨‚èCŒÜ\—’‹v‰Ài“àj: J. Phys. Ther. Sci., 9: 93`97, 1998.

985. mŒ´’˜n Kinesin and cytoplasmic dynein in spinal spheroids with motor neuron disease. Toyoshima, I.CSugawara, M.CKato, K.C˜a“c’m‰vCL“c˜a‰iC’·’JìˆêŽqCŒÃ˜a‹vKi“àjCMasamune, O.: JNS, 159: 38`44, 1998.

986. mŒ´’˜n Worsening of hypoxemia with nitric oxide inhalation during bronchospasm in humans. ‚‹´ˆ¤“TC¬—ÑO—SC“c’†’¼•FC–{‘½Œ¤–çi“àjCìã—Ïi¶—jC•y“c—FKi“àj: Respir. Physiol., 112: 113`119, 1998.

987. mŒ´’˜n Use of rat adjuvant-induced arthritis as a model for rheumatoid arthritis gene therapy. Koch, A.E.CKurata, H.C•äâ–Îi“àjCHalloran, M.M.CArai, K.I.: Transgenics, 2: 299`309, 1998.

988. mŒ´’˜n ‹z‹Cˆ³”­¶Žž‚̃qƒgŒz•”‹z‹C•â•‹ØŒQ‚Ì“d‹C“IŠˆ“®. ‰¡ê³“TCˆ¢•”’¼CŽR“c‘ñŽÀC“y‹´‚ä‚©‚èC•Ð‹Ë^lC•y“c—FKi“àj: “ú–{ŒÄ‹zŠíŠw‰ïŽGŽ, 37(2): 102, 1999.

989. mŒ´’˜n Clinical features and antinuclear antibodies including anti-centromere and anti-RNP antibodies in idiopathic Raynaud's syndrome. ‹ß“¡Œ[•¶C“c’†Z–¾C‚‹´“¹—Yi“àj: –k—¢ˆãŠw, 28: 479`483, 1998.

990. mŒ´’˜n SŒ´«”]ÇðÇ‹}«Šú‚É‚¨‚¯‚éPLEDs‚Ì—Õ°“IˆÓ‹`. ”уP’J”ü•ôC”Ñ’Ë‚_i“àjC‹g–{gŽqi—ÕŒŸjCâˆä•¶•Fi“àj: —Õ°”]”g, 41(1): 23`30, 1999.

991. m€Œ´’˜n ¬ldÇ‹}«ŒÄ‹z•s‘SÇ—á‚É‚¨‚¯‚é“–‰@‚ł̈êŽ_‰»’‚‘f‹z“ü—Ö@‚ÌŒ»ó. ŽO“¡‹vC¬—ÑO—SC‚‹´—TŽqC‚‹´ˆ¤“TC“c’†’¼•Fi“àjC‘Š”nˆêˆåi‹~–½jC•y“c—FKi“àj: Therapeutic Research, 19(4): 57`61, 1998.

992. m€Œ´’˜n ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€‚P; “à‰Èˆã‚à”畆•a•Ï‚ðf‚Ä‚¢‚é. ‹ß“¡Œ[•¶i“àj: “ú–{”畆‰ÈŠw‰ï‰ïŽ, 108: 1623`1624. 1998.

993. mŒ¤‹†•ñiŒú¶Èjn _“Þ쌧2Ž{Ý‚É‚¨‚¯‚éALS—×{‚ÌŒ»ó. ’·’JìˆêŽqCŠÛ–ì’mŽqC—À³•£Cf‘ò’BŽuCŒÃ‹´‹I‹vi“àjC•ŸŽR‰Ãji‘‡‘Š’k•”jCŒ˘aŽqi“àjCŠÝ—ÑC‘ºãŒc˜Y: Œú¶È“Á’莾Š³ALSŠ³ŽÒ‚Ȃǂ̗×{ŠÂ‹«®”õ‚ÉŠÖ‚·‚錤‹†”Ç•½¬9”N“xŒ¤‹†•ñ‘, p.111`115, 1998.

994. mŒ¤‹†•ñiŒú¶Èjn ŠÖ“Œ¥b‰z’n‹æ‚É‚¨‚¯‚éƒXƒ‚ƒ“Š³ŽÒ‚ÌŒŸf|‘æ10•ñ|. ç“cŒõˆêCˆÀ“¡“¿•FC‰ª–{KŽsC‰ªŽRŒ’ŽŸCŒKŒ´••vC‰–àV‘SŽiC¯ŽiiˆêCç–ì’¼ˆêC’†]Œö—TC’†£_ŽjC’·’JìˆêŽqi“àjC•ž•”F“¹C‰Ô˜U—LjêCœA£˜a •FC’·‰ª³”ÍC‚{r–¾CŽu•û‚¦‚肳: Œú¶È“Á’莾Š³ƒXƒ‚ƒ“’²¸•ª‰È‰ï1997”N“xŒ¤‹†•ñ‘, p.30`36, 1998.

995. mŒ¤‹†•ñiŒú¶Èjn _“Þ쌧‚̃Xƒ‚ƒ“ŒŸf‚ðŽóf‚µ‚½Š³ŽÒ‚ÌADL, Šˆ“®”\—Í, –ž‘«“x‚ÉŠÖ‚·‚錤‹†. ˆÀ“¡“¿•FC’·’JìˆêŽqi“àj: Œú¶È“Á’莾Š³ƒXƒ‚ƒ“’²¸•ª‰È‰ï1997”N“xŒ¤‹†•ñ‘, p.78`79, 1998.

996. mŒ¤‹†•ñiŒú¶Èjn ¬”]”玿ˆÞkÇ‚ÌŠá‹…‰^“®‚ÉŠÖ‚·‚錤‹†. “í~ˆêC’·’JìˆêŽqC—À³•£CŽO•x“N˜YCâˆä•¶•Fi“àjC–ö‰ºŽO˜Yi•a—j: Œú¶È“Á’莾Š³‰^“®Ž¸’²Ç’²¸Œ¤‹†•ª‰È‰ï•½¬9”N“xŒ¤‹†•ñ‘, p.23`25, 1998.

997. mŒ¤‹†•ñiŒú¶Èjn ‘åÀ’n‹æ‚É‚¨‚¯‚é‰Æ‘°«Parkinsonism‚Ì5p15.3—̈æ‚̃nƒvƒƒ^ƒCƒv‰ðÍ. ŒÃ‘ò‰p–¾C—À³•£C’·’JìˆêŽqCâˆä•¶•Fi“àj: Œú¶È“Á’莾Š³_Œo•Ï«Ž¾Š³’²¸•ª‰È‰ï1997”N“xŒ¤‹†•ñ‘, p.97`99, 1998.

998. mŒ¤‹†•ñiŒú¶Èjn _ŒoŽ¾Š³Š³ŽÒ‚ÌS—|‹ØˆÞk«‘¤õd‰»ÇŠ³ŽÒ‚ð’†S‚É|. ’·’JìˆêŽqC—À³•£Câˆä•¶•Fi“àjC•ŸŽR‰Ãji‘‡‘Š’k•”jC––‹g”ü‰ÀCŒÃ‹´‹I‹vi“àj: Œú¶È“Á’莾Š³_Œo•Ï«Ž¾Š³’²¸•ª‰È‰ï1997”N“xŒ¤‹†•ñ‘, p.62`64, 1998.

999. mŒ¤‹†•ñiŒú¶Èjn MCTD‚Ì—Õ°Œo‰ß‚ɂ‚¢‚ẴvƒƒWƒFƒNƒgŒ¤‹†|MCTD‚Æ‘¼‚ÌäPŒ´•a‚Æ‚Ì”äŠr. ‹ß“¡Œ[•¶C‰ª“cƒC“ŒžŠ‹Bi“àj: Œú¶È“Á’莾Š³”畆Œ‹‡‘gDŽ¾Š³’²¸Œ¤‹†”Ç, ¬‡«Œ‹‡‘gD•a•ª‰È‰ï•½¬9”N“xŒ¤‹†•ñ‘, p.8`10, 1998.

1000. mŒ¤‹†•ñiŒú¶Èjn –³‹Û«‘–Œ‰Š‚ÆRU1-RNPR‘Ì. ‹ß“¡Œ[•¶C‰ª“cƒC•l–¼r–çi“àj: Œú¶È“Á’莾Š³”畆Œ‹‡‘gDŽ¾Š³’²¸Œ¤‹†”Ç, ¬‡«Œ‹‡‘gD•a•ª‰È‰ï•½¬9”N“xŒ¤‹†•ñ‘, p.46`49, 1998.

1001. mŒ¤‹†•ñiŒú¶Èjn ‚w˜A½—D«Charcot-Marie-Tooth•a(CMTX1)‚Ì1‰ÆŒn‚É‚¨‚¯‚é—Õ°, •ªŽqˆâ“`Šw“IŒŸ“¢. Ä“¡–L˜aCf‘ò’BŽui“àjC‹àŽqmi‘‡‘¾“c•a‰@jC—R‘ºŒ’•vi‹ã‘åjCŽR–{’C‹IC‘å¼W¶iŽY‹Æˆã‘åj: ¸_¥_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ï, ˆâ“`Žq«ƒjƒ…[ƒƒpƒ`[‚̬ˆö‚¨‚æ‚ÑŽ¡—ÂɊւ·‚錤‹†•½¬10”N“xŒ¤‹†•ñ‘, p.30, 1999.

1002. mÇ—á•ñn Significance of facial and trigeminal nerve involvement in Charcot-Marie tooth disease type 1A. ˆÉ“¡”Ž–¾C’ÒrˆêCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: Muscle Nerve, p.1108`1110, 1998.

1003. mÇ—á•ñn “øʉŠ‚ƌ㕠–ŒüˆÛǂ𔺂Á‚½seronegative spondylorthropathy‚Ì‚PÇ—á. ‚‹´“¹—YCÎìÍC‹ß“¡Œ[•¶i“àj: ƒŠƒEƒ}ƒ`, 39: 17`21, 1999.

1004. mÇ—á•ñn ‹CŠÇŽx“®–¬– óŒŒŠÇŽî‚Ì2—á. “y‹´‚ä‚©‚èC•Ð‹Ë^lC‚“cM˜ai“àjC•i“cƒi‹¹ŠOjC–î“ߣM—Yi“àjC‘Š”nˆêˆåi‹~–½jC‹g‘º”Ž–Mi‹¹ŠOjC•y“c—FKi“àj: ‹CŠÇŽxŠw, 21(1): 16`21, 1999.

1005. mÇ—á•ñn •àsŽn“®ŠJŽn•s‘SÇŒóŒQ. Ä“¡–L˜ai“àj: _Œo“à‰È, 49(Suppl.1): 224`225, 1998.

1006. m‘àn Migraine with advancing age. âˆä•¶•Fi“àj: Cephalaligia, (Suppl.18): 171`173, 1998.

1007. m‘àn Œ´’˜‚ð’T‚é; Bell–ƒáƒ. ’·’JìˆêŽqi“àj: Clin. Neurosci., 16: 1090`1091, 1998.

1008. m‘àn …•½ŠáU‚Æ‚’¼ŠáU. ’·’JìˆêŽqi“àj: Clin. Neurosci., 16: 34`37, 1998.

1009. m‘àn NO_Œo‚Æ”]ŒŒŠÇ•½ŠŠ‹Ø. ´…—˜•Fi…ŒËÔ\Žš•a‰@jC—é–Ø‘¥Gi“àj: Clin. Neurosci., 16: 768`771, 1998.

1010. m‘àn ALS‚̉h—{ŠÇ—. ’·’JìˆêŽqi“àj: Clin. Neurosci., 16: 932`934, 1998.

1011. m‘àn Thyrotropin releasing hormone (TRH). ’·’JìˆêŽqi“àj: Clin. Neurosci., 17: 92, 1999.

1012. m‘àn i•à‚µ‚½Ž¡—Ö@‚Æ‚»‚Ì—Õ°‚ւ̉ž—p|Šˆ“®«‚Ì•]‰¿‚ÆŽ¡—ÃŒø‰Ê‘ª’è. Ô¯“§i“àj: Medical Practice, 15(2): 2127`2129, 1998.

1013. m‘àn RA‚Ì–òŒøŒŸ¸. ‹ß“¡Œ[•¶i“àj: RA & ƒZƒ‰ƒs[, 5: 42`49, 1999.

1014. m‘àn “ª’É‚Ì•ª—ނƉuŠw. âˆä•¶•Fi“àj: ‚©‚炾‚̉Ȋw, (203): 21`24, 1998.

1015. m‘àn “ª’É‚ÌŽí—Þ‚ÆÇó. âˆä•¶•Fi“àj: ƒuƒŒƒCƒ“ƒi[ƒVƒ“ƒO, 15(2): 10`13, 1999.

1016. m‘àn Ž©ŒÈ–ƉuŽ¾Š³‚ƃAƒ|ƒg[ƒVƒX. ‰ª“cƒi“àj: ƒŠƒEƒ}ƒ`‰È, 19: 489`495, 1998.

1017. m‘àn RScl-70R‘Ì. ‹ß“¡Œ[•¶C•l–¼r–çi“àj: ƒŠƒEƒ}ƒ`‰È, 20: 236`241, 1998.

1018. m‘àn Žå—vÇó‚©‚ç‚Ý‚½ƒŠƒEƒ}ƒ`«Ž¾Š³‚Ìf’f|‹Ø“÷’É. ‰ª“cƒi“àj: ƒŠƒEƒ}ƒ`‰È, 20: 8`13, 1998.

1019. m‘àn RA‚Ì‘Šú‘Îô|f’f¥Ž¡—Ã|“ú–{ƒŠƒEƒ}ƒ`Šw‰ïŠî€‚ɂ‚¢‚Ä. ‹ß“¡Œ[•¶C“c’†Z–¾i“àj: ƒŠƒEƒ}ƒ`‰È, 21: 117`121, 1998.

1020. m‘àn ‹­”çÇ‚Ì•aŒ^•ª—Þ. ‰ª“cƒi“àj: ƒŠƒEƒ}ƒ`‰È, 21: 197`203, 1998.

1021. m‘àn —D«ˆâ“`«ParkinsonÇŒóŒQ. ’·’JìˆêŽqi“àj: ˆãŠw‚Ì‚ ‚ä‚Ý, 186: 99`102, 1998.

1022. m‘àn ŠÖ߉Š‚ƃPƒ‚ƒJƒCƒ“. Ô¯“§i“àj: ŒŒ‰t¥–Ɖu¥Žîá‡, 3(2): 46`50, 1998.

1023. m‘àn ŒQ”­“ª’É. âˆä•¶•Fi“àj: ŒŽŠ§_Œo‰ÈŠw, 16(5): 106, 1998.

1024. m‘àn ƒPƒ‚ƒJƒCƒ“‚ÆŠÖ߉Š. Ô¯“§i“àj: ÅVˆãŠw, 53(4): 84`89, 1998.

1025. m‘àn Ž©ŒÈ–ƉuŽ¾Š³‚Ì—Õ°1998|R‚s×–ER‘Ì–@. ‰ª“cƒC‹ß“¡Œ[•¶i“àj: ÅVˆãŠw, 53: 259`266, 1998.

1026. m‘àn “ª’É‚ÌŠÓ•Ê‚Ìi‚ß•û‚ÆŽ¡—Ã, _ŒoŽ¾Š³‚Ìf—Ã¥Ž¡—Ã. ŒÜ\—’‹v‰ÀCâˆä•¶•Fi“àj: _ŒoŽ¾Š³‚Ìf—Ã, 15(5): 797`800, 1998.

1027. m‘àn ”畆Çó‚É‚æ‚èf’f‚µ“¾‚½Histiocytosis ‡]—á. ’·’JìˆêŽqC—À³•£i“àjC–ö‰ºŽO˜YC–{‹§i•a—j: _Œo“à‰È, 49(Suppl.1): 212`213, 1998.

1028. m‘àn Chiasmal syndrome. ’·’JìˆêŽqi“àj: f’f‚ÆŽ¡—Ã, 86(suppl.): 33, 1998.

1029. m‘àn ŠëŒ¯‚È‚ß‚Ü‚¢‚Ɗ댯‚Å‚È‚¢‚ß‚Ü‚¢‚ÌŠÓ•Ê. ’·’JìˆêŽqi“àj: f’f‚ÆŽ¡—Ã, 86: 1169`1174, 1998.

1030. m‘àn L-DOPA‚ª–³Œø‚ÈŠ³ŽÒ. ’·’JìˆêŽqi“àj: ‘‡ˆãŠwŽÐ, 7: 67`70, 1998.

1031. m‘àn ‹­”çÇ. ‹ß“¡Œ[•¶C‰““¡•½mi“àj: “à‰È, 83: 66`68, 1999.

1032. m‘àn •Ð“ª’ɂƃjƒ…[ƒƒgƒ‰ƒ“ƒXƒ~ƒbƒ^[. —é–Ø‘¥Gi“àj: “ú–{“à‰ÈŠw‰ïŽGŽ, 87(2): 365`372, 1998.

1033. m‘àn Rƒgƒ|ƒCƒ\ƒƒ‰[ƒ[‚PR‘Ì¥RƒZƒ“ƒgƒƒƒAR‘Ì. ‹ß“¡Œ[•¶i“àj: “ú–{“à‰ÈŠw‰ïŽGŽ, 87: 2409`2413, 1998.

1034. m‘àn äPŒ´•a‚É‚¨‚¯‚é–Ɖu—}§–ò. ‰ª“cƒC‹ß“¡Œ[•¶i“àj: “ú–{—Õ°, 57: 432`438, 1999.

1035. m‘àn “ÁW; ARDS, ARDS‚ÌŽ¡—Ã(4)NO‹z“ü—Ö@‚Ì“K‰ž‚Ì¥”ñ‚ɂ‚¢‚Ä. ŽO“¡‹vC‚‹´ˆ¤“TC¬—ÑO—Si“àj: —Õ°‰ÈŠw, 34(6): 756`764, 1998.

1036. m‘àn “ª’É‚Ì•a‘Ô‚Æf—ÂÌi•à. …‘ò‰p—mCŠâ“c½Câˆä•¶•Fi“àjCì“cŠw: —Õ°ŽGŽu“à‰Èv, 81(4): 715`728, 1998.

1037. m‘àn is«Šjã–ƒáƒ(protressive supranuclear palsy: PSP). ’·’JìˆêŽqi“àj: —Õ°_Œo, 37: 1128`1130, 1997.

1038. m‘àn –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚éD’†‹…ƒAƒ|ƒg[ƒVƒX. Ô¯“§i“àj: —Õ°–Ɖu, 30(12): 1620`1623, 1998.

1039. m‘àn CX3Cƒ‚ƒ`[ƒt‚ð—L‚·‚éV‚½‚È–ŒŒ‹‡Œ^ƒPƒ‚ƒJƒCƒ“. •äâ–ÎC“c’†Z–¾i“àj: —Õ°–Ɖu, 30(4): 521`525, 1998.

1040. m‘àn RƒPƒ‚ƒJƒCƒ“—Ö@‚É‚æ‚鉊Ǘ}§. Ô¯“§i“àj: —Õ°–Ɖu, 30(9): 1194`1198, 1998.

1041. muÀn Œûo¥Š{ŠÖߎ¡—Â̂½‚ß‚Ì“à‰È“I—Ö@‚Ì‚·‚·‚ß 6.’†•«‹Ø’oŠÉ–ò. ¡ˆä¸i“àj: the Quintessence, 17(11): 1960`1962, 1998.

1042. muÀn Œûo¥Š{ŠÖߎ¡—Â̂½‚ß‚Ì“à‰È“I—Ö@‚Ì‚·‚·‚ß 3.”ñƒXƒeƒƒCƒhR‰ŠÇ–ò NSAIDs(2). ¡ˆä¸i“àj: the Quintessence, 17(5): 816`818, 1998.

1043. muÀn Œûo¥Š{ŠÖߎ¡—Â̂½‚ß‚Ì“à‰È“I—Ö@‚Ì‚·‚·‚ß 4.R•sˆÀ–òƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn. ¡ˆä¸i“àj: the Quintessence, 17(7): 1254`1256, 1998.

1044. muÀn Œûo¥Š{ŠÖߎ¡—Â̂½‚ß‚Ì“à‰È“I—Ö@‚Ì‚·‚·‚ß 5.R•sˆÀ–òƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn(2). ¡ˆä¸i“àj: the Quintessence, 17(9): 1550`1552, 1998.

1045. muÀn Œûo¥Š{ŠÖߎ¡—Â̂½‚ß‚Ì“à‰È“I—Ö@‚Ì‚·‚·‚ß 7.R‚¤‚–ò. ¡ˆä¸i“àj: the Quintessence, 18(1): 119`121, 1999.

1046. muÀn Œûo¥Š{ŠÖߎ¡—Â̂½‚ß‚Ì“à‰È“I—Ö@‚Ì‚·‚·‚ß 8.ŽO³_Œo’É‚Ì–ò•¨—Ö@. ¡ˆä¸i“àj: the Quintessence, 18(3): 603`607, 1999.

1047. muÀn “ª’É‚ð–h‚®‚½‚ß‚É. âˆä•¶•Fi“àj: ‚ ‚È‚½‚ðŽç‚錒Nƒtƒ@ƒCƒ‹, 1998.

1048. muÀn •Ð“ª’É‚Ì–ò•¨Ž¡—Âð‚ß‚®‚Á‚Ä. âˆä•¶•Fi“àj: ƒZƒ‰ƒsƒ…[ƒeƒbƒN¥ƒŠƒT[ƒ`, 19(7): 27`37, 1998.

1049. muÀn ƒ^ƒCƒv‚É‚æ‚Á‚ĈقȂé, ‚‚炢–«“ª’É‚ÌÅVŽ¡—Ö@. âˆä•¶•Fi“àj: ƒ‰¥ƒZ[ƒk, 7: 295`301, 1998.

1050. muÀn (À’k‰ï)Œyǃp[ƒLƒ“ƒ\ƒ“•a‚Ì–ò•¨—Ö@‚ð„‚Á‚Ä. ’·’JìˆêŽqi“àjC‘º“c”ü•äC•ž•”—DŽqC‹ß“¡’q‘P: ˆãŠw‚Ì‚ ‚ä‚Ý, 1998.

1051. muÀn ‘ŠúRA‚Ìf’f‚ÆŽ¡—Ã(1). ‹ß“¡Œ[•¶C¥“´Œ\Žqi“àj: ‰ŠÇ‚ƖƉu, 7: 190`194, 1999.

1052. muÀn ‹¹Šs¥ŒÄ‹z‹Ø. ‰¡ê³“TCˆ¢•”’¼i“àj: ŒÄ‹z, 18(3): 271`278, 1999.

1053. muÀn ”ñƒXƒeƒƒCƒh«R‰ŠÇ–ò‚Ì•ª—Þ‚Æ“Á’¥. ‹ß“¡Œ[•¶i“àj: Ž¡—Öò, 4: 21`24, 1999.

1054. muÀn (À’k‰ï)ƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—Â̎ÀÛ. ‹ß“¡’q‘PC’·’JìˆêŽqi“àjCŽRª´”üCA–ز: f’f‚ÆŽ¡—Ã, 1999.

1055. muÀn Common cold syndrome (‚©‚ºÇŒóŒQ). ò–õOC‹v•Û“cŸCˆ¢•”’¼i“àj: f’f‚ÆŽ¡—Ã, ÇŒóŒQŽ–“T, 86(‘Š§): 304, 1998.

1056. muÀn CO2 narcosis (”x«”]Ç). ‹v•Û“cŸCˆ¢•”’¼i“àj: f’f‚ÆŽ¡—Ã, ÇŒóŒQŽ–“T, 86(‘Š§): 305, 1998.

1057. muÀn ”x‹@”\Œv‘ª‘•’u¥Ž_‘fƒ{ƒ“ƒx. –î“ߣM—Yi“àjC‹g‘º”Ž–Mi‹¹ŠOj: ‘Ž‡—Õ°, 47(11): 2904`2906, 1998.

1058. muÀn (À’k‰ï)“ª’É‚Ì•a‘Ô‚Æf’f‚Ìi•à. âˆä•¶•Fi“àj: “à‰È, 81(4): 715`728, 1998.

1059. muÀn (À’k‰ï)ê–åˆã‚É‚«‚­ƒp[ƒLƒ“ƒ\ƒ“•a|f—Â̊î–{“IƒXƒgƒ‰ƒeƒW[‚Æ’ˆÓ‚·‚ׂ«ƒ|ƒCƒ“ƒg. “íiC’†–ì¡Ž¡C’·’JìˆêŽqi“àjC‘–{‰ë–ç: “à‰È, 83: 513`524, 1999.

1060. muÀn ‹C“¹’ïR‚ƌċz’ïR‘ª’è. ˆ¢•”’¼i“àj: “ú–{ˆãŽt‰ïŽGŽ, 120(8): 44`46, 1998.

1061. muÀn •Ð“ª’É; —«‚̈ãŠwÅ‘Oü. âˆä•¶•Fi“àj: •wlŒö˜_, (1020): 158`160, 1998.

1062. muÀn (À’k‰ï)_ŒoÇŒóŠw‚Ì‚ ‚è‚©‚½. Šâ“c½C’ÒÈŽ¡Câˆä•¶•Fi“àjCˆä㹌[: —Õ°ˆã, 24(10): 94`107, 1998.

1063. muÀn Ç—á‚ÉŠw‚Ô; ‰t‘ÌNSAID‚É‚æ‚è—U”­‚³‚ꂽšb‘§. ¡è‹M¶C–{‘½Œ¤–çC“c’†’¼•Fi“àj: šb‘§, 11(2): 85`88, 1998.

1064. mŠwp‘n i•ª’SŽ·•Mj ÅV“à‰ÈŠw‘åŒn|––½¥Ž©—¥_ŒoŽ¾Š³; Refsum•a, 70: 75`81, Ä“¡–L˜ai“àj. •ÒW ˆä‘º—T•vi‹ž‘åjC”öŒ`‰x˜YiŠàŒ¤jC‚‹vŽj–›iŽ©Ž¡ˆã‘åjC‚ˆä´ˆê˜Yi‘åŽè‘O•a‰@jC•ÒC ’†ŽR‘“X, “Œ‹žC99.00.00”­s.

1065. mŠwp‘n i•ª’SŽ·•Mj —Õ°¸_ˆãŠwuÀ14¸_‰È–ò•¨—Ö@; RParkinson•a–ò, 14: 397`407, Ä“¡–L˜ai“àj. •ÒW ¼‰º³–¾i“s¸_Œ¤jC•ÒC ’†ŽR‘“X, “Œ‹žC99.03.30”­s.

1066. mŠwp‘n i•ª’SŽ·•Mj Annual Review_Œo; •Ð“ª’ÉŽ¡—Öò‚Ìi•à; ‹@”\«Ž¾Š³, p.367`370, âˆä•¶•Fi“àj. ’†ŠOˆãŠwŽÐ, 99.00.00”­s.

1067. mŠwp‘n i•ª’SŽ·•Mj —Õ°ŒŸ¸–@’ñ—v; ‘æ19Í‹CŠÇŽx¥ŠÌ‹@”\ŒŸ¸‡U”x‹@”\ŒŸ¸|11.ŒÄ‹z’²ß‚ÉŠÖ‚·‚錟¸, 12.ŒÄ‹z¢“ï‚Ì•]‰¿, 13.ŒÄ‹z‹Ø‹@”\‚ÌŒŸ¸, 14. ‡–°ŽžŒÄ‹záŠQ‚ÌŒŸ¸, p.1769`1778, •Ð‹Ë^li“àj. •ÒW ‹àˆä³ŒõC ‹àŒ´o”Å, “Œ‹ž, 98.09.20”­s.

1068. mŠwp‘n i•ª’SŽ·•Mj •ÊûˆãŠw‚Ì‚ ‚ä‚Ý|ŒÄ‹zŠíŽ¾Š³State of Arts, Ver.3; NO‹z“ü—Ö@, p.248`252, ¬—ÑO—SC¡è‹M¶i“àj. •ÒW –k‘º—@iŽ©Ž¡ˆã‘åjC ˆãŽ•–òo”Å, “Œ‹ž, 99.03.25”­s.

1069. mŠwp‘n i•ª’SŽ·•Mj ƒ‚ƒTƒvƒŠƒh‚ÆÁ‰»ŠÇ‰^“®New 5-HT4Žó—e‘̃AƒSƒjƒXƒg; ‹­”çÇ‚É”º‚¤Á‰»ŠíÇó‚Ìf’f‚Æ•]‰¿, p.136`139, ‹ß“¡Œ[•¶i“àj. •ÒW ŽO—Ö„CŒ´‘ò–ÎC•ÒC ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, 98.00.00”­s.

1070. mŠwp‘n i•ª’SŽ·•Mj •ÊûŽ¡—Öò|”ñƒXƒeƒƒCƒh«R‰ŠÇ–ò‚Ìô‘ó‚Æ“K³Žg—p; ”ñƒXƒeƒƒCƒh«R‰ŠÇ–ò‚Ì’m‚Á‚Ä‚¨‚­‚ׂ«–ò•¨‘ŠŒÝì—p, p.65`69, ‹ß“¡Œ[•¶i“àj. •ÒW Ž¡—Öò•ÒWˆÏˆõ‰ïC•ÒC “ú–{ˆãŠwo”Å, 99.00.00”­s.

1071. mŠwp‘n i•ª’SŽ·•Mj Ž¡—ÖòƒKƒCƒh1999-2000; ”ñƒXƒeƒƒCƒhR‰ŠÇÜ, p.831`836, ‹ß“¡Œ[•¶i“àj. •ÒW Medical Practice•ÒWˆÏˆõ‰ïC•ÒC •ªŒõ“°, “Œ‹ž, 99.00.00”­s.

1072. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj 1999¡“ú‚ÌŽ¡—ÃŽwj; ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX, p.614`615, ‹ß“¡Œ[•¶i“àj. •ÒW ‘½‰ê{K’jC”öŒ`‰x’jC•ÒC ˆãŠw‘‰@, 99.01.00”­s.

1073. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj 1999¡“ú‚ÌŽ¡—ÃŽwj; ¬lƒXƒ`ƒ‹•a, p.627`628, ‰ª“cƒi“àj. •ÒW ‘½‰ê{K’jC”öŒ`‰x’jC•ÒC ˆãŠw‘‰@, 99.01.00”­s.

1074. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj 1998¡“ú‚ÌŽ¡—ÃŽwj; ¬‡«Œ‹‡‘gD•a, p.606`607, ‰ª“cƒi“àj. •ÒW ‘½‰ê{K’jC”öŒ`‰x’jC•ÒC ˆãŠw‘‰@, 98.01.00”­s.

1075. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ƒNƒŠƒjƒJƒ‹ƒXƒ^ƒfƒBƒuƒbƒN‚R; ƒi[ƒVƒ“ƒOƒvƒƒZƒX@¬l¥˜V”NŠÅŒìE‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚ÌŠÅŒì, –Ɖu‚Ì‚µ‚­‚Ý, p.220`223, ‰ª“cƒCƒ‰ƒi”ü‘ãŽqi“àj. ƒƒfƒBƒJƒ‹ƒtƒŒƒ“ƒhŽÐ, 98.01.00”­s.

1076. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ƒNƒŠƒjƒJƒ‹ƒXƒ^ƒfƒBƒuƒbƒN‚R; ƒi[ƒVƒ“ƒOƒvƒƒZƒX@¬l¥˜V”NŠÅŒìE‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚É•a‘Ô®—, f’f, Ž¡—Ã, p.224`231, ‰ª“cƒCƒ‰ƒi”ü‘ãŽqi“àj. ƒƒfƒBƒJƒ‹ƒtƒŒƒ“ƒhŽÐ, 98.06.00”­s.

1077. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj Year Note; ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg 1999; ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX, p.181`185, ‰ª“cƒi“àj. Medic MIDA, 98.06.00”­s.

1078. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj Year Note; Selected Articles 1999; ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX|f’f‚ÆŽ¡—Ã, p.757`764, ‰ª“cƒi“àj. Medic MIDA, 98.06.00”­s.

1079. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj •S‰È‰Æ’ë‚̈ãŠw; –«“ª’É, p.300`301, âˆä•¶•Fi“àj. Žå•w‚ƶŠˆŽÐ, 99.00.00”­s.

1080. m‚»‚Ì‘¼n i•ª’SŽ·•Mj “à‰Èê–åˆã‰ïŽ; Žã“¢˜_(Ç—á’ñŽ¦ŽÒ‚©‚ç‚̉ð“š), 9: 530`531, –{ŠÔ˜a•vi“àj. •ÒW ”F’è“à‰Èê–åˆã‰ïC ”F’è“à‰Èê–åˆã‰ï, “Œ‹ž, 97.11.00”­s.

1081. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Three livodopa non-responsive Parkinsonism patients with peculiar gaits. ’·’JìˆêŽqC—À³•£C“í~ˆêCŒÃ˜a‹vKi“àj: ‘æ‚T‰ñ‘Û‰^“®áŠQ-ƒp[ƒLƒ“ƒ\ƒ“•aƒVƒ“ƒ|ƒWƒEƒ€ i98.00.00j.

1082. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Gas exchange in biological counter-current systems. ¬—ÑO—Si“àjC‘ê‘ò’¼’èi‹³—{j: 3rd World Congress of Biomechanics i98.08.05j, ŽD–y, —\eW, p.786, 1998.

1083. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Prevalence and distribution of migraine in Asia. —é–Ø‘¥Gi“àj: Consensus Symposium on Improving Migraine Management i98.10.01j, Washington D.C..

1084. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j A microcoaxial electrode for nitric oxide measurement. Kitamura, Y.CUzana, T.COka, K.CKomai, Y.COgawa, H.iŒc‘åjC¬—ÑO—Si“àjC‘ê‘ò’¼’èi‹³—{jCTanishita, K.iŒc‘åj: 3rd World Congress of Biomechanics i98.08.06j, ŽD–y, —\eW, p.386, 1998.

1085. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Current medical care status of amyotrophic lateral sclerosis (ALS) in Kanagawa, Japan. ’·’JìˆêŽqCŠÛ–ì’mŽqC—À³•£CŒÃ˜a‹vKC•ŸŽR‰ÃjCŒ˘aŽqi“àj: ‘æ‚X‰ñ‘Û_Œo‹ØŠw‰ï i98.08.28`09.03j, ƒI[ƒXƒgƒ‰ƒŠƒA.

1086. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Characteristics of cerebral infarctions in APS: Relationship to valve disease. ‰ª“cƒCƒ‰ƒi”ü‘ãŽqC‹ß“¡Œ[•¶CŠC–ì‰ÀŽqi“àjC›Mˆêi•új: 8th International Symposium on Antiphospholipid Antibodies i98.10.06`09j, ŽD–y.

1087. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Oxygen flow rate to prevent nocturnal desaturation in patients with chronic respiratory failure on home oxygen therapy. ‚“cM˜aCˆ¢•”’¼C“y‹´‚ä‚©‚èC‰Ô“cL‰pC‹v•Û“cŸC•Ð‹Ë^lC•y“c—FKi“àj: 5th Congress of the Asian Pacific Society of Respirology i98.10.10j, Sydney, Australia, Respirology, 3(Suppl.): 6, 1998.

1088. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Anti GM2 antibody and Guillain-Barre syndrome. Ä“¡–L˜ai“àj: International GBS Meeting i98.11.14j, ƒ_ƒ‰ƒX, ƒeƒLƒTƒX.

1089. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j New insight on the pathogenesis of stroke-like episode in MELAS syndrome; A possible role of cortical laminar hemorrhage. ”Ñ’Ë‚_Câˆä•¶•FCŠC–ì‰ÀŽqC’ËŒ´M–çC“y‹´‚©‚¨‚èC”уP’J”ü•ôC–kˆä‘¥•vi“àjC_“c’¼iˆã—Éq¶j: 50th Annual Meeting of the American Academy of Neurology i98.00.00j, ƒ~ƒlƒ\ƒ^, Neurology, 50(4): Suppl., 1998.

1090. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Neck Muscle Activity During Sniff. •Ð‹Ë^lCˆ¢•”’¼C‰¡ê³“TC“y‹´‚ä‚©‚èCŽR“c‘ñŽÀC•y“c—FKi“àjCEaston, Paul A.iƒJƒ‹ƒKƒŠ[‘åj: American Thoracic Society 1998 International Conference i98.04.27j, ƒVƒJƒS, ƒAƒƒŠƒJ, Am. J. Respir. Crit. Care Med., 157(3): 359, 1998.

1091. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Nitrosyl hemoglobin in the blood of normoxic and hypoxic sheep during nitric oxide inhalation. ¬—ÑO—SC‚‹´—TŽqC“c’†’¼•FC²“¡“N–çi“àjC‘ê‘ò’¼’èi‹³—{jC•y“c—FKi“àj: American Thoracic Society 1998 International Conference i98.04.27j, ƒVƒJƒS, ƒAƒƒŠƒJ, Am. J. Respir. Crit. Care Med., 157(3): 372, 1998.

1092. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Relation between respiratory muscle EMG and mouth pressure during voluntary isometric contraction. ‰¡ê³“TC•Ð‹Ë^li“àjCEaston, P.A.iƒJƒ‹ƒKƒŠ[‘åjC“y‹´‚ä‚©‚èCŽR“c‘ñŽÀC•y“c—FKCˆ¢•”’¼i“àj: American Thoracic Society 1998 International Conference i98.04.27j, ƒVƒJƒS, ƒAƒƒŠƒJ, Am. J. Respir. Crit. Care Med., 157(3): 348, 1998.

1093. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of chemical stimulation and posture on EMG activity of neck muscles. ˆ¢•”’¼CŽR“c‘ñŽÀC•Ð‹Ë^lC‰¡ê³“TC“y‹´‚ä‚©‚èC•y“c—FKi“àjCEaston, P.A.iƒJƒ‹ƒKƒŠ[‘åj: American Thoracic Society 1998 International Conference i98.04.27j, ƒVƒJƒS, ƒAƒƒŠƒJ, Am. J. Respir. Crit. Care Med., 157(3): 364, 1998.

1094. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Gas exchange during high-frequency intermittent oscillation in rabbits. Itoh, J.CFujioka, H.CKasahara, S.CHayashi, M.iŒc‘åjC¬—ÑO—Si“àjC‹g‘º”Ž–Mi‹¹ŠOjCOka, K.CTanishita, K.iŒc‘åj: 3rd World Congress of Biomechanics i98.08.05j, ŽD–y, —\eW, p.455, 1998.

1095. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j VAS headache diary to evaluate chronic headache. “y‹´‚©‚¨‚èCâˆä•¶•FCŒÜ\—’‹v‰ÀCŠC–ì‰ÀŽqi“àj: 12th Migraine Trust International Symposium i98.09.01`04j, London, Cephalalgia, 18(6): 403, 1998.

1096. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effectiveness of muscle relaxant for chronic tension-type headache. ŠC–ì‰ÀŽqCâˆä•¶•Fi“àjCSaito, E.CKawashima, E.: 12th Migraine Trust International Symposium i98.09.01`04j, London, Cephalalgia, 18(6): 407, 1998.

1097. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Anti phospholipid antibodies and flere of SLE in pregnancy. ƒ‰ƒi”ü‘ãŽqC‰ª“cƒC‹ß“¡Œ[•¶i“àj: 8th International Symposium on Antiphospholipid Antibodies i98.10.06`09j, ŽD–y.

1098. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Characteristics of cerebral infarctions in APS relation to valve disease. ‰ª“cƒCƒ‰ƒi”ü‘ãŽqC‹ß“¡Œ[•¶i“àj: 8th International Symposium on Antiphospholipid Antibodies i98.10.06`09j, ŽD–y.

1099. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Expression of C-C chemokine in polymyositis. “c’†Z–¾C•äâ–ÎCÔ¯“§C‹ß“¡Œ[•¶i“àj: American College of Rheumatology 62 National Scientific Meeting i98.11.08j, San Diago.

1100. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Somatostatin Analogue, Octreotide, on Severe Hemicrania after Pituitary Operation; An implication to pathogenesis of chronic cluster headache. ‰““¡ŠîC—é–Ø‘¥GCŠC–ì‰ÀŽqC”Ñ’Ë‚_Câˆä•¶•Fi“àj: 9th International Headache Research Seminar i98.11.22j, Copenhagen.

1101. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŠúRA‚Ìf’f‚ÆŽ¡—Ã-pros and cons: Overview. ‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1102. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ALS‚Ì’·Šú“ü‰@‚¨‚æ‚ÑÝ‘î—×{; ALS‚̬ˆö‚ÆŽ¡—Ã. Ä“¡–L˜ai“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.22j, ‹ž“s, ´˜^W, p.13, 1998.

1103. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹«ŠE—̈掾Š³‚Æ‚µ‚Ä‚ÌäPŒ´•a u“à‰Èˆã‚à”畆•a•Ï‚ðf‚Ä‚¢‚év. ‹ß“¡Œ[•¶i“àj: ‘æ97‰ñ“ú–{”畆‰ÈŠw‰ï i98.05.29`31j, ‘åã.

1104. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j —Õ°‚Ìê‚É‚¨‚¯‚éŒÄ‹z’²ß‚Ì–ðŠ„|_Œo¥‹ØŽ¾Š³‚ƌċz’²ß|. ˆ¢•”’¼C•Ð‹Ë^lCŽR“c‘ñŽÀC“y‹´‚ä‚©‚èC‰¡ê³“TC•y“c—FKi“àj: ‘æ39‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i99.03.26j, ‰¡•l, “ú–{ŒÄ‹zŠíŠw‰ïŽGŽ, 37(‘Š§): 40, 1999.

1105. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚É‘±”­‚µ‚½ŒŒ‹…æÃHÇŒóŒQ‚Ì‚P—á. ‚‹´“¹—YC‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1106. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj RƒZƒ“ƒgƒƒƒAR‘Ì(ACA)—z«—á‚É‚¨‚¯‚é”x‚ŒŒˆ³(PH)‚̇•¹‚ÉŠÖ‚·‚錟“¢. ÎìŽçC‰ª“cƒC“àŽR^Žå”üC‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1107. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj äPŒ´•a‚É”º‚¤”x‚ŒŒˆ³Ç‚ɑ΂·‚éNO‹z“ü—Ö@. 㑺–¾ŽqC•l–¼r–çCÎìŽçC“c’†Z–¾C•äâ–ÎCÔ¯“§C‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1108. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ”DP‚ÌSLE‚ɑ΂·‚é‰e‹¿|RƒŠƒ“Ž‰Ž¿R‘Ì(aPL)‚Æ‚ÌŠÖ˜A«. ƒ‰ƒi”ü‘ãŽqC–ΖؗR‹IŽqCŒIŒ´—[ŽqC‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1109. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚éD’†‹…ƒAƒ|ƒg[ƒVƒX§Œä‹@\. Ô¯“§C“c’†Z–¾C‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1110. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‹Ø‰Š‚Ì”­Ç‚¨‚æ‚Ñ•a‘ÔŒ`¬‚É‚¨‚¯‚éHLA‚̈Ӌ`. ŒÃ’J••¶C” “c‰ë”VC‰±ãŒªŽmCã“cŠ°”VC¼¬“c^C‹ß“¡Œ[•¶C“¿‰iŸŽmC”è’õ•vi“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1111. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‹Ø‰Š”­Ç‚É‚¨‚¯‚é‚s×–ERŒ´Žó—e‘Ì(TCR)VƒÀˆâ“`Žq‘½Œ^‚Ì–ðŠ„. ŒÃ’J••¶C” “c‰ë”VC‰±ãŒªŽmCã“cŠ°”VC¼¬“c^C‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1112. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj Ž©ŒÈRŒ´‚ÌŽ_‰»‚É‚æ‚éRŒ´Cü‚̈Ӌ`. ‰ª“cƒi“àjCˆî‘º—zŽqiŠñ•tuÀjCƒ‰ƒi”ü‘ãŽqC‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1113. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚éProstaglandin EŽó—e‘̃Tƒuƒ^ƒCƒv‚Ì”­Œ»‚ƧŒä‹@˜. ‰““¡•½mC•äâ–Îi“àjC‚ŠÝŒ›“ñi®ŠOjC‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1114. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj äPŒ´•a‚Ì–³‹Û«‘–Œ‰Š‚Ì—Õ°ŒŸ“¢. •l–¼r–çC‰ª“cƒC㑺–¾ŽqC“n•”—msi“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1115. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒ‹[ƒvƒX• –Œ‰Š‚Ì—Õ°‘œ‚ÌŒŸ“¢. “c’†Z–¾C•äâ–ÎC‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1116. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ”xüˆÛÇ‚Å”­Ç‚µ‚½PSS2—á. ¥“´ŒjŽqC‹gˆäº•vi“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1117. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‹}«ŒÄ‹z•s‘S‚ð’悵‚½‚Ñ‚Ü‚ñ«”xŽ¾Š³‚Ìf’f‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰t•ªÍ‚Ì—L—p«. ‚“cM˜aC–{‘½Œ¤–çC‚‹´ˆ¤“TC“y‹´‚ä‚©‚èCŽO“¡‹vC‹v•Û“cŸC–î“ߣM—YC•Ð‹Ë^li“àjC¡ˆäŠ°i–@ˆãjC‘Š”nˆêˆåi‹~–½j: ‘æ21‰ñ“ú–{‹CŠÇŽxŠw‰ï‘‰ï i98.05.29j, L“‡, ‹CŠÇŽxŠw, 20(3): 234, 1998.

1118. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œo‰ß’†‚ÉS“à–Œ‰Š‚ð‡•¹‚µ‚½Group G streptococcus”sŒŒÇ‚Ì‚P—á. 㑺–¾ŽqC–ΖؗR‹IŽqCÎìŽçC•äâ–ÎC”Ñ‘–í¶C‰ª“cƒC‹ß“¡Œ[•¶i“àjCŠÖŒb—“ÞC’Ϙa•FCæѳŠîC’¹ˆäWŽOC•½“cNLiŠOj: ‘æ72‰ñ“ú–{Š´õÇŠw‰ï‘‰ï i98.04.00j, ‘åã.

1119. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘½”­«‹Ø‰Š‹Ø‘gD‚É‚¨‚¯‚éInterleukin-15‚Ì”­Œ»‚ɂ‚¢‚Ä. •äâ–ÎC“c’†Z–¾CÔ¯“§C‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1120. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž©ŒÈ–Ɖu«ŠÌ‰Š(AIH)‚ð‡•¹‚µ‚½ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ(SjS)‚Ì2—á. ‹gˆäº•vC¥“´ŒjŽqC¼–Ø–ÎŽ÷i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

1121. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •Ð“ª’ɂ̈â“`‚ÉŠÖ‚·‚é‰uŠw“I’²¸. ŠC–ì‰ÀŽqCâˆä•¶•FCŒÜ\—’‹v‰Ài“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.21j, ‹ž“s, —Õ°_ŒoŠw, 38(12): 1998.

1122. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PGEŽó—e‘Ì(EP)ƒTƒuƒ^ƒCƒv‚Ì”­Œ»‚Æ‚»‚Ì’²ß‹@˜, ‚»‚Ì‚P: –«ŠŠ–Œ‚É‚¨‚¯‚éEP‚Ì”­Œ». ‰““¡•½mCŒIŒ´—[ŽqCŒIŒ´²’qŽqC“c’†Z–¾C•äâ–ÎC‹ß“¡Œ[•¶i“àj: ‘æ19‰ñ“ú–{‰ŠÇŠw‰ï i98.09.03`04j, “Œ‹ž.

1123. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PGEŽó—e‘Ì(EP)ƒTƒuƒ^ƒCƒv‚Ì”­Œ»‚Æ‚»‚Ì’²ß‹@˜, ‚»‚Ì‚Q: ˆÝ”S–Œ”S‰tŽY¶×–E‚ÌEP4”­Œ»‚ƃ€ƒ`ƒ“ŽY¶‹@”\. ‰““¡•½mCŒIŒ´²’qŽqi“àjCŽs쑸•¶i¶‰»jCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»jC‹ß“¡Œ[•¶i“àj: ‘æ19‰ñ“ú–{‰ŠÇŠw‰ï i98.09.03`04j, “Œ‹ž.

1124. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j NO‹z“ü‚É‚æ‚é”x‘gDáŠQ«‚ÌŒŸ“¢. ”¨Î—²Ž¡C¬—ÑO—SC–{‘½Œ¤–çCHŽRŽuDC¡è‹M¶CŽO“¡‹vC•y“c—FKi“àj: MEŠw‰ï i98.11.07j, VŠƒ.

1125. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j dÇ‹Ø–³—ÍÇ‚É‚¨‚¯‚éWaningŒ»Û‚Ì•ª•z|Šç–Ê, Œz•”, ŽlŽˆ‚Å‚ÌŒŸ“¢. ’ÒrˆêCˆÉ“¡”Ž–¾CÄ“¡–L˜ai“àjC²‹´–M•FCŒ´“cGŽ÷i—ÕŒŸj: ‘æ28‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ïŠwp‘å‰ï i98.11.12j, _ŒË, ”]”g‚Æ‹Ø“d}, 27(2): 193, 1999.

1126. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Sumatriptan‚̃‰ƒbƒg”]zŠÂ‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä. •Ÿ“c—Ï–çC—é–Ø‘¥GC“y‹´‚©‚¨‚èC–k‘ººCâˆä•¶•Fi“àj: ‘æ10‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï i98.11.17j, ‘åã.

1127. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Prostaglandin EŽó—e‘Ì”­Œ»’²ß‹@˜‚̉ðÍ. ‰““¡•½mC‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ48‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï i98.12.01`03j, _ŒË.

1128. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “ª’É“ú‹L‚É‚æ‚é–«“ª’ÉŠ³ŽÒ‚Ì’·ŠúƒtƒHƒ[ƒAƒbƒv. “y‹´‚©‚¨‚èCâˆä•¶•FCŠC–ì‰ÀŽqi“àj: ‘æ26‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï i98.12.05j, “Œ‹ž.

1129. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒQ”­“ª’ɂɂ‚¢‚Ä‚ÌŽ•‰Èˆã‚ւ̃Aƒ“ƒP[ƒg’²¸. ˆäì‰ëŽqi´…Žs—§•a‰@jC¡ˆä¸i“àj: ‘æ26‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï i98.12.05j, “Œ‹ž.

1130. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”x‚ŒŒˆ³‚ð’悵‚ÄŽ€–S‚µ‚½–«ŠÖ߃ŠƒEƒ}ƒ`‚Ì‚P—á. “n•”—msC¥“´Œ\ŽqC“c’†Z–¾CÔ¯“§C‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ13‰ñ“ú–{—Õ°ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.12.10`11j, –¼ŒÃ‰®.

1131. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éjŽh‚µŽ–ŒÌ‚ÌŒ»ó‚ɂ‚¢‚Ä|7”NŠÔ507Œ‚ÌlŽ@|. •äâ–ÎC”Ñ‘–í¶C‹ß“¡Œ[•¶i“àj: ‘æ23‰ñ“ú–{Š´õÇŠw‰ï‘‰ï i99.03.30`31j, “Œ‹ž.

1132. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰»Šw“IŽhŒƒŽž‚̃qƒg• ‰¡‹Ø‚ÌŠˆ“®‚ɑ΂·‚éŽp¨‚̉e‹¿. ŽR“c‘ñŽÀCˆ¢•”’¼C•Ð‹Ë^lC“y‹´‚ä‚©‚èC‰¡ê³“TC¶ˆä¢—YC•y“c—FKi“àj: ‘æ38‰ñ“ú–{ŒÄ‹zŠíŠw‰ï‘‰ï i99.03.30j, ŒF–{, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 36(‘Š§): 390, 1998.

1133. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬”]”玿ˆÞkÇ(CCA)‚Æ•a—Šw“I‚Éf’f‚³‚ꂽ2Ç—á‚ÌŠá‹…‰^“®áŠQ‚ɑ΂·‚錟“¢. “í~ˆêCŽO•x“N˜YC—À³•£C’·’JìˆêŽqCâˆä•¶•FC–ö‰ºŽO˜Yi“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.20j, ‹ž“s, ´˜^W, p.111, 1998.

1134. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ`ƒAƒ~ƒ“Œ‡–R”]ǃ‚ƒfƒ‹‚É‚¨‚¯‚éÓ”C•a‘ƒ‚Ì”­Œ»‹@˜‚ÉŠÖ‚·‚錟“¢|‘æ2•ñ. •y•Û˜aGC¡ˆä–¾i϶‰ï‰F“s‹{•a‰@jC‹à‘ò’¼”üi¶•¨‰»ŠwŒnjCÄ“¡–L˜ai“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.20j, ‹ž“s, ´˜^W, p.130, 1998.

1135. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j _“Þ쌧2Ž{݂ɉ—‚¯‚éALS—×{‚ÌŒ»ó. Œ˘aŽqC‘ºãŒc˜YC’·’JìˆêŽqC“í~ˆêCâˆä•¶•Fi“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.20j, ‹ž“s, ´˜^W, p.135, 1998.

1136. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j _ŒoŽ¾Š³Š³ŽÒ‚ÌS—Šw“IŒŸ“¢|‹ØˆÞk«‘¤õd‰»ÇŠ³ŽÒ‚ð’†S‚É. —À³•£C’·’JìˆêŽqCâˆä•¶•FCŒÃ‹´‹I‹vi“àjC•ŸŽR‰Ãji‘‡‘Š’k•”jC––‹g”ü‰À: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.20j, ‹ž“s, ´˜^W, p.136, 1998.

1137. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘åÀ’n‹æ‚ɉ—‚¯‚é‰Æ‘°«Parkinsonism‚Ì5p15.3—̈æ‚̃nƒvƒƒ^ƒCƒv‰ðÍ. ŒÃ‘ò‰p–¾C—À³•£C’·’JìˆêŽqCâˆä•¶•FCŒÃ˜a‹vKi“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.20j, ‹ž“s, ´˜^W, p.157, 1998.

1138. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹…–ƒáƒÇó‚𔺂¤Guillain-BarreÇŒóŒQ‹y‚Ñ‚»‚Ì—Þ‰Ž¾Š³‚É‚¨‚¯‚éRƒKƒ“ƒOƒŠƒIƒVƒhR‘Ì. “ü]KŽqCf‘ò’BŽuC‰¬–ì—TCÄ“¡–L˜ai“àjC‹à‘ò’¼”üi¶•¨‰»ŠwŒnj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.20j, ‹ž“s, ´˜^W, p.195, 1998.

1139. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j dÇ‹Ø–³—ÍÇ‚Ì‹¹‘B“EoŒã‚É‚¨‚¯‚鋹‘BŽîŒQ‚Æ”ñ‹¹‘BŽîŒQ‚Å‚Ì—\Œã‚ÌŒŸ“¢. ‰Á“¡’m–çC‰¡ŽRÆ•vCˆÉ“¡”Ž–¾CÄ“¡–L˜ai“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.20j, ‹ž“s, ´˜^W, p.94, 1998.

1140. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’s•ð‘Š’k‚É—ˆ‚½Š³ŽÒ‚Ì—\Œã’²¸. ¡ˆä¸C“¡À–M•FC‹{“c‰Ã¢Žqi“àjCÎŒ´’¼‹Bi´…Žs—§•a‰@j: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.21j, ‹ž“s.

1141. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j POEMSÇŒóŒQ‚É‚¨‚¯‚évascular endothelial growth factor (VEGF)‚ÌŽ¾Š³“ÁˆÙ«‚ÌŒŸ“¢. —L‘ºmŽuC—L‘ºŒö—ÇC”[ŒõOCŠÛŽRª˜YC–k“‡ŒMiŽ­Ž™“‡‘åjCÄ“¡–L˜ai“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.21j, ‹ž“s, ´˜^W, p.192, 1998.

1142. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Multifocal Motor Neuropathy‚Ì—Õ°Œo‰ß‚ÆRGM1R‘Ì. ˆÉ“¡”Ž–¾Cf‘ò’BŽuC“ü]KŽqCÄ“¡–L˜ai“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.21j, ‹ž“s, ´˜^W, p.196, 1998.

1143. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ò‘¬”]•Ï«Ç‚ÌŠá‹…‰^“®áŠQ‚ÉŠÖ‚·‚錤‹†(1)‘½Œn“ˆÞkǂɂ‚¢‚Ä. ’·’JìˆêŽqC“í~ˆêCŽO•x“N˜YC—À³•£Câˆä•¶•Fi“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.21j, ‹ž“s, ´˜^W, p.204, 1998.

1144. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰ºŽˆ‚É‚¨‚¯‚锽•œŽhŒƒŽŽŒ±|³í—á‚ÆdÇ‹Ø–³—ÍÇ—á‚ɂ‚¢‚Ä|. ’ÒrˆêCˆÉ“¡”Ž–¾CÄ“¡–L˜ai“àjC²‹´–M•FCŒ´“cGŽ÷i—ÕŒŸj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.21j, ‹ž“s, ´˜^W, p.221, 1998.

1145. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Extraceptive supression (ES)“Á‚ÉES1‚É‚æ‚éŽO³_ŒoáŠQ‚Ì•]‰¿‚Ì—L—p«. aˆä—߈êC’·’JìˆêŽqCŠC–ì‰ÀŽqCâˆä•¶•Fi“àjCÄ“¡]”üŽqi—ÕŒŸj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.21j, ‹ž“s, ´˜^W, p.223, 1998.

1146. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j CIDP‚Ì—Õ°Œo‰ß‚É‚¨‚¯‚éƒTƒCƒgƒJƒCƒ“‚Ì•Ï“®. f‘ò’BŽuCˆÉ“¡”Ž–¾C“ü]KŽqCÄ“¡–L˜ai“àjC‹à‘ò’¼”üi¶•¨‰»ŠwŒnj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.22j, ‹ž“s, ´˜^W, p.283, 1998.

1147. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒMƒ‰ƒ“¥ƒoƒŒ[ÇŒóŒQ(GBS)‚É‚¨‚¯‚éŠç–Ê_Œo–ƒáƒ‡•¹Ç—á‚Ì—\Œã‚ÌŒŸ“¢. ‰ª‹{‘CŠÛ–ì’mŽqC‰¡ŽRÆ•vCˆÉ“¡”Ž–¾CÄ“¡–L˜ai“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.22j, ‹ž“s, ´˜^W, p.283, 1998.

1148. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ALSŠ³ŽÒ‚É‚Ý‚ç‚ꂽNF-HƒŠƒ“Ž_‰»•”ˆÊKSP‚ɑ΂·‚éR‘Ì‚ÌŒŸ“¢|“ÁˆÙ‚ÈALSŠ³ŽÒIgAŒ^‚l’`”’‚Æ‘ÎÆŒQ—z«—á‚ÌR‘Ì‚Æ‚Ì‘Šˆá‚ɂ‚¢‚Ä. ‰¬–ì—TC‰¬–ì”üŒbŽqCÄ“¡–L˜ai“àj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.22j, ‹ž“s, ´˜^W, p.322, 1998.

1149. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ò‘˜J‚Ì1–UŒŸ—á. ŠÛ–ì’mŽqC—À³•£C’·’JìˆêŽqCâˆä•¶•Fi“àjC–ö‰ºŽO˜Yi•a—j: ‘æ39‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i98.05.29j, •Ÿ‰ª, Neuropathology, 18(Suppl.): 262, 1998.

1150. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “ÁˆÙ‚È•a—‘œ‚ð’悵‚½‘½”­«d‰»Ç‚Ì1—á. ‰Á“¡’m–çC—À³•£C’·’JìˆêŽqCâˆä•¶•Fi“àjC–ö‰ºŽO˜Yi•a—j: ‘æ39‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i98.05.29j, •Ÿ‰ª, Neuropathology, 18(Suppl.5): 256, 1998.

1151. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬”]”玿ˆÞkÇ(CCA)‚Ì–UŒŸ2Ç—á‚ÌŒŸ“¢. “í~ˆêC—À³•£CŽO•x“N˜YC’·’JìˆêŽqCâˆä•¶•Fi“àjC–ö‰ºŽO˜Yi•a—j: ‘æ39‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i98.05.30j, •Ÿ‰ª, Neuropathology, 18(Suppl.): 350, 1998.

1152. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘e‘åU‚¹‚ñ‚ÆŽ‘±«ˆ««‚”MÇ—ló‘Ô‚ðŽ¦‚µL”Í‚È•a‘ƒ•”ˆÊ‚ð”F‚ß‚½MSA—á. ’·’JìˆêŽqC—À³•£C‰Á“¡’m–çCŒÃ‘ò‰p–¾Câˆä•¶•Fi“àjCˆÀˆä”ü]iŒ`‘ÔŒnjC–ö‰ºŽO˜Yi•a—j: ‘æ39‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i98.05.30j, •Ÿ‰ª, Neuropathology, 18(Suppl.): 358, 1998.

1153. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j is«‚Ì’s•ð|“ª’¸, Œã“ª—t‚ÉŒÀ‹Ç‚µ‚½CJI—l•a—•Ï‰»‚ð‚Ý‚Æ‚ß‚½1Ç—á. —À³•£C“í~ˆêC’·’JìˆêŽqCâˆä•¶•Fi“àjC–ö‰ºŽO˜Yi•a—j: ‘æ39‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i98.05.30j, •Ÿ‰ª, Neuropathology, 18(Suppl.): 371, 1998.

1154. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰„‘ŠO‘¤[Ç‚É‚¨‚¯‚éMRI‚ÌŒoŽž“I•Ï‰»‚ÌŒŸ“¢. ¡ˆä¸C“¡À–M•FC‹{“c‰Ã¢Žqi“àjCÎŒ´’¼‹Bi´…Žs—§•a‰@j: ‘æ23‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i98.06.25j, ŽD–y.

1155. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”]‘²’†”­Ç‚ÌTŠÔ‹y‚Ñ‹Gߕω»‚ɂ‚¢‚Ä‚ÌŒŸ“¢. •Ÿ“c—Ï–çC_“c’¼C”Ñ’Ë‚_C–kˆä‘¥•vCâˆä•¶•Fi“àj: ‘æ23‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i98.06.26j, ŽD–y.

1156. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “–‰@‚É‚¨‚¯‚é”­Œ©“®‹@•Ê‚É‚Ý‚½”xŠàŽ¡—ìÑ. ”¼’JŽµdi•½’ËŽs–¯•a‰@jC“팴”Í”VC—é–Ø“¹Oi“àjC‹{‘ò’¼li•½’ËŽs–¯•a‰@j: ‘æ39‰ñ“ú–{”xŠàŠw‰ï‘‰ï i98.10.29j, ‹à‘ò, ”xŠà, 38(5): 559, 1998.

1157. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ‚É‚¨‚¯‚é•Ù–ŒÇ‚Æ”][Ç‚Æ‚ÌŠÖŒW. ‰ª“cƒCƒ‰ƒi”ü‘ãŽqC‹ß“¡Œ[•¶i“àj: “ú–{—Õ°–ƉuŠw‰ïC“ú–{–ƉuŠw‰ï i98.12.02`04j, _ŒË.

1158. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”DP’†“ÅÇ‚ð‡•¹‚µ‚½‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX6—á‚ÌŒŸ“¢. ƒ‰ƒi”ü‘ãŽqC‰ª“cƒC‹ß“¡Œ[•¶i“àj: “ú–{—Õ°–ƉuŠw‰ïC“ú–{–ƉuŠw‰ï i98.12.02`04j, _ŒË.

1159. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒÀ2ŽhŒƒÜ‚ÌŒ¢ŒÄ‹z‹Ø‚É‹y‚Ú‚·‰e‹¿. “팴”Í”VC—é–Ø“¹OC•Ð‹Ë^lCˆ¢•”’¼C•y“c—FKi“àjCEaston, Paul A.iƒJƒ‹ƒKƒŠ[‘åj: ‘æ38‰ñ“ú–{ŒÄ‹zŠíŠw‰ï‘‰ï i99.03.30j, ŒF–{, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 36(‘Š§): 390, 1998.

1160. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j •Ð“ª’É‚Ì•a‘Ô‚ÆŽ¡—Ã|Å‹ß‚Ìi•à. âˆä•¶•Fi“àj: ‘æ20‰ñ¶ŠU‹³ˆçu‰‰‰ï, “ú–{“à‰ÈŠw‰ï–kŠC“¹Žx•” i98.11.08j, ŽD–y.

1161. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’`”’˜Ro«ˆÝ’°Ç‚ð’悵‚½SLE‚Ì‚P—á. ¥“´Œ\ŽqC•äâ–ÎC씨‹IŽqC“’–{‰ÀGC㑺–¾ŽqC•l–¼r–çC‹ß“¡Œ[•¶i“àj: ‘æ463‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.05.09j, “Œ‹ž.

1162. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ã•”Œz‘[Ç‚ð’悵‚½31΂̒jŽq—á. ŠÛ–ì’mŽqC‰Á“¡’m–çCŒÃ‘ò‰p–¾C‰¬–ì—TCÄ“¡–L˜ai“àj: ‘æ145‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i98.06.06j, “Œ‹ž.

1163. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰º‚‘ÌpŒã‚̕Б¤“ª’ɂɃTƒ“ƒhƒXƒ^ƒ`ƒ“‚ª’˜Œø‚ðŽ¦‚µ‚½‚P—á. ŠC–ì‰ÀŽqC‰““¡ŠîC”уP’J”ü•ôC“y‹´‚©‚¨‚èCâˆä•¶•Fi“àj: ‘æ145‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i98.06.06j, “Œ‹ž, —Õ°_ŒoŠw, 38(6): 534, 1998.

1164. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒãcŠuŒ´”­‚ÌŠŒF×–EŽî‚Ì1—á. ‘O‘ºˆÀ•¶C•Ð‹Ë^lCtŽR”üC²“¡˜aŒÈC‚‹´ˆ¤“TC‚“cM˜aC¬—ÑO—SC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj: ‘æ464‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.06.13j, “Œ‹ž.

1165. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’·Šú‚ɂ킽‚èš‹‰º‹@”\‚ª•ÛŽ‚³‚ê, –³“®, –³Œ¾Çó‚ð’悵‚½ƒŒ[ƒ”ƒB¬‘Ì•a‚Ì–UŒŸ—á. ‰ª‹{‘CŒÃ‘ò‰p–¾C‰¬–ì—TCÄ“¡–L˜ai“àjC–ö‰ºŽO˜Yi•a—j: ‘æ146‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i98.09.12j, “Œ‹ž.

1166. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j SLE‚É”x‚ŒŒˆ³Ç‚¨‚æ‚ÑNRH‚ð‡•¹‚µ, ”xoŒŒ‚ÅŽ€–S‚µ‚½‚P—á. “àŽR^Žå”üC‰ª“cƒCƒ‰ƒi”ü‘ãŽqC“c’†Z–¾C‘•ª–ΔŽC‹ß“¡Œ[•¶i“àj: ‘æ466‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.09.12j, “Œ‹ž.

1167. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Good pastureÇŒóŒQ‚Ì1—á. ‘åãŠwC‰F²”üCC¼‘º²‘ãŽqC“›ˆä‹M˜NCL“c˜a‰iC¯’qi“àj: ‘æ156‰ñ“ú–{“à‰ÈŠw‰ï“Œ–k’n•û‰ï i98.09.12j, ŽRŒ`, “ú–{“à‰ÈŠw‰ï“Œ–k’n•û‰ï‰ïŽ, 10(3): 19`19, 1998.

1168. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j tŒŒŠÇ‹ØŽ‰–bŽî‚ðŒ_‹@‚É”­Œ©‚³‚ꂽ‚Ñ‚Ü‚ñ«‰ßŒëŽî«”x–¬ŠÇ‹ØŽîÇ‚Ì1—á. —é–Ø“¹OC“팴”Í”Vi“àjC“à“¡˜a•FC”ä‰ÃŒ÷C”¼’JŽµdC‹{‘ò’¼li•½’ËŽs–¯•a‰@j: ‘æ131‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠÖ“Œ’n•û‰ï i98.09.19j, “Œ‹ž.

1169. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠoÁÜí—pŽÒ‚É”F‚ß‚ç‚ꂽ”x”^ᇂÌ1—á. ¶ˆä¢—YCž`ŒE–LC‹g‘º®‚i“àj: ‘æ131‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠÖ“Œ’n•û‰ï i98.09.19j, “Œ‹ž.

1170. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j š\á‚×–Ef‚ªf’f‚É—L—p‚Å‚ ‚Á‚½’Pƒƒwƒ‹ƒyƒXƒEƒBƒ‹ƒX”x‰Š‚Ì1—á. ”’ˆäŠx“ñC•Ð‹Ë^lC¬—ÑO—SC¬–ì“c´C²“¡˜aŒÈC‚‹´ˆ¤“TC‚“cM˜aC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj: ‘æ467‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.10.03j, “Œ‹ž.

1171. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¸_”­’B’x‘Ø‚ðŽåÇó‚Æ‚µ‚½BeckerŒ^‹ØƒWƒXƒgƒƒtƒB[Ç‚ÌŒZ’í—á. ‹{“c‰Ã¢ŽqC¡ˆä¸i“àjCÎŒ´’¼‹Bi´…Žs—§•a‰@j: ‘æ92‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï i98.10.31j, •Ÿˆä.

1172. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”]Š²”]‰Š‚ðŠù‰‚É—L‚·‚éFisherÇŒóŒQ‚Ì1—á. ’·’Jì‚ЂƂÝCL£—²ˆêC“ü]KŽqCÄ“¡–L˜ai“àj: “ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i98.11.28j, “Œ‹ž.

1173. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œ´”­«”xƒNƒŠƒvƒgƒRƒbƒJƒXÇ‚Ì1—á. ‘Ÿº—²”VC–{ŠÔ˜a•vCŽR–{”Ž”VC“cŠ‰qi“àj: ‘æ83‰ñ“ú–{‹CŠÇŽxŠw‰ïŠÖ“Œ’n•û‰ï i98.11.29j, “Œ‹ž.

1174. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “à‰È“IŽ¾Š³‚ɑ΂·‚éNO‹z“ü—Ö@‚ÉŠÖ‚·‚錤‹†. ”¨Î—²Ž¡C¬—ÑO—Si“àjCŠ}Œ´^Œåi‹¹ŠOj: zŠÂŠí•aŒ¤‹†ˆÏ‘õŽ–‹Æ|Ž_‰»’‚‘f‹z“üŽ¡—Ö@‚ÌŠm—§‚ÉŠÖ‚·‚錤‹†”ljï‹c i98.12.11j, ‘åã.

1175. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ‡•¹SLE‚ÌŽo–…—á. •l–¼r–çCŒIŒ´—[ŽqC¥“´Œ\ŽqC•äâ–ÎC‰““¡•½mCÔ¯“§C‹ß“¡Œ[•¶i“àj: “ú–{ƒŠƒEƒ}ƒ`Šw‰ïŠÖ“Œ’n•û‰ï i98.12.12j, ‘O‹´.

1176. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒŒŸ÷ŒðŠ·—Ö@‚É‚æ‚è‹~–½‚µ“¾‚½”xoŒŒ‚Æ‹}«t•s‘S‚ð’悵‚½MPO-ANCA—z«‹­”çÇ‚Ì1—á. ²“¡‘å•ãC“n•”—msC¥“´Œ\ŽqC•l–¼r–çC‰““¡•½mCÔ¯“§C‰ª“cƒC‹ß“¡Œ[•¶i“àj: “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.12.13j, “Œ‹ž.

1177. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Žá”N«–«ŠÖ߃ŠƒEƒ}ƒ`‚ƃAƒ~ƒƒCƒh[ƒVƒX‚ð‡•¹‚µ‚½‘å’°ƒNƒ[ƒ“•a‚Ì1—á. Žs쇎qC‚‹´—T”VC“’–{‰ÀGC‰¡ŽRŒOC¬—Ñ´“TCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çC“c’†Z–¾C‹ß“¡Œ[•¶i“àj: “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.12.13j, “Œ‹ž.

1178. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Lymphomatoid granulomatosis‚Ì1—á. “y‹´‚ä‚©‚èi“àjC_’J‹I‹Pi‹¹ŠOjC‚“cM˜aC•Ð‹Ë^lC¬—ÑO—SC–î“ߣM—YCˆ¢•”’¼i“àjC‹g‘º”Ž–Mi‹¹ŠOjC•y“c—FKi“àj: ‘æ133‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠÖ“Œ’n•û‰ï i99.02.06j, “Œ‹ž.

1179. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’˜–¾‚ÈDŽ_‹…‘‘½, IgE‚’l‚𔺂¢, ƒJƒŠƒ“”x‰Š‚Å”­Ç‚µ‚½AIDS‚Ì1—á. –{‹´²’mŽqC‘O‘ºˆÀ•¶C•l–¼r–çC²“¡˜aŒÈC“c’†Z–¾C•äâ–ÎC‹ß“¡Œ[•¶C•y“c—FKC‚“cM˜aC•Ð‹Ë^li“àj: ‘æ470‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i99.02.13j, “Œ‹ž.

1180. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒŒ´RGM2R‘Ì‚ªã¸‚µ, Šç–ʑΖƒáƒ‚ðŽå’¥‚Æ‚µ‚½ƒTƒCƒgƒƒKƒƒEƒCƒ‹ƒXŠ´õ‚Ì1—á. ‚–ØŽqC’†”ö’¼Ž÷C’†X‘¾˜YCŽ­ŽR³lCŒF‘ò˜a•FC‘å’|ç¶Cˆß”ã’BC–žŠÔÆ“Tiˆ¤’mˆã‘åjCÄ“¡–L˜ai“àj: ‘æ93‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï i99.02.20j, –¼ŒÃ‰®.

1181. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j MRI‚Å‹´ã•”‚ɈÙíM†‚ð”F‚ß‚½FisherÇŒóŒQ‚Ì1—á. ¡ˆä¸C‹{“c‰Ã¢Žqi“àjCÎŒ´’¼‹Bi´…Žs—§•a‰@j: ‘æ93‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï i99.02.20j, –¼ŒÃ‰®.

1182. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘½Ê‚È”]Š²Çó‚ðŽå’¥‚Æ‚µf’f‚É‹ê—¶‚µ‚½Guillain-BarreÇŒóŒQ‚Ì1—á. “ú”ä—mŽqC•Ÿ“c—Ï–çi“àjC㞊‹glCŒF’JŒªC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC”уP’J”ü•ôC”Ñ’Ë‚_i“àj: ‘æ46‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i99.02.20j, ‰¡•l.

1183. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”]è‹’«•a•Ï‚Å”­Ç‚µ, ŽO³_Œo߶ŒŸ‚ÅŠm”F‚µ‚½_ŒoƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ”уP’J”ü•ôC”Ñ’Ë‚_C’ËŒ´M–çC—é–Ø‘¥GCâˆä•¶•Fi“àj: ‘æ148‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i99.03.06j, “Œ‹ž.

1184. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œo‰ß’†‚Ɉê‰ß«‚Ì‘‰t’`”’‚̈Ùí‚’l‚ð‚«‚½‚µ‚½“Á”­«’ᓪŠW“àˆ³ÇŒóŒQ‚Ì1—á. ŒÃ‘ò‰p–¾C‰¡ŽRÆ•vC‰¬–ì—TCÄ“¡–L˜aCâˆä•¶•Fi“àj: ‘æ148‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i99.03.06j, “Œ‹ž.

1185. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”x, ”]‹y‚є牺‚É“]ˆÚ‚ð”F‚ß‚½Œ´”­‘ƒ•s–¾‚̈««•FŽî‚Ì1—á. ‘Ÿº—²”VC–{ŠÔ˜a•vCŽR–{”Ž”Vi“àjC“ÈŒ´•q•FCΈ亘Y: ‘æ60‰ñ_“Þ쌧“à‰ÈˆãŠw‰ïW’k‰ï i99.03.29j, “Œ‹ž.

1186. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Šç–eˆÙí‚𔺂킸—Õ°’¥Œó‚Ì‹É‚ß‚Ä­‚È‚¢centronuclear myopathy‚Ì•a—‘œ‚ð’悵‚½‚P—á. ‰¬–ì”üŒbŽqC‰¬–ì—TCÄ“¡–L˜ai“àjCŠâèr”ViŽ™j: ‘æ37‰ñ_Œo‹ØŒ¤‹†‰ï i98.00.00j.

1187. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Ý‘îˆã—Âɂ¨‚¯‚é–òÜŽt‚Ì–ðŠ„. Ä“¡–L˜ai“àj: ‘æ5‰ñ—A‰t‰h—{—Ö@Œ¤‹†‰ï i98.05.30j, ‘åã, ‹L˜^W, p.3`17, 1998.

1188. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘s”NŠú‚É”­Ç‚µ, äC• ‹Ø‚É’˜‚µ‚¢Ž‰–b•Ï«‚ð’悵, ˆô“ª¥‘ÌŠ²‹Ø‚̋ؗ͒ቺ‚𔺂Á‚½ƒ~ƒIƒpƒ`[‚Ì’jŽq—á. ŠÛ–ì’mŽqC‰¬–ì—TC‰¬–ì”üŒbŽqCÄ“¡–L˜ai“àj: ‘æ35‰ñ_Œo’ÉiƒJƒ“ƒtƒ@ƒŒƒ“ƒXjŒ¤‹†‰ï i98.07.11j, “Œ‹ž.

1189. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠO‰ÈŽèpŒã‚ÉŽlŽˆ‚ɉ^“®–ƒáƒ‚ª‘ˆ«‚µ‚½ƒjƒ…[ƒƒpƒ`[—á. ‰ª‹{‘CŒÃ‘ò‰p–¾C‰¬–ì—TCˆÉ“¡”Ž–¾CÄ“¡–L˜ai“àj: ‘æ16‰ñ‰^“®áŠQŒ¤‹†‰ï i98.07.18j, “Œ‹ž.

1190. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`‚Ì–ò•¨—Ö@(DMARDs‚ð’†S‚É). ‹ß“¡Œ[•¶i“àj: ‘æ15‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ï”F’胊ƒEƒ}ƒ`ˆãŽ‘ŠiŽæ“¾, Œp‘±‚Ì‚½‚ß‚ÌŒ¤C‰ï i98.08.23j, “Œ‹ž.

1191. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j MCTD up date. ‹ß“¡Œ[•¶i“àj: ‘æ28‰ñ“ú–{”畆‰ÈŠw‰ïŒãŽÀѶŠU‹³ˆçƒVƒ“ƒ|ƒWƒEƒ€; äPŒ´•a‚ÌŠî‘b‚Æ—Õ° i98.08.30j, “Œ‹ž.

1192. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j LPS‹CŠÇ“à“Š—^ƒ‰ƒbƒg‚É‚¨‚¯‚éD’†‹…‚Ì”x“àWÏ‚Ö‚ÌNO‹z“üŒø‰Ê. ”¨Î—²Ž¡C¬—ÑO—SC–{‘½Œ¤–çC¡è‹M¶C•y“c—FKi“àj: ALI(Acute Lung Injury)Œ¤‹†‰ï i99.02.20j, “Œ‹ž.

1193. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`‚Ì•a‘Ô‚ÆŽ¡—Ã. ‹ß“¡Œ[•¶i“àj: ‘æ9‰ñŒ§‰›®Œ`ŠO‰ÈŒ¤‹†‰ï i98.06.12j, Œú–Ø.

1194. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j äPŒ´•a‚É‚¨‚¯‚é”x•a•Ï. ‹ß“¡Œ[•¶i“àj: ‘æ8‰ñŒQ”nŒ§ƒŠƒEƒ}ƒ`«Ž¾Š³Œ¤‹†‰ï i98.09.05j, ‘O‹´.

1195. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`‚Ì–ò•¨—Ö@. ‹ß“¡Œ[•¶i“àj: ‘æ4‰ñã_ƒŠƒEƒ}ƒ`ƒZƒ~ƒi[ i98.12.03j, ¼‹{.

1196. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j “ª’ɂ̘b¥Ž¿‹^‰ž“š. âˆä•¶•Fi“àj: –«“ª’É•a‚̉ï i98.05.31j, “Œ‹ž.

1197. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‹¹•”‰æ‘œf’f. –î“ߣM—Yi“àj: •½¬10”N“x_“Þ쌧f—ÕúŽËü‹ZpuK‰ï i98.07.12j, ‰¡•l.

1198. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j “úíf—Âɂ¨‚¯‚éŒÄ‹z‰¹‚Ì’®f–@|Å‹ß‚Ì’mŒ©‚𓥂܂¦‚Ä|. ˆ¢•”’¼i“àj: ‘Š–ÍŒ´ˆãŽt‰ï i98.07.15j, ‘Š–ÍŒ´.

1199. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ý‘îŒÄ‹z—Ö@‚Ì[ŽÀ‚ð‚ß‚´‚µ‚Ä. ˆ¢•”’¼i“àj: ‘æ9‰ñ_“ÞìÝ‘îŒÄ‹zŠÇ—Œ¤‹†‰ï i98.10.31j, ‰¡•l.

1200. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹}«”xáŠQ‚Ì•a‘Ô‚ÆŽ¡—Ã. ŽO“¡‹vi“àj: ‘æ5‰ñ_“Þ쑽‘ŸŠí‹@”\áŠQƒZƒ~ƒi[ i98.11.20j, ‰¡•l.

1201. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j MCP-1ŠÖß“àŽ‘±’“ü‚É‚æ‚éŠÖ߉Š‚Ì—U“±‚Æ‚»‚̧Œä. Ô¯“§C‹ß“¡Œ[•¶i“àj: Œú¶ÈŒú¶‰ÈŠwŒ¤‹†ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€ i99.01.18j, “Œ‹ž.

1202. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ž¡Œ±‚̃‚ƒjƒ^ƒŠƒ“ƒO‚¨‚æ‚ъĸ‚ÌŒ»ó‚Æ–â‘è“_; ˆã—Ë@ŠÖ‚ÌŒ»óiŽ¡Œ±Ó”CˆãŽt‚©‚ç). ‹ß“¡Œ[•¶i“àj: ‘æ3‰ñƒVƒ“ƒ|ƒWƒEƒ€ i99.03.26j, “Œ‹ž.

1203. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j —‘‘ƒˆ««Žîᇂɂæ‚é”ñ׋۫ŒŒð«S“à–Œ‰Š‚É‚æ‚è”][Ç‚ð”­Ç‚µ‚½‚P—á. ‰““¡ŠîC”Ñ’Ë‚_C”уP’J”ü•ôi“àj: ‘æ13‰ñ_“ÞìVisual Neurology i98.00.00j, ‰¡•l.

1204. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹U«’°•ÂÇ‚ð’悵‚½‘½”­«‹Ø‰Š‚Ì‚P—á. ŒIŒ´—[ŽqC²–ì—zŽqC•l–¼r–çC“c’†Z–¾C‰““¡•½mC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï i98.06.27j, ‰¡•l.

1205. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”ÄŒŒ‹…Œ¸­ŒXŒü‚ð’悵•s®–¬S“à–Œ‰Š‚ð”F‚ß‚½¬l”­ÇStill•a‚Ì‚P—á. ‘O“c’å‘¥C•Ûâ”ü¶CVˆätŽ}C‹ß“¡Œ[•¶i“àj: ‘æ39‰ñŠÖ“ŒƒŠƒEƒ}ƒ`Œ¤‹†‰ï i98.06.27j, “Œ‹ž.

1206. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘½”­«‘å’°’×ᇂð’悵‚½ˆ««ŠÖ߃ŠƒEƒ}ƒ`‚Ì‚P—á. “n•”—msCÔ¯“§C•l–¼r–çC㑺–¾ŽqC¥“´Œ\ŽqC•äâ–ÎC‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ39‰ñŠÖ“ŒƒŠƒEƒ}ƒ`Œ¤‹†‰ï i98.06.27j, “Œ‹ž.

1207. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˜b‘è’ñ‹Ÿ; MCTD‚Æ‚Í‚Ç‚ñ‚ÈäPŒ´•a‚©H ‹ß“¡Œ[•¶i“àj: ‘æ7‰ñäPŒ´•a‚ÌtáŠQŒ¤‹†‰ï i98.07.04j, “Œ‹ž.

1208. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`‚Ì“à‰ÈŽ¡—Ã. ‹ß“¡Œ[•¶i“àj: ƒŠƒEƒ}ƒ`‚Ì–³—¿ŒöŠJu‰‰‰ï i98.08.22j, ìè.

1209. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Diabetic Amyotrophy (“œ”A•a«‹ØˆÞkÇ). Ä“¡–L˜ai“àj: ‘æ4‰ñ“œ”A•a«_ŒoáŠQ‚ðl‚¦‚é‰ï i98.09.14j, “Œ‹ž.

1210. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j RHIV–ò|•¹—p—Ö@(AZT, 3TC, IDV)‚ª—L—p‚ÆŽv‚í‚ê‚édrug fever‚Ì‚Q—á. ¥“´Œ\ŽqC–{‹´²’mŽqC•l–¼r–çC“c’†Z–¾C•äâ–ÎC•Ð‹Ë^lC‹ß“¡Œ[•¶i“àj: ‘æ44‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï i98.09.19j, ‰¡•l.

1211. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j 10”N—ˆ‚Ì”xüˆÛÇ‚É‹}«ŠÔŽ¿«”x‰Š‚ð’悵‚½RA, ‹­”çÇ, PMƒI[ƒo[ƒ‰ƒbƒvÇŒóŒQ‚Ì‚P—á. •l–¼r–çC•äâ–ÎC씨‹IŽqC…“‡ŽžºC¥“´Œ\ŽqC‹ß“¡Œ[•¶i“àj: ‘æ39‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï i98.11.14j, ‰¡•l.

1212. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹}«”xáŠQ‚ɑ΂·‚éNO‹z“ü—Ö@. ŽO“¡‹vi“àjC‘Š”nˆêˆåi‹~–½j: ‘æ5‰ñ_“Þ쑽‘ŸŠí‹@”\áŠQƒZƒ~ƒi[ i98.11.20j, ‰¡•l.

1213. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j •Ï««_ŒoŽ¾Š³‚É‚¨‚¯‚éŠJáÙ¢“ï. “í~ˆêCÄ“¡–L˜aC‰ª‹{‘C‰¡ŽRÆ•vi“àj: _“Þ쌧“ï•a‘Îô•]‹c‰ï i98.12.14j.

1214. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‚Q”N‚ÌŒo‰ß‚ÅŠÉ™is«‚ÉŽlŽˆ‘ÌŠ²‹Ø‚É”ñ‘ÎÌ«‚̋ؗ͒ቺ‚𗈂µ‚½ƒtƒBƒŠƒsƒ“—«‚Ì‚P—á. ”Ñ’Ë‚_C“ú”ä—mŽqC‰¬–ì—TC‰¬–ì”üŒbŽqCÄ“¡–L˜aC—é–Ø‘¥GCâˆä•¶•Fi“àj: ‘æ36‰ñ_Œo’ÉŒ¤‹†‰ï(Neuromuscular Conference) i98.12.19j, “Œ‹ž.

1215. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˆê‰ß«‚Ìcontinuous tonic facial spasm‚ð’悵‚½‘½”­«d‰»Ç‚ÆŽv‚í‚ê‚é1—á. Žº‰êç‰pŽqC‰Á“¡’m–çC‰¬–ì—TCÄ“¡–L˜ai“àj: ‘æ17‰ñ‰^“®áŠQŒ¤‹†‰ï i99.01.23j, “Œ‹ž.

1216. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Guillain-BarreÇŒóŒQ‚Ì‘S‘‰uŠw’²¸|‘æ1ŽŸƒAƒ“ƒP[ƒg’²¸‚ÌŒ‹‰Ê•ñ|. Ä“¡–L˜ai“àjC—L‘ºŒö—ÇC”[ŒõOiŽ­Ž™“‡‘åj: Œú¶È“Á’莾Š³–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†”ljï‹c i99.02.15j, “Œ‹ž, ´˜^W, p.38`39.

1217. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ALSŠ³ŽÒŒŒ´’†‚É‚¨‚¯‚éNFHƒŠƒ“Ž_‰»•”ˆÊ—ÞŽ—ƒGƒsƒg[ƒv‚ɑ΂·‚éR‘Ì‚ÌŒŸ“¢. ‰¬–ì—TC‰¬–ì”üŒbŽqCâˆä•¶•FCÄ“¡–L˜ai“àjC‹à‘ò’¼”üi¶‰»Œnj: •½¬10”N“xŒú¶È“Á’莾Š³–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†”ljï‹c i99.02.15j, “Œ‹ž, ´˜^W, p.60`61, 1999.

1218. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚郌ƒWƒIƒlƒ‰”x‰Š6—á‚Ì‚Ü‚Æ‚ß. ŒÜ–ì—R‰À—CŽR–{”Ž”VC–{ŠÔ˜a•vi“àj: –k—¢‹¹•”Ž¾Š³Œ¤‹†‰ï i99.03.20j, _“Þì.


<<1404 ?? >>

1219. mŒ´’˜n Cooperative stimulatory effects of tumor necrosis factor and granulocyte-macrophage colony-stimulating factor on the particular respiratory burst activity in human neutrophils: synergistic priming effect on concanavalin A-induced response, no interactive priming effect on the chemotactive peptide-induced response and additive triggering effect. ²”Œ‹v”üŽqC–k콈êi‘Ûˆã—ÃZƒ“jC‘åŒFŒb”üŽqi‘åãŽs—§‘åjC”‹Œ´«‘¾˜Yi“àjC”ª–ØàV‰ëŽqC“’”ö–¾i‘Ûˆã—ÃZƒ“j: Int. J. Hematol., 68: 269`278, 1998.

1220. mŒ´’˜n Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines; analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules. ”‹Œ´«‘¾˜Yi“àjCˆëŠò¹ŽqC²”Œ‹v”üŽqCŽO—Ö“N‹`CŒËì“ÖC¬‘òŒh–çC‚‹vŽj–C“’”ö–¾i‘Ûˆã—ÃZƒ“j: Int. J. Hematol., 68: 387`402, 1998.

1221. mŒ´’˜n Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. ¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠâ£m—Ei¶‰»jC“c’†“ÖŽuCŒËŠÀˆêEiˆ®‰»¬jC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj: JASN, 9: 2048`2054, 1998.

1222. mŒ´’˜n Analysis of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. ”äŠé”\”ViŠÅŒìŠw•”jC“c’†“ÖŽuiˆ®‰»¬jC¬‹v•Û“§i“àjCŠâ£m—Ei¶‰»jCNishikido, J.iˆ®‰»¬jC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj: JASN, 9: 577`582, 1998.

1223. mŒ´’˜n Exposed peptide core of IgA1 hinge region in IgA nephropathy. ¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠâ£m—Ei¶‰»jC“c’†“ÖŽuCNishikido, J.iˆ®‰»¬jC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj: Nephrol. Dial. Transplant., 14: 81`85, 1999.

1224. mŒ´’˜n Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentration. ¬’r—R‰ÀŽqC•ÄŽR²ŽqC”’ˆäCΓcŒšC³“cŠG—¢ŽqC‹{è_“ñC{‰i^ŽiC–x]—LjêC–؎ŒÈC¬’r˜a•FC”öŒ`ˆí˜Yi“Œ‘åjC“cŒ´’mKC‰Á“¡®ŽuiƒLƒŠƒ“ ƒr[ƒ‹jC’†Œ´ˆê•Fi“Œ‘åjCŠ ‰Æ—˜³i“Œ‹žŒú¶”N‹à•a‰@jC“ŒŒ´³–¾i“àj: Thromb. Haemost., 79: 1106`1110, 1998.

1225. mŒ¤‹†•ñiŒú¶Èjn is«IgAtǂɑ΂·‚é‚Q”NŠÔ‚̃XƒeƒƒCƒh—Ö@|10”NŠÔ‚ÌŒo‰ßŠÏŽ@‚É‚æ‚é•]‰¿. ¬—Ñ–Li“àjC”äŠé”\”ViŠÅŒìŠw•”jC¬‹v•Û“§CŠÚ–샶i“àj: Œú¶È“Á’莾Š³is«táŠQ’²¸Œ¤‹†”Ç, •½¬‚X”N“xŒ¤‹†‹ÆÑW, p.1`4, 1999.

1226. mÇ—á•ñn A rare atypical myeloproliferative disorder-like hemopathy with marked dysplasia, peripheral dominant myeloblast proliferation and extramedullary hematopoiesis was converted into typical acute myeloid leukemia with an interval hematological remission. ”‹Œ´«‘¾˜Yi“àjC“’”ö–¾CŽO—Ö“N‹`C’|”—’¼Ž÷C•½–ì’¼lCŒËì“Öi‘Ûˆã—ÃZƒ“j: Int. J. Hematol., 67: 411`416, 1998.

1227. mÇ—á•ñn Crescentic glomerulonephritis associated with membranous nephropathy in a case with primary Sjogren's syndrome. ’F—mCŠÚ–샶i“àjC”äŠé”\”ViŠÅŒìŠw•”jCd¼GˆêiMB‘åjC¬—Ñ–Li“àj: Nephrol. Dial. Transplant., 13: 2624`2627, 1998.

1228. mÇ—á•ñn Š´õ«S“à–Œ‰Š‚É‚æ‚è‹}«Ž…‹…‘Ìt‰Š‚ƉºŽˆŽ‡”Á‚Ì‚Ý‚ç‚ꂽ‚P—á. “c‘º‰ëlC“¡XˆŸŠóC’F—mC‰Ô‰ª³lC¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠ™“cvŽõC’Ë–{—Y‰îCŠÚ–샶C¬—Ñ–Li“àjCd¼GˆêiMB‘åj: t‰ŠÇ—ጤ‹†, 15: 34`45, 1999.

1229. m‘àn —Õ°ˆã‚ªŠú‘Ò‚·‚éƒgƒƒ“ƒ{ƒ|ƒGƒ`ƒ“(TPO)‚ÌŠJ”­‚ÌŒ»ó‚Æ“W–]. “ŒŒ´³–¾i“àjC‹{è—miƒLƒŠƒ“ƒr[ƒ‹jC–Ñ—˜”Ži‰¡•lŽs‘åj: Medico, 29: 31`40, 1998.

1230. m‘àn ƒAƒ‹ƒR[ƒ‹‚ÆŒŒ‰tŽ¾Š³. ”‹Œ´«‘¾˜YC“ŒŒ´³–¾i“àj: ƒNƒŠƒjƒJ, 25: 218`222, 1998.

1231. m‘àn ’†“Å. Žá—Ñ–õ‹vi“àj: ƒi[ƒVƒ“ƒOƒŒƒR[ƒh, 7(12): 49`55, 1998.

1232. m‘àn tŽ¾Š³‚ÌŽ¡—Ã; –«t‰ŠÇŒóŒQ. ¬—Ñ–LC²–ì—²C¼”öFri“àj: ˆãŠw‚Æ–òŠw, 41: 21`25, 1999.

1233. m‘àn •a‰@‚Ì’†‚Å‚È‚ºcompromized host‚ª¶‚Ü‚ê‚é‚Ì‚©. ”‹Œ´«‘¾˜Yi“àj: ŠÅŒìŠwŽGŽ, 62: 119`123, 1998.

1234. m‘àn ê–åˆã‚É•·‚­•nŒŒ‚Ìf—Ã. “ŒŒ´³–¾i“àj: ¡ŒŽ‚ÌŽ¡—Ã, 6: 72`74, 1998.

1235. m‘àn ––½ŒŒŠ²×–EˆÚAp. HŽR’¨C“ŒŒ´³–¾i“àj: î•ñ, 38: 1`6, 1999.

1236. m‘àn IgAtÇ30”N; IgAtÇ‚ÌŽ¡—Â̎‹“_. ¬—Ñ–Li“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠÚ–샶i“àj: t‚Æ“§Í, 46: 91`94, 1999.

1237. m‘àn Ž~ŒŒ‹@”\ŒŸ¸; ŒŒ¬”‹@”\ŒŸ¸|ŒŒ¬”‹ÃW”\, ŒŒ¬”Â’â‘Ø—¦|. “ŒŒ´³–¾i“àj: ‘‡—Õ°, 47: 156`161, 1998.

1238. m‘àn Ž~ŒŒ‹@”\ŒŸ¸; TAT, AT-‡V, P1C, P1g, ƒ¿2-P1. “ŒŒ´³–¾i“àj: ‘‡—Õ°, 47: 162`165, 1998.

1239. m‘àn t«•nŒŒ‚Ìf’f‚ÆŽ¡—Ã. “¡XˆŸŠóCŠ™“cvŽõC“ŒŒ´³–¾i“àj: “à‰È, 62: 508`511, 1998.

1240. m‘àn ƒxƒbƒhƒTƒCƒh‚ÌHematology; ŒŒ‰tŽ¾Š³Š³ŽÒ‚̃Cƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚ƃ^[ƒ~ƒiƒ‹ƒPƒA. “ŒŒ´³–¾i“àj: “à‰È, 82: 565`568, 1998.

1241. m‘àn ŒŒ‰tÇŒóŒQ‡V: LennertƒŠƒ“ƒpŽî. ‹àŽq‘½Žqi“àj: “ú–{—Õ°, (22): 279`282, 1998.

1242. m‘àn ŒŒ‰tÇŒóŒQ‡V: T-zoneƒŠƒ“ƒpŽî. ‹àŽq‘½Žqi“àj: “ú–{—Õ°, (22): 283`286, 1998.

1243. m‘àn ŒŒ‰tÇŒóŒQ‡V: NK×–EƒŠƒ“ƒpŽî. ‹àŽq‘½Žqi“àj: “ú–{—Õ°, (22): 309`314, 1998.

1244. m‘àn ŒŒ¬”‘‘½‚ð‚«‚½‚·Ž¾Š³‚ւ̃Aƒvƒ[ƒ`‚ÆŽ¡—Ã. ŒS”ü‰ÀC“ŒŒ´³–¾i“àj: —Õ°ˆã, 25: 42`45, 1999.

1245. m‘àn ŒŒ¬”‚Ǝ~ŒŒŒŒð. “ŒŒ´³–¾i“àjC¬“c~i–kŠC“¹Ô\ŽšŒŒ‰tƒZƒ“jC”¼“c½iŒc‘åjC“àŽR^ˆê˜Yi“Œ—ˆã‘åj: —Õ°ˆã, 25: 96`107, 1999.

1246. muÀn ^‹ÛÇ‚Ìf’f; 3)ƒJƒ“ƒWƒ_Ç. ŽR‰º‚¦‚èŽqi“àjC‹v•ÄŒõi•a—j: —Õ°”÷¶•¨ŠwŽGŽ, 8(2): 25`30, 1998.

1247. mŠwp‘n i•ª’SŽ·•Mj “à‰È—Õ°ƒŠƒtƒ@ƒŒƒ“ƒXƒuƒbƒN: Ž¾Š³•Ò; ”’ŒŒ•a‚¨‚æ‚Ñè÷—±‹…ŒnŽ¾Š³, 2: 305`313, “ŒŒ´³–¾i“àj. •ÒW ¡ˆä_ŽOiŽD–yˆã‘åjC’†Œ´ˆê•Fi“Œ‘åjC–I‰®‡ˆêiˆÇ—Ñ‘åjCŽRŒû“Oi“Œ–M‘åjC•ÒC ’†ŽR‘“X, “Œ‹ž, 98.07.31”­s.

1248. mŠwp‘n i•ª’SŽ·•Mj Á‰»Ší‚É‚¨‚¯‚銴õÇEŠñ¶’ŽÇ; MRSA’°‰Š, p.172`175, ”‹Œ´«‘¾˜Yi“àj. •ÒW çŽí—YˆêCã“c‘P•FiàÕ‹¦‘åjC•ÒC V‹»ˆãŠwo”Å, “Œ‹ž, 98.00.00”­s.

1249. mŠwp‘n i•ª’SŽ·•Mj Ž¾Š³•ÊÅVˆ•û; –«t‰ŠÇŒóŒQ, p.596`597, ¬—Ñ–Li“àj. •ÒW –îè‹`—YC•ÒC ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 98.00.00”­s.

1250. mŠwp‘n i•ª’SŽ·•Mj “à‰ÈŠw‘, ‘æ‚T”Å; Žå‚ÈŒ´”­«Ž…‹…‘Ìt‰Š, p.1901`1913, ¬—Ñ–Li“àjCd¼GˆêiMB‘åj. •ÒW •ì´C•ÒC ’†ŽR‘“X, “Œ‹ž, 98.00.00”­s.

1251. mŠwp‘n i•ª’SŽ·•Mj “à‰ÈŠw‘, ‘æ‚T”Å; Ž…‹…‘Ìt‰Š‚ÌŽ¡—ÊT—v, p.1913`1917, ¬—Ñ–Li“àj. •ÒW •ì´C•ÒC ’†ŽR‘“X, “Œ‹ž, 98.00.00”­s.

1252. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Isolation and structural characterization of "glomerulophilic" IgA1 in IgA nephropathy. ”äŠé”\”ViŠÅŒìŠw•”jC¬‹v•Û“§i“àjCŠâ£m—Ei¶‰»jC“c’†“ÖŽuCŒËŠÀˆêEiˆ®‰»¬jC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj: 8th International IgA Nephropathy Symposium i98.00.00j, Leiden.

1253. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extramatrix proteins. ¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠâ£m—Ei¶‰»jC“c’†“ÖŽuCŒËŠÀˆêEiˆ®‰»¬jC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj: 8th International IgA Nephropathy Symposium i98.00.00j, Leiden.

1254. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Two-year steroid therapy in progressive IgA nephropathy; A prospective, non-randomized 10-year follow-up study with a control group. ¬—Ñ–Li“àjC”äŠé”\”ViŠÅŒìŠw•”jC¬‹v•Û“§C²–ì—²C‹´’ÜŒ’ŽŸ˜YCŠÚ–샶i“àj: 8th International IgA Nephropathy Symposium i98.00.00j, Leiden.

1255. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j A randomized, prospective, controlled study of effect of angiotensin-comverting enzyme inhibition in IgA nephropathy patients. ‹´’ÜŒ’ŽŸ˜YC²–ì—²C¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠ™“cvŽõCŠÚ–샶C¬—Ñ–Li“àj: 8th International IgA Nephropathy Symposium i98.00.00j, Leiden.

1256. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j A certain role of under-o-glycosylation of IgA1 hinge for its glomerular deposition in IgA nephropathy. ”äŠé”\”ViŠÅŒìŠw•”jC¬‹v•Û“§i“àjCŠâ£m—Ei¶‰»jC^è‹`•FiŽÀ“®ŒnjC“c’†“ÖŽuCŒËŠÀˆêEiˆ®‰»¬jC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj: ‘æ31‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i98.10.25`28j, Philadelphia.

1257. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Two-year steroid therapy in progressive IgA nephropathy: Prognostic significance of serial biopsies in 10-year clinical courses. ²–ì—²C‹´’ÜŒ’ŽŸ˜YC¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠÚ–샶C¬—Ñ–Li“àj: ‘æ31‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i98.10.25`28j, Philadelphia.

1258. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Two-year steroid therapy in progressive IgA nephropathy: Comparison of steroid responsive and non-responsive cases. ¬—Ñ–Li“àjC”äŠé”\”ViŠÅŒìŠw•”jC¬‹v•Û“§C²–ì—²C‹´’ÜŒ’ŽŸ˜YCŠÚ–샶i“àj: ‘æ31‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i98.10.25`28j, Philadelphia.

1259. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Humoral immune response against proline-rich peptide epitope of IgA1 hinge region in IgA nephropathy. ¬‹v•Û“§C‹´’ÜŒ’ŽŸ˜YC²–ì—²i“àjCŠâ£m—Ei¶‰»jCArai, K.CŒËŠÀˆêEiˆ®‰»¬jC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj: ‘æ31‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i98.10.25`28j, Philadelphia.

1260. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j A randomized, prospective, controlled study of effect of angiotensin-converting enzyme inhibition on proteinuria and renal function in IgA nephropathy. ‹´’ÜŒ’ŽŸ˜YC²–ì—²C¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠ™“cvŽõCŠÚ–샶C¬—Ñ–Li“àj: ‘æ31‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i98.10.25`28j, Philadelphia.

1261. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Correction of metabolic acidosis, although to a lesser degree the dialysance, may inhibit the high level of amadori products in non-diabetic hemodialysis patients. ¬—Ñ–LCŠ™“cvŽõC’|“àN—YC’F—mC‹g“càˆC‘å‹v•Û[li“àj: ‘æ31‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i98.10.25`28j, Philadelphia.

1262. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Calcitriol further stimulates enhanced apoptosis of PTH-activated monocyte in uremia. ‰Ô‰ª³lC’·ê‘×CÖ“¡‚xC“¡XˆŸŠóC¬—Ñ–LC’Ë–{—Y‰îi“àj: ‘æ31‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i98.10.25`28j, Philadelphia.

1263. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Prognostic scoring system for myelodysplastic syndrome by COX's proportional hazard model. HŽR’¨C‘å˜a“cŒ[C‘å’|_”VC’hŒ´Š²¶i“àjC•½”ü–çŽqiŒ`‘ÔŒnjC‰¬Œ´«‘¾˜YC‹àŽq‘½ŽqC‰–’J–ÎC“ŒŒ´³–¾i“àj: ASH Meeting i98.12.04`08j, Florida, USA, Blood, 92: 2597, 1998.

1264. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j IgA1‚ÌŽ©ŒÈ‹ÃW, matrix”S’…‚ɉʂ·“œ½‚Ì–ðŠ„|IgAtÇ‚Å‚ÌŽ…‹…‘ÌIgA’~Ï‹@˜‚Ö‚ÌŠÖ—^|. ¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠâ£m—Ei¶‰»jC“c’†“ÖŽuCŒËŠÀˆêEiˆ®‰»¬jC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj: ‘æ41‰ñ“ú–{t‘ŸŠw‰ïŠwp‘å‰ï i98.05.11j, “Œ‹ž.

1265. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j IgAtÇ‚É‚¨‚¯‚鎅‹…‘Ì’¾’…«IgA1‚ÌŒŸ“¢|•ª—£‚Æ‚»‚Ì\‘¢‰ðÍ|. ¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠâ£m—Ei¶‰»jC“c’†“ÖŽuCŒËŠÀˆêEiˆ®‰»¬jC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj: ‘æ41‰ñ“ú–{t‘ŸŠw‰ïŠwp‘å‰ï i98.05.11j, “Œ‹ž.

1266. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Watanabe heritable hyperlipidemic (WHHL) rabbit‚ÌLDL”íŽ_‰»«‚ɑ΂·‚éÔƒƒCƒ“’·Šú“Š—^‚ÌŒø‰Ê. Žá—Ñ–õ‹vC“ŒŒ´³–¾i“àj: ‘æ21‰ñ“ú–{ŒŒðŽ~ŒŒŠw‰ïŠwp‘‰ï i98.09.17j, •xŽR, “ú–{ŒŒðŽ~ŒŒŠw‰ïŽ, 9: 255, 1998.

1267. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j May-HegglinˆÙí—ÞŽ—‚Ì•a‘Ô‚Æ“ÁˆÙ‚ÈŽ…‹…‘Ì•a•Ï‚ðŽ¦‚µ‚½t‹@”\áŠQ‚Ì‚P—á. ŽR’†^—ŽqCŠ™“cvŽõC“¡XˆŸŠóC‰Ô‰ª³lC’F—mC’|“àN—YC¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠÚ–샶C¬—Ñ–LC“ŒŒ´³–¾i“àjCd¼GˆêiMB ‘åj: ‘æ28‰ñ“ú–{t‘ŸŠw‰ï“Œ¥¼•”Šwp‘å‰ï i98.10.02`03j, “Þ—Ç, “ú–{t‘ŸŠw‰ïŽ, 40(6): 516, 1998.

1268. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚霑ˆÙŒ`¬ÇŒóŒQ‚Ì—\Œã‰ðÍi‘æ‚Q•ñ). HŽR’¨C’hŒ´Š²¶CŒS”ü‰ÀC‘å’|_”VC‘å˜a“cŒ[C‰¬Œ´«‘¾˜YC‹àŽq‘½ŽqC‰–’J–ÎC“ŒŒ´³–¾i“àj: ‘æ40‰ñ—Õ°ŒŒ‰tŠw‰ï‘‰ï i98.11.11`13j, ‹à‘ò, —Õ°ŒŒ‰t, 39(10): 971, 1998.

1269. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒWƒqƒhƒƒvƒŒƒŠƒ“Ž_‚É‚æ‚éƒqƒg‘½”­«œ‘ŽîŠ”‚ÌDNA’f•Ð‰». ŽO—Ö“N‹`CŽR“à–í¶C–¼Žæˆê•FC’|”—’¼Ž÷i‘—§‘Ûˆã—ÃZƒ“jC‰¬Œ´«‘¾˜Yi“àjC•½–ì’¼lC“’”ö–¾C²“¡—TŽqCŒËì“Öi‘—§‘Ûˆã—ÃZƒ“j: ‘æ60‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ï i99.03.25`27j, ‘åã, Int. J. Hematol., Suppl.: 223, 1999.

1270. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž©ŒÈ––½ŒŒ—R—ˆ‚“xCD34—z«×–E‚©‚çCD19×–E‚𜋎‚µ‚½double purged×–E‚ðˆÚA‚µ¶’…‚ðŠm”F‚µ‚½follicular lymphoma‚Ì‚P—á. ’|”—’¼Ž÷CŽO—Ö“N‹`CŽR“à–í¶C–¼Žæˆê•Fi‘—§‘Ûˆã—ÃZƒ“jC‰¬Œ´«‘¾˜Yi“àjC•½–ì’¼lC“’”ö–¾C²“¡—TŽqCŒËì“Öi‘—§‘Ûˆã—ÃZƒ“j: ‘æ60‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ï i99.03.25`27j, ‘åã, Int. J. Hematol., Suppl.: 245, 1999.

1271. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j FISH–@‚ňꕔ‚É×–EBCR/ABL—Z‡ƒVƒOƒiƒ‹‚ð”F‚ß‚½PhõF‘̉A«BCR/ABLmRNA‰A«‚Å‚ ‚Á‚½–«œ‘«”’ŒŒ•a‚Ì‚P—á. ŽR“à–í¶CŽO—Ö“N‹`C–¼Žæˆê•FC’|”—’¼Ž÷i‘—§‘Ûˆã—ÃZƒ“jC‰¬Œ´«‘¾˜Yi“àjC•½–ì’¼lC“’”ö–¾C²“¡—TŽqCŒËì“Öi‘—§‘Ûˆã—ÃZƒ“j: ‘æ60‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ï i99.03.25`27j, ‘åã, Int. J. Hematol., Suppl.: 84, 1999.

1272. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒlƒtƒ[ƒ[ÇŒóŒQ‚ɑ΂·‚éƒXƒeƒƒCƒh—Ö@. ²–ì—²C¬—Ñ–Li“àj: ‘æ28‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï i98.11.21j, “Œ‹ž.

1273. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒJƒ‹ƒ{ƒvƒ‰ƒ`ƒ“‚Ì• o“à“Š—^‚ª‘tŒ÷‚µ‚½’°ŠÇŒ´”­¬l‚s×–E«”’ŒŒ•aEƒŠƒ“ƒpŽî(ATLL)‚É”º‚¤“«• …‚Ì‚P—á. HŽR’¨CŒS”ü‰ÀC’hŒ´Š²¶C‘å’|_”VC‘å˜a“cŒ[C‹àŽq‘½ŽqC‰–’J–ÎC“ŒŒ´³–¾i“àj: ‘æ132‰ñ—Õ°ŒŒ‰tŠw‰ï—á‰ï i98.05.23j, “Œ‹ž, —Õ°ŒŒ‰t, 39(7): 533, 1998.

1274. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆê‰ß«‚Ìœ‘Œ`‘ÔˆÙ킪‚Ý‚ç‚ꂽ–òÜ—U”­«–³è÷—±‹…Ç‚Ì‚P—á. ‘å’|_”VC”‹Œ´«‘¾˜YC‘å˜a“cŒ[CŒS”ü‰ÀC’hŒ´Š²¶CHŽR’¨C‹àŽq‘½ŽqC‰–’J–ÎC“ŒŒ´³–¾i“àj: ‘æ133‰ñ—Õ°ŒŒ‰tŠw‰ï—á‰ï i98.10.24j, “Œ‹ž, —Õ°ŒŒ‰t, 39(12): 1202, 1998.

1275. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒXƒeƒƒCƒh—Ö@‚É”½‰ž‚µ‚½Fibrillary glomerulonephritis‚Ì‚P—á. ‹´’ÜŒ’ŽŸ˜YC’F—mi“àjC“싽‰p–¾i‚ ‚¯‚Ú‚Ì•a‰@jC”äŠé”\”ViŠÅŒìŠw•”jC¬—Ñ–Li“àjCd¼GˆêiMB‘åj: ‘æ28‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï i98.11.21j, “Œ‹ž.

1276. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”¼ŒŽ‘ÌŒ`¬«Ž…‹…‘Ìt‰Š‚𔺂Á‚½ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚Ì‚P—á. ’F—mC“c‘º‰ëli“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠÚ–샶C¬—Ñ–Li“àjCd¼GˆêiMB‘åj: ‘æ28‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï i98.11.21j, “Œ‹ž.

1277. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j œŒ´”­ˆ««ƒŠƒ“ƒpŽî‚Ì‚Q—á. ˆÀ–ì’‡ŽqC‹g“cGC‘å˜a“cŒ[C‘å’|_”VCŒS”ü‰ÀC’hŒ´Š²¶C‰¬Œ´«‘¾˜YCHŽR’¨C‹àŽq‘½ŽqC‰–’J–ÎC“ŒŒ´³–¾i“àj: ‘æ460‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.12.13j, “Œ‹ž.

1278. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j t(8;21)‚ð—L‚·‚éCD19—z«AML(M2)‚Ì‚P—á. ŽO‹´~CHŽR’¨C‘å˜a“cŒ[C‘å’|_”VCŒS”ü‰ÀC’hŒ´Š²¶C‰¬Œ´«‘¾˜YC‹àŽq‘½ŽqC‰–’J–ÎC“ŒŒ´³–¾i“àj: ‘æ134‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï—á‰ï i99.02.13j, “Œ‹ž.

1279. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •às’†‚̈ӎ¯ÁŽ¸”­ì‚ðŽåÇó‚Æ‚µ‚½‹}«S‹Ø‰Š‚Ì‚P—á. “¡“c˜aŒÈC•Ÿ“c’¼lC’·“c˜a”VC¼ŽR¬‘¾˜YC˜aò“OC•‘ò—˜˜YC•ìMŒåC´…Š®‰xC’¬“c—z“ñi“àj: “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i99.02.14j, “Œ‹ž.

1280. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j Š´õ«S“à–Œ‰Š‚É”º‚¤Ž…‹…‘Ìt‰Š‚Ì‚Q—á. “c‘º‰ëlC’F—mC‰Ô‰ª³lC“¡XˆŸŠói“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠÚ–샶C¬—Ñ–Li“àjCd¼GˆêiMB‘åj: ‘æ28‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï i98.11.21j, “Œ‹ž.

1281. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ŠO—ˆf—Âł݂ç‚ê‚錌‰tŽ¾Š³‚Ì•a‘Ô‚ÆŽ¡—Ã|Ž~ŒŒEŒŒð—̈æ‚ð’†S‚É|. “ŒŒ´³–¾i“àj: ‘æ41‰ñPharamaceutical CareŒ¤C‰ï i98.05.17j, _“Þì.

1282. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘S‘‚Ì‘åŠw•a‰@‚É‚¨‚¯‚éŠÉ˜aƒPƒA‚ÌŒ»ó|ƒAƒ“ƒP[ƒg’²¸‚æ‚è|. ‰¬Œ´—Di¹ƒ}ƒŠˆã‘åjC‚‹{—L‰îiº˜a‘åjC¬–ì[ˆêiŒË“c’†‰›•a‰@jC–Ø‘º—ŒbŽqiŒc‘åjC•ŽqKˆêi¹ƒˆƒ[ƒt•a‰@jCŽ™“‡Ž”üiŽ™“‡ƒNƒŠƒjƒbƒNjC‘ò “c—SŽqiº˜a‘åjC”’“y’CŽqi“ú‘åjC’£CŽqi¹ƒ}ƒŠˆã‘åjCŽ›“ˆ‹g•Ûi“¿“‡‘åjC“ŒŒ´³–¾i“àjC“IꌳOi–ƒjCŽR“cŠ°KiŒc‘åjC“n•Ó³i“¡“c•Û‰q ‘åj: ‘æ22‰ñ“ú–{Ž€‚Ì—Õ°Œ¤‹†‰ï”NŽŸ‘å‰ï i98.11.07`08j, ²‰ê, Ž€‚Ì—Õ°, 21(2): 172, 1998.

1283. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “Á”­«ŒŒ¬”ÂŒ¸­«Ž‡”Á•a‚ɑ΂·‚鎡—Â̓®Œü. “ŒŒ´³–¾i“àj: “ŒŠC‘åŠw•a‰@¢“ï•auÀ£ŒŒ‰t“ï•a‚ðl‚¦‚é i98.11.19j, ˆÉ¨Œ´.

1284. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆ««ƒŠƒ“ƒpŽî‚É‚¨‚¯‚é’´‰¹”gf’f‚Ì—L—p«. ”‹Œ´«‘¾˜YC“ŒŒ´³–¾i“àjCŽO—Ö“N‹`CŒËì“Öi‘—§‘Ûˆã—ÃZƒ“j: ‘æ‚T‰ñ_“Þ쌌‰tƒVƒ“ƒ|ƒWƒA i98.07.18j, _“Þì.

1285. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˆê‰ß«‚Ìœ‘Œ`‘ÔˆÙ킪‚Ý‚ç‚ꂽ–òÜ—U”­«–³è÷—±‹…Ç‚Ì‚P—á. ‘å’|_”VC”‹Œ´«‘¾˜YC‘å˜a“cŒ[CŒS”ü‰ÀC’hŒ´Š²¶CHŽR’¨C‹àŽq‘½ŽqC‰–’J–ÎC“ŒŒ´³–¾i“àj: ‘æ38‰ñ_“Þ쌌‰tŒ¤‹†‰ï i98.09.12j, _“Þì.

1286. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”A˜H•Âǂ̉ðœ‚É‚æ‚èƒlƒtƒ[ƒ[ÇŒóŒQ‚Æt‹@”\‚̉ü‘P‚ð”F‚ß‚½‚P—á. ¼”öFrCŠ™“cvŽõC‰Ž“c‹M”VC“¡XˆŸŠóCŽR’†^—ŽqC“c‘º‰ëli“àjC”äŠé”\”ViŠÅŒìŠw•”jC’Ë–{—Y‰îCŠÚ–샶C¬—Ñ–Li“àjCd¼GˆêiMB‘åj: ‘æ31‰ñ_“Þìt‰ŠŒ¤‹†‰ï i99.02.00j, ‰¡•l.


<<15 ŠO‰ÈŠw>>

1287. mŒ´’˜n Outcome of endoscopic mucosal resection (EMR) and laser irradiation for residual tumor after EMR in early gastric cancer. “ˆ”ömCX£¹Ž÷C’çCC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷iŠOjC“c•Ó‘C¼Œ³Ž›Ž—çi“àjC÷–{MˆêCŠ`“cÍiŠOj: Acta Endoscopica, 28(2): 139`145, 1998.

1288. mŒ´’˜n Endoscopic treatment of cancer. “ˆ”ömC”äŠé”\Ž÷C匴÷CŠ`“cÍiŠOj: Asia Med. J., 41(10): 495`501, 1998.

1289. mŒ´’˜n Results of resection of gastric cancer with distant metastases. ‹e’rŽj˜YC’Ë–{GlCŽOd–슰ŠìC²“¡ŒõŽjC¬—ÑLsC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: Hepato-Gastroenterology, 45(20): 592`596, 1998.

1290. mŒ´’˜n Gastric cancer with metastases to the distant peritoneum: A 20-year surgical experience. ‹e’rŽj˜YCrˆä‹`FCX£¹Ž÷C¬—ÑLsC’Ë–{GlC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: Hepato-Gastroenterology, 45(22): 1183`1188, 1998.

1291. mŒ´’˜n Immediate effects of hepatic denervation on hepatic hemodynamics in dogs. ˆÉ“¡‹`–çC‚‹´‹BCŠ`“cÍC”Ñ–ì‘Pˆê˜YC²“¡ŒõŽjiŠOj: Int. Surg., 83: 48`52, 1998.

1292. mŒ´’˜n Low levels of apoptosis and proliferative activity in colorectal villous tumors: Comparison with tubular tumors. ’r‰i½iŠOjC‚–ìN—Yi•a—jC‘å’J„³C’Ë–{GlC”äŠé”\Ž÷CŠ`“cÍiŠOjC‰ªˆÀŒMi•a—j: Pathol. Int., 48: 453`459, 1998.

1293. mŒ´’˜n The 5D4 antibody (anti-cyclin D1/D2) related antigen: Cytoplasmic staining is correlated to the progression of gastric cancer. ”ª\ì—v•½iŠOjC‚–ìN—YC‰ªˆÀŒMi•a—jCŠ`“cÍiŠOj: Pathol. Int., 48: 717`722, 1998.

1294. mŒ´’˜n Basic clinical study of an easy and effective leukocytapheresis by the use of nonwoven polyester filter. 쑺–¾•vC¬ŽR“à½iŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjC•Ä쌳Ž÷CÄ“¡‰ë—YiŽD–y–kž¾•a‰@j: Ther. Apher., 2(4): 292`296, 1998.

1295. mŒ´’˜n Cryofiltration apheresis for major ABO-incompatible kidney transplantation. ‹Ê’u“§C“c’†ŽO’ÃŽqiŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjC¬ŽR“à½CˆÀŒ´–ž•vC–Ú•‡ˆêC‹v–Ø“c˜a‹uC•Ä쌳Ž÷C쑺–¾•viŽD–y–kž¾•a‰@j: Ther. Apher., 2(4): 308`310, 1998.

1296. mŒ´’˜n Cryofiltration‚É‚æ‚éR‘Ìœ‹Ž‚ª—LŒø‚Å‚ ‚Á‚½ABOŒŒ‰tŒ^•s“K‡tˆÚAÇ—á. “c’†ŽO’ÃŽqC‹Ê’u“§iŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjC‚‹´¹GC¬ŽR“à½CˆÀŒ´–ž•vC‹v–Ø“c˜a‹uC–Ú•‡ˆêC•Ä쌳Ž÷C쑺–¾•vC‚—ä–FFC‰¡“c˜jO iŽD–y–kž¾•a‰@j: ˆÚA, 33(2): 116`122, 1998.

1297. mŒ´’˜n ‹‘å”X–E‚ð—L‚·‚éˆÚA•Ð‚̶‘ÌtˆÚAÇ—á. ¬ŽR“à½C‹Ê’u“§C“c’†ŽO’ÃŽqiŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjCˆÀŒ´–ž•vC‹v–Ø“c˜a‹uC–Ú•‡ˆêC•Ä쌳Ž÷C쑺–¾•viŽD–y–kž¾•a‰@jC‚‹´’õl iŠOjC“à“¡¹–¾C‚‹´¹GiŽD–y–kž¾•a‰@j: ˆÚA, 33(3): 193`198, 1998.

1298. mŒ´’˜n ŠÌ“àŒ‹ÎÇ. Š`“cÍC‹g“c@‹IiŠOj: ˆãŠw‚Æ–òŠw, 40(5): 851`855, 1998.

1299. mŒ´’˜n ƒqƒgŠÌ‘gD‚É‚¨‚¯‚éCa++ATPase, ƒAƒNƒ`ƒ“üˆÛ‚Ì‹ÇÝ|“dŒ°×–E‰»Šw“IŠÏŽ@|. ”ª\ì—v•½iŠOjC‰¡XOºi–kŒ¤ƒƒfƒBƒJƒ‹ƒZƒ“jC¼”ªŽkiŠOj: ŠÌ‘Ÿ, 39(9): 621`627, 1998.

1300. mŒ´’˜n ˆÛŽ“§ÍŠ³ŽÒ‚É‚¨‚¯‚é•ÂÇ«“®–¬d‰»Ç‚ÌŒŸ“¢. –Ú•‡ˆêC‹v–Ø“c˜a‹uC¬ŽR“à½CŠ—’r_•¶C“à“¡¹–¾iŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjCˆÀŒ´–ž•vC“c’†ŽO’ÃŽqC•Ä쌳Ž÷C쑺–¾•viŽD–y–kž¾•a‰@j: ŽDˆã’ÊM, (‘:‘æ23‰ñŽD–yŽsˆãŽt‰ïˆãŠwŽGŽ): 37`38, 1998.

1301. mŒ´’˜n äXØœŒã‚ÌÄŒš‚É‚¨‚¯‚éäX‹ó’°–§’…•«‡–@‚ÌŽè‹Z‚ƬÑ. Š`“cÍC‹g“c@‹IC‚‹´‹BC’†‘ºlLC“‡“cŒªiŠOj: Žèp, 52(5): 667`672, 1998.

1302. mŒ´’˜n pŒã‡•¹Ç‚Æ‚»‚ÌŠÇ—; ŠÌ•s‘S. Š`“cÍC“‡“cŒªC‚‹´‹BiŠOj: Á‰»ŠíŠO‰È, 21(5): 911`911, 1998.

1303. mŒ´’˜n ŒuŒõF‘fPropidium iodide‚ð—p‚¢‚½•Û‘¶S‚Ìviability‘ª’è–@‚ÌŠJ”­. ŸŽ}‹`‹LC‹Ê’u“§C쑺–¾•viŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjC“c’†ŽO’ÃŽqC‰¡“c˜jOC—Ñ—²‘¥iŽD–y–kž¾•a‰@jC‚‹´’õlCŠ`“cÍiŠOj: ’ቷˆãŠw, 24(1): 41`48, 1998.

1304. mŒ´’˜n ŠÌE’_“¹EäX‘ŸŠO‰ÈŠw. Š`“cÍC“‡“cŒªC‹g“c@‹IC’†‘ºlLiŠOj: “ú–{ˆãŽ–V•ñ, (3861): 1`5, 1998.

1305. mŒ´’˜n ŠÔŸ[«æêsŽˆ‚Ì‹qŠÏ“IdÇ“x•]‰¿‚Æ‚µ‚Ä‚Ì‹ßÔŠOü•ªŒõ–@‚Ì—L—p«‚ÉŠÖ‚·‚錤‹†. ²“¡ˆêŠìC‹à鳉ÀC¼Šª”ŽC¼ŽR’¼‹vCŠ`“cÍiŠOj: “ú–{ŒŒŠÇŠO‰ÈŠw‰ïŽGŽ, 7(7): 13`20, 1998.

1306. mŒ´’˜n ˆÝŠàŽ¡—Â̑½—l«|‚Æ‚­‚É‘ŠúˆÝŠàŽ¡—Â̕ϑJ‚ɂ‚¢‚Ä|. ”äŠé”\Ž÷iŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(3): 803`812, 1998.

1307. mŒ´’˜n ™•ú«5-Fu (5-Fluorouracil)»Ü‚Ì–å–¬“àŒŒ’†”Z“x„ˆÚ. ²“¡–ÎC‘å’J„³C”äŠé”\Ž÷CŠ`“cÍiŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(4): 935`939, 1998.

1308. mŒ´’˜n ŠÌ×–EŠà”j—ôÇ—á‚ɑ΂·‚鉊úŽ¡—Õûj. “‡“cŒªC‚‹´‹BC‹g“c@‹IC–k‘º‰ë–çC”äŠé”\Ž÷CŠ`“cÍiŠOjCˆé•”‹`Œ›i•új: “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 18(2): 279`285, 1999.

1309. mŒ´’˜n ŒŸ¸‚ɑ΂·‚éf—ÕñVŠO•Û˜AŽŽˆÄ‚ɂ‚¢‚Ä. ”äŠé”\Ž÷iŠOj: “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 59(5): 7`10, 1998.

1310. mŒ´’˜n äXŠÇŒ`‘Ô‚¨‚æ‚ÑäXŠÇŒû‚ÌŠJ‘¶•]‰¿–@‚Æ‚µ‚Ä‚Ìmagnetic resonance cholangiopancreatography (MRCP)‚Ì—L—p«. –k‘º‰ë–çC‚‹´‹BC‹g“c@‹IC“‡“cŒªCŠ`“cÍiŠOjCˆé•”‹`Œ›i•új: “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 60(2): 344`350, 1999.

1311. m€Œ´’˜n Cryofiltration: A new approach for removal of anti-blood group antibody. ‚‹´¹GC‹Ê’u“§C“c’†ŽO’ÃŽqiŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjC‰¡“c˜jOC‚—ä–FFC¬ŽR“à½C“à“¡¹–¾CˆÀŒ´–ž•vC‹v–Ø“c˜a‹uC–Ú•‡ˆêC•Ä쌳Ž÷C 쑺–¾•viŽD–y–kž¾•a‰@j: Transplant. Proc., 30(7): 3275`3276, 1998.

1312. m€Œ´’˜n Efficacy of heat-shock proteins induced by severe fasting to protect rat livers preserved for 72 hours from cold ischemia/reperfusion injury. ‚‹´’õlCŽ­Žæ³“¹CŠ`“cÍiŠOjC‹Ê’u“§C“c’†ŽO’ÃŽqCŸŽ}‹`‹LC쑺–¾•viŽD–y–kž¾•a‰@j: Transplant. Proc., 30(7): 3700`3702, 1998.

1313. m€Œ´’˜n Expression of heart shock proteins induced by L(+)-glutamine injection and survival of hypothermically stored heart grafts. ¬“‡—»‘¾˜Yi“ú´»•²jC‹Ê’u“§C쑺–¾•vCŸŽ}‹`‹LiŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjC‰¡“c˜jOC—Ñ—²‘¥iŽD–y–kž¾•a‰@jC‚‹´’õlCŠ`“cÍiŠOj: Transplant. Proc., 30(7): 3746`3747, 1998.

1314. m€Œ´’˜n Experimental evaluation of hepatic circulation, energy metabolism and morphologic changes in brain death. ¡ˆäŒ‰C²“¡ŒõŽjC‚‹´‹BCˆÉ“¡‹`–çC’†ŽR‹`‰îCŠ`“cÍiŠOj: Transplant. Proc., 30: 3282`3283, 1998.

1315. m€Œ´’˜n How to support Japanese liver transplant candidates and recipients throughout the transplant process; Role of family coordinators. r”g‚悵CŽá—ѳC‰¡“c˜a•FC‹v•Û“cŠî—\ŽqC–ØTŽ¡iJR“Œ‹ž‘‡•a‰@j: Transplant. Proc., 30: 3635`3637, 1998.

1316. m€Œ´’˜n ˆÝŠàEMR‚̈ꊇ؜‚Æ•ªŠ„Øœ‚ÌŽ¡—ÃŒø‰Ê‚ƃŒ[ƒU[‚ð’†S‚Æ‚µ‚½ˆÝŽcÄ”­‚ÌŽ¡—Ã. “ˆ”ömC”äŠé”\Ž÷C’çCCX£¹Ž÷C‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC匴÷CŠ`“cÍiŠOjC“c•Ó‘C¼Œ³Ž›Ž—çi“àj: ˆÝ‚Æ’°, 33(13): 1711`1717, 1998.

1317. m€Œ´’˜n QOL‰ü‘P‚Ì‚½‚ß‚ÌH“¹ƒXƒeƒ“ƒg—¯’up. “ˆ”ömCX£¹Ž÷C’çCC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ŠO‰È, 60(6): 638`643, 1998.

1318. m€Œ´’˜n ‘ŠúˆÝŠà‹ÇŠØœ(EMR). “ˆ”ömC”äŠé”\Ž÷iŠOj: ŠO‰È, 60(6): 689`691, 1998.

1319. m€Œ´’˜n ”S–ŒØœp‚ÌŽè‹Z‚ƬÑ. “ˆ”ömC’çCCX£¹Ž÷C‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC“c•Ó‘C¼Œ³Ž›Ž—çi“àj: ŠO‰È, 60(9): 988`991, 1998.

1320. m€Œ´’˜n ––ŠúŠàŠ³ŽÒ‚ÌQOL‚̉ü‘P‚ð–Ú“I‚Æ‚µ‚½“àŽ‹‹¾“IˆÝŠà‘¢Ýp|Šà«• –Œ‰Š‚É‚æ‚éƒCƒŒƒEƒX‚ɑ΂µ‚Ä|. ’çCC“ˆ”ömCX£¹Ž÷Crˆä‹`FC‹{“à–M_C‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: Ý‘îˆã—Ã‚Æ“àŽ‹‹¾Ž¡—Ã, 2(1): 27`29, 1998.

1321. m€Œ´’˜n “–‰@‚É‚¨‚¯‚鋾o‹¾‰ºŽ©‘R‹C‹¹‚ÌŽèp—á‚ÌŒŸ“¢. “‡’J‰p–¾C“ú‹g—˜Œõiã”ö’†‰›‘‡•a‰@jCã–쑈ê˜YC‹{“à–M_C’†ŒF‘¸ŽmC”¼“cŠì”ü–çC—é–Ø“N‘¾˜YC’†‘º—²rC‘哇s•FiŠOjC¬’†çŽçC’†‘ºG•vC‰Á “¡Ž¡•¶iã”ö’†‰›‘‡•a‰@j: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 33(1): 31`35, 1998.

1322. m€Œ´’˜n ‚—îŽÒ‹Ù‹}ŠJ• Žèp—á‚ÌŒŸ“¢. —é–Ø“N‘¾˜YCã–쑈ê˜YC’†‘º—²rC”¼“cŠì”ü–çC’†ŒF‘¸ŽmiŠOjC“‡’J‰p–¾iã”ö’†‰›‘‡•a‰@jC‹{“à–M_C‘哇s•FiŠOjC’†‘ºG•viã”ö’†‰›‘‡•a ‰@j: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 33(1): 97`99, 1998.

1323. m€Œ´’˜n ˆÝüˆÛ‰è×–E‚ÌŠàŠÔŽ¿“à‚É‚¨‚¯‚é“Á«, In-vitroƒXƒLƒ‹ƒXˆÝŠàƒ‚ƒfƒ‹‚ð—p‚¢‚½ŒŸ“¢. ‹e’rŽj˜YC’çCC‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC¬—ÑLsC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: Á‰»ŠíŠà‚Ì”­¶‚Æ“W–], 10(•Êû): 361`362, 1998.

1324. m€Œ´’˜n Ý‘îˆã—Â̂½‚ß‚ÌH“¹ƒXƒeƒ“ƒgŽ¡—Ã|Šà«H“¹‹·ó‚Ì“àŽ‹‹¾Ž¡—Ã|. “ˆ”ömCX£¹Ž÷C’çCC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 10(5): 549`554, 1998.

1325. m€Œ´’˜n _“Þ쌧‚É‚¨‚¯‚é‚—îŽÒÁ‰»ŠíŠO‰ÈŽèp‚ÌŒ»‹µ‚Æ–â‘è“_|‘æ27‰ñ_“Þ쌧Á‰»ŠíŠO‰ÈŒ¤‹†‰ïƒAƒ“ƒP[ƒg’²¸WŒvŒ‹‰Ê•ñ|. Š`“cÍC’Ë–{GliŠOj: _“ÞìˆãŠw‰ïŽGŽ, 26(1): 213`218, 1999.

1326. m’Z•ñE‘¬•ñn 21¢‹I‚Ì“àŽ‹‹¾‚𖲌©‚Ä. ”äŠé”\Ž÷iŠOj: Progress of Digestive Endoscopy, 53: 30`31, 1999.

1327. m’Z•ñE‘¬•ñn “¯Œn“¯Š«ƒ‰ƒbƒgŠÌˆÚAŒã‚ÌŠÌ_ŒoĶ‚ÉŠÖ‚·‚é–Ɖu‘gD‰»Šw“IŒ¤‹†. ‚‹´‹BC‚‹´’õlC“cŠ•¶•FC—Ñ‹žŽqCâ–{‚¢‚ÂÝC”Ñ–ì‘Pˆê˜YC²“¡ŒõŽjCŠ`“cÍiŠOj: ŠÌ‘Ÿ, 39(12): 934`935, 1998.

1328. m’Z•ñE‘¬•ñn ƒ_ƒuƒ‹ƒ‹[ƒƒ“ƒJƒe[ƒeƒ‹‚ÌŒ`ó‚Ì–â‘è“_‚Æ‘Îô. •Ä쌳Ž÷C‹v–Ø“c˜a‹uC“à“¡¹–¾C¬ŽR“à½iŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjCˆÀŒ´–ž•vC“c’†ŽO’ÃŽqC‚‹´¹GC‹Ê’u“§C–Ú•‡ˆêC쑺–¾•viŽD–y–kž¾•a ‰@j: W’†Ž¡—Ã, 10(•Êû): 37`38, 1998.

1329. mŒ¤‹†•ñi•¶•”Èjn Ý‘î‰îŒì‰ü‘P‚Ì‚½‚ß‚Ì”ñNPŽ¡—Ã|“àŽ‹‹¾“IˆÝá‘‘¢Ýp(PEG)‚Ì•‹y|. “ˆ”ömC’çCCX£¹Ž÷C”äŠé”\Ž÷iŠOj: •¶•”ÈŠwpƒtƒƒ“ƒeƒBƒA„iŽ–‹Æ¢Œ’N¥’·Žõ‚Ɗ‹«ˆã‰ÈŠw£•½¬‚X”N“x‹¤“¯Œ¤‹†•ñ‘, p.87`89, 1998.

1330. mŒ¤‹†•ñi•¶•”Èjn ƒXƒLƒ‹ƒXˆÝŠàƒ‚ƒfƒ‹‚ð—p‚¢‚½ŠàŠÔŽ¿‚Ì‘¶, d‰», Žûk‚Ì‹@˜‚ÉŠÖ‚·‚錤‹†. ‹e’rŽj˜YiŠOj: •½¬‚V`‚X”N“x‰ÈŠwŒ¤‹†”ï(Šî‘bŒ¤‹†C-2)Œ¤‹†¬‰Ê•ñ‘, 1998.

1331. mŒ¤‹†•ñiŒú¶Èjn ‚ª‚ñ‚ɑ΂·‚é“àŽ‹‹¾“IŽ¡—Ö@‚Ì•]‰¿‚Æ‚»‚Ì“K‰žŠg‘å‚ÉŠÖ‚·‚錤‹†. ”’”ö‘ºi‘—§‚ª‚ñƒZƒ“jC‰Á“¡Ž¡•¶i“Œˆã‰È‘åjC‹g“c‘€i“s—§‹îž•a‰@jC“¡XF”Ži“Æ‹¦ˆã‰È‘åjC‘½“c³OiŽRŒû‘åjC“ˆ”ömiŠOjC×ì’ÁŽjiŽl‘ ‚ª‚ñƒZƒ“jC[£˜a—˜iŽRŒ`Œ§—§¬l•aƒZƒ“jC’†‘º“N–çi‘—§_ŒË•a‰@jC‘Oì‚“Vi‘—§‹ž“s•a‰@jCH’JŽõˆêiŒQ”nŒ§—§‚ª‚ñƒZƒ“jC“¹“c’mŽ÷i‘—§‘åã •a‰@j: Œú¶È‚ª‚ñŒ¤‹†•¬‹à‚É‚æ‚錤‹†•ñ‘, p.373`380, 1998.

1332. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn • •”“à‘Ÿ«áu’ɂɑ΂·‚鋹o‹¾‰º‘å“à‘Ÿ_ŒoØ—£p‚Ì—Õ°‰ž—p. ‚‹´‹BC²“¡ŒõŽjCŠ`“cÍiŠOj: •½¬‚X”N“xŠwpƒtƒƒ“ƒeƒBƒA„iŽ–‹Æ‹¤“¯Œ¤‹†•ñ‘, p.114`118, 1998.

1333. mÇ—á•ñn A primary solitary tumor of the lesser omentum with immunohitochemical features of gastrointestinal stromal tumors. ‚‹´‹BiŠOjCŒK”ö’èmi•a—jC–öŒ´³’qCŠ`“cÍiŠOj: Am. J. Gastroenterol., 93(11): 2269`2273, 1998.

1334. mÇ—á•ñn An aggressive desmoid tumor in a patient with familial adenomatous polyposis: Immunohistochemical findings. VˆäLNiŠOjCŽO•xO”VCã™G‰ii•a—jC‘ŠŒ´¬ºC‘å’J„³iŠOjC‰ªˆÀŒMi•a—j: Am. J. Gastroenterol., 94(2): 530`532, 1999.

1335. mÇ—á•ñn Multiple liver hemangiomas enlargement during long-term steroid therapy for myasthenia gravis. ‚‹´‹BiŠOjCŒK”ö’èmi•a—jC•Ð‹ËŠ°”VCŠ`“cÍiŠOj: Dig. Dis. Sci., 43(7): 1553`1561, 1998.

1336. mÇ—á•ñn • o‹¾‰º’_”X“EopŒã‚É”­Ç‚µ‚½”xÇðÇ‚Ì‚P—á. “‡“cŒªC‚‹´‹BCŒÃ“cˆê“¿C‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: JSES“àŽ‹‹¾ŠO‰È, 3(4): 317`321, 1998.

1337. mÇ—á•ñn ‘gDŠw“I‚Éf’f¢“ï‚Å‚ ‚Á‚½Œ´”­«ŠÌŠà‚Ì‚PØœ—á. ’†‘ºlLC“‡“cŒªC‹g“c@‹IC‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOjCŒK”ö’èmi•a—j: Liver Cancer, 4(1): 50`53, 1998.

1338. mÇ—á•ñn L”͈͈ÝØœŒã‚Q‚©ŒŽ‚Å”­Ç‚µ‚½ŒÇ—§«äB”^ᇂ̂PÇ—á. ŒIŒ´’¼lCŽÂŒ´ŽjC’©ŒË—TC—Ñ“ÄC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjC¼–x‰pŽ÷i‘—§‘å‘ •a‰@jC“y‹´½ˆê˜YiŠOjC•Ç“‡N˜Yi‘—§‘å‘ •a‰@j: ˆã—Ã, 52: 186`189, 1998.

1339. mÇ—á•ñn • •”Šæ’ɂɑ΂·‚éŒoH“¹—ôE«‘å“à‘Ÿ_ŒoØ—£p. ‚‹´‹BC“‡“cŒªC’†‘ºlLC‹g“c@‹IC²“¡ŒõŽjCŠ`“cÍiŠOj: Žèp, 52(12): 1911`1914, 1998.

1340. mÇ—á•ñn H“¹ŒeŽº‚𔺂Á‚½æ“V«H“¹¶‹CŠÇŽxá‘‚Ì‚P—á. —é–Ø“N‘¾˜YC‹ß“¡NŽjC—§ÎWC“cŠ•¶•FC¼”ªŽkC”ª\ì—v•½C–{‹§C”äŠé”\Ž÷CŠ`“cÍiŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(10): 2080`2084, 1998.

1341. mÇ—á•ñn \“ñŽw’°Œ´”­ˆ««ãO–Ñã”çŽî‚Ì‚P—á. “‡“cŒªC‹g“c@‹IC’†ŽRLˆêC‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(5): 1102`1106, 1998.

1342. mÇ—á•ñn äX“ª\“ñŽw’°ØœŒã‚É”­Ç‚µ‚½ŒŒð«ŒŒ¬”ÂŒ¸­«Ž‡”Á•a‚Ì‚P—á. •Ð‰ª—SˆêC‹{–{‰p—Yi–kM‘‡•a‰@jC‚–ì—eKC–Lì‹MŽiCˆÉ“¡“OiŠOjC¬À”Ži–kM‘‡•a‰@jC‰¡“c“™C¼‘º”ŽsiŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(5): 1122`1125, 1998.

1343. mÇ—á•ñn ”]“]ˆÚ‚ʼn”­‚µ‚S”N‚S‚©ŒŽŒã‚ÉŽ€–S‚µ‚½Voter“û“ª•”Šà‚Ì‚P–UŒŸ—á. ’©ŒË—TC‹“‡N‰hCŒ´²’jCŒGŒ³—Y‰îCÎ’Ë—TlC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCŒIŒ´’¼lCâ“c“¹¶CÎŒ´³–¤i‘—§‘å‘ •a‰@j: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 32: 36`40, 1999.

1344. mÇ—á•ñn von Recklinghausen•a‚ɇ•¹‚µ‚½‘å–ÔŒ´”­‹‘啽ŠŠ‹Ø“÷Žî‚Ì‚P—á. “‡“cŒªC‰¡“c“™C¼ŽR•Û”äŒÃCò‰Æ‹v’¼C‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 59(2): 545`551, 1998.

1345. mÇ—á•ñn ’¼’°Œ´”­“à•ª”å×–EŠà‚Ì‚P—á. “‡“cŒªCã–쑈ê˜YC‘哇s•FiŠOjC’†‘ºG•viã”ö’†‰›‘‡•a‰@jC”äŠé”\Ž÷CŠ`“cÍiŠOj: “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 59(5): 1346`1349, 1998.

1346. mÇ—á•ñn ’_`Ž_’°Î‚É‚æ‚鬒°ƒCƒŒƒEƒX‚Ì‚P—á. “y‹´½ˆê˜YiŠOjCŒIŒ´’¼lCŒÃìrŽ¡CŽÂŒ´ŽjC’©ŒË—TC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjC¼–x‰pŽ÷C•Ç“‡N˜Yi‘—§‘å‘ •a‰@j: “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 59: 2592`2596, 1998.

1347. mÇ—á•ñn ŠÇŠOŒ^”­ˆç‚ð’悵‚½ãè–åŠÇ–¢•ª‰»Šà‚Ì‚P—á. ¼–x‰pŽ÷i‘—§‘å‘ •a‰@jC“y‹´½ˆê˜YiŠOjCŽÂŒ´ŽjC’©ŒË—TC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCŒIŒ´’¼lC•Ç“‡N˜YCŒüˆä”ü˜aŽqi‘—§‘å‘ •a ‰@j: “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 59: 2882`2886, 1998.

1348. mÇ—á•ñn Š®‘S“à‘Ÿ‹tˆÊŠà‚ɇ•¹‚µ‚½ŠŒF×–EŽî‚Ì‚P—á. •Ç“‡N˜YCŒIŒ´’¼lC’¬‘º‹M˜YC’©ŒË—TCŽÂŒ´ŽjC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCŒÃìrŽ¡C¼–x‰pŽ÷i‘—§‘å‘ •a‰@jC“y‹´½ˆê˜YiŠOj: “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 59: 2913`2916, 1998.

1349. mÇ—á•ñn ŠÌ‰èŽî‚̬݂ð”F‚ß‚½¬lŒ^ŠÌ×–EŠá‚Ì‚P—á. ‰|–{‘ñ–ÎiŠOjC–{–¼•q˜YCŒ´Í•FC™ŽR³•FCãˆä‹`”VC´…‹»ˆêi‘—§¬Ž™•a‰@j: –k—¢ˆãŠw, 28(4): 386`390, 1998.

1350. m‘àn Çó‚ɉž‚¶‚½• •”ƒGƒR[‚ÌŠˆ—p–@; ‰º• •”’É. H–{LC‹v•Û”ŽŽki‰¡•l‘‡•a‰@jC•½–ìiiŠOj: Medicina, 35(9): 1600`1603, 1998.

1351. m‘àn ˆÝE\“ñŽw’°ŒeŽº‚ÌŽèp. “ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: Žèp, 52(4): 457`460, 1998.

1352. m‘àn ŠÌŠà‚ÌŽèp; ŠÌ’†‰›‚Q‹æˆæØœp. Š`“cÍC‚‹´‹BC‹g“c@‹ICŒÃ“cˆê“¿C‘å‹{“Œ¶iŠOj: Á‰»ŠíŠO‰È, 21: 2105`2114, 1998.

1353. m‘àn i“W—lŽ®‚©‚ç‚Ý‚½’_”XŠà‚ɑ΂·‚épŽ®‚Ì‘I‘ð. Š`“cÍC‹g“c@‹IiŠOj: Á‰»ŠíŠO‰È, 22(1): 11`18, 1999.

1354. m‘àn ƒAƒ‹ƒSƒ“ƒvƒ‰ƒYƒ}‹ÃŒÅ–@|ˆÓ‹`‚Æ«—ˆ“W–]|. ”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 10(12): 1587`1590, 1998.

1355. m‘àn Ý‘îˆã—Âð‰Â”\‚É‚·‚邽‚ß‚Ì“àŽ‹‹¾Ž¡—Ã|‚»‚ÌðŒ‚Æ–â‘è“_|. ”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 10(5): 536`537, 1998.

1356. m‘àn ˆ««‹·ó‚ɑ΂·‚éƒXƒeƒ“ƒgŽ¡—Ã. “ˆ”ömiŠOj: Á‰»Ší“àŽ‹‹¾, 11(1): 128`131, 1999.

1357. m‘àn ‘ŠúˆÝŠà‚ÌŽ¡—Ã, ‚¢‚Ü‘Û“IŠÖS‚Í. ”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 11(2): 301`304, 1999.

1358. m‘àn “àŽ‹‹¾‰ºƒXƒeƒ“ƒeƒBƒ“ƒOŽ¡—Â̊T‹µ. X£¹Ž÷C’çCC²“¡ˆêŠìC“ˆ”ömC”äŠé”\Ž÷iŠOj: Vˆã—Ã, 25: 114`115, 1998.

1359. m‘àn —Õ°ˆãŠw‚Ì“W–]; ŠÌ’_äXŠO‰È. Š`“cÍC‹g“c@‹IC‚‹´‹BC“‡“cŒªC’†‘ºlLiŠOj: “ú–{ˆãŽ–V•ñ, (3861): 1`5, 1998.

1360. m‘àn “û–[‰·‘¶—Ö@|‚»‚ÌŒã‚Ì“WŠJ; “û–[‰·‘¶—Ö@‚Ì“K‰ž‚ɂ‚¢‚Ä. •ŸŠÔ‰p—Si’é‹ž‘åjC‘ •ÀŸiŠOjC‰J‹{Œúi‘å‘D’†‰›•a‰@j: “û‘B¥bó‘BŠO‰ÈPractical Discussion, p.15`21, 1998.

1361. m‘àn “û–[‰·‘¶—Ö@|‚»‚ÌŒã‚Ì“WŠJ; “û‘BŽîᎂÌØœ•û–@‚Æãüâ|Šs´‚͈̔Í. •ŸŠÔ‰p—Si’é‹ž‘åjC‘ •ÀŸiŠOjC‘ºŽRÍ—Ti‘å‘D’†‰›•a‰@j: “û‘B¥bó‘BŠO‰ÈPractical Discussion, p.22`30, 1998.

1362. m‘àn “û–[‰·‘¶—Ö@|‚»‚ÌŒã‚Ì“WŠJ; Š³ŽÒ‚³‚ñ‚Ì–ž‘«“x‚ɂ‚¢‚Ä. ¼ì“Oi¹ƒ}ƒŠˆã‘åjCÎìFi‰¡•lŽs‘åjC‘ •ÀŸiŠOj: “û‘B¥bó‘BŠO‰ÈPractical Discussion, p.62`67, 1998.

1363. muÀn “ÁW; ‹}«ŒŒŠÇ«•a•Ï‚Ìf’f‚ÆŽ¡—Ö@‚Ì‘I‘ð. ‹à鳉ÀC¼ŽR’¼‹vCrˆä‹`FiŠOjC•½“cŒõ”Ži‹~–½jCŠ`“cÍiŠOj: ‹~‹}ˆãŠw, 22(9): 1036`1041, 1998.

1364. mŠwp‘n i’P’˜j ‰b’mEŽÀ‘HE‚»‚µ‚Ä’§í|“ú–{Á‰»ŠíŠO‰ÈŠw‰ï50‰ñ‚Ì‹OÕ|. ”äŠé”\Ž÷iŠOj. •ÒW ”äŠé”\Ž÷i–k—¢‘åjC•ÒC ˆãŠw‘‰@, “Œ‹ž, 98.07.15”­s.

1365. mŠwp‘n i•ª’SŽ·•Mj •W€ŠO‰ÈŠw; –³‹Û–@i–Å‹Û–@‚¨‚æ‚ÑÁ“Å–@),Šà‚̉»Šw—Ö@, p.31`36, Š`“cÍiŠOj. •ÒW ¬–ömi“Œ—ˆã‘åjC¼–쳋Ii“Œ–k‘åjC–k“‡­Ž÷iŒc‘åjC•ÒC ˆãŠw‘‰@, “Œ‹ž, 98.05.15”­s.

1366. mŠwp‘n i•ª’SŽ·•Mj Á‰»Ší“àŽ‹‹¾Ž¡—Ã}ƒjƒ…ƒAƒ‹i‰ü’ù‘æ2”Å); Ž¡—Âɓ–‚½‚Á‚Ä‚ÌS\‚¦, p.5`10, ”äŠé”\Ž÷iŠOj. •ÒW “¡“c—Íiº˜a‘åjC”äŠé”\Ž÷i–k—¢‘åjC•ÒC “ìŒõ“°, “Œ‹ž, 98.12.10”­s.

1367. mŠwp‘n i•ª’SŽ·•Mj Á‰»Ší“àŽ‹‹¾Ž¡—Ã}ƒjƒ…ƒAƒ‹i‰ü’ù‘æ2”Å); Á‰»ŠÇ‹·ó‚ɑ΂·‚鎡—Ã, p.115`136, “ˆ”ömiŠOj. •ÒW “¡“c—Íiº˜a‘åjC”äŠé”\Ž÷i–k—¢‘åjC•ÒC “ìŒõ“°, “Œ‹ž, 98.12.10”­s.

1368. mŠwp‘n i•ª’SŽ·•Mj Ž¦´‚É•x‚ÞŠÌŽ¾Š³i‘æ‚P”Å); ƒXƒeƒƒCƒh•ž—p’†‚É‘‘債‚½ŠÌŠC–È󌌊ǎî‚Ì•a—‘gDŠw“IŠÏŽ@, p.221`227, ‚‹´‹BiŠOjCŒK”ö’èmi•a—jC•Ð‹ËŠ°”VC‰|–{‘ñ–ÎC’†‘ºlLC“‡“cŒªC‹g“c@‹ICŠ`“cÍiŠOj. •ÒW ²“¡rˆêiŠâŽèˆã‘åjC•ÒC V‹»ˆãŠwo”ÅŽÐ, “Œ‹ž, 99.01.05”­s.

1369. mŠwp‘n i•ª’SŽ·•Mj ŠO—ˆf—Â̂·‚ׂÄ; ‹}«ˆÝ”S–Œ•a•Ï(AGML), p.352`353, ’Ë–{GlC”äŠé”\Ž÷iŠOj. ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 99.01.14”­s.

1370. mŠwp‘n i•ª’SŽ·•Mj ŽèpŽºŒ¤Cˆãƒ}ƒjƒ…ƒAƒ‹; Ž~ŒŒ, p.122`131, “ˆ”ömC”äŠé”\Ž÷CŠ`“cÍiŠOj. •ÒW ‹g–씣ˆêi“Œ‹žŽ•‰È‘åjCŒÃŽRM–¾iç—t‘åjC•ÒC f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 99.02.10”­s.

1371. mŠwp‘n i•ª’SŽ·•Mj —Õ°ŽŽŒ±iVGCP)‚ð‚ß‚®‚é”–â‘è; ‰^‰c, ‚ ‚Æ‚ª‚«, p.151`152, Š`“cÍC”äŠé”\Ž÷iŠOj. •ÒW ŽR‰ª‹`¶CŽ›–ì²C•ÒC Šw‰ïo”ŃZƒ“ƒ^[, ‘åã, 99.02.00”­s.

1372. mŠwp‘n i•ª’SŽ·•Mj TEXTŠO‰ÈŠw; ’_“¹, p.630`655, Š`“cÍC‘å‹{“Œ¶C‹g“c@‹IiŠOj. •ÒW ™’¬Œ\‘ i‹ã‘åjC–›ˆÉ³‹`i‹à‘ò‘åjC‰ª“c³iã‘åjC•“¡“Oˆê˜Yi“Œ‘åjC•ÒC “ìŽR“°, “Œ‹ž, 98.03.30”­s.

1373. m‹³‰È‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚Ìf’f‚Æ“à‰È“IŽ¡—Ã; ¬’°Šà, ‘å’°Šà‚̉»Šw—Ö@, ‘å’J„³iŠOj. •ÒW ¼Œ³Ž›Ž—çi–k—¢‘åjC’JŒû–Òi“Œ‹ž‚ª‚ñ‰»Šw—Ö@Œ¤‹†‰ïjCŽÄ“c‹v—YCŸ–””º‰hi–k—¢‘åjC•ÒC ˆãŠw‘‰@, “Œ‹ž, 98.04.15”­s.

1374. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ÒWj Šà«H“¹‹·ó‚̃Xƒeƒ“ƒgŽ¡—Ã. “ˆ”ömiŠOj. •ÒW “ˆ”ömi–k—¢‘åjC•ÒC Care Net TV, “Œ‹ž, 99.02.22”­s.

1375. mŠw‰ïi‘Ûjn i“Á•Êu‰‰j Premalignant and early stages of carcinomas of the gastrointestinal tract. ”äŠé”\Ž÷iŠOj: 28th Congress der Deutschen Gesellschaft fur Endoskopie i98.03.26j, Munchen.

1376. mŠw‰ïi‘Ûjn i“Á•Êu‰‰j ˆÝŠà“I‹ß‘㎡—Ã. ”äŠé”\Ž÷iŠOj: ‘æ‚T‰ñ‘ÛÁ‰»“àŽ‹‹¾Á‰»Œn•a‰ï i98.12.05j, LB.

1377. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Nitric oxide donor induces upregulation of stress proteins in cold ischemic rat heart. Ž­Žæ³“¹iŠOjC‹Ê’u“§C“c’†ŽO’ÃŽqCŸŽ}‹`‹LC—t‹PC{“¡ƒˆêC‰¡“c˜jOC—Ñ—²‘¥C쑺–¾•viŽD–y–kž¾•a‰@jC‚‹´’õlCŠ`“cÍiŠOj: 17th World Congress of the Transplantation Society i98.07.12`17j, Montreal, Canada.

1378. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Cytoprotective role of antioxidant stress protein induced by adenosine A1 receptor antagonist in rat heart ischemic injury. Ž­Žæ³“¹iŠOjC‹Ê’u“§C“c’†ŽO’ÃŽqCŸŽ}‹`‹LC—t‹PC{“¡ƒˆêC‰¡“c˜jOC—Ñ—²‘¥C쑺–¾•viŽD–y–kž¾•a‰@jCŠ`“cÍiŠOj: 17th World Congress of the Transplantation Society i98.07.12`17j, Montreal, Canada.

1379. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Transhiatal bilateral splanchinicectomy for the relief of intractable abdominal pain in patients with end-stage of pancreas cancer. “‡“cŒªC‚‹´‹BC’†‘ºlLC‹g“c@‹IC²“¡ŒõŽjCŠ`“cÍiŠOj: 15th Congress of the Pan-pacific Surgical Association i98.10.29`31j, Saipan, Abstracts, p.55, 1998.

1380. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j A simpler technique of pancreatojejunal anastomosis in pancreatoduocdnectomy. ‹g“c@‹ICŠ`“cÍC‚‹´‹BC’†‘ºlLC“‡“cŒªC²“¡ŒõŽjiŠOj: 15th Congress of the Pan-pacific Surgical Association i98.10.29`31j, Saipan, Abstracts, p.56, 1998.

1381. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Immunohistochemical and electron microscopic studies on the extrinsic hepatic reinnervation following orthotopic liver transplantation in rats. â–{‚¢‚ÂÝC‚‹´‹BC‚‹´’õlC—Ñ‹žŽqC“cŠ•¶•FC”Ñ–ì‘Pˆê˜YCˆÉ“¡‹`–çC²“¡ŒõŽjCŠ`“cÍiŠOj: 15th Congress of the Pan-pacific Surgical Association i98.10.30j, Saipan, Abstracts, p.39, 1998.

1382. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j An outcome of failure to detect pancreatic injury in patients with blunt trauma in the abdomen. â–{‚¢‚ÂÝC‚‹´‹BC“‡“cŒªC’†‘ºlLC‹g“c@‹IiŠOjC‘å˜a“c—²i‹~–½jC‘꓇í‰ëCŠ`“cÍiŠOj: 7th International Conference of Emergency Medicine i98.03.26`29j, Vancouver, Canada.

1383. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Correlation between the hepatic reinnervation and the recovery of altered hepatic blood flow following surgical hepatic denervation in dogs. ‚‹´‹BCˆÉ“¡‹`–çC“cŠ•¶•FC”Ñ–ì‘Pˆê˜YC—Ñ‹žŽqC‚‹´’õlC²“¡ŒõŽjCŠ`“cÍiŠOj: ‘æ33‰ñ‰¢BŽÀŒ±ŠO‰ÈŠw‰ï i98.04.22`25j, ƒCƒ^ƒŠƒA, ƒvƒƒOƒ‰ƒ€, p.67, 1998.

1384. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The effectiveness of self-expandable metallic stent (SEMS) insertion for malignant upper gastrointestinal tract stricture. X£¹Ž÷C“ˆ”ömC’çCC‹ß“¡Œ«ŽiCrˆä‹`FC•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷iŠOj: ‘æ‚V‰ñ‘ÛƒXƒeƒ“ƒgEƒOƒ‰ƒtƒgƒVƒ“ƒ|ƒWƒEƒ€ i98.05.21j, “Þ—Ç, ´˜^W, p.55, 1998.

1385. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j An application of water jets to laparoscopic surgery. ‹g“c@‹ICŠ`“cÍC’†‘ºlLC“‡“cŒªC‚‹´‹BiŠOj: 6th World Congress of Endoscopic Surgery i98.05.31`06.06j, Rome.

1386. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Comparison plastic stent with self expandable stents in a standpoint of quality of life for upper GI malignant stenosis. “ˆ”ömC’çCCX£¹Ž÷C•Ð“c‰Ä–çC‹ß“¡Œ«ŽiC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: 11th World Congress of Gastroenterology i98.09.10j, Vienna, Austria, Digestion, 58(Suppl. 3): 636, 1998.

1387. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j A eight years study with antithrombotic therapy for deep vein thrombosis. ¼ŽR’¼‹vC‹à鳉ÀCrˆä‹`FC“‡’÷ˆêCŠ`“cÍiŠOj: 18th World Congress of the International Union of Angiology i98.09.15j, “Œ‹ž, Abstract, p.204, 1998.

1388. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Laparoscopic-guided cholecystectomy in patients with acute cholecystitis. ¯–ìOŽ÷C“‡“cŒªC’†‘ºlLC‚‹´‹BC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: 16th World Congress Collegium Internationale Chirurgiae Digestivae i98.09.16`19j, Madrid, Spain, Digestive Surgery, 15(5): 433, 1998.

1389. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Result of EMR to the location of early gastric cancer. “ˆ”ömC’çCC”äŠé”\Ž÷CX£¹Ž÷C¯–ìOŽ÷C匴÷CŠ`“cÍiŠOj: 16th World Congress Collegium Internationale Chirurgiae Digestivae i98.09.16`19j, Madrid, Spain, Digestive Surgery, 15(5): 454, 1998.

1390. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Decompression PEG to improve the QOL with terminal cancer. ’çCC“ˆ”ömC”äŠé”\Ž÷C¯–ìOŽ÷CX£¹Ž÷C匴÷CŠ`“cÍiŠOj: 16th World Congress Collegium Internationale Chirurgiae Digestivae i98.09.16`19j, Madrid, Spain, Digestive Surgery, 15(5): 456, 1998.

1391. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Is stent placement effective with respect to quality of life? “ˆ”ömC’çCCX£¹Ž÷C”äŠé”\Ž÷C匴÷C‹e’rŽj˜YC¬—ÑLsCŠ`“cÍiŠOj: 16th World Congress Collegium Internationale Chirurgiae Digestivae i98.09.16`19j, Madrid, Spain, Digestive Surgery, 15(5): 467`468, 1998.

1392. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Re-evaluation of laporoscopic herniorrhepty. ŒÃ“cˆê“¿iŠOjC’©ŒË—TC‰ºŽR–LCŒIŒ´’¼lCâ“c“¹¶i‘—§‘å‘ •a‰@jC”äŠé”\Ž÷CŠ`“cÍiŠOj: ELSA i98.11.03`06j, ãŠC.

1393. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j An improved procedure of laparoscopic surgery for colorectal cancer; Expanding indication. ‘êK‹ÏC‘å’J„³C‹à‘òG‹ICÎ씎˜aC‘ŠŒ´¬ºC–ì‘ò’¼ŽjCŒÃì—T‰îC¼ŽR•Û”äŒÃCˆäŒ´ŒúC”äŠé”\Ž÷iŠOj: •Ä‘“àŽ‹‹¾ŠO‰ÈŠw‰ï i99.03.24`25j, San Antonio, USA.

1394. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Reevaluation of laparoscopic herniorrhaphy. ŒÃ“cˆê“¿iŠOjC’©ŒË—TC‰ºŽR–LCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤i‘—§‘å‘ •a‰@jC”äŠé”\Ž÷CŠ`“cÍiŠOj: Society of American Gastrointestinal Endoscopic Surgeons i99.03.24`25j, San Antonio, USA.

1395. mŠw‰ïi‘S‘jn ih‘è•ñj • o‹¾‰º’_”X“EopŒã‚É”­Ç‚µ‚½”x[Ç‚Ì‚Q—á. “n•Ó‹v”üŽqC²“¡–ÎC“c‘ºK•äCù–{_C•Ð“c‰Ä–çCX£¹Ž÷iŠOj: ‘æ11‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï i98.12.10`11j, “Œ‹ž, “àŽ‹‹¾ŠO‰È, 3(7): 150, 1998.

1396. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j H“¹Šà«‹·ó‚ɑ΂·‚éƒXƒeƒ“ƒeƒBƒ“ƒO‚ÆPEG. “ˆ”ömiŠOj: ‘æ40‰ñ“ú–{Á‰»Ší•aŠw‰ïPost-Graduate CourseƒZƒ~ƒi[ i98.10.30j, “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 95(—Õ‘): 83, 1998.

1397. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’ጌˆ³ó‘Ô‚É‚¨‚¯‚éŠÌzŠÂ“®‘Ԃƃzƒ‹ƒ‚ƒ““®‘Ô‚Ì‘Šˆá‚ɂ‚¢‚Ä|”]Ž€ƒ‚ƒfƒ‹‚Æ’EŒŒƒ‚ƒfƒ‹‚Ì”äŠr|. ‘åÀ“cŽ¡C²“¡ŒõŽjC¬ìŒ›ÍC¡ˆäŒ‰C‚‹´‹BC’†ŽR‹`‰îCŠ`“cÍiŠOj: ‘æ5‰ñ“ú–{‘ŸŠí•Û‘¶¶•¨ˆãŠw‰ï‘‰ï i98.05.28`29j, “Œ‹ž, Organ Biol., 5(2): 57, 1998.

1398. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒ‰ƒbƒgS‘jŒŒÄŠÁ—¬ŠQ‚É‚¨‚¯‚é“àˆö«EŠOˆö«Nitric oxide (NO)‹Ÿ—^‘Ì‚Ì—L—p«. Ž­Žæ³“¹iŠOjC‹Ê’u“§C“c’†ŽO’ÃŽqCŸŽ}‹`‹LC“à“c‘׎ŠC—t‹PC‰¡“c˜jOC—Ñ—²‘¥C쑺–¾•viŽD–y–kž¾•a‰@jC‚‹´’õlCŠ`“cÍiŠOj: ‘æ25‰ñ“ú–{’ቷˆãŠw‰ï‘‰ï i98.07.24`25j, ˆ®ì.

1399. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j äX“ª•”ŠàpŒãÄ”­—á‚ɑ΂·‚鎡—Õûj. “‡“cŒªC‚‹´‹BC’†‘ºlLC’çCC“ˆ”ömC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ31‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i98.09.04j, ç—t, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 18(5): 676, 1998.

1400. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŠúˆÝŠàEMRˆâŽc‚ɑ΂·‚é’ljÁƒŒ[ƒU[ÆŽË. X£¹Ž÷C“ˆ”ömC’çCC‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷iŠOjC“c•Ó‘C¼Œ³Ž›Ž—çi“àj: ‘æ19‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï i98.09.25j, “Œ‹ž, ´˜^W, p.68, 1998.

1401. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j H“¹Šà«‹·ó‚ÌŠg’£EƒXƒeƒ“ƒgp. “ˆ”ömiŠOj: “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘æ‚S‰ñd“_‘²Œã‹³ˆçƒZƒ~ƒi[ i98.11.07j, “Œ‹ž, —\•ñW, p.12`22, 1998.

1402. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹¾Ž‹‰º‘å’°Žèp‚É‚¨‚¯‚éPitfall‚̉ñ”ð. ‘êK‹ÏC‘å’J„³C‹à‘òG‹ICÎ씎˜aC‘ŠŒ´¬ºC–ì‘ò’¼ŽjCŒÃì—T‰îC¼ŽR•Û”äŒÃCˆäŒ´ŒúC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 167, 1998.

1403. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j H“¹ƒAƒJƒ‰ƒVƒA‚ɑ΂·‚é• o‹¾‰º‹Ø‘wØŠJp. •Ð“c‰Ä–çC÷–{MˆêC“ˆ”ömC‹ß“¡Œ«ŽiC’çCC¬—ÑLsC‹e’rŽj˜YC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC“c•Ó‘i“àj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 180, 1998.

1404. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘½‘ŸŠíƒhƒi[‚É‚¨‚¯‚éŠÌ, äX, t‹@”\‚Ì•]‰¿|Potential cadaver donor‚É‚¨‚¯‚錟“¢|. ’†ŽR‹`‰îC‘åÀ“cŽ¡C¬ìŒ›ÍC¡ˆäŒ‰C²“¡ŒõŽjCŠ`“cÍiŠOj: ‘æ34‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i98.11.30`12.02j, “Œ‹ž, ˆÚA, 33(‘): 140, 1998.

1405. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j • o‹¾‰º‘å’°Žèp‚É‚¨‚¯‚éno-touch isolation technique‚ÌH•v|Œã• –ŒƒAƒvƒ[ƒ`•¹—p|. ‘êK‹ÏC‘å’J„³CÎ씎˜aC‹à‘òG‹IC‘ŠŒ´¬ºC¼ŽR•Û”äŒÃCˆäŒ´ŒúC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 241, 1999.

1406. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒXƒLƒ‹ƒXˆÝŠàƒ‚ƒfƒ‹‚ð—p‚¢‚½ŠÔŽ¿ƒRƒ‰[ƒQƒ“ˆÝüˆÛ‰è×–E, Šà×–E‚Ì‘ŠŒÝì—p‚ÉŠÖ‚·‚錤‹†. ‹e’rŽj˜YC¬—ÑLsC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 44, 1999.

1407. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ØœŒãĶäX‚É‚¨‚¯‚é“à•ª”å×–E‚Ì‘B“®‘Ô‚ÉŠÖ‚·‚é–Ɖu‘gD‰»Šw“IŒ¤‹†. —Ñ‹žŽqCŠ`“cÍiŠOj: “ú–{‰ð–UŠw‰ï i99.03.29j, “Œ‹ž.

1408. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj “ûŠà• o“à‘ŸŠí“]ˆÚ‚ɂ‚¢‚Ä‚ÌŒŸ“¢; “Á‚ÉÁ‰»Ší“]ˆÚÇ—á‚ɂ‚¢‚Ä. ‘ •ÀŸCŒ´‰pCŒY•”“ŒŽ¡CΓc˜a•vC‘åê³›ßCŠ`“cÍiŠOj: ‘æ‚U‰ñ“ú–{“ûŠàŠw‰ï‘‰ï i98.05.23j, “Œ‹ž, ´˜^W, p.19, 1998.

1409. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ––ŠúŠàŠ³ŽÒ‚ɑ΂·‚錸ˆ³PEG. ’çCC“ˆ”ömCX£¹Ž÷C‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ70‰ñ“ú–{ˆÝŠàŠw‰ï i98.06.19j, “Œ‹ž.

1410. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‘ŠúˆÝŠà‚ɑ΂·‚é“àŽ‹‹¾Ž¡—ìьüã‚Ì‚½‚ß‚ÌH•v|EMR‚Æ‚o—̓Œ[ƒU[‚Ì•¹—p—Ö@|. “ˆ”ömC’çCCX£¹Ž÷C•Ð“c‰Ä–çC‹ß“¡Œ«ŽiC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷C÷–{MˆêC’Ë–{GlCŠ`“cÍiŠOjC“c•Ó‘C¼Œ³Ž›Ž—çi“àj: ‘æ70‰ñ“ú–{ˆÝŠàŠw‰ïƒrƒfƒIƒ[ƒNƒVƒ‡ƒbƒv¢“àŽ‹‹¾Ž¡—ÂÌV‚½‚ÈH•v£ i98.06.19j, “Œ‹ž, ´˜^W, p.50, 1998.

1411. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‰©át‚Å”­Ç‚µ‚½’_“¹•ÂÇ‚ÌŽ¡—Õûj. ŒÃ“cˆê“¿iŠOjC’©ŒË—TC‰ºŽR–LC¼–x‰pŽ÷CŒIŒ´’¼li‘—§‘å‘ •a‰@jC“y‹´½ˆê˜YiŠOjC•Ç“‡N˜YC—Ñ“ÄC‘¼i‘—§‘å‘ •a‰@j: ‘æ31‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i98.09.03j, ç—t.

1412. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŠÉ˜aˆã—Ãiáu’ɈȊOj‚É‚¨‚¯‚é”ñ–ò•¨—Ö@|Šà«‹·ó‚ɑ΂·‚éstenting•À‚Ñ‚ÉŠà«• –Œ‰Š‚É‚¨‚¯‚錸ˆ³ˆÝá‘‚Ì“K‰ž‚ð‚ß‚®‚Á‚Ä|. ”äŠé”\Ž÷C“ˆ”ömiŠOj: ‘æ57‰ñ“ú–{ŠàŠw‰ï‘‰ï i98.09.30j, ‰¡•l, ‘‰ï‹LŽ–, p.46, 1998.

1413. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ”÷×ΊD‰»•a•Ï‚𔺂¤”ñG’m•a•Ï‚ÌŒŸ“¢. Œ´‰pCΓc˜a•vC‘ •ÀŸC‘åê³›ßCŠ`“cÍiŠOj: ‘æ‚W‰ñ“ú–{“ûŠàŒŸfŠw‰ï‘‰ï i98.11.19j, ’·è, —\eW, p.315, 1998.

1414. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ˆÝE\“ñŽw’°’×á‡úE‚ɑ΂·‚é•Û‘¶—Ö@‚ÌŒŸ“¢. ’Ë–{GlC—é–Ø“N‘¾˜YC’çCCrˆä‹`FC÷–{MˆêCˆ¢‘]˜a“NC‹e’rŽj˜YC‘꓇í‰ëC“ˆ”ömCΓc˜a•vC²“¡ŒõŽjC”äŠé”\Ž÷CŠ`“cÍiŠOjC•½“cŒõ”Ži‹~ –½j: ‘æ32‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i99.03.18j, ‰¡•l, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 19(2): 184, 1999.

1415. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒ‰ƒbƒgS‹•ŒŒÄŠÁ—¬ŠQ‚É‚¨‚¯‚éNitric Oxide‹Ÿ—^‘̂̃hƒi[‘O“Š—^‚ÌŒø‰Ê. Ž­Žæ³“¹iŠOjC‹Ê’u“§C“c’†ŽO’ÃŽqCŸŽ}‹`‹LiŽD–y–kž¾•a‰@jC“à“c‘׎ŠiŠOjC‰¡“c˜jOC—Ñ—²‘¥C‰œ‰ÍŽéŠóC쑺–¾•viŽD–y–kž¾•a‰@jCŠ`“cÍ iŠOj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽGŽ, 100(‘): 73, 1999.

1416. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰EŠÌ“®–¬, ‰EŠÌÖ¬, –å–¬‚𓯎žŒ‹ãF‚µƒtƒHƒ[‚µ‚½ŠÌŽîᇂ̂P—á. “cŠ•¶•FC•½ˆär’jC²“¡–qC—§ÎWCX£¹Ž÷C¼”ªŽkC”ª\ì—v•½iŠOj: ‘æ51‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.02.19j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 31(2): 487, 1998.

1417. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒZƒNƒŒƒ`ƒ“•‰‰×Œã‚ÌMRCP‰æ‘œ‚É‚æ‚éäX“ª\“ñŽw’°ØœŒã‚Ì•«‡•”äXŠÇŠJ‘¶•]‰¿‚̉”\«. “‡“cŒªC‚‹´‹BC‹g“c@‹IC’†‘ºlLC–k‘º‰ë–çC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ98‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i98.04.08`10j, “Œ‹ž, “ú–{ŠO‰ÈŠw‰ïŽGŽ, 99(—Õ‘): 313, 1998.

1418. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚킪‘‚̈ÚAŠO‰È‚Ì«—ˆ|“–‰@‚É‚¨‚¯‚éPotential cadaver donor‚ÌŒŸ“¢|. ’†ŽR‹`‰îC²“¡ŒõŽjC‘åÀ“cŽ¡C¬ìŒ›ÍCˆÉ“¡‹`–çC¡ˆäŒ‰Cˆ¢‘]˜a“NiŠOjC‰““¡’‰—Yi”åjC‘å˜a“c—²i‹~–½jCŠ`“cÍiŠOj: ‘æ98‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i98.04.08`10j, “Œ‹ž, “ú–{ŠO‰ÈŠw‰ïŽGŽ, 99(—Õ‘): 378, 1998.

1419. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgSˆÚA‚É‚¨‚¯‚éS“Eo‘ONO‹Ÿ—^‘Ì“Š—^‚Ì—L—p«. Ž­Žæ³“¹iŠOjC—t‹PC‹Ê’u“§CŸŽ}‹`‹LC“c’†ŽO’ÃŽqC{“¡ƒˆêC‰¡“c˜jOC—Ñ—²‘¥C쑺–¾•viŽD–y–kž¾•a‰@jCŠ`“cÍiŠOj: ‘æ98‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i98.04.08`10j, “Œ‹ž, “ú–{ŠO‰ÈŠw‰ïŽGŽ, 99(—Õ‘): 394, 1998.

1420. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌ–å•”‚É‚¨‚¯‚éˆÚAŠÌ_Œo‚ÌĶ‰ß’ö‚Ì‘gDŠw“IŠÏŽ@. ‚‹´‹BC‚‹´’õlC”Ñ–ì‘Pˆê˜YC—Ñ‹žŽqC“cŠ•¶•FCˆÉ“¡‹`–çC²“¡ŒõŽjCŠ`“cÍiŠOj: ‘æ34‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï i98.04.15`16j, ‰¡•l, ŠÌ‘Ÿ, 39(Suppl.): 162, 1998.

1421. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚T•a‘ƒ‚ð—L‚µ‚½ˆÝ‘½”­Šà‚Ì‚P—á. ²–쌛iŠƒ–è“¿F‰ï•a‰@jC¼è”ŽsiŠOjC•s“®Ž›ƒ–¾C‘“c‘äŽjCŽO—Ö”Ž‹viŠƒ–è“¿F‰ï•a‰@j: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.04.15j, ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽ, 95(—Õ‘): 191, 1998.

1422. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˜AŒgE—û’BEŒ¤èr‚ÌÁ‰»Ší•aŠw|‘å’°Ž¾Š³f’fEŽ¡—Â̕ϑJ‚æ‚è|. ”äŠé”\Ž÷iŠOj: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.04.16j, ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽ, 95(—Õ‘): 89, 1998.

1423. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝØœŒãÇ—á‚ɑ΂·‚é“àŽ‹‹¾“IˆÝá‘‘¢Ýp. ’çCC“ˆ”ömCX£¹Ž÷C‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ55‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.04.18j, ‰¡•l, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 40(339): 432, 1998.

1424. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j IABPƒoƒ‹[ƒ““à‚ÌŒŒð‚É‚æ‚è‘å“®–¬•ÂÇ‚ð‚«‚½‚µ‚½‚PÇ—á. ¼ŽR’¼‹vC‹à鳉ÀCrˆä‹`FC²“¡ˆêŠìCŠ`“cÍiŠOjCÂŽR’¼‘Pi‹~–½j: ‘æ26‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ï i98.05.13j, “Œ‹ž, “ú–{ŒŒŠÇŠO‰ÈŠw‰ïŽGŽ, 7(2): 376, 1998.

1425. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —tóŽîá‡23—á‚̖Ɖu‘gDŠwõF‚É‚æ‚é—Õ°•a—Šw“IŒŸ“¢. ’©ŒË—TCŒüˆä”ü˜aŽqCŽÂŒ´Žji‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCŒIŒ´’¼lC‹“‡N‰hCŒ´²’jCŒGŒ³—Y‰îi‘—§‘å‘ •a‰@j: ‘æ‚U‰ñ“ú–{“ûŠàŠw‰ï‘‰ï i98.05.23j, “Œ‹ž, ´˜^W, p.195, 1998.

1426. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™‘lŒaƒwƒ‹ƒjƒAŽèp‚̇•¹Ç‚©‚ç‚Ý‚½Žèp•ûj‚ÌÄŒŸ“¢. Γc˜a•vCŠ“cç”ü”TC’©’·“N–íCŠ`“cÍiŠOj: ‘æ35‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i98.05.27j, ‹à‘ò, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽ, 34(3): 523, 1998.

1427. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 5FU­—ÊŽ‘±‚¨‚æ‚ÑCDDP•p‰ñ’“ü•¹—p—Ö@‚ÌäXŠàŠÌ“]ˆÚ—}§Œø‰Ê. ’†‘ºlLC‹g“c@‹IC–k‘º‰ë–çC“‡“cŒªC‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.04`05j, ˜a‰ÌŽR, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46(Suppl. A): 105, 1998.

1428. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “àŽ‹‹¾“IˆÝá‘‘¢Ýp‚É‚¨‚¯‚錸ˆ³Œø‰Ê‚ÌŒŸ“¢. ’çCC“ˆ”ömCX£¹Ž÷C•Ð“c‰Ä–çC‹ß“¡Œ«ŽiC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ23‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ïŠwpW‰ï i98.06.05j, ŒF–{, “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 23(3): 521, 1998.

1429. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠJ• Žèp‚É‚¨‚¯‚éƒvƒ‰ƒYƒ}ƒRƒAƒMƒ…ƒŒ[ƒ^[(PC)‚ÌŽg—pŒoŒ±. “ˆ”ömC’çCCrˆä‹`FC•Ð“c‰Ä–çC‹ß“¡Œ«ŽiC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC¼ˆäÆK: ‘æ23‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ïŠwpW‰ï i98.06.05j, ŒF–{, “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 23(3): 528, 1998.

1430. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äXŠÇ–ü‡•s‘SÇ(Divism)‚ɇ•¹‚µ‚½äX_Œo“à•ª”å×–EŠà‚Ì‚P—á. “‡“cŒªC‚‹´‹BCù–{MKC’†‘ºlLC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ23‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ïŠwpW‰ï i98.06.05j, ŒF–{, “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 23(3): 548, 1998.

1431. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹‘å‚Ȍ㕠–ŒŽ‰–b“÷Žî‚Ì‚QØœ—á. â–{‚¢‚ÂÝC¬—ÑLsC“n•Ó‹v”üŽqC¬‘ò•½‘¾CדcŒjCÄ“¡Œöˆê˜YCŒI“c~Cª–{—S‘¾C‹e’rŽj˜YC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ23‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ïŠwpW‰ï i98.06.05j, ŒF–{, “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 23(3): 580, 1998.

1432. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¶’°œ‹Ø”^á‡, ¶‘å‘ډ󎀫‹Ø, ‹Ø–Œ‰Š‚Ì‚PŽèp—á. ‘匴ˆê‹KiJR“Œ‹ž‘‡•a‰@jC‰¡“c˜a•FC“cŒ´@“¿iŠOjC“c’†Œ·C•Ÿ¬M”ŽC“c’†Œ‰C•ŸŒõ³sC”nŸºº•FCŠ›ì·GCŽRŠÝ“ñ˜YiJR“Œ‹ž‘‡•a‰@j: ‘æ52‰ñ“ú–{Œð’ʈãŠw‰ï‘‰ï i98.06.06`07j, ŽD–y, Œð’ʈãŠw, 52(1,2): 47, 1998.

1433. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ã• •”‚šŽšŒ^ØŠJ, Pringle–@, ƒAƒCƒmƒƒ^[ƒ[, CUSA‚É‚æ‚éŠÌØœp‚ÌŒŸ“¢. “c’†Œ‰C•Ÿ¬M”ŽC“c’†Œ·iJR“Œ‹ž‘‡•a‰@jC“cŒ´@“¿iŠOjC‘匴ˆê‹KC‰¡“c˜a•FC•ŸŒõ³siJR“Œ‹ž‘‡•a‰@j: ‘æ52‰ñ“ú–{Œð’ʈãŠw‰ï‘‰ï i98.06.06`07j, ŽD–y, Œð’ʈãŠw, 52(1,2): 49, 1998.

1434. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹»–¡‚ ‚éŒo‰ß‚ð‚½‚Ç‚Á‚½ŠO«ŠÌ”j—ô‚Ì‚P—á. “cŒ´@“¿iŠOjC“c’†Œ·C•Ÿ¬M”ŽC“c’†Œ‰C‘匴ˆê‹KC‰¡“c˜a•FC•ŸŒõ³siJR“Œ‹ž‘‡•a‰@j: ‘æ52‰ñ“ú–{Œð’ʈãŠw‰ï‘‰ï i98.06.06`07j, ŽD–y, Œð’ʈãŠw, 52(1,2): 50, 1998.

1435. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • o“àoŒŒ‚ð‚«‚½‚µ‹Ù‹}Žèp‚ðs‚Á‚½ˆÝŠà‚Ì‚PŽèp—á. ‰¡“c˜a•FC“cŒ´@“¿iŠOjC‘匴ˆê‹KC“c’†Œ‰C•Ÿ¬M”ŽC“c’†Œ·C•ŸŒõ³sC’O–ì³—²C‘ì‹ÔÆiJR“Œ‹ž‘‡•a‰@j: ‘æ52‰ñ“ú–{Œð’ʈãŠw‰ï‘‰ï i98.06.06`07j, ŽD–y, Œð’ʈãŠw, 52(1,2): 51, 1998.

1436. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’·Šú—\Œã‚ÆQOL‚©‚ç‚Ý‚½‰º•”’¼’°Šà‚ÌŽ¡—Õûj. ˆäŒ´ŒúC‘å’J„³CÎ씎˜aC‘ŠŒ´¬ºC–ì‘ò’¼ŽjCŒÃì—T‰îC‘êK‹ÏC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.16j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(6): 1419, 1998.

1437. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œoãè–å“I“àŽ‹‹¾‰ºƒ}ƒCƒNƒƒT[ƒWƒFƒŠ(TZM)‚É‚¨‚¯‚é“K‰ž‚ÆŽèpŽè‹Z. ‘å’J„³CÎ씎˜aC‘ŠŒ´¬ºC–ì‘ò’¼ŽjCŒÃì—T‰îC¼ŽR•Û”äŒÃC‘êK‹ÏCˆäŒ´ŒúC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.16j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(6): 206, 1998.

1438. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j is«äXŠà‚É‚¨‚¯‚é• •”Šæ’ɂɑ΂·‚éŒoH“¹—ôE«‘å“à‘Ÿ_ŒoØ—£p. ‚‹´‹BC“‡“cŒªC’†‘ºlLC‹g“c@‹IC²“¡ŒõŽjCŠ`“cÍiŠOj: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.16j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(6): 211, 1998.

1439. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • –Œ“]ˆÚˆÝŠà‚É‚¨‚¯‚é”ñŽ¡–üØœ—á‚̃Šƒ“ƒpߊs´p‚ÌŽ¡—ÃŒø‰Ê‚ÌŒŸ“¢. ŒI“c~C‹e’rŽj˜YC’çCCrˆä‹`FC¬—ÑLsC’Ë–{GlC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.16j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(6): 255, 1998.

1440. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “û“ª•”ŠàÇ—á‚Ì—Õ°•a—Šw“IŒŸ“¢. “‡“cŒªC‚‹´‹BC‹g“c@‹IC’†‘ºlLC–k‘º‰ë–çC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.16j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 32(‘): 1590, 1998.

1441. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j H“¹ƒAƒJƒ‰ƒVƒA‚ɑ΂·‚é• o‹¾‰º‹Ø‘wØŠJp. •Ð“c‰Ä–çC÷–{MˆêC“ˆ”ömC‹ß“¡Œ«ŽiC’çCCrˆä‹`FC¬—ÑLsC‹e’rŽj˜YC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC“c•Ó‘i“àj: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.17j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(6): 1379, 1998.

1442. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ØœŒãĶäX‚É‚¨‚¯‚éŠO•ª”å×–E‚Ì‘B“®‘Ô‚ÉŠÖ‚·‚é–Ɖu‘gD‰»Šw“IŒ¤‹†. —Ñ‹žŽqC‚‹´‹BCŠ`“cÍiŠOjCŽR‰È³•½i‰ðj: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.17j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(6): 248, 1998.

1443. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒoŒû™•ú«5-Fu»Ü‚É‚æ‚éŠÌ“]ˆÚ—}§Œø‰Ê‚ÌŒŸ“¢. ²“¡–ÎC‘å’J„³C‰ª‘º—¥ŽqC’Ò—ºìC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.17j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(6): 313, 1998.

1444. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j L”͈͂ɂ킽‚é‰óŽ€Œ^‹•ŒŒ«‘å’°‰Š‚Ì‚P—á. ’†‘º—²rCã–쑈ê˜YC‹{“à–M_C’†ŒF‘¸ŽmiŠOjC“‡’J‰p–¾iã”ö’†‰›‘‡•a‰@jCŒI“c~C‘哇s•FiŠOjC’†‘ºG•viã”ö’†‰›‘‡•a‰@j: ‘æ31‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i98.09.04j, ç—t.

1445. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝüˆÛ‰è×–E‚ÌŠàŠÔŽ¿“à‚É‚¨‚¯‚é“Á«; In-vitroƒXƒLƒ‹ƒXˆÝŠàƒ‚ƒfƒ‹‚ð—p‚¢‚½ŒŸ“¢. ‹e’rŽj˜YC’çCC‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC¬—ÑLsC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚X‰ñ“ú–{Á‰»ŠíŠà”­¶Šw‰ï i98.09.11j, ‰F“s‹{, ´˜^W, p.61, 1998.

1446. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°ŠàŠÌ“]ˆÚ‚É‚¨‚¯‚éWŠw“IŽ¡—Õû–@‚ÌŒŸ“¢. ‘å’J„³CÎ씎˜aC‹à‘òG‹IC‘ŠŒ´¬ºCŒÃì—T‰îC¼ŽR•Û”äŒÃC“‡“cŒªC‘êK‹ÏCˆäŒ´ŒúC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï i98.10.16j, •Ÿ‰ª, “ú–{‘å’°ãè–å•aŠw‰ïŽ, 51(9): 762, 1998.

1447. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰E‘¤isŒ‹’°ŠàÇ—á‚Ì—Õ°•a—Šw“IŒŸ“¢‚©‚ç‚Ý‚½ŽŠ“KƒŠƒ“ƒpߊs´. ˆäŒ´ŒúC‘å’J„³CÎ씎˜aC‹à‘òG‹IC‘ŠŒ´¬ºC–ì‘ò’¼ŽjCŒÃì—T‰îC¼ŽR•Û”äŒÃC‘êK‹ÏC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï i98.10.16j, •Ÿ‰ª, “ú–{‘å’°ãè–å•aŠw‰ïŽ, 51(9): 782, 1998.

1448. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°Šà‚É‚¨‚¯‚é“K‰žŠg‘å‚Ì‚½‚ß‚ÌŽè‹Z‚ÌH•v. ‘êK‹ÏC‘å’J„³C‹à‘òG‹ICÎ씎˜aC‘ŠŒ´¬ºC–ì‘ò’¼ŽjCŒÃì—T‰îC¼ŽR•Û”äŒÃCˆäŒ´ŒúC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï i98.10.17j, •Ÿ‰ª, “ú–{‘å’°ãè–å•aŠw‰ïŽ, 51(9): 917, 1998.

1449. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “àŽ‹‹¾‰ºŽèp‚̇•¹Ç‚Æ‚µ‚Ä‚ÌŒŒðÇ‚Ì—\–h‘Îô. ŒÃ“cˆê“¿iŠOjC’©ŒË—TC‰ºŽR–LCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤i‘—§‘å‘ •a‰@jCª–{—S‘¾iŠOjC“Œò—: ‘æ53‰ñ‘—§•a‰@—×{Š‘‡ˆãŠw‰ï i98.10.22j, ‹à‘ò.

1450. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j QOL‚©‚ç‚Ý‚½ƒXƒeƒ“ƒg‘}“üp‚ÆH“¹ƒoƒCƒpƒXŽèp‚Ì”äŠr. “ˆ”ömC’çCCX£¹Ž÷C‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.10j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 217, 1998.

1451. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Venous aneurysm‚Ìf’f‚ÆŽ¡—Ã. Š“cç”ü”TCΓc˜a•vC‹à鳉ÀCŠ`“cÍiŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.10j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 271, 1998.

1452. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j in situ repair‚ðs‚Á‚½Š´õ«• •”‘å“®–¬áŽ‚Ì‚P—á. ¼è”ŽsiŠOjCŽO—Ö”Ž‹viŠƒ–è“¿F‰ï•a‰@j: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.10j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 326, 1998.

1453. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j GardnerÇŒóŒQ, ‹‘åƒfƒXƒ‚ƒCƒh‚Ì‚P—á. Î씎˜aC‘å’J„³CˆäŒ´ŒúC‘êK‹ÏC‘ŠŒ´¬ºC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.10j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 382, 1998.

1454. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j isäXŠàŠà«áu’ɂɑ΂·‚é‘å“à‘Ÿ_ŒoØ—£p. “‡“cŒªC‚‹´‹BC‹g“c@‹IC¯–ìOŽ÷C’†‘ºlLC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 254, 1998.

1455. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘’_ŠÇŠg’£Ç‚T—á‚ÌŒŸ“¢. —§ÎWC¬–ì—¢qC¬”ª–ØaˆêCŠÝ–{ˆê˜YC‹ß“¡NŽjC’|“cC¼”ªŽkC”ª\ì—v•½iŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 332, 1998.

1456. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌ“]ˆÚ‘ƒ‚Ì”j—ô‚ð‚«‚½‚µ‚½äX”X–E‘BŠà‚Ì‚P—á. ¯–ìOŽ÷C“‡“cŒªC•“c^’qŽqC‚‹´‹BC‹g“c@‹IC’†‘ºlLC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 420, 1998.

1457. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • o‹¾‰ºƒwƒ‹ƒjƒAC•œp‚ÌÄ•]‰¿. ŒÃ“cˆê“¿iŠOjC’©ŒË—TC‰ºŽR–LC¼–x‰pŽ÷CŒIŒ´’¼lCâ“c“¹¶C•Ç“‡N˜Yi‘—§‘å‘ •a‰@jCª–{—S‘¾C–Ø‘º“OC‹à“cŒå—ÇC‚‹´r‹BC”Ñ–ì‘Pˆê˜YC’†‘ºl LC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 438, 1998.

1458. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠO‰È“IŽ¡—Âð—v‚µŽ¡—Âɓïa‚µ‚½ƒAƒ[ƒo«ŠÌ”^ᇂ̂P—á. •Ç“‡N˜Yi‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjC’©ŒË—TC‰ºŽR–LC¼–x‰pŽ÷CŒIŒ´’¼lCâ“c“¹¶i‘—§‘å‘ •a‰@jCª–{—S‘¾iŠOjCŒüˆä”ü˜aŽq: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 473, 1998.

1459. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚ÄŒoŒ±‚µ‚½‹ó’°Šà‚Ì‚P—á. •“¡NŽiiŠƒ–è“¿F‰ï•a‰@jC¼è”ŽsiŠOjCŽO—Ö”Ž‹viŠƒ–è“¿F‰ï•a‰@j: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 541, 1998.

1460. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PEG‚É‚æ‚èimplantation‚ð‚«‚½‚µ‚½‚ÆŽv‚í‚ê‚éˆÝ•¬–å•”Šà‚Ì‚P—á. ’çCC“ˆ”ömCX£¹Ž÷C‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ56‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i98.11.19j, ‰ªŽR, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 40(347): 1687, 1998.

1461. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äX‚ÌÄŒš‚É‚¨‚¯‚é‰äX‚ÌpŽ®|äX‹ó’°–§’…–D‡–@‚Ì—v“_‚ƬÑ|. ‹g“c@‹ICŠ`“cÍC’†‘ºlLC“‡“cŒªC–k‘º‰ë–çC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿C‚‹´‹BC”äŠé”\Ž÷iŠOj: ‘æ10‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ï‘‰ï i98.11.26`27j, ŽOd, ´˜^W, p.99, 1998.

1462. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgS—â‘jŒŒÄŠÁ—¬ŠQ‚É‚¨‚¯‚éNitric oxide (NO)‚Ì—L—p«. Ž­Žæ³“¹iŠOjC‹Ê’u“§C“c’†ŽO’ÃŽqCŸŽ}‹`‹LC‰¡“c˜jOC—Ñ—²‘¥iŽD–y–kž¾•a‰@jC“à“c‘׎ŠiŠOjC쑺–¾•viŽD–y–kž¾•a‰@jC‚‹´’õlCŠ`“cÍ iŠOj: ‘æ34‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i98.11.30`12.02j, “Œ‹ž, ˆÚA, 33(‘): 195, 1998.

1463. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j S‘jŒŒÄŠÁ—¬ŠQ‚É‚¨‚¯‚éAdenosine A1 Receptor (AA1R)‘jŠQÜ‚Ì×–E•ÛŒìŒø‰Ê. Ž­Žæ³“¹iŠOjC‹Ê’u“§C“c’†ŽO’ÃŽqCŸŽ}‹`‹LiŽD–y–kž¾•a‰@jC“à“c‘׎ŠiŠOjC—t‹PC‰¡“c˜jOC—Ñ—²‘¥C쑺–¾•viŽD–y–kž¾•a‰@jC‚‹´’õlCŠ`“cÍ iŠOj: ‘æ34‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i98.11.30`12.02j, “Œ‹ž, ˆÚA, 33(‘): 195, 1998.

1464. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠeŽí–Ɖuì“­•¨Ž¿‚É‚æ‚éRŽ_‰»ƒXƒgƒŒƒX’`”’Hemo Oxgenese-1 (HO-1)‚Ì”­Œ»‚ƃ‰ƒbƒgŠÌ‹•ŒŒÄŠÁ—¬ŠQ‚ɑ΂·‚éŒø‰Ê. “à“c‘׎ŠiŠOjC‹Ê’u“§CŸŽ}‹`‹LC“c’†ŽO’ÃŽqiŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjC‰¡“c˜jOC—Ñ—²‘¥C쑺–¾•viŽD–y–kž¾•a‰@jC‚‹´’õlCŠ`“cÍ iŠOj: ‘æ34‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i98.11.30`12.02j, “Œ‹ž, ˆÚA, 33(‘): 199, 1998.

1465. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒzƒ‹ƒ‚ƒ“‚ÌŠÌzŠÂ“®‘Ô, ŠÌ‹@”\‚É‹y‚Ú‚·‰e‹¿|”]Ž€ƒ‚ƒfƒ‹‚Æ’EŒŒƒ‚ƒfƒ‹‚Ì”äŠr|. ‘åÀ“cŽ¡C²“¡ŒõŽjC¬ìŒ›ÍC¡ˆäŒ‰C‚‹´‹BC’†ŽR‹`‰îCŠ`“cÍiŠOj: ‘æ34‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i98.11.30`12.02j, “Œ‹ž, ˆÚA, 33(‘): 201, 1998.

1466. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j isäXŠà• •”Šà«áu’ɂɑ΂·‚鋹o‹¾‰º‘å“à‘Ÿ_ŒoØ—£p. “‡“cŒªC‚‹´‹BC¯–ìOŽ÷C’†‘ºlLC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ11‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï i98.12.10`11j, “Œ‹ž, “àŽ‹‹¾ŠO‰È, 3(7): 102, 1998.

1467. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • o‹¾‰º’_”X“Eop‚ÌpŒãD‘i|“ú‹A‚èp‚É‚Þ‚¯‚Ä|. ù–{_C²“¡–ÎC“n•Ó‹v”üŽqC“c‘ºK•äC•Ð“c‰Ä–çCX£¹Ž÷C÷–{MˆêiŠOj: ‘æ11‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï i98.12.10`11j, “Œ‹ž, “àŽ‹‹¾ŠO‰È, 3(7): 104, 1998.

1468. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • o‹¾‰ºŽèp‚É‚¨‚¯‚錌ðÇ”­¶—\–h‚É‚¨‚¯‚é‹ÃŒÅŒn‚Ì•Ï“®. ŒÃ“cˆê“¿iŠOjC’©ŒË—TC‰ºŽR–LCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤i‘—§‘å‘ •a‰@jCª–{—S‘¾C“Œò—C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ11‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï i98.12.10`11j, “Œ‹ž, “àŽ‹‹¾ŠO‰È, 3(7): 151, 1998.

1469. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°Šà“K‰žŠg‘å‚Ì‚½‚ß‚Ìno-touch isolation technique‚ÌH•v. ‘êK‹ÏC‘å’J„³C‹à‘òG‹ICÎ씎˜aC‘ŠŒ´¬ºC¼ŽR•Û”äŒÃCˆäŒ´ŒúC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ11‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï i98.12.10`11j, “Œ‹ž, “àŽ‹‹¾ŠO‰È, 3(7): 177, 1998.

1470. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • o‹¾‰ºƒAƒJƒ‰ƒVƒAŽèp‚É‚¨‚¯‚é‹t—¬–hŽ~‹@\‚ÌH•v. •Ð“c‰Ä–çC÷–{MˆêC“ˆ”ömC‹ß“¡Œ«ŽiC’çCC¬—ÑLsC‹e’rŽj˜YC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC“c•Ó‘i“àj: ‘æ11‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï i98.12.10`11j, “Œ‹ž, “àŽ‹‹¾ŠO‰È, 3: 142, 1998.

1471. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’É‚­‚È‚¢, Á‚¦‚É‚­‚¢ƒXƒLƒ“ƒCƒ“ƒN‚É‚æ‚éƒXƒgƒ}ƒTƒCƒgƒ}[ƒLƒ“ƒO. ¼Œ´N”üC‘å’|—¥ŽqC^–ì“oŠìŽqiŠÅŒì•”jC‘å’J„³C‘êK‹ÏCˆäŒ´ŒúiŠOj: ‘æ16‰ñ“ú–{ƒXƒgƒ}ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ï‘‰ï i99.02.06j, ‘åã, “ú–{ƒXƒgƒ}ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽ, 14(3): 47, 1998.

1472. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒwƒ‹ƒjƒA‚ɑ΂·‚é‚í‚ê‚í‚ê‚ÌInlay Mesh Repair Method. ŒÃ“cˆê“¿iŠOjC’©ŒË—TC‰ºŽR–LCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤i‘—§‘å‘ •a‰@jCª–{—S‘¾C‹{•”—C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s.

1473. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’_“¹‘¹‚É”º‚¤’_ŠÇ‹·ó‚ɑ΂·‚é’_“¹ÄŒšp. ²“¡ŒõŽjC’†‘ºlLC“‡“cŒªCŠ“cç”ü”TCˆ¢‘]˜a“NC÷–{MˆêC’Ë–{GlC‹g“c@‹ICΓc˜a•vCŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 335, 1999.

1474. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ªŽ¡“IØœ‚µ“¾‚½Stage ‡Vb‘å’°ŠàpŒã‰»Šw—Ö@‚ÌŒŸ“¢. ˆäŒ´ŒúC‘å’J„³CÎ씎˜aC‘ŠŒ´¬ºC‹à‘òG‹IC–ì‘ò’¼ŽjCŒÃì—T‰îC‘êK‹ÏC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 338, 1999.

1475. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒZƒNƒŒƒ`ƒ“•‰‰×‚É‚æ‚éäX‰t•ª”å—Ê‚Ì‘‰Á‚ÍPFD’l‚𔽉f‚µ‚Ä‚¢‚é‚©H “‡“cŒªC‚‹´‹BC‹g“c@‹IC’†‘ºlLC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 373, 1999.

1476. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äXØœŠ³ŽÒ‚É‚¨‚¯‚éŽèp‘OŒã‚Ì‘Ï“œ”\‚̕ω»‚ÉŠÖ‚·‚錤‹†. ’†‘ºlLC‚‹´‹BC“‡“cŒªC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOjC_N”Vi“àj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 374, 1999.

1477. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒRƒ“ƒsƒ…[ƒ^ƒOƒ‰ƒtƒBƒNƒX‚ð—p‚¢‚½ˆÝŠà‚ÌV‚µ‚¢•a—Šw“I‰ðÍ–@|Žîᇂ̑傫‚³‚͈««“x”»’è‚ÌŽw•W‚ƂȂ蓾‚é‚©|. ‹e’rŽj˜YC¼è”ŽsC¬—ÑLsC’Ë–{GlC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 427, 1999.

1478. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j pŒãŠÌÄ”­‚©‚ç‚Ý‚½is’_”XŠà‚ɑ΂·‚鉉ñŠÌŽèp‚Ì‘I‘ð|Ä”­—\–h‚ð–ÚŽw‚µ‚½ŽŠ“KŠÌØœ”͈Í|. ‹g“c@‹ICŠ`“cÍC’†‘ºlLC“‡“cŒªC‚‹´‹BC²“¡ŒõŽjC”äŠé”\Ž÷iŠOj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 489, 1999.

1479. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚—îŽÒiN«ƒCƒŒƒEƒXÇ—á‚ÌŒŸ“¢. ¼‘òŽ“TC”‹´_ˆêiŠOjC¼‘òMŒÜi¬”’쎊½“°•a‰@jC’çCC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ32‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i99.03.18j, ‰¡•l, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 19(2): 219, 1999.

1480. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j H“¹ŠàpŒã‹“ãˆÝŠÇ’×á‡úE‚É‚æ‚èSƒ^ƒ“ƒ|ƒi[ƒf‚ð‚«‚½‚µ‚½‚P—á. ”¼“cŠì”ü–çC¬—ÑLsC‹ß“¡Œ«ŽiC’çCC•Ð“c‰Ä–çC‹e’rŽj˜YC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ32‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i99.03.18j, ‰¡•l, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 19(2): 226, 1999.

1481. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ØœŒãĶäX‚É‚¨‚¯‚é×–E‚Ì‘B“®‘Ô‚ÉŠÖ‚·‚é–Ɖu‘gD‰»Šw“IŒ¤‹†. —Ñ‹žŽqC‚‹´‹BCŠ`“cÍiŠOjCŽR‰È³•½i‰ðj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 201, 1999.

1482. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°Šà‚Ì”­Šà‰ß’ö‚É‚¨‚¯‚錌ŠÇV¶ˆöŽq‚Ì”­Œ». ‰|–{‘ñ–ÎC‘ •ÀŸCŠ`“cÍiŠOj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 203, 1999.

1483. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒhƒi[‚̉h—{ó‘Ô‚É‚¨‚¯‚éde novo’`”’Ž¿‡¬‚ÆŠÌ‹•ŒŒÄŠÁ—¬ŠQ‚ɑ΂·‚é‘Ï«‚Ì”äŠrŒŸ“¢. “à“c‘׎ŠiŠOjC‹Ê’u“§C“c’†ŽO’ÃŽqiŽD–y–kž¾•a‰@jCŽ­Žæ³“¹iŠOjCŸŽ}‹`‹LC—Ñ—²‘¥C‰œ‰ÍŽéŠóC쑺–¾•viŽD–y–kž¾•a‰@jC‚‹´’õlCŠ`“cÍ iŠOj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 211, 1999.

1484. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j isäXŠà• •”Šà«áu’ɂɑ΂·‚éŒoH“¹—ôE«‘å“à‘Ÿ_ŒoØ—£p. “‡“cŒªC‚‹´‹BC’†‘ºlLC‹g“c@‹IC²“¡ŒõŽjC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 304, 1999.

1485. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘å’°Šà‚Ì”­Šà‰ß’ö‚É‚¨‚¯‚錌ŠÇV¶ˆöŽq”­Œ»‚̈Ӌ`. ‰|–{‘ñ–ÎC‘ •ÀŸCŠ`“cÍiŠOj: ‘æ98‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i98.04.08`10j, “Œ‹ž, “ú–{ŠO‰ÈŠw‰ïŽGŽ, 99(—Õ‘): 410, 1998.

1486. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j äXŠà‚ɑ΂·‚é5FU­—ÊŽ‘±‚¨‚æ‚ÑCDDP•p‰ñ’“ü•¹—p—Ö@‚̈Ӌ`. ’†‘ºlLC‹g“c@‹IC–k‘º‰ë–çC“‡“cŒªC‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ98‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i98.04.08`10j, “Œ‹ž, “ú–{ŠO‰ÈŠw‰ïŽGŽ, 99(—Õ‘): 476, 1998.

1487. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j V‚½‚ÉŠJ”­‚µ‚½‘½‹@”\Water JetØŠJ”—£‘•’u‚Ì—L—p«‚ƈÀ‘S«‚ÉŠÖ‚·‚éŽÀŒ±“IŒŸ“¢. ‹g“c@‹ICŠ`“cÍC’†‘ºlLC‘êK‹ÏC“‡“cŒªC‚‹´‹BC‘å‹{“Œ¶iŠOj: ‘æ98‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i98.04.08`10j, “Œ‹ž, “ú–{ŠO‰ÈŠw‰ïŽGŽ, 99(—Õ‘): 493, 1998.

1488. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘å’°Šà‚ÌŠÌ“]ˆÚ‚ɑ΂·‚鎡—Ö@. “‡“cŒªC‚‹´‹BCŒÃì—T‰îC’†‘ºlLC–ì‘ò’¼ŽjC‘êK‹ÏC‹g“c@‹IC‘å’J„³C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.04.15`18j, ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽ, 95(—Õ‘): 282, 1998.

1489. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”ñ‹@”\«äX“à•ª”åŽîᇂ̂R—á. ’†‘ºlLC“‡“cŒªC‚‹´‹BC‹g“c@‹IC–k‘º‰ë–çC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ84‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i98.04.15`18j, ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽ, 95(—Õ‘): 292, 1998.

1490. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j PTHrP—R—ˆˆ««‚ƒJƒ‹ƒVƒEƒ€ŒŒÇiHHM)‚ɑ΂µPamidronate disodium (PD)‚ª—LŒø‚Å‚ ‚Á‚½Ä”­«“ûŠà‚Ì‚P—á. å΋I•FC‘ •ÀŸCŒ´‰pCŒY•”“ŒŽ¡CΓc˜a•vC‘åê³›ßCŠ`“cÍiŠOj: ‘æ‚U‰ñ“ú–{“ûŠàŠw‰ï‘‰ï i98.05.22j, “Œ‹ž, ´˜^W, p.115, 1998.

1491. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “û‘B—tóŽîá‡13—á‚Ì—Õ°•a—Šw“IŒŸ“¢. “ñ“nM]C‰|–{‘ñ–ÎC‘ •ÀŸCŒ´‰pCΓc˜a•vC‘åê³›ßCŠ`“cÍiŠOj: ‘æ‚U‰ñ“ú–{“ûŠàŠw‰ï‘‰ï i98.05.22j, “Œ‹ž, ´˜^W, p.134, 1998.

1492. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “´Šá“IŒŒ«“û“ªˆÙ핪”åÇ—á‚ÌŒŸ“¢. •“c^’qŽqC“n•ÓŒ’Ž™C’|’†°KC–x]˜aLiŠOj: ‘æ‚U‰ñ“ú–{“ûŠàŠw‰ï‘‰ï i98.05.23j, “Œ‹ž, ´˜^W, p.151, 1998.

1493. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒgSˆÚAƒ‚ƒfƒ‹‚É‚¨‚¯‚éNO‹Ÿ—^‘Ì‚É‚æ‚éHeat Shock Protein (HSP)‚Ì—U“±‚Æ‚»‚Ì×–E•ÛŒìŒø‰Ê. Ž­Žæ³“¹iŠOjC‹Ê’u“§C“c’†ŽO’ÃŽqCŸŽ}‹`‹LC‰¡“c˜jOC—Ñ—²‘¥C{“¡ƒˆêC—t‹PC쑺–¾•viŽD–y–kž¾•a‰@jC‚‹´’õlCŠ`“cÍiŠOj: ‘æ5‰ñ“ú–{‘ŸŠí•Û‘¶¶•¨ˆãŠw‰ï‘‰ï i98.05.28`29j, “Œ‹ž, Organ Biol., 5(2): 130, 1998.

1494. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”]Ž€ó‘Ô‚É‚¨‚¯‚éŠÌzŠÂ“®‘Ô‚ÆŠÌ•Û‘¶ó‘Ô‚¨‚æ‚ÑDopamine“Š—^‚̉e‹¿‚ÉŠÖ‚·‚éŽÀŒ±“IŒŸ“¢. ¡ˆäŒ‰C²“¡ŒõŽjCˆÉ“¡‹`–çC‚‹´‹BC’†ŽR‹`‰îCŠ`“cÍiŠOj: ‘æ5‰ñ“ú–{‘ŸŠí•Û‘¶¶•¨ˆãŠw‰ï‘‰ï i98.05.28`29j, “Œ‹ž, Organ Biol., 5(2): 139, 1998.

1495. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j o¶‘O‘ÙŽ™S•s‘Só‘Ô‚Æf’f‚³‚êŽüpŠúŠÇ—¢“ï‚Å‚ ‚Á‚½‹‘åå”ö•”ŠïŒ`Žî—á. Γc˜a•vCŠ“cç”ü”TCŒã“¡‹BCŠ`“cÍiŠOjCŽR“cr•FC¬ŒûO‹BiŽ™j: ‘æ35‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i98.05.29j, ‹à‘ò, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽ, 34(3): 263, 1998.

1496. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j æ“V«’_“¹Šg’£Ç‚Ì’_ŠÇŒ`‘Ô‚Æ‚»‚Ì•aˆö‚ɑ΂·‚élŽ@. Š“cç”ü”TCΓc˜a•vCŠ`“cÍiŠOj: ‘æ35‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i98.05.29j, ‹à‘ò, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽ, 34(3): 342, 1998.

1497. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Volume rendering–@‚ð—p‚¢‚½V‚µ‚¢ˆÝŠà‚ÌŽîᇑÌÏŒv‘ª–@‚Æ‚»‚Ì—Õ°“IˆÓ‹`. ‹e’rŽj˜YC’çCCrˆä‹`FC¬—ÑLsC’Ë–{GlC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ70‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï i98.06.19j, “Œ‹ž, ´˜^W, p.153, 1998.

1498. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”xŠàØœpŒã‚É‘å’°“]ˆÚ‚É‚ÄÄ”­‚µ‚½‹H‚È‚P—á. ‘ŠŒ´¬ºC‘êK‹ÏCÎ씎˜aC–ì‘ò’¼ŽjCˆäŒ´ŒúC‘å’J„³C匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.17j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(6): 1540, 1998.

1499. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j is‘å’°Šà‚É‚¨‚¯‚éPyNPaseŠˆ«‚Ì—Õ°•a—Šw“IˆÓ‹`‚Æp‘O5'-DFUR“Š—^‚É‚æ‚éŒø‰Ê‚ÌŒŸ“¢. ŒÃì—T‰îC–öŒ´³’qiŠOjCÄ“¡Œ’lC²“¡’¼•vC•½“cŸCãÈ’B–çi‰¡•l‘Dˆõ•ÛŒ¯•a‰@j: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.17j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(6): 527, 1998.

1500. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j lH•Ù’uŠ·pŒã, R‹ÃŒŒ–ò—Ö@’†‚ÌÁ‰»ŠíŠO‰ÈŽèp. ¼‘òŽ“TC”‹´_ˆêiŠOjC¼‘òMŒÜiŽŠ½“°‘‡•a‰@j: ‘æ52‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i98.07.17j, “Œ‹ž, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 31(6): 592, 1998.

1501. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œoãè–å“Iƒ}ƒCƒNƒƒT[ƒWƒFƒŠ[iTEM)‚É‚¨‚¯‚é“K‰ž‚ÆŽèpŽè‹Z. ‘å’J„³C¼ŽR•Û”äŒÃC‘êK‹ÏCˆäŒ´ŒúC匴÷C”äŠé”\Ž÷C“ˆ”ömiŠOj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.07j, •Ÿ‰ª, “ú–{ŠàŽ¡—Êw‰ïŽ, 33(3): 244, 1998.

1502. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “û‘B”S‰t‚Ì‚¤–E«Ž¾Š³‚Ì‚R—á. ’©ŒË—TCŒüˆä”ü˜aŽqC‹“‡N‰hCŒ´²’jCŒGŒ³—Y‰îC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjC¼–x‰pŽ÷CŒIŒ´’¼li‘—§‘å‘ •a‰@jCª–{—S‘¾iŠOjC•Ç“‡ N˜Yi‘—§‘å‘ •a‰@j: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.10j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 621, 1998.

1503. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “û‘BŒ´”­ˆ««ƒŠƒ“ƒpŽî‚Ì‚Q—á. ˆäã–F³C’|‰º—˜•vCŽO–Ø_‰hi‘å˜aŽs—§•a‰@jCò‰Æ‹v’¼iŠOjCŽñ“¡º•FC’I‹´’Bˆê˜YC—é–Ø”ŽC‘å‹{“Œ¶i‘å˜aŽs—§•a‰@j: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.10j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 628, 1998.

1504. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”xŠà‚Ì“]ˆÚ‚É‚æ‚鬒°úE‚Ì‚P—á. _ŽRˆç’jC’|‰º—˜•vCŽO–Ø_‰hi‘å˜aŽs—§•a‰@jCò‰Æ‹v’¼iŠOjCŽñ“¡º•FC’I‹´’Bˆê˜YC—é–Ø”ŽC‘å‹{“Œ¶i‘å˜aŽs—§•a‰@j: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.10j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 633, 1998.

1505. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j \“ñŽw’°”S–Œ“àŠàpŒã‘½”­ŠÌ“]ˆÚ‚𗈂µ‚½‰Æ‘°«‘å’°‘BŽîÇ‚Ì‚P—á. ‘ŠŒ´¬ºC‘å’J„³CÎ씎˜aC–ì‘ò’¼ŽjCŒÃì—T‰îC‘êK‹ÏCˆäŒ´ŒúC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.10j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 648, 1998.

1506. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j pŒã‚Ì’á‰h—{ó‘Ô‚ªˆø‚«‹N‚±‚µ‚½‚ÆŽv‚í‚ê‚é‚“x‚ÈŽ‰–bŠÌ‚ð’悵‚½‚P—á. “cŒ´@“¿C’†‘ºlLC“‡“cŒªC‚‹´‹BC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 657, 1998.

1507. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ|ƒŠƒvƒƒsƒŒƒ“»ƒƒbƒVƒ…‚ð—p‚¢‚½• oá­ƒwƒ‹ƒjƒAŽèpÇ—á‚ÌŒŸ“¢. ’Ë–{GlCŠøŽè˜a•FCΈ䌒ˆê˜YCˆ¢‘]˜a“NC÷–{MˆêCΓc˜a•vC²“¡ŒõŽjC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 666, 1998.

1508. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j • •ÇŒ´”­ˆ««üˆÛ«‘gD‹…Ç‚Ì‚P—á. ‹{“à–M_C‘哇s•FCã–쑈ê˜YC’†ŒF‘¸ŽmiŠOjC“‡’J‰p–¾iã”ö’†‰›‘‡•a‰@jC’†‘º—²rCŒI“c~C—é–Ø“N‘¾˜YiŠOjC’†‘ºG•viã”ö’†‰›‘‡•a‰@j: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.11j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽ, 59(‘): 666, 1998.

1509. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œü¸_•a–òŽg—pŠ³ŽÒ‚É‚¨‚¯‚é‹Ù‹}Žèp—á‚ÌŒŸ“¢. ã–쑈ê˜YC‹{“à–M_C‘哇s•FiŠOjC’†‘ºG•viã”ö’†‰›‘‡•a‰@j: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.13j, ‚¼, “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 9(9): 507, 1998.

1510. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “û‘BƒAƒ|ƒNƒŠƒ“Šà‚Ì‚P—á. “n•ÓŒ’Ž™C“ñ“nM]C’|’†°KiŠOj: ‘æ‚W‰ñ“ú–{“ûŠàŒŸfŠw‰ï‘‰ï i98.11.19j, ’·è.

1511. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j äX‘S“EŒã‚ÌŠÌ–å–¬•Âǂɑ΂·‚éZ-stent‚ð—p‚¢‚½ŒŒsÄŒšp‚ÌŒoŒ±. “‡“cŒªC‚‹´‹BiŠOjCˆé•”‹`Œ›i•újC’†‘ºlLC‹g“c@‹IC²“¡ŒõŽjC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ10‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ï‘‰ï i98.11.26`27j, ŽOd, ´˜^W, p.260, 1998.

1512. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰Æ“e”]Ž€ƒ‚ƒfƒ‹‚É‚¨‚¯‚édopamine‚ÌŠÌzŠÂ“®‘Ô‚ÆŠÌ‹@”\‚ɑ΂·‚é‰e‹¿‚¨‚æ‚Ñ•a—‘gDŠw“IŒŸ“¢. ¡ˆäŒ‰C²“¡ŒõŽjCˆÉ“¡‹`–çC‚‹´‹BC’†ŽR‹`‰îCŠ`“cÍiŠOj: ‘æ34‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i98.11.30j, “Œ‹ž, ˆÚA, 33(‘): 230, 1998.

1513. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÝŠà‚Ì• –Œ“]ˆÚ—á‚ɑ΂·‚é• o“àƒŠƒU[ƒo[‚Ì—L—p«‚ɂ‚¢‚Ä. ª–{—S‘¾iŠOjCŒIŒ´’¼lC’©ŒË—TCŒüˆä”ü˜aŽqC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCâ“c“¹¶CÎŒ´‰ë–¤C‹{•”—i‘—§‘å‘ •a‰@j: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 489, 1999.

1514. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j úE‚µ‚½‰¡sŒ‹’°ˆ««ƒŠƒ“ƒpŽî‚Ì‚P—á. ’©ŒË—TC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤i‘—§‘å‘ •a‰@jCª–{—S‘¾iŠOjC‹{•”—CŒüˆä”ü˜aŽqi‘—§‘å‘ •a ‰@j: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 493, 1999.

1515. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Borrmann ‡WŒ^ˆÝŠàØœ—á56—á‚ÌŽ¡—ìт̌Ÿ“¢. –î–ì„ŽiC‹e’rŽj˜YC‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC’çCC¬—ÑLsC’Ë–{GlC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 594, 1999.

1516. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j 5'-DFUR LV‚ÌŒoŒû“Š—^‚É‚ÄÁŽ¸‚µ‚½‘å’°ŠàŠÌ“]ˆÚ‚Ì‚P—á. ‘ŠŒ´¬ºC¯–ìOŽ÷C‘å’J„³CÎ씎˜aCŒÃì—T‰îC‘êK‹ÏCˆäŒ´ŒúC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 595, 1999.

1517. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÚA—pŠÌ‘Ÿ‚Ì‚ˆ³¥•X“_‰º•Û‘¶–@‚ÌŠJ”­: ŠÌ‘Ÿ‚̉Áˆ³‘Ï—e«‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†. ‚‹´‹BC‚‹´’õliŠOjC“¡¶rOi¶•¨‰»ŠwŒnjCâ–{‚¢‚ÂÝCŠ`“cÍiŠOjCŽR‰È³•½i‰ðjC‚‘ò‹`ºC‘º’Ö—ÇŽiiƒXƒMƒmƒ}ƒVƒ“Œ¤‹†j: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 676, 1999.

1518. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j MirizziÇŒóŒQ‚T—á‚ÌŽ¡—Ö@‚ÌŒŸ“¢. דcŒjC÷–{MˆêCˆ¢•””üŠ°C•½ˆär’jCª–{—YŽ¡CŠC’ËMŽjC’†‘ºlLC“‡“cŒªCˆ¢‘]˜a“NC‚‹´‹BC’Ë–{GlC‹g“c@‹IC²“¡ŒõŽjC”äŠé”\Ž÷iŠOj: ‘æ53‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i99.02.18`19j, ‹ž“s, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽ, 32(2): 770, 1999.

1519. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰Áˆ³‰ß—â‹p•Û‘¶‚É‚¨‚¯‚éŠÌ‘Ÿ‚̉ˆÚA«‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†. ‚‹´’õlC‚‹´‹BCâ–{‚¢‚ÂÝiŠOjC“¡¶rOi¶•¨‰»ŠwŒnjC²“¡ŒõŽjCŠ`“cÍiŠOjCŽR‰È³•½i‰ðjC‹Ê’u“§iŽD–y–kž¾•a‰@jC‚‘ò‹`ºC‘º’Ö—ÇŽi iƒXƒMƒmƒ}ƒVƒ“j: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 122, 1999.

1520. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’ጌˆ³ó‘Ô‚ÌŠÌzŠÂ“®‘Ô, ŠÌ‹@”\‚É‹y‚Ú‚·‰e‹¿|”]Ž€ƒ‚ƒfƒ‹‚Æ’EŒŒƒ‚ƒfƒ‹‚Ì”äŠr|. ‘åÀ“cŽ¡C²“¡ŒõŽjC¬ìŒ›ÍC¡ˆäŒ‰C‚‹´‹BC’†ŽR‹`‰îCŠ`“cÍiŠOj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 351, 1999.

1521. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “àŽ‹‹¾•¹—p“û–[‰·‘¶pŽ®‚Æ‚»‚Ì“K‰ž‚ɂ‚¢‚Ä. ’©ŒË—TCŒÃ“cˆê“¿iŠOjC‰ºŽR–LCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤i‘—§‘å‘ •a‰@jCª–{—S‘¾iŠOjC‹{•”—: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 503, 1999.

1522. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒCƒ“ƒXƒŠƒ“Š´Žó«‚©‚猩‚½äXØœŠ³ŽÒ‚É‚¨‚¯‚ép‘OŒã‚Ì‘Ï“œ”\‚̕ω»‚ÉŠÖ‚·‚錤‹†. ’†‘ºlLC‚‹´‹BC“‡“cŒªC‹g“c@‹IC²“¡ŒõŽjC”äŠé”\Ž÷CŠ`“cÍiŠOjC_N”Vi“àj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 570, 1999.

1523. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÚAŒã‚̃‰ƒbƒgŠÌ_ŒoĶ‚ÉŠÖ‚·‚é“dŽqŒ°”÷‹¾“IŒ¤‹†. â–{‚¢‚ÂÝC‚‹´‹BC“cŠ•¶•FC‚‹´’õlC—Ñ‹žŽqC”Ñ–ì‘Pˆê˜YCˆÉ“¡‹`–çC²“¡ŒõŽjCŠ`“cÍiŠOjCŽR‰È³•½i‰ðj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 63, 1999.

1524. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’×ᇫ‘å’°‰Š“—á‚É‚¨‚¯‚éŽèp“K‰ž‚ÆŽ¡—Õûj. ‘å’J„³CÎ씎˜aC‘ŠŒ´¬ºC‹à‘òG‹IC¼ŽR•Û”äŒÃC‘êK‹ÏCˆäŒ´ŒúC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24`26j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽ, 100(—Õ‘): 86, 1999.

1525. mŠw‰ïi’n•ûjn ih‘è•ñj ŒÀ‹Ç«• –Œ‰Š‚ÌÇó‚É‚Ä”­Ç‚µ‚½’j«ãO–ÑŠà‚Ì‚P—á. “n•Ó‹v”üŽqCù–{_C“c‘ºK•äC•Ð“c‰Ä–çCX£¹Ž÷C²“¡–ÎiŠOj: ‘æ93‰ñ_“Þì—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï i98.11.28j, ‘Š–ÍŒ´.

1526. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹Ù‹}“àŽ‹‹¾‚Ì’è‹`. “ˆ”ömiŠOj: ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.11.27j, “Œ‹ž.

1527. mŠw‰ïi’n•ûjn iƒ[ƒNƒVƒ‡ƒbƒvj ˆ««H“¹E‹CŠÇ, ‹CŠÇŽxᑂɑ΂·‚éƒXƒeƒ“ƒgŽ¡—Â̌Ÿ“¢. X£¹Ž÷C“ˆ”ömiŠOj: ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.11.27j, “Œ‹ž.

1528. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éäX“ª\“ñŽw’°Øœ—á‚ÌŒŸ“¢. ²“¡–qC•½ˆär’jC—§ÎWCX£¹Ž÷C“cŠ•¶•FC¼”ªŽkC”ª\ì—v•½iŠOj: ‘æ35‰ñé‹ÊˆãŠw‰ï‘‰ï i98.01.25j, ‰Y˜a.

1529. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒeŽº‚É”­¶‚µ‚½‚Æ„Ž@‚³‚ꂽ‚r󌋒°Šà‚Ì‚P—á. ‹ß“¡NŽjC¬–ì—¢qC¬”ª–ØaˆêCŠÝ–{ˆê˜YC’|“cC—§ÎWC¼”ªŽkC”ª\ì—v•½iŠOj: ‘æ249‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.05.16j, é‹Ê, ƒvƒƒOƒ‰ƒ€, p.8, 1998.

1530. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’ራ«“xŽq‹{“÷Žî‚ª–ñ‚T”NŒã‚É• –Œ”dŽí‚𗈂µ‚½‚P—á. ’†ŒF‘¸ŽmC‘哇s•FCã–쑈ê˜YC‹{“à–M_iŠOjC“‡’J‰p–¾iã”ö’†‰›‘‡•a‰@jC’†‘º—²rC—é–Ø“N‘¾˜YiŠOjC’†‘ºG•viã”ö’†‰›‘‡•a‰@jC”äŠé”\ Ž÷CŠ`“cÍiŠOjC‘å•”½CŠâŸºŒ[ˆêi•a—j: ‘æ249‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.05.16j, é‹Ê, ƒvƒƒOƒ‰ƒ€, p.9, 1998.

1531. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚—îŽÒiN«ƒCƒŒƒEƒXÇ—á‚ÌŒŸ“¢. ¼‘òŽ“TC”‹´_ˆêiŠOj: ‘æ12‰ñ“Œ–k‹~‹}ˆãŠw‰ï‘‰ï i98.05.23j, ŽRŒ`, ´˜^W, p.68, 1998.

1532. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’ጌ“œ”]Ç‚É‚¨‚¯‚铪•”‰æ‘œŠŒ©‚ÌŒoŽž“I•Ï‰». å΋I•FiŠOjCHŽR‹v®C–kŒ´F—YC“à‹{—çŽkC“c’†Œ[Ži‚aCŒüŽRŒMC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ45‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i98.06.27j, “y‰Y.

1533. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘I‘ð“I‰“ˆÊäBtÖ¬•«‡pŒã‚Ì––½ŒŒŒŒ‹…”‚ÆäB—eÏ‚Ì•Ï“®. Ž­Žæ³“¹iŠOjC‰Ô–{‘¸”VC¬ŽR“à½C‰Ô“c—T”ViŽD–y–kž¾•a‰@jC“à“c‘׎ŠiŠOjC‘Žq‰ÀOCˆÀŒ´–ž•vC“c’†ŽO’ÃŽqC‹Ê’u“§C‹v–Ø“c˜a‹uC–Ú•‡ˆêC•Äì Œ³Ž÷C쑺–¾•viŽD–y–kž¾•a‰@j: ‘æ69‰ñ–kŠC“¹ŠO‰ÈŠw‰ï i98.09.05j, ŽD–y.

1534. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éæ“V«\“ñŽw’°•Â½E‹·óÇ—á‚ÌŒŸ“¢. Š“cç”ü”TCΓc˜a•vC’©’·“N–íCŠ`“cÍiŠOj: ‘æ33‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i98.11.07j, “Œ‹ž.

1535. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’°ŠÇd•¡Ç‚Ì“ÁŽêŒ^‚ÆŽv‚í‚ê‚é‚P—á. ’†‘ºFLCΓc˜a•vC’©’·“N–íCŠ“cç”ü”TCŠ`“cÍiŠOj: ‘æ33‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i98.11.07j, “Œ‹ž.

1536. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Šà«H“¹cŠuá‘‚É‚æ‚é”^‹¹Œ`¬‚ɑ΂µƒXƒeƒ“ƒg—¯’u‚ª—LŒø‚Å‚ ‚Á‚½‚PÇ—á. ¬‘ò•½‘¾C“ˆ”ömC’çCCX£¹Ž÷C‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.11.27j, “Œ‹ž.

1537. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’°dÏÇ‚Æ‚µ‚Ä”­Ç‚µ‚½–Ó’°ãO–ÑŽîᇂ̂Q—á. •ŽRMˆêC–ì‘ò’¼ŽjC‰Á“¡NsiŠOjCŽRãp‚³‚ä‚èCŽR“cŽŠli“àjCã™G‰ii•a—j: ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i98.11.27j, “Œ‹ž.

1538. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j äX”ç—l”XŽî‚Ì‚P—á. ²“¡KˆêC–ΖØ_ŽqC¡ˆäŒ‰CŽ‰Æ–ÎŽ÷iŠOj: ‘æ93‰ñ_“Þì—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï i98.11.28j, ‘Š–ÍŒ´.

1539. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j f’f‚É“ïa‚µ‚½“«á‘E‚𔺂¤Œz•”ƒŠƒ“ƒpߌ‹Šj‚Ì‚P—á. –¶¶FŽiC‘ •ÀŸCŒY•”“ŒŽ¡CŒ´‰pCª–{—YŽ¡C•½ˆär’jCדcŒjCŠC’ËMŽiC¯–ìOŽ÷CŠøŽè˜a•FC’†ŽRLˆêC¡…N“ñCX’JGNCΓc˜a•vC‘åê³›ßCŠ` “cÍiŠOj: ‘æ93‰ñ_“Þì—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï i98.11.28j, ‘Š–ÍŒ´.

1540. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠO‰È“I‚É“Eo‚µ‚½‹‘åˆÝ΂̂P—á. ‰FˆäF‘¾˜YCˆÉ“¡—ÇmiŠOjCˆÉ“¡–Îi‘Š–ÍŒ´ˆÉ“¡•a‰@j: ‘æ93‰ñ_“Þì—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï i98.11.28j, ‘Š–ÍŒ´.

1541. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j \“ñŽw’°Vater“û“ª•”‚æ‚è”­¶‚µ‚½‚ÆŽv‚í‚ê‚éŠà“÷Žî‚Ì‚P—á. _ŽRˆç•vi‘å˜aŽs—§•a‰@jCò‰Æ‹v’¼iŠOjCŽO–Ø_‰hCŽñ“¡º•FC’I‹´’Bˆê˜YC—é–Ø”ŽC’|‰º—˜•vC‘å‹{“Œ¶i‘å˜aŽs—§•a‰@j: ‘æ93‰ñ_“Þì—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï i98.11.28j, ‘Š–ÍŒ´.

1542. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “û‘BG•½ã”çŠà‚Ì‚P—á. “ñ“nM]C“n•ÓŒ’Ž™C–x]˜aLC’|’†°KiŠOj: ‘æ93‰ñ_“Þì—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï i98.11.28j, ‘Š–ÍŒ´.

1543. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j p‘Of’f‚ª¢“ï‚Å‚ ‚Á‚½äXŒ´”­limphoepithlial cyst‚Ì‚P—á. Έ䌒ˆê˜YC‹g“c@‹IC’†‘ºlLC“‡“cŒªC‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ252‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i98.12.12j, ‰¡•l.

1544. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹›œ‚É‚æ‚鬒°úE‚Ì‚P—á. ã–쑈ê˜YC‹{“à–M_C’†ŒF‘¸ŽmiŠOjC“‡’J‰p–¾iã”ö’†‰›‘‡•a‰@jC’†‘º—²riŠOjC’†‘ºG•viã”ö’†‰›‘‡•a‰@j: ‘æ46‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i99.02.20j, ‰¡•l.

1545. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘å’°ŒeŽºÇŽ¡—×á‚ÌŒŸ“¢. ã–쑈ê˜YC‹{“à–M_C’†ŒF‘¸ŽmiŠOjC“‡’J‰p–¾iã”ö’†‰›‘‡•a‰@jC’†‘º—²rCŒI“c~iŠOjC’†‘ºG•viã”ö’†‰›‘‡•a‰@j: ‘æ36‰ñé‹ÊŒ§ˆãŠw‰ï‘‰ï i99.02.28j, é‹Ê.

1546. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j HEN‚É‚¨‚¯‚éPEG‚Ì–ðŠ„‚ÆŽè‹Z‚ÌŽÀÛEŠÇ—. “ˆ”ömiŠOj: ‘æ‚V‰ñHITŒ¤‹†‰ïŒöŠJƒZƒ~ƒi[ i98.08.29j, VŠƒ.

1547. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j is’_”XŠà‚ÌpŒãŠÌÄ”­‚©‚ç‚Ý‚½ŠÌ‚Ö‚Ìi“WŒ`¬‚ÆÄ”­—\–h‘Îô. ‹g“c@‹ICŠ`“cÍC’†‘ºlLC“‡“cŒªC‚‹´‹BC²“¡ŒõŽjiŠOj: ‘æ27‰ñ“ú–{’_“¹ŠO‰ÈŒ¤‹†‰ï i98.05.14j, ‰¡•l, Proceedings, p.58`59, 1998.

1548. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚ép’†’_“¹‘¹—á‚ÌŒŸ“¢. ¼”ªŽkC•½ˆär’jC²“¡–qC—§ÎWCX£¹Ž÷C“cŠ•¶•FC”ª\ì—v•½iŠOj: ‘æ27‰ñ“ú–{’_“¹ŠO‰ÈŒ¤‹†‰ï i98.05.14j, ‰¡•l, Proceedings, p.124`125, 1998.

1549. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j • o‹¾‰º’_”X“Eop‚É‚¨‚¯‚ép’†’_“¹‘¹‚ÌŒŸ“¢. “‡“cŒªCŠ`“cÍC‹g“c@‹IC’†‘ºlLC–k‘º‰ë–çC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‚‹´‹BC”äŠé”\Ž÷iŠOj: ‘æ27‰ñ“ú–{’_“¹ŠO‰ÈŒ¤‹†‰ï i98.05.14j, ‰¡•l, Proceedings, p.144`145, 1998.

1550. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “àŽ‹‹¾‰º’_”X“Eo‚É‚æ‚é’_“¹‘¹‚ɑ΂·‚é’_“¹ÄŒšp. ²“¡ŒõŽjCŠÝ–{ˆê˜YC’·’J쌒C’†‘ºlLC“‡“cŒªC÷–{MˆêC‚‹´‹BC’Ë–{GlC‹g“c@‹ICŠ`“cÍiŠOj: ‘æ27‰ñ“ú–{’_“¹ŠO‰ÈŒ¤‹†‰ï i98.05.14j, ‰¡•l, Proceedings, p.228`229, 1998.

1551. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌ–å•”’_ŠÇ‹ó’°•«‡pŒã‚Ì’_ŠÇ‹·ó‚Ì‚P—á. ŒÃ“cˆê“¿iŠOjCŽÂŒ´ŽjC’©ŒË—TC‰ºŽR–LC¼–x‰pŽ÷CŒIŒ´’¼li‘—§‘å‘ •a‰@jC“y‹´½ˆê˜YC•Ç“‡N˜YC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ27‰ñ“ú–{’_“¹ŠO‰ÈŒ¤‹†‰ï i98.05.14j, ‰¡•l, Proceedings, p.82, 1998.

1552. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j —H–å—Ö‰·‘¶äX“ª\“ñŽw’°ØœpŒã‚ÌpŒã‡•¹Ç‚ÉŠÖ‚·‚錟“¢. “‡“cŒªC‚‹´‹BC’†‘ºlLC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ25‰ñ“ú–{äXØœŒ¤‹†‰ï i98.06.12`13j, •Ÿ‰ª.

1553. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Øœ•W–{‚É‚Ä‘gDŠw“I‚ÉGrade 3‚Å‚ ‚Á‚½H“¹Šàp‘O‰»Šw—Ö@PR, CRÇ—á‚ÌŒŸ“¢. ¬—ÑLsC’çCCrˆä‹`FC‹e’rŽj˜YiŠOjCŽO•xO”Vi•a—jC‹ß“¡ˆê‰pC¬ò˜aŽO˜Yi“àjC“ˆ”ömCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ52‰ñ“ú–{H“¹Ž¾Š³Œ¤‹†‰ï i98.06.25`26j, ‰¡•l, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 32(3): 955, 1999.

1554. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j äX“ª\“ñŽw’°ØœpiPD)Œã‚ÌMRCP‘œ‚ÆäXŠO•ª”å‹@”\. “‡“cŒªC‚‹´‹BC’†‘ºlLC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOjCˆé•”‹`Œ›i•új: ‘æ15‰ñ“ú–{’_äX¶—‹@”\Œ¤‹†‰ï i98.07.04j, “Œ‹ž, ´˜^W, p.17, 1998.

1555. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ”]Ž€ó‘Ô‚ÌŠÌzŠÂ“®‘Ô, ŠÌ‹@”\‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä|”]Ž€ƒ‚ƒfƒ‹‚Æ’EŒŒƒ‚ƒfƒ‹‚Ì”äŠr|. ‘åÀ“cŽ¡C²“¡ŒõŽjC¬ìŒ›ÍC¡ˆäŒ‰C‚‹´‹BC’†ŽR‹`‰îCŠ`“cÍiŠOj: ‘æ16‰ñŠÌˆÚAŒ¤‹†‰ï i98.07.30j, “¿“‡, ´˜^W, p.96, 1998.

1556. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éŒo”ç“àŽ‹‹¾“IˆÝá‘‘¢Ýp. ‰Í–ìŒ\ˆêC”Ñ–ì‘Pˆê˜YiŠOjCŽÄN•FC–xì½–çi“àj: ‘æ‚R‰ñHEQŒ¤‹†‰ïiÝ‘îˆã—Ã‚Æ“àŽ‹‹¾Ž¡—Ãj i98.08.08j, “Œ‹ž.

1557. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Øœ•s”\H“¹Šà«‹·ó‚ɑ΂·‚éƒXƒeƒ“ƒg‘}“üp‚ÆPEG•¹—p‚Ì—LŒø«‚ɂ‚¢‚Ä. ‹ß“¡Œ«ŽiC“ˆ”ömC•Ð“c‰Ä–çC’çCC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚R‰ñHEQŒ¤‹†‰ïiÝ‘îˆã—Ã‚Æ“àŽ‹‹¾Ž¡—Ãj i98.08.08j, “Œ‹ž.

1558. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒðœ‹Ž—pƒtƒBƒ‹ƒ^[‚ª—L—p‚Å‚ ‚Á‚½‚ÆŽv‚í‚ꂽ• o‹¾‰ºŽèp‚Ì‚P—á. ª–{—S‘¾CŒÃ“cˆê“¿iŠOjC’©ŒË—TC‰ºŽR–LCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤C“Œò—C’Ë’J‘׎iC‰ª“c—Çsi‘—§‘å‘ •a‰@j: ‘æ771‰ñŠO‰ÈW’k‰ï i98.10.12j, “Œ‹ž, ´˜^W, p.47, 1998.

1559. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “àŽ‹‹¾‰ºãüâ|Šs´p‚ɂ‚¢‚Ä. ŒÃ“cˆê“¿iŠOj: ‘æ‚Q‰ñ‘—§•a‰@—×{Š“àŽ‹‹¾‰ºŽèpŒ¤‹†‰ï i98.10.23j, ‹à‘ò.

1560. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j •¬–呤ˆÝØœŒã‚̇•¹Ç‚ɑ΂·‚錟“¢. ‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC’çCC‹e’rŽj˜YC¬—ÑLsC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ28‰ñˆÝŠO‰ÈEpŒãáŠQŒ¤‹†‰ï i98.11.07j, ‘åã.

1561. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j T.E.M.‚É‚¨‚¯‚é“K‰ž‚ÆŽèpŽè‹Z. ‘å’J„³C‘ŠŒ´¬ºCÎ씎˜aC–ì‘ò’¼ŽjC‘êK‹ÏCˆäŒ´ŒúC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚R‰ñŒoãè–å“àŽ‹‹¾‰ºŽèpŒ¤‹†‰ï i98.12.10j, “Œ‹ž, ´˜^W, p.21, 1998.

1562. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ’×ᇫ‘å’°‰Š‚É‚¨‚¯‚éƒCƒŒƒIƒXƒgƒ~[‚̔畆áŠQ‚ÌŽí—Þ‚Æ”­¶ŽžŠú. ¼Œ´N”üiŠÅŒì•”jC‘å’J„³iŠOj: ‘æ‚W‰ñ“ú–{‘nEƒIƒXƒgƒ~[EŽ¸‹ÖƒPƒAŒ¤‹†‰ï i99.01.09j, “Œ‹ž, “ú–{‘n¥ƒIƒXƒgƒ~[¥Ž¸‹ÖƒPƒAŒ¤‹†‰ïŽ, 2(2): 16, 1998.

1563. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ’¼’°ŠàRb‚ɑ΂·‚鎊“KƒŠƒ“ƒpߊs´‚̉“Šu¬Ñ. Î씎˜aCˆäŒ´ŒúC‹à‘òG‹IC‘ŠŒ´¬ºC–ì‘ò’¼ŽjCŒÃì—T‰îC‘êK‹ÏC‘å’J„³C匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ50‰ñ‘å’°ŠàŒ¤‹†‰ï i99.01.29j, “Œ‹ž.

1564. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j •¬–啔؜Œã‚ÌŽcˆÝ’×ᇂ̂QÇ—á. ‹ß“¡Œ«ŽiC“ˆ”ömC•Ð“c‰Ä–çC’çCC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚R‰ñŽcˆÝ‰ŠŒ¤‹†‰ï i99.01.30j, “Œ‹ž.

1565. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j H“¹ƒAƒJƒ‰ƒVƒA‚ɑ΂·‚é• o‹¾‰ºŽèp. •Ð“c‰Ä–çC“ˆ”ömC÷–{MˆêC‹ß“¡Œ«ŽiC’çCC¬—ÑLsC‹e’rŽj˜YC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC“c•Ó‘i“àj: ‘æ‚V‰ñƒNƒŠƒjƒJƒ‹ƒrƒfƒIƒtƒH[ƒ‰ƒ€ i99.02.04j, “Œ‹ž, ´˜^W, p.41, 1999.

1566. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‹¾Ž‹•â•‰ºƒhƒi[“EotˆÚAŒã‚̈ÚA”AŠÇ”j—ô‚Ì‚PŽ¡Œ±—á. Ž­Žæ³“¹iŠOjC“c’†ŽO’ÃŽqC‹Ê’u“§C¬ŽR“à½CˆÀŒ´–ž•vC‘Žq‰ÀOC‰Ô“c—T”VC“à“c‘׎ŠC‰Ô–{‘¸”VC‹v–Ø“c˜a‹uC–Ú•‡ˆêC•Ä쌳Ž÷C쑺–¾•viŽD–y–k ž¾•a‰@j: ‘æ32‰ñ“ú–{tˆÚA—Õ°Œ¤‹†‰ï i99.03.03`05j, VŠƒ.

1567. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j tˆÚAŒã• –Œ‰Š‚É‚æ‚鎀–S—á‚ÌŒŸ“¢. ‘åÀ“cŽ¡C²“¡ŒõŽjC¬ìŒ›ÍC¡ˆäŒ‰Cˆ¢‘]˜a“NC‚‹´‹BC’†ŽR‹`‰îCŠ`“cÍiŠOjC‰““¡’‰—Yi”åjC“n•”_“ñi–ƉujC’|“àN—YCŠ™“cvŽõi“àj: ‘æ32‰ñ“ú–{tˆÚA—Õ°Œ¤‹†‰ï i99.03.03`05j, VŠƒ.

1568. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j tˆÚAŒã‚É‘–Œ‰Š‚𕹔­‚µŽ€–S‚µ‚½Ç—á‚ÌŒŸ“¢. ¬ìŒ›ÍC²“¡ŒõŽjC‘åÀ“cŽ¡C¡ˆäŒ‰Cˆ¢‘]˜a“NC‚‹´‹BC’†ŽR‹`‰îCŠ`“cÍiŠOjC‰““¡’‰—Yi”åjC“n•”_“ñi–ƉujC’|“àN—YCŠ™“cvŽõi“àj: ‘æ32‰ñ“ú–{tˆÚA—Õ°Œ¤‹†‰ï i99.03.03`05j, VŠƒ.

1569. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒŠƒ“ƒpß“]ˆÚ‚©‚猩‚½‰E‘¤isŒ‹’°Šà‚ÌŽèppŽ®‚ÌŒŸ“¢. ‘ŠŒ´¬ºCˆäŒ´ŒúCÎ씎˜aC–ì‘ò’¼ŽjC‘êK‹ÏC‘å’J„³C匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ49‰ñ‘å’°ŠàŒ¤‹†‰ï i98.07.03j, “Œ‹ž, ´˜^W, p.105, 1998.

1570. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j 2.0 cmˆÈ‰º‚Ìis‘å’°Šà‚ÌŒŸ“¢. ’r“c“ÄiŠOjCˆ¢ìçˆê˜YCŒÃ“ˆŒOC•ˆä‰ë•FC¬£ŸrC–ì‰ÆŠÂCˆÉ“¡Œ_C–ìŒû••vCˆ¢•”“N•vC¬¼•q˜YCÎŒ´Œh•viŠÖ“Œ’üM•a‰@j: ‘æ49‰ñ‘å’°ŠàŒ¤‹†‰ï i98.07.03j, “Œ‹ž, ´˜^W, p.71, 1998.

1571. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j äXŠÇ’_“¹‡—¬ˆÙí‚ð”F‚ß‚È‚¢æ“V«’_“¹Šg’£Ç‚Ì‚PŽèp—á. Š“cç”ü”TCΓc˜a•vC‹g“c@‹IC’†‘ºlLC“‡“cŒªC‚‹´‹BCŠ`“cÍiŠOj: ‘æ21‰ñ“ú–{äXŠÇ’_“¹‡—¬ˆÙ팤‹†‰ï i98.09.25j, b•{.

1572. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠÌ“à’_ŠÇŠàÇ—á‚Ì—Õ°•a—Šw“IŒŸ“¢. “‡“cŒªC‚‹´‹BC‹g“c@‹IC’†‘ºlLC–k‘º‰ë–çC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿Cò‰Æ‹v’¼C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ34‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï i98.10.14`15j, ‹à‘ò, ´˜^W, p.109, 1998.

1573. mŒ¤‹†‰ïi’n•ûjn i‹L”Ou‰‰j PEG‚ÌŽÀۂƇ•¹Ç‘Îô. “ˆ”ömiŠOj: _“Þì•ÛŒ¯ˆã‹¦‰ï‘æ‚V‰ñÝ‘îˆã—ÃE‰îŒìƒZƒ~ƒi[‹L”Ou‰‰ i98.05.24j, ‰¡•l.

1574. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‚ª‚ñ‚à‚±‚í‚­‚È‚¢. ”äŠé”\Ž÷iŠOj: ‚Ђç‚‚©ƒJƒ‹ƒ`ƒƒ[Ž–‹Æ‰^‰cˆÏˆõ‰ï¢‚ӂ邳‚Æu‰‰‰ï£Žs–¯ŒöŠJuÀ i98.05.09j, •½’Ë.

1575. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “àŽ‹‹¾Žèp‚ÌŒ»‹µ‚Æ«—ˆ‚Ì“W–]. ”äŠé”\Ž÷iŠOj: •½¬10”N“x•½’ËŽsˆãŽt‰ïŠO‰È•”‰ï‘‰ï i98.06.13j, •½’Ë.

1576. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‘å’°‚Ì•a‹C‚ɂ‚¢‚Ä. ”äŠé”\Ž÷iŠOj: ‘æ49‰ñ–k—¢‘åŠwPPA’n•û§˜b‰ï i98.10.17j, L“‡.

1577. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Á‰»ŠíŠO‰È—̈æ‚É‚¨‚¯‚é^‹ÛŠ´õÇ|Œ»ó‚Æ–â‘è“_|. ’Ë–{GliŠOj: _ŒË[Ý«^‹ÛÇu‰‰‰ï'98 i98.12.10j, _ŒË.

1578. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ˆÝŠàE‘å’°ŠàŽ¡—Â̑½—l«|‚»‚Ìf’f, Ž¡—Â̕ϑJ‚æ‚è|. ”äŠé”\Ž÷iŠOj: ‘æ22‰ñŒcœäŠO‰ÈƒtƒH[ƒ‰ƒ€‘‰ï i99.02.13j, “Œ‹ž.

1579. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j “àŽ‹‹¾“IˆÝá‘‘¢ÝpiPEG)‚É‚æ‚é‰h—{’“ü–@. “ˆ”ömiŠOj: ‘æ‚R‰ñL“‡Œo’°‰h—{ƒZƒ~ƒi[ i98.06.27j, L“‡.

1580. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j “àŽ‹‹¾“IˆÝá‘‘¢ÝpiPEG)‚É‚æ‚é‰h—{’“ü–@. “ˆ”ömiŠOj: ‘æ‚R‰ñ‰¡•lŒo’°‰h—{ƒZƒ~ƒi[ i98.07.18j, ‰¡•l.

1581. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‘å’°Šà, Œã• –ŒƒAƒvƒ[ƒ`•¹—p‚ʼn½‚ª•Ï‚í‚Á‚½H ‘êK‹ÏiŠOj: ‘æ‚S‰ñ‰«“ꌧ“àŽ‹‹¾‰ºŠO‰ÈŽèpŒ¤‹†‰ï i98.09.11j, ‰«“ê.

1582. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Ý‘î‚É‚¨‚¯‚éˆÝá‘ŠÇ—‚ÌŽÀÛ. “ˆ”ömiŠOj: ìèŽs–K–âŠÅŒìlÞ—{¬Œ¤C‰ï i99.02.10j, ìè.

1583. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “ûŽ™stage ‡WA_Œo‰èŽî‚Ì”ñŽèp—á‚ÌŒo‰ß‚ɂ‚¢‚Ä. Š“cç”ü”TCΓc˜a•viŠOjC¡ˆäƒDiŽ™j: ‘æ28‰ñ_“Þ쬎™Žîᇌ¤‹†‰ï i98.03.07j, ‰¡•l.

1584. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é‚—îŽÒ‚Ì• o‹¾‰º’_”X“Eop‚ÌŒŸ“¢. ù–{_C²“¡–ÎC“c‘ºK•äC•Ð“c‰Ä–çC÷–{MˆêC“n•Ó‹v”üŽqCX£¹Ž÷iŠOj: ‚—îŽÒ‚ÌŽ¡—ÃŒ¤‹†‰ï i98.04.00j, ‰¡•l.

1585. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘gDŠw“I‚Éf’f¢“ï‚Å‚ ‚Á‚½ŠÌ“÷Žî‚Ì‚P—á. ’†‘ºlLC“‡“cŒªC‚‹´‹BC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOjCŒK”ö’èmi•a—j: ‘æ17‰ñŠÌŠàǗጟ“¢‰ï i98.04.25j, “Œ‹ž.

1586. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹‘å‘’_ŠÇƒ|ƒŠ[ƒv‚Ì‚QÇ—á. ‰z“c‰À–¾C“‡“cŒªC‹g“c@‹IC“cŒ´@“¿C“c’†‘•cC•“c^’qŽqC’†‘ºlLC‚‹´‹BCŠ`“cÍiŠOj: ‘æ102‰ñŠÌ’_äXŽ¾Š³Œ¤‹†‰ï i98.05.21j, ‰¡•l, ƒvƒƒOƒ‰ƒ€, p.1, 1998.

1587. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j pŒã‘Šú‚ÉÄ”­‚µ‚½‚—îŽÒ’¼’°Šà‚Ì‚P—á. ²“¡KˆêC–ΖØ_ŽqC¡ˆäŒ‰iŠOjCŽ‰Æ–ÎŽ÷i•£–ì•Ó‘‡•a‰@j: ‘æ27‰ñ_“ÞìÁ‰»ŠíŠO‰ÈŒ¤‹†‰ï i98.05.23j, ‰¡•l.

1588. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’´‚—îŽÒ‚Ì‘å’°ŠàŽèp‚Ì‚P—á. ‰FˆäF‘¾˜YCˆÉ“¡—ÇmC÷–{MˆêiŠOjCˆÉ“¡–Îi‘Š–ÍŒ´ˆÉ“¡•a‰@jCŠ`“cÍiŠOj: ‘æ27‰ñ_“ÞìÁ‰»ŠíŠO‰ÈŒ¤‹†‰ï i98.05.23j, ‰¡•l.

1589. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‚—îŽÒ‚Ì‘å’°ŠàŽèp‚É‚¨‚¯‚éŽèp•ûj. ˆäŒ´ŒúC‘å’J„³CÎ씎˜aC–ì‘ò’¼ŽjC‘ŠŒ´¬ºC‘êK‹ÏC’Ë–{GlC²“¡ŒõŽjC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ27‰ñ_“ÞìÁ‰»ŠíŠO‰ÈŒ¤‹†‰ï i98.05.23j, ‰¡•l.

1590. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œã• –ŒƒAƒvƒ[ƒ`‚𕹗p‚µ‚½• o‹¾‰º‚r󌋒°Øœp‚ÌŒoŒ±. –ØìŽOŽl˜YC’·’J쌒C•Ð‹ËŠ°”VC“à“¡³‹KC•½ˆä˜a–íC¬ŽÅÍ„C‘êK‹ÏC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚S‰ñ–kŠC“¹“àŽ‹‹¾ŠO‰ÈŒ¤‹†‰ï i98.06.06j, ˆ®ì.

1591. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j pŒã’á‰h—{‚É‚æ‚é‚ÆŽv‚í‚ê‚é‚“x‚ÈŽ‰–bŠÌ‚ð’悵‚½‚P—á. “cŒ´@“¿C’†‘ºlLC“‡“cŒªC‚‹´‹BC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOjCa’J–¾—²i“àj: ‘æ‚S‰ñŠÌ•s‘S‚Ɖh—{Œ¤‹†‰ï i98.06.12j, “Œ‹ž.

1592. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”]Ž€ƒ‚ƒfƒ‹‚Æ’EŒŒƒ‚ƒfƒ‹‚ÌŠÌzŠÂ“®‘Ô‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä|ŽÀŒ±“IŒ¤‹†|. ‘åÀ“cŽ¡C²“¡ŒõŽjC¬ìŒ›ÍC¡ˆäŒ‰C‚‹´‹BC’†ŽR‹`‰îCŠ`“cÍiŠOj: ‘æ10‰ñ_“ÞìŠÌˆÚAŒ¤‹†‰ï i98.06.13j, ‰¡•l.

1593. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j WŠw“IŽ¡—Âɂæ‚艄–½‚Å‚«‚½ŠÌŠà‚Ì‚P—á. ‹gè’q–çCŠâéŒ[CC•Ð‰ª—Sˆêi–kM‘‡•a‰@jCˆî–؉pŽ¡C–Lì‹MŽiC‚–ì—eKC‰¡“c“™iŠOj: ‘æ91‰ñMBŠO‰ÈW’k‰ï i98.06.14j, ¼–{.

1594. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’·Šú¶‘¶’†‚Ì”j—ôŠÌ×–EŠà‚Ì‚PØœ—á. “‡“cŒªC‹g“c@‹IC’†‘ºlLC‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚Q‰ñ_“ÞìŠÌ‚ª‚ñŽ¡—ÃŒ¤‹†‰ï i98.06.23j, ‘Š–ÍŒ´.

1595. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‚—îŽÒˆÝŠà‚ÌŽèpŽ¡—ÃÇ—á‚ÌŒŸ“¢. ‹ß“¡Œ«ŽiC’çCC•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC“ˆ”ömC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ14‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i98.07.04j, ‰¡•l.

1596. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ò’Å–ƒŒ‰º’Ž‚‰ŠŽèp’†‚ÉS’âŽ~‚𗈂µ‚½‚P—á. ”‹´_ˆêC¼‘òŽ“TiŠOj: ‘æ16‰ñŽRŒ`ŠO‰È’k˜b‰ï i98.07.04j, ŽRŒ`.

1597. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Borrmann ‡WŒ^ˆÝŠàØœ—á56—á‚ÌŽ¡—ìт̌Ÿ“¢. –î–ì„ŽiC‹e’rŽj˜YC‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC’çCC¬—ÑLsC’Ë–{GlC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ14‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i98.07.04j, ‰¡•l, ´˜^W, p.25, 1998.

1598. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j f’f‚É‹ê—¶‚µ‚½’_‚Ì‚¤•a•Ï‚Ì‚P—á. ŒÃ“cˆê“¿iŠOjC’©ŒË—TC‰ºŽR–LCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤i‘—§‘å‘ •a‰@jCª–{—S‘¾iŠOjC‘¼: ‘æ36‰ñ“Œ‹ž’n‹æ‘—§•a‰@ŠO‰ÈŒ¤‹†‰ï i98.07.18j, “Œ‹ž.

1599. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éŒo”ç“àŽ‹‹¾“IˆÝá‘‘¢Ýp. ”‹´_ˆêC¼‘òŽ“TiŠOj: ‘æ‚Q‰ñŽRŒ`“àŽ‹‹¾ŠO‰ÈŒ¤‹†‰ï i98.08.29j, ŽRŒ`.

1600. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j tŠàpŒãŒ‹’°Ä”­‚ð‚«‚½‚µ‚½‚P—á. ’r“c“ÄiŠOjCŒÃ“ˆŒOCˆ¢ìçˆê˜YC¡ˆä‰„”NC•ˆä‰ë•FC–ì‰ÆŠÂCˆÉ“¡Œ_Cˆ¢•”“N•vC¬¼•q˜YCÎŒ´Œh•viŠÖ“Œ’üM•a‰@j: ‘æ‚U‰ñé“ì’n‹æ‘å’°Ž¾Š³§˜b‰ï i98.09.04j, “Œ‹ž.

1601. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’·Šú¶‘¶’†‚ÌH“¹–¢•ª‰»Šà‚Ì‚P—á. •Ð“c‰Ä–çC¬—ÑLsCŽOd–슰ŠìC‹ß“¡Œ«ŽiC’çCC‹e’rŽj˜YC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOj: ‘æ36‰ñ_“ÞìH“¹Ž¾Š³§˜b‰ï i98.09.10j, ‰¡•l.

1602. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éˆÝŒ´”­ˆ««ƒŠƒ“ƒpŽî‚ÌŒŸ“¢. â“c“¹¶C’©ŒË—TC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCŒIŒ´’¼li‘—§‘å‘ •a‰@jCª–{—S‘¾C“Œò—CŒüˆä”ü˜aŽqiŠOj: ‘æ770‰ñŠO‰ÈW’k‰ï i98.09.12j, “Œ‹ž, ´˜^W, p.23, 1998.

1603. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ãsŒ‹’°‚É’°dÏ‚ð‚¨‚±‚µ‚½‰ñ’°malignant lymphoma‚Ì‚P—á. –öŒ´³’qiŠOjC¡¼G–¾CÄ“¡Œ’lC²“¡’¼li‰¡•l‘Dˆõ•ÛŒ¯•a‰@jCŒÃì—T‰îiŠOjCãÈ’B–çi‰¡•l‘Dˆõ•ÛŒ¯•a‰@j: ‘æ770‰ñŠO‰ÈW’k‰ï i98.09.12j, “Œ‹ž, ´˜^W, p.33, 1998.

1604. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹t—¬«H“¹‰Š‚ÌŽèp. •Ð“c‰Ä–çiŠOj: ‘æ‚W‰ñ_“ÞìŽèpŽè‹ZŒ¤‹†‰ï i98.10.23j, ‰¡•l.

1605. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j f’f‚É‹ê—¶‚µ‚½‚•ª‰»Œ^ŠÌ×–EŠà‚Ì‚P—á. “‡“cŒªC’†‘ºlLC‚‹´‹BC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOjCa’J–¾—²i“àjCŽO•xO”VC‘å•”½i•a—j: ‘æ18‰ñŠÌŠàǗጟ“¢‰ï i98.10.24j, “Œ‹ž, ´˜^W, p.22, 1998.

1606. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j tˆÚAŠ³ŽÒ‚É‚¨‚¯‚épŒãƒŠƒ“ƒp‹…ƒTƒuƒZƒbƒg‚Ì•Ï“®|FACS‚É‚æ‚épŒã–Ɖuó‘Ԃ̃‚ƒjƒ^ƒŠƒ“ƒO|. Ž­Žæ³“¹iŠOjC‹Ê’u“§C“c’†ŽO’ÃŽqCŸŽ}‹`‹LC‰Ô–{‘¸”VC“à“c‘׎ŠC‰Ô“c—T”VC¬ŽR“à½C‘Žq‰ÀOCˆÀŒ´–ž•vC‹v–Ø“c˜a‹uC–Ú•‡ˆêC•Ä쌳Ž÷C쑺–¾ •viŽD–y–kž¾•a‰@j: ‘æ‚X‰ñ–kŠC“¹tˆÚA’k˜b‰ï i98.11.07j, ŽD–y.

1607. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˆÙ•¨‚É‚æ‚é’¼’°úE‚Ì‚P—á. ÎŒ´‰ë–¤C’©ŒË—TC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCŒIŒ´’¼lCâ“c“¹¶i‘—§‘å‘ •a‰@jCª–{—S‘¾C‹{•”—iŠOj: ‘æ37‰ñ“Œ‹ž’n‹æ‘—§•a‰@ŠO‰ÈŒ¤‹†‰ï i98.11.14j, “Œ‹ž.

1608. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j AFPŽY¶ˆÝŠà‚Ì‚P—á. ¬”ª–ØaˆêC¬–ì—¢qCŠÝ–{ˆê˜YC‹ß“¡NŽjC’|“cC—§ÎWC¼”ªŽkC”ª\ì—v•½C–{‹§iŠOj: ‘æ16‰ñé‹ÊŒ§ŠO‰ÈW’k‰ï i98.11.21j, ‰Y˜a.

1609. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¬’°Šà‚Q—á‚ÌŽ¡—ÃŒoŒ±. ŒI“c~Cã–쑈ê˜YC‹{“à–M_C’†ŒF‘¸ŽmiŠOjC“‡’J‰p–¾iã”ö’†‰›‘‡•a‰@jC’†‘º—²rC‘哇s•FiŠOjC’†‘ºG•v: ‘æ16‰ñé‹ÊŒ§ŠO‰ÈW’k‰ï i98.11.21j, ‰Y˜a.

1610. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j •Â½Eƒwƒ‹ƒjƒA‚Ì‚P—á. ’†‘º—²rCã–쑈ê˜YC‹{“à–M_C’†ŒF‘¸ŽmiŠOjC“‡’J‰p–¾iã”ö’†‰›‘‡•a‰@jCŒI“c~C‘哇s•FiŠOjC’†‘ºG•v: ‘æ16‰ñé‹ÊŒ§ŠO‰ÈW’k‰ï i98.11.21j, ‰Y˜a.

1611. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j CRESTÇŒóŒQ‚É•¹”­‚µ‚½‹t—¬«H“¹‰Š‚ɑ΂µ• o‹¾‰ºŽèp‚ðŽ{s‚µ‚½‚P—á. •Ð“c‰Ä–çC¬—ÑLsC‹ß“¡Œ«ŽiC’çCC‹e’rŽj˜YC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOj: ‘æ37‰ñ_“ÞìH“¹Ž¾Š³§˜b‰ï i98.11.28j, ‰¡•l.

1612. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‰E“û‘BŽîáŽ. ‹{•”—C’©ŒË—TCŒüˆä”ü˜aŽqC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤i‘—§‘å‘ •a‰@j: ‘æ27‰ñ“Œ‹ž“û‘BŒ¤‹†‰ï i98.11.28j, “Œ‹ž.

1613. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒNƒ[ƒ“•aŠ³ŽÒ‚̃Xƒg[ƒ}ŠÇ—. ¼Œ´N”üiŠÅŒì•”jC‘å’J„³iŠOjCŸ–””º‰hi“àj: ‘æ‚T‰ñ_“ÞìIBDŒ¤‹†‰ï i98.12.04j, ‰¡•l, —\eW, p.3, 1998.

1614. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j oŒŒ«’×ᇂ𗈂µ‚½ƒƒbƒPƒ‹ŒeŽº‚Ì‚PŽèp—á. ™“c”ŽriŠOjC“c’†Œ·CŽRèŒö–õCì’[‰pFCˆ¢•”GŽ÷C‰¡“c˜a•FC“c’†Œ‰iJR“Œ‹ž‘‡•a‰@j: ‘æ771‰ñŠO‰ÈW’k‰ï i98.12.05j, “Œ‹ž, ´˜^W, p.35, 1998.

1615. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j f’f‚É‹ê—¶‚µ‚½H“¹Šà‡•¹äXŠà‚Ì‚P—á. ’r“c“ÄiŠOjCˆ¢•”“N•vC¡ˆä‰„”NC•ˆä‰ë•FCXŒ“Œ[‘¾C–ì‰ÆŠÂCˆÉ“¡Œ_CŒÃ“ˆŒOCˆ¢ìçˆê˜YC–ìŒû••vC¬¼•q˜YCÎŒ´Œh•viŠÖ“Œ’üM•a‰@j: ‘æ771‰ñŠO‰ÈW’k‰ï i98.12.05j, “Œ‹ž, ´˜^W, p.38, 1998.

1616. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’×ᇫ‘å’°‰Š‚É‚¨‚¯‚éƒCƒŒƒIƒXƒg[ƒ}‚ƘA‘±‚·‚éŠJ•ú‘n‚̃PƒA‚ðŒoŒ±‚µ‚Ä. “àŽR“ÞŽqC‘å’|—¥ŽqC¼Œ´N”üC^–ì“oŠìŽqiŠÅŒì•”jC‰HLŒ’mC‘å’J„³iŠOj: ‘æ21‰ñ_“ÞìƒXƒg[ƒ}Œ¤‹†‰ï i98.12.12j, ‰¡•l.

1617. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘å’°ŒŒŠÇŽî‚Ì‚P—á. ‰¡“c“™C–Lì‹MŽiiŠOjC‹´“s³—mC‹gè’q–çi–kM‘‡•a‰@jCˆÀ“c‹gGiŒ`ŠOjC•Ð‰ª—Sˆêi‹~–½jCˆî–؉pŽ¡C‚–ì—eKiŠOj: ‘æ92‰ñMBŠO‰ÈW’k‰ï i98.12.13j, ¼–{.

1618. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j •¬–呤ˆÝØœŒã‚É‚¨‚¯‚釕¹ÇÇ—á‚ÌŒŸ“¢. ‹ß“¡Œ«ŽiC•Ð“c‰Ä–çC•½ˆär’jC’çCC‹e’rŽj˜YC¬—ÑLsC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ15‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i98.12.19j, ‰¡•l.

1619. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘O‰ñ‚ÌŒŸ“¢‰ï‚ÅЉ‚ꂽäX“ª•”ŽîáŽÇ—á‚ÌŽèpÇ—á. “‡“cŒªC‹g“c@‹IC¯–ìOŽ÷C’†‘ºlLC‚‹´‹BC²“¡ŒõŽjC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ14‰ñ–k—¢ŠÌ’_äXǗጟ“¢‰ï i99.01.20j, ‘Š–ÍŒ´.

1620. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹~–½“IŠÌØœppŒã‘Šú‚ÉÄ”­Ž€–S‚µ‚½’ᕪ‰»Œ^ŠÌ×–EŠà‚Ì‚P—á. ã–ì‘ôÆC‚‹´‹BC“‡“cŒªC’†‘ºlLC‹g“c@‹IC—Ñ‹žŽqC²“¡ŒõŽjC”äŠé”\Ž÷CŠ`“cÍiŠOjCŒK”ö’èmi•a—j: ‘æ28‰ñ_“ÞìŠÌ’k˜b‰ï i99.01.30j, ‰¡•l.

1621. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œã• –ŒƒAƒvƒ[ƒ`‚É‚æ‚é• o‹¾•â•‰º‘å’°Øœp‚Ì—L—p«. ”Ñ–ì‘Pˆê˜YC‰Í–ìŒ\ˆêiŠOjC–xì½–çCŽÄN•Fi’†ð’†‰›•a‰@j: ‘æ69‰ñVŠƒÁ‰»Ší•aŒ¤‹†‰ï i99.02.13j, VŠƒ.

1622. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “¯‘¤“û–[‚É‹}‘¬‘‘債‚½Z«‘BŠà‚Æ—Ç«—tóŽîá‡‚ð‡•¹‚µ‚½‚P—á. ‹{•”—C’©ŒË—TC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤i‘—§‘å‘ •a‰@jCª–{—S‘¾iŠOjCŒüˆä”ü˜aŽq: ‘æ22‰ñŒcœäŠO‰ÈƒtƒH[ƒ‰ƒ€‘‰ï i99.02.13j, “Œ‹ž.

1623. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œã• –Œ‚ÌL”Í‚ÈüˆÛ‰»‚𔺂¢f’f‚É‹ê—¶‚µ‚½äX“ª•”—̈æŽîᇂ̂PØœ—á. ¯–ìOŽ÷C“‡“cŒªC‹g“c@‹IC’†‘ºlLC‚‹´‹BC²“¡ŒõŽjCŠ`“cÍiŠOj: ‘æ6‰ñBPƒNƒ‰ƒu i99.03.02j, ‰¡•l.

1624. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‚ ‚È‚½‚Ì‚¨• ‘åä•v‚Å‚·‚©H|‚¿‚á‚ñ‚ÆH‚ׂç‚ê‚éˆ×‚É|. ”äŠé”\Ž÷iŠOj: ƒƒfƒBƒJƒ‹ƒZƒ~ƒi[_“Þì i99.03.04j, ‰¡•l.

1625. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Harmonic Scalpel‚ð—p‚¢‚½“ûŠàŽèp‚ÌŒoŒ±. ŠÖª’q‹vi¬”’쎊½“°•a‰@jC”‹´_ˆêC¼‘òŽ“TiŠOj: ‘æ‚T‰ñ“Œ–k“û‘BŽ¾Š³Œ¤‹†‰ï i99.03.06j, å‘ä.

1626. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Øœ•s”\‚È’°ŠÔ–Œˆ««ƒŠƒ“ƒpŽî‚ɑ΂µƒGƒgƒ|ƒVƒh­—Ê’·ŠúŒoŒû“Š—^‚ª’˜Œø‚µ‚½‚P—á. –öŒ´³’qiŠOjC²“¡’¼•vC‰Í“cŒõOi‰¡•l‘Dˆõ•ÛŒ¯•a‰@jCŒÃì—T‰îiŠOjC¡¼G–¾CãÈ’B–ç: ‘æ772‰ñŠO‰ÈW’k‰ï i99.03.06j, “Œ‹ž, ´˜^W, p.90, 1999.

1627. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é• o‹¾‰º’Ž‚Øœp‚ÌŒŸ“¢. ²“¡•˜YC’Ò—ºìiŠOjC–q“c‰prC’¬“c²’jC‹v•ÛK—SC¬‘ò³KC‚‹´•‹Xi“Œ‘å˜a•a‰@j: 鼊O‰ÈŒ¤‹†‰ï i99.03.07j, —§ì.

1628. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¬Ž™’j«‰»•›tŽîᇂ̂P—á. Š“cç”ü”TCΓc˜a•viŠOjC‰¡“csŽjiŽ™jCŠâŸºŒ[ˆêi•a—j: ‘æ30‰ñ_“Þ쬎™Žîᇌ¤‹†‰ï i99.03.13j, ‰¡•l.

1629. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”x‘BŠà‚ɇ•¹‚µ‚½”w•”MFH‚Ì‚P—á. ’©ŒË—TC‰ºŽR–Li‘—§‘å‘ •a‰@jCŒÃ“cˆê“¿iŠOjCŒIŒ´’¼lCâ“c“¹¶CÎŒ´‰ë–¤i‘—§‘å‘ •a‰@jCª–{—S‘¾iŠOjC“Œò—: ‘æ38‰ñ“Œ‹ž’n‹æ‘—§•a‰@ŠO‰ÈŒ¤‹†‰ï i99.03.13j, “Œ‹ž.

1630. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Šà«• –Œ‰Š‚ɑ΂·‚éƒCƒŒƒEƒXŠÇ‚Ì‘ã—p‚Æ‚µ‚Ä‚ÌŒ¸ˆ³“àŽ‹‹¾ˆÝá‘‘¢Ýp. ‹ß“¡Œ«ŽiC“ˆ”ömC’çCCX£¹Ž÷C•Ð“c‰Ä–çC‹e’rŽj˜YC¬—ÑLsC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ22‰ñ_“ÞìŠàŽ¡—ç˜b‰ï i99.03.19j, ‰¡•l.

1631. mŠw‰ïŽåÃi‚»‚Ì‘¼jn ‘æ27‰ñ“ú–{’_“¹ŠO‰ÈŒ¤‹†‰ïi98.05.14`15j Š`“cÍiŠOj.

1632. mŠw‰ïŽåÃi‚»‚Ì‘¼jn ‘æ27‰ñ_“ÞìÁ‰»ŠíŠO‰ÈŒ¤‹†‰ïi98.05.23j Š`“cÍiŠOj.


<<16 ‹¹•”ŠO‰ÈŠw>>

1633. mŒ´’˜n ã‘åÖ¬‹}«ŽÕ’f‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†. X“c’mŒhi‘—§‘Ûˆã—ÃZƒ“jC‚ŽRr­Cˆä㔹lC‹g‘º”Ž–Mi‹¹ŠOj: –k—¢ˆãŠw, 28(3): 268`279, 1998.

1634. mŒ´’˜n Coronary artery bypass grafting for coronary artery disease in pediatric patients with Kawasaki disease. ¬Œ´–M‹`i‹¹ŠOjC”ª–ØŒ´rŽCŠÝ–{‰p•¶Cˆé•”•¶—²CŽR–{•¶—YC‹S“ª‹`ŽŸC“¡“c‹Bi‘—§zŠÂŠí•aƒZƒ“ƒ^[j: –k—¢ˆãŠw, 28(4): 365`371, 1998.

1635. mŒ´’˜n Coronary artery aurgery in patients with aortitis syndrome. ¬Œ´–M‹`i‹¹ŠOjC‹S“ª‹`ŽŸCì•›_•½C¬âˆä‰Ã•vCˆÀ“¡‘¾ŽOC’†“‡L”VC“¡“c‹Bi‘—§zŠÂŠí•aƒZƒ“ƒ^[j: –k—¢ˆãŠw, 28(4): 372`380, 1998.

1636. mŒ´’˜n Evaluation of emergency coronary artery bypass grafting within 2 weeks of acute myocardial infarction. ¬Œ´–M‹`i‹¹ŠOjCì•›_•½C¬âˆä‰Ã•vCùŽq‰À–åC‹S“ª‹`ŽŸC“¡“c‹Bi‘—§zŠÂŠí•aƒZƒ“ƒ^[j: –k—¢ˆãŠw, 28(5): 421`427, 1998.

1637. mÇ—á•ñn Arteriovenous fistula complicating chest tube insertion. •—ŠÔ”ÉCæѳŠîCŽOD–Li‹¹ŠOj: Ann. Thorac. Surg., 67(1): 294`295, 1999.

1638. mÇ—á•ñn ”A˜HŒ‹Î‚𔺂Á‚½‰ñ“]ˆÙít. ‚ŽRr­i‹¹ŠOjC‚ŽR^•½i‚ŽRˆã‰@jC“ŒŒ´‰p“ñiˆÇ—Ñ‘åj: t‘Ÿ, 21(4): 230`234, 1999.

1639. mÇ—á•ñn Blow outŒ^‚̶ŽºŽ©—R•Ç”j—ô‚ɑ΂µ‚Ä, GRFR glue‚ð—p‚¢‚½ƒEƒ}S–Œƒpƒbƒ`•Â½‚ª—LŒø‚ÆŽv‚í‚ꂽ‚P—á. ’ËvˆäGsi¹˜H‰Á‘Û•a‰@jC¬Œ´–M‹`i‹¹ŠOjCH–{„GCŒüˆä“c¹”VCˆ¢•”P•½i¹˜H‰Á‘Û•a‰@j: “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 46(9): 898`901, 1998.

1640. mÇ—á•ñn ¶ã—t”xŠà‚ɑ΂·‚郊ƒ“ƒpߊs´p. ‹g‘º”Ž–MC•i“cƒC‹{‰i–ÎŽ÷C“V–ì‰pŽ÷i‹¹ŠOj: ”xŠà, 12: 65`70, 1998.

1641. m‘àn “à‰ÈƒGƒ}[ƒWƒFƒ“ƒV[‚É‚¨‚¯‚é‹~‹}ˆ’u|ŠÏŒŒ“IŽ¡—Ö@|. •—ŠÔ”Éi‹¹ŠOj: ƒƒfƒBƒ`[ƒi, 35(11): 39`43, 1998.

1642. muÀn ”x“®–¬‚Ì–ü’…”—£. ‹g‘º”Ž–Mi‹¹ŠOj: ‹¹•”ŠO‰È, 51(1): 73, 1998.

1643. mŠwp‘n i•ª’SŽ·•Mj ‰æ‘œ‚Æ•a—‘œ‚©‚ç‚Ý‚½ŒÄ‹zŠíŽ¾Š³; ”xŒ´”­ãO–ÑŠà, p.256`257, ‹g‘º”Ž–Mi‹¹ŠOj. •ÒW ‰““¡Œ[Œá, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹žC98.05.10”­s.

1644. m‹³‰È‘n i•ª’SŽ·•Mj Œn“ŠÅŒìŠwuÀ, ¬lŠÅŒìŠw[3]zŠÂŠíŽ¾Š³‚ÌŠÅŒì, ŒŒ‰t¥‘¢ŒŒŠíŽ¾Š³Š³ŽÒ‚ÌŠÅŒì; ‘æ2Í, Šî‘b’mŽ¯ A. ‰ð–U¶—, p.20`29, ¬Œ´–M‹`i‹¹ŠOj. ˆãŠw‘‰@, “Œ‹žC99.01.15”­s.

1645. m‹³‰È‘n i•ª’SŽ·•Mj Œn“ŠÅŒìŠwuÀ, ¬lŠÅŒìŠw[3]zŠÂŠíŽ¾Š³‚ÌŠÅŒì, ŒŒ‰t¥‘¢ŒŒŠíŽ¾Š³Š³ŽÒ‚ÌŠÅŒì; ‘æ3Í, Ž¾Š³‚Ì—‰ð A. æ“V«SŽ¾Š³, p.74`85, ¬Œ´–M‹`i‹¹ŠOj. ˆãŠw‘‰@, “Œ‹žC99.01.15”­s.

1646. m‹³‰È‘n i•ª’SŽ·•Mj Œn“ŠÅŒìŠwuÀ, ¬lŠÅŒìŠw[3]zŠÂŠíŽ¾Š³‚ÌŠÅŒì, ŒŒ‰t¥‘¢ŒŒŠíŽ¾Š³Š³ŽÒ‚ÌŠÅŒì; ‘æ3Í, Ž¾Š³‚Ì—‰ð B. Œã“V«SŽ¾Š³, p.87`92, ¬Œ´–M‹`i‹¹ŠOj. ˆãŠw‘‰@, “Œ‹žC99.01.15”­s.

1647. m‹³‰È‘n i•ª’SŽ·•Mj Œn“ŠÅŒìŠwuÀ, ¬lŠÅŒìŠw[3]zŠÂŠíŽ¾Š³‚ÌŠÅŒì, ŒŒ‰t¥‘¢ŒŒŠíŽ¾Š³Š³ŽÒ‚ÌŠÅŒì; ‘æ3Í, Ž¾Š³‚Ì—‰ð E. “®–¬áŽ, p.147`155, ¬Œ´–M‹`i‹¹ŠOj. ˆãŠw‘‰@, “Œ‹žC99.01.15”­s.

1648. m‹³‰È‘n i•ª’SŽ·•Mj Œn“ŠÅŒìŠwuÀ, ¬lŠÅŒìŠw[3]zŠÂŠíŽ¾Š³‚ÌŠÅŒì, ŒŒ‰t¥‘¢ŒŒŠíŽ¾Š³Š³ŽÒ‚ÌŠÅŒì; ‘æ3Í, Ž¾Š³‚Ì—‰ð F. pŒãŠÇ—, p.156`165, ¬Œ´–M‹`i‹¹ŠOj. ˆãŠw‘‰@, “Œ‹žC99.01.15”­s.

1649. m‹³‰È‘n i•ª’SŽ·•Mj V—Õ°ŠO‰ÈŠw‘æ3”Å; cŠu¥‹¹•Ç¥‹¹–Œ, p.263`272, ‹g‘º”Ž–Mi‹¹ŠOj. •ÒW X‰ª‹±•F, ˆãŠw‘‰@, “Œ‹žC98.03.15”­s.

1650. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Large cell neuroendocrine carcinoma‚Ì—Õ°“IŒŸ“¢. •i“cƒC‹{‰i–ÎŽ÷CŒã“¡®”üC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ15‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï i98.04.28j, “Œ‹ž, “ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‰ïŽ, 12(3): 365, 1998.

1651. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ìè•aŠ³Ž™‚ɑ΂·‚銥“®–¬ƒoƒCƒpƒXp‚É‚¨‚¯‚é‘啚ݶÖ¬ƒOƒ‰ƒtƒg‚ÌŒÀŠE‚Æ—LŒø«. ’¹ˆäWŽOC¬Œ´–M‹`C‹g‘º”Ž–Mi‹¹ŠOjC{–K‘ i“Œ—ˆã‘åjC’|“à–õ•viŠÖ“Œ’üM•a‰@j: ‘æ35‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i98.05.27j, ‹à‘ò, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 34(3): 137, 1998.

1652. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ESŒnŠ´õ«S“à–Œ‰Š‚ɑ΂·‚éŠO‰ÈŽ¡—ÂQÇ—á‚ÌŒŸ“¢. ’¹ˆäWŽOC‹g“c‘ŽqCŽOD–LC’Ϙa•FCŠ}Œ´^ŒåCæѳŠîC¬Œ´–M‹`C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ60‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï i98.11.10j, L“‡, “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 59(‘): 280, 1998.

1653. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žá”NŽÒ(40Ζ¢–žj‚ÌŠ´õ«S“à–Œ‰Š‚ɑ΂·‚éŠO‰ÈŽ¡—Â̌Ÿ“¢. ’¹ˆäWŽOCXŒõ°C“n•Ór–¾CŽOD–LC’Ϙa•FCŠ}Œ´^ŒåCæѳŠîC¬Œ´–M‹`C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ29‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï i99.02.09j, ç—t, “ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŽGŽ, 28(Suppl.): 147, 1999.

1654. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Š´õ«S“à–Œ‰Š‚ɑ΂·‚éŠO‰ÈŽ¡—ìт̌Ÿ“¢|Šî‘bSŽ¾Š³‚ª—\Œã‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä|. ’¹ˆäWŽOC‹g“c‘ŽqCŽOD–LC’Ϙa•FCŠ}Œ´^ŒåCæѳŠîC¬Œ´–M‹`C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ51‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï i98.10.04j, “Œ‹ž, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 46(Suppl.): 333, 1998.

1655. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ò‘‹•ŒŒŠQ‚ɑ΂·‚éPentobarbital‚ÌŒø‰Ê. ŽOD–LC•—ŠÔ”ÉCæѳŠîC‘q“c“ÄC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ99‰ñ“ú–{ŠO‰ÈŠw‰ï‘‰ï i99.03.24j, •Ÿ‰ª, “ú–{ŠO‰ÈŠw‰ïŽGŽ, 100(‘‰ï†): 325, 1999.

1656. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j NeoadjuvantŽ¡—Ã’˜ŒøØœ—á‚ÌŒŸ“¢. •i“cƒC_’J‹I‹PC‹g“c‘ŽqC‹g‘º”Ž–Mi‹¹ŠOjC‹T’J“Oi•a—j: ‘æ122‰ñ“ú–{”xŠàŠw‰ïŠÖ“Œ•”‰ï i98.07.18j, “Œ‹ž.

1657. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œo”çj¶ŒŸ’†‚É‹ó‹CÇð‚ª¶‚¶‚½1—á. _’J‹I‹Pi‹¹ŠOjC‰¡ˆä•½i“È–ØŒ§—§‚ª‚ñƒZƒ“jCŒã“¡®”üi‹¹ŠOjC’¬“c—DCX´ŽuC•x‰iŒcëi“È–ØŒ§—§‚ª‚ñƒZƒ“j: ‘æ122‰ñ“ú–{”xŠàŠw‰ïŠÖ“Œ•”‰ï i98.07.18j, “Œ‹ž.

1658. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œ´”­‘ƒ‚ƃŠƒ“ƒpß“]ˆÚ•”ˆÊ‚ªˆÙ‚È‚Á‚½‘gDŒ^‚Å‚ ‚Á‚½Induction ChemotherapyŒã‚Ì”xŠà‚Ì1Øœ—á. ‹g“c‘ŽqC•i“cƒC_’J‹I‹PC‘•c“wCŒ´‰p‘¥C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ107‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i98.09.12j, “Œ‹ž.

1659. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Valsalva sinus‚Ì“Ëo‚É‚æ‚è‚“x‰EŽº—¬o˜H‹·ó‚ð’悵‚½VSDIŒ^{AR‚Ì‚P—á. XŒõ°C’¹ˆäWŽOCæѳŠîC’Ϙa•FCŽOD–LC‹g“c‘ŽqC¬Œ´–M‹`C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ107‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i98.09.12j, “Œ‹ž, —vŽ|W, p.20, 1998.

1660. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹¹‘BŽî‚É‚¨‚¯‚é—\ŒãˆöŽq‚ÌŒŸ“¢. •i“cƒC‹{‰i–ÎŽ÷CŒã“¡®”üCŠÖŒb—“ÞC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ122‰ñ“ú–{”xŠàŠw‰ïŠÖ“Œ•”‰ï i98.10.03j, “Œ‹ž.

1661. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹‘åŒÇ—§«üˆÛŽî‚Ì‚PŽèp—á. ‘•c“wC•i“cƒC_’J‹I‹PCXŒõ°C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ108‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i98.12.05j, “Œ‹ž, Jpn. J. Thorac. Cardiovasc. Surg., 47(Suppl.): 147, 1999.

1662. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j 21Η«‚ÉŒ©‚ç‚ꂽ‹CŠÇŽx•Â½Ç‚Æl‚¦‚ç‚ꂽ1Žèp—á. XŒõ°C•i“cƒC‘•c“wC_’J‹I‹PCŒ´‰p‘¥C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ87‰ñ“ú–{‹CŠÇŽxŠw‰ïŠÖ“ŒŽx•”‰ï i98.12.19j, “Œ‹ž.

1663. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚ˆÊ‘å“®–¬•ÂÇ¥[•”Ö¬ŒŒðǂ𔺂¢ƒOƒ‰ƒtƒg‘I‘ð‚É“ïa‚µ‚½Žá”NŽÒŠ¥“®–¬ƒoƒCƒpƒX‚Ì‚P—á. “n•Ór–¾C‹g“c‘ŽqCŽOD–LC’Ϙa•FCæѳŠîC’¹ˆäWŽOC•—ŠÔ”ÉC¬Œ´–M‹`C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ109‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i99.02.20j, “Œ‹ž, —vŽ|W, p.22, 1999.

1664. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j SŽºáŽØœ, Š¥“®–¬ƒoƒCƒpƒXpŒã20”N‚Ì’·ŠúŠÏŽ@‚ðs‚Á‚½‚P—á. ’¹ˆäWŽOC¬Œ´–M‹`C‹g‘º”Ž–Mi‹¹ŠOjC’|“à–õ•vi“Œ—ˆã‘åj: ‘æ18‰ñ“ú–{ìè•aŒ¤‹†‰ï i98.10.31j, _ŒË, ´˜^W, p.85, 1998.

1665. m“Á‹–¥ˆÓ “o˜^n S‘Ÿ–|“]‹ï(‘æ2580836†). •—ŠÔ”Éi‹¹ŠOj.


<<17 ”]_ŒoŠO‰ÈŠw>>

1666. mŒ´’˜n Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor. ‰ªGGi”]ŠOjCLong JinCJean Claude ReubiCXiang QianCBernd W. ScheithauerC“¡ˆä´Fi”]ŠOjC‹T’J“Oi•a—jCRichardo Lloydo: Am. J. Pathol., 153(6): 1787`1796, 1998.

1667. mŒ´’˜n ‘¤”]Žº‚̉ð–U. ‘ˆä³„C“c’†–ö…C“¡ˆä´Fi”]ŠOj: Clin. Neurosci., 16(12): 18`23, 1998.

1668. mŒ´’˜n Moderate hypothermia reduces hypotensive, but not hypercapnic vasodilation of pial arterioles in rats. “ü‘qŽŒÈC‹{â‰À’jC‰iˆä¬Ž÷C“’‘òòCXˆä½“ñC“¡ˆä´Fi”]ŠOj: J. Cereb. Blood Flow Metab., 18: 1294`1297, 1998.

1669. mŒ´’˜n Long-term functional outcome of suprasellar germinomas: Usefulness and limitations of radiotherapy. ‰ªGGCì–ìM”VC“c’†’qŽqC‰F’ÖؑC¬—шè•vC‘O‘ò_C“¡ˆä´Fi”]ŠOj: J. Neuro-Oncol., 40: 185`190, 1998.

1670. mŒ´’˜n Preoperative superselective embolization of skull base meningiomas: Indications and limitations. ‰ªGGC‘q“c²Cì–ìM”VCŽOŽ}GˆÉC¬—шè•vC‘å“ä’mC‹{â‰À’jC“¡ˆä´Fi”]ŠOj: J. Neuro-Oncol., 40: 67`71, 1998.

1671. mŒ´’˜n Clinical and neuroimaging features of chiari type ‡T malformations with and without associated syringomyelia. ŽRè‹`‹éC‹kŽ ‘C‚–ì½C“¡ˆä´Fi”]ŠOj: Neurol. Med. Chir., 38(9): 541`547, 1998.

1672. mŒ´’˜n Pial arteriovenous malformation with massive perinodal edema. ´…‹ÅC‹{â‰À’jC“c’†–ö…C‘q“c²C“¡ˆä´Fi”]ŠOj: Neurol. Res., 20: 249`252, 1998.

1673. mŒ´’˜n Efficacy of the stump pressure ratio as a guide to the safety of permanent occlusion of the internal carotid artery. X“ˆŒ[”VC‘q“c²C‹{â‰À’jC“¡ˆä´Fi”]ŠOjC›Mˆêi•új: Neurol. Res., 20: 732`736, 1998.

1674. mŒ´’˜n Dural-pial arteriovenous malformation after sinus thrombosis. ¬‘ò’B–çC‹{â‰À’jC“c’†–ö…C‘q“c²C“¡ˆä´Fi”]ŠOj: Stroke, 29: 1721`1724, 1998.

1675. mŒ´’˜n The significance of retrograde thrombosis following removal arteriovenous malformations in elderly patients. ‹{â‰À’jC‘q“c²C“c’†–ö…C“ü‘qŽŒÈCŽR“cŸC“¡ˆä´Fi”]ŠOj: Surg. Neurol., 49: 399`405, 1998.

1676. mŒ´’˜n dÇ“ª•”ŠO‚ɑ΂·‚é”]’ቷŠÇ—‚ð—p‚¢‚½_ŒoW’†ŠÇ—‚ɂ‚¢‚Ä. ‰““¡¹Fi”]ŠOjC‚‹´Œ÷C–kŒ´F—Yi‹~–½jC“’‘òòC‰F’ÖؑC•½ŽRŽõC‹{â‰À’ji”]ŠOjC‘å˜a“c—²i‹~–½jC“¡ˆä´Fi”]ŠOj: _ŒoŠO, 21: 33`38, 1998.

1677. mŒ´’˜n ‘I‘ð“I‰–Ž_ƒpƒpƒxƒŠƒ““®’Œã‚Ì‹}«Šú”]ŒŒŠÇ‚¨‚æ‚ÑŒŒ‰t¬‘÷“x, pH‚ւ̉e‹¿. X“ˆŒ[”Vi”]ŠOj: ¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠwŽGŽ, 26(4): 179`186, 1998.

1678. mŒ´’˜n ƒgƒ‹ƒRˆÆŽü•ÓŽîᇂւ̃Aƒvƒ[ƒ`; pterional approach‚ÌŠî–{. “c’†–ö…C“¡ˆä´Fi”]ŠOj: ”]_ŒoŠO‰È‘¬•ñ, 18(9): 727`735, 1998.

1679. m€Œ´’˜n The efficacy of endovascular surgery for treatment of giant aneurysms with special reference to coil embolization for endosaccular. X“ˆŒ[”VC‘q“c²C‘å“ä’mC‹{â‰À’jC“¡ˆä´Fi”]ŠOjC›Mˆêi•újC–kŒ´F—Yi‹~–½j: Interventional Neuroradiology, 4(Suppl. 1): 135`143, 1998.

1680. m€Œ´’˜n ŽèpŠŒ©‚©‚猟“¢‚µ‚½–³ÇŒó«”]“®–¬áŽ‚ÌŽèp“K‰ž. ‹{â‰À’jC´…‹ÅC•½ŽRŽõC‰F’ÖؑC‘å“ä’mC“c’†–ö…C“ü‘qŽŒÈC‘q“c²C‰““¡¹FC“¡ˆä´Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: Mt. Fuji Workshop on CVD, 16: 60`62, 1998.

1681. m€Œ´’˜n ”]ŒŒŠÇ¹k‚ɑ΂µ‚ĉ–Ž_ƒpƒpƒxƒŠƒ““®’—Ö@‚Í–{“–‚É—LŒø‚©H ‰““¡¹Fi”]ŠOjC‚‹´Œ÷C–kŒ´F—Yi‹~–½jCX“ˆŒ[”VC‰F’Öؑi”]ŠOjCë“à—²—Yi•újC‘å“ä’mC‘q“c²C‹{â‰À’ji”]ŠOjC‘å˜a“c—²i‹~–½jC“¡ ˆä´Fi”]ŠOj: ”]ŒŒŠÇ¹k, 13: 190`195, 1998.

1682. m’Z•ñE‘¬•ñn ”]EÒ‘‚ÌMRI‰æ‘œƒAƒgƒ‰ƒX; ’†“ªŠW’ê‘O—§‘BŠà“]ˆÚ. ‘O‘ò_C“c’†ç•Fi”]ŠOj: Brain and Nerve, 50(11): 1034`1035, 1998.

1683. mŒ¤‹†•ñi•¶•”Èjn ’á‘̉·ŽžŽ_‰–Šî•½tŠÇ—‚ª”]zŠÂ, ”]‹•ŒŒ•a‘Ô‚É‹y‚Ú‚·‰e‹¿. “¡ˆä´FC“ü‘qŽŒÈC‰iˆä¬Ž÷C“’‘òòC‹{â‰À’ji”]ŠOj: Œ’NE’·Žõ‚Ɗ‹«ˆã‰»Šw, p.29`31, 1998.

1684. mŒ¤‹†•ñi•¶•”Èjn ‰º‚‘Ì‘BŽî‚É‚¨‚¯‚éGHRHŽó—e‘Ì‚ÆPit-1 mRNA‚Ì”­Œ»—Ê‚Ì‘ŠŠÖŠÖŒW‚Æ‚»‚Ì‹ÇÝ. ¬—шè•vC‰ªGGi”]ŠOj: •½¬10”N“xŒ¤‹†ŽÀÑ•ñ‘, 1998.

1685. mŒ¤‹†•ñi•¶•”Èjn ”]Žîᇂɂ¨‚¯‚éGH-R, IGF-1-R‚Ì”­Œ»‚ÆŽîᇑB. ‰ªGGC¬—шè•vCì–ìM”Vi”]ŠOj: •½¬‚X”N“x•¶•”ȉȊwŒ¤‹†•¬ÅI•ñ‘, 1998.

1686. mŒ¤‹†•ñiŒú¶Èjn ƒ‰ƒbƒg¬”]G“ƒwƒ‹ƒjƒAƒ‚ƒfƒ‹‚É‚¨‚¯‚铪ŠWŒz’ňÚs•”’†SŠÇŒ`‘Ô‚ÌŒ¤‹†. ‹kŽ ‘CŽRè‹`‹éC‚–ì½i”]ŠOj: “«‚ÌÒ‘‹ó“´Ç‚Æ“ñ•ªÒ’ÅÇ‚É”º‚¤Ò‘‹@”\Ç, p.13`18, 1998.

1687. mŒ¤‹†•ñiŒú¶Èjn ƒŠƒEƒ}ƒ`«ŠÂ’ÅŽ²’Å’E‰PEƒpƒkƒXŒ`¬EƒLƒAƒŠŠïŒ`‚𔺂Á‚½Ò‘‹ó“´Ç‚ÌŽ¡—ÃŒoŒ±. ‹kŽ ‘CŽRè‹`‹éC‚–ì½i”]ŠOj: “«‚ÌÒ‘‹ó“´Ç‚Æ“ñ•ªÒ’ÅÇ‚É”º‚¤Ò‘‹@”\Ç, p.69`74, 1998.

1688. mÇ—á•ñn Malignant meningioma with a new intracytoplasmic inclusion body. ‰F’ÖؑCì–ìM”VC‰ªGGCz–K’m–çC“¡ˆä´Fi”]ŠOjCŠâŸºŒ[ˆêC–ö‰ºŽO˜Yi•a—j: Clin. Neuropathol., 17(4): 216`220, 1998.

1689. mÇ—á•ñn A chondromyxoid fibroma-like tumor of the cranial convexity: immunohistochemical and ultrastructural study. —é–Ø˶C‰ªGGC“c’†–ö…Cì–ìM”VC“¡ˆä´Fi”]ŠOj: Clin. Neuropathol., 18(1): 37`41, 1999.

1690. mÇ—á•ñn Juvenile symptomatic Rathke's cleft cyst; Case report. “c’†’qŽqC‰ªGGCì–ìM”VC¬—шè•vCŽOŽ}GˆÉC“¡ˆä´Fi”]ŠOj: Neurol. Med. Chir., 38(9): 578`581, 1998.

1691. mÇ—á•ñn GH-PRLŽY¶‰º‚‘ÌŽîᇂÆ_Œoß×–EŽî‚Ƃ̬‡Žîᇂ̂P—á. ¬—шè•vi”]ŠOjC‹T’J“Oi•a—jC‰ªGGC¬‚•½Ž¡Cì–ìM”VC“¡ˆä´Fi”]ŠOj: ƒzƒ‹ƒ‚ƒ“‚Æ—Õ°, 46(‘): 27`32, 1998.

1692. mÇ—á•ñn “ªŠW’ê•”‘–ŒŽî‚Ö‚Ìextensive embolization‚̉ž—p|Ç—á•ñ|. ´…‹ÅC‘q“c²C‰ªGGC‘å“ä’mC‘ˆä³„CX“ˆŒ[”VCŽR“cŸC‚–ØGCì–ìM”VC‹{â‰À’jC“¡ˆä´Fi”]ŠOjC›Mˆêi•új: ‘–ŒŽî‚ÌŠO‰È, p.280`286, 1998.

1693. mÇ—á•ñn Atypical teratoid/rhabdoid tumor|L”Í‚Èependymal differentiation‚𔺂Á‚½Ç—á|. ‰F’ÖؑCì–ìM”VC‰ªGGCŽOŽ}GˆÉC“¡ˆä´Fi”]ŠOjC–ö‰ºŽO˜Yi•a—jCBernd W. Scheithauer: ”]_ŒoŠO‰ÈƒWƒƒ[ƒiƒ‹, 7(8): 507`512, 1998.

1694. mÇ—á•ñn “«‚Ä‚ñ‚©‚ñ‚𔺂Á‚½‘å”]ŠC–È󌌊ǎî‚Ì‚Q—á|ŠO‰È“IŽ¡—Â̖â‘è“_|. ¼”örŽkCX‰ª—²lC“¡ˆä´Fi”]ŠOjCŒã“¡ƒMC•ŸˆämŽm: —Õ°”]”g, 40(9): 609`614, 1998.

1695. m‘àn Pathologic features of ependymoma: Histologic patterns and a review of the literature. ì–ìM”Vi”]ŠOj: Neuropathology, 18: 1`12, 1998.

1696. m‘àn ”]_ŒoŠO‰ÈŽ¾Š³. ‘q“c²i”]ŠOj: ‚ ‚½‚炵‚¢Šá‰È, 15(—Õ‘): 148`151, 1998.

1697. m‘àn CPAŠ³ŽÒ‚Ì‹~‹}‘h¶‚Æ–â‘è“_. ‰““¡¹Fi”]ŠOj: ƒuƒŒƒCƒ“ƒi[ƒVƒ“ƒO, 14(7): 32`39, 1998.

1698. m‘àn •½ŽR•a‚Ì”­¶‹@˜|‚Æ‚­‚Édissociated motor loss‚Æ‚ÌŠÖ˜A‚É‚¨‚¢‚Ä|. ‹kŽ ‘i”]ŠOj: _Œo“à‰È, 48(4): 338`342, 1998.

1699. m‘àn ƒ‰ƒbƒg¬”]G“ƒwƒ‹ƒjƒAƒ‚ƒfƒ‹‚É‚¨‚¯‚éÒ‘‹ó“´”­¶‹@˜. ŽRè‹`‹éi”]ŠOj: Ò’ÅÒ‘ƒWƒƒ[ƒiƒ‹, 11(8): 727`732, 1998.

1700. mŠwp‘n i•ª’SŽ·•Mj ”]‘²’†—Õ°ƒ}ƒjƒ…ƒAƒ‹; ‚à‚â‚à‚â•a, p.354`364, “ü‘qŽŒÈC“¡ˆä´FC‹{â‰À’ji”]ŠOj. ƒVƒ…ƒvƒŠƒ“ƒK[EƒtƒFƒAƒ‰, “Œ‹ž, 98.00.00”­s.

1701. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj1999; ˆê‰ß«”]‹•ŒŒ”­ì‚ÌŠO‰È“IŽ¡—Ã, p.213`214, “¡ˆä´Fi”]ŠOj. ˆãŠw‘‰@, “Œ‹ž, 98.00.00”­s.

1702. mŠwp‘n i•ª’SŽ·•Mj Ò‘EÒ’Å‚ÌŠO‰È; Ò’ÅEÒ‘‚Ì—ÍŠw, p.37`40, ‹kŽ ‘i”]ŠOj. •ÒW ”’”n–¾CŽR‰Y»•ÒC ˆãŠw‘‰@, “Œ‹ž, 98.00.00”­s.

1703. mŠwp‘n i•ª’SŽ·•Mj The Management of Pituitary Tumors; Pituitary tumors: pathologic-clinical correlates, p.47`61, Lloyd, R.V.CJin, L.C‰ªGGi”]ŠOjCKuling, E.CQian, X. Bio Scientifica Ltd., 98.00.00”­s.

1704. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Recent advances in pituitary pathology. Lloyd, R.V.CJin, L.CKulig, E.C‰ªGGi”]ŠOjCQian, X.CScheithauer, B.W.: 7th International Pituitary Pathology Club Meeting i98.10.03j, “Œ‹ž.

1705. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Newly developed covered stent for the treatment of untreatable broad neck cerebral aneurysms. ‘å“ä’mC‘q“c²CX“ˆŒ[”VC‹{â‰À’jC“¡ˆä´Fi”]ŠOj: 7th International and Interdisciplinary Symposium i98.05.23j, “Þ—Ç.

1706. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Diagnostic significance of the eosinophilic inclusion bodies in ependymoma. ì–ìM”Vi”]ŠOjC‘åê—Y‰îC’·“‡˜a˜YC‘åꕶ—_C¬—шè•vCŽOŽ}GˆÉC‰ªGGC“¡ˆä´Fi”]ŠOj: American Neuropathology Meeting i98.06.19j, Minneapolis.

1707. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP receptors (‡T,‡U,‡V) mRNA expression in non-neoplastic human. ‰ªGGi”]ŠOjCJin, L.CQian, X.CReubi, J.C.CScheithauer, B.W.C“¡ˆä´Fi”]ŠOjC‹T’J“Oi•a—jCKovacs, K.CLloyd, R.V.: 80th Annual Meeting of the Endocrine Society i98.06.26j, New Orleans.

1708. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Growth hormone-releasing hormone receptor (GHRH-R) mRNA expression in human pituitary adenomas; A study by cataryzed reporter. ‰ªGGi”]ŠOjCJin, L.CSchethauer, B.W.C“¡ˆä´Fi”]ŠOjC‹T’J“Oi•a—jCŽR‰¤’¼ŽqCKovacs, K.CLloyd, R.V.: 80th Annual Meeting of the Endocrine Society i98.06.26j, New Orleans.

1709. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Role of cell cycle proteins during pituitary tumor development. Lloyd, R.V.CJin, L.CKulig, E.C‰ªGGi”]ŠOjCQian, X.CScheithauer, B.W.: 7th International Pituitary Pathology Club Meeting i98.10.04j, ” ª.

1710. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Growth hormone-releasing hormone receptor (GHRH-R) mRNA expression in human pituitary adenomas; A study by catalyzed receptor. ‰ªGGi”]ŠOjCJin, L.CScheithauer, B.W.C“¡ˆä´Fi”]ŠOjC‹T’J“Oi•a—jCŽR‰¤’¼ŽqCPlummer, T.B.CLloyd, R.V.: 7th International Pituitary Pathology Club Meeting i98.10.05j, ” ª.

1711. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Expression of Pit-1 and growth hormone releasing hormone receptor (GHRH-R) mRNA in human pituitary adenomas in relation to the ¬—шè•vi”]ŠOjC‹T’J“Oi•a—jC¬‚•½Ž¡Cì–ìM”VC“¡ˆä´Fi”]ŠOj: 7th International Pituitary Pathology Club Meeting i98.10.05j, ” ª.

1712. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Long-term functional outcome of suprasellar germinomas: Usefulness and limitations of radiotherapy. ì–ìM”VC‰ªGGC“c’†’qŽqC‰F’ÖؑC—é–Ø˶C¬—шè•vCŽOŽ}GˆÉC“¡ˆä´Fi”]ŠOj: 7th International Pituitary Pathology Club Meeting i98.10.06j, ” ª.

1713. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Pituitary adenylate cyclase-activiting polypeptide (PACAP) binding sites and PACAP/VIP receptor (PVR) expression in human pituitary. ‰ªGGi”]ŠOjCJin, L.CReubi, J.C.CSheithauer, B.W.C“¡ˆä´Fi”]ŠOjC‹T’J“Oi•a—jCLloyd, R.V.: 7th International Pituitary Pathology Club Meeting i98.10.06j, ” ª.

1714. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Examination of 6 cases with cerebral aneurysm|associated dural arteriovenous fisturas. —é–Ø˶C“c’†–ö…C‘q“c²C‹{â‰À’jC‚–ì½C‚–ØGC“¡ˆä´Fi”]ŠOj: 2nd International Symposium on Cerebral i98.06.13j, ‹ž“s.

1715. mŠw‰ïi‘S‘jn i“Á•Êu‰‰j ŠÂŽ²’Å•a•Ï‚ɑ΂·‚éOne Piece Cervical Device (OPCD)‚ÌŽg—pŒoŒ±. ‹kŽ ‘CŽRè‹`‹éC‚–ì½i”]ŠOj: ‘æ13‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï i98.06.12j, ‘å’Ã.

1716. mŠw‰ïi‘S‘jn i“Á•Êu‰‰j Multiple receptors in human anterior pituitary cells and adenomas. Lloyd, R.V.CJin, L.CQian, X.CKulig, E.CSanno, N.C‰ªGGi”]ŠOjCOsamura, R.Y.CScheithauer, B.W.: ‘æ‚X‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï i99.02.19j, “Œ‹ž.

1717. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j ŒŒŠÇ«Žîᇂ¨‚æ‚ÑŒŒŠÇŠïŒ`‚Ì•a—. ì–ìM”Vi”]ŠOj: ‘æ16‰ñ“ú–{”]Žîᇕa—Šw‰ï i98.05.27j, •Ÿ‰ª.

1718. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j Ò’Å, Ò‘Ž¾Š³‚Ì_ŒoŠw“IŒŸ¸. ‹kŽ ‘i”]ŠOjC‘Šˆä•½”ª˜Y: ‘æ13‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï i98.06.11j, ‘å’Ã.

1719. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ò’Å“®‘Ô‚ÆÒ‘“®‘Ô|“Á‚ÉÒ‘“àˆ³•Ï‰»‚ÌŒv‘ª‚Æ‚»‚̈Ӌ`‚ɂ‚¢‚Ä|. ‹kŽ ‘i”]ŠOj: ‘æ76‰ñ“ú–{‹@ŠíŠw‰ï i98.10.03j, å‘ä.

1720. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “ª•”ŠOÅdÇ—á‚ɑ΂·‚é”]’ቷ—Ö@‚Ì“K‰ž‚Æ–â‘è“_. ‰““¡¹Fi”]ŠOjC‚‹´Œ÷C–kŒ´F—Yi‹~–½jC“’‘òòC´…‹ÅC‹{â‰À’jCΓn‰ë’ji”]ŠOjC‘å˜a“c—²i‹~–½jC“¡ˆä´Fi”]ŠOj: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.15j, ŽD–y.

1721. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰º‚‘Ì‘BŽî‚É‚¨‚¯‚éPituitary Adenylate-Activating Polypeptide (PACAP)‚¨‚æ‚ÑPACAP/VIP receptor (PVR) mRNA”­Œ»‚Ì•ªŽq•a—Šw“IŒŸ“¢. ‰ªGGi”]ŠOjCJin, L.CReubi, J.CScheithauer, B.W.C¬—шè•vCì–ìM”VC“¡ˆä´Fi”]ŠOjC‹T’J“Oi•a—jCLloyd, R.V.: ‘æ‚X‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï i99.02.19j, “Œ‹ž.

1722. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ò‘‘O³’†—ôi“ü–@‚ÌŒŸ“¢. ŽOˆäŒö•FC´…‹ÅC“¡ˆä´Fi”]ŠOjC’£àVˆÀCHŠÔ“¹•v: ‘æ71‰ñ“ú–{®Œ`ŠO‰ÈŠwpW‰ï i98.04.17j, “¿“‡.

1723. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •Ð‘¤Šç–Êáz¹iHFS)‚Ì“d‹C¶—Šw“IŒŸ“¢|‚Æ‚­‚É”½ŽË«ˆÙí˜A‡‰^“®isynkinesis)‚ɂ‚¢‚Ä|. ²“¡Ÿli”]ŠOjCÄ“¡]”üŽqC‰Í“‡]”üi—ÕŒŸjC‹kŽ ‘C“¡ˆä´Fi”]ŠOj: ‘æ39‰ñ“ú–{_ŒoŠw‰ï‘‰ï i98.05.22j, ‹ž“s.

1724. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Tanycytic ependymoma‚ÆŽv‚í‚ê‚é‚Q—á‚ɂ‚¢‚Ä; ‚»‚ÌŒõŒ°‚¨‚æ‚Ñ“dŒ°‘œ. ì–ìM”Vi”]ŠOjC–ö‰ºŽO˜Yi•a—j: ‘æ16‰ñ“ú–{”]Žîᇕa—Šw‰ï i98.05.27j, •Ÿ‰ª.

1725. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ependymoma‚ÉŒ©‚ç‚ê‚éDŽ_«••“ü‘Ì|‚»‚Ì–{‘Ô‚Æ•a—f’fã‚Ì—L—p«|. ì–ìM”Vi”]ŠOjC‘åê—Y‰îC’·“‡˜a˜YC‘åꕶ—_C´…‹ÅC—é–Ø˶C¬—шè•vCŽOŽ}GˆÉC‰ªGGC“¡ˆä´Fi”]ŠOj: ‘æ16‰ñ“ú–{”]Žîᇕa—Šw‰ï i98.05.27j, •Ÿ‰ª.

1726. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Atypical teratoid/rhabdoid tumor: A malignant pediatric brain tumor to be distinguished from medulloblastoma, PNET and germ cell tumor. ‰ªGGi”]ŠOjCBernd W. Scheithauer: ‘æ16‰ñ“ú–{”]Žîᇕa—Šw‰ï i98.05.28j, •Ÿ‰ª.

1727. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Atypical teratoid/rhabdoid tumor: A malignant pediatric brain tumor to be distinguished from medulloblastoma, PNET and germ cell tumor. ‰ªGGi”]ŠOjCBernd W. Scheithauer: ‘æ39‰ñ“ú–{_Œo•a—Šw‰ïŠwp‘‰ï i98.05.28j, •Ÿ‰ª.

1728. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒg¬”]G“ƒwƒ‹ƒjƒAƒ‚ƒfƒ‹‚É‚¨‚¯‚铪ŠWŒz’ňÚs•”’†SŠÇŒ`‘Ô‚ÌŒ¤‹†. ŽRè‹`‹éC‹kŽ ‘C‚–ì½C“¡ˆä´Fi”]ŠOj: ‘æ13‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï i98.06.11j, ‘å’Ã.

1729. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘‰tŠÂ—¬‚ÌÄŒš‚É‚æ‚è‹ó“´k¬‚ð”F‚ß‚½ŠO«Ò‘‹ó“´Ç. ŽOˆäŒö•FCŽRè‹`‹éCz–K’m–çi”]ŠOj: ‘æ13‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï i98.06.11j, ‘å’Ã.

1730. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`«ŠÂŽ²’Å’E‰PE“÷‰èŒ`¬, ƒLƒAƒŠŠïŒ`‚𔺂Á‚½Ò‘‹ó“´Ç‚ÌŽ¡—ÃŒoŒ±. ‹kŽ ‘CŽRè‹`‹éC‚–ì½i”]ŠOj: ‘æ13‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï i98.06.11j, ‘å’Ã.

1731. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ³íŽÒ‰Á—î‚É”º‚¤Œz’ÅEŒz‘•a•Ï. ”Ñ“cG•vC‹kŽ ‘C‘ˆä³„C“¡ˆä´Fi”]ŠOj: ‘æ13‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï i98.06.11j, ‘å’Ã.

1732. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œz’ŒŊԔƒwƒ‹ƒjƒA‚ÌŽ©‘RÁŽ¸. ‹kŽ ‘C‚–ì½CŽRè‹`‹éi”]ŠOjC›Mˆêi•új: ‘æ13‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï i98.06.12j, ‘å’Ã.

1733. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”]“®–¬áŽ‚ɑ΂·‚éƒRƒCƒ‹Çðp, ᎑¢‰e, ƒoƒ‹[ƒ“Œz•”Œ`¬‚Ì—L—p«. ‘q“c²C‹{â‰À’jC‘å“ä’mCX“ˆŒ[”VC¬‘òmC“¡ˆä´Fi”]ŠOjC›Mˆêi•újC–kŒ´F—Yi‹~–½jCóˆäˆê˜YC—é–Ø—´‘¾: ‘æ27‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï i98.06.24j, ŽD–y.

1734. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽO³_Œo’É‚ðŽ¦‚µ‚½”]Š²•”AVM‚ɑ΂·‚é“Eop. ‹{â‰À’jC‚–ØGC´…‹ÅCŽR“cŸC‘å“ä’mC“c’†–ö…C“ü‘qŽŒÈC‘q“c²C“¡ˆä´Fi”]ŠOjC–kŒ´F—Yi‹~–½j: ‘æ27‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï i98.06.24j, ŽD–y.

1735. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Tanycytic component‚ð—L‚·‚éÒ‘ependymoma‚Ì‚P—á. ¡–ìTŒáC‹kŽ ‘C‰F’ÖؑC“c’†–ö…C“¡ˆä´Fi”]ŠOj: ‘æ70‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.06.27j, “Œ‹ž.

1736. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œã“ªŠWâ|”j—ô”]“®–¬áŽ‚ɑ΂·‚éplatinum coil embolization‚ÌŽ¡—ìт̌Ÿ“¢. ‘å“ä’mC‘q“c²C‹{â‰À’jC“¡ˆä´FC‰““¡¹Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC‘å‚O–«i”]ŠOjCóˆäˆê˜YC—é–Ø—´‘¾: 17th Mt. Fuji Workshop on CVD i98.08.29j, ·‰ª.

1737. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ò‘ƒwƒ‹ƒjƒA‚ÌŽèp. ‹kŽ ‘Cë“à—²—Yi”]ŠOj: ‘æ33‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i98.10.13j, ŽD–y.

1738. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Atypical teratoid/rhabdoid tumors (AT/RTs); V‚µ‚¢¬Ž™ˆ««Žîᇂ̒ñŒ¾‚Æ•ªŽq¶•¨Šw“If’f‚Ì—L—p«. ‰ªGGi”]ŠOjCScheithauer, B.W.CBurger, P.C.Cì–ìM”VC“¡ˆä´Fi”]ŠOj: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.14j, ŽD–y.

1739. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¶’Åœ“®–¬Š®‘S•ÂÇ, ‰E’Åœ“®–¬‚“x‹·ó‚𔺂Á‚½”]’ê“®–¬æ’[•””j—ô”]“®–¬áŽ‚ɑ΂·‚錌ŠÇ“àŽ¡—Ã. ‘å“ä’mC‘q“c²C‹{â‰À’jC“¡ˆä´FC‰““¡¹Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.14j, ŽD–y.

1740. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘I‘ð“I‰–Ž_ƒpƒpƒxƒŠƒ““®’Œã‚Ì‹}«Šú”]ŒŒŠÇ‹y‚ÑŒŒ‰t‚ւ̉e‹¿|¬Œ¢‚É‚¨‚¢‚Ä|. X“ˆŒ[”VC‘q“c²C‘å“ä’mC‹{â‰À’jC“¡ˆä´Fi”]ŠOj: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.15j, ŽD–y.

1741. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œz’ŒŊԔƒwƒ‹ƒjƒA‚ÌŽ©‘R‹zŽûi‘æ‡U•ñ). ‹kŽ ‘CŽRè‹`‹éC‚–ì½C”Ñ“cG•vi”]ŠOj: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.16j, ŽD–y.

1742. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’á‘̉·ŽžŽ_‰–Šî•½tŠÇ—‚ªpenumbra”]ŒŒ—¬‚É‹y‚Ú‚·‰e‹¿. “ü‘qŽŒÈC‹{â‰À’jC‰iˆä¬Ž÷C“’‘òòC‘O‘ò_C“c’†–ö…C‘q“c²C“¡ˆä´Fi”]ŠOj: ‘æ10‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï i98.11.18j, ‘åã.

1743. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –¢”j—ô”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp. ŽOŽ}GˆÉC‘q“c²C‹{â‰À’jC‘å“ä’mCX“ˆŒ[”VC¬‘òmC´…‹ÅC“¡ˆä´Fi”]ŠOjC›Mˆêi•újC–kŒ´F—Yi‹~–½jCóˆäˆê˜Y: ‘æ14‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï i98.11.19j, …ŒË.

1744. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚—îŽÒ”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp. ‘q“c²C‹{â‰À’jC‘å“ä’mCŽOŽ}GˆÉCX“ˆŒ[”VC¬‘òmC´…‹ÅC“¡ˆä´Fi”]ŠOjC›Mˆêi•újC–kŒ´F—Yi‹~–½jCóˆäˆê˜Y: ‘æ14‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï i98.11.19j, …ŒË.

1745. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —±ó”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp. X“ˆŒ[”VC“cŒû–F—YC‘ì”ü“ÞŽqC‘q“c²C‹{â‰À’jC‘å“ä’mC¬‘òmC“¡ˆä´Fi”]ŠOjC›Mˆêi•újC–kŒ´F—Yi‹~–½j: ‘æ14‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï i98.11.20j, …ŒË.

1746. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”j—ô‰ð—£«’Åœ“®–¬áŽ‚ɑ΂·‚éƒvƒ‰ƒ`ƒiƒRƒCƒ‹‚ð—p‚¢‚½Çðp‚ÌŒŸ“¢. ‘å“ä’mC‘q“c²C‹{â‰À’jC“¡ˆä´FC‰““¡¹Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC›Mˆêi•új: ‘æ14‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï i98.11.20j, …ŒË.

1747. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œo’±Œ`œŽèp‚Ƀgƒ‹ƒRˆÆ’êC•œ‚Ì‚½‚ß‚ÌH•v; ƒnƒCƒhƒƒLƒVƒAƒpƒ^ƒCƒgEƒZƒ‰ƒ~ƒbƒNƒXEƒvƒŒ[ƒg‚ÌŠJ”­. ì–ìM”VC¬—шè•vC‰ªGGC“¡ˆä´Fi”]ŠOjC’JŒûK—YC’†“‡••F: ‘æ‚X‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï i99.02.18j, “Œ‹ž.

1748. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰º‚‘Ì‘BŽî‚É‚¨‚¯‚éGrowth Hormone-Releasing Hormone Receptor mRNA”­Œ»‚Ì•ªŽq•a—Šw“IŒŸ“¢: ”÷—Ê‚ÈŽó—e‘̈â“`ŽqŒŸo‚É‚¨‚¯‚é. ‰ªGGi”]ŠOjCJin, L.CScheithauer, B.W.C¬—шè•vCì–ìM”VC“¡ˆä´Fi”]ŠOjC‹T’J“Oi•a—jCŽR‰¤’¼ŽqCLloyd, R.V.: ‘æ‚X‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï i99.02.19j, “Œ‹ž.

1749. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒg‰º‚‘Ì‘BŽî”|—{×–EiHP75)‚É‚¨‚¯‚éPituitary Adenylate-Activating Polypeptide (PACAP)‚¨‚æ‚Ñ‚»‚ÌŽó—e‘̈â“`Žq”­Œ»‚Æ ‰ªGGi”]ŠOjCJin, L.CScheithauer, B.W.CLloyd, R.V.: ‘æ‚X‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï i99.02.19j, “Œ‹ž.

1750. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰º‚‘Ì‘BŽî‚É‚¨‚¯‚éPit-1‚Ƭ’·ƒzƒ‹ƒ‚ƒ“•úoƒzƒ‹ƒ‚ƒ“Žó—e‘Ì‚Ì”­Œ»|‚Æ‚­‚É•sŒ°«‘BŽî‚ÌŠT”O‚ÆŠÖ˜A‚ɂ‚¢‚Ä|. ¬—шè•vi”]ŠOjC‹T’J“Oi•a—jC¬‚•½Ž¡C‰ªGGCì–ìM”VC“¡ˆä´Fi”]ŠOj: ‘æ‚X‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï i99.02.19j, “Œ‹ž.

1751. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Eosinophilic granular bodiesiDŽ_«••“ü‘Ìj‚ð”F‚ß‚½Ò‘Schwannoma‚Ì‚QÇ—á. —é–Ø˶Cì–ìM”VC´…‹ÅCŽOŽ}GˆÉC“¡ˆä´Fi”]ŠOjCˆÀˆä”ü]iŒ`‘ÔŒnjC’çŒ[C¬“‡‰p–¾: ‘æ16‰ñ“ú–{”]Žîᇕa—Šw‰ï i98.05.27j, •Ÿ‰ª.

1752. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Olfactory neuroepithelioma‚Ì‚P—á. ‰F’ÖؑCì–ìM”VC´…‹ÅCŽOŽ}GˆÉC“¡ˆä´Fi”]ŠOjCŽsì‚‚íi•a‰@•a—jC–ö‰ºŽO˜Yi•a—j: ‘æ16‰ñ“ú–{”]Žîᇕa—Šw‰ï i98.05.27j, •Ÿ‰ª.

1753. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Malignant mixed glio-neuronal tumor‚Ì‚P—á. ŽOŽ}GˆÉCì–ìM”VC—é–Ø˶C‰F’ÖؑCŽO“‡‘å“¿C´…‹ÅC‰ªGGC“¡ˆä´Fi”]ŠOjC–ö‰ºŽO˜Yi•a—jCŽsì‚‚íi•a‰@•a—j: ‘æ16‰ñ“ú–{”]Žîᇕa—Šw‰ï i98.05.27j, •Ÿ‰ª.

1754. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘S“EoŒã‚É”x“]ˆÚ‚𔺂Á‚½“ªŠW“àŒ´”­«ˆ««•FŽî‚Ì‚P–UŒŸ—á. ¬—шè•vC‰ªGGCì–ìM”VC‘q“c²C‘ˆä³„CŽR“cŸC–î“cŒ«ŽOC“¡ˆä´Fi”]ŠOjC‹T’J“Oi•a—jCˆÀˆä”ü]iŒ`‘ÔŒnj: ‘æ16‰ñ“ú–{”]Žîᇕa—Šw‰ï i98.05.27j, •Ÿ‰ª.

1755. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j AVM‚É‚æ‚錌Žî—Ê‚ÉŠÖ—^‚·‚éˆöŽq. ‹{â‰À’jC´…‹ÅC‘å“ä’mC“c’†–ö…C“ü‘qŽŒÈC‘q“c²C‰““¡¹FC“¡ˆä´Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ23‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i98.06.25j, ŽD–y.

1756. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”]oŒŒƒ‚ƒfƒ‹‚É‚¨‚¯‚éƒJƒ‹ƒVƒEƒ€hR–ò‚Ì“ªŠW“àˆ³‚É‹y‚Ú‚·‰e‹¿. “c’†–ö…C‹{â‰À’jC´…‹ÅC“ü‘qŽŒÈC‘q“c²C“¡ˆä´Fi”]ŠOj: ‘æ23‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i98.06.25j, ŽD–y.

1757. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Tanycytic ependymoma‚Ì‘¶Ý‚Æ‚»‚Ì”FŽ¯. ì–ìM”VC´…‹ÅC•½ŽRŽõC‰F’ÖؑC—é–Ø˶C‘O‘ò_C¬—шè•vCŽOŽ}GˆÉC‰ªGGC‹kŽ ‘C“¡ˆä´Fi”]ŠOj: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.14j, ŽD–y.

1758. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Hemifacial spasmŽ¡—Âɂ¨‚¯‚é“d‹C¶—Šw“IŒŸ“¢|”½ŽË«ˆÙí˜A‡‰^“®isynkinesis)‚ɂ‚¢‚Ä|. ²“¡ŸlC‹kŽ ‘C”Ñ“cG•vC“¡ˆä´Fi”]ŠOj: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.14j, ŽD–y.

1759. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬”]G“ƒwƒ‹ƒjƒAƒ‚ƒfƒ‹‚É‚¨‚¯‚铪ŠWŒz’ňÚs’†SŠÇŒ`‘Ô‚ÌŒ¤‹†. ŽRè‹`‹éC‹kŽ ‘C‚–ì½C“¡ˆä´Fi”]ŠOj: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.16j, ŽD–y.

1760. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –¢”j—ô”]“®–¬áŽ‚Ì•Ç‚Ì”–‚³‚ÉŠÖŒW‚·‚éˆöŽq‚ɂ‚¢‚Ä. ‹{â‰À’jC‘q“c²C“c’†–ö…C“ü‘qŽŒÈC‰““¡¹FC´…‹ÅC“’‘òòC“¡ˆä´Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.16j, ŽD–y.

1761. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp, Œ»Žž“_‚Å‚Ì–â‘è“_‚Æ‚»‚ÌŒÀŠE‚ɂ‚¢‚Ä. ‘q“c²C‹{â‰À’jC‘å“ä’mCX“ˆŒ[”VC¬‘òmC“¡ˆä´Fi”]ŠOjC›Mˆêi•újC–kŒ´F—Yi‹~–½jCóˆäˆê˜YC—é–Ø—´‘¾C“¡–{Ži: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.16j, ŽD–y.

1762. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹ØŽûk—}§‹@”\iES)‚ð—˜—p‚µ‚½ŽO³_Œo‚Ì“d‹C¶—Šw“IŒŸ“¢|Å“KŽhŒƒ‹­“x‚ÌŒŸ“¢|. Ä“¡]”üŽqC‰Í“‡]”üi—ÕŒŸjC‹kŽ ‘i”]ŠOjC’·’JìˆêŽqi“àjC‰ª“‡dF: ‘æ28‰ñ”]”gE‹Ø“d}Šw‰ïŠwp‘å‰ï i98.11.12j, _ŒË.

1763. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’´‘I‘ð“IŽîᇌŒŠÇ“àÇðp‚ðŽ{s‚µ‚½Šç–Ê•”‚ÌNeurofibroma‚Ì‚RÇ—á. ŽOŽ}GˆÉC‘q“c²C‹{â‰À’jC‘å“ä’mCX“ˆŒ[”VC¬‘òmCì–ìM”VC“¡ˆä´Fi”]ŠOjC›Mˆêi•újC’†–kMºiŒ`ŠOj: ‘æ14‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï i98.11.20j, …ŒË.

1764. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘I‘ð“I‰–Ž_ƒpƒpƒxƒŠƒ““®’Œã‚Ì‹}«Šú”]ŒŒŠÇ‹y‚ÑŒŒ‰t‚ւ̉e‹¿|¬Œ¢‚É‚¨‚¢‚Ä|. X“ˆŒ[”VC‘q“c²C‘å“ä’mC‹{â‰À’jC“¡ˆä´Fi”]ŠOj: ‘æ14‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï i98.11.20j, …ŒË.

1765. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠO«“ª”çEŠç–Ê“®Ã–¬á‘‚R—á‚ɑ΂·‚錌ŠÇ“àŽèp. ´…‹ÅC‘q“c²CŽR“cŸC‚–ØGC‹{â‰À’jC“¡ˆä´Fi”]ŠOj: ‘æ14‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï i98.11.20j, …ŒË.

1766. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹}«Šú”j—ô”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp. ‘q“c²C‹{â‰À’jC‘å“ä’mCŽOŽ}GˆÉCX“ˆŒ[”VC¬‘òmC´…‹ÅC“¡ˆä´Fi”]ŠOjC›Mˆêi•újC–kŒ´F—Yi‹~–½jCóˆäˆê˜Y: ‘æ14‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï i98.11.20j, …ŒË.

1767. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¬”]ŽîᇂÌpŒã‚É–³Œ¾Ç‚ðŽ¦‚µ‚½‚Q—á. ¬‘ò’B–çC‘q“c²C‹{â‰À’jC“¡ˆä´Fi”]ŠOj: ‘æ71‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.09.06j, “Œ‹ž.

1768. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”]•\ƒwƒ‚ƒWƒfƒŠƒ“’¾’…Ç‚Ì‚P—á. ¡–ìTŒáC“ü‘qŽŒÈCŽOŽ}GˆÉC´…‹ÅC“¡ˆä´Fi”]ŠOj: ‘æ72‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.11.28j, “Œ‹ž.

1769. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘½”­”]oŒŒ‚ð’悵‚½‘½”­”]“®Ã–¬ŠïŒ`‚Ì‚P—á. ŽO“‡‘å“¿C‰F’ÖؑC‘å‚O–«i”]ŠOj: ‘æ72‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i98.11.28j, “Œ‹ž.

1770. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j 201 TI-SPECT‚Åhigh uptake‚ðŽ¦‚µÄ”­ˆ««ƒOƒŠƒI[ƒ}‚Æ‚ÌŠÓ•Ê‚É‹ê—¶‚µ‚½”]Žîᇂ̂P—á. Γn‰ë’jC‰ªGGCì–ìM”VC“’‘òòC“¡ˆä´Fi”]ŠOj: ‘æ73‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i99.03.06j, “Œ‹ž.

1771. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Œã“ªŠWâ|”j—ô”]“®–¬áŽ‚ɑ΂·‚é‹}«ŠúIDC Embolization‚ÌŒŸ“¢. ‘å“ä’mC‘q“c²C‹{â‰À’jC“¡ˆä´FC‹ß“¡GŽ¡CX“ˆŒ[”VC—é–Ø˶C‰““¡¹Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC›Mˆêi•újC‚–ì½C—é–Ø—´‘¾ i”]ŠOj: ‘æ11‰ñ“ú–{_Œo‹~‹}Œ¤‹†‰ï i98.05.10j, “Þ—Ç.

1772. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j pŒãÒ‘•‚Žî‚𗈂µ‚½Œz’ÅÇ‚Ì‚P—á. ŽRè‹`‹éCŽOˆäŒö•FCz–K’m–çi”]ŠOj: ‘æ‚T‰ñÒ’ÅÒ‘_ŒoŽèpŽè‹ZŒ¤‹†‰ï i98.09.06j, “Œ‹ž.

1773. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j C1/2Ö¬oŒŒ‚̈’u. ŽOˆäŒö•FCŽRè‹`‹éCz–K’m–çi”]ŠOj: ‘æ‚T‰ñÒ’ÅÒ‘_ŒoŽèpŽè‹ZŒ¤‹†‰ï i98.09.06j, “Œ‹ž.

1774. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Šç–Ê‚¯‚¢‚ê‚ñ‚ɑ΂·‚é_ŒoŒ¸ˆ³p–³Œø—á‚ÌŒŸ“¢. ¬‘ò’B–çC“ü‘qŽŒÈC²“¡ŸlC´…‹ÅC“c’†–ö…C“¡ˆä´Fi”]ŠOj: ‘æ‚P‰ñ”]_ŒoŒ¸ˆ³pŒ¤‹†‰ï i98.10.13j, ŽD–y.

1775. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰º‚‘Ì‘BŽî‚É‚¨‚¯‚éPit-1‚¨‚æ‚ÑGHRH-R mRNA‚Ì”­Œ»‚ɂ‚¢‚Ä|“Á‚Ésilent adenoma‚Ìê‡|. ¬—шè•vi”]ŠOjC‹T’J“Oi•a—jC¬‚•½Ž¡Cì–ìM”VC“¡ˆä´Fi”]ŠOj: “à•ª”å•a—Œ¤‹†‰ï i98.10.31j, ‹ž“s.

1776. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒRƒƒCƒh”X–E‚ð“àŽ‹‹¾‚É‚ÄŠÏŽ@‚µ‚½‚P—á. ¬‘ò’B–çC‘ˆä³„C´…‹ÅC‘q“c²C“ü‘qŽŒÈC“¡ˆä´Fi”]ŠOj: ‘æ‚T‰ñ“ú–{_Œo“àŽ‹‹¾Œ¤‹†‰ï i98.11.14j, ¼Ž}.

1777. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j To be or not to be, that is a question. ‹kŽ ‘i”]ŠOj: ‘æ‚X‰ñÒ‘Ž¾Š³VTRŒ¤‹†‰ï i98.11.21j, ‘å’Ã.

1778. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‹»–¡‚ ‚é‘gD‘œ‚ð’悵‚½Ä”­ƒOƒŠƒI[ƒ}‚Ì‚P—á. Γn‰ë’jC‰ªGGCì–ìM”VC“’‘òòC“¡ˆä´Fi”]ŠOj: ‘æ‚R‰ñ”]_ŒoŠO‰ÈŽ¾Š³‚Ì—Õ°‚Æ•a—‚ÌJoint Conference i99.02.26j, “Œ‹ž.

1779. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Microanatomy for teh combined supra/infratentorial-transsinus approach. ‘O‘ò_C‰ªGGC“c’†–ö…C“¡ˆä´Fi”]ŠOj: 12th Japan Neurosurgery English Forum i99.03.13j, “Œ‹ž.

1780. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Glioma‚Ì”N—î”­¶—¦‚ÉŠÖ‚·‚élŽ@. ‘O‘ò_C‰ªGGCì–ìM”VC“¡ˆä´Fi”]ŠOj: ‘æ‚V‰ñ“ú–{”]ŽîᇃJƒ“ƒtƒ@ƒ‰ƒ“ƒX i98.11.10j, ‰Á‰ê.

1781. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ”]“®Ã–¬ŠïŒ`‚Ì•a‘Ô‚ÆŽ¡—Ã. ‹{â‰À’ji”]ŠOj: ‘æ18‰ñ‘½–€’n‹æ”]‘²’†Œ¤‹†‰ï i98.05.30j, —§ì.

1782. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Large cell medulloblastoma‚ÆŽv‚í‚ê‚é‚PÇ—á. —é–Ø˶C‰ªGGCì–ìM”VC“¡ˆä´FC‚–ì½C‚–ØGi”]ŠOj: ‘æ74‰ñ“Œ‹ž”]Žîᇌ¤‹†‰ï i99.01.23j, “Œ‹ž.

1783. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘Sg“I‚ȈÙ튌©‚ð”F‚ß‚¸f’f‚É‹ê—¶‚µ‚½Neurosarcoidosis‚ÆŽv‚í‚ꂽ‚P—á. •Ÿ“‡_C‰ªGGCì–ìM”VC—é–Ø˶C¬—шè•vC“¡ˆä´Fi”]ŠOjCŠâŸºŒ[ˆêC–ö‰ºŽO˜Yi•a—j: ‘æ74‰ñ“Œ‹ž”]Žîᇌ¤‹†‰ï i99.01.23j, “Œ‹ž.

1784. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Combined supra/infratentorial-transsinus approach‚Ƽ‰Ê‘Ì, ¬”]ƒeƒ“ƒgŽü•Ó‚̉ð–U. ‘O‘ò_C‰ªGGC“c’†–ö…C“¡ˆä´Fi”]ŠOj: ‘æ4‰ñ–k—¢”]_ŒoŠO‰È”÷¬‰ð–UƒZƒ~ƒi[ i99.02.13j, ‘Š–ÍŒ´.

1785. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j p’†v‘¬×–Ef‚ªf’f‚É—L—p‚Å‚ ‚Á‚½ˆ««ƒŠƒ“ƒpŽî‚Ì‚P—á. ²“¡Ÿli”]ŠOjCŠ`ÀL–Mi•a‰@•a—jC‰ªGGC“’‘òòCì–ìM”VC“¡ˆä´Fi”]ŠOj: ‘æ‚P‰ñ–k—¢×–EfŒ¤‹†‰ï i99.02.18j, ‘Š–ÍŒ´.

1786. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‰º‚‘Ì‘²’†—lÇó‚Å”­Ç‚µ‚½ƒ‰ƒgƒP”X–E‚Ì‚P—á. â–{—FŒ©ŽqC‰ªGGC•Ÿ“‡_C“’‘òòC“¡ˆä´Fi”]ŠOj: ‘æ266‰ñ_“Þì_Œo’k˜b‰ï i99.02.18j, _“Þì.

1787. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”j—ô‰ð—£«’Åœ“®–¬áŽ‚ɑ΂·‚éƒRƒCƒ‹Çðp‚Ì—L—p«‚ɂ‚¢‚Ä. ‘q“c²C‘å“ä’mC‹{â‰À’jC“ü‘qŽŒÈC“¡ˆä´Fi”]ŠOjC–kŒ´F—Yi‹~–½jC›Mˆêi•új: ‘æ‚P‰ñŒ§‰›ƒXƒgƒ[ƒNƒJƒ“ƒtƒ@ƒŒƒ“ƒX i99.02.26j, _“Þì.


<<18 ¬Ž™‰ÈŠw>>

1788. mŒ´’˜n High-dose growth hormone (GH) treatment in prepubertal GH-deficient children. Yokoya, S.iŒÕƒm–å•a‰@jCAraki, K.i‚’m‘åjCIgarashi, Y.i“Œ–k‘åjCKohno, H.CNishi, Y.CHasegawa, Y.CFujita, K.CIwatani, N.CTachibana, K.C‘åŽR‹XGiŽ™jCSeino, Y.CStoh, M.CFujieda, K.CTanaka, T.: Acta Paediatr. Suppl., 428: 76`79, 1999.

1789. mŒ´’˜n Prospective echocardiographic analysis of progressive obstruction of the proximal pulmonary artery in congenital heart disease and obstructed pulmonary flow. •½Î‘Cãp—z‘¾˜YCŽO‘òmŽiC–xŒû‘דTC“¡–ìé”VC•“cM—TiŽ™jC’†]¢–¾CŠ}Œ´TŒåi‹¹ŠOj: Am. Heart J., 136: 837`843, 1998.

1790. mŒ´’˜n Effect of suture closure of coronary artery fistula on aneurysmal coronary artery and myocardial ischemia. •½Î‘CŽO‘òmŽiC–xŒû‘דTC“¡–ìé”VC•“cM—TiŽ™jC’†]¢–¾CŠ}Œ´TŒåi‹¹ŠOj: Am. J. Cardiol., 81: 1263`1267, 1998.

1791. mŒ´’˜n Correlation between antigen-specific IL2 response test and provocation test for egg allergy in atopic dermatitis. –ìŠÔ„C‹g‘ò‚¢‚ÂÝiŽ™jC–ؑ‹Pi’•ƒŽs—§•a‰@jC›Œ´—zŽqiŽ™jC¬“c“ˆ”Ži“ì•Ÿ‰ª•a‰@jCŠ‘‘ò–õOi‘—§‰¤Žq•a‰@jC¼ˆä–Ò•Fi“s—§–L“‡•a‰@jC –î“cƒˆêi“ŒˆãŽ•‘åjCŽRŒûŒöˆêCŒüŽR“¿ŽqC”nêŽÀi“¯ˆ¤‹L”O•a‰@j: Clin. Exp. Allergy, (28): 1120`1130, 1998.

1792. mŒ´’˜n Reduced IL-1 production in adolescents with mite antigen asthma in remission. –ìŠÔ„iŽ™jCŽsì–M’ji“¯ˆ¤‹L”O•a‰@jC‹g‘ò‚¢‚ÂÝiŽ™jC–ؑ‹Pi’•ƒŽs—§•a‰@jCì–ì–LiŽ™jC”nêŽÀi“¯ˆ¤‹L”O•a‰@j: Clin. Exp. Immunol., 113(1): 10`16, 1998.

1793. mŒ´’˜n Insulin management and metabolic control of Type-1 diabetes mellitus in childhood and dolescence in 18 countries. Mortensen, H.B.CRobertson, K.J.CAanstoot, H.J.CDanne, T.CHoll, R.W.CHougaad, P.CAtchison, J.A.CChiaelli FCDarneman DCDihsen BCDorchy HCGarandeau PCGreene SCHoey HCKaprio EACKocova MCMartul PC¼‰YM•viŽ™jCSchoenle EJCSovik OCSwift PGFCTsou RMCVanelli MCAman JCfor Hvidore Study Group on Childhood Diabetes: Diabet. Med., 15(9): 752`759, 1998.

1794. mŒ´’˜n Descriptive epidemiology of IDDM in Hokkaido, Japan: The childhood IDDM Hokkaido Registry. ¼‰YM•viŽ™jC•Ÿ“cŸ—mi‹v—¯•Ä‘åjC‰œ–ìW³iˆ®ìˆã‘åjCŒ´“c³•½iŽs—§çΑ‡•a‰@jC•Ÿ“‡’¼Ž÷iŽs—§ŽD–y•a‰@jC¬’r–¾”üi–y“ì•a‰@jCˆÉ“¡‘P –çiˆ®ìˆã‘åjC•ê’Ø’qsiŽD–yˆã‘åj: Diabetes Care, 21(10): 1632`1636, 1998.

1795. mŒ´’˜n Puberty, IDDM, and Death in Japan. ¼‘º—–¾C“c›×®ŽqC¼“‡‰ëliŽœŒbˆã‘åjCLaPorte RECfor the Diabetes Epidemiology Research International Study GroupC–kìÆ’ji‘ÛŠw‰@é‹Ê’Z‘åjC¼‰YM•viŽ™jC–L“c—²Œªi“Œ–k‘åjC’r“c‹`—YiŽœŒbˆã‘åjC“ú”äˆí˜Yi‘—§¬Ž™•a‰@jCŽO–؉pŽiiŽO–Ø•a ‰@jCŠÛŽR”Ži¼ŒËƒNƒŠƒjƒbƒNjC쑺³•Fi–¼é•a‰@jCˆêFŒºi‘åãŽs—§‘åŠwjC•“c˜éi¼]Ô\Žš•a‰@jC‹M“c‰Ãˆêiˆ¤•Q‘åjC‰Í–ì‘׎qiŽ­Ž™“‡Žs’† ‰›•ÛŒ’ŠjCŽO‘ºŒå˜Yi®ãDŠw‰€’Z‘åjC¼“‡‰ëlC–ì^—R”üiŽ›“c’¬‚±‚Ç‚àf—ÊjC–ì”É—Yi“¯jCŠÛŽR“¹•FC´…‰À•cC¼‘º—–¾Có”öŒ[ŽqiŽœŒbˆã ‘åj: Diabetes Care, 21(10): 1674`1679, 1998.

1796. mŒ´’˜n Onset age-dependent variations of islet specific autoantibodies in Japanese IDDM patients. ŽR“c‚ЂƂÝC“àŠƒˆÀŽqi“Œ—ˆã‘åjCìè‰p“ñi’·è‘åjC¼‰YM•viŽ™jC‘å’J•q‰ÃC²“¡º—YCMutoh KCŠ}Œ´“Âi“Œ—ˆã‘åjC•Ÿ“‡’¼Ž÷iŽs—§ŽD–y•a‰@jC¬’r–¾”üi–y“ì•a‰@jCa“c”ü’q‘ãiŽ­Ž™“‡‘åjCŽO‰Y‡”V•i“Œ—ˆã‘åjC‹v•Û‚Ђ©‚éCŽRŒûW¶iƒw ƒLƒXƒgƒWƒƒƒpƒ“jC’·‘ëdMi’·è‘åjC‘åXˆÀŒbCŠâ–{ˆÀ•Fi“Œ—ˆã‘åj: Diabetes Res. Clin. Pract., 39(3): 211`217, 1998.

1797. mŒ´’˜n Secretory immune system of the duck (Avas platyrhynchos). Identification and expression of the genes encoding IgA and IgM heavy chains. Magor, K.E.CWarr, G.W.iUniv. Hong KongjCâ“Œ—R‹IiŽ™jCMiddleton, D.L.iSouth Carolina Univ.j: Eur. J. Immunol., 28: 1063`1068, 1998.

1798. mŒ´’˜n Effect of oxatomide on T-cell activation and the production of interferon-gamma in mit sensitive asthma. –ìŠÔ„C‹g‘ò‚¢‚ÂÝCì–ì–LiŽ™jC’†“‡’‰ié‹Êˆã‘åj: Eur. J. Pharmacol., 343(2-2): 239`247, 1998.

1799. mŒ´’˜n Correlation of chromosome abnormalities with presence or absence of WTI deletions/mutations in Wilms tumor. ’†ŠÚ®–çiŽ™jC“y‰®“oŽkC’I–ØM’jié‹Ê‚ª‚ñƒZƒ“jC”¨]–F˜Yi‘—§ŽD–y•a‰@jCí¼—R‹LŽqi‘—§¬Ž™•a‰@jC–x‰z‘×—Yiɪ‚±‚Ç‚à•a‰@jCΓc–õiˆ¤ •Q‘åjC‹e“c“Öi•Ÿ‰ªˆã‘åjC]ŒûŽ¡•Fi‹v—¯•Äˆã‘åjC‰““¡Š²–çiŠâŽèˆã‘åjCŽO‘î@“Ti‘åãˆã‘åjC÷ˆäŽÀiŽOd‘åjC‹àŽqˆÀ”äŒÃié‹Ê‚ª‚ñƒZƒ“j: Genes, Chromosomes & Cancer, 25: 26`32, 1999.

1800. mŒ´’˜n The polymorphic 43The bcl-2 protein confers relative resistance to autoimmunity: an analytical evaluation. ‹î–Ø’qiŒF‘åjC‰Í–ì’ÊŽjiŽD–yŽs—§•a‰@jC¼‰YM•viŽ™jC“‡’ÃMiŽO•H‰»ŠwjC‘«—§®“oC¯o—´ŽuC¼ŽR@˜ZC¼“cˆê˜YiŒF‘åj: Hum. Genet, 103(4): 435`440, 1998.

1801. mŒ´’˜n A comparative investigation of therestorative effects of roxithromycin on neutrophil activities. –ìŠÔ„iŽ™jC—щë°i–јC•a‰@jC‹g‘ò‚¢‚ÂÝiŽ™jC–ؑ‹Pi’•ƒŽs—§•a‰@jC•~“‡NŽjCì–ì–LiŽ™j: Internat. J. Immunopharamacol., 20: 615`624, 1998.

1802. mŒ´’˜n A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. Yoshikawa, N.CIto, H.CŽðˆä‹Ši”åjCTakekoshi, Y.CHonda, M.CAwazu, M.CIto, K.C”Ñ‚Šì‹v—YiŽ™jCKoitabashi, Y.CYamaoka, K.CNakagawa, K.CNakamura, H.CMatsuyama, S.CSeino, Y.CTakada, N.CHattori, S.CNinomiya, M.: J. Am. Soc. Nephrol., 10: 101`109, 1999.

1803. mŒ´’˜n ƒ_ƒjRŒ´‚Å—U“±‚³‚ê‚éIL-4, IL-5, IFN-gŽY¶Œn‚É—^‚¦‚éroxithromycin‚̈—Œø‰Ê. –ؑ‹Pi’•ƒŽs—§•a‰@jC—щë°i–јC•a‰@jC–ìŠÔ„iŽ™j: J. Antibiot., 51: 20`24, 1998.

1804. mŒ´’˜n The prevalence of mitochondrial gene mutations in childhood diabetes in Japan. ¼‰YM•viŽ™jC—é–Øii“Œ–k‘åjC‰¡“csŽjC•—’£KŽiC•—’£^—R”üiŽ™jC–L“c—²Œªi“Œ–k‘åjC•½ˆäŠ®ŽjC‰œ–ìW³iˆ®ìˆã‘åjCŒ´“c³•½iŽs—§çΑ ‡•a‰@jC•Ÿ“‡’¼Ž÷iŽs—§ŽD–y•a‰@jC¬’r–¾”üi–y“ì•a‰@j,ˆÉ“¡‘P–çiˆ®ìˆã‘åjC•ê’Ø’qsiŽD–yˆã‘åj: J. Pediatr. Endocrinol. Metab., 12(1): 27`30, 1999.

1805. mŒ´’˜n Comparison of growth during continuous ambulatory peritoneal dialysis and renal transplantation using conventional immunosuppressive drugs in children. ”Ñ‚Šì‹v—YC–kžŠ‚Ý‚Ç‚èCŽç‰®r‰îiŽ™jCŽðˆä‹ŠC‰““¡’‰—Yi”åj: Perit. Dial. Int., 18: 395`401, 1998.

1806. mŒ´’˜n ‹CŠÇŽxšb‘§¬Ž™‚Ì––½ŒŒƒŠƒ“ƒp‹…‚É‚¨‚¯‚éƒ_ƒjRŒ´“ÁˆÙ“IIL2”½‰ž«—U“±‚É—^‚¦‚銿•û•ûÜ; ŽÄ–p“’, ¬Â—³“’, ‹y‚ÑŽÄ—è“’‚̈—Œø‰Ê‹y‚Ñ‚»‚Ì”äŠrŒŸ“¢. –ìŠÔ„iŽ™jC’†“‡’‰ié‹Êˆã‘åjCì–ì–LC‹g‘ò‚¢‚ÂÝCŠ¥–Ø’q”Vi–h‰qˆã‘åjC”nêŽÀi“¯ˆ¤‹L”O•a‰@j: ƒAƒŒƒ‹ƒM[, 45(5): 494`502, 1996.

1807. mŒ´’˜n ‹CŠÇŽxšb‘§Š³Ž™ƒŠƒ“ƒp‹…‚̃_ƒjRŒ´“ÁˆÙ“IIL2”½‰ž«—U“±‚É—^‚¦‚éRoxithromycin‘Oˆ’u‚ÌŒø‰Ê. ’†“‡’‰ié‹Êˆã‘åjC‹g‘ò‚¢‚ÂÝCì–ì–LC–ìŠÔ„iŽ™j: ƒAƒŒƒ‹ƒM[, 45(6): 554`561, 1996.

1808. mŒ´’˜n RŒ´“ÁˆÙ“IIL2”½‰ž«ŒŸ¸‚Æ•‰‰×ŽŽŒ±‚Ì‘ŠŠÖ‹y‚уAƒgƒs[«”畆‰Š‚Ì‚¨‚¯‚éŒ{—‘ƒAƒŒƒ‹ƒM[f’f‚É‚¨‚¯‚éˆÓ‹`. –ìŠÔ„C‹g‘ò‚¢‚ÂÝiŽ™jC‰©‘‹Pi’•ƒŽs—§•a‰@jCì–ì–LiŽ™jC•ô“c‹ªbi”Ñ”\’†‰›•a‰@jC¬“c“ˆ”Ži“ì•Ÿ‰ª•a‰@jCŠ‘‘ò–õOi‘—§‰¤Žq•a‰@jC¼ˆä –Ò•Fi“s—§–L“‡•a‰@jC–î“cƒˆêi“ŒˆãŽ•‘åjCŽsì–M’jCŽRŒûŒöˆêCŒüŽR“¿ŽqC”nêŽÀi“¯ˆ¤‹L”O•a‰@j: ƒAƒŒƒ‹ƒM[, 45(7): 660`671, 1996.

1809. mŒ´’˜n ‹CŠÇŽxšb‘§Š³Ž™ƒŠƒ“ƒp‹…‚̃_ƒjRŒ´“ÁˆÙ“Iintereron-g (IFN-g), interleukin-4 (IL-4)ŽY¶‚ɑ΂·‚éTYB-2285‹y‚Ñ‚»‚Ì‘ãŽÓ•¨‚ÌŒø‰Ê. ‰©‘‹Pi’•ƒŽs—§•a‰@jC’†“‡’‰ié‹Êˆã‘åjC—щë°i–јC•a‰@jC‹g‘ò‚¢‚ÂÝCì–ì–LC•~“‡NŽjC–ìŠÔ„iŽ™j: ƒAƒŒƒ‹ƒM[, 46: 502`510, 1997.

1810. mŒ´’˜n –Ɖuƒ~ƒ‹ƒN‚ð—p‚¢‚½ƒEƒCƒ‹ƒXŠ´õ–hŒäŒø‰Ê‚ÌŒŸ“¢. ‹g“cmCX“c–«C¬—ÑŒ›’‰C’|“àCC˜e“cŽj˜Ni–k—¢Œ¤ƒƒfƒBƒJƒ‹ƒZƒ“•a‰@jC–I‰h’B”ViƒVƒoƒ„ƒMjCŒ´^liŽ™jC—é–Ø’B•vi–k—¢Œ¤ƒƒfƒBƒJƒ‹ƒZƒ“•a ‰@j: Š´õÇŠwŽGŽ, 73(2): 122`129, 1999.

1811. mŒ´’˜n Acetaminophen¿Ü‚Ì•¹—p‚ªdiazepam¿Ü‚Ì’¼’°‚©‚ç‚Ì‹zŽû‚É‚¨‚æ‚Ú‚·‰e‹¿|”½•œ“Š—^Žž‚Ì–ò•¨“®‘ÔŠw“I‰ðÍ‚ÆŽŠ“K“Š—^ÝŒv|. •ˆäŒ¤“ñCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™jC¼–{‹X–¾iº˜a–ò‘åj: ¬Ž™‰È—Õ°, 51(11): 2297`2301, 1998.

1812. mŒ´’˜n ¬Ž™• –Œ“§ÍŠ³ŽÒ‚É‚¨‚¯‚édextran 70‚ð—p‚¢‚½peritoneal net fluid absorption rate (PNFAR)‚ÌŒoŽž“I•Ï‰»‚ÌŒŸ“¢. ’©’·C”Ñ‚Šì‹v—YC’†‘ºM–çCŽç‰®r‰îC–kžŠ‚Ý‚Ç‚èiŽ™j: “§Í‰ïŽ, 31(12): 1449`1453, 1998.

1813. mŒ´’˜n V¶Ž™Šú‚É”­Œ©‚³‚ꂽæ“V«•›t‰ßŒ`¬Ç(21-…Ž_‰»y‘fŒ‡‘¹j70—á‚Ì’ÇÕ’²¸Œ‹‰Ê; ‘æ‚Q•Ò Ž¡—ÃŒo‰ß. z–K¬ŽOi_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“jC“í“c‘i‘åãŽs—§‘‡ˆã—ÃZƒ“jC–L‰Y‘½Šì—Yi“ŒˆãŽ•‘åjC“¡Ž}Œ›“ñi–k‘åjCb“c’¼–çié‹ÊŒ§—§¬Ž™ˆã—ÃZ ƒ“jC¼ŽR@˜ZiŒF–{‘åjCr–Ø‹v”üŽqi‚’mˆã‘åjCˆßŠ}º•Fi‹ž“s•{—§ˆã‘åjC‰Á“¡¸•FiŽR—œˆã‘åjC‘åŽR‹XGiŽ™jC㑺Œ›Žii–¼ŒÃ‰®Žs—§‘åjC‘åŠÖ ••Fi’¹Žæ‘åjC—§‰ÔŽ•Fi_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“j: “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 101(12): 1658`1666, 1997.

1814. mŒ´’˜n V¶Ž™Šú‚É”­Œ©‚³‚ꂽæ“V«•›t‰ßŒ`¬Ç(21-…Ž_‰»y‘fŒ‡‘¹j70—á‚Ì’ÇÕ’²¸Œ‹‰Ê; ‘æ‚P•Ò Ž¡—ÊJŽn‘O‚É‚¨‚¯‚é—Õ°ŠŒ©. z–K¬ŽOi_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“jC“í“c‘i‘åãŽs—§‘‡ˆã—ÃZƒ“jC–L‰Y‘½Šì—Yi“ŒˆãŽ•‘åjC“¡Ž}Œ›“ñi–k‘åjCb“c’¼–çié‹ÊŒ§—§¬Ž™ˆã—ÃZ ƒ“jC¼ŽR@˜ZiŒF–{‘åjCr–Ø‹v”üŽqi‚’mˆã‘åjCˆßŠ}º•Fi‹ž“s•{—§ˆã‘åjC‰Á“¡¸•FiŽR—œˆã‘åjC‘åŽR‹XGiŽ™jC㑺Œ›Žii–¼ŒÃ‰®Žs—§‘åjC‘åŠÖ ••Fi’¹Žæ‘åjC—§‰ÔŽ•Fi_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“j: “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 101(7): 1149`1157, 1997.

1815. mŒ´’˜n ¬Ž™‚È‚ç‚Ñ‚ÉŽvtŠú”N—ŽÒ‚É‚¨‚¯‚éƒJƒ‹ƒoƒ}ƒ[ƒsƒ“‚È‚ç‚тɃJƒ‹ƒoƒ}ƒ[ƒsƒ“-10,11-ƒGƒ|ƒLƒTƒCƒh‚Ì—V—£Œ^ŒŒ’†”Z“x‚ÉŠÖ‚·‚錤‹†; ‘æ‚P•Ò|—V—£Œ^ŒŒ’†”Z“x‚̔䗦‚ÉŠÖ‚·‚錟“¢|. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂC•Ð‹Ë’q–çC•ˆäŒ¤“ñiŽ™j: “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(10): 1066`1072, 1998.

1816. mŒ´’˜n ¬Ž™‚È‚ç‚Ñ‚ÉŽvtŠú”N—ŽÒ‚É‚¨‚¯‚éƒJƒ‹ƒoƒ}ƒ[ƒsƒ“‚È‚ç‚тɃJƒ‹ƒoƒ}ƒ[ƒsƒ“-10,11-ƒGƒ|ƒLƒTƒCƒh‚Ì—V—£Œ^ŒŒ’†”Z“x‚ÉŠÖ‚·‚錤‹†; ‘æ‚Q•Ò|ƒJƒ‹ƒoƒ}ƒ[ƒsƒ“-10,11-ƒGƒ|ƒLƒTƒCƒh/ƒJƒ‹ƒoƒ}ƒ[ƒsƒ“‚ÌŒŒ’†”Z“x‚̔䗦‚ÉŠÖ‚·‚錤‹†|. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂC•Ð‹Ë’q–çC•ˆäŒ¤“ñiŽ™j: “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(10): 1073`1078, 1998.

1817. mŒ´’˜n ¬Ž™ƒCƒ“ƒXƒŠƒ“ˆË‘¶«“œ”A•a‚É‚¨‚¯‚éRƒOƒ‹ƒ^ƒ~ƒ“Ž_’E’YŽ_y‘fR‘Ì‚¨‚æ‚ÑRƒqƒgƒCƒ“ƒXƒŠƒ“R‘Ì, Rbó‘BR‘Ì‚ÌŒŸ“¢. •—’£^—R”üC¼‰YM•vC•—’£KŽiCŽÄŽRŒ[ŽqC‰¡“csŽjC‘åŽR‹XGiŽ™j: “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(4): 416`420, 1998.

1818. mŒ´’˜n æ“V«bó‘B‹@”\’ቺǃ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚̃KƒCƒhƒ‰ƒCƒ“i1998”N“x”Å). ƒNƒŒƒ`ƒ“ǃ}ƒXƒXƒNƒŠ[ƒjƒ“ƒOEƒKƒCƒhƒ‰ƒCƒ“쬈ψõ‰ï; ’–ŒÒO–¾i’é‹ž‘åjC¼‰YM•viŽ™jC—§‰ÔŽ•Fi_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“jC“í“c‘i‘åãŽs—§‘‡ˆã—ÃZƒ“jC•ŸŽmŸiŽD–yŽs‰q¶Œ¤‹†ŠjC”~‹´–L‘  i‰»ŠwŒŒ´Œ¤‹†ŠjCz–KéŽOi_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“jCV”üm’jiç—t‘åjC“¡Ž}Œ›“ñi–k‘åj: “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(7): 817`819, 1998.

1819. mŒ´’˜n ¬Ž™‚ª‚ñŠ³ŽÒ‚Ö‚Ì^ŽÀ’m‚ÌS—“I‰e‹¿. ¬‘ò”ü˜aiŽ™jC×’J—º‘¾i¹˜H‰Á‘Û•a‰@jC¡ˆäƒDiŽ™j: “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(9): 990`996, 1998.

1820. mŒ´’˜n S–[’†ŠuŒ‡‘¹Ç‚É‚¨‚¯‚é”x‘ÌŒŒ—¬—Ê”ä‚Ì•]‰¿–@|ŽíX‚ÌSƒGƒR[Žw•W‚̸“x|. ‚“Œ”~C•½Î‘CŽO‘òmŽiC•“cM—TC–xŒû‘דTC“¡–ìé”VC¬ì‰ÄŽqiŽ™j: “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 14(5): 595`602, 1998.

1821. mŒ´’˜n –Ɖu«‘½”­«ƒjƒ…[ƒƒpƒ`[‚ɑ΂·‚é–ƉuƒOƒƒuƒŠƒ“‘å—ʗÖ@. ×ì•C–쑺‹±ˆêCà_ŒûŸ•Fié‹Êˆã‘åjCì–ì–LC–ìŠÔ„iŽ™j: –ò—‚Æ—Õ°, 7: 967`974, 1997.

1822. m€Œ´’˜n High-dose pyridoxal phosphate in four divided daily dose for the treatment of West syndrome. •ˆäŒ¤“ñCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèCŠâèr”VC•ÐŽR•¶•FiŽ™j: Brain Dev., 20(7): 553`554, 1998.

1823. m€Œ´’˜n Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients in childhood and adolescence. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ˆäŒ¤“ñC•ÐŽR•¶•FCŠâèr”ViŽ™j: Int. Clin. Psychopharmacol., 14(1): 59, 1999.

1824. m€Œ´’˜n ¬Ž™‚È‚ç‚Ñ‚ÉŽvtŠú”N—ŽÒ‚É‚¨‚¯‚écarbamazepine‚È‚ç‚Ñ‚Écarbamazepine-10,11-epoxide‚Ì—V—£Œ^ŒŒ’†”Z“x‚ÉŠÖ‚· ‚錤‹†|ŒŒ´ƒ¿1-acid glycoprotein”Z“x‚Æ‚ÌŠÖ˜A|. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂCדc‚Ì‚¼‚ÝC•ˆäŒ¤“ñiŽ™j: TDMŒ¤‹†, 15(2): 159`160, 1998.

1825. m€Œ´’˜n ˆãŽt‚Ì—§ê‚©‚ç‚Ý‚½TDM‚ÌŒ»ó‚Æ«—ˆ; ¬Ž™‰È—̈æ|R‚Ä‚ñ‚©‚ñ–ò‚ð’†S‚É|. ŽO‰YŽõ’jiŽ™j: TDMŒ¤‹†, 15(2): 67`68, 1998.

1826. m€Œ´’˜n Šg’£, ŽÖs‚ðŽ¦‚·“®–¬ŠÇ. •½Î‘iŽ™j: “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 14(3): 424`425, 1998.

1827. m€Œ´’˜n Clonazepam‚Ì•¹—p‚ªzonisamide‚ÌŒŒ’†”Z“x‚É‚¨‚æ‚Ú‚·‰e‹¿i‘±•ñ). •ˆäŒ¤“ñCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝiŽ™j: “ú–{¬Ž™—Õ°–ò—Šw‰ïŽGŽ, 11(1): 92`94, 1998.

1828. mŒ¤‹†•ñi•¶•”Èjn R‚Ä‚ñ‚©‚ñ–ò‚Ì”­’B–ò—‚Æ‘Ì“à“®‘Ôƒ‚ƒjƒ^ƒŠƒ“ƒO(—Õ°–ò—ˆâ“`Šw“IŒŸ“¢‚àŠÜ‚ß‚Ä). ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂC•ˆäŒ¤“ñCŠâèr”VCדc‚Ì‚¼‚ÝiŽ™j: •½¬10”N“x‰ÈŠwŒ¤‹†”ï•â•‹àŽÀÑ•ñ‘(Œ¤‹†ŽÀÑ•ñ‘: Šî”ÕŒ¤‹†‚b), 1999.

1829. mŒ¤‹†•ñi•¶•”Èjn ‹CŠÇŽxšb‘§‚̖ƉuŠw“IŽ¡–ü‹@\‚ÉŠÖ‚·‚錤‹†. –ìŠÔ„iŽ™j: •½¬10”N“x•¶•”ȉȊwŒ¤‹†”ï•â•‹à‚bŒ¤‹†¬‰Ê•ñ‘, 1999.

1830. mŒ¤‹†•ñi•¶•”Èjn ‹CŠÇŽxšb‘§‚̖ƉuŠw“IŽ¡–ü‹@\‚ÉŠÖ‚·‚錤‹†. –ìŠÔ„iŽ™j: •½¬‚W”N“x•¶•”ȉȊwŒ¤‹†”ï•â•‹à‚bŒ¤‹†¬‰Ê•ñ‘, 1997.

1831. mŒ¤‹†•ñi•¶•”Èjn ‹CŠÇŽxšb‘§‚̖ƉuŠw“IŽ¡–ü‹@\‚ÉŠÖ‚·‚錤‹†. –ìŠÔ„iŽ™j: •½¬‚X”N“x•¶•”ȉȊwŒ¤‹†”ï•â•‹à‚bŒ¤‹†¬‰Ê•ñ‘, 1998.

1832. mŒ¤‹†•ñiŒú¶Èjn ƒXƒNƒŠ[ƒjƒ“ƒO‚ÌŒp‘±“I¸“xŠÇ—‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錤‹†. ¼‰YM•viŽ™jC¬£_iˆÇ—Ñ‘åjC•ŸŽmŸiŽD–yŽs‰q¶Œ¤‹†ŠjCˆÀ“c•qsiç—t‘åjCÅŠƒŒhi“ŒˆãŽ•‘åjC”~‹´–L‘ i‰»ŒŒŒ¤jC“¡–{º‰hi‘åãŽsŠÂ‹« •ÛŒ’‹¦jCˆ°“cM”Viã‘åjCŽRã—SŽŸi_“Þ쌧—\–hˆãŠw‹¦‰ïj: Œú¶ÈSgáŠQŒ¤‹†; Œø‰Ê“I‚ȃXƒNƒŠ[ƒjƒ“ƒOƒVƒXƒeƒ€‚ÌŽ{ô‚ÉŠÖ‚·‚錤‹†, •½¬‚X”N“xŒ¤‹†•ñ‘, p.129`134, 1998.

1833. mŒ¤‹†•ñiŒú¶Èjn _Œo‰è×–EŽîƒXƒNƒŠ[ƒjƒ“ƒO‚É‚¨‚¯‚éŠO•”¸“xŠÇ—. ‰ÔˆäŽtC•ŸŽmŸC–쑺—R‰Á—˜C“¡“cWŽOiŽD–yŽs‰q¶Œ¤jCŒŠ‘òºCŽ™‹Ê‹žŽqi“Œ‹ž“s—\–hˆãŠw‹¦jCÀ“cŒö‰îi‘å㌌´jCàV“c~i‹ž“s•{—§ˆã‘åjC¼‰Y M•viŽ™j: Œú¶ÈSgáŠQŒ¤‹†; Œø‰Ê“I‚ȃXƒNƒŠ[ƒjƒ“ƒOƒVƒXƒeƒ€‚ÌŽ{ô‚ÉŠÖ‚·‚錤‹†, •½¬‚X”N“xŒ¤‹†•ñ‘, p.147`149, 1998.

1834. mŒ¤‹†•ñiŒú¶Èjn ‘ãŽÓˆÙíƒXƒNƒŠ[ƒjƒ“ƒO‚É‚¨‚¯‚é“à•”¸“xŠÇ—‚ÌŒø‰Ê“IŽÀŽ{‚Ì‚½‚ß‚ÌŽèˆø‚«(ˆÄ)‚Ìì¬. ¼‰YM•viŽ™jCŽsŒ´Š¤i–kŠC“¹—§‰q¶Œ¤jC“¡–{º‰hi‘åãŽsŠÂ‹«•ÛŒ’‹¦jCŽR–ìŒö–¾CVˆäƒ—CŽ›ˆäŠiC’‡’J“ÖŽqC—Ñ—æŽqi“¹—§‰q¶Œ¤jC•ŸŽmŸCŽRŒû ºOiŽD–yŽs‰q¶Œ¤j: Œú¶ÈSgáŠQŒ¤‹†; Œø‰Ê“I‚ȃXƒNƒŠ[ƒjƒ“ƒOƒVƒXƒeƒ€‚ÌŽ{ô‚ÉŠÖ‚·‚錤‹†, •½¬‚X”N“xŒ¤‹†•ñ‘, p.157`161, 1998.

1835. mŒ¤‹†•ñiŒú¶Èjn –kŠC“¹‚É‚¨‚¯‚鬎™Šú”­ÇIDDM‚̉uŠw. ¼‰YM•vC‰¡“csŽjiŽ™jC•Ÿ“cŸ—mi‹v—¯•Ä‘åj: Œú¶ÈSgáŠQŒ¤‹†; ¬Ž™–«“Á’莾Š³Œ¤‹†Ž–‹Æ‚Ì•]‰¿‚ÉŠÖ‚·‚錤‹†, •½¬‚X”N“xŒ¤‹†•ñ‘, p.100`101, 1998.

1836. mŒ¤‹†•ñiŒú¶Èjn ¬Ž™Šú”­ÇIDDM‚Ì‘½—l«‚ÉŠÖ‚·‚錤‹†. ¼‰YM•vC‰¡“csŽjiŽ™jC•Ÿ“cŸ—mi‹v—¯•Ä‘åj: Œú¶ÈSgáŠQŒ¤‹†E¬Ž™–«“Á’莾Š³Œ¤‹†Ž–‹Æ‚Ì•]‰¿‚ÉŠÖ‚·‚錤‹†, •½¬‚X”N“xŒ¤‹†•ñ‘, p.189`191, 1998.

1837. mŒ¤‹†•ñiŒú¶Èjn ŒõŠ´Žó«”­ì‚ÉŠÖ‚·‚é—Õ°Œ¤‹†. ŽR“àr—Yié‹Êˆã‘åjCŽO‰YŽõ’jiŽ™jC‘¼: •½¬‚X”N“xŒú¶‰ÈŠw“Á•ÊŒ¤‹†uŒõŠ´Žó«”­ì‚ÉŠÖ‚·‚é—Õ°Œ¤‹†vŒ¤‹†•ñ‘, 1998.

1838. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn IDDMŠ³ŽÒŒŒ´‚æ‚ècoxsackie virus B (cox B)“ÁˆÙ“IRNA‚ÌŒŸo‚ÌŽŽ‚Ý. –쌳‚¯‚¢Žqi¶‰»ŒnjC‘å’ì”VC•—’£KŽiC•—’£^—R”üCŽÄŽRŒ[ŽqC‰¡“csŽjC‘åŽR‹XGC¼‰YM•viŽ™j: Œ’NE’·Žõ‚Ɗ‹«ˆã‰ÈŠw, •½¬‚X”N“xŠwpƒtƒƒ“ƒe²ƒA„iŽ–‹Æ‹¤“¯Œ¤‹†•ñ‘, p.105`107, 1998.

1839. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn •ai‚â‚Ü‚¢j‚É‚È‚è‚â‚·‚³‚ƈâ“`Žq; HLAƒNƒ‰ƒX‡U‚Ì‘ÌŒn“IƒV[ƒNƒGƒ“ƒX‰ðÍŽŽs. ‚Š_—m‘¾˜Yi•ª¶jC–쌳‚¯‚¢Žqi¶‰»ŒnjC–ì“n³•FiŽ™jC‰£—m”üi¶‰»ŒnjC¼‰YM•viŽ™j: Œ’NE’·Žõ‚Ɗ‹«ˆã‰ÈŠw, •½¬‚X”N“xŠwpƒtƒƒ“ƒe²ƒA„iŽ–‹Æ‹¤“¯Œ¤‹†•ñ‘, p.39`42, 1998.

1840. mÇ—á•ñn ‚¯‚¢‚ê‚ñdÏÇ‚ð—Uˆö‚Æ‚µ‚½‰¡–ä‹Ø—Z‰ðÇ‚É‚æ‚é‹}«t•s‘S‚Ì‚P—á. ¼‘ºbC“c‘ºNŽqC•x“cKŽ¡C“cŠ–Îi•l¼Ô\Žš•a‰@jCŽO‰YŽõ’jiŽ™j: ¬Ž™‰Èf—Ã, 61(12): 2267`2270, 1998.

1841. mÇ—á•ñn ƒtƒŒƒJƒCƒjƒh‚ª‘tŒø‚µ‚½ãŽº«•p”Ç, ‘ÙŽ™…Žî‚Ì‚P—á. Îì‹`lC•½Î‘CŽO‘òmŽiC“¡–ìé”VC–xŒû‘דTC•“cM—TC¬ŒûO‹BiŽ™jC“V–슮iŽY•wj: “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(8): 908`911, 1998.

1842. m‘àn “ÁW; ƒAƒgƒs[Ž™‚ɑ΂·‚éearly intervention/ƒAƒŒƒ‹ƒQƒ“Š´ì‚ÌŽn‚Ü‚è‚Æ‚»‚Ìf’f. –ìŠÔ„iŽ™j: ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 17(11): 831`835, 1997.

1843. m‘àn ‹CŠÇŽxšb‘§¬Ž™‚É‚¨‚¯‚éƒ_ƒjRŒ´Šˆ«‰»‚s×–E‚É—^‚¦‚銿•û•ûÜ; ŽÄ–p“’, ¬Â—³“’, ‹y‚ÑŽÄ—è“’‚Ì”äŠrŒŸ“¢. –ìŠÔ„iŽ™jC”nêŽÀi“¯ˆ¤‹L”O•a‰@j: Š¿•û‚ƖƉuEƒAƒŒƒ‹ƒM[, 10(12): 90`101, 1996.

1844. m‘àn V‚µ‚¢ŒŸ¸•û–@(AIRŒŸ¸j‚ð—p‚¢‚½¬Ž™ƒAƒgƒs[«”畆‰Š‚É‚¨‚¯‚éH•¨ƒAƒŒƒ‹ƒM[‚Ìf’f. •ô“c‹ªbi”Ñ”\’†‰›•a‰@jC–ìŠÔ„iŽ™j: é‹ÊŒ§ˆãŽt‰ïŽGŽ, 568: 40`44, 1997.

1845. m‘àn IDDM (infants of diabetic mothers). ¼‰YM•viŽ™j: ŽY•wl‰ÈŽ¡—Ã, 76(6): 1101`1104, 1998.

1846. m‘àn “ÁW; •W€ˆ•ûƒKƒCƒh96, ‹CŠÇŽxšb‘§i¬Ž™). –ìŠÔ„iŽ™j: Ž¡—Ã, 78: 1250`1253, 1996.

1847. m‘àn bó‘BŽ¾Š³‡•¹Ç”D•w‚©‚ço¶‚µ‚½Ž™‚̃XƒNƒŠ[ƒjƒ“ƒO. ¼‰YM•viŽ™j: ŽüŽYŠúˆãŠw, 28(5): 665`669, 1998.

1848. m‘àn “Á‘å†; ¬Ž™ƒAƒŒƒ‹ƒM[‚Ì‚·‚×‚Ä (‡U)ƒAƒŒƒ‹ƒM[‚ƃAƒŒƒ‹ƒQƒ“‚Ìf’fEŒŸ¸/ƒTƒCƒgƒJƒCƒ“‘ª’è. –ìŠÔ„iŽ™j: ¬Ž™‰Èf—Ã, 61: 146`153, 1998.

1849. m‘àn ¬Ž™‚ÌŠ´õÇ(‡U)‹U–Œ«’°‰Š. –ìXŽRŸliŽ™jCˆî‘º—zŽqC»ìŒc‰îiŠñ•tuÀj: ¬Ž™‰È—Õ°, 52(4): 471`473, 1999.

1850. m‘àn Ž‹°‰º•”-‰º‚‘Ì-bó‘B|‚»‚Ì‘ŠŒÝì—p. ¼‰YM•viŽ™j: ¬Ž™“à‰È, 30(7): 847`855, 1998.

1851. m‘àn Aaskog syndrome. ¼‰YM•viŽ™j: f’f‚ÆŽ¡—Ã, 86(Suppl.): 728`728, 1998.

1852. m‘àn ŠwZŒŸ”A‚Ì‚»‚ÌŒã; –Œ«‘B«t‰Š‚Ì‘Šú”­Œ©¥‘ŠúŽ¡—Â̈Ӌ`. ”Ñ‚Šì‹v—YiŽ™j: t‚Æ“§Í, 45(5): 601`604, 1998.

1853. m‘àn ƒŠƒ“ƒp‹…EAPC‹@”\‚Ìin vitroŒŸ¸; R‘ÌŽY¶”\. –ìŠÔ„iŽ™j: —Õ°‚ƖƉu, 28(Suppl.17): 219`223, 1997.

1854. m‘àn “ÁW; ¬Ž™‚Ö‚Ì“Š–ò‚ðl‚¦‚é, ƒAƒŒƒ‹ƒM[«Ž¾Š³‚Ö‚Ì“Š–ò‚̉”Û. –ìŠÔ„iŽ™j: —Õ°‚Æ–ò•¨Ž¡—Ã, 16: 726`726, 1997.

1855. m‘àn ‡•¹Ç‚𔺂¤“§ÍŠ³ŽÒ‚̉h—{Žw“±; ‰h—{áŠQ, ¬Ž™. ”Ñ‚Šì‹v—YiŽ™jC²“¡ÆŽqi‰h—{•”j: —Õ°“§Í, 14(14): 1965`1972, 1998.

1856. muÀn ƒŠƒ“ƒp‹…‚Ì‘gD“ÁˆÙ“IˆÚ; Th1‚ÆTh2×–E‚Ìd—v‚È–ðŠ„. –ìŠÔ„iŽ™j: Allergy/Up to Date, 4(2-3): 1997.

1857. muÀn ‚Ä‚ñ‚©‚ñÅ‘Oü(115)‘æ32‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï•ñ. דc‚Ì‚¼‚ÝiŽ™j: ”g(“ú–{‚Ä‚ñ‚©‚ñ‹¦‰ï), 23(3): 102`105, 1999.

1858. muÀn ‡–°–ò‚ÆR•sˆÀ–ò‚ÌŽg‚¢•û‚ÌŽÀÛ|ŽvtŠú|. ”’ˆäGKCŽO‰YŽõ’jiŽ™j: —Õଂƌ¤‹†, 76(2): 300`304, 1999.

1859. mŠwp‘n i•ª’SŽ·•Mj Ç—á‚ÅŠw‚Ô¬Ž™‘̉t¥“d‰ðŽ¿ˆÙí‚Æ—A‰t; –«t•s‘S, ”Ñ‚Šì‹v—YiŽ™j. •ÒW ¬”‹´–õi¹ƒ}ƒŠˆã‘åjC•ÒC ‰iˆä‘“X, ‘åã, 98.06.10”­s.

1860. mŠwp‘n i•ª’SŽ·•Mj Year Note, Selected Articles 1999; dÇSŠïŒ`‚Ìf’f‚ÆŽ¡—Ã, p.287`301, •½Î‘iŽ™j. •ÒW –ؗT”üC•ÒC Medic Media, “Œ‹ž, 98.06.00”­s.

1861. mŠwp‘n i•ª’SŽ·•Mj ƒCƒ“ƒXƒŠƒ“—Ö@1998; ƒCƒ“ƒXƒŠƒ“—Ö@‚Ƈ•¹Ç, p.79`99, ¼‰YM•viŽ™j. •ÒW ’r“c‹`—Y(ŽœŒbˆã‘åjC ƒmƒ{ƒmƒ‹ƒfƒBƒXƒNƒtƒ@[ƒ}iŠ”jC“Œ‹žC98.08.01”­s.

1862. mŠwp‘n i•ª’SŽ·•Mj ‘æ32‰ñ“œ”A•aŠw‚Ìi•à: “œ”A•a‚̗×{Žw“±'98; ƒVƒ“ƒ|ƒWƒ…ƒEƒ€‚P¢ŠÇ—‚Ì‚½‚ß‚É£1.IDDM‚ÌŠÇ—, ¼‰YM•viŽ™j. •ÒW “ú–{“œ”A•aŠw‰ïC•ÒC f’f‚ÆŽ¡—ÃŽÐC“Œ‹žC98.08.25”­s.

1863. mŠwp‘n i•ª’SŽ·•Mj “§Íƒtƒƒ“ƒeƒBƒA, “§Í—Ö@‚É‚¨‚¯‚é—lX‚È‹^–â‚É“š‚¦‚éiƒVƒŠ[ƒY2); “§ÍŠ³ŽÒ‚ÌQOL|AŠw: ¬Ž™“§ÍŠ³ŽÒ‚ÌAŠw‚Ì–â‘è, p.222`226, ”Ñ‚Šì‹v—YC–kžŠ‚Ý‚Ç‚èiŽ™j. ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, “Œ‹ž, 98.08.25”­s.

1864. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj¥1998; ¬Ž™‚Ì“œ”A•a, p.553`554, ¼‰YM•viŽ™j. ˆãŠw‘‰@C“Œ‹žC98.00.00”­s.

1865. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwjiVol. 40); ¬Ž™‚Ì”x‰Š, p.776`777, ”~Œ´ŽÀiŽ™j. ˆãŠw‘‰@, “Œ‹ž, 98.00.00”­s.

1866. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj¥1999; ¬Ž™‚̃lƒtƒ[ƒ[ÇŒóŒQ, 41: 819`820, ”Ñ‚Šì‹v—YiŽ™j. •ÒW ‘½‰ê{K’jC”öŒ`‰x˜YC•ÒC ˆãŠw‘‰@, “Œ‹ž, 99.01.01”­s.

1867. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚̬Ž™Ž¡—ÃŽwji‘æ10”Å); ‰ßŒÄ‹zÇŒóŒQ, p.374`375, ”~Œ´ŽÀiŽ™j. •ÒW ”·Šì”VCŽO‰ÍtŽ÷Cd“c­MC–î“cƒˆêC•ÒC ˆãŠw‘‰@, “Œ‹ž, 93.00.00”­s.

1868. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì‹~‹}Ž¡—ÃŽwj; šq“f, p.460`462, ”~Œ´ŽÀiŽ™j. •ÒW ‘Oì˜a•FC‘Šì’¼Ž÷C•ÒC ˆãŠw‘‰@, “Œ‹ž, 96.00.00”­s.

1869. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚̬Ž™Ž¡—ÃŽwj(‘æ11”Å); ‹CŠÇŽxŠg’£Ç, p.289`290, ”~Œ´ŽÀiŽ™j. •ÒW –î“cƒˆêC–ö‘ò³‹`CŽRŒû‹K—eŽqC•ÒC ˆãŠw‘‰@, “Œ‹ž, 97.00.00”­s.

1870. mŠwp‘n i•ª’SŽ·•Mj ƒAƒŒƒ‹ƒM[‚ƃTƒCƒgƒJƒCƒ“(‘æ1”Å); H•¨ƒAƒŒƒ‹ƒM[‚ÆIL2, p.227`241, –ìŠÔ„iŽ™jC‰©‘‹Pi’•ƒŽs—§•a‰@j. •ÒW ‹{–{º³CÎìšKC”Ñ‘q—mŽ¡C•ÒC ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, “Œ‹ž, 96.00.00”­s.

1871. mŠwp‘n i•ª’SŽ·•Mj ƒAƒŒƒ‹ƒM[ŒŸ¸–@(‘æ1”Å); ƒŠƒ“ƒp‹…‹@”\, p.113`118, –ìŠÔ„iŽ™jC‰©‘‹Pi’•ƒŽs—§•a‰@j. •ÒW ‹{–{º³CÎìšKC”Ñ‘q—mŽ¡C•ÒC ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, “Œ‹ž, 96.00.00”­s.

1872. mŠwp‘n i•ª’SŽ·•Mj ‹CŠÇŽxšb‘§Ž¡—ÂÌÅ‘Oü(‘æ1”Å); ¬Ž™šb‘§‚̬’·‚É‚æ‚é•Ï‰»‚Æ‚»‚ÌŒ´ˆö, p.40`47, –ìŠÔ„iŽ™j. •ÒW ˆÉ“¡KŽ¡C•ÒC Ž½“°, “Œ‹ž, 97.00.00”­s.

1873. m‹³‰È‘n i•ª’SŽ·•Mj ¬Ž™‚̌ċzŠíŽ¾Š³; ‡W. ˆô“ª‚ÌŽ¾Š³, ‡X. A“ª‚ÌŽ¾Š³, p.47`68, ”~Œ´ŽÀiŽ™j. •ÒW X캜AC•ÒC ‰iˆä‘“X, “Œ‹ž, 98.00.00”­s.

1874. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ¬Ž™tŽ¾Š³Q & A; ‹}‘¬is«t‰ŠÇŒóŒQ‚Æ‚ÍH, p.73`74, ”Ñ‚Šì‹v—YiŽ™j. •ÒW ˆÉ“¡‘ñC‹gì“¿–ÎC•ÒC ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 99.01.10”­s.

1875. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ƒAƒŒƒ‹ƒM[Ž¾Š³ƒCƒ‰ƒXƒgƒŒƒCƒeƒbƒh(‘æ1”Å); ƒAƒŒƒ‹ƒM[‚ƃTƒCƒgƒJƒCƒ“, p.137`144, –ìŠÔ„iŽ™j. •ÒW X“cŠ°C‰i‘qr˜aC•ÒC ƒƒaƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 98.00.00”­s.

1876. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ¶•¨Šw“I»Ü¥Ž¿‹^‰ž“š; ”M«‚¯‚¢‚ê‚ñŠ³Ž™‚ɑ΂·‚é—\–hÚŽí(•½¬‚X”N“x”Å), 2: 1`2, ŽO‰YŽõ’jiŽ™j. •ÒW •“c–ò•iH‹ÆŠ”Ž®‰ïŽÐC•ÒC “ú–{ˆãŽ–V•ñŽÐC“Œ‹žC99.02.01”­s.

1877. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ª’SŽ·•Mj ‘æ‚X‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï(ƒrƒfƒI); Œ{—‘ƒAƒŒƒ‹ƒM[Š³Ž™‚É‚¨‚¯‚é—‘”’RŒ´“ÁˆÙ“IIL2”½‰ž«ŒŸ¸(AIR)‚Ìf’f“IˆÓ‹`, (‡V)IgE RASTƒXƒRƒA‚Æ‚Ì”äŠr, –ìŠÔ„iŽ™j. •ÒW ƒƒaƒJƒ‹î•ñƒZƒ“ƒ^[C•ÒC 98.00.00”­s.

1878. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Therapeutic drug monitoring; Epilepsies. ŽO‰YŽõ’jiŽ™j: ‘æ8‰ñ‘Û¬Ž™_ŒoŠw‰ï‹c(8th International Child Neurology Congress) i98.09.17j, Ljubljana, Brain Dev., 20(6): ‡Y, 1998.

1879. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j I. Association of autoantibodies to ICA512 and phogrin with clinical heterogeneity in Japanese patients with type 1 diabetes. ìè‰p“ñC¢—…N“¿Cˆ¢”ä—¯‹³¶C‘ë–씎•¶CŽRè_“TCŽRŒû‹`•FCÔàVºˆêi’·è‘åjC“àŠƒˆÀŽqi“Œ—ˆã‘åjC¼‰YM•viŽ™jC]ŒûŸ”üi’·è‘åj: 58th Annual Meeting of American Diabetes Association i98.06.03`06j, Chicago, USA, Diabetes, 47(Suppl. 1): 147, 1998.

1880. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Long-term outcome after surgery to close coronary artery fistulae. ŽO‘òmŽiC•½Î‘C•“cM—TC¬ì‰ÄŽqiŽ™j: ‘æ22‰ñ‘Û¬Ž™‰ÈŠw‰ï i98.08.11`13j, ƒAƒ€ƒXƒeƒ‹ƒ_ƒ€.

1881. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Extracellular superoxide dismutase in various pediatric disease. ‘å–ìGŽ÷C‘å‰ÍŒ´’m…i–h‰qˆã‘åjCNakao, C.C¼‰YM•viŽ™jCChishi, T.CKizaki, T.CImazeki, N.CMatsubara, O.CHaga, S.CKondo, T.CTaniguchi, N.: 9th Biennial Meeting International Society for Free Radical Research i98.09.07`11j, San Paulo, Brazil.

1882. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical course of systemic lupus erythematous membranous glomerulonephritis in children. ”Ñ‚Šì‹v—YCŽç‰®r‰îC’©’·C–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: 11th Congress of the International Pediatric Nephrology Association i98.09.15j, London, Pediatr. Nephrol., 12(7): 170, 1998.

1883. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Spontaneous remission in four patients with West syndrome. Šâèr”VCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ˆäŒ¤“ñC•ÐŽR•¶•FiŽ™j: ‘æ8‰ñ‘Û¬Ž™_ŒoŠw‰ï‹c(8th International Child Neurology Congress) i98.09.16`17j, Ljubljana, Brain Dev., 20(6): 475, 1998.

1884. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Mutation and deletion of the WTI gene and loss heterozygosity (LOH) on chromosome arm 11p in Wilms' tumors in Japan. ’†ŠÚ®–çiŽ™jCŒö•¶˜aŽqC“y‰®“oŽkC‹àŽqˆÀ”äŒÃié‹Ê‚ª‚ñƒZƒ“j: International Society of Pediatric Oncology SIPO 30th Meeting i98.10.04`08j, ‰¡•l, Med. Pediatr. Oncol., 31(4): 283, 1998.

1885. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The value of electron beam CT in the assessment of coarctation of aorta. –xŒû‘דTC•½Î‘CŽO‘òmŽiC“¡–ìé”VCL“c•l•vC•“cM—TiŽ™j: Advances in Electron Beam Computed Tomography, 1998 i98.10.16`18j, San Francisco.

1886. mŠw‰ïi‘S‘jn i‰ï’·u‰‰j R‚Ä‚ñ‚©‚ñ–ò‚Ì”­’B–ò—‚Æ—Õ°. ŽO‰YŽõ’jiŽ™j: ‘æ32‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï i98.10.10j, ‰¡•l, ‚Ä‚ñ‚©‚ñŒ¤‹†, 17(1): 35, 1999.

1887. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –«”xŽ¾Š³‚Ì•a‘Ô¶—‚ÆŠÇ—. ”~Œ´ŽÀC’·’Jì‹v–íiŽ™j: ‘æ29‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï i97.00.00j, ‰F“s‹{, “ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ïŽGŽ, 8(1): 63, 1997.

1888. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒTƒCƒƒOƒƒuƒŠƒ“ˆâ“`Žqƒ~ƒXƒZƒ“ƒX•ÏˆÙ‚É‚æ‚éæ“V«bó‘BŽî‚Q—á|¬l—á‚ƬŽ™—á‚Ì”äŠr|. •HÀºiàÕ‹¦ˆã‘åjC‘åŽR‹XGC¼‰YM•viŽ™jC‰Æ“ü‘“¶•viàÕ‹¦ˆã‘åj: ‘æ71‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï i98.06.04`06j, •Ÿ‰ª, “ú–{“à•ª”åŠw‰ïŽGŽ, 74(1): 70, 1998.

1889. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€j R‚Ä‚ñ‚©‚ñ–ò‚Ì”­’B–ò—‚ÆTDM; ¬Ž™–ò•¨Ž¡—Ã|¬Ž™‚Ì–ò•¨‘Ì“à“®‘Ô‚ÆTDM|. ŽO‰YŽõ’jiŽ™j: ‘æ25‰ñ“ú–{¬Ž™—Õ°–ò—Šw‰ï i98.09.11j, “Œ‹ž, ´˜^W, 1998.

1890. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ¬Ž™‹CŠÇŽxƒtƒ@ƒCƒo[ƒXƒRƒs[‚ÌŒ»‹µ. ŠÖª“OC”~Œ´ŽÀiŽ™j: ‘æ31‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï i98.11.28j, ‰¡•l.

1891. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ¬Ž™PICU‚Í‚Ç‚¤‚ ‚é‚ׂ«‚©|‘åŠw•a‰@‚É‚¨‚¯‚éPICU|. ”~Œ´ŽÀiŽ™j: ‘æ10‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ï i96.00.00j, ‹v—¯•Ä.

1892. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒ_ƒjRŒ´—U”­‹CŠÇŽxšb‘§Š³Ž™––½ŒŒ‚a×–E—R—ˆ“ÁˆÙIgEŽY¶×–EŠ”‚ÌŽ÷—§. –ìŠÔ„C‹g‘ò‚¢‚ÂÝiŽ™jC–î“cƒˆêi“ŒˆãŽ•‘åj: ‘æ26‰ñ“ú–{—Õ°–ƉuŠw‰ï i98.12.01`03j, _ŒË, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 28: 119, 1998.

1893. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ”x‰Š‹…‹Û‚É‚æ‚é‹}«A“ªŠW‰Š, ”x‰Š‚É•¹”­‚µ‚½ŒŒ‹…æÃHÇŒóŒQ‚Ì‚P—Ž™—á|ŒŒ´ƒTƒCƒgƒJƒCƒ“‚ÌŒŸ“¢|. Îì‹`lC–ìŠÔ„C•~“‡NŽjC²”Œ•q—ºCì–ì–LC¼‰YM•viŽ™j: ‘æ26‰ñ“ú–{—Õ°–ƉuŠw‰ï i98.12.01`03j, _ŒË, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 28: 165, 1998.

1894. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒ_ƒjRŒ´“ÁˆÙƒqƒgIgEŽY¶‚a×–EŠ”‚ÌŽ÷—§‚ƃTƒCƒgƒJƒCƒ“‚É‚æ‚钲ߋ@\‚̉ðÍ. –ìŠÔ„C‹g‘ò‚¢‚ÂÝCì–ì–LC›Œ´—zŽqC¼‰YM•viŽ™jC–ؑ‹Pi’•ƒŽs—§•a‰@j: ‘æ28‰ñ“ú–{–ƉuŠw‰ï‘‰ï i98.12.02`04j, _ŒË, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 28: 207, 1998.

1895. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PBSCT‚àŠÜ‚Þ‰»Šw—Ö@‚Ì‚Ý‚Å’·ŠúŠ®‘SŠ°‰ð‚ðˆÛŽ‚µ‚Ä‚¢‚éG“Œ´”­‰¡–ä‹Ø“÷Žî. ’†ŠÚ®–çiŽ™jC”¨]–F˜YC”Ñ’ËiC•“c••vi‘—§ŽD–y•a‰@j: ‘æ21‰ñ“ú–{‘¢ŒŒŠ²×–EˆÚAŠw‰ï‘‰ï i98.00.00`00j, –¼ŒÃ‰®.

1896. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ_ƒj—U”­‹CŠÇŽxšb‘§Š³Ž™––½ŒŒ’PŠj×–E‚É‚¨‚¯‚éƒAƒ|ƒg[ƒVƒX‚̉ðÍ. ›Œ´—zŽqiŽ™jC–ؑ‹Pi’•ƒŽs—§•a‰@jCì–ì–LCÎì‹`lC²”Œ•q—ºC•~“‡NŽjC¼‰YM•vC–ìŠÔ„iŽ™j: ‘æ10‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï i98.04.23`25j, –¼ŒÃ‰®, ƒAƒŒƒ‹ƒM[, 47(2,3): 325, 1998.

1897. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ_ƒj—U”­‹CŠÇŽxšb‘§Š³Ž™––½ŒŒ’PŠj×–E‚É‚¨‚¯‚éƒCƒ“ƒ^[ƒtƒFƒƒ“(IFN)-ƒÁŽY¶’ቺ‚̉ðÍ. Îì‹`lCì–ì–LiŽ™jC–ؑ‹Pi’•ƒŽs—§•a‰@jC²”Œ•q—ºC•~“‡NŽjC¼‰YM•vC–ìŠÔ„iŽ™j: ‘æ10‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï i98.04.23`25j, –¼ŒÃ‰®, ƒAƒŒƒ‹ƒM[, 47(2,3): 325, 1998.

1898. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”x‰Š, ’†Ž¨‰Š‚È‚Ç‚ÌŠ´õ‚ðŒJ‚è•Ô‚µidiopathic CD4+ T-lymphocytopenia (ICL)‚Æl‚¦‚ç‚ꂽ‚P’jŽ™—á‚ÌŒŸ“¢. –ؑ‹Pi’•ƒŽs—§•a‰@jCì–ì–LC–ìŠÔ„iŽ™j: ‘æ10‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï i98.04.23`25j, –¼ŒÃ‰®, ƒAƒŒƒ‹ƒM[, 47(2,3): 345, 1998.

1899. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Â—³“’‹y‚Ñ”ž–å“~“’‚ª‚à‚ÂRƒAƒŒƒ‹ƒM[ì—p‚̖ƉuŠw“IŒŸ“¢. ì–ì–LC¬ì—ÏŽjCÎì‹`lC²”Œ•q—ºC•~“‡NŽjC–ìŠÔ„C¼‰YM•viŽ™j: ‘æ10‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï i98.04.23`25j, –¼ŒÃ‰®, ƒAƒŒƒ‹ƒM[, 47(2,3): 351, 1998.

1900. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j NADP: quinone oxidoreductase (NQ01, DT-diaphorase) ˆâ“`Žq‚Æ“œ”A•a‚ÌŠÖ˜A«. t“ú–ÎC—é–ØiC•½ˆäŠ®ŽjCç—t‰ëŽ÷i“Œ–k‘åjC¼‰YM•vC‰¡“csŽjiŽ™jC‹e’rMsi‰¡•lŽs‘åjC–L“c—²Œªi“Œ–k‘åj: ‘æ41‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï i98.05.20`22j, ˜a‰ÌŽR, “œ”A•a, 41(Suppl.): 219, 1998.

1901. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™‚ÌŠoÁŽž‘å”­ì‚Ä‚ñ‚©‚ñ‚ɑ΂·‚ésodium valproate’PÜŽ¡—Â̌ø‰Ê‚ÆŒŒ’†”Z“x. •ˆäŒ¤“ñCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ÐŽR•¶•FCŠâèr”ViŽ™j: ‘æ15‰ñ“ú–{TDMŠw‰ï i98.05.30j, _ŒË, —vŽ|W, 1998.

1902. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒNƒƒ}ƒ`ƒ“\‘¢‚ð’†S‚Æ‚µ‚½¬’·ƒzƒ‹ƒ‚ƒ“ˆâ“`Žq‚Ì×–EŒ^“ÁˆÙ“I‚È”­Œ»‹@\; ƒ‰ƒbƒg¬’·ƒzƒ‹ƒ‚ƒ“ƒ[ƒJƒX‚Ì“Á’¥. •—’£KŽiiŽ™jC–쌳‚¯‚¢Žqi¶‰»ŒnjC¼‰YM•viŽ™jC¬–ì‰ë•vi•ª¶j: ‘æ71‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï i98.06.04`06j, •Ÿ‰ª, “ú–{“à•ª”åŠw‰ïŽGŽ, 74(1): 123, 1998.

1903. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “û–[Žî‘å‚ðŽå‘i‚É—ˆ‰@‚µ‚½—Ž™‚É‚¨‚¯‚éf’fã‚Ì–â‘è“_. ‰¡“csŽjC•—’£^—R”üCŽÄŽRŒ[ŽqC‘åŽR‹XGC¼‰YM•viŽ™j: ‘æ71‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï i98.06.04`06j, •Ÿ‰ª, “ú–{“à•ª”åŠw‰ïŽGŽ, 74(1): 131, 1998.

1904. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j WestÇŒóŒQ‚ɑ΂·‚éACTH‚Æclonazepam•¹—p—Ö@‚Ì’ZŠúŒø‰Ê‚Æ’·Šú—\Œã. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ˆäŒ¤“ñC•ÐŽR•¶•FCŠâèr”ViŽ™j: ‘æ40‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï i98.06.05j, ‰¡•l, ”]‚Æ”­’B, 30(‘‰ï†): 114, 1998.

1905. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j BPD‚ɑ΂·‚éDexamethasone (Dex)—Ö@Œã‚É‹}«•›t‹@”\’ቺ‚ð’悵ƒXƒeƒƒCƒh•â[‚È‚µ‚ɉñ•œ‚µ‚½’´’áo¶‘Ìd(VLBW)Ž™‚Ì‚P—á. “c‹v•ÛŒ›sC‰¡“csŽjC‹÷‰z½C•y‰Á’ÉëŒÈC“àŽR’q–¾CŽR“cr•FC¬ŒûO‹BC¼‰YM•viŽ™j: ‘æ34‰ñ“ú–{V¶Ž™Šw‰ï‘‰ïŠwpW‰ï i98.07.12`14j, •Ÿ‰ª, “ú–{V¶Ž™Šw‰ïŽGŽ, 34(2): 317, 1998.

1906. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V¶Ž™×‹ÛŠ´õÇ‚É‚¨‚¯‚錌’†G-CSF”Z“x‚ÌŒŸ“¢(‘æ7•ñ)‚ƒTƒCƒgƒJƒCƒ“ŒŒÇ‚É‚¨‚¯‚é—Õ°‘œ‚ÌŒŸ“¢. ŽR“cr•FC–ì“n³•FC¼–{^‹IC”ó‰YDC“n•Ó’qŽqCŽO{—zŽqC²“¡‰ë•FCŠ—Œ´FC¬ŒûO‹BC‰¬Œ´ƒ‘ãC’†‘ºP•äiŽ™j: ‘æ34‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï¥ŠwpW‰ï i98.07.12`14jC •Ÿ‰ª, “ú–{V¶Ž™Šw‰ïŽGŽ, 34(2): 430, 1998.

1907. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j o¶Ž™‚Ìä`‘ÑŒŒpH 7.0–¢–ž‚ð’悵‚½73Ç—á‚ÌŽüŽYŠúŒo‰ß‚ÌŒŸ“¢. ¼–{^‹IC¬ŒûO‹BC”ó‰YDCŽO{—zŽqC“n•Ó’qŽqCŽR“cr•FC²“¡‰ë•FC–ì“n³•FCŠ—Œ´FiŽ™jC¯“c—²iŽY•wj: ‘æ34‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï¥ŠwpW‰ï i98.07.12`14jC •Ÿ‰ª, “ú–{V¶Ž™Šw‰ïŽGŽ, 34(2): 472, 1998.

1908. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éV¶Ž™ŠïŒ`ŽîÇ—á‚ÌŒŸ“¢. “n•Ó’qŽqC”ó‰YDC¼–{^‹ICŽO{—zŽqCŽR“cr•FC–ì“n³•FC¬ŒûO‹BiŽ™jCŠâ‰i‹v”üCÖ“¡ŽC“V–슮iŽY•wj: ‘æ34‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï¥ŠwpW‰ï i98.07.12`14jC •Ÿ‰ª, “ú–{V¶Ž™Šw‰ïŽGŽ, 34(2): 486, 1998.

1909. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j So“àŒŒð‚̃GƒR[«ó•]‰¿‚ÆŽ¡—ÃŒø‰Ê. ŽO‘òmŽiC•½Î‘C•“cM—TC¬ì‰ÄŽqC“¡–ìé”VC–xŒû‘דTC‰Í‘º½ŽŸiŽ™j: ‘æ34‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï i98.07.23j, “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 14(2): 260, 1998.

1910. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆâ“`«‹…óÔŒŒ‹…Ç26—á‚Ì—Õ°“IŒŸ“¢. Îì‹`lC’†ŠÚ®–çC–ìŠÔ„CŽO‘îòCŒIŒ´Œ‰C¬‘ò”ü˜aC¡ˆäƒDC‰““¡‹I—YC¼‰YM•viŽ™j: ‘æ40‰ñ“ú–{¬Ž™ŒŒ‰tŠw‰ï i98.09.18`19j, L“‡, “ú–{¬Ž™ŒŒ‰tŠw‰ïŽG, 12(4): 263, 1998.

1911. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™‹}«ƒŠƒ“ƒp«”’ŒŒ•a‚Ì’·ŠúŽ¡—ìт̌Ÿ“¢(1974`1998). ’†ŠÚ®–çC–ìŠÔ„CŽO‘îòCŒIŒ´Œ‰C¬‘ò”ü˜aC¡ˆäƒDCŽR–{OŽqC‰““¡‹I—YC¼‰YM•viŽ™j: ‘æ40‰ñ“ú–{¬Ž™ŒŒ‰tŠw‰ï i98.09.18`19j, L“‡, “ú–{¬Ž™ŒŒ‰tŠw‰ïŽGŽ, 12(4): 241, 1998.

1912. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Š°‰ðŒãœ‘’áŒ`¬‚ðŽ¦‚µƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŠ´õǂ𔽕œ‚µ‚ÄŽ€–S‚µ‚½ƒo[ƒLƒbƒg—l‚a×–Eˆ««ƒŠƒ“ƒpŽî‚Ì‚P’jŽ™—á. ¬ì—ÏŽjC–ìŠÔ„Cì–ì–LC•~“‡NŽjC²”Œ•q—ºCÎì‹`lC¼‰YM•viŽ™jC‚ŽR‡C‘啽–r˜YC¼–ì‹gGi‘—§‚ª‚ñƒZƒ“j: ‘æ40‰ñ“ú–{¬Ž™ŒŒ‰tŠw‰ï i98.09.18`19j, L“‡, “ú–{¬Ž™ŒŒ‰tŠw‰ïŽGŽ, 12(4): 296, 1998.

1913. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ_ƒj—U”­‹CŠÇŽxšb‘§Š³Ž™––½ŒŒ’PŠj×–E‚É•\o‚³‚ê‚éFASƒŠƒKƒ“ƒh‚̉ðÍ. ›Œ´—zŽqiŽ™jC–ؑ‹Pi’•ƒŽs—§•a‰@jCÎì‹`lC²”Œ•q—ºC•~“‡NŽjC–ìŠÔ„iŽ™j: ‘æ35‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï i98.09.26`27j, ‰H‰g–ì, “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ, 12(2): 180, 1998.

1914. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j BM16R‘Ì‚É‚æ‚éƒ_ƒj—U”­¬Ž™‹CŠÇŽxšb‘§Š³Ž™‚s×–E‚̉ðÍ. –ìŠÔ„C¬ì—ÏŽjCÎì‹`lC²”Œ•q—ºC•~“‡NŽjC›Œ´—zŽqCì–ì–LC¼‰YM•viŽ™jC‰i“c“S–çCŒ•Žˆê”üC‚–츈êiƒr[ƒGƒ€ƒGƒ‹j: ‘æ35‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï i98.09.26`27j, ‰H‰g–ì, “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ, 12(2): 180, 1998.

1915. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V¶Ž™ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚Å”­Œ©‚³‚ê‚é’†•«bó‘B‹@”\’ቺÇ. “àŽR’q–¾C‰¡“csŽjC‘åŽR‹XGCŽÄŽRŒ[ŽqC¼‰YM•viŽ™jC¬’r–¾”üi“l“ì•a‰@jCŒ´“c³•½iŽs—§çΑ‡•a‰@jC•ŸŽmŸC“¡“cWŽOiŽD–yŽs‰q¶Œ¤j: ‘æ26‰ñ“ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ï i98.10.09`10j, å‘ä, “ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ, 8(2): 89, 1998.

1916. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j uƒ|ƒPƒ‚ƒ“vŽ‹’®‚É‚æ‚èŒõŠ´Žó«”­ì‚ð‹N‚±‚µ‚½Š³Ž™‚Ì‘MŒõ•ŠŠˆ”]”gŠŒ©‚É‚¨‚æ‚Ú‚·ƒrƒfƒIƒQ[ƒ€‚̉e‹¿|ƒrƒfƒIƒQ[ƒ€‚Ä‚ñ‚©‚ñŠ³Ž™‚Æ‚Ì”äŠr|. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ˆäŒ¤“ñC•ÐŽR•¶•FCŠâèr”ViŽ™j: ‘æ32‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï i98.10.10j, ‰¡•l, ‚Ä‚ñ‚©‚ñŒ¤‹†, 17(1): 49, 1999.

1917. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”畆‹Ø‰Š‚Ì‚P—Ž™—á|ŒŒ´ƒTƒCƒgƒJƒCƒ“‚ÌŒŸ“¢|. Îì‹`lC¬ì—ÏŽjC•~“‡NŽjC²”Œ•q—ºCì–ì–LC–ìŠÔ„iŽ™j: ‘æ‚W‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï i98.10.17`18j, •Ÿ‰ª.

1918. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒCƒ‹ƒ€ƒXŽîᇂɂ¨‚¯‚éŠà—}§ˆâ“`Žq. ’†ŠÚ®–çiŽ™jCŒö•¶˜aŽqC“y‰®“oŽkC‹àŽqˆÀ”äŒÃié‹Ê‚ª‚ñƒZƒ“j: ‘æ14‰ñ“ú–{¬Ž™‚ª‚ñŠw‰ï i98.10.19`20j, ŽD–y, ¬Ž™‚ª‚ñ, 35: 344, 1998.

1919. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚鬎™‰º—ŸÇ‚Ì—Õ°“IŒŸ“¢. ‹÷‰z½C–ìXŽRŸliŽ™jCΊڕ•vi–k—¢Œ¤•a‰@ƒƒfƒBƒJƒ‹ƒZƒ“j: ‘æ30‰ñ“ú–{¬Ž™Š´õÇŠw‰ï i98.11.07j, ¼–{.

1920. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™‹}«œ‘«”’ŒŒ•a‚ÌŽ¡—ìт̌Ÿ“¢(1971`1998). ’†ŠÚ®–çC–ìŠÔ„CŽO‘îòCŒIŒ´Œ‰C¬‘ò”ü˜aC¡ˆäƒDCŽR–{OŽqC“‡–{—R‹IŽqC‰““¡‹I—YC¼‰YM•viŽ™j: ‘æ40‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï i98.11.11`13j, ‹à‘ò, —Õ°ŒŒ‰t, 39(10): 1998.

1921. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’†—tØœp‚ðŽ{s‚µ‚½–Ɖu•s‘SÇ‚Ì‚P—á. ‘º¼GŽ÷C”~Œ´ŽÀCã“cN‹vCŒ´^lCŠÖª“OCŒÜ\—’@—YiŽ™jC•i“cƒi‹¹ŠOj: ‘æ31‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï i98.11.28j, ‰¡•l.

1922. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •Ð”x‘S“EœpŒã’·ŠúŠÔŠÏŽ@‚µ“¾‚½‚QÇ—á. •Ÿ“‡’‹`C”~Œ´ŽÀC–¥‰YŽ‘¥CŽl‘q³”ŽCŠÖª“OCŒ´^lCã“cN‹viŽ™jC•i“cƒC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ31‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï i98.11.28j, ‰¡•l.

1923. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •ê‘Ì‹i‰Œ‚ª“ûŽ™‚̌ċz’²ß‚É‹y‚Ú‚·‰e‹¿. ã“cN‹viŽ™jCStick, S.M.CSly, P.D.: ‘æ31‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï i98.11.29j, ‰¡•l.

1924. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ_ƒj—U”­‹CŠÇŽxšb‘§Ž™‚s×–E‚É‚¨‚¯‚éTh2×–EˆŸŒQ‚̉ðÍ. ŽRŠÝ—¢’ÃŽqC–ìŠÔ„C¬ì—ÏŽjCÎì‹`lC²”Œ•q—ºC•~“‡NŽjC›Œ´—zŽqCì–ì–LC¼‰YM•viŽ™jC‰i“c“S–çCŒ•Žˆê”üC‚–츈ê: ‘æ48‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï i98.12.01`03j, _ŒË, ƒAƒŒƒ‹ƒM[, 47(9,10): 1024, 1998.

1925. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ_ƒj—U”­‹CŠÇŽxšb‘§Š³Ž™––½ŒŒ’PŠj×–E‚É‚¨‚¯‚éƒAƒ|ƒg[ƒVƒX‚̉ðÍ(‡V). ›Œ´—zŽqiŽ™jC–ؑ‹Pi’•ƒŽs—§•a‰@jCì–ì–LC‹g‘ò‚¢‚ÂÝCÎì‹`lCŽRŠÝ—¢’ÃŽqC¬ì—ÏŽjC²”Œ•q—ºC•~“‡NŽjC¼‰YM•vC–ìŠÔ„iŽ™j: ‘æ48‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï i98.12.01`03j, _ŒË, ƒAƒŒƒ‹ƒM[, 47(9,10): 946, 1998.

1926. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™‹CŠÇŽxšb‘§‚ÆŽžŠÔŠOf—Ã. ì–ì–LC¬ì—ÏŽjCÎì‹`lC²”Œ•q—ºC•~“‡NŽjC–¥‰YŽ‘¥C–ìŠÔ„C¼‰YM•viŽ™j: ‘æ48‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï i98.12.01`03j, _ŒË, ƒAƒŒƒ‹ƒM[, 47(9,10): 951, 1998.

1927. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŽvtŠú‚̃AƒŒƒ‹ƒM[; ƒTƒCƒgƒJƒCƒ“‚̕ω». –ìŠÔ„iŽ™j: ‘æ10‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï i98.04.23`25j, –¼ŒÃ‰®, ƒAƒŒƒ‹ƒM[, 47(2,3): 242, 1998.

1928. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j WestÇŒóŒQ‚ɑ΂·‚éƒrƒ^ƒ~ƒ“B6‘å—Ê‚P“ú‚S•ªŠ„“Š—^–@‚ÌŒø‰Ê. •ˆäŒ¤“ñCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèCŠâèr”VC•ÐŽR•¶•FiŽ™j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15), ’¹Žæ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 255, 1998.

1929. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j V¶Ž™–«”xŽ¾Š³Š³Ž™‚Ì‹CŠÇ“à‹zˆø‰t’†‚ÌŠeŽíƒƒfƒBƒG[ƒ^[‚Ì„ˆÚ. Œ´^lC”~Œ´ŽÀC–¥‰YŽ‘¥CŽl‘q³”ŽCŠÖª“OC•Ÿ“‡’‹`C’†“ˆ‰p•FC¼‰YM•viŽ™j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15j, •ÄŽq, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 241, 1998.

1930. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –k—¢‘åŠw•a‰@¬Ž™‰È‚É‚¨‚¯‚é“”–û”x‰Š‚Ì—Õ°“IŒŸ“¢. •Ÿ“‡’‹`C”~Œ´ŽÀCŒ´^lC–¥‰YŽ‘¥CŽl‘q³”ŽCŠÖª“OC’†“ˆ‰p•FC¼‰YM•viŽ™j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15j, •ÄŽq, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 246, 1998.

1931. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž©‘RŠ°‰ð‚µ‚½WestÇŒóŒQ‚Ì‚S—á. Šâèr”VCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ˆäŒ¤“ñC•ÐŽR•¶•FiŽ™j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15j, ’¹Žæ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 254, 1998.

1932. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ׋۫‘–Œ‰Š‚É‚¨‚¯‚é‘¢‰eMRI‚Ì—L—p«‚ɂ‚¢‚Ä. ”’ˆäGKC“‡ŠÑˆèCŽO{—zŽqC•~“‡NŽjC–x“c‰p•vC–xŒû‘דTiŽ™jC‘å–î’B’ji¹˜H‰Áj: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15j, ’¹Žæ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 259, 1998.

1933. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ä`‘ÑŒŒ’PŠj×–E‚Ì“¯Ží×–EŠQŠˆ«‚ÆIL12‚̉e‹¿‹y‚Ñ×–E•\–ÊRŒ´‚̉ðÍ. •~“‡NŽjC²”Œ•q—ºCì–ì–LC–ìŠÔ„C¼‰YM•viŽ™j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15`17j, •ÄŽq, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 304, 1998.

1934. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œ’Nl––½ŒŒ—R—ˆ’PŠj×–E‚æ‚èŽY¶‚³‚ê‚éRŒ´“ÁˆÙ“IIgE‚̃qƒXƒ^ƒ~ƒ“—V—£ì—p. –ìŠÔ„Cì–ì–LC’†ª˜aŽqC¼‰YM•viŽ™jC–ؑ‹Pi’•ƒŽs—§•a‰@jC•½”ü–çŽqiŒ`‘ÔŒnj: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15`17j, •ÄŽq, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 325, 1998.

1935. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹CŠÇŽxšb‘§Š°‰ðŠ³ŽÒ‹y‚ÑŒ’NŽÒ—R—ˆ‚̃_ƒjRŒ´“ÁˆÙ“I‚s×–EƒNƒ[ƒ“‚Ì”äŠr. ì–ì–LC–ìŠÔ„CÎì‹`lC¬ì—ÏŽjC•~“‡NŽjC²”Œ•q—ºC¼‰YM•viŽ™j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15`17j, •ÄŽq, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 326, 1998.

1936. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ_ƒj—U”­¬Ž™‹CŠÇŽxšb‘§Š³Ž™‚É‚¨‚¯‚éinterferon-gŽY¶”\‚ɂ‚¢‚ẲðÍ. ŽRŠÝ—¢’ÃŽqC¬ì—ÏŽjCÎì‹`lC²”Œ•q—ºC•~“‡NŽjCì–ì–LC–ìŠÔ„C¼‰YM•viŽ™j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15`17j, •ÄŽq, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 326, 1998.

1937. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Granulocyte-clony stimulating factor (G-CSF)‚ɂĉÁ—µ‘¢ŒŒ‚RŒn“×–E‚Ì‘‰Á‚ð”F‚ß‚½Ä¶•s—Ç«•nŒŒŠ³Ž™œ‘×–EˆŸŒQ‚ÌG-CSFŽó—e‘̂̉ðÍ. ¬ì—ÏŽjCÎì‹`lC²”Œ•q—ºC•~“‡NŽjCì–ì–LC–ìŠÔ„C¼‰YM•viŽ™j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15`17j, •ÄŽq, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 351, 1998.

1938. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒoƒ‹[ƒ“Šg‘åpŒã11”N‚ðŒo‰ß‚µ‚½‘å“®–¬kõ‚Ì‚P—á, ’´‚‘¬CT‚É‚æ‚éŽOŽŸŒ³•]‰¿‚ð’†S‚É. –xŒû‘דTC•½Î‘CŽO‘òmŽiC“¡–ìé”VCL“c•l•vC•“cM—TiŽ™j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15j, •ÄŽq, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 357, 1998.

1939. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘哤•‰‰×ŽŽŒ±—z«‚ðŽ¦‚µ‚½H‰aƒAƒŒƒ‹ƒM[Š³Ž™‚É‚¨‚¯‚é‘哤RŒ´“ÁˆÙ“IIL-2”½‰ž«ŒŸ¸(AIR)‚Ì—Õ°“IˆÓ‹`. –ؑ‹Pi’•ƒŽs—§•a‰@jCì–ì–LC–ìŠÔ„iŽ™jCŽRŒûŒöˆêC”nêŽÀi“¯ˆ¤‹L”O•a‰@j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.15`17j, •ÄŽq, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 393, 1998.

1940. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •ÂÇ«–³ŒÄ‹z‚𔺂¤‚“x”ì–žŽ™‚É, ‹}«Ž…‹…‘Ìt‰Š‚É‚æ‚é‚ŒŒˆ³«”]Ç‚ð”F‚ß‚½‚P—á. “‡ŠÑˆèC”’ˆäGKC•~“‡NŽjCŽO{—zŽqCŽO‰YŽõ’jiŽ™j: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.16j, ’¹Žæ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 296, 1998.

1941. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –«DŽ_‹…«”x‰Š‚Ì‚P—Ž™—á. Î앶ŽqC”~Œ´ŽÀCŒ´^lC‰z–ì_]C–¥‰YŽ‘¥Câ“Œ—R‹IC’†“ˆ‰p•FC¼‰YM•viŽ™jC•i“cƒC‹{‰i–ÎŽ÷i‹¹ŠOj: ‘æ101‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i98.05.17j, •ÄŽq, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 102(3): 195, 1998.

1942. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j IDDMŠ³ŽÒŒŒ´‚æ‚ècoxackie virus (cox B)“ÁˆÙ“IRNA‚ÌŒŸo‚ÌŽŽ‚Ý. –쌳‚¯‚¢Žqi¶‰»ŒnjC‘å’ì”VC•—’£KŽiC•—’£^—R”üiŽ™jCŽÄŽRŒ[ŽqC‰¡“csŽjC‘åŽR‹XGC¼‰YM•viŽ™j: ‘æ41‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï i98.05.20`22j, ˜a‰ÌŽR, “œ”A•a, 41(Suppl.): 332, 1998.

1943. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™Šú”­ÇIDDMŽ™‚Ì“œ”A•a‡•¹Ç. ¬’r–¾”üC‰ª‘º‹ÅŽqC”ª\“ˆOˆêC‚‹´–Li“l“ì•a‰@jC¼‰YM•viŽ™j: ‘æ41‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï i98.05.20`22j, ˜a‰ÌŽR, “œ”A•a, 41(Suppl.): 485, 1998.

1944. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‡TŒ^“œ”A•a‚É‚¨‚¯‚éäXŽ©ŒÈR‘Ì‚Æ”­Ç”N—î‹y‚Ñ”­Ç—lŽ®‚Æ‚ÌŠÖ˜A. ¢—…N“¿Cìè‰p“ñC‘ë–씎•¶C”öè•ûŽqCˆÀ•”KOCŽðŠªGsC‹ß“¡‰p–¾CŽRè_‘¥CŽRŒû‹`•FCÔàVºˆêC’·‘êdMi’·è‘åjC“àŠƒˆÀŽqi“Œ—ˆã‘åjC¼ ‰YM•viŽ™jC]ŒûŸ”üi’·è‘åj: ‘æ41‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï i98.05.20`22j, ˜a‰ÌŽR, “œ”A•a, 41(Suppl.): 495, 1998.

1945. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’ág’·‚ð’悵‚½XYYÇŒóŒQ‚É‚¨‚¯‚é“à•ª”å“IŒŸ“¢. ‘å’ì”VC‰¡“csŽjC¼‰YM•viŽ™j: ‘æ71‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï i98.06.04`06j, •Ÿ‰ª, “ú–{“à•ª”åŠw‰ïŽGŽ, 74(1): 149, 1998.

1946. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™ƒoƒZƒhƒE•a‚É‚¨‚¯‚éTSAb, TRAb’l‚Ì’è—Ê“IŒŸ“¢. ŽÄŽRŒ[ŽqC‘åŽR‹XGC‰¡“csŽjC•—’£KŽiC•—’£^—R”üC¼‰YM•viŽ™j: ‘æ71‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï i98.06.04`06j, •Ÿ‰ª, “ú–{“à•ª”åŠw‰ïŽGŽ, 74(1): 168, 1998.

1947. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘å“®–¬‹|—£’f‚É‘æ‚T‘å“®–¬‹|ˆâŽc‚¨‚æ‚Ñ“¯•”‚Ékó‚ð‡•¹‚µ‚½“ûŽ™—á. ¬ì‰ÄŽqCŽO‘òmŽiC•½Î‘C•“cM—TC“¡–ìé”VC–xŒû‘דTiŽ™jCŠ}Œ´^ŒåC’†]¢–¾i‹¹ŠOj: ‘æ34‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï i98.07.22j, “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 14(2): 348, 1998.

1948. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ìè•a‚ÌŠ¥“®–¬‹·ó«•a•Ï‚Ìf’fi‘æ‚P•ñ)’´‰¹”g’f‘w–@i7.5 MHz)‚É‚æ‚é•`o‚Æ‚»‚̸“x. •½Î‘CŽO‘òmŽiC•“cM—TC–xŒû‘דTC“¡–ìé”VC¬ì‰ÄŽqiŽ™j: ‘æ34‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï i98.07.22j, “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 14(2): 351, 1998.

1949. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰Æ‘°«‚ƒRƒŒƒXƒeƒ[ƒ‹ŒŒÇ‚É‚¨‚¯‚é“®–¬d‰»ŠŒ©|’´‚‘¬CT‚É‚æ‚é•]‰¿|. –xŒû‘דTC•½Î‘CŽO‘òmŽiC“¡–ìé”VC•“cM—TiŽ™j: ‘æ34‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï i98.07.23j, “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 14(2): 357, 1998.

1950. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Lipo-prostagrandin E1’ᔽ‰ž—á‚Ì‹@˜i‘æ‚P•ñ)|Œ`‘Ô–Ê‚©‚ç‚ÌŒŸ“¢|. •“cM—TC•½Î‘Cãp—z‘¾˜YCŽO‘òmŽiC–xŒû‘דTCL“c•l•vC‰Í‘º½“ñC¬ì‰ÄŽqiŽ™jC’†]¢–¾CŠ}Œ´TŒái‹¹ŠOj: ‘æ34‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï i98.07.23j, “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 14(2): 382, 1998.

1951. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™‚È‚ç‚Ñ‚ÉŽvtŠú”N—î‚Ä‚ñ‚©‚ñŠ³ŽÒ‚É‚¨‚¯‚écarbamazepine‚È‚ç‚Ñ‚Écarbamazepine-10,11-epoxide‚Ì—V—£Œ^ŒŒ’†”Z “x‚ÉŠÖ‚·‚錤‹†. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ˆäŒ¤“ñC•ÐŽR•¶•FCŠâèr”ViŽ™j: ‘æ8‰ñ“ú–{—Õ°¸__Œo–ò—Šw‰ï i98.09.18j, ŽD–y, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.91, 1998.

1952. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j • o‚Ö‚Ì’`”’˜Ro‚É‚æ‚莀–S‚µ‚½Idiopathic CD4 deficiency‚Ì‚P—á. ¬ì—ÏŽjC–ìŠÔ„Cì–ì–LC•~“‡NŽjC²”Œ•q—ºCÎì‹`lC¼‰YM•viŽ™j: ‘æ40‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï i98.11.11`13j, ‹à‘ò, —Õ°ŒŒ‰t, 39(10): 1040, 1998.

1953. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒAƒfƒmƒEƒCƒ‹ƒX‚VŒ^‚É‚æ‚éƒEƒCƒ‹ƒXŠÖ˜AŒŒ‹…æÃHÇŒóŒQ(VAHS)‚Ì‚RÇ—á. Îì‹`lC–ìŠÔ„C¬ì—ÏŽjC•~“‡NŽjC²”Œ•q—ºC’†ŠÚ®–çCì–ì–LC¼‰YM•viŽ™j: ‘æ40‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï i98.11.11`13j, ‹à‘ò, —Õ°ŒŒ‰t, 39(10): 932, 1998.

1954. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒeƒŒƒrŽ‹’®’†‚ÉŽ‹ŠoáŠQ‚ ‚é‚¢‚͈ӎ¯áŠQ‚ð”F‚ß, “–‰@ŠO—ˆ‚ðŽóf‚µ‚½Œõ‰ß•q«‚Ä‚ñ‚©‚ñ‚Ì‚Q—Ž™—á. “‡ŠÑˆèCŽO{—zŽqC•~“‡NŽjC”’ˆäGKiŽ™jC‘å–î’B’ji¹˜H‰Áj: ‘æ232‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i98.04.25), ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 26(1): 123, 1999.

1955. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰ÄŒ^‰ß•q«”x‰Š‚Ì‚P’jŽ™—á. ¯–ì’Œ[CŽRŠÝ—’ÃŽqC¬ì‰ÄŽqC‘å“c„•äCŒ´^lC”~Œ´ŽÀCâ“Œ—R‹IC¼‰YM•viŽ™j: ‘æ233‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï i98.06.20j, ‰¡•l.

1956. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”­”M—U”­‚¯‚¢‚ê‚ñŒãˆê‰ß«Ž‹—ÍáŠQ“™”ñ“ÁˆÙ“IÇó‚ð”F‚ß‚½ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚`(H3N2)Š´õÇ‚Ì‚V—á. –ì–{Œ÷ˆêiŠƒ–è“¿F‰ïjC”’ˆäGKC“‡ŠÑˆèC•~“‡NŽjC–x“c‰p•vCŽO{—zŽqiŽ™jCŠÛŽRŸ•FC‘弌b—ŽqiŠƒ–è“¿F‰ïj: ‘æ233‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i98.06.20j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 26(1): 125, 1999.

1957. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ä”­Žž‚ÉdÇS‹Ø‰ŠE”]‰ŠEŠÌ‰Š“™‚Ì‘½Ê‚ÈÇó‚ð’悵‚½ìè•a‚Ì‚P—á. çÝŽŠwCŽRŠÝ—¢—¥ŽqC¼‘º^—¢ŽqCÎì‹`lC‰¡“csŽjC¬ì‰ÄŽqC•“cM—TCŽO‘òmŽiC•½Î‘iŽ™j: “ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï i98.09.19j, ‰¡•l.

1958. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¬Ž™‹}«ƒŠƒ“ƒp«”’ŒŒ•a‚Ì’·Šú¶‘¶—á‚ÌŒŸ“¢. •½ŽRƒnƒ‹ƒiC’†ŠÚ®–çC–ìŠÔ„C¼‰YM•viŽ™j: ‘æ235‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i98.10.14j, ‰¡•l, ´˜^W.

1959. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚顉Ăɗ¬s‚µ‚½–³‹Û«‘–Œ‰Š‚ɂ‚¢‚Ä|¬l—á‚àŠÜ‚ß‚Ä|. Z’J[OiŠƒ–è“¿F‰ïjC”’ˆäGKC“‡ŠÑˆèC•~“‡NŽjC–x“c‰p•viŽ™jCŠâØ•¶C^–ì•×iŠƒ–è“¿F‰ïj: ‘æ235‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i98.11.14j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 26(2): 1999.

1960. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j FrasierÇŒóŒQ‚Æl‚¦‚ç‚ꂽ‚P—Ž™—á. “y‰®³ŒÈC‹g쇎qC‘å‹´—²Ž¡C—§–ƒ“TŽqCˆÀ•Û˜arC‹ž‘œŒb”üŽqC‘ºã–r”üC’Óc³•FCŽç‰®r‰îC”Ñ‚Šì‹v—YiŽ™j: ‘æ28‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï i98.11.20j, “Œ‹ž, “ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ïŽ, 40(6): 489, 1998.

1961. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¸_”­’B’x‰„‚𔺂¤æ“V«•›t’áŒ`¬‚ÌŒZ’í—á. ŽR–Ø–ƒŽqC‹ÊˆäLÆCŒã“¡—ºCŠÖª“OC”Ñ‚Šì‹v—YiŽ™j: ‘æ236‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï i99.02.20j, ‰¡•l.

1962. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”½•œ‚·‚é”­”M—U”­‚¯‚¢‚ê‚ñ‚ð‰”­Çó‚Æ‚µ‚½ìè•a‚Ì9‚©ŒŽ—Ž™—á. ŠâØ•¶iŠƒ–è“¿F‰ïjC”’ˆäGKC“‡ŠÑˆèC•~“‡NŽjC–x“c‰p•vC–xŒû‘דTiŽ™jC‘D“c˜a‰ÁiŠƒ–è“¿F‰ïj: ‘æ236‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i99.02.20j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 26(2): 1999.

1963. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œ€Ç—n˜A‹ÛŠ´õÇ‚Ì‚P—Ž™—á. –x“c‰p•vC”’ˆäGKC“‡ŠÑˆèC•~“‡NŽjC•y‰Á’É떤iŽ™jC“à“c—TŽiC¼Œ´TiŠƒ–è“¿F‰ïj: ‘æ237‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i99.03.20j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 26(2): 1999.

1964. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Å‹ß‚R”NŠÔ‚ÉŒoŒ±‚µ‚½”]ŽºŽüˆÍ”’Žº“ǂɔº‚µ‚½WestÇŒóŒQ‚Ì—\Œã. Šâèr”VCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ˆäŒ¤“ñC•ÐŽR•¶•FiŽ™j: ‘æ30‰ñ“ú–{¬Ž™_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i99.03.27j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.25, 1999.

1965. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j •p‰ñÄ”­Œ^ƒlƒtƒ[ƒ[ÇŒóŒQ‚ɑ΂·‚éƒVƒNƒƒXƒ|ƒŠƒ“—Ö@’†‚Éáz¹‚𗈂µ‚½10Î’jŽ™—á. –{ŽRŽ¡Cd•x‚ä‚©‚èi“Œ–M‘åjC”Ñ‚Šì‹v—YiŽ™j: ‘æ28‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï i98.11.20j, “Œ‹ž, “ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ïŽ, 40(6): 516, 1998.

1966. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j PCR–@‚É‚æ‚éƒRƒAƒOƒ‰[ƒ[Œ^•Ê. –ìXŽRŸliŽ™jC‹v‰ä–¾’jCˆä㼋vi”÷j: ‘æ43‰ñƒuƒhƒE‹…‹ÛŒ¤‹†‰ï i98.09.10j, “Œ‹ž.

1967. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j ‚Ä‚ñ‚©‚ñŽ¡—ÂÆTDM; ‚Ä‚ñ‚©‚ñ‚ÆTDM. ŽO‰YŽõ’jiŽ™j: ‘æ25‰ñ–ò•¨Ž¡—ƒjƒ^ƒŠƒ“ƒOŒ¤‹†“Á•Êƒ[ƒ~ƒi[ƒ‹ i98.09.06j, “Œ‹ž, ‘æ25‰ñ–ò•¨Ž¡—ƒjƒ^ƒŠƒ“ƒO“Á•Êƒ[ƒ~ƒi[ƒ‹u‹`˜^: Clinical Pharmacokinetics‚Ì—˜_‚ÆŽÀÛ, ‚V•Å•ª, 1998.

1968. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŠÇ—‚Ì‚½‚ß‚É; 1.IDDM‚ÌŠÇ—. ¼‰YM•viŽ™j: ‘æ32‰ñ“œ”A•aŠw‚Ìi•à i99.02.20`21j, å‘äŽs, ƒvƒƒOƒ‰ƒ€Eu‰‰—vŽ|, p.101, 1999.

1969. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ¬Ž™EŽvtŠú“œ”A•aŠÇ—‚Ì–â‘è“_; 1.—cŽ™‚©‚笎™Šú. ¼‰YM•viŽ™j: ‘æ33‰ñ“œ”A•aŠw‚Ìi•à i99.02.26`27j, •xŽRŽs.

1970. mŒ¤‹†‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŠwZŒŸ”AƒVƒXƒeƒ€‚ÌŒ»ó; ‰¡•lŽs‚É‚¨‚¯‚éŠwZŒŸ”AƒVƒXƒeƒ€. ”Ñ‚Šì‹v—YiŽ™jC“¡Œ´–Fli_“Þ쌧—\–hˆãŠw‹¦‰ïj: ‘æ‚P‰ñŠw“¶t‘Ÿ•aŒŸfŒ¤‹†‰ï i99.02.20j, “Œ‹ž.

1971. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é‹s‘Ò–hŽ~ƒVƒXƒeƒ€. ’†ŠÚ®–çC“à“¡„•FC‘¾“c„•äC¼‰YM•viŽ™jC–ìè—SŽqC“í–{‹v”üŽqC²“¡‚ä‚©‚èiŠÅŒì•”jC²“¡ç•äŽqi¸jC–@—R”üŽqi‘‡‘Š’k•”j: ‘æ4‰ñ“ú–{Žq‚Ç‚à‚Ì‹s‘Ò–hŽ~Œ¤‹†‰ïŠwpW‰ï˜a‰ÌŽR‘å‰ï i98.00.00`00j, ˜a‰ÌŽR, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.61, 1998.

1972. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ˆã—Ë@ŠÖ‚Å”­Œ©‚³‚ꂽ‹s‘ÒŽ–—á|Ä”­–hŽ~‚Ö‚ÌŽæ‘g‚Ý|. ²“¡ç•äŽqi¸jC“à“¡„•FC’†ŠÚ®–çiŽ™jC–ìè—SŽqC“í–{‹v”üŽqC²“¡‚ä‚©‚èiŠÅŒì•”jC–@—R”üŽqi‘‡‘Š’k•”j: ‘æ4‰ñ“ú–{Žq‚Ç‚à‚Ì‹s‘Ò–hŽ~Œ¤‹†‰ïŠwpW‰ï˜a‰ÌŽR‘å‰ï i98.00.00`00j, ˜a‰ÌŽR, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.67, 1998.

1973. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j WestÇŒóŒQ‚ɑ΂·‚éƒrƒ^ƒ~ƒ“B6‘å—Ê‚P“ú‚S•ªŠ„“Š—^–@‚ÌŽŽ‚Ý. •ˆäŒ¤“ñCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèCŠâèr”VC•ÐŽR•¶•FiŽ™j: ‘æ‚P‰ñ“û—cŽ™‚¯‚¢‚ê‚ñŒ¤‹†‰ï i98.04.04j, “Œ‹ž, ¬Ž™‰È—Õ°, 52(1): 142, 1999.

1974. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒoƒ‹ƒ“Šg‘åpŒã12”NŠÔŒo‰ß—ÇD‚È‘å“®–¬kó‚Ì‚P—á. –xŒû‘דTC•½Î‘CŽO‘òmŽiC“¡–ìé”VCL“c•l•vC•“cM—TiŽ™j: ‘æ10‰ñJapan Pediatric Interventional CardiologyŒ¤‹†‰ï i99.01.30j, “Œ‹ž.

1975. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰¡–ä‹ØŽî‚QÇ—á‚ÌŽ¡—ÃŽwj. Šâ”g’¼”üC•½Î‘CŽO‘òmŽiC•“cM—TC¬ì‰ÄŽqC¬ŒûO‹BiŽ™j: ‘æ‚T‰ñ“ú–{‘ÙŽ™S‘Ÿ•aŒ¤‹†‰ï i99.02.20j, •Ÿ‰ª.

1976. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j “úíf—Âɂ¨‚¯‚鬎™ŒÄ‹zŠíŽ¾Š³. ”~Œ´ŽÀiŽ™j: ‘æ196‰ñ‰¡•l¼•”¬Ž™‰Èˆã‰ï i98.00.00j, ‰¡•l.

1977. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”x“®–¬iNp‚ª–³Œø‚Å‚ ‚Á‚½’PS–[, S•s‘S‚Ì‚PÇ—á. •“cM—TC¬ì‰ÄŽqCŽO‘òmŽiC•½Î‘iŽ™j: ‘æ20‰ñ_“Þ쬎™zŠÂŠí’k˜b‰ï i98.04.11j, ‰¡•l, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 14(5): 728`729, 1998.

1978. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹}Œƒ‚ÈŒo‰ß‚ð‚½‚Ç‚Á‚½‰EŽº“àŽîᎂƔx‚ŒŒˆ³‚Ì‚P—Ž™—á. •“cM—TC¬ì‰ÄŽqCŽO‘òmŽiC•½Î‘iŽ™j: ‘æ20‰ñ_“Þ쬎™zŠÂŠí’k˜b‰ï i98.04.11j, ‰¡•l, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 14(5): 729, 1998.

1979. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹»–¡[‚¢ŒŒs“®‘Ô‚ðŽ¦‚µ‚½‘å“®–¬‹|—£’f, “®–¬ŠÇŠJ‘¶, ‘æ5éÒ‹|ˆâŽc‚¨‚æ‚Ñ‘¤•›ŒŒs˜H‚ð—L‚µ‚½‚P—á. ¬ì‰ÄŽqC•½Î‘CŽO‘òmŽiC•“cM—TiŽ™j: ‘æ20‰ñ_“Þ쬎™zŠÂŠí’k˜b‰ï i98.04.11j, ‰¡•l, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 14(5): 729, 1998.

1980. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŋߌoŒ±‚µ‚½×‹Û«‘–Œ‰Š‚̉摜f’f|‘¢‰eMRI‚Ì‘–Œ‘‹­Œø‰Ê‚ð’†S‚É|. ”’ˆäGKC“‡ŠÑˆèC•~“‡NŽjC–x“c‰p•vCŽO‰YŽõ’jiŽ™j: ‘æ22‰ñ_“Þ쬎™_Œo§˜b‰ï i98.07.04jC ‰¡•l, ´˜^W, p.4, 1998.

1981. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒrƒfƒIƒQ[ƒ€‚ªuƒ|ƒPƒ‚ƒ“vŽ‹’®‚É‚æ‚èŒõŠ´Žó«”­ì‚ð‹N‚±‚µ‚½¬Ž™‚Ì‘MŒõ•ŠŠˆ”]”gŠŒ©‚É‚¨‚æ‚Ú‚·‰e‹¿. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ˆäŒ¤“ñC•ÐŽR•¶•FCŠâèr”ViŽ™j: ‘æ42‰ñ_“Þì‚Ä‚ñ‚©‚ñ§˜b‰ï i98.07.18j, ‰¡•l.

1982. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Å‹ß3”NŠÔ‚ÉŒoŒ±‚µ‚½”]ŽºŽüˆÍ”’Žº“ǂɔº‚µ‚½WestÇŒóŒQ‚Ì—\Œã. Šâèr”VCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ˆäŒ¤“ñC•ÐŽR•¶•FiŽ™j: ‘æ23‰ñ_“Þ쬎™_Œo§˜b‰ï i99.01.23j, ‰¡•l, ´˜^W, p.8, 1999.

1983. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹}Œƒ‚Éd–Œ‰º…Žî‚ªoŒ»‚µ‚½ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‹Û‘–Œ‰Š‚Ì‚P—Ž™—á. “à“c—TŽiiŠƒ–è“¿F‰ïjC”’ˆäGKC“‡ŠÑˆèC•~“‡NŽjC–x“c‰p•viŽ™jC¼Œ´TiŠƒ–è“¿F‰ïjC‘å–î’B’ji¹˜H‰Áj: ‘æ23‰ñ_“Þ쬎™_Œo§˜b‰ï i99.01.23j, ‰¡•l, ´˜^W, p.8, 1999.

1984. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¬Ž™Šú”­ÇŠoÁŽž‘å”­ì‚Ä‚ñ‚©‚ñ‚Ì’f–òŒã‚Ì”­ìÄ”­—á. •ˆäŒ¤“ñCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝC“‡ŠÑˆèC•ÐŽR•¶•FCŠâèr”ViŽ™j: ‘æ43‰ñ_“Þì‚Ä‚ñ‚©‚ñ§˜b‰ï i99.01.30j, ‰¡•l.

1985. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj ‚±‚Ç‚à‚Ì‚Ä‚ñ‚©‚ñ‚𳂵‚­—‰ð‚·‚邽‚ß‚É. ŽO‰YŽõ’jiŽ™j: “ú–{‚Ä‚ñ‚©‚ñ‹¦‰ï_“Þ쌧Žx•”‚UŒŽ—á‰ï i98.6.21j, ‘Š–ÍŒ´, ‚±‚Ç‚à‚Ì‚Ä‚ñ‚©‚ñ‚𳂵‚­—‰ð‚·‚邽‚ß‚É, p.1`20.

1986. mŠw‰ïŽåÃi‘“àŠw‰ïjn ‘æ31‰ñ“ú–{¬Ž™“à•ª”åŠw‰ïE‰ï’·i98.10.02`03j ¼‰YM•viŽ™j.

1987. mŠw‰ïŽåÃi‘“àŠw‰ïjn ‘æ32‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ïi98.10.09`10.10j, ‰¡•l ŽO‰YŽõ’jiŽ™j.

1988. mŠw‰ïŽåÃi‘“àŠw‰ïjn ‘æ31‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ïE‰ï’·, ”~Œ´ŽÀiŽ™j.

1989. mŠw‰ïŽåÃi‚»‚Ì‘¼jn ‘æ14‰ñ“œ”A•a‚Æ”DP‚ÉŠÖ‚·‚錤‹†‰ïE“–”Ô¢˜bli98.11.28j ¼‰YM•viŽ™j.


<<19 ŽY‰ÈŠw>>

1990. mŒ´’˜n Elective induction at 39 weeks of gestation: A prospective randomized trial. “V–슮CÄ“¡ŽC¯“c—²C’Jº”ŽC‹gŒ´ˆêC¼“‡³”ŽiŽY•wj: J. Obstet. Gynaecol. Res., 25(1): 33`37, 1999.

1991. mŒ´’˜n l‚Ì•ª•Ø‚ɂ͉½ŒÌŠÄŽ‹‚ÆŠÇ—‚ª•K—v‚©. “‡“cMGiŽY•wj: ŽüŽYŠúˆãŠw, 28(12): 1639`1641, 1998.

1992. mŒ´’˜n •ê‘Ì”À‘—‚ÌŒ»ó|_“Þ쌧–k‘Š’n‹æ‚É‚¨‚¯‚錻ó‚Æ–â‘è“_. Vˆä—zŽqC‹{—¢˜aŽqiŠÅŒìŠw•”jCÄ“¡ŽC“V–슮C¼“‡³”ŽiŽY•wj: _“Þì•ê«‰q¶Šw‰ïŽ, 2(1): 31`35, 1999.

1993. mŒ´’˜n ‘ÙŽ™“®–¬ŒŒŽ_‘f–O˜a“xiF-SpO2jƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì—L—p«‚ƈÀ‘S«. “V–슮C•½–ì‘ŽqC¼“‡³”ŽiŽY•wjC‰J‹{´C—é–ØŒ’Ž¡i‚¯‚¢‚䂤•a‰@j: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽ, 50(7): 389`395, 1998.

1994. mŒ´’˜n Monitoring of fetal arterial oxygen saturation during labour anal gesia. “V–슮C¼“‡³”ŽiŽY•wjC—é–ØŒ’Ž¡iŒx—F•a‰@j: –k—¢ˆãŠw, 29(1): 24`31, 1999.

1995. m€Œ´’˜n ŽüŽYŠúŠwƒVƒ“ƒ|ƒWƒEƒ€; 16i“ú–{ŽüŽYŠúŠw‰ï‘æ16‰ñŠwpW‰ïjŽq‹{“àŠ´õ‚Ì—\’m. ’Jº”ŽC‹g“ck‘¾˜YC¡ˆä‰ë•vC“cŒû‰ë”VCrˆä’‰ŽmC‘OŒ´‘å‰îC‹àˆä—Y“ñCVˆä–±CìŒû”ü˜aCÄ“¡ŽC¯“c—²C‹gŒ´ˆêC“V–슮C“‡“cMGC¼“‡³”ŽiŽY •wjCŽsìŒbŽqi¶‰»Œnj: ŽüŽYŠúƒVƒ“ƒ|ƒWƒEƒ€, (16): 101`110, 1998.

1996. mŒ¤‹†•ñiŒú¶Èjn ”DŽYåñ•w‚ւ̃Gƒ‚[ƒVƒ‡ƒiƒ‹ƒTƒ|[ƒg‚ÉŠÖ‚·‚鑽Ž{Ý‹¤“¯Œ¤‹†|Œ¤‹†‚ÌŠT—v‚Æ”DPŠúŠÔ’†‚Ì—}‚¤‚ÂÇó¥•sˆÀÇó‚̊댯ˆöŽq|. –k‘ºr‘¥C‰ª‘ºB”Ži“Œ–k‘åjC–؉ºŸ”VCH“¡®•¶C²“¡¹ŽiC¼“‡³”ŽiŽY•wjC’†–ìm—Y: Œú¶ÈSgáŠQŒ¤‹†u‚±‚ê‚©‚ç‚Ì”DŽYåñ•w‚ÌŒ’NŠÇ—ƒVƒXƒeƒ€‚ÉŠÖ‚·‚錤‹†v•½¬9”N“xŒ¤‹†•ñ‘, p.25`44, 1998.

1997. mŒ¤‹†•ñiŒú¶Èjn ”D•w‚Ì”DP’†‚Ì•sˆÀ‚ª•ª•Ø—\Œã‚É—^‚¦‚é‰e‹¿. ¼“‡³”ŽC‹gŒ´ˆêiŽY•wj: Œú¶ÈSgáŠQŒ¤‹†u‚±‚ê‚©‚ç‚Ì”DŽYåñ•w‚ÌŒ’NŠÇ—ƒVƒXƒeƒ€‚ÉŠÖ‚·‚錤‹†v•½¬9”N“xŒ¤‹†•ñ‘, p.49`50, 1998.

1998. mÇ—á•ñn æ“V«H“¹•Â½Ç‚Æ‹CŠÇH“¹á‘‚Ì‚P—á. ’F‰pŽ÷iŽY•wj: ŽüŽYŠúˆãŠw, 29(3): 347`350, 1999.

1999. m‘àn —r…ÇðÇ. ’Jº”ŽiŽY•wj: ƒyƒŠƒlƒCƒ^ƒ‹ƒPƒA, 17(4): 318`322, 1998.

2000. m‘àn ŽŸ‰ñ”DP‚ւ̃AƒhƒoƒCƒX|”÷Žãw’É. ‹gŒ´ˆêiŽY•wj: ŽY‰È‚Æ•wl‰È, 65(11): 1510`1513, 1998.

2001. m‘àn ‘ÙŽ™•”ˆÊ•Ê‰æ‘œf’f|‹¹•”‚Æ‚»‚̈Ùí¥ƒGƒR[. ‹gŒ´ˆêiŽY•wj: ŽY‰È‚Æ•wl‰È, 65(‘): 297`302, 1998.

2002. m‘àn ‘ÙŽ™‚Ì“ª•”ŠïŒ`‚Ì’´‰¹”gf’f. ‹gŒ´ˆêCŠÖ–{—»•½C‹gŒ´‹žŽqiŽY•wj: ŽY•wl‰ÈŽ¡—Ã, 77(3): 252`257, 1998.

2003. m‘àn •ê“û‚Ì•ª”å‚ɉe‹¿‚ð—^‚¦‚é–òÜ. ‹gŒ´ˆêiŽY•wj: –ò‹Ç, 49(2): 33`36, 1998.

2004. muÀn –³’É•ª•Ø|d–ŒŠO–ƒŒ‚É‚æ‚é–³’É•ª•Ø, ’éØ‚Ì•p“x‚Í‚‚­‚È‚ç‚È‚¢. “V–슮iŽY•wj: LISA, 6(2): 152`155, 1999.

2005. muÀn —r…‚̶—‚Æ“®‘Ô. ¼“‡³”ŽC’Jº”ŽC‘O“c@“¿iŽY•wj: ƒyƒŠƒlƒCƒ^ƒ‹ƒPƒA, 17(11): 1032`1036, 1998.

2006. muÀn CST (Contraction Stress Test). ¼“‡³”ŽC“V–슮Crˆä’‰ŽmiŽY•wj: ŽY‰È‚Æ•wl‰È, 65: 1293`1299, 1998.

2007. muÀn ˆêŽ™Ž€–S‘½‘Ù”D•w‚ÌŽæ‚舵‚¢–@. “V–슮CÄ“¡ŽiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 47(6): 821`826, 1998.

2008. muÀn ‚킪‹³Žº‚É‚¨‚¯‚鑽‘Ù”DP‚ÌŠÇ—. ¼“‡³”ŽCÄ“¡ŽiŽY•wj: ŽY•wl‰ÈŽ¡—Ã, 77: 327`331, 1998.

2009. muÀn –³’É•ª•Ø‚ÌŒ»ó. ¼“‡³”ŽC¯–ì—TŽqiŽY•wj: ŽY•wl‰ÈŽ¡—Ã, 77: 521`524, 1998.

2010. muÀn w’É—U”­¥‘‹­‚̃ƒŠƒbƒg¥ƒfƒƒŠƒbƒg. ’Jº”ŽiŽY•wj: ŽüŽYŠúˆãŠw, 28(12): 1603`1607, 1998.

2011. muÀn •Øo‘ٔՂ̈—. ’Jº”ŽiŽY•wj: ŽüŽYŠúˆãŠw, 28(6): 813`814, 1998.

2012. muÀn ”A–ŒŠÇ”X–E. “‡“cMGiŽY•wj: ŽüŽYŠúˆãŠw, 29(2): 142`143, 1998.

2013. muÀn Š´õÇ‚Æ•ê‘ÌŽ€–S¥‚»‚Ì‘Îô. ¼“‡³”ŽC¯“c—²iŽY•wj: ŽüŽYŠúˆãŠw, 29: 213`217, 1998.

2014. muÀn _“Þ쌧ŽY‰È•wl‰Èˆã‰ï‚ÌŽüŽYŠú‹~‹}‘ÎôƒVƒXƒeƒ€iÀ’k‰ïj. •l“cGC¼“‡³”ŽiŽY•wjC²“¡Œ[Ž¡CŽR–{ŽŽqC‹{‰º”ü‘ãŽqC–L‘qߎq: •ŽY•wŽGŽ, 52: 396`403, 1998.

2015. muÀn ‹}‘¬‹•Øp. ¼“‡³”ŽiŽY•wj: “úŽY•w‰«“êŽ, 20: 6`14, 1998.

2016. muÀn ¶ŠU‹³ˆçƒVƒŠ[ƒY47; ¶‘Ì¥‹@”\ŒŸ¸‚ÌABC|•ª•ØŠÄŽ‹‘•’u‚É‚æ‚錟¸, ‘ÙŽ™S”w’É}(CTG). ¼“‡³”ŽiŽY•wj: “ú–{ˆãŽt‰ïŽGŽ, “Á•Ê†, 120(8): 260`262, 1998.

2017. muÀn Žq‹{Žûk—}§Ü‚̃ŠƒXƒN, ƒxƒlƒtƒBƒbƒg. ¼“‡³”ŽC’Jº”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽ, 50(3): 55`58, 1998.

2018. muÀn ”DP’†“ÅÇŠ³ŽÒ‚Ìf—Âɂ¨‚¯‚éŽÐ‰ï•ÛŒ¯ã‚Ì’ˆÓ“_‚Æ–â‘è“_. ’Jº”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽ, 51(1): 19`23, 1999.

2019. muÀn •ª•Ø‘æ1Šú‚ÌŽæ‚舵‚¢. ¼“‡³”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽ, Œ¤CƒR[ƒi[, 51(3): 63`66, 1999.

2020. muÀn ‰ßŠú”DP‚ÌŽæ‚舵‚¢|•ª•Ø”­—ˆ‹@˜‚ÌŽ‹“_‚©‚ç|‰ßŠú”DP@ƒ[ƒNƒVƒ‡ƒbƒv‚Q. ¼“‡³”ŽiŽY•wj: “ú–{V¶Ž™Šw‰ïŽGŽ, 34: 750`751, 1998.

2021. muÀn —«‚̈ãŠwÅ‘Oü, ‘æ15‰ñ–³’É•ª•Ø. ¼“‡³”ŽiŽY•wj: •wlŒö˜_, p.166`168, 1998.

2022. muÀn Cerircal adhesion. “V–슮iŽY•wj: —Õ°•wl‰ÈŽY‰È, 52(10): 1292`1294, 1998.

2023. muÀn ‘ŽY‚ÌŒ´ˆö‚Æ•a‘Ô. ¼“‡³”ŽC’Jº”ŽiŽY•wj: —Õ°•wl‰ÈŽY‰È, 52(5): 664`667, 1998.

2024. mŠwp‘n i•ª’SŽ·•Mj V—«ˆãŠw‘ÌŒn 25: ³í•ª•Ø; •ª•Ø‚Ì—Õ°Œo‰ß‚ÆŠÇ—, B.•ê‘ÌŠÇ—, 171`187, ¼“‡³”ŽiŽY•wj. •ÒW •’J—Y“ñi“Œ‘åjC‰ª‘ºB”Ži“Œ–k‘åjC•ÒC ’†ŽR‘“X, “Œ‹žC98.00.00”­s.

2025. mŠwp‘n i•ª’SŽ·•Mj •ª•Ø‰î•‚ÆŽüŽYŠúŠÇ—; w’ÉŽº‚ł̃PƒA: ˜a’É–@, p.77`81, ¼“‡³”ŽC’Jº”ŽiŽY•wj. •ÒW Ž›”ör•FC•ÒC ƒƒaƒJo”Å, ‘åãC98.09.05”­s.

2026. mŠwp‘n i•ª’SŽ·•Mj f—Ãã‚̃AƒNƒVƒfƒ“ƒg; Žö“û•w‚Ö‚Ì–ò•¨“Š—^‚Æ“ûŽ™‚ւ̉e‹¿, p.150`152, ¼“‡³”ŽC¯“c—²iŽY•wj. •ÒW –،p–«i“Œ–M‘åjC‘ë“c½Žiiº˜a‘åjC‘ºã–r”üi“úˆã‘åjC–î“cƒˆêi“ŒˆãŽ•‘åjC•ÒC ‹àŒ´o”Å, “Œ‹žC98.04.20”­s.

2027. mŠwp‘n i•ª’SŽ·•Mj V—«ˆãŠw‘ÌŒn23ˆÙí”DP; E.ŠÌ, ’_, äX, Á‰»ŠíŽ¾Š³, p.304`308, “V–슮iŽY•wj. •ÒW –ì•q”Ži“¿“‡‘åjC–ƒ¶•Žui“ŒˆãŽ•‘åjC’†–ìm—Yi‹ã‘åjC–ì‘òŽu˜NiŒc‘åjC²“¡Íi•Ÿ“‡ˆã‘åjC•ÒC ’†ŽR‘“X, “Œ‹žC98.07.31”­s.

2028. mŠwp‘n i•ª’SŽ·•Mj V—«ˆãŠw‘ÌŒn 23: ˆÙí”DP; “à•ª”厾Š³, p.387`395, “V–슮iŽY•wj. •ÒW –ì•q”Ži“¿“‡‘åjC–ƒ¶•Žui“ŒˆãŽ•‘åjC’†–ìm—Yi‹ã‘åjC–ì‘òŽu˜NiŒc‘åjC²“¡Íi•Ÿ“‡ˆã‘åjC•ÒC ’†ŽR‘“X, “Œ‹žC98.07.31”­s.

2029. mŠwp‘n i•ª’SŽ·•Mj ŽüŽYŠúˆã—ÂɕK—v‚È‹Ù‹}ˆ’u‚ƃPƒAƒ|ƒCƒ“ƒg; •ª•Ø’†‚Ì‘ÙŽ™‰¼Ž€‚ÆŽq‹{“à‘ÙŽ™‘h¶p, p.31`38, ’Jº”ŽCA–ìM…C“V–슮iŽY•wj. ƒƒfƒBƒJo”Å, ‘åãC98.09.30”­s.

2030. mŠwp‘n i•ª’SŽ·•Mj •ª•Ø‰î•‚ÆŽüŽYŠúŠÇ—; ˜a’É–@, p.77`81, ¼“‡³”ŽC’Jº”ŽiŽY•wj. •ÒW Ž›”ör•Fi•l¼ˆã‘åjC•ÒC ƒƒfƒBƒJo”Å, ‘åãC98.09.05”­s.

2031. mŠwp‘n i•ª’SŽ·•Mj ŽüŽYŠúˆã—ÂɕK—v‚È‹Ù‹}ˆ’u‚ƃPƒAƒ|ƒCƒ“ƒg; ’oŠÉoŒŒ, p.147`151, “‡“cMGiŽY•wj. •ÒW “‡“cMGiŽY•wjC•ÒC ƒƒfƒBƒJo”Å, ‘åãC98.09.30”­s.

2032. mŠwp‘n i•ª’SŽ·•Mj •ª•Ø‰î•ƒeƒNƒjƒbƒN; “ªˆÊ•ª•Ø‚Å‚Ì‘ÙŽ™•Øop‚ÌŠî–{, p.3`11, “‡“cMGiŽY•wj. •ÒW “‡“cMGiŽY•wjC•ÒC ƒƒfƒBƒJo”Å, ‘åãC98.08.20”­s.

2033. mŠwp‘n i•ª’SŽ·•Mj •ª•Ø‰î•ƒeƒNƒjƒbƒN; —U”­•ª•Ø‚ÉÛ‚µ‚Ä‹N‚±‚蓾‚釕¹Ç‚Æ‚»‚Ì‘Îô, p.244`250, “‡“cMGiŽY•wj. •ÒW “‡“cMGiŽY•wjC•ÒC ƒƒfƒBƒJo”Å, ‘åãC98.08.20”­s.

2034. mŠwp‘n i•ÒWj ŽüŽYŠúˆã—ÂɕK—v‚È‹Ù‹}ˆ’u‚ƃPƒAƒ|ƒCƒ“ƒg; •ÒW “‡“cMGiŽY•wjC•ÒC ƒƒfƒBƒJo”Å, ‘åãC98.09.30”­s.

2035. mŠwp‘n i•ÒWj •ª•Ø‰î•ƒeƒNƒjƒbƒNi‰ü’ù‚Qü); •ÒW “‡“cMGiŽY•wjC•ÒC ƒƒfƒBƒJo”Å, ‘åãC98.08.20”­s.

2036. m‹³‰È‘n i•ª’SŽ·•Mj •ê«ŠÅŒìŠw; p.34`219, “à–ì’¼Ž÷iŽY•wj. ˆãŠwŒ|pŽÐ, “Œ‹žC98.05.00”­s.

2037. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i’P’˜j ƒGƒ“ƒWƒ‡ƒC¥ƒ†ƒA”DPƒ‰ƒCƒt; “‡“cMGiŽY•wj. “ìŽR“°, “Œ‹žC99.01.06”­s.

2038. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj }àŽY•wl‰ÈVIEW-33’鉤؊Jp‚ÆŽY‰ÈŽè‹Z; ˜a’É¥–³’É•ª•Ø–@, p.114`123, “V–슮iŽY•wj. •ÒW ‰¬“cK—Yiã‘åjC–‘i“Œ–k‘åjCŒKŒ´Œc‹Ii‡‘åj•ÒC ƒƒWƒJƒ‹ƒrƒ…[, “Œ‹žC98.09.10”­s.

2039. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj –³’É•ª•Ø, p.46`47, ¼“‡³”ŽiŽY•wj. 98.10.00”­s.

2040. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Evaluation of fetal well-being by fetal pulse oximetry. ¼“‡³”ŽC“V–슮iŽY•wj: ‘æ10‰ñƒAƒWƒAƒIƒZƒAƒjƒAŽüŽYŠúŠw‰ï i98.10.27j, ƒ\ƒEƒ‹.

2041. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Study of neonetal bone mineral density. Έ䑸—YC“à–ì’¼Ž÷CA–ìM…C¼“‡³”ŽiŽY•wj: ‘æ10‰ñƒAƒWƒAƒIƒZƒAƒjƒAV¶Ž™Šw‰ï i98.10.25j, ƒ\ƒEƒ‹.

2042. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Žq‹{“àŠ´õ‚Æ‘ŽY; Žq‹{“àŠ´õ‚Ì—\’m. ’Jº”ŽC‹g“ck‘¾˜YC¡ˆä‰ë•vC“cŒû‰ë”VCrˆä’‰ŽmC‘OŒ´‘å‰îC‹àˆä—Y“ñCVˆä“wCìŒû”ü˜aCÄ“¡ŽC¯“c—²C‹gŒ´ˆêC“V–슮C“‡“cMGC¼“‡³”ŽiŽY •wjCŽsìŒbŽqi¶‰»Œnj: ‘æ16‰ñ“ú–{ŽüŽYŠúŠw‰ï i98.01.24j, _ŒË, Year Book of Japan Society of Perinatology, 16: 101`110, 1998.

2043. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‘OŠú”j…(PROM)‚ÌŽæ‚舵‚¢. “V–슮iŽY•wj: ‘æ50‰ñ“ú–{ŽY•wl‰ÈŠw‰ï i98.04.18j, å‘ä, “ú–{ŽY•wl‰ÈŠw‰ïŽGŽ, 50(9): 279`282, 1998.

2044. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‰ßŠú”DP‚ÌŽæ‚舵‚¢|•ª•Ø”­—ˆ‹@˜‚ÌŽ‹“_‚©‚ç; ƒL[ƒm[ƒgƒXƒs[ƒJ[. ¼“‡³”ŽiŽY•wj: ‘æ34‰ñ“ú–{V¶Ž™Šw‰ï i98.07.13j, •Ÿ‰ª.

2045. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj Šà‘ÙŽ™«ƒtƒBƒuƒƒlƒNƒ`ƒ“’è—Ê–@‚ð—p‚¢‚½•ª•ØŽžŠú‚Ì—\’m‚ÉŠÖ‚·‚錟“¢. ¡ˆä‰ë•vC’Jº”ŽCÄ“¡ŽC¯“c—²C‹gŒ´ˆêC“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ34‰ñ“ú–{V¶Ž™Šw‰ï i98.07.13j, •Ÿ‰ª, “ú–{V¶Ž™Šw‰ïŽ, 34(2): 234, 1998.

2046. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽYåñ¥Žö“ûŠú‚É‚¨‚¯‚霖§“x•Ï‰»‚ÉŠÖ‚·‚錟“¢. ª–{—æŽqC“à–ì’¼Ž÷C‘å‰ÍŒ´‘C–]ŒŽˆ¤˜YiŽY•wj: ‘æ50‰ñ“ú–{ŽY•wl‰ÈŠw‰ï‘‰ï i98.04.18j, å‘ä.

2047. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j AT‡V, ŒŒ¬”’ቺ‚ªŽ‘±‚µ‚½•i‘Ù‚Ì‚P—á. Vˆä“wC¯–ì—TŽqCÄ“¡ŽC“V–슮C¼“‡³”ŽC“à–ì’¼Ž÷iŽY•wj: 332‰ñ“ú–{ŽY•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï i98.05.16j.

2048. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘ÙŽ™ŠïŒ`Žî‚ÌŽüŽYŠúŠÇ—. rˆä’‰ŽmCŠâ‰i‹v”üCÄ“¡ŽC“V–슮C¼“‡³”ŽiŽY•wj: ‘æ34‰ñ“ú–{V¶Ž™Šw‰ï i98.07.12j, •Ÿ‰ª.

2049. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V¶Ž™‚Ìœ–§“x‚ÉŠÖ‚·‚錟“¢. Έ䑸—YC“à–ì’¼Ž÷C–]ŒŽˆ¤˜YiŽY•wjC“n•Ó’qŽqCŠ—Œ´FiŽ™j: ‘æ34‰ñ“ú–{V¶Ž™Šw‰ï i98.07.14j, •Ÿ‰ª.

2050. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •êbŒŒ‚Ì—AŒŒ‚ª‘ÙŽezŠÂŒn‚É—^‚¦‚é‰e‹¿. ›”ŽˆûCª–{‘‘ˆêC‹gŒ´ˆêC“‡“cMGC¼“‡³”ŽC‰–’Ép”ViŽY•wjC²“¡ˆêŠì: ‘æ21‰ñ“ú–{ŽY‰È•wl‰ÈME§˜b‰ï i98.08.08j, “Œ‹ž.

2051. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j MPA—Ö@Œã, ŽîᇂÌÁŽ¸‚ð”F‚ß”DP‚ÉŽŠ‚Á‚½Žq‹{‘ÌŠà‚Ì‚P—á. ìŒû”ü˜aCã–V•qŽqC¡ˆäˆ¤CçÝŽ–«CŠÖ–{—»•½C‘ –{”ŽsiŽY•wj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.09j, •Ÿ‰ª, “úŠàŽ¡Ž, 33(3): 396, 1998.

2052. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ³í•ª•ØŒã, ‘Šú‚É”­Ç‚µ‚½ãO–ÑŠà‚Ì1—á. ìŒû”ü˜aCã–V•qŽqCŒ´“c—RC‰¬–ì‹|ŠóŽqC‘å‰ÍŒ´‘C“à–ì’¼Ž÷C“cŒû–¾iŽY•wjC‘å–ì‰pŽ¡i•a‰@•a—jC‘ –{”ŽsiŽY•wj: ‘æ37‰ñ“ú—Õ×–EŠw‰ïHŠú‘å‰ï i98.11.20j, å‘ä, “ú—Õ×–EŽ, 37(Suppl.2): 495, 1998.

2053. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ‹}‘¬‹•Øp. ¼“‡³”ŽiŽY•wj: ìèŽsŽY•wl‰Èˆã‰ïŠwpu‰‰‰ï i99.02.06j, ìè.

2054. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j íˆÊ‘Ù”Õ‘Šú”—£66—á‚Ì—Õ°“IŒŸ“¢. –{‹´Œb”üŽqC“cŒû‰ë”VCrˆä’‰ŽmC¯–ì—TŽqCÄ“¡ŽC¯“c—²C“V–슮C¼“‡³”ŽiŽY•wj: ‘æ96‰ñ“ú–{ŽY•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï i98.10.18j, ‰F“s‹{.

2055. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j 32T–¢–ž‘o‘ÙŽ™”j…—á‚ÌŽüŽYŠú—\Œã. ¯–ì—TŽqCÄ“¡ŽCrˆä’‰ŽmC“V–슮C¼“‡³”ŽiŽY•wj: ‘æ96‰ñ“ú–{ŽY•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï i98.10.18j, ‰F“s‹{.

2056. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é’鉤؊J—á‚ÌŒŸ“¢. Έ䑸—YCª–{—æŽqC‘å‰ÍŒ´‘C–]ŒŽˆ¤˜YC“à–ì’¼Ž÷iŽY•wj: ‘æ336‰ñ“úŽY•w_“Þì’n•û•”‰ï i98.12.26j, ‰¡•l.

2057. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Body stalk anomaly‚Ì‚P—á. •‘òŒbŽqC¯–ì—TŽqC“V–슮C¼“‡³”ŽiŽY•wj: ‘æ97‰ñ•ª•Ø‚Æ–ƒŒŒ¤‹†‰ï, ‘æ336‰ñ“úŽY•w_“Þì’n•û•”‰ï i98.12.26j, ‰¡•l.

2058. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j èI‹„—Ö@‚Ìœ”Ոʋ¸³‚ɑ΂·‚éŒø‰Ê. rˆä’‰ŽmC¯“c—²C“V–슮C¼“‡³”ŽiŽY•wjC‰œ•xr”VCŠO{”ü•vi–ƒj: ‘æ337‰ñ“úŽY•w_“Þì’n•û•”‰ï i99.01.16j, ‰¡•l.

2059. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘ÙŽ™S‘ŸŽîᇂ̂P—á. ¯“c—²C“V–슮C¼“‡³”ŽiŽY•wj: ‘æ338‰ñ“ú–{ŽY•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï i99.02.20j, ‰¡•l.

2060. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j æ“V”~“Å‚Ì‚P—á. –]ŒŽƒŽqC•{•s“ñ’jiŽY•wjC—Ñ–¾LCåêQd—²i‰¡•l‘‡•a‰@j: “ú–{ŽY•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï i99.03.20j, ‰¡•l.

2061. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j ƒgƒŠƒvƒ‹ƒ}[ƒJ[ƒeƒXƒg‚É‚æ‚éŽüŽYŠú—\Œã—\‘ª‚ÉŠÖ‚·‚錟“¢. ¯“c—²C“V–슮C‘O“c“OC¼“‡³”ŽiŽY•wj: ‘æ96‰ñ“ú–{ŽY•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï i98.10.18j, ‰F“s‹{.

2062. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j ”DP’†Šú‚ÌŒŸ¸‹Zp|‘ŽY‚Æ‘OŠú”j…. ¼“‡³”ŽiŽY•wj: ƒ‰ƒWƒI’Z”g•ú‘— i98.05.11j.

2063. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j •êeŠw‹‰‚Å‹³‚¦‚Ä—~‚µ‚¢‚±‚Æ. “‡“cMGiŽY•wj: ‘æ11‰ñŽÀ’nˆã‰Æ‚Æ•ŽY•w‚Ì‚½‚ß‚ÌŽüŽYŠúƒZƒ~ƒi[ i98.07.04j, –kŠC“¹.

2064. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j ³í•ª•Ø‚̉î•. “‡“cMGiŽY•wj: ‘æ11‰ñŽÀ’nˆã‰Æ‚Æ•ŽY•w‚Ì‚½‚ß‚ÌŽüŽYŠúƒZƒ~ƒi[ i98.07.05j, –kŠC“¹.

2065. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j •ª•ØŽžŽ‘±d–ŒŠO–ƒŒ‚É‚¨‚¯‚éƒGƒsƒlƒtƒŠƒ““Y‰Á‚̈Ӌ`‚ɂ‚¢‚Ä. –]ŒŽƒŽqC“cŒû‰ë”VCrˆä’‰ŽmC¯–ì—TŽqC“V–슮C¼“‡³”ŽiŽY•wjC‰œ•xr”Vi–ƒj: ‘æ96‰ñ•ª•Ø‚Æ–ƒŒŒ¤‹†‰ï i98.06.13j, “Œ‹ž.

2066. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‹‘厙‚Ì•ª•ØŽèp. Šâ‰i‹v”üC‹gŒ´ˆêCÄ“¡ŽC¯“c—²C“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ14‰ñ“œ”A•a‚Æ”DP‚ÉŠÖ‚·‚錤‹†‰ï i98.11.28j, “Œ‹ž.

2067. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Ž©‘R•ª•Ø‚É‚¨‚¯‚é“ïŽY‚Æ‚Í. ’F‰pŽ÷iŽY•wj: •ª•Ø‚Æ–ƒŒŒ¤‹†‰ï i98.06.13j, “Œ‹ž.

2068. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‘ÙŽ™‰¼Ž€‚Æ”]«–ƒáƒ‚Ì–hŽ~. ¼“‡³”ŽiŽY•wj: •ºŒÉŒ§ŽY‰È•wl‰È”F’èˆã¶ŠUŒ¤C‰ï i98.08.01j, •P˜H.

2069. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ŽüŽYŠúˆã—Â̌»ó‚Æ–â‘è“_. ’Jº”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï¥“ú–{•ê«•ÛŒìŽY•wl‰Èˆã‰ïŒQ”nŒ§Œ¤C‰ï i98.08.21j, ŒQ”n.

2070. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ”]«–ƒáƒ‚Ì”­¶–hŽ~‚ð‚ß‚´‚µ‚Ä. ¼“‡³”ŽiŽY•wj: “ñ…‰ï i98.10.14j, L“‡.

2071. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j •½¬5`7”N_“Þ쌧”DŽY•wŽ€–SŒ´ˆö•Ê—\–h‘Îô¥ŠÇ—–@. ¯“c—²C“V–슮C¼“‡³”ŽiŽY•wj: ‘æ40‰ñŽüŽYŠú‹~‹}˜A—‰ï i98.11.19j, ‰¡•l.

2072. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ”DPŒã”¼Šú‚ÌŒŒ‰tŒŸ¸‚ÆR‚è‚ñŽ‰Ž¿R‘ÌÇŒóŒQ. “‡“cMGiŽY•wj: “Œ–kŽüŽYŠúƒZƒ~ƒi[ i98.07.25j, å‘ä, “Œ–kŽüŽYŠúƒZƒ~ƒi[1998”N, p.29`42, 1998.

2073. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‰ßŠú”DP. ¼“‡³”ŽiŽY•wj: ‘Š–ÍŒ´ŽY•wl‰Èˆã‰ï i98.08.22j, ‘Š–ÍŒ´.

2074. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j •ª•Ø‚ð—U”­¥‘£i‚µ‚½‚è‚·‚éÇ—á‚Ìp‘OfŽ@‚Æf’f‚¨‚æ‚Ñ‚»‚ÌŽè‹Z‚ÆŽÀÛ. “‡“cMGiŽY•wj: ‘æ20‰ñŽüŽYŠúˆãŠwŠÅŒìƒZƒ~ƒi[ i98.09.26j, ‰ÔŠª, u‰‰—vŽ|W, p.1`25, 1998.

2075. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘Ù”Õ‘”—á‚ÌFHRŠŒ©‚Ì„ˆÚ‚ÆF-SpO2. “cŒû‰ë”VC“V–슮C¼“‡³”ŽiŽY•wj: ‘æ11‰ñ•ª•ØŠÄŽ‹Œ¤‹†‰ï i98.06.27j, “Œ‹ž.

2076. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j HELLPÇŒóŒQ¥‹}«”DP«Ž‰–bŠÌ. ¯“c—²C“V–슮C¼“‡³”ŽiŽY•wj: ‘æ39‰ñ_“ÞìŽüŽYŠú‹~‹}˜A—‰ï i98.07.16j, ‰¡•l.


<<20 •wl‰ÈŠw>>

2077. mŒ´’˜n Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells. `GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC“n•Óƒi•a—jC‘ –{”ŽsiŽY•wj: Oncology, 55(Suppl.1): 35`44, 1998.

2078. mŒ´’˜n ‹@”\‰·‘¶¥’áNP‚ðŽuŒü‚µ‚½•wl‰ÈŠàŽ¡—Ã; 1.Žá”NŽÒ‚É‚¨‚¯‚é‹@”\‰·‘¶¥‹@”\‘ãž(1)Žq‹{ŒzŠà|”D›s«‰·‘¶|i‚Æ‚­‚ɃŒ[ƒU[—Ö@‚É‚æ‚éj. ˜e“c–M•vC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ŽY‰È‚Æ•wl‰È, 65(6): 703`710, 1998.

2079. mŒ´’˜n Žq‹{ŒzŠà‡TŠú‚ÌVFIGO•ª—Þ‚Æ‹Œ“úŽY•w•ª—Þ‚Æ‚Ì”äŠr. ‘ –{”ŽsCŠp“cV•½Cã–V•qŽqCŒãŒ«C‹àˆä“”VC¡ˆäˆ¤iŽY•wj: ŽY•w‚Ì¢ŠE, 50(7): 523`531, 1998.

2080. mŒ´’˜n •½¬9”N“x_“ÞìŽY‰È•wl‰Èˆã‰ï•wl‰Èˆ««Žîᇓo˜^WŒv•ñ. –Ø‘ºº—TC–ö‘ò˜aFC–Ø”ÒvŽœC“ú–스C“c“‡•q‹vC‚‹´‹œ³CŒÜ–؈í—YCÄ“¡Š]C`GŽ÷iŽY•wjCŽÂ’ËF’jC´…“ÄCŠÖ’J—²•vC‰J‹{´C’†ŽR—TŽ÷C‰ª“‡O Ki_“Þ쌧ŽY‰È•wl‰Èˆã‰ïˆ««ŽîᇑÎô•”j: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ïŽ, 35(2): 45`50, 1999.

2081. mŒ´’˜n Secondary acute leukemia following chemotherapy for ovarian malignancy. ã–V•qŽqC•½–ì‘ŽqCŠâ’JO–¾C²“¡—Ï–çC‘ –{”ŽsiŽY•wj: –k—¢ˆãŠw, 28(6): 507`513, 1998.

2082. m’Z•ñ¥‘¬•ñn Œ¤‹†‘¬•ñ; Žq‹{“à–ŒÇ. ¼“‡³”ŽCã–V•qŽqiŽY•wj: ŽY•wŽ¡—Ã, 78: 263, 1999.

2083. m’Z•ñ¥‘¬•ñn ¼”—•½—Y涂̎€‚𓉂Þ. ‘ –{”ŽsiŽY•wj: _“ÞìŽY•wˆã‰ï•ñ, (66): 63, 1998.

2084. m’Z•ñ¥‘¬•ñn HPV-Žq‹{ŒzŠà. ò‹M•¶C‘ –{”ŽsiŽY•wj: “úˆãƒjƒ…[ƒX, ‘æ888†, 1998.

2085. mÇ—á•ñn Žq‹{“à–Œ×–Ef‚Åf’f‚µ‚½“ûŠàŽq‹{“]ˆÚ‚Ì2—á. ¡ˆäˆ¤Cã–V•qŽqC¡ˆä‰ë•vC‹àˆä“”ViŽY•wjC–L‰i^ŸC‘å–ì‰pŽ¡i•a‰@•a—jC‘ –{”ŽsiŽY•wj: “ú–{—Õ°×–EŠw‰ïŽGŽ, 37(5): 475`480, 1998.

2086. mÇ—á•ñn ‹}Œƒ‚É“]‹A‚ð‚½‚Ç‚Á‚½Žq‹{‘Ì•”Šà“÷Žî‚Ì‚P—á. –]ŒŽƒŽqCã–V•qŽqC“cŒû‰ë”VC²“¡—Ï–çC‘ –{”ŽsiŽY•wj: “ú–{—Õ°×–EŠw‰ï_“Þ쌧Žx•”‰ïŽ, 3(1): 23`27, 1998.

2087. m—Õ°Ž¡Œ±n —‘‘ƒˆ««Žîᇂ̎¡—Ã|• o“à‰»Šw—Ö@. ã–V•qŽqC‹÷‰z‚©‚ÂŽqC‘ –{”ŽsiŽY•wj: ŽY•wl‰È‚Ì¢ŠE, 50(Suppl.): 298`303, 1998.

2088. m—Õ°Ž¡Œ±n Žq‹{‘ÌŠà‚ÆŽq‹{“à–Œ‘BÇ. ã–V•qŽqiŽY•wj: “ú–{—Õ°×–EŠw‰ï‘啪Œ§Žx•”‰ïŽ, 8: 3`6, 1998.

2089. m‘àn V•ª—Þ‚É‚æ‚éŽq‹{“à–Œ‘BÇ‚Ì×–Ef’f. ‘å–ì‰pŽ¡C–L‰i^ŸC•ž•”ŠwC‰¡ŽR‘åi•a‰@•a—jC‘ –{”ŽsiŽY•wj: Medical Technol., 26(6): 625`628, 1998.

2090. m‘àn ’†‚”N—«‚Ìf—Ããd—v‚ÈŽ¾Š³‚Ìf’f‚ÆŽ¡—Ã|Žq‹{“à–ŒŠà. `GŽ÷C¡ˆäˆ¤Cã–V•qŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: Modern Physician, 18(19): 1047`1049, 1998.

2091. m‘àn Ž„‚Ìs‚Á‚Ä‚¢‚é—‘‘ƒŠà‚ɑ΂·‚é‹@”\‰·‘¶—Ö@|‡U. ã–V•qŽqCŠâ’JO–¾C‘ –{”ŽsiŽY•wj: Oncol. Chemoth., 14(4): 317`319, 1998.

2092. m‘àn ƒŒ[ƒU[Žèpi‰~Øœp‚ÆöŽU–@j|“Á‚ÉŽq‹{Œz•”‘ŠúŠà‚ɑ΂·‚é|. ˜e“c–M•vC‘ –{”ŽsC²“¡—Ï–çC‹àˆä“”VC¡ˆäˆ¤C¼“‡³”ŽiŽY•wj: ŽY•w‚ÌŽÀÛ, 47(12): 1955`1960, 1998.

2093. m‘àn —‘‘ƒŠà‚É‚¨‚¯‚éSecond-look operation (SLO)‚Ì•]‰¿. ‘ –{”ŽsCŒãŒ«Cã–V•qŽqiŽY•wj: ŽY•w‚Ì¢ŠE, 50(12): 1015`1021, 1998.

2094. m‘àn ’†‚”N—«‚Æ—‘‘ƒŠà. Šâ‰i‹v”üCã–V•qŽqC²“¡—Ï–çCŒ´“c—RC‘ –{”ŽsiŽY•wj: ŽY•wl‰ÈŽ¡—Ã, 76(‘Š§): 950`954, 1998.

2095. m‘àn Žq‹{Œz‚ª‚ñ¥‘Ì‚ª‚ñŒŸf‚ɂ‚¢‚Ä. ‘ –{”ŽsiŽY•wj: ‘æ6‰ñé‹ÊŒ§Žq‹{‚ª‚ñŒŸfƒZƒ~ƒi[‹L˜^, é‹ÊŒ§ˆãŽt‰ï, p.13`28, 1998.

2096. m‘àn Žq‹{“à–Œ‘BÇ‚Ì•a‘Ô‚ÆŠÇ—. ‘ –{”ŽsCã–V•qŽqC‘å‰ÍŒ´‘C²“¡—Ï–çC¡ˆäˆ¤C‹àˆä“”VC—Ñ—æŽqCìŒû”ü˜aiŽY•wj: “ú•wŽîᇉïŽ, 16(2): 133`137, 1998.

2097. m‘àn ŽY•wl‰Èˆ««Žîᇂ̋@”\‰·‘¶—Ö@. ã–V•qŽqiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 35(2): 170`174, 1999.

2098. m‘àn Žq‹{“à–Œ‘BÇ‚Ì×–EŠŒ©‚Æ‚»‚Ì—Õ°“I”wŒi. ²“¡—Ï–çCã–V•qŽqC¡ˆäˆ¤C‘å‰ÍŒ´‘C‘ –{”ŽsiŽY•wjC‘å–ì‰pŽ¡C‰¡ŽR‘åC–L‰i^ŸCŠ`ÀL–Mi•a‰@•a—j: “ú—Õ×–EŽ, 37(6): 637`642, 1998.

2099. m‘àn •¡ŽGŒ^Žq‹{“à–Œ‘BÇ‚Ì×–Ef‚É—L—p‚Ȉٌ^“à–Œ‘B×–E‰ò‚ɂ‚¢‚Ä. ¡ˆä’‰˜NC‰¡–ìGŽ÷i–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“jCò‹M•¶CŒ¹“c’C—YiŽY•wjC–{‹§i•a—jC‘ –{”ŽsiŽY•wj: “ú—Õ×–EŽ, 37(6): 660`665, 1998.

2100. m‘àn Žq‹{“à–Œ‘BÇ‚Ì×–EŠŒ©. ã–V•qŽqC²“¡—Ï–çC‹àˆä“”VC¡ˆäˆ¤C‘ –{”ŽsiŽY•wj: “ú—Õ×–EH“c‰ïŽ, (5): 44`49, 1999.

2101. m‘àn Žq‹{“à–Œ×–Ef|f’fã‚̈Ӌ`. ã–V•qŽqC‘å‰ÍŒ´‘C²“¡—Ï–çC¡ˆäˆ¤C‘ –{”ŽsiŽY•wj: •a—‚Æ—Õ°, 16(5): 573`578, 1998.

2102. m‘àn Žq‹{ŒzŠà‚ÌW’cŒŸf. ‘ –{”ŽsiŽY•wj: —\–hˆãŠw, (40): 56`60, 1998.

2103. muÀn Žq‹{‹ØŽî‚ÌŽ¡—Õûj. ¼“‡³”ŽiŽY•wj: “ú–{ˆãŽ–V•ñ, (3865): 106, 1998.

2104. mŠwp‘n i•ª’SŽ·•Mj V—«ˆãŠw‘ÌŒn‚X—«‚Æ—\–hˆãŠw; Žq‹{‘ÌŠàŒŸf, p.103`115, ‘ –{”ŽsC²“¡—Ï–çiŽY•wj. •ÒW ‰Á“¡ãEC•ÒC ’†ŽR‘“X, “Œ‹žC98.12.31”­s.

2105. mŠwp‘n i•ª’SŽ·•Mj •wl‰ÈoŒŒ‚Ì—Õ°; Žq‹{‘ÌŠà, p.110`115, ‘ –{”ŽsC¡ˆäˆ¤Cã–V•qŽqiŽY•wj. •ÒW –î“àŒ´IC–ì‘òŽu˜NCŽ›”ör•FCr–Ø‹ÎC•ÒC Medical ViewŽÐ, “Œ‹žC98.03.00”­s.

2106. mŠwp‘n i•ª’SŽ·•Mj Žq‹{‘ÌŠà‚Ìf’f‚ÆŽ¡—Ã; ‘æ2Í.f’f|‡T.‘ÌŠàŒŸf, p.17`26, ‘ –{”ŽsiŽY•wj. •ÒW ‰F“cìN”ŽC’Ë莌ÈC•ÒC ‰iˆä‘“X, ‘åãC99.03.20”­s.

2107. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŠÄCj •wl‰È‰»Šw—Ö@|–òÜŽt‚Ì’S‚¤–ðŠ„; p.1`9, ŠÄC ‘ –{”ŽsiŽY•wj. ‹¦˜aŠé‰æ, “Œ‹žC99.03.30”­s.

2108. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Symposium endometrium/Endocervix half day; Targeted population screening of endometrial cancer in Japan. ‘ –{”ŽsCã–V•qŽqC²“¡—Ï–çiŽY•wjC‘å–ì‰pŽ¡i•a‰@•a—j: 13th International Congress of Cytology i98.05.12j, “Œ‹ž, Acta Cytol., 42(Suppl.2): 521, 1998.

2109. mŠw‰ïi‘Ûjn iƒ[ƒNƒVƒ‡ƒbƒvj Panel 1-c: Endometrial cancer and related lesions; Role of hyperplasia in the natural history and early diagnosis of endometrial carcinoma. ã–V•qŽqC²“¡—Ï–çC¡ˆäˆ¤C‘å‰ÍŒ´‘CVˆä³GC‘ –{”ŽsiŽY•wj: 13th International Congress of Cytology i98.05.14j, “Œ‹ž, Acta Cytol., 42(Suppl.2): 499, 1998.

2110. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Comparative cytology of tumor contents and stump smears in malignant ovarian tumors. ŠÖ–{—»•½Cã–V•qŽqCŠâ’JO–¾CŒÃì‚©‚ÂŽqC‘ –{”ŽsiŽY•wj: 13th International Congress of Cytology i98.05.12j, “Œ‹ž, Acta Cytol., 42(Suppl.2): 565, 1998.

2111. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Cytologic evaluation of the effect of MPA therapy for atypical hyperplasia and carcinoma of the endometrium. ¡ˆäˆ¤Cã–V•qŽqiŽY•wjC“cŠ‰xŽqi•a‰@•a—jC`GŽ÷C‘ –{”ŽsiŽY•wj: 13th International Congress of Cytology i98.05.13j, “Œ‹ž, Acta Cytol., 42(Suppl.2): 491`492, 1998.

2112. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j A cyto- and histopathologic study of serous, papillary adenocarcinoma of the endometrium. Šâ‰i‹v”üCã–V•qŽqCŠp“cV•½C—§‰ª˜aOC‘ –{”ŽsiŽY•wj: 13th International Congress of Cytology i98.05.11j, “Œ‹ž, Acta Cytol., 42(Suppl.2): 497, 1998.

2113. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Prognostic value of peritoneal cytology in endometrial carcinoma. ²“¡—Ï–çCã–V•qŽqCVˆä³GC‹àˆä“”VCŒãŒ«C‘ –{”ŽsiŽY•wj: 13th International Congress of Cytology i98.05.13j, “Œ‹ž, Acta Cytol., 42(Suppl.2): 561`562, 1998.

2114. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j Žq‹{“à–Œ‘BÇ‚Ì•a‘Ô‚ÆŠÇ—. ‘ –{”ŽsiŽY•wj: ‘æ27‰ñ“ú–{•wl‰È•a—ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ï i98.07.16j, ‘åã, “ú–{•wl‰È•a—ƒRƒ‹ƒ|Ž, 16(1): 30, 1998.

2115. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j —‘‘ƒŠà, • o“à×–E‚ÌÌŽæ–@‚ÆŠÓ•Êf’f 6.—‘‘ƒŽîᇓà—e˜Ro–hŽ~•túŽhj‚É‚æ‚éŽîᇓà—e×–Ef‚ƗLj««ŠÓ•Êf’f. ²X–ØŠ°CΈä•Û‹gC²–ì—TìC“s’|³•¶C‰º’n‚¢‚Ù”TCŠ”–{˜a”üCã–V•qŽqiŽY•wjCŠ¦‰Í]ŒåCH“¡—²ˆêC“c’†’‰•v: ‘æ39‰ñ“ú—Õ×–EŠw‰ï‘‰ï i98.06.20j, ŽD–y, “ú—Õ×–EŽ, 37(Suppl.1): 82, 1998.

2116. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Žq‹{Œz•””÷¬ZŠà‚ɑ΂·‚é•Û‘¶—Ö@; Žq‹{Œz•”•a•Ï‚ɑ΂·‚郌[ƒU[Ž¡—Â̑Š‡‚Æ«—ˆ‚Ö‚Ì“W–]. ò‹M•¶CŒ¹“c’C—YC‹àˆä“”VC˜e“c–M•vC‘ –{”ŽsiŽY•wj: ‘æ19‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï i98.09.24j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€, ´˜^W, p.55, 1998.

2117. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Žq‹{“à–ŒŠà‚Ì×–Ef. ã–V•qŽqiŽY•wj: ‘æ37‰ñ“ú—Õ×–EŠw‰ïHŠú‘å‰ï i98.11.20j, å‘ä, “ú—Õ×–EŽ, 37(Suppl.2): 370, 1998.

2118. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj •wl‰È‚ª‚ñŒŸf‚Ì—LŒø«‚ð‚ß‚®‚Á‚Ä|Žq‹{‘ÌŠàŒŸf. ã–V•qŽqiŽY•wj: ‘æ50‰ñ“ú–{ŽY•wl‰ÈŠw‰ï‘‰ï i98.04.18j, å‘ä, “ú–{ŽY•wl‰ÈŠw‰ï‰ïŽ, 50(Suppl.): 94, 1998.

2119. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŠàŽ¡—Âɂ¨‚¯‚éMiniorum invasive surgery‚Ì“K‰ž‚ÆŒÀŠE; Žq‹{Œz•”G•½ã”çŠà‚ɑ΂·‚郌[ƒU[¥ƒ‹[ƒv‚É‚æ‚é•Û‘¶—Ö@‚Ì“K‰ž. ‹àˆä“”VC˜e“c–M•vCã–V•qŽqCŠp“cV•½Cò‹M•¶C‘ –{”ŽsiŽY•wj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.09j, •Ÿ‰ª, “úŠàŽ¡Ž, 33(3): 112, 1998.

2120. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ˆÙŒ^‘Bǂɑ΂·‚鎡—Ö@•ÊŒø‰Ê‚ÉŠÖ‚·‚錟“¢; ‘OŠà•a•Ï‚ɑ΂·‚é‘Ήž‚ƑΈ. ¡ˆäˆ¤Cã–V•qŽqCìŒû”ü˜aCŠâ‰i‹v”üC—Ñ—æŽqC‘ –{”ŽsiŽY•wj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.09j, •Ÿ‰ª, “úŠàŽ¡Ž, 33(3): 115, 1998.

2121. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{‘ÌŠà‚É‚¨‚¯‚ép53Šà—}§ˆâ“`ŽqˆÙí‚̉ðÍ. `GŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC“n•Óƒi•a—jC—§‰ª˜aOC“cŒû‰ë”VCŠâ‰i‹v”üC¼“‡³”ŽiŽY•wj: ‘æ50‰ñ“ú–{ŽY•wl‰ÈŠw‰ï‘‰ï i98.04.21j, å‘ä, “ú–{ŽY•wl‰ÈŠw‰ï‰ïŽ, 50(Suppl.): 259, 1998.

2122. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚É‚¨‚¯‚éPTENŠà—}§ˆâ“`ŽqˆÙí‚ÌŒŸõ. `GŽ÷C‘ –{”ŽsC¡ˆäˆ¤C‹àˆä“”ViŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC“n•Óƒi•a—j: “ú–{‘gD”|—{Šw‰ï‘æ71‰ñ‘å‰ï i98.05.21j, å‘ä, ‘gD”|—{Œ¤‹†, 17(1): 33, 1998.

2123. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Large cell neuroendocrine carcinoma‚Ì‹CŠÇŽxŽC‰ß×–Ef‚É‚¨‚¯‚é×–E‘œ‚ÌŒŸ“¢. Š`ÀL–MC‰¡ŽR‘åC¬—Ñ–¾ŽqC–L‰i^ŸC‚”¨”ü–çŽqC‘å–ì‰pŽ¡C•ž•”Šwi•a‰@•a—jC•i“cƒi‹¹ŠOjC‘ –{”ŽsiŽY•wjCŠâŸºŒ[ˆêC‰ªˆÀŒMi•a—j: ‘æ39‰ñ“ú—Õ×–EŠw‰ï‘‰ï i98.06.19j, ŽD–y, “ú—Õ×–EŽ, 37(Suppl.1): 109, 1998.

2124. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘BŽî—lbó‘BŽî‚É‚¨‚¯‚é“û“ªóW‰ò‚Æ‚•ª‰»Œ^“û“ªŠà‚Ì×–EŠw“IŠÓ•Ê. ‰¡ŽR‘åC¬—Ñ–¾ŽqC–L‰i^ŸCŠ`ÀL–MC‚”¨”ü–çŽqC‘å–ì‰pŽ¡C•ž•”Šwi•a‰@•a—jCŒY•”“ŒŽ¡iŠOjC‘ –{”ŽsiŽY•wjCŠâŸºŒ[ˆêC‹T’J“OC‰ªˆÀŒMi•a —j: ‘æ39‰ñ“ú—Õ×–EŠw‰ï‘‰ï i98.06.19j, ŽD–y, “ú—Õ×–EŽ, 37(Suppl.1): 121, 1998.

2125. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž©‘R”A‚¨‚æ‚ÑäNã÷ƒJƒe[ƒeƒ‹”A×–Ef‚Ì”äŠrŒŸ“¢. •ž•”ŠwC‘å–ì‰pŽ¡C‰¡ŽR‘åC¬—Ñ–¾ŽqC–L‰i^ŸCŠ`ÀL–MC‚”¨”ü–çŽqi•a‰@•a—jCŠâŸºŒ[ˆêi•a—jC“à“c–Lºi”åjC‘ –{”ŽsiŽY•wj: ‘æ39‰ñ“ú—Õ×–EŠw‰ï‘‰ï i98.06.20j, ŽD–y, “ú—Õ×–EŽ, 37(Suppl.1): 258, 1998.

2126. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j œ‘ˆÙŒ`«ÇŒóŒQ‡•¹”DP‚Ì‚P—á. ‰E“‡•xŽm’jC’Jº”ŽC¡ˆäˆ¤C¼“‡³”ŽiŽY•wj: “ú–{ŽY•wl‰È¥V¶Ž™ŒŒ‰tŠw‰ï i98.06.26j, –k‹ãB.

2127. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒŒ[ƒU[‰~Øœp‚ÌŽ¡—ÃŒø‰Ê‚ÆHPV-DNA—z«, Øœ’f’[‚É‚¨‚¯‚é•a•Ï‚Ì—L–³‚Æ‚ÌŠÖ˜A. ò‹M•¶C‚ŽR˜a‹vC‹÷‰z‚©‚ÂŽqC‹v“ˆ‘¥sCŒ¹“c’C—YC˜e“c–M•vC‘ –{”ŽsiŽY•wj: ‘æ27‰ñ“ú–{•wl‰È•a—ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ï i98.07.15j, ‘åã, “ú–{•wl‰È•a—ƒRƒ‹ƒ|Ž, 16(1): 52, 1998.

2128. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{“à–ŒŠà¥ˆÙŒ^‘BÇ‚ÌMPA“Š—^‚É”º‚¤‘gDŠw“I‚È‚ç‚Ñ‚ÉER, PR, bcl-2, cerb B2‚̖ƉuŠw“I”­Œ»‚̕ω»‚ÉŠÖ‚·‚錟“¢. ¡ˆäˆ¤Cã–V•qŽqC²“¡—Ï–çC`GŽ÷CŒ´“c—RC‘ –{”ŽsiŽY•wj: ‘æ27‰ñ“ú–{•wl‰È•a—ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ï i98.07.16j, ‘åã, “ú–{•wl‰È•a—ƒRƒ‹ƒ|Ž, 16(1): 55, 1998.

2129. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚É‚¨‚¯‚éPTENˆâ“`ŽqˆÙí‚ÌŒŸ“¢. `GŽ÷C¡ˆäˆ¤C‹àˆä“”VCŠâ‰i‹v”üCVˆä³GiŽY•wjC“n•Óƒi•a—jC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‘ –{”ŽsiŽY•wj: ‘æ27‰ñ“ú–{•wl‰È•a—ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ï i98.07.16j, ‘åã, “ú–{•wl‰È•a—ƒRƒ‹ƒ|Ž, 16(1): 57, 1998.

2130. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –¾×–E‘BŠà‚ÆG•½ã”çŠà‚𓯈ꗑ‘ƒ“à‚É”F‚ß‚½‚P—á. ìŒû”ü˜aC¡ˆäˆ¤CŠâ‰i‹v”üC²“¡—Ï–çCã–V•qŽqC‘ –{”ŽsiŽY•wj: ‘æ27‰ñ“ú–{•wl‰È•a—ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ï i98.07.16j, ‘åã, “ú–{•wl‰È•a—ƒRƒ‹ƒ|Ž, 16(1): 74, 1998.

2131. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˜VŒ’–@‚É‚æ‚éŽq‹{‘Ì‚ª‚ñŒŸf‚ÌŽÀÑ|“ú•ê‘S‘“s“¹•{Œ§Žx•”‚ւ̃Aƒ“ƒP[ƒg’²¸‚ð‚à‚Æ‚É|. ²“¡—Ï–çCã–V•qŽqCVˆä³GC‹àˆä“”VC¡ˆäˆ¤C`GŽ÷C‘ –{”ŽsiŽY•wj: ‘æ7‰ñ“ú–{•wl‰È‚ª‚ñŒŸfŠw‰ï i98.11.07j, “Œ‹ž.

2132. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{“à–ŒŠÔŽ¿“÷Žî‚ÌŒŸ“¢. “¡‘ò•ŽuC‘å–ì‰pŽ¡C•ž•”ŠwC‰¡ŽR‘åi•a‰@•a—jC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷C‘ –{”ŽsiŽY•wj: ‘æ37‰ñ“ú—Õ×–EŠw‰ïHŠú‘å‰ï i98.11.20j, å‘ä, “ú—Õ×–EŽ, 37(Suppl.2): 408, 1998.

2133. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “û‘BúŽh‹zˆø×–Ef‚Æ‘gDf‚Æ‚Ì•sˆê’v—á‚ÌŒŸ“¢. ‚”¨”ü–çŽqC‰¡ŽR‘åC–L‰i^ŸCŠ`ÀL–MC‘å–ì‰pŽ¡C•ž•”Šwi•a‰@•a—jC‘ –{”ŽsiŽY•wjC‘ •ÀŸiŠOjCŠâŸºŒ[ˆêC‰ªˆÀŒMi•a—j: ‘æ37‰ñ“ú—Õ×–EŠw‰ïHŠú‘å‰ï i98.11.20j, å‘ä, “ú—Õ×–EŽ, 37(Suppl.2): 424, 1998.

2134. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚É‚¨‚¯‚éFHITˆâ“`ŽqˆÙí‚ÌŒŸ“¢. `GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‘ –{”ŽsC‹àˆä“”VC¡ˆäˆ¤C¼“‡³”ŽiŽY•wjC“n•Óƒi•a—j: ‘æ3‰ñ“ú–{ŽY•wl‰ÈŽîᇃ}[ƒJ[¥ˆâ“`Žqf’fŠw‰ï i99.02.05j, ²‰ê, ´˜^W, p.56, 1999.

2135. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{‘ÌŠà‚ɑ΂·‚éMPA—Ö@‚ÌŽ¡—ÃŒø‰Ê‚ÆPR, BCL-2, C-erb B-2‚Ì”­Œ»‚ɑ΂·‚錟“¢. ¡ˆäˆ¤Cã–V•qŽqC`GŽ÷CŠâ’JO–¾C—Ñ—æŽqCŒÃì‚©‚ÂŽqC¯–ì—TŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ50‰ñ“ú–{ŽY•wl‰ÈŠw‰ï‘‰ï i98.04.20j, å‘ä, “ú–{ŽY•wl‰ÈŠw‰ï‰ïŽ, 50(Suppl.): 371, 1998.

2136. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{“à–ŒŸ÷‰t«‘BŠà‚Ì—\Œã‚Æp53, WAF-1‚̖Ɖu‘gD‰»Šw“IŒŸ“¢. Šâ‰i‹v”üCã–V•qŽqCã•Ð•½º“ñC“cŒû‰ë”VC—§‰ª˜aOC²“¡—Ï–çC`GŽ÷C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ50‰ñ“ú–{ŽY•wl‰ÈŠw‰ï‘‰ï i98.04.20j, å‘ä, “ú–{ŽY•wl‰ÈŠw‰ï‰ïŽ, 50(Suppl.): 374, 1998.

2137. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{ŒzŠà‡TaŠú‚ɑ΂·‚鎡—Ö@‚Ì•Ï‘J. ‹àˆä“”VCã–V•qŽqC˜e“c–M•vCŠp“cV•½C²“¡—Ï–çCrˆä’‰ŽmCŠÖ–{—»•½C‘OŒ´‘å‰îC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ50‰ñ“ú–{ŽY•wl‰ÈŠw‰ï‘‰ï i98.04.20j, å‘ä, “ú–{ŽY•wl‰ÈŠw‰ï‰ïŽ, 50(Suppl.): 401, 1998.

2138. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‡TaŠú—‘‘ƒŸ÷‰t«¥”S‰t«‘BŠà‚É‚¨‚¯‚ép53, ki67–Ɖu‘gD‰»Šw“IŒŸ“¢. Šâ’JO–¾Cã–V•qŽqC¡ˆäˆ¤C—§‰ª˜aOC²“¡—Ï–çC`GŽ÷C‘ –{”ŽsC¼“‡³”ŽC’F‰pŽ÷iŽY•wj: ‘æ50‰ñ“ú–{ŽY•wl‰ÈŠw‰ï‘‰ï i98.04.21j, å‘ä, “ú–{ŽY•wl‰ÈŠw‰ï‰ïŽ, 50(Suppl.): 453, 1998.

2139. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ×–Ef‚Åf’f‚µ‚½‚r󌋒°ŠàŽq‹{“]ˆÚ‚Ì1—á. –{‹´Œb”üŽqC¡ˆäˆ¤Cã–V•qŽqiŽY•wjCŠ`ÀL–MC‰¡ŽR‘åi•a‰@•a—jC‘ –{”ŽsiŽY•wj: ‘æ39‰ñ“ú—Õ×–EŠw‰ï‘‰ï i98.06.20j, ŽD–y, “ú—Õ×–EŽ, 37(Suppl.1): 286, 1998.

2140. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{‘ÌŠà×–E‚É‚¨‚¯‚éPTENˆâ“`Žq‚̈Ùí‚ÌŒŸ“¢. `GŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC“n•Óƒi•a—j: ‘æ57‰ñ“ú–{ŠàŠw‰ï‘‰ï i98.10.02j, ‰¡•l, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, 89(Suppl): 476, 1998.

2141. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{‘ÌŠà‚ɑ΂·‚鉺•”Á‰»ŠÇŒŸ¸‚ɂ‚¢‚Ä. Vˆä³GC–{‹´Œb”üŽqC¡ˆäˆ¤C²“¡—Ï–çCã–V•qŽqC‘ –{”ŽsiŽY•wj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.07j, •Ÿ‰ª, “úŠàŽ¡Ž, 33(3): 138, 1998.

2142. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j 15΂̭—‚É‚Ý‚ç‚ꂽ—‘‘ƒ”S‰t«‘BŠà‚Ì‚P—á. ‘OŒ´‘å‰îCã–V•qŽqC²“¡—Ï–çC`GŽ÷C‘ –{”ŽsiŽY•wj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.07j, •Ÿ‰ª, “úŠàŽ¡Ž, 33(3): 159, 1998.

2143. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •s³«ŠíoŒŒ‚ð”F‚ß‚È‚©‚Á‚½Žq‹{‘ÌŠàÇ—á‚ÌŒŸ“¢. Vˆä“wCã–V•qŽqC²“¡—Ï–çCVˆä³GC`GŽ÷C‘ –{”ŽsiŽY•wj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.09j, •Ÿ‰ª, “úŠàŽ¡Ž, 33(3): 400, 1998.

2144. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •wl‰ÈŠà‚É‚¨‚¯‚écell cycleŠÖ˜A’`”’”­Œ»‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ò‹M•¶C‚ŽR˜a‹vCŒÃì‚©‚ÂŽqC‹v“ˆ‘¥sCŒ¹“c’C—YiŽY•wjC¬—ÑŒ›’‰C‰¡–ìGŽ÷i–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“jC`GŽ÷C‘ –{”ŽsiŽY•wj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.09j, •Ÿ‰ª, “úŠàŽ¡Ž, 33(3): 403, 1998.

2145. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”][Ç¥DIC‚ðŒ_‹@‚É”­Œ©‚³‚ꂽ—‘‘ƒ–¾×–E‘BŠà‚Ì‚P—á. Œ´“c—RC²“¡—Ï–çCã–V•qŽqC‰¬–ì‹|ŠóŽqCìŒû”ü˜aiŽY•wjC”Ñ’Ë‚_i“àjC‘ –{”ŽsiŽY•wjC‰¡ŽR‘åC‘å–ì‰pŽ¡i•a‰@•a—j: ‘æ37‰ñ“ú—Õ×–EŠw‰ïHŠú‘å‰ï i98.11.20j, å‘ä, “ú—Õ×–EŽ, 37(Suppl.2): 484, 1998.

2146. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j Žq‹{“à–Œ×–Ef‚ÌÅ‹ß‚Ì’mŒ©. ‘ –{”ŽsiŽY•wj: •½¬10”N“x“ú—Õ×–EŠw‰ïɪŒ§Žx•”tŠúŠw‰ï i98.06.13j, ɪ.

2147. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j Žq‹{“à–Œ×–Ef. ‘ –{”ŽsiŽY•wj: ‘æ13‰ñ“ú—Õ×–EŠw‰ï’†‘Žl‘˜A‡‰ï i98.09.26j, ¼ŽR, “ú—Õ×–E’†‘Žl‘‰ï•ñ, 13: 11, 1998.

2148. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j Žq‹{‘ÌŠà‚Ì×–Ef. ã–V•qŽqiŽY•wj: ‘æ17‰ñ“ú—Õ×–EŠw‰ï_“Þ쌧Žx•”’n•û•”‰ï i98.09.05j, ‰¡{‰ê, “ú—Õ×–EŠw‰ï_“Þì‰ïŽ, 3(2): 55, 1998.

2149. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚霑eé ÇŠ³ŽÒŽ¡—Â̌»‹µ|ƒGƒ`ƒhƒƒ“Ž_ƒiƒgƒŠƒEƒ€‚ÌŽ¡—ÃŒø‰Ê|. ¼–{Œõ”VCã–ì˜a“TC—§‰ª˜aOiŽY•wjCŠâè^–çCõ’JŒ’ˆêC¡¼Ž•F: “ú–{ŽY•wl‰ÈŠw‰ïɪ’n•û•”‰ï i98.06.06j, ɪ.

2150. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆÙŒ^‘Bǂɑ΂·‚鎡—ìтɂ‚¢‚Ä. ìŒû”ü˜aC¡ˆäˆ¤Cã–V•qŽqC²“¡—Ï–çCŠâ‰i‹v”üC‘OŒ´‘å‰îCVˆä“wC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ95‰ñ“úŽY•wŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï i98.06.21j, “Œ‹ž, “úŽY•wŠÖ“Œ˜A‡‰ï•ñ, 35(2): 166, 1998.

2151. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Žq‹{‘̊઎¡pŒã‚É”x“®–¬ŒŒðÇ‚ð‚«‚½‚µ‚½‚Q—á. ŠÖ–{—»•½C—§‰ª˜aOC˜e“c–M•vC`GŽ÷C¡ˆäˆ¤C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ95‰ñ“úŽY•wŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï i98.06.21j, “Œ‹ž, “úŽY•wŠÖ“Œ˜A‡‰ï•ñ, 35(2): 169, 1998.

2152. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •wl‰ÈŠà‚É‚¨‚¯‚éƒTƒCƒNƒŠƒ“D1‚È‚ç‚Ñ‚ÉRbˆâ“`Žq”­Œ». ò‹M•¶C‚ŽR˜a‹vC‰E“‡•xŽm’jC‹v“ˆ‘¥sCŒ¹“c’C—YC˜e“c–M•vC`GŽ÷Cã–V•qŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ95‰ñ“úŽY•wŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï i98.06.21j, “Œ‹ž, “úŽY•wŠÖ“Œ˜A‡‰ï•ñ, 35(2): 174, 1998.

2153. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •½¬9”N“x_“Þ쌧ŽY‰È•wl‰Èˆã‰ï•wl‰Èˆ««Žîᇓo˜^WŒv•ñ. –Ø‘ºº—TC–ö‘ò˜aFC–Ø”ÒvŽœC“ú–스C“c“‡•q‹vC‚‹´‹œ³CŒÜ—ˆˆí—YCÄ“¡Š]C`GŽ÷iŽY•wjCŽÂ’ËF’jC´…“ÄCŠÖ’J—²•vC‰J‹{´C’†ŽR—TŽ÷C‰ª“‡O Ki_“Þ쌧ŽY‰È•wl‰Èˆã‰ïˆ««ŽîᇑÎô•”j: ‘æ333‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï i98.07.11j, ¬“cŒ´, “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 35(2): 107, 1999.

2154. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “û‘BPleomorphie Lobular Carcinoma‚Ì×–EfŠŒ©. Ô¯½iˆã—Éq¶jC‘å–ì‰pŽ¡C•ž•”ŠwC¬—Ñ–¾Žqi•a‰@•a—jCŠâŸºŒ[ˆêi•a—jC‘ –{”ŽsiŽY•wj: ‘æ17‰ñ“ú—Õ×–EŠw‰ï_“Þ쌧Žx•”’n•û•”‰ï i98.09.05j, ‰¡{‰ê, “ú—Õ×–EŠw‰ï_“Þì‰ïŽ, 3(2): 64, 1998.

2155. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŽY•wl‰È‚ÅŒoŒ±‚µ‚½ˆ««ƒŠƒ“ƒpŽî‚Ì‚S—á. ŒãŒ«CŠp“cV•½Cã–V•qŽqC‘ –{”ŽsC‘å‰ÍŒ´‘C¼”—Œ[iŽY•wj: ‘æ17‰ñ“ú—Õ×–EŠw‰ï_“Þ쌧Žx•”’n•û•”‰ï i98.09.05j, ‰¡{‰ê, “ú—Õ×–EŠw‰ï_“Þì‰ïŽ, 3(2): 67, 1998.

2156. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒ_ƒOƒ‰ƒXâ|‚ÉŒ´”­‚µ‚½–¾×–E‘BŠà‚Ì‚P—á. ‘OŒ´‘å‰îCã–V•qŽqC²“¡—Ï–çC‹àˆä“”VCVˆä³GC’r“c‘×—TC‘ –{”ŽsiŽY•wj: ‘æ17‰ñ“ú—Õ×–EŠw‰ï_“Þ쌧Žx•”’n•û•”‰ï i98.09.05j, ‰¡{‰ê, “ú—Õ×–EŠw‰ï_“Þì‰ïŽ, 3(2): 69, 1998.

2157. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚ÅŒoŒ±‚µ‚½Žq‹{“à–ŒŠÔŽ¿“÷Žî(‚ˆ««“x)‚Ì‚P—á. “¡‘ò•Žuiˆã—Éq¶jC‘å–ì‰pŽ¡C•ž•”ŠwC‰¡ŽR‘åi•a‰@•a—jC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷C‘ –{”ŽsiŽY•wj: ‘æ17‰ñ“ú—Õ×–EŠw‰ï_“Þ쌧Žx•”’n•û•”‰ï i98.09.05j, ‰¡{‰ê, “ú—Õ×–EŠw‰ï_“Þì‰ïŽ, 3(2): 70, 1998.

2158. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ³í•ª•ØŒã‘Šú‚É”­Ç‚µ‚½ãO–ÑŠà‚Ì‚P—á. ìŒû”ü˜aCã–V•qŽqCŒ´“c—RC‰¬–ì‹|ŠóŽqC‘å‰ÍŒ´‘C“à–ì’¼Ž÷C“cŒû–¾iŽY•wjC‘å–ì‰pŽ¡i•a‰@•a—jC‘ –{”ŽsiŽY•wj: ‘æ17‰ñ“ú—Õ×–EŠw‰ï_“Þ쌧Žx•”’n•û•”‰ï i98.09.05j, ‰¡{‰ê, “ú—Õ×–EŠw‰ï_“Þì‰ïŽ, 3(2): 71, 1998.

2159. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰ï‰AŽl“x—ô‚̈’u‚ÆpŒãŠÇ—. Œ´“c—RC“V–슮iŽY•wj: ‘æ334‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï i98.09.26j, ìè.

2160. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”][Ç¥DIC‚ðŒ_‹@‚É”­Œ©‚³‚ꂽ—‘‘ƒ–¾×–E‘BŠà‚Ì‚P—á. ‰¬–ì‹|ŠóŽqC²“¡—Ï–çCŒ´“c—RiŽY•wjC”Ñ’Ë‚_i“àjCã–V•qŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ96‰ñ“ú–{ŽY•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï i98.10.18j, ‰F“s‹{, “úŽY•wŠÖ“Œ˜A‰ï•ñ, 35(3): 313, 1998.

2161. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —‘ŠÇŒ´”­‚Ì—Þ“à–Œ‘BŠà‚Ì‚Q—á. ¬–죂݂ǂèCVˆä³GCŠÖ–{—»•½C²“¡—Ï–çC`GŽ÷Cã–V•qŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ96‰ñ“ú–{ŽY•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï i98.10.18j, ‰F“s‹{, “úŽY•wŠÖ“Œ˜A‰ï•ñ, 35(3): 344, 1998.

2162. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Šm’èf’f‚É‹ê—¶‚µ‚½«ŠíŒ‹Šj‚Ì‚P—á. —Ñ—æŽqCˆÀ’BŒhˆêC›”ŽˆûC¡ˆä‰ë•vCŠâ’JO–¾C’F‰pŽ÷iŽY•wj: ‘æ96‰ñ“ú–{ŽY•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï i98.10.18j, ‰F“s‹{, “úŽY•wŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 35(3): 391, 1998.

2163. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —‘ŠÇ…Žî‚𔺂¤AIDŠ³ŽÒ‚ÉFT‚ðŽ{s‚µ”DP‚𓾂½‚P—á. •Ð‰ªŽj’jCŠâè^–çC—§‰ª˜aOiŽY•wjCõ’JŒ’ˆêC¼–{Œõ”V: “ú–{ŽY•wl‰ÈŠw‰ïɪ’n•û•”‰ï i98.11.07j, •l¼.

2164. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹¹…’™—¯‚ð‚«‚½‚µ‚½‹‘å• •”Žîᎂ̂P—á. ‰E“‡•xŽm’jC`GŽ÷C²“¡—Ï–çC’r“c‘×—TCVˆä³GCã–V•qŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ335‰ñ“úŽY•w_“Þì’n•û•”‰ï, ‘æ40‰ñ_“ÞìˆãŠw‰ï‘‰ïŽY•wl‰È•ª‰È‰ï i98.11.21j, ‰¡•l.

2165. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j “ûŠàpŒãƒ^ƒ‚ƒLƒVƒtƒFƒ““Š—^’†‚É”­Ç‚µ‚½Žq‹{‘ÌŠà‚Ì‚P—á. ’r“c‘×—TC²“¡—Ï–çC‘OŒ´‘å‰îCVˆä³GCã–V•qŽqC‘ –{”ŽsiŽY•wj: ‘æ12‰ñ“ú—Õ×–EŠw‰ïŠÖ“Œ˜A‡‰ï i98.09.12j, ‰F“s‹{, —\eW, p.21, 1998.

2166. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j Žq‹{“à–Œ×–Ef. ‘ –{”ŽsiŽY•wj: ‘æ23‰ñ“ú—Õ×–EŠw‰ï×–Ef’fŠwƒZƒ~ƒi[ i98.08.02j, “Œ‹ž.

2167. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j Žq‹{“à–Œ‚Ì×–Ef. ‘ –{”ŽsiŽY•wj: ‘æ103‰ñ“ú–{—Õ°×–EŠw‰ï×–EŒŸ¸Žm—{¬uK‰ï i98.07.07j, “Œ‹ž.

2168. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j •wl‰È‚Ì×–Ef. ‘ –{”ŽsiŽY•wj: ‘æ105‰ñ“ú—Õ×–EŠw‰ï×–EŒŸ¸Žm—{¬uK‰ï i98.07.24j, “Œ‹ž.

2169. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj «ŠíŠà‚Ìk¬Žèp. ‘ –{”ŽsiŽY•wj: “ú–{ˆãŽt‰ïƒ‰ƒWƒI’Z”guˆãŠwuÀv i98.07.15j, “Œ‹ž.

2170. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ƒRƒ‹ƒ|f‚ÌŽÀÛ. ‘ –{”ŽsiŽY•wj: •½¬10”N“x“ú•êŒ¤C‰ï i98.11.08j, ŽRŒû.

2171. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ³íŽüŠú‚Æ‹@”\•s‘S“™‚É‚¨‚¯‚é“à–Œ×–Ef. ‘ –{”ŽsiŽY•wj: •½¬10”N“x“Œ‹ž“s¬l•aŒŸf]Ž–ŽÒuK‰ï i98.11.11j, “Œ‹ž.

2172. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ƒXƒ‰ƒCƒhƒJƒ“ƒtƒ@ƒŒƒ“ƒX|•wl‰È. ‘ –{”ŽsiŽY•wjC‘å–ì‰pŽ¡i•a‰@•a—j: •½¬10”N“x“Œ‹ž“s¬l•aŒŸf]Ž–ŽÒuK‰ï i98.11.11j, “Œ‹ž.

2173. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Žq‹{‘ÌŠà‚Ì—Õ°‚Æ•a‘Ô. ‘ –{”ŽsiŽY•wj: •½¬10”N“x_“Þ쌧זEf]Ž–ŽÒuK‰ï i99.01.23j, ‰¡•l.

2174. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Žq‹{“à–Œ×–Ef. ‘ –{”ŽsiŽY•wj: ŠàŒ¤×–EŒŸ¸Žm—{¬Š i98.05.06j, “Œ‹ž.

2175. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Žq‹{‘Ì•”—Ç«•a•Ï‚Ì—Õ°×–EŠw, Žq‹{‘Ì•”ˆ««•a•Ï‚Ì—Õ°×–EŠw. ‘ –{”ŽsiŽY•wj: ˆÇ—Ñ‘åŠw•ÛŒ’Šw•”×–EŒŸ¸Žm—{¬‰ß’ö i98.05.20j, “Œ‹ž.


<<21 ®Œ`ŠO‰ÈŠw>>

2176. mŒ´’˜n Problems of various fixation methods for open tibia fractures: Experience in a Japanese level trauma center. b”ãGŽÀC‰¡ŽRˆê•Fi®ŠOjCV“¡³‹Pi‹~–½jCŽ…–ž·Œ›i®ŠOj: Am. J. Orthop., 27(9): 631`636, 1998.

2177. mŒ´’˜n Time course of superoxide generation in reperfusion after arterial ischemia and venous congestion. ’†‘ºŒõLC‰¡ŽRˆê•FC–Ø‘º³“i®ŠOjC’†‘º‘‰qi•ª¶jCŽ…–ž·Œ›i®ŠOj: Br. J. Plast. Surg., 51: 633`636, 1998.

2178. mŒ´’˜n Regular article: Thyroid hormone-induced chondrocyte teminal differention in rat femur organ culture. ˜e“c—²ŽiCò•qOCŽ…–ž·Œ›i®ŠOj: Cell Tissue Res., 293(2): 357`364, 1998.

2179. mŒ´’˜n Functional outcomes of "Floating Elbow" injuries in adult patients. ‰¡ŽRˆê•FCŽ…–ž·Œ›C¬—Ñ–¾³CV“¡³‹PC“ñŒ©r˜Yi®ŠOj: J. Orthop. Trauma, 12(4): 284`290, 1998.

2180. mŒ´’˜n R¶•¨Ž¿¬“üœƒZƒƒ“ƒgƒXƒy[ƒT[‚©‚ç‚Ì—°Ž_ƒQƒ“ƒ^ƒ}ƒCƒVƒ“—no—Ê‚ÌŒŸ“¢. —˜ªì‰ëri®ŠOjC‹´–{²Žqi–òÜ•”jCŠÖŒû¹˜aC–q–ìk•¶C•Ð‹Ë’•¶Cò•qOCŽ…–ž·Œ›i®ŠOj: œEŠÖßEèÕ‘Ñ, 11(8): 1019`1024, 1998.

2181. mŒ´’˜n ”玿œ1ƒ¿-TPCœƒZƒƒ“ƒgŠE–Ê‚É‚¨‚¯‚éŒoŽž“I‘gDŠw“IŒŸ“¢. å‚Œ´—L’ji®ŠOjCX“c^Žjiˆã—Éq¶jCŽ…–ž·Œ›i®ŠOj: ¶‘ÌÞ—¿, 17(1): 5`11, 1999.

2182. mŒ´’˜n Ò’Å•ª—£Ç‚ɑ΂·‚éPedicle screw and wiring–@. å‚Œ´—L’jCˆÀ’BŒöCŽR‰®’qNC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: “ú–{˜’ɉïŽ, 4(1): 13`19, 1998.

2183. mŒ´’˜n •GŠWE‘å‘ÚŠÖßáŠQ‚̶‘Ì—ÍŠw“I‰ðÍ|•GŠWœ‘¤•û“®—h«‚Ì’è—Ê“IŒ¤‹†|. ’r“c‹M‰pi®ŠOjC‘ºÎ–¾•Fiç—t‘åj: –k—¢ˆãŠw, 28(2): 190`200, 1998.

2184. mŒ´’˜n Paratenon‚ðŠÜ‚Þretinaculum‚É‚æ‚è”í•¢‚µ‚½•GŠWäF‚É‚æ‚錢‘O\ŽšèÕ‘ÑÄŒšp‚ÌŽÀŒ±“IŒ¤‹†. ‘•ªˆê³C–k’ÜLmC’Ë–{s’jCŽ…–ž·Œ›i®ŠOj: –k—¢ˆãŠw, 28(2): 206`215, 1998.

2185. mŒ´’˜n —â“€•Û‘¶“¯Žíœ‚ð—p‚¢‚½ˆ««Žîᇊ³ŽˆÄŒšp‚ÌŒoŒ±i’†ŠÔ‘}“üˆÚA‚Æ‚µ‚Ä). “ß{–ìG“ñC‘å–ìŽiC’Ë–{’B˜YC•x‰irsCŠÖŒû¹˜aCò•qOC‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: –k—¢ˆãŠw, 29(1): 19`23, 1999.

2186. m€Œ´’˜n Total Hip Prosthesis. Ž…–ž·Œ›i®ŠOjC‚‰ª–M•viMB‘åj: The Hip, p.43`96, 1998.

2187. m€Œ´’˜n —Ç«œŽîᇎ¡—Âɂ¨‚¯‚éƒÁü–Å‹Û“¯ŽíœˆÚA‚Ì—˜—p. ˜e“c—²ŽiCò•qOC“n•Ó“NÆCŠÖŒû¹˜aC“ß{–ìG“ñC‘å–ìŽiC¬—Ñ–¾³C“ìàVˆç—YCŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 29(2): 154`158, 1998.

2188. m€Œ´’˜n ŽèŽw‚É”­¶‚µ‚½glomusŽîᇂ̎¡—ÃŒoŒ±. •‚“c–L•FC“ñŒ©r˜YC¬—Ñ–¾³C‰““¡‘¾“’jCŒiŽRŒ³¬C’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 29(2): 164`166, 1998.

2189. m€Œ´’˜n žôœ‰“ˆÊ’[œÜ‚ɇ•¹‚µ‚½³’†_Œo–ƒáƒ—á‚ÌŒŸ“¢. ’†‘ºŒõLC“ñŒ©r˜YC¬—Ñ–¾³C˜e“c—²ŽiCÄ“cN”VC’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 29(4): 374`377, 1998.

2190. m€Œ´’˜n “Á”­«ŽèªŠÇÇŒóŒQ‚É‚¨‚¯‚銊–Œ, x‘Ñ‚ÌŒŸ“¢. ¬—Ñ–¾³C“ñŒ©r˜YC‰““¡‘¾“’jC’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 30(1): 1`3, 1999.

2191. m€Œ´’˜n •GŠW“à‘¤ŠŠ–Œƒqƒ_‚Ì’f—ôŒ`‘Ô, ‚»‚Ì—Õ°Ç󂨂æ‚Ñ‘gDŠw“IŒŸ“¢. ‹{‰ºŒªˆêC–k’ÜLmC‘Šì~C”ª–؉pŒ›C’r“c‹M‰pC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ŠÖ“Œ•G‚ðŒê‚é‰ï‰ïŽ, 14(1): 48`52, 1998.

2192. m€Œ´’˜n ‰º‘ÚœŠJ•úœÜ‚ɑ΂·‚éUnreamed‚ÆReamed IM nailing‚ÌŒŸ“¢. –kŒ©Œ\Žii®ŠOjCV“¡³‹Pi‹~–½jC“c’†Œ[Ži‚aC‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: œÜ, 20(1): 284`287, 1998.

2193. m€Œ´’˜n •GŠW“à‘¤ŠŠ–Œƒqƒ_‚ÌŒŸ“¢. ‹{‰ºŒªˆêC–k’ÜLmC‘Šì~C”ª–؉pŒ›C’r“c‹M‰pC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: “Œ‹ž•GŠÖߊw‰ï‰ïŽ, 19: 158`162, 1998.

2194. m€Œ´’˜n •G”¼ŒŽ”ÂC•œpŒã‚Ì‹¾Ž‹ŠŒ©. –k’ÜLmC‹{‰ºŒªˆêCŠÖ”EC”ª–؉pŒ›C’r“c‹M‰pC¬“‡—²ŽjC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: “Œ‹ž•GŠÖߊw‰ï‰ïŽ, 19: 42`46, 1998.

2195. m€Œ´’˜n Kienbock•a‚ɑ΂·‚éSTT (scaphoid-trapezium-trapezoid)ŒÅ’èp‚ÌŒŸ“¢. ‰““¡‘¾“’jC“ñŒ©r˜YC¬—Ñ–¾³C’Ë–{s’ji®ŠOj: “Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ïŽGŽ, 11(1): 51`56, 1999.

2196. m€Œ´’˜n Pedicle screw–@‚𕹗p‚µ‚½˜’Ō㑤•ûŒÅ’èp‚Ì—×Ú’ÅŠÔ‚É‹y‚Ú‚·‰e‹¿. ŽR‰®’qNCˆÀ’BŒöCå‚Œ´—L’jCŽO—Ö´ŽuC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: “Œ“ú–{—Õ°®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 10(4): 424`427, 1998.

2197. m€Œ´’˜n ‰“ˆÊžôŽÚŠÖß•sˆÀ’èǂɑ΂·‚éHuiŽèp‚ÌpŒã¬Ñ. ‰““¡‘¾“’jC“ñŒ©r˜YC¬—Ñ–¾³C’Ë–{s’ji®ŠOj: “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 15(1): 207`210, 1998.

2198. m€Œ´’˜n “Á”­«ŽèªŠÇÇŒóŒQ‚É‚¨‚¯‚é‹Ø• ‚ÌŒŸ“¢. ¬—Ñ–¾³C“ñŒ©r˜YC‰““¡‘¾“’jC’Ë–{s’ji®ŠOj: “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 15(4): 12`14, 1998.

2199. m€Œ´’˜n ƒQƒ“ƒ^ƒ}ƒCƒVƒ“ŠÜ—LƒZƒƒ“ƒgƒXƒy[ƒT[‚ð—p‚¢‚½Š´õŒÒŠÖ߂ɑ΂·‚鎡—ìÑ. ŠÖŒû¹˜aCŽ…–ž·Œ›Cò•qOC—˜ªì‰ërC•i“c®FC’Ë–{’B˜YC•‘òˆê–çi®ŠOjC‹´–{²Žqi–òÜ•”j: “ú–{lHŠÖߊw‰ïŽ, 28: 79`80, 1998.

2200. mŒ¤‹†•ñiŒú¶Èjn Œ’N•â•‹ï‚ÌŠJ”­|Š´õ«ŒÒŠÖß‚É‚¨‚¯‚éR¶ÜŠÜ—LƒZƒƒ“ƒgƒXƒy[ƒT[‚Ì—Õ°‰ž—p. Ž…–ž·Œ›C—˜ªì‰ërCŠÖŒû¹˜aCò•qOi®ŠOj: Œ’NE’·Žõ‚Ɗ‹«ˆã‰ÈŠw; •½¬‚X”N“xŠwpƒtƒƒ“ƒeƒBƒA„iŽ–‹Æ‹¤“¯Œ¤‹†•ñ‘, p.83, 1998.

2201. mŒ¤‹†•ñiŒú¶Èjn ‘½”­«œ‰óŽ€‚É‚¨‚¯‚é‘å‘ÚœMRI‘œ|‚wü‘œ‚Æ‚Ì”äŠr‚ðŠÜ‚ß‚Ä|. Ž…–ž·Œ›Cò•qOCŠÖŒû¹˜ai®ŠOj: Œú¶È“Á’莾Š³œEŠÖߌnŽ¾Š³’²¸Œ¤‹†”Ç•½¬‚X”N“xŒ¤‹†•ñ‘, P.192`193, 1998.

2202. mŒ¤‹†•ñiŒú¶Èjn ‘gDˆÚAƒlƒbƒgƒ[ƒN‚ÉŠÖ‚·‚錤‹†. ‚–{áÁˆêi“Œ‘åjC‘¾“c@•vi‘åã•{—§ç—¢‹~‹}ƒZƒ“jC‰_ˆäŒ’—Yi•ºŒÉƒCƒA[ƒoƒ“ƒNjC–k‘º‘yˆê˜Yi‘—§zŠÂŠí•aƒZƒ“jCŽ…–ž·Œ›i®ŠOjC’JŒû”ÉŽ÷i“Þ —Ljã‘åjCó–ì•Giç—t‘åjC‚Œ´Žj˜Yiã‘åjC“’óŒõ—˜i‚‹´ƒNƒŠƒjƒbƒNjC’†“‡~i“Œ‘åj: Œú¶È–ƉuEƒAƒŒƒ‹ƒM[“™Œ¤‹†Ž–‹Æ‘ŸŠíˆÚA•”–啽¬‚X”N“xŒ¤‹†•ñ‘, p.288`291, 1998.

2203. mÇ—á•ñn Bone transport combined with free flap reconstruction and antibiotic bead spacers for a type ‡V open tibial fracture; Case report. •ôŒ´G¹C‰¡ŽRˆê•FCŠÖŒû¹˜aC’†‘º‘–¾i®ŠOjCV“¡³‹Pi‹~–½jCŽ…–ž·Œ›i®ŠOj: J. Trauma, 44(6): 1103`1107, 1998.

2204. mÇ—á•ñn lHŠÖ߬ѕs—Ç‚RÇ—á‚ÌŒŸ“¢. ŽR‰®’qNC–k’ÜLmC¬—Ñ–¾³CˆÀ’BŒöCå‚Œ´—L’jC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 20(3): 227`230, 1998.

2205. mÇ—á•ñn ŽèŽw––ßœ‚ɶ‚¶‚½—Þã”ç”XŽî‚Ì‚R—á. –{•”ƒŽqC¬—Ñ–¾³C”ª–؉pŒ›C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 29(4): 441`444, 1998.

2206. mÇ—á•ñn ˜r_Œo‘p–ƒáƒ‚𔺂¢ŠÏŒŒ“I®•œ‚ð—v‚µ‚½’‹Œ«Œ¨ŠÖß’E‰P‚Ì‚P—á. ’爨ŽÀC‘å‚•¶“TC‚ŠÝŒ›“ñCŠÖŒû¹˜aC•ôŒ´G¹CŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 29(5): 488`492, 1998.

2207. mÇ—á•ñn ó‘å‘Ú“®Ã–¬‘¹‚ð‡•¹‚µ‚½‘å‘ÚœœŠ²•””牺œÜ‚Ì‚R—á. —˜ªì‰ërC‰¡ŽRˆê•Fi®ŠOjCV“¡³‹Pi‹~–½jCb”ãGŽÀC’†‘ºŒõLCŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 30(1): 45`50, 1999.

2208. mÇ—á•ñn Ä”­‚ðŒJ‚è•Ô‚µŽüˆÍZ«‚É”­ˆç‚µ‚½•GF‘f«ãO–ÑŒ‹ß«ŠŠ–Œ‰Š‚Ì‚P—á. ‘Šì~C–k’ÜLmC‹{‰ºŒªˆêC”ª–؉pŒ›C’r“c‹M‰pC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ŠÖ“Œ•G‚ðŒê‚é‰ï‰ïŽ, 14(1): 27`32, 1998.

2209. mÇ—á•ñn LerichieÇŒóŒQ‚Ì‚P—á. ŽR“cW‹BCˆÀ’BŒöCå‚Œ´—L’jCŽR‰®’qNCŠÖ”EC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: _“Þ쮌`ЊQŠO‰Èˆã‰ïŽGŽ, 11(2): 85`88, 1998.

2210. mÇ—á•ñn ƒL[ƒ“ƒxƒbƒN•a‚É”º‚Á‚½ŽèªŠÇÇŒóŒQ‚Ì‚P—á. “ŒŒvC“ñŒ©r˜YC‰““¡‘¾“’jCˆÀ’BŒöC–k’ÜLmC¬—Ñ–¾³C’Ë–{s’ji®ŠOj: _“Þ쮌`ЊQŠO‰Èˆã‰ïŽGŽ, 11(5): 169`172, 1998.

2211. mÇ—á•ñn lHŒÒŠÖß’uŠ·pŒã‚ɶ‚¶‚½ƒJƒ“ƒWƒ^Š´õÇ‚Ì‚P—á. ‘å’Ë•q”VC•i“c®FCŠÖŒû¹˜aCò•qOC’Ë–{’B˜YCŒiŽRŒ³¬CŽ…–ž·Œ›i®ŠOj: _“Þ쮌`ЊQŠO‰Èˆã‰ïŽGŽ, 11(5): 205`208, 1998.

2212. mÇ—á•ñn •às¢“ï‚ð’悵‚½d–Œ“à’Eo˜’ŒŊԔƒwƒ‹ƒjƒA‚Ì‚P—á. ‘Šì~Cå‚Œ´—L’jCˆÀ’BŒöCŽR‰®’qNC“c•Ó‰ê‘¥C‹{‰ºŒªˆêCŠÖ”EC“ñŒ©r˜YC’Ë–{s’jC‹v•ÛŽ›‘å–çi®ŠOj: _“Þ쮌`ЊQŠO‰Èˆã‰ïŽGŽ, 11(5): 231`234, 1998.

2213. mÇ—á•ñn ‘“à“B‚ð—˜—p‚µ‚½—¼‰ºŽˆœ‰„’·p‚Ì‚P—á. ŠÖŒû¹˜aCŽ…–ž·Œ›Cò•qOC“茴G”VC”’{ˆê–çCŠ}ˆäŒª˜ai®ŠOj: ®Œ`ŠO‰È, 49(5): 1253`1256, 1998.

2214. mÇ—á•ñn 圕”ŽîᇂɉEtŽîá‡‚ð‡•¹‚µ‚½‚P—á. ’Ë–{’B˜Yi®ŠOjCŽOŽ}Mi•a—jC“ß{–ìG“ñi®ŠOj: –k—¢ˆãŠw, 28(3): 299`301, 1998.

2215. m—Õ°Ž¡Œ±n –«ŠÖ߃ŠƒEƒ}ƒ`, •ÏŒ`«•GŠÖßÇ, ˜’ÉÇ, ŽèpŒã‚Ìáu’ɂɑ΂·‚éƒfƒBƒXƒ|[ƒUƒuƒ‹’“ü“îpÜ: ƒWƒNƒƒtƒFƒiƒNƒiƒgƒŠƒEƒ€(OED25, 50)‚Ì—Õ°•]‰¿. –،ՋgC›Œ´KŽqC’Ë–{s’jC—§Îº•vCˆäãK—YC–؎¡lC–öì’‰“ñi®ŠOj: –ò—‚ÆŽ¡—Ã, 26(3): 133`170, 1998.

2216. m‘àn RSD‚ÌŒ»ó‚Æ–â‘è“_. “ñŒ©r˜Yi®ŠOjC¬ìߘYC@d”ŽC‰““¡‘¾“’ji®ŠOj: Medical Academy News, 711: 6`7, 1999.

2217. m‘àn •I“à‘¤‘¤•›èÕ‘Ñ•s‘S‚ɑ΂·‚éJobe–@‚É‚æ‚éÄŒš. “ñŒ©r˜YC“¡“c³i®ŠOj: Monthry Book Orthopaedics, 11(4): 49`54, 1998.

2218. m‘àn ‰º‘ÚœŠJ•úœÜ‚ɑ΂·‚é“àŒÅ’èpŒã‚Ì[•”Š´õ‚Æ‚»‚ÌŽ¡—Ö@. ‰¡ŽRˆê•FCŽ…–ž·Œ›CŠÖŒû¹˜aC—˜ªì‰ëri®ŠOj: Monthry Book Orthopaedics, 12(2): 33`44, 1999.

2219. m‘àn ’†ŽèœEŽwßœœÜ‚ÌŽ¡—Ã. ¬—Ñ–¾³i®ŠOj: New Mook®Œ`ŠO‰È, (5): 153`158, 1998.

2220. m‘àn ’·ŠÇœœÜ‚ɑ΂·‚é‘“à“B‚Ë‚¶‰¡Ž~‚ß–@. ò•qOCŽ…–ž·Œ›C‰¡ŽRˆê•Fi®ŠOjCV“¡³‹Pi‹~–½j: Pharma Medica, 16(12): 85`89, 1998.

2221. m‘àn ƒeƒjƒX•I. “ñŒ©r˜Yi®ŠOj: ‚¯‚ñ‚Û‚¾‚æ‚è, 97: 18, 1998.

2222. m‘àn •ÏŒ`«ŒÒŠÖßÇ. ŠÖŒû¹˜aCŽ…–ž·Œ›i®ŠOj: ˆãŠw‚Æ–òŠw, 39(5): 937`943, 1998.

2223. m‘àn žôœ‰“ˆÊ’[œÜ‚ÌŽ¡—Ã|ŠÖß“àœÜ‚Ìf’f‚ÆŽ¡—Ãã‚ÌH•v|. “ñŒ©r˜YCå‚Œ´—L’jC“¡“c³C–ذ•FC¬—Ñ–¾³C‰““¡‘¾“’ji®ŠOj: ŠÖߊO‰È, 11(11): 38`42, 1998.

2224. m‘àn ‘å‘Úœè÷ãœÜ‚ɑ΂·‚é‡s«‘“à“B‰¡Ž~‚ß–@. ‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: ŠÖߊO‰È, 17(10): 68`74, 1998.

2225. m‘àn ‘J‰„–ü‡‚Æ‹UŠÖß‚Ìl‚¦•û. Ž…–ž·Œ›i®ŠOj: œEŠÖßEèÕ‘Ñ, 11(4): 345`350, 1998.

2226. m‘àn ‘ŸŠíˆÚA–@‚Æ“¯ŽíœˆÚA. Ž…–ž·Œ›i®ŠOj: œEŠÖßEèÕ‘Ñ, 11(5): 473`475, 1998.

2227. m‘àn Ž{Ýœ‹âs. ŠÖŒû¹˜aCŽ…–ž·Œ›Cò•qOi®ŠOj: œEŠÖßEèÕ‘Ñ, 12(3): 273`278, 1999.

2228. m‘àn ŒÒŠÖߎèp‚É‚¨‚¯‚霈ÚA–@. ò•qOCŽ…–ž·Œ›CŠÖŒû¹˜ai®ŠOj: ®Œ`EЊQŠO‰È, 41(5): 661`666, 1998.

2229. m‘àn ‚wüf’fQ & A. ŠÖŒû¹˜ai®ŠOj: ®Œ`ŠO‰È, 50(4): 355`356, 1999.

2230. m‘àn ‰º‘ÚŠJ•úœÜ‚̉ŠúŽ¡—Ã. Ž…–ž·Œ›i®ŠOj: “ŒŠC®Œ`ŠO‰ÈŠOŒ¤‹†‰ïŽ, 11: 3`11, 1998.

2231. m‘àn ŠÖß“îœC•œ‚Ƭ’·ˆöŽq. ò•qOCŽ…–ž·Œ›i®ŠOj: –k—¢ˆãŠw, 28(5): 411`414, 1998.

2232. m‘àn ƒeƒjƒX•Ii®Œ`ŠO‰È/’m‚Á‚Ä‚é‚‚à‚è). “ñŒ©r˜Yi®ŠOj: —Õ°®Œ`ŠO‰È, 34(3): 350`351, 1999.

2233. mŠwp‘n i•ª’SŽ·•Mj ŒÒŠÖß‚ÌŠO‰È; ŠO«Ž¾Š³, p.331`342, Ž…–ž·Œ›i®ŠOj. •ÒW Έä—ÇÍiˆÇ—Ñ‘åjC¼–ìä•viˆ®ìˆã‘åjC⊪–L‹³i‘—§¬Ž™•a‰@j.

2234. mŠwp‘n i•ª’SŽ·•Mj “ú–{ˆãŽt‰ïŽGŽáŠQ‹³ˆçƒVƒŠ[ƒY46. áu’ɃRƒ“ƒgƒ[ƒ‹‚ÌABC; ŽlŽˆ‚Ìáu’É, p.268`272, “ñŒ©r˜Yi®ŠOj. •ÒW ‰Ô‰ªˆê—Y‘¼C ˆãŠw‘‰@, “Œ‹ž, 1998.06.00”­s.

2235. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ‚wü‚Å‚Ý‚éœÜŽ¡—ÃŽè‹Z; ŒÒŠÖß’E‰PœÜi‰PŠWŒã•ÇœÜ‚Æ‘å‘Úœ“ªœÜ‚𔺂¤), Ž…–ž·Œ›i®ŠOj. •ÒW …–ìkìi_ŒË‘åjC•ÒC Z—F»–ò, ‘åã, 1998.00.00”­s.

2236. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ª’SŽ·•Mj Kienbock's Syndrome; ÇŒóŒQŽ–“TŽ¡—ÂÆf’f, p.699, “ñŒ©r˜Yi®ŠOj. •ÒW ‰Y”{•v»C f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 1998.04.00”­s.

2237. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ª’SŽ·•Mj Preiser Syndrome; ÇŒóŒQŽ–“TŽ¡—ÂÆf’f, p.715, “ñŒ©r˜Yi®ŠOj. •ÒW ‰Y”{•v»C f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 1998.04.00”­s.

2238. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ª’SŽ·•Mj Panner Syndrome; ÇŒóŒQŽ–“TŽ¡—ÂÆf’f, p.713, “ñŒ©r˜Yi®ŠOj. •ÒW ‰Y”{•v»C f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 1998.04.00”­s.

2239. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ª’SŽ·•Mj Sudeck Syndrome; ÇŒóŒQŽ–“TŽ¡—ÂÆf’f, p.720, “ñŒ©r˜Yi®ŠOj. •ÒW ‰Y”{•v»C f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 1998.04.00”­s.

2240. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.1; ƒnƒ“ƒ}[æä•ÏŒ`‚ÉŠÖ‚·‚éÅ‹ß‚Ìl‚¦•û, p.3`5, Ž…–ž·Œ›i®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1997.06.00”­s.

2241. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.1; ƒXƒL[ŠO: ”­¶•p“x‚Æ—\–h‘Îô, p.10`11, Ž…–ž·Œ›i®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1997.06.00”­s.

2242. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.2; ”¼ŒŽC•œp, p.3`4, ò•qOi®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1997.10.00”­s.

2243. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.2; äF”ÂŽèpŒã‚ÌŒ¨‚Ìáu’É‚Ì•]‰¿, p.10`11, ò•qOi®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1997.10.00”­s.

2244. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.2; ƒXƒL[ŠO: ”­¶•p“x‚Æ—\–h‘Îô‚ÉŠÖ‚·‚鎿–â‚Ɖñ“š, p.12, ò•qOi®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1997.10.00”­s.

2245. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.3; lH•GŠÖß’uŠ·pŒã‚Ì’·Šú¬Ñ, p.3`5, ‰¡ŽRˆê•Fi®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1998.02.00”­s.

2246. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.3; ãøœœŠ²•”œÜ‚Ì‘“àŒÅ’è: “K‰ž‚Ƈ•¹Ç, p.10`12, ‰¡ŽRˆê•Fi®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1998.02.00”­s.

2247. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.1; äF”ÂŽèpŒã‚ÌŒ¨‚Ìáu’É‚Ì•]‰¿‚ÉŠÖ‚·‚鎿–â‚Ɖñ“š, p.12, ò•qOi®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1997.06.00”­s.

2248. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.4; lHŠÖß’uŠ·p‚É‚¨‚¯‚éƒ|ƒŠƒGƒ`ƒŒƒ“‚Æ‚»‚Ì‘¼‚̜Г®–Ê, p.3`5, ŠÖŒû¹˜ai®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1998.05.00”­s.

2249. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.4; ’†”NŠ³ŽÒ‚É‚¨‚¯‚é•GŠÖßÇ‚ÌŠÇ—, p.10`11, ŠÖŒû¹˜ai®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1998.05.00”­s.

2250. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.5; ‘å‘Úœ“]Žq‰ºœÜ‚ÌŽ¡—Ã, p.3`4, –k’ÜLmi®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1998.08.00”­s.

2251. m–|–ón i•ª’SŽ·•Mj The Journal of Bone & Joint Diseases: INDEX & REVIEWS, No.5; ‰^“®‘IŽè‚É‚¨‚¯‚é•GŠWäFáŠQ‚ÌŽ¡—Ã, p.10`11, –k’ÜLmi®ŠOj. •ÒW Ž…–ž·Œ›i®ŠOjC ƒG[ƒUƒC, “Œ‹ž, 1998.08.00”­s.

2252. mŠw‰ïi‘Ûjn i‹³ˆçu‰‰j Role of Valgus-Flexion osteotomy for advanced OA of the hip joint in middle-aged patients. Ž…–ž·Œ›CŠÖŒû¹˜aCò•qOC–{•”ƒŽqC•i“c®Fi®ŠOj: WPOA '98 FUKUOKA i98.11.02`06j, •Ÿ‰ª.

2253. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Role of aceabular reinforcement ring (ARR) combined with allograft reconstruction in revision THR. Ž…–ž·Œ›CŠÖŒû¹˜aCò•qOC‘OŒ´G•vC•x‰irsi®ŠOj: 9th Korean-Japanese Combined Orthopaedic Symposium i98.07.02`04j, Korea.

2254. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Bone allografts in the massive bone defect around the knee. ò•qOCŽ…–ž·Œ›CŠÖŒû¹˜aC“ß{–ìG“ñC‘å–ìŽii®ŠOj: WPOA '98 FUKUOKA i98.11.02`06j, •Ÿ‰ª.

2255. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Restorative laminectomy and pediculectomy for thoracic and lumbar spine. ˆÀ’BŒöCå‚Œ´—L’jCŽR‰®’qNC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: 5th International Meeting on Advanced SP Techniqus i98.05.01`03j, ƒiƒ|ƒŠ.

2256. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Restorative laminectomy and pediculectomy for thoracic and lumbar spine. ˆÀ’BŒöCå‚Œ´—L’jCŽR‰®’qNC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: NASS 13th Annual Meeting i98.10.28`31j, San Francisco, NASS 13th Annual Meeting Proceedings, p.49, 1998.

2257. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Open method for Dupuytren's contracture. ¬—Ñ–¾³C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘ÛŽè‚ÌŠO‰ÈŠw‰ï i98.05.25`28j, ƒoƒ“ƒN[ƒo[, ƒJƒiƒ_.

2258. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The use of acetabular reinforcement ring combined with strut screws in revision total hip arthroplasty-biomechanical study. ŠÖŒû¹˜aCŽ…–ž·Œ›Cò•qOC•i“c®Fi®ŠOjCX“c^ŽjC”n•£´Ž‘iˆã—Éq¶jC“ŒŒvi®ŠOj: 1st Combined Meeting European Association of Tissue Banks (EATB) and Muscule Skeletal Tranplantation (EAMST) i98.09.10`12j, ƒtƒBƒ“ƒ‰ƒ“ƒh.

2259. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Cortical revascularization after reamed and unreamed intramedullary nailing in the rabbit femur. ’†‘º‘–¾CŽ…–ž·Œ›C‰¡ŽRˆê•Fi®ŠOj: Orthopaedic Trauma Association i98.10.08`10j, ƒoƒ“ƒN[ƒo[, ƒJƒiƒ_.

2260. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The role of nitric oxide in interleukin-‚Pƒ¿ induced synthesis of proteoglycans and hyaluronan by cultured rabbit chondroytes. ‚•½®LCŽ…–ž·Œ›i®ŠOjC‚ŠÝŒ›“ñiŒQ‘åjC¼‘º–¾lC—˜ªì‰ërC‘å‚•¶“Ti®ŠOj: Osteo Arthritis Research Society i98.10.15`17j, ƒCƒ^ƒŠƒA.

2261. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Experimental arthritis induced by continuous infusion of MCP-1 in rabbit knee joint. ¼‘º–¾li®ŠOjCÔ¯“§i“àjC‘å‚•¶“TC“ß{–ìG“ñC‚ŠÝŒ›“ñi®ŠOjC‹ß“¡Œ[•¶i“àjCŽ…–ž·Œ›i®ŠOj: American College of Rheumatology 62 National Scientific Meeting i98.11.08j, San Diago.

2262. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of fixation stability on fracture callus. •ôŒ´G¹Cò•qOC˜e“c—²ŽiC•x‰irsC“à–ì³—²C‘å’JL‹vCŽ…–ž·Œ›i®ŠOj: 45th Annual Meeting of the Orthopaedics Research Society i99.02.01`04j, California.

2263. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The role of nitric oxide in interleukin-1 induced synthesis of proteoglycans and hyaluronan by rabbit chondrocytes from rib growth plate in monolayer cultures. ‚•½®LCŽ…–ž·Œ›i®ŠOjC‚ŠÝŒ›“ñiŒQ‘åjC¼‘º–¾lC—˜ªì‰ërC‘å‚•¶“Ti®ŠOj: 45th Annual Meeting of the Orthopaedics Research Society i99.02.01`04j, California.

2264. mŠw‰ïi‘S‘jn i“Á•Êu‰‰j isŠúE––ŠúŒÒŠÖßǂɑ΂·‚éŠO”½œØ‚èp‚¨‚æ‚ÑChiariœ”՜؂èp•¹—pŽèp‚Ì’†Šú¬Ñ|ŠO”½‹ü‹ÈœØ‚èp’P“ÆŽèp—á‚Æ‚Ì”äŠr|iŽóÜu‰‰j. ŠÖŒû¹˜aCŽ…–ž·Œ›Cò•qOC“ß{–ìG“ñCb”ãGŽÀC•i“c®Fi®ŠOj: ‘æ25‰ñ“ú–{ŒÒŠÖߊw‰ï i98.10.29`30j, –k‹ãBŽs.

2265. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰PŠWœŒ‡‘¹‚ɑ΂·‚铯ŽíœˆÚA‚ƃTƒ|[ƒgƒŠƒ“ƒO‚É‚æ‚éC•œicemented). ŠÖŒû¹˜aCŽ…–ž·Œ›Cò•qOC•i“c®Fi®ŠOjCX“c^Žjiˆã—Éq¶j: ‘æ71‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i98.04.17`20j, “¿“‡, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 70(2): 41, 1998.

2266. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘å‘Úœè÷ã, è÷ŠÔœÜ‚Ì‹@”\¬Ñ. ‰¡ŽRˆê•FC“ŒŒvCŠÖŒû¹˜aCò•qOi®ŠOjCV“¡³‹Pi‹~–½jCŽ…–ž·Œ›i®ŠOj: ‘æ46‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï i98.10.14`15j, –¼ŒÃ‰®.

2267. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj MCP-1‚Ì“e•GŠÖß“à‚Ö‚ÌŽ‘±“Š—^‚̉e‹¿. ¼‘º–¾li®ŠOjCÔ¯“§i“àjC‚•½®LCŽ…–ž·Œ›i®ŠOjC‹ß“¡Œ[•¶i“àj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

2268. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “«ã˜rœŠOãè÷‰Š‚ɑ΂·‚éŽèp|pŒã¬Ñ‚¨‚æ‚Ñ‘gDŠŒ©‚ð’†S‚É|. •‚“c–L•FC“ñŒ©r˜YC‰““¡‘¾“’jC¬—Ñ–¾³CˆÀ’BŒöC–k’ÜLmC’Ë–{s’ji®ŠOj: ‘æ71‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i98.04.17`20j, “¿“‡, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 70(2): 455, 1998.

2269. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Floating KneeœÜ‚Ì‹@”\¬Ñ‚É‹y‚Ú‚·”ˆöŽq‚ÌŒŸ“¢. ‰¡ŽRˆê•FCŽ…–ž·Œ›C’†‘º‘–¾i®ŠOjCV“¡³‹Pi‹~–½jCŠÖŒû¹˜ai®ŠOjC“c’†Œ[Ži‚ai‹~–½jCã“cºŒái‚’mˆã‘åj: ‘æ71‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i98.04.17`20j, “¿“‡, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 70(2): 493, 1998.

2270. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é•G”¼ŒŽ”ÂC•œp‚ÌŒŸ“¢. –k’ÜLmC‹{‰ºŒªˆêC”ª–؉pŒ›Cå‚Œ´—L’jC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ71‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i98.04.17`20j, “¿“‡, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 70(3): 540, 1998.

2271. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j RA‚É”­¶‚µ‚½ŽèŽw‹ü‹ØäF”牺’f—ô‚Ì‚R—á. ¬—Ñ–¾³C“ñŒ©r˜YC‰““¡‘¾“’jC’Ë–{s’ji®ŠOj: ‘æ42‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i98.05.07`09j, “Œ‹ž.

2272. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰“ˆÊžôŽÚŠÖß•sˆÀ’èǂɑ΂·‚éHuiŽèp‚ÌpŒã¬Ñ. ‰““¡‘¾“’jC“ñŒ©r˜YC¬—Ñ–¾³C’Ë–{s’ji®ŠOj: ‘æ41‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï i98.05.14`15j, ‘åã, “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 15(´): 153, 1998.

2273. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Reamed‚¨‚æ‚Ñunreamed nailingŒã‚Ìœ”玿ŒŒ—¬‚̒ቺ‚Æ‚»‚̉ñ•œ|‰Æ“e‘“à“Bƒ‚ƒfƒ‹‚ð—p‚¢‚Ä|. ’†‘º‘–¾CŽ…–ž·Œ›C‰¡ŽRˆê•Fi®ŠOj: ‘æ24‰ñ“ú–{œÜŽ¡—Êw‰ï i98.07.10`11j, ‘åã.

2274. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “¯‘¤‘å‘ÚœE‰º‘ÚœœÜ‚Ì‹@”\¬Ñ|“Á‚ÉFreser ‡TŒ^‚ɂ‚¢‚Ä|. ‰¡ŽRˆê•FCŽ…–ž·Œ›C’†‘º‘–¾i®ŠOjCV“¡³‹PC“c’†Œ[Ži‚ai‹~–½jCŠÖŒû¹˜aCò•qOi®ŠOj: ‘æ24‰ñ“ú–{œÜŽ¡—Êw‰ï i98.07.10`11j, ‘åã, ´˜^W, p.11, 1998.

2275. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —â“€•Û‘¶“¯Žíœ‚ð—p‚¢‚½Š³ŽˆÄŒšp‚ÌŒoŒ±i’†ŠÔ‘}“üˆÚA‚Æ‚µ‚Ä). “ß{–ìG“ñC‘å–ìŽiC’Ë–{’B˜YC•x‰irsCŒiŽRŒ³¬C•àVˆê–çCŠÖŒû¹˜aCò•qOC‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: ‘æ31‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïœE“î•”ŽîᇊwpW‰ï i98.07.18`19j, –‹’£, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 72(6): 1138, 1998.

2276. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j MCP-1 (MCAF)‚Ì“eŠÖß“à‚Ö‚ÌŽ‘±“Š—^‚̉e‹¿. ¼‘º–¾li®ŠOjCÔ¯“§i“àjC“ß{–ìG“ñi®ŠOjC‹ß“¡Œ[•¶i“àjC‚ŠÝŒ›“ñiŒQ‘åjCŽ…–ž·Œ›i®ŠOj: ‘æ13‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i98.09.25`27j, –¼ŒÃ‰®, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 72(8): 1318, 1998.

2277. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ³íŠÖ߉t’†‚̃qƒAƒ‹ƒƒ“Ž_”Z“x‚Æ•ªŽq—Ê. ‰““¡‘¾“’jC’Ë–{s’jC¬—Ñ–¾³C–k’ÜLmi®ŠOjCì“c³ŽõC‰ª–{²•vi“d‹C‰»Šw‘‡Œ¤‹†Šj: ‘æ13‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i98.09.25`27j, –¼ŒÃ‰®, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 72(8): 1486, 1998.

2278. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÖ߉t‚Ì”S’e«. ’Ë–{s’jC‰““¡‘¾“’ji®ŠOjCì“c³ŽõC‰ª–{²•vi“d‹C‰»ŠwH‹Æ‘‡Œ¤‹†Šj: ‘æ13‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i98.09.25`27j, –¼ŒÃ‰®, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 72(8): 1487, 1998.

2279. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •úŽËüÆŽËœ‚É‚æ‚é”|—{œ‘×–E‚Ì•ª‰». •x‰irsCò•qOC˜e“c—²ŽiC“à–ì³—²C•ôŒ´G¹C‘åŠÑ—TŽqCŽ…–ž·Œ›i®ŠOjCˆÉ“¡‹Ïi“ú–{Œ´Žq—ÍŒ¤‹†Šj: ‘æ13‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i98.09.25`27j, –¼ŒÃ‰®, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 72(8): 1718, 1998.

2280. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‡VBŒ^‰º‘ÚœŠJ•úœÜ‚ÌŽ¡—Ã. “c’†Œ[Ži‚aCV“¡³‹Pi‹~–½jCŽ…–ž·Œ›i®ŠOj: ‘æ46‰ñ“ú–{ЊQˆãŠw‰ï i98.10.15j, –¼ŒÃ‰®, “ú–{ЊQˆãŠw‰ïŽ, 46(‘): 136, 1998.

2281. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j RAŽè‚É”­¶‚µ‚½äF”牺’f—ô|L‹ØäFC‹ü‹ØäF‚Ì”äŠrŒŸ“¢|. ¬—Ñ–¾³C“ñŒ©r˜YC‰““¡‘¾“’jC’Ë–{s’ji®ŠOj: ‘æ26‰ñ“ú–{ƒŠƒEƒ}ƒ`EŠÖߊO‰ÈŠw‰ï i98.10.22`23j, ‘å’Ã.

2282. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬l‚Ì•ÏŒ`«ŒÒŠÖßǂɑ΂·‚éChiariœ”՜؂èp‚Ì’†E’·Šú¬Ñ. ŠÖŒû¹˜aCŽ…–ž·Œ›Cò•qOC–{•”ƒŽqC“ŒŒvCŽu‘ºKFi®ŠOj: ‘æ25‰ñ“ú–{ŒÒŠÖߊw‰ï i98.10.29`30j, –k‹ãBŽs, Hip Joint, 24: 116`120, 1998.

2283. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰Æ“e‘å‘Ú’¼‹Ø‰·“x‘jŒŒŒãÄŠÁ—¬ƒ‚ƒfƒ‹‚É‚¨‚¯‚éˆêŽ_‰»’‚‘f(NO)‚ÆŠˆ«Ž_‘fiO2)‚ÌŒoŽž“I•Ï‰». ’†‘ºŒõLC‰¡ŽRˆê•Fi®ŠOjC’†‘º‘‰qi•ª¶jC¼‘º–¾lCÄ“cN”VCŽ…–ž·Œ›i®ŠOj: ‘æ25‰ñ“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ï i98.10.30`31j, “Œ‹ž.

2284. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠOŒããøœŒ‡‘¹‹UŠÖ߂ɑ΂·‚鎡—Ö@|—V—£ŒŒŠÇ•¿•t‚«œˆÚAp vs.Ilizarov–@|. ‰¡ŽRˆê•FCŠÖŒû¹˜ai®ŠOjC“c’†Œ[Ži‚ai‹~–½jC’†‘ºŒõLC’Ë–{’B˜Yi®ŠOjCV“¡³‹Pi‹~–½jCŽ…–ž·Œ›i®ŠOj: ‘æ25‰ñ“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ï i98.10.30`31j, “Œ‹ž.

2285. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Kaneda multisegmental instrumentation system‚ð—p‚¢‚½“Á”­«‘¤œ]ǂɑ΂·‚é‘O•û‹¸³ŒÅ’èp‚ÌŒŸ“¢. ˆÀ’BŒöCå‚Œ´—L’jCŽR‰®’qNC“c•Ó‰ê‘¥C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ32‰ñ“ú–{‘¤œ]ÇŠw‰ï i98.11.14`15j, ç—t.

2286. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽíX‚È‹@˜‚É‚æ‚élH•GŠÖß‚Ì”j’]. ‹{‰ºŒªˆêC–k’ÜLmC”ª–؉pŒ›CŽR‰®’qNCŠÖ”EC‘Šì~C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ29‰ñ“ú–{lHŠÖߊw‰ï i99.01.28`30j, ‘q•~.

2287. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒZƒ‰ƒ~ƒbƒNƒXEƒZƒ‰ƒ~ƒbƒNƒXlHŒÒŠÖß‚É”­¶‚·‚éˆø‚«”²‚«—Í. ”n•£´Ž‘iˆã—Éq¶jCã–ìŸi‹žƒZƒ‰jC•i“c®FCŽ…–ž·Œ›i®ŠOj: ‘æ29‰ñ“ú–{lHŠÖߊw‰ï i99.01.28`30j, ‘q•~.

2288. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒÅ’è–@‚̈Ⴂ‚É‚æ‚éœÜ“¼œ‚Ì‘B‚ÆTGF-ƒÀ1‚Ì‹ÇÝ. •ôŒ´G¹Cò•qOC˜e“c—²ŽiC“à–ì³—²C•x‰irsC‘å’JL‹vCŽ…–ž·Œ›i®ŠOj: ‘æ12‰ñ“ú–{“ãŽÓŠw‰ï i99.03.05`06j, ‰ªŽR.

2289. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰º‘ÚœŠJ•úœÜ‚ɑ΂·‚é‘nŠOŒÅ’èŒã‘“à“BÇ—á‚ÌŽ¡—ÃŒoŒ±|[•”Š´õ‚ɉe‹¿‚·‚锈öŽq‚ÌŒŸ“¢|. ‰¡ŽRˆê•FCŽ…–ž·Œ›C’Ë–{’B˜Yi®ŠOjCV“¡³‹PC“c’†Œ[Ži‚ai‹~–½j: ‘æ12‰ñ“ú–{‘nŠOŒÅ’èEœ‰„’·Šw‰ï i99.03.12`13j, å‘ä, ´˜^W, p.64, 1999.

2290. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “Á”­«ŽèªŠÇÇŒóŒQ‚É‚¨‚¯‚é‹Ø• ‚ɂ‚¢‚Ä|—Õ°—á, ‰ð–U—á‚ÌŒŸ“¢|. ¬—Ñ–¾³C“ñŒ©r˜YC‰““¡‘¾“’jC’Ë–{s’ji®ŠOj: ‘æ41‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï i98.05.14`15j, ‘åã, “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 15(´): 263, 1998.

2291. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Móœ‹UŠÖß‚ÌpŒã¬Ñ|criss-cross–@‚ÆRusse–@‚Ì”äŠr|. ŠÖ”EC“ñŒ©r˜YC¬—Ñ–¾³C‰““¡‘¾“’jC’Ë–{s’ji®ŠOj: ‘æ41‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï i98.05.14`15j, ‘åã, “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 15(´): 196, 1998.

2292. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Š®‘SŠÒ”[Ž®’Å‹|‹y‚Ñ’Å‹|ªØ—£p. ˆÀ’BŒöCå‚Œ´—L’jCŽR‰®’qNC“c•Ó‰ê‘¥C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ18‰ñ“ú–{Ò’ÅŠO‰ÈŠw‰ï i98.06.18`19j, ŽD–y.

2293. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Intravenous leiomyomatosis‚Ìi“W—lŽ®‚ð’悵‚½NSEŽY¶«—Þã”畽ŠŠ‹Ø“÷Žî‚Ì‚P—á. –ìŒû‚Žji®ŠOjC“y‹´—mi•a—jC“ß{–ìG“ñCŽ…–ž·Œ›i®ŠOjC‹T’J“Oi•a—j: ‘æ31‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïœE“î•”ŽîᇊwpW‰ï i98.07.18`19j, –‹’£, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 72(6): 1049, 1998.

2294. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ž™“Ë‹NcŠ„Ž®Ò’ŒŠÇŠg‘åp‚É‚æ‚鎡—ìтƂ»‚ÌŒŸ“¢. å‚Œ´—L’jCˆÀ’BŒöCŽR‰®’qNC“n•Ó®C‹{‰ºŒªˆêC‘Šì~Cˆä‘º‹M”VC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ36‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï i98.05.23j, “Œ‹ž.

2295. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “¯ˆê‰ÆŒn“à‚É”­¶‚µ‚½von Recklinghausen •ai‘½”­«_ŒoüˆÛŽîÇ‚Ì‚S—á). ‹{•”ŠîCˆÀ’BŒöCŠ}ˆäŒª˜aC–k’ÜLmC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ103‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i98.06.06j, ‰¡•l.

2296. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œy”÷‚ÈŠO—Í‚É‚æ‚è–TÒ’Œ‹Ø“à‚É”­¶‚µ‚½œ‰»«‹Ø‰Š‚Ì‚P—á. ‘å’Ë•q”VC“ß{–ìG“ñC²“¡r”ŽC–ØMˆêCÄ“cN”VC‚•½®LC‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: ‘æ103‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i98.06.06j, ‰¡•l.

2297. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰Æ“e‚É‚¨‚¯‚éACLˆêŽŸC•œp‚Ì‘gDŠw‹y‚Ñ—ÍŠw“IŒŸ“¢. ”ª–؉pŒ›C–k’ÜLmC“ñŒ©r˜YC’Ë–{s’jC•Ÿ“‡é–¾CŽ…–ž·Œ›i®ŠOj: ‘æ47‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï i98.09.04`05j, H“c.

2298. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘½”­«œ’[ˆÙŒ`¬Ç‚Ì“ñŽŸ«ŠÖßǂɑ΂µŒÒŠÖß‹y‚Ñ•GŠÖߌ`¬p‚ðŽ{s‚µ‚½‚P—á. ´…ËŽjC—˜ªì‰ërCò•qOCŠÖŒû¹˜aC•i“c®FC“ŒŒvC•Ð–ì’•¶CŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï‘æ591‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï i98.10.24j, “Œ‹ž.

2299. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j isŠúE––ŠúŒÒŠÖßǂɑ΂·‚éŠO”½‹ü‹ÈœØ‚èp‚¨‚æ‚ÑChiariœ”՜؂èp•¹—pŽèp‚ÌŽ¡—ìÑ. –{•”ƒŽqCŽ…–ž·Œ›CŠÖŒû¹˜aCò•qOC“ŒŒvCŽu‘ºKFi®ŠOj: ‘æ37‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï i98.11.21j, “Œ‹ž.

2300. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠOŒãMRSA[•”Š´õÇ‚ÌŽ¡—ìÑ. •Ð–ì‘fºC‰¡ŽRˆê•FCŠÖŒû¹˜aCŽ…–ž·Œ›i®ŠOjCV“¡³‹Pi‹~–½j: ‘æ37‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï i98.11.21j, “Œ‹ž.

2301. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Von Recklinghausen•a‚ɇ•¹‚µ‚½Ò‘Žîᇂ̎¡—ìÑ. Š}ˆäŒª˜aCˆÀ’BŒöCå‚Œ´—L’jCŽR‰®’qNC“c•Ó‰ê‘¥C‹{•”ŠîC’Ë–{s’ji®ŠOj: ‘æ37‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï i98.11.21j, “Œ‹ž.

2302. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘O\ŽšèՑшꎟC•œp‚ÌpŒã¬Ñ‚ÆÄ‹¾Ž‹‘œ. –k’ÜLmC”ª–؉pŒ›C‘Šì~C‚–Ø~C‹{‰ºŒªˆêCŠÖ”EC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ20‰ñ“Œ‹ž•GŠÖߊw‰ï i99.02.20j, “Œ‹ž.

2303. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j œ”՜܂ɇ•¹‚µ‚½¶‘’°œÃ–¬‘¹‚Ì‚P—á. ‘å’ËGC“c’†Œ[Ži‚aCV“¡³‹PC‚•½®LCŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï‘æ595‰ñ“Œ‹ž’n•û‰ï i99.03.27j, “Œ‹ž.

2304. mŒ¤‹†‰ïi‘Ûjn i‹³ˆçu‰‰j ––ŠúŒÒŠÖßǂɑ΂·‚éŠO”½‹ü‹ÈœØ‚èp|‚»‚Ìì—p‹@˜‚ð’†S‚É|. Ž…–ž·Œ›i®ŠOj: œØ‚èƒZƒ~ƒi[i’†“ú—FD•a‰@œ‰Èj i98.10.14`16j, –k‹ž.

2305. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰PŠW‘¤‚ÌÄ’uŠ·p‚É‚¨‚¯‚éH•v. –{•”ƒŽqCŽ…–ž·Œ›CŠÖŒû¹˜aC“ŒŒvC“àŽRŸ•¶C‚èƒFi®ŠOj: ‘æ‚U‰ñHip Forum i98.10.09`10j, ÏB“‡, ŠØ‘.

2306. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Š´õŒÒŠÖ߂ɑ΂·‚éR¶ÜŠÜ—LƒZƒƒ“ƒgƒXƒy[ƒT[‚ð—˜—p‚µ‚½lHŒÒŠÖß’uŠ·p. “ŒŒvCŽ…–ž·Œ›CŠÖŒû¹˜aC–{•”ƒŽqC“àŽRŸ•¶C‚èƒFi®ŠOj: ‘æ‚U‰ñHip Forum i98.10.09`10j, ÏB“‡, ŠØ‘.

2307. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j èÕ‘Ñ‘¹f’f‚ɑ΂·‚郃{ƒeƒBƒNƒX‚̉ž—p. •ì’q”VCù“c’¼iç—tH‘åjC“¡]—T“¹iã‘åjC’Ë–{s’jCŠÖ”Ei®ŠOjC”n•£´Ž‘iˆã—Éq¶j: ‘æ19‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ i99.03.13j, “Œ‹ž.

2308. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘½”­«œ‰óŽ€Ç—á‚ÌWÏ‚Æ‚»‚ÌŒŸ“¢|’†ŠÔ•ñ|. ò•qOCŠÖŒû¹˜aCŽ…–ž·Œ›i®ŠOj: Œú¶È“Á’莾Š³œEŠÖߌnŽ¾Š³’²¸Œ¤‹†”Ç“Á”­«‘å‘Úœ“ª‰óŽ€Ç•ª‰È‰ï•½¬10”N“x‰ï‹c i98.08.29j, “Œ‹ž.

2309. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j æ“V«‰º‘Úœ‹UŠÖßǂɑ΂·‚錌ŠÇ•¿•t‚«œˆÚAŒãĜ܂̎¡—Âɓïa‚µ‚½‚P—á. ‰¡ŽRˆê•FC¬‹{Gˆê˜YC•i“c®FC’Ë–{’B˜YCŽ…–ž·Œ›i®ŠOjC•Ê•{”ŒZCù‰v—Yi¹ƒ}ƒŠˆã‘åj: ‘æ‚S‰ñ“ú–{ƒCƒŠƒUƒƒt–@Œ¤‹†‰ï i98.09.06j, “Œ‹ž.

2310. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒvƒŒ[ƒg‚𕹗p‚µ‚½èò’Å‘O•ûœˆ³ŒÅ’èp‚ÌŽèp¬Ñ. “c•Ó‰ê‘¥CˆÀ’BŒöCå‚Œ´—L’jCŽR‰®’qNC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ‚V‰ñ“ú–{ҒŃCƒ“ƒXƒgƒDƒ‹ƒƒ“ƒe[ƒVƒ‡ƒ“Œ¤‹†‰ï i98.10.10j, ŽD–y.

2311. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ˜•”Ò’ŒŠÇ‹·óǂɑ΂·‚é’Å‹|ŠÒ”[Ž®Ò’ŒŠÇŠg‘åp. ŽR‰®’qNCˆÀ’BŒöCå‚Œ´—L’jC“c•Ó‰ê‘¥C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ‚U‰ñ“ú–{˜’ÉŒ¤‹†‰ï i98.11.21j, ‹{è.

2312. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j •I•”ŠÇÇŒóŒQ‚É‚¨‚¯‚éElbow flexion test‚ÌM—Š«. ‹î“c•üGC“ñŒ©r˜YC¬—Ñ–¾³C—é–ØrCˆÀ’BŒöC–k’ÜLmC’Ë–{s’ji®ŠOj: ‘æ11‰ñ“ú–{•IŠÖߌ¤‹†‰ï i99.02.20j, _ŒË.

2313. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚é•I“ªœÜ‚ÌŽ¡—ìÑ. —é–ØrC“ñŒ©r˜YC¬—Ñ–¾³C‚–Ø~C‘å’ËGC’Ë–{s’ji®ŠOj: ‘æ11‰ñ“ú–{•IŠÖߌ¤‹†‰ï i99.02.20j, _ŒË.

2314. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ”ñÚGŒ^ŽOŽŸŒ³•ÏˆÊŒv‘ª‘•’u‚ð—p‚¢‚½•IŠÖ߉^“®‰ðÍi‘æ3•ñ). “¡“c³C“ñŒ©r˜YC–ذ•FC’†‘ºˆêmC’Ë–{s’ji®ŠOjC”n•£´Ž‘iˆã—Éq¶j: ‘æ11‰ñ“ú–{•IŠÖߌ¤‹†‰ï i99.02.20j, _ŒË.

2315. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j •ÏŒ`«ŒÒŠÖßǂɑ΂·‚éœØ‚èp‚Ìì—p‹@˜. Ž…–ž·Œ›i®ŠOj: ‘æ‚P‰ñ“Þ—ÇŒ§œEŠÖߌ¤‹†‰ï i98.04.04j, “Þ—Ç.

2316. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ㎈‰^“®áŠQ‚ɂ‚¢‚Ä|Ò‘áŠQ, –•½_ŒoáŠQ‚¨‚æ‚Ñ”]«–ƒáƒ‚ð’†S‚Æ‚µ‚Ä|. “ñŒ©r˜Yi®ŠOj: _“ÞìáŠQŽÒE‹ÆƒZƒ“ƒ^[ i98.06.30j, ‘Š–ÍŒ´.

2317. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ––ŠúŒÒŠÖßǂɑ΂·‚éŠO”½‹ü‹ÈœØ‚èp|‚»‚Ìì—p‹@˜‚ð’†S‚É|. Ž…–ž·Œ›i®ŠOj: ‘æ20‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ i98.08.22`23j, ž–ìŽs.

2318. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ––Šú•ÏŒ`«ŒÒŠÖßǂɑ΂·‚éœØ‚èp‚Ìl‚¦•û. Ž…–ž·Œ›i®ŠOj: ‘æ‚Q‰ñ‡®‰ï i98.09.17j, ŽO“‡.

2319. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ––ŠúŒÒŠÖßǂɑ΂·‚éŠO”½‹ü‹ÈœØ‚èp|‚»‚Ìì—p‹@˜‚ð’†S‚É|. Ž…–ž·Œ›i®ŠOj: ‘æ203‰ñ–k‹ãB®Œ`ŠO‰Èˆã‰ï i98.10.02j, –k‹ãBŽs.

2320. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Osteotomy of the thumb MC arthritis. “ñŒ©r˜Yi®ŠOj: ‘æ13‰ñ‰¡{‰êŠCŒR•a‰@®Œ`ŠO‰ÈƒJƒ“ƒtƒ@ƒŒƒ“ƒX i98.11.13j, ‰¡•l.

2321. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “¯ŽíœˆÚA‚É‚æ‚霌‡‘¹‚ÌC•œ. Ž…–ž·Œ›i®ŠOj: “ú–{ˆã‰È‘åŠw®Œ`ŠO‰È“¯‘‹‰ïŒ¤C‰ï i98.11.14j, “Œ‹ž.

2322. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j œ‘eé Ç, ˜’É. ˆÀ’BŒöi®ŠOj: ‘²Œã‹³ˆçuÀ i98.05.06j, ‘Š–ÍŒ´.

2323. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j •I•”ŠÇÇŒóŒQ‚ɑ΂·‚éŽÚœ_Œo‘O•ûˆÚsp‹y‚ÑŽ¦ŽwŠO“]‹@”\ÄŒšp. “ñŒ©r˜Yi®ŠOj: ‘æ14‰ñ_“Þ쮌`ŠO‰ÈŽèpŽè‹ZŒ¤‹†‰ï i98.06.05j, ‰¡•l.

2324. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`. ¬—Ñ–¾³i®ŠOj: ‘²Œã‹³ˆçuÀ i98.06.13j, ‘Š–ÍŒ´.

2325. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ㎈‚Ì‹@”\‰ð–U. “ñŒ©r˜Yi®ŠOj: i98.10.29j, ‘Š–ÍŒ´.

2326. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰º‘ÚŠJ•úœÜ‚ɑ΂·‚霉„’·–@‚ɂ‚¢‚Ä. ´…ËŽjC¼‘º–¾lC‰¡ŽRˆê•FCŠÖŒû¹˜aCŽ…–ž·Œ›i®ŠOjCV“¡³‹Pi‹~–½j: ‘æ27‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï i98.09.19j, ‰¡•l.

2327. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j “–‰È‚É‚¨‚¯‚é•I“ªœÜ‚ÌŽ¡—ÃŒoŒ±. ‚–Ø~C“ñŒ©r˜YC¬—Ñ–¾³C—é–ØrCâZ‰ë—_C‘å’ËGC’Ë–{s’ji®ŠOj: ‘æ‚S‰ñ_“ÞìŽèE•I‚ÌŠO‰ÈŒ¤‹†‰ï i98.10.17j, ‰¡•l.

2328. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j •GŠWE‘å‘ÚŠÖßáŠQ‚̶‘Ì—ÍŠw“I‚È•a‘Ô‰ðÍ|•GŠWœ‘¤•û“®—h«‚Ì’è—Ê“IŒ¤‹†|. ’r“c‹M‰pC–k’ÜLmC‘Šì~C‹{‰ºŒªˆêCŠÖ”EC”ª–؉pŒ›C¬“‡—²ŽjC“ñŒ©r˜YC’Ë–{s’jCŽ…–ž·Œ›i®ŠOj: ‘æ‚U‰ñ‚悱‚͂܃Xƒ|[ƒc®Œ`ŠO‰ÈƒtƒH[ƒ‰ƒ€ i98.05.16j, ‰¡•l.

2329. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j è÷ŠÔ—²‹NœÜ‚ðŽv‚킹‚½—¼‘¤•G—£’f«œ“Š‚Ì‚P—á. ‘Šì~C–k’ÜLmCŠ}ˆäŒª˜aCŠÖ”ECˆÀ’BŒöC¬—Ñ–¾³C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ27‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï i98.09.19j, ‰¡•l.

2330. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Žèª•sˆÀ’èǂɑ΂·‚éƒLƒ‹ƒVƒ…ƒi[|ü‚ð—p‚¢‚½ŽèªœŠÔ‰¼ŒÅ’è‚ÌŽŽ‚Ý. “ñŒ©r˜YC¬—Ñ–¾³C‰““¡‘¾“’jCˆÀ’BŒöC–k’ÜLmC’Ë–{s’ji®ŠOj: ‘æ‚S‰ñ_“ÞìŽèE•I‚ÌŠO‰ÈŒ¤‹†‰ï i98.10.17j, ‰¡•l.

2331. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠO‘¤•I“ª’E‰P‚ɑ΂µ‚ÄExtension block–@‚ð—p‚¢‚½ŽŽ‚Ý. ‘å’ËGC“ñŒ©r˜YC—é–ØrCŠ}ˆäŒª˜aC‚–Ø~C’Ë–{s’ji®ŠOj: ‘æ‚S‰ñ_“ÞìŽèE•I‚ÌŠO‰ÈŒ¤‹†‰ï i98.10.17j, ‰¡•l.

2332. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‰¡Ž~‚ߎ®ƒXƒeƒ€‚ð—p‚¢THR‚Æ‘å‘Úœ•ÏŒ`–ü‡‚Ì‹¸³‚𓯎ž‚ÉŽ{s‚µ‚½‚P—á. ‚èƒFC“ŒŒvCŠÖŒû¹˜aCò•qOC–{•”ƒŽqCŽ…–ž·Œ›i®ŠOj: ‘æ104‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i98.11.07j, ‰¡•l.

2333. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j äCœœŠ²•”‚É”­¶‚µ‚½’˜–¾‚ȓ`¬‚𔺂¤üˆÛ«œˆÙŒ`¬‚Ì‚P—á. ‹î“c•üGC–k’ÜLmCŠ}ˆäŒª˜aCˆÀ’BŒöC¬—Ñ–¾³C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ104‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i98.11.07j, ‰¡•l.

2334. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é•G”¼ŒŽ”‘¹—á‚ÌMR‘œ‚ÆŠÖß‹¾ŠŒ©‚Ì”äŠr. ŠÖ”EC–k’ÜLmC‘Šì~C‹{‰ºŒªˆêC”ª–؉pŒ›C’Ë–{s’ji®ŠOj: ‘æ25‰ñŠÖ“Œ•G‚ðŒê‚é‰ï i98.11.28j, “Œ‹ž.

2335. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j —¼‘¤•GŠW‘å‘ÚŠÖß‚É”­¶‚µ‚½—£’f«œ“Š‚Ì‚P—á. ‘Šì~C–k’ÜLmC‹{‰ºŒªˆêCŠÖ”EC”ª–؉pŒ›C’Ë–{s’ji®ŠOj: ‘æ25‰ñŠÖ“Œ•G‚ðŒê‚é‰ï i98.11.28j, “Œ‹ž.

2336. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Neuropathic pain‚ɑ΂·‚éDrug Challenge Test‚Ì—L—p«. ‰““¡‘¾“’jC“ñŒ©r˜YC¬—Ñ–¾³C’Ë–{s’ji®ŠOj: ‘æ13‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï i99.02.06j, ‰¡•l.

2337. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j BennettœÜ‚ɑ΂·‚鎡—ìÑ. —é–ØrC“ñŒ©r˜YC¬—Ñ–¾³C‚–Ø~CÄ“cN”VC“c•Ó‰ê‘¥CˆÀ’BŒöC–k’ÜLmC’Ë–{s’ji®ŠOj: ‘æ13‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï i99.02.06j, ‰¡•l.

2338. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒL[ƒ“ƒxƒbƒN•a‚ð‡•¹‚µ‚½ŽèªŠÇÇŒóŒQ‚Ì‚R—á. ’†ŽR’mŽqC¬—Ñ–¾³C“ñŒ©r˜YC‰““¡‘¾“’jC’Ë–{s’ji®ŠOj: ‘æ13‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï i99.02.06j, ‰¡•l.

2339. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j LisfrancŠÖß’E‰PœÜ‚Ì‚P—á. ‘åìFC–{•”ƒŽqCŠÖŒû¹˜aC“ŒŒvCŽ…–ž·Œ›i®ŠOj: ‘æ105‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i99.02.13j, ‰¡•l.

2340. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘gDˆÚA‚É‚¨‚¯‚é—‘z“I‚È•ÛŒ¯“K‰ž. ŠÖŒû¹˜aCŽ…–ž·Œ›i®ŠOj: ‘æ‚P‰ñŠÖ“Œ‘ŸŠíE‘gDˆÚAŒ¤‹†‰ï i99.02.15j, “Œ‹ž.

2341. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j úŽhŽè‹Z‚ð—p‚¢‚½‰Æ“e•G”¼ŒŽ”ÂC•œp‚ÌŽÀŒ±“IŒ¤‹†. ŠÖ”EC–k’ÜLmC‘Šì~C‹{‰ºŒªˆêC”ª–؉pŒ›C’Ë–{s’ji®ŠOj: ‘æ20‰ñ“Œ‹ž•GŠÖߊw‰ï i99.02.20j, “Œ‹ž.

2342. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j \ŽšƒXƒeƒ€iIMCF)lHŒÒŠÖß. •i“c®FCŽ…–ž·Œ›CŠÖŒû¹˜ai®ŠOjC”n•£´Ž‘iˆã—Éq¶j: ‘æ28‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï i99.03.06j, ‰¡•l.

2343. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj •ÏŒ`«ŠÖßÇ‚É‚¨‚¯‚鬒·ˆöŽq‚Ì–ðŠ„. ò•qOi®ŠOj: ‘æ40‰ñ_“ÞìˆãŠw‰ï‘‰ïEŠwp‘å‰ï“ú–{ˆãŽt‰ï¶ŠU‹³ˆçuÀ i98.11.23j, ‰¡•l.

2344. mŠwpÜi‘“àÜjn ‘å³AWARDŽóÜi‘æ25‰ñ“ú–{ŒÒŠÖߊw‰ïj; isŠúE––ŠúŒÒŠÖßǂɑ΂·‚éŠO”½œØ‚èp‚¨‚æ‚ÑChiariœ”՜؂èp•¹—pŽèp‚Ì’†Šú¬Ñ|ŠO”½‹ü‹ÈœØ‚èp’P“ÆŽèp—á‚Æ‚Ì”äŠr|, ŠÖŒû¹˜ai®ŠOj.

2345. mŠw‰ïŽåÃi‘“àŠw‰ïjn ‘æ17‰ñ“ú–{œEŠÖßE“î•”‘gDˆÚAŒ¤‹†‰ï, ‰ï’·i98.12.03), “Œ‹ž, Ž…–ž·Œ›i®ŠOj.

2346. mŠw‰ïŽåÃi’n•û‰ïjn “Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ïi99.02.06), ‰¡•l, “ñŒ©r˜Yi®ŠOj.

2347. mŠw‰ïŽåÃi’n•û‰ïjn _“Þ윑ãŽÓƒZƒ~ƒi[i99.01.09j, ‰¡•l, Ž…–ž·Œ›i®ŠOj.

2348. mŠw‰ïŽåÃi’n•û‰ïjn ‘æ19‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€i99.03.13j, “Œ‹ž, Ž…–ž·Œ›i®ŠOj.


<<22 Œ`¬ŠO‰ÈŠw>>

2349. mŒ´’˜n Eyelid Reconstruction Using a Vascularized Composite Flap. “àÀ‰hŽ÷C’Ò–ìˆê˜YC‰–’JMKiŒ`ŠOj: Aesthetic Plast. Surg., (22): 126`129, 1998.

2350. mŒ´’˜n Expansion of the oral end of free revascularlsed jejunum with a jejunal patch flap rotated like a folding fan. Yoshida, T.CShimizu, S.i‰¡•lŽs‘åjCŽðˆä’¼•FiŒ`ŠOjCMochimatsu, I.CEnomoto, H.CNakano A.i‰¡•lŽs‘åj: Br. J. Plast. Surg., 51: 103`108, 1998.

2351. mŒ´’˜n Development of new wound dressing composed of spongy collagen sheet containing dibutyryl cyclic AMP. ŽÄ“c—T’BC‰–’JMKiŒ`ŠOjC•–ö”\Œõiˆã—Éq¶j: J. Biomater. Sci. Polym. Ed., 8(8): 601`621, 1997.

2352. mŒ´’˜n The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at extraskeletal site of the rat. Isobe, M.i“ŒˆãŽ•‘åjCŽRèˆÀ°iŒ`ŠOjCMori, M.CÎŒ´˜a•Fiˆã—Éq¶jCNakabayashi, N.CAmagasa, T.i“ŒˆãŽ•‘åj: J. Biomed. Mater. Res., 45: 36`41, 1999.

2353. mŒ´’˜n Biological activities of bone extract containing TGF-b superfamily protein. Oida, S.i“ŒˆãŽ•‘åjCŽRèˆÀ°iŒ`ŠOjCMori, M.CAsahina, I.i“ŒˆãŽ•‘åj: J. Hard Tissue Biol., 7(1): 27`34, 1998.

2354. mŒ´’˜n The Effect of Essential Fatty Acid Supplementation on Keratinocyte Replication. Garner, W.L.iƒ~ƒVƒKƒ“‘åjC‘å’J’˱”ViŒ`ŠOjCZuccaro, C.CRodriquez, J.L.CSmith, D.J.CMarcelo, C.L.iƒ~ƒVƒKƒ“‘åj: Prostaglandins Leukot. Essent. Fatty Acids, 52: 349`355, 1995.

2355. mŒ´’˜n Histodifferentiation of hair follicles in grafting of cell aggregates obtained by rotation culture of embryonic rat skin. •“cŒ[C¼‹´–ÎŽqC‰–’JMKC’–Œ´ß”V‰îiŒ`ŠOj: Scand. J. Plast. Reconstr. Hand Surg., 32(4): 359`364, 1998.

2356. mŒ´’˜n “¯Ží”|—{^”ç‚É‚æ‚é“«’×ᇂ̎¡—Ã. ŽR‰º—ŠGC“àÀ‰hŽ÷iŒ`ŠOjC•–ö”\Œõiˆã—Éq¶j: Œ`¬ŠO‰È, 41(10): 917`923, 1998.

2357. mŒ´’˜n ‰ºŠ{œ‘Ì•”‚É”­¶‚µ‚½’†S«œŽî‚Ì1—á. ŽÄ“c—T’BC²“¡‰p–¾C“àÀ‰hŽ÷iŒ`ŠOj: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 70(6): 363`365, 1998.

2358. mŒ´’˜n g‘ÌŠe•”‚Ì‘nˆ’ui“ª•”). ŽR“c’¼lC“àÀ‰hŽ÷C‘º‰ºˆêWCV‘ò”ŽŽqCª–{[CŽO“c–ƒ’ÃŽqiŒ`ŠOj: “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 23: 220`224, 1998.

2359. mŒ´’˜n –k—¢‘åŠwŒ`¬ŠO‰È‚É‚¨‚¯‚éŠî’ê×–Eã”çŽî‚ÌŒŸ“¢. —јaOC‰FˆäŒª“ñiŒ`ŠOjCŠâŸºŒ[ˆêi•a—jC“àÀ‰hŽ÷iŒ`ŠOj: “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 18(11): 575`582, 1998.

2360. mŒ´’˜n ŽOŠp•Ù–@‚É‚æ‚é•Ð‘¤•sŠ®‘SŒûO—ô‰‰ñŽèpŒã‚ÌŠ³‘¤ãO‰º‚‚ɂ‚¢‚Ä. ’†–kMºC£èWˆê˜YCŽRèˆÀ°C“àÀ‰hŽ÷iŒ`ŠOj: “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 19(2): 71`79, 1999.

2361. mŒ´’˜n ‚pƒXƒCƒbƒ`ND: YAGƒŒ[ƒU[iƒT[ƒ‚ƒŒ[ƒYƒ\ƒtƒgƒ‰ƒCƒgSL-100j‚É‚æ‚é’E–ÑŽ¡—Ã. ‰–’JMKC‘å’|®”VC•“cŒ[C‰F’Öؗ´ˆêiŒ`ŠOj: “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 19(3): 151`159, 1999.

2362. mŒ´’˜n ring injury‚Q—á‚ÌŽ¡—ÃŒoŒ±. ŽÄ“c—T’BCV‘ò”ŽŽqC²“¡‰p–¾C‰–’JMKiŒ`ŠOj: “ú–{ЊQˆãŠw‰ï‰ïŽ, 45(12): 787`791, 1997.

2363. mŒ´’˜n –k—¢‘åŠw•a‰@‹~–½‹~‹}ƒZƒ“ƒ^[‚É‚¨‚¯‚éŠJÝ‘O”¼‚T”NŠÔ‚ƌ㔼‚T”NŠÔ‚Ì”MŠ³ŽÒ‚Ì”äŠrŒŸ“¢. V‘ò”ŽŽqCŽR“c’¼liŒ`ŠOj: “ú–{ЊQˆãŠw‰ï‰ïŽ, 46(10): 606`610, 1998.

2364. mŒ´’˜n V‚µ‚¢ƒCƒAƒŠƒ“ƒO‚ÌŠJ”­. ’†‘ºŒ³MiŒ`ŠOjC’r“c•qŽqi‰ðjCˆÉ“¡³ŽkiŒ`ŠOjC“¡Šª–ÒC–—Ç•vibŽY¤‰ïj: “ú–{”ü—eŠO‰ÈŠw‰ï‰ï•ñ, 20(1): 6`12, 1998.

2365. mŒ´’˜n ƒŒ[ƒU[Ž¡—ÃŒã‚ɶ‚¸‚鉊ǫF‘f’¾’…‚ÌŽ¡—Ã. ŽR‰º—ŠGiŒ`ŠOj: “ú–{”ü—eŠO‰ÈŠw‰ï‰ï•ñ, 20(2): 39`45, 1998.

2366. mŒ´’˜n Œã“V«Ž¨‚—ô‚ɑ΂·‚éŽèp–@. Xìˆê•FCŽR–{”ŽC’Ï‹MŽqC•Ÿ“c—ŠGŽqC‘å’|®”VC“àÀ‰hŽ÷iŒ`ŠOj: “ú–{”ü—eŠO‰ÈŠw‰ï‰ï•ñ, 20(3): 21`26, 1998.

2367. mŒ´’˜n ƒIƒgƒKƒCŒ`¬p‚É‚¨‚¯‚釬‹zŽû«œ•ÐÚ‡Þ—¿‚Ì—L—p«‚ɂ‚¢‚Ä. —јaOC’†–kMºCŽRèˆÀ°C‘å’|®”VC“àÀ‰hŽ÷iŒ`ŠOj: “ú–{”ü—eŠO‰ÈŠw‰ï‰ï•ñ, 20(3): 31`36, 1998.

2368. mŒ´’˜n Å‹ß‚Ìä`‚ÌŒ`‘Ô”ü‚ðl—¶‚µ‚½ä`Œ`¬p. ’Ò–ìˆê˜YC‰F’Öؗ´ˆêC‰–’JMKC“àÀ‰hŽ÷iŒ`ŠOj: “ú–{”ü—eŠO‰ÈŠw‰ï‰ï•ñ, 20(3): 5`11, 1998.

2369. mŒ´’˜n ŠááÙ‰º‚‚Æ”ü—eŠO‰È. Xìˆê•FC‘å’|®”VC“àÀ‰hŽ÷iŒ`ŠOj: “ú–{”ü—eŠO‰ÈŠw‰ïŽ, 35(4): 99`104, 1998.

2370. mŒ´’˜n –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éŠç–ÊœœÜ‚Ì—Õ°“IŒŸ“¢. ª–{[CŽRèˆÀ°C²“¡–¾’jC“c’†³‰pCŽR“c’¼lC“àÀ‰hŽ÷iŒ`ŠOj: –k—¢ˆãŠw, 28(4): 380`385, 1998.

2371. m€Œ´’˜n V‹K”|—{”畆(K-CDS)‚Ì“®•¨ŽÀŒ±•]‰¿. ²“¡–¾’jCΕ‹§ŽjCŽR–{”ŽC¼ˆäŒ‰C“àÀ‰hŽ÷iŒ`ŠOjC•–ö”\Œõiˆã—Éq¶j: Progress in Medicine, 18(8): 172`173, 1998.

2372. m€Œ´’˜n e…«ƒ|ƒŠƒEƒŒƒ^ƒ“ƒhƒŒƒbƒVƒ“ƒOiƒnƒCƒhƒƒTƒCƒgRj‚ÌŽg—pŒoŒ±. ŽR‰º—ŠGCó–ìŠwC¼ˆäŒ‰C“àÀ‰hŽ÷iŒ`ŠOj: Progress in Medicine, 18(8): 175`177, 1998.

2373. m€Œ´’˜n ‘n–ÊŸøo‰t‚É‚æ‚éŠÈ•Ö‚ÈŽ¡–ü‰ß’ö‚Ì•]‰¿–@. “c’†³‰pC•“cŒ[C‰FˆäŒª“ñC“àÀ‰hŽ÷C‰–’JMKiŒ`ŠOj: Progress in Medicine, 18(8): 180`181, 1998.

2374. m€Œ´’˜n ƒPƒƒCƒh, ”ìŒú«á­‚Å‚ÌCTGF, SCFmRNA‚Ì”­Œ». •“cŒ[C‰FˆäŒª“ñC’†–kMºCÎìCˆêiŒ`ŠOjC‘]ª—R”üŽqi¶‰»ŒnjC£èWˆê˜YC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ4‰ñƒPƒƒCƒh”ìŒú«á­Œ¤‹†‰ï‹L˜^W, p.69`72, 1998.

2375. m€Œ´’˜n ‹~–½‹~‹}ƒZƒ“ƒ^[‚É‚¨‚¯‚éŒ`¬ŠO‰Èf—Ã. ŽR“c’¼lC’†–kMºCΕ‹§ŽjCV‘ò”ŽŽqC“àÀ‰hŽ÷iŒ`ŠOj: “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 23(6): 980`983, 1998.

2376. mÇ—á•ñn Œz•”‚É”­¶‚µ‚½ƒGƒbƒNƒŠƒ“‚点‚ñŽî‚Ì1—á. ’†–kMºCŽR‰º—ŠGCó–ìŠwC¼ˆäŒ‰C“àÀ‰hŽ÷iŒ`ŠOj: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 71(3): 187`190, 1999.

2377. mÇ—á•ñn lH^”çiƒyƒ‹ƒiƒbƒNRj‚ÌŽg—pŒoŒ±|‘O˜r”ç•ÙÌŽæ•”‚É“K—p‚µ‚½1—á. “c’†³‰pC¼ˆäŒ‰CŠâéŒ[CC¬ì‹±ŽjiŒ`ŠOj: f—ÂÆV–ò, 35(4): 26`27, 1998.

2378. mÇ—á•ñn ‘O“ª‘¤“ª”ç•Ù(Schmid flap)‚É‚æ‚è•@’Œ¥•@ë•”‚ÌÄŒš‚ðs‚Á‚½1—á. ’†–kMºCŽR–{”ŽCŽR“c’¼lC“àÀ‰hŽ÷iŒ`ŠOj: “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 19(3): 188`193, 1999.

2379. m‘àn lH”畆‚Æ”|—{”畆. ’†–kMºC•“cŒ[C“àÀ‰hŽ÷iŒ`ŠOj: –k—¢ˆãŠw, 28(3): 249`253, 1998.

2380. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Treatment of senile Lentigines of Face with Q-switched Ruby Laser. ŽR‰º—ŠGC¼ˆäŒ‰C“àÀ‰hŽ÷iŒ`ŠOj: 6th International Congress of Oriental Aesthetic Plastic Surgery i98.12.06j, Hong Kong.

2381. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The expression of connective tissue growth factor in hypertrophic scar and keloids. •“cŒ[iŒ`ŠOjC‘]ª—R”üŽqi¶•¨‰»ŠwŒnjC£èWˆê˜YC‰FˆäŒª“ñC“àÀ‰hŽ÷iŒ`ŠOj: 8th Annual Meeting of the European Tissue Repair Society i98.08.26j, Copenhagen, Denmark.

2382. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŠááÙ‰º‚‚Æ”ü—eŠO‰È. Xìˆê•FiŒ`ŠOjCX캕Fi‹âÀ”ü—eŠO‰ÈjC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ74‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï i98.05.17j, “Œ‹ž.

2383. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒŒ[ƒU[ˆã—ÂƌoÏŒø‰Ê. ŽR‰º—ŠGC¼ˆäŒ‰C“àÀ‰hŽ÷iŒ`ŠOj: ‘æ21‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï, ‘æ72‰ñŠwpW‰ï i98.10.10j, Šò•Œ.

2384. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒŒ[ƒU[Ž¡—Âɂ¨‚¯‚釕¹Ç‚̉ñ”ð. ’Ò–ìˆê˜YC‰F’Öؗ´ˆêC‰–’JMKC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ21‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï i98.10.10j, Šò•Œ, ‘æ21‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€´˜^W, p.72, 1998.

2385. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj Cultured Dermis for Burn Therapy. •–ö”\Œõiˆã—Éq¶jCŽR‰º—ŠGCŽR“c’¼lC²“¡–¾’jC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ97‰ñ“ú–{”畆‰ÈŠw‰ï i98.05.29j, ‘åã.

2386. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚鎨‘Oá‘E‚ÌŒŸ“¢. ŽR–{”ŽC“àÀ‰hŽ÷CŽðˆä’¼•FCΕ‹§ŽjC‰–’JMKiŒ`ŠOj: ‘æ40‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠwpW‰ï i97.04.09j, ‹{è, ´˜^W, p.190, 1997.

2387. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¨‚‚̶‰E·‚ɂ‚¢‚Ä|‘æ10•ñ|ƒsƒAƒXŽ{s–@‚ÌŽÀÛ. ’†‘ºŒ³MiŒ`ŠOjC’r“c•qŽqi‰ðjCˆÉ“¡³ŽkiŒ`ŠOj: “ú–{”ü—eŠO‰ÈŠw‰ï, ‘æ74‰ñŠwpW‰ï i98.01.23j, “Œ‹ž.

2388. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹“‹ØäF–Œ‘O“]‚É‚æ‚éŠááÙ‰º‚Žèp’¼Œã‚É‚¨‚¯‚éÄŽèp‚Ì•p“x, “K‰ž, Œ´ˆö‚ɂ‚¢‚Ä. ’Ò–ìˆê˜YC‰F’Öؗ´ˆêC‰–’JMKC“àÀ‰hŽ÷iŒ`ŠOjC¼”ö´iMB‘åj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠwpW‰ï i98.04.21`24j, ‹ž“s.

2389. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰EŽè”w•”‚É”­¶‚µ‚½F‘f«—²‹N«”畆üˆÛ“÷ŽîiBednarŽîá‡j‚Ì1—á. Ε‹§ŽjC£èWˆê˜YC•Ÿ“c—ŠGŽqC“àÀ‰hŽ÷iŒ`ŠOjC“cŠ‰qi‘Š–ÍŒ´‹¦“¯•a‰@j: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠwpW‰ï i98.04.21`24j, ‹ž“s, ´˜^W, 1998.

2390. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒ‹ƒgƒ‰ƒpƒ‹ƒX’YŽ_ƒKƒXƒŒ[ƒU[‚ÌŽ¡—ÃŒoŒ±. ŽR‰º—ŠGC¼ˆäŒ‰Có–ìŠwC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.22j, ‹ž“s.

2391. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Pachydermadactyly‚Ì‚QŽ¡Œ±—á‚Æ‘gDŠw“IŒŸ“¢. Žðˆä’¼•FC“àÀ‰hŽ÷C‘å’|®”ViŒ`ŠOjC–å’J‹vmŽqiŒ`‘ÔŒnj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.22j, ‹ž“s.

2392. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”ç•ÙŒŒ—¬—Ê‚ÌŽžŒn—ñƒf[ƒ^‰ðÍ|‘æ3•ñ|ŒŒs“®‘Ô‚ÌŒp‘±“I•Ï‰»‚Æ—V—£”ç•Ù‚ÌŒŒsˆÀ’艻. ŽO㑾˜YC´…’²i‰¡•lŽs‘åjCŽðˆä’¼•FiŒ`ŠOjC’†‘º‰À‘ãC‹g“c–Lˆêi‰¡•lŽs‘åj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.22`24j, ‹ž“s.

2393. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«”^”çÇ|Ž©Œ±3—á‚Ì•ñ‚ÆlŽ@|. ’†‘º‰À‘ãC‹g“c–Lˆêi‰¡•lŽs‘åjCŽðˆä’¼•FiŒ`ŠOjC´…’²CŽO㑾˜YC²“¡‘ñ“ñi‰¡•lŽs‘åj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.22`24j, ‹ž“s.

2394. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’Zæä‹ü‹Ø•Ù‚ð—p‚¢‚½‘«’êæù•”ÄŒš‚Ì—L—p«. ´…’²CŽO㑾˜Yi‰¡•lŽs‘åjCŽðˆä’¼•FiŒ`ŠOjC’†‘º‰À‘ãC²“¡‘ñ“ñC‹g“c–Lˆêi‰¡•lŽs‘åj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.22`24j, ‹ž“s.

2395. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œz•”Žh‘n‚Ìp‘Of’f‚Ìd—v«‚ɂ‚¢‚Ä. V‘ò”ŽŽqCŽR“c’¼lC‚‹´Žk–¾Cƒ’r“Þ’ÃŽqC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.22`24j, ‹ž“s.

2396. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‹~–½‹~‹}ƒZƒ“ƒ^[‚É‚¨‚¯‚é”MŽ€–S—á‚ÌŒŸ“¢. ‚‹´Žk–¾CŽR“c’¼lCV‘ò”ŽŽqCƒ’r“Þ’ÃŽqC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.22`24j, ‹ž“s.

2397. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Mucinous Carcinoma of the Skin‚ÌŽ¡—ÃŒoŒ±. ŽR–{”ŽC—é–Ø•q•FC‰ºŒS‘ãŽqC“àÀ‰hŽ÷C‘å’|®”ViŒ`ŠOj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.22`24j, ‹ž“s, ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï´˜^W, p.145, 1998.

2398. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “®•¨™ù‚É‚¨‚¯‚éÅ‹ß‚ÌŒXŒü|“–‰@‚É‚¨‚¯‚é5”NŠÔ105Ç—á‚ÌŒŸ“¢. “잊º—YCª–{[C—јaGC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.22j, ‹ž“s, —\eW.

2399. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚¢‚¿‚²óŒŒŠÇŽî‚ɑ΂·‚é‘ŠúƒŒ[ƒU[Ž¡—Â̗LŒø«. ŽR‰º—ŠGC¼ˆäŒ‰Có–ìŠwC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.23j, ‹ž“s.

2400. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ã• •”³’†• •Çƒwƒ‹ƒjƒA‚Ì2—á. ŽODGC‘å’J’˱”VC‚ŽR“ÖŽqC‘º‰ºˆêWC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.23j, ‹ž“s, ´˜^W, p.110, 1998.

2401. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Š{—ô•”‚Ö‚ÌŽ©‰Æ’°œŠC–ȜוЂÆãk–§œ•¹—pˆÚA‚Ì—L—p«‚ɂ‚¢‚Ä. ŽRèˆÀ°C’†–kMºCª–{[C‚£ÅC“àÀ‰hŽ÷C’¹Ž”ŸsiŒ`ŠOjC•“cŒh”Vi“ŒˆãŽ•‘åj: ‘æ22‰ñ“ú–{ŒûŠW—ôŠw‰ïŠwpW‰ï i98.05.00j, “Þ—Ç.

2402. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j R‹ÛÜŠÜ—L‘n”í•¢Þiƒ~ƒJƒLƒ…ƒARj‚̬Ž™”M‚Ö‚Ì—L—p«. ŽR‰º—ŠGC¼ˆäŒ‰C“àÀ‰hŽ÷iŒ`ŠOjC•–ö”\Œõiˆã—Éq¶j: ‘æ24‰ñ“ú–{”MŠw‰ï‘‰ï i98.05.13j, “Œ‹ž.

2403. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒAƒ‹ƒƒ“Ž_‚ðŠîÞ‚Æ‚µ‚½ƒVƒuƒ`ƒ‹ƒTƒCƒNƒŠƒbƒNAMPŠÜ—L‘n”í•¢Þ‚ÌŠJ”­: “®•¨ŽÀŒ±•]‰¿. •–ö”\ŒõC—é–ØCiˆã—Éq¶jCΕ‹§ŽjC²“¡–¾’jC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ24‰ñ“ú–{”MŠw‰ï‘‰ï i98.05.13j, “Œ‹ž.

2404. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —â“€•Û‘¶“¯Ží”|—{^”ç‚Æ—â“€•Û‘¶“¯Ží”畆‚Ì“÷‰è‘gDŒ`¬‘£iŒø‰Ê‚ÉŠÖ‚·‚é”äŠrŒŸ“¢; ƒEƒTƒM‚ð—p‚¢‚½“®•¨ŽÀŒ±•]‰¿. •–ö”\ŒõC¬‘ì‚¢‚¸‚Ýiˆã—Éq¶jCΕ‹§ŽjC²“¡–¾’jC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ24‰ñ“ú–{”MŠw‰ï‘‰ï i98.05.13j, “Œ‹ž.

2405. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “¯Ží”|—{^”ç‚É‚æ‚é”M, ŠO«”畆Œ‡‘¹‘n¥åñጂ̎¡—Ã. •–ö”\Œõiˆã—Éq¶jCŽR‰º—ŠGCŽR“c’¼lC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ1‰ñ‘gDHŠw‰ï i98.06.26j, ¼ŽR.

2406. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œã“V«Ž¨‚—ô‚ɑ΂·‚éV‚µ‚¢Žèp–@. Xìˆê•FC’Ï‹MŽqC•Ÿ“c—ŠGŽqC‘å’|®”VC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ72‰ñ“ú–{”ü—eŠO‰ÈŠw‰ïŠwpW‰ï i98.07.18j, ‘åã.

2407. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚“x—¼‘¤Šç–Ê•ÏŒ`‚ð’悵‚½ŒÀ‹Ç«‹­”çÇ‚Ì1—á. Žðˆä’¼•FiŒ`ŠOjC’†‘º‰À‘ãC‹g“c–LˆêC´…’²CŽO㑾˜YC‘Oì“ñ˜YC‰œ‘ºmi‰¡•lŽs‘åj: ‘æ16‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï i98.09.24`25j, ŽD–y.

2408. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠOŽ¨“¹‹·óÇ‚ÌŽ¡—ÃŒoŒ±. ’†‘º‰À‘ãi‰¡•lŽs‘åjCŽðˆä’¼•FiŒ`ŠOjC‹g“c–LˆêC‰¬–ì—mˆêi‰¡•lŽs‘åj: ‘æ16‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï i98.09.24`25j, ŽD–y.

2409. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒTƒM‘O˜r•”—£’fƒ‚ƒfƒ‹‚É‚¨‚¯‚érhBM P-2/PLGAƒJƒvƒZƒ‹‚̜Ķ‚Ì•]‰¿. X‰ëOCˆé•”¹Œpi“ŒˆãŽ•‘åjCŽRèˆÀ°iŒ`ŠOjC“VŠ}Œõ—Yi“ŒˆãŽ•‘åj: ‘æ43‰ñ“ú–{ŒûoŠO‰ÈŠw‰ï‘‰ï i98.10.00j, ¼–{.

2410. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éåñጂ̊O‰È“IŽ¡—Â̌»ó. ¼ˆäŒ‰Cª–{[C¬ì‹±ŽjC‹›’×¥C“c’†³‰pC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ47‰ñ“ú–{”_‘ºˆãŠw‰ïŠwpW‰ï i98.10.02j, Šò•Œ, “ú–{”_‘ºˆãŠw‰ïŽGŽ, 47(3): 461, 1998.

2411. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒJ[ƒ{ƒ“ƒ[ƒVƒ‡ƒ“‚𕹗p‚µ‚½Q-Switched Nd Yag Laser‚É‚æ‚é’E–ÑŽ¡—Â̌oŒ±. ’Ò–ìˆê˜YC‰F’Öؗ´ˆêC‰–’JMKC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ21‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï i98.10.10j, Šò•Œ, ‘æ21‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€´˜^W, p.101, 1998.

2412. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¨‚‚̶‰E·‚ɂ‚¢‚Ä|‘æ9•ñ|”h¶“I‚ÈŒ¤‹†. ’†‘ºŒ³MiŒ`ŠOjC’r“c•qŽqi‰ðjCˆÉ“¡³ŽkiŒ`ŠOj: ‘æ21‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï, ‘æ72‰ñŠwpW‰ï i98.10.10j, Šò•Œ, —\eW, p.105`105, 1998.

2413. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “ª•”ŠO‚𔺂¤Šç–ÊœœÜ‚ÌŒŸ“¢. ŽR“c’¼lCV‘ò”ŽŽqiŒ`ŠOj: ‘æ46‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï i98.10.14j, –¼ŒÃ‰®.

2414. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j BMP-2‚É‚æ‚éƒEƒTƒMŽ¨‰î“Œ‰ºœŒ`¬. ·“ø–¾C²“¡‘ñ“ñi‰¡•lŽs‘åjCŽðˆä’¼•FiŒ`ŠOjC‹g“c–Lˆêi‰¡•lŽs‘åj: ‘æ7‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i98.10.22`23j, ì.

2415. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • –Œ’†”ç‚ÌŽüˆÍã”ç’uŠ·‚ÉŠÖ‚·‚錤‹†. ·“ø–¾C²“¡‘ñ“ñi‰¡•lŽs‘åjCŽðˆä’¼•FiŒ`ŠOjC´…’²C‹g“c–Lˆêi‰¡•lŽs‘åj: ‘æ7‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i98.10.22`23j, ì.

2416. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —â“€•Û‘¶‚µ‚½“¯Ží”|—{^”ç‚Æ“¯Ží”畆‚̔핢Œø‰Ê‚ÉŠÖ‚·‚é”äŠrŒŸ“¢: ƒEƒTƒM‚ð—p‚¢‚½“®•¨ŽÀŒ±•]‰¿. Ε‹§ŽjiŒ`ŠOjC¬‘ì‚¢‚¸‚ÝC•–ö”\Œõiˆã—Éq¶jC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ7‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i98.10.22`23j, ì.

2417. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒPƒƒCƒh, ”ìŒú«á­‚É‚¨‚¯‚éCTGF mRNA‚Ì”­Œ». •“cŒ[C‰FˆäŒª“ñCÎìCˆêiŒ`ŠOjC‘]ª—R”üŽqi¶‰»ŒnjC£èWˆê˜YC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ7‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i98.10.22`23j, ì.

2418. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j rhBMP-2/PLGAƒJƒvƒZƒ‹‚ÉœC•œì—p‚̉ðÍ. X‰ëOCˆé•”¹Œpi“ŒˆãŽ•‘åjCŽRèˆÀ°iŒ`ŠOjCÎŒ´ˆê•FC“VŠ}Œõ—YC’†—Ñé’ji“ŒˆãŽ•‘åj: ‘æ20‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï i98.11.00j, “Œ‹ž, ´˜^W, p.162, 1998.

2419. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰ºŽˆ‚É”­¶‚µ‚½ƒƒ‹ƒPƒ‹×–EŠà‚Ì–UŒŸ—á. ΋TLŽ÷i²‹v‘‡•a‰@jC‘å’J’˱”ViŒ`ŠOjCÎì—YˆêiŠàŒ¤jCd¼GˆêiMB‘åj: ‘æ87‰ñ“ú–{•a—Šw‰ï‘‰ï i98.04.14`16j, L“‡, “ú–{•a—Šw‰ïŽGŽ, 87(1): 510, 1998.

2420. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹~–½‹~‹}ƒZƒ“ƒ^[‚É‚¨‚¯‚éŒ`¬ŠO‰Èf—Ã. ŽR“c’¼lCV‘ò”ŽŽqC‚‹´Žk–¾Cƒ’r“Þ’ÃŽqC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i98.04.22j, ‹ž“s.

2421. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žè‘«‚É—p‚¢‚½lH^”çÇ—á‚ÌŒŸ“¢. £èWˆê˜YCΕ‹§ŽjC•Ÿ“c—ŠGŽqC•“cŒ[C’†–kMºC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ41‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠwpW‰ï i98.04.22j, ‹ž“s, ´˜^W, p.173, 1998.

2422. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘O“ªŠW’êØœŒã—V—£• ’¼‹Ø”ç•Ù‚É‚ÄÄŒš‚ðs‚Á‚½â¿œ“´Šà‚Ì1—á. “c’†³‰pC¼ˆäŒ‰C‹›Z—¥Cª–{[C—é–Ø•q•FC“àÀ‰hŽ÷iŒ`ŠOjCª–{Œö‹³C’ËŒ´—²Žii–kM‘‡•a‰@j: “ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï‘æ18‰ñ‘‰ï‘æ36‰ñ—á‰ï i98.06.20j, ¼–{.

2423. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘lŒa”ç•Ù‚ð—p‚¢‚Ĕ畆’×ᇖIâ|D‰Š‚̉ü‘P‚ðŒ©‚½‰ºŽˆƒŠƒ“ƒp•‚Žî‚Ì1—á. ŽODGC‘å’J’˱”ViŒ`ŠOj: “ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï‘æ18‰ñ‘‰ï‘æ36‰ñ—á‰ï i98.06.20j, ¼–{.

2424. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •Iâ|•”‚É”­¶‚µ‚½Chronic Expanding Hematoma‚Ì‚P—á. ’†‘º‰À‘ãC‘Oì“ñ˜YC´…’²C瓇N–«i‰¡•lŽs‘åjCŽðˆä’¼•FiŒ`ŠOjC‰œ‘ºmC‹g“c–Lˆêi‰¡•lŽs‘åj: ‘æ209‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠÖ“ŒŽx•”“Œ‹ž’n•û‰ï i98.07.04j, “Œ‹ž.

2425. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éåñጂ̊O‰È“IŽ¡—Â̌»ó. “c’†³‰pC¼ˆäŒ‰C‹›Z—¥Cª–{[iŒ`ŠOj: ‘æ26‰ñ’·–쌧”_‘ºˆãŠw‰ï i98.07.04j, ‹îƒ–ª.

2426. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Šç–Ê”¼‘¤ˆÞkÇ‚Ì1—á. ”nêŽqC•Ÿ“c—ŠGŽqC‚‹´Žk–¾C‰FˆäŒª“ñC“àÀ‰hŽ÷iŒ`ŠOj: _“ÞìŒ`¬ŠO‰ÈǗጟ“¢‰ï i98.07.11j, ‘Š–ÍŒ´.

2427. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Adamantinoid BCE‚Ì1—á. ˜a“cG•¶C‰ª–ìŠG—¢ŽqC–Ñ—˜”Ei‰¡•lŽs–¯•a‰@jCŽÄ“c—T’BiŒ`ŠOj: ‘æ740‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.09.00j, ‰¡•l.

2428. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j –j•”F‘f’¾’…‚Ìf’f‚ÆŽ¡—Ã. ¼ˆäŒ‰CŽR‰º—ŠGiŒ`ŠOj: _“ÞìǗጟ“¢‰ï i98.12.00j, _“Þì.

2429. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “û–[‰·‘¶pŒã•ÏŒ`‚ɑ΂·‚éC³Žèp‚Ì1—á. ‹´–{MŽqCŽÄ“c—T’BiŒ`ŠOjCÎŽR‹ÅC´…‘å•ãC‹S“ª•¶•FC•Ÿ“‡P’ji‰¡•lŽs–¯•a‰@j: ‘æ94‰ñ_“Þ쌧—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï i99.02.00j, ‰¡•l.

2430. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠOŒãá­‚É‚æ‚é•@E‹·ó‚Ì2—á. ‰œ‘ºmC‹g“c–Lˆêi‰¡•lŽs‘åjCŽðˆä’¼•FiŒ`ŠOjC’†‘ºM‘ãi‰¡•lŽs‘åj: ‘æ212‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠÖ“ŒŽx•”“Œ‹ž’n•û‰ï i99.02.06j, “Œ‹ž.

2431. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹}«–³Î’_”X‰Š‚ɑ΂µP7GBD‚ðs‚Á‚½dÇ”MÇ‚Ì1—á. ŽODGC‘å’J’˱”VC’†–ì‘ãŽqiŒ`ŠOjC‰ª“c–M•Fi²‹v‘‡•a‰@j: ‘æ12‰ñ“ú–{”MŠw‰ïMB’n•û‰ï i99.03.20j, ’·–ì.

2432. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “¯Ží”畆ˆÚA‚ðs‚Á‚½“ûŽ™L”͈͔M‚Ì1—á. ‘ºã”Ž‘¥Cª–{[C“c’†³‰piŒ`ŠOj: ‘æ12‰ñ“ú–{”MŠw‰ïMB’n•û‰ï i99.03.20j, ’·–ì.

2433. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒŒ[ƒU[Ž¡—ÂÌi•à‚Æ‚»‚Ì–â‘è“_. ’Ò–ìˆê˜YiŒ`ŠOj: ”ü—e”畆‰ÈŠw i99.02.07j, “Œ‹ž.

2434. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ}ƒCƒgƒ}ƒCƒVƒ“‚b(MMC)‚ÌŒŒŠÇŠO˜Ro‚É‚æ‚é”畆’×ᇂÌ1—á. ˜a“cG•¶C“c‘º’¨ŽqC–Ñ—˜”Ei‰¡•lŽs–¯•a‰@jCŽÄ“c—T’BiŒ`ŠOj: ‘æ97‰ñ“ú–{”畆‰ÈŠw‰ï i98.05.29j, ‘åã.

2435. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹UŠÖß‹y‚шÚAœ‰ßŒ`¬‚ð”F‚ß‚½‘æ‚Ræä’ZkÇŽèpŒã‚Ì1—á. ‹g’ÃNŽqC“잊º—YC—é–Ø•q•FiŒ`ŠOj: _“ÞìŒ`¬ŠO‰ÈǗጟ“¢‰ï i98.07.11j, ‘Š–ÍŒ´.

2436. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒJ[ƒ{ƒ“ƒ[ƒVƒ‡ƒ“‚𕹗p‚µ‚½Q-Swiched Nd Yag Laser‚É‚æ‚é’E–ÑŽ¡—Ã. ’Ò–ìˆê˜YC‰F’Öؗ´ˆêC‰–’JMKC‘å’|®”VC•“cŒ[C’†‘ºŒ’‚aC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ5‰ñ“ú–{ˆãŠw’E–ÑŠw‰ï’n•ûŒ¤‹†‰ï i98.09.30j, “Œ‹ž.

2437. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j –j•”F‘f”Á‚ÌŽ¡—Ã. ¼ˆäŒ‰CŽR‰º—ŠGiŒ`ŠOj: _“ÞìŒ`¬ŠO‰ÈǗጟ“¢‰ï i98.11.21j, ˆÉ¨Œ´.

2438. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒŒ[ƒU[Ž¡—Â̌»‹µ: Ó슙‘q‘‡•a‰@‚É‚¨‚¯‚é3”NŠÔ‚ÌŠˆ“®Œ‹‰Êi‚pƒXƒCƒbƒ`ƒ‹ƒr[ƒŒ[ƒU[, ƒ_ƒCƒŒ[ƒU[j. ŽR‰º—ŠGC¼ˆäŒ‰iŒ`ŠOj: ‘æ1‰ñ–k—¢Œ`¬ŠO‰ÈŒ¤‹†‰ï i98.12.00j, ‰¡•l.

2439. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œ‹’°‚É‚æ‚éH“¹ÄŒš|ŒŒs‰ü‘P‚Ì‚½‚ß‚ÌÖ¬•«‡‚ɂ‚¢‚Ä|. ŽÄ“c—T’BiŒ`ŠOj: ‘æ21‰ñ•a]˜AŒgƒJƒ“ƒtƒ@ƒŒƒ“ƒX i99.03.24j, ‰¡•l.

2440. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj ‚ ‚´, ‚µ‚݂̃Œ[ƒU[Ž¡—Ã. ŽR‰º—ŠGiŒ`ŠOj: ‘æ10‰ñÓ슙‘qŒöŠJuÀ i98.08.20j, ‘å‘D.

2441. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj ‚µ‚Ý, ‚µ‚í, ‚Ù‚­‚ë, ‚ ‚´‚̃Œ[ƒU[Ž¡—ÂƔ畆Šà‚ÌŽ¡—Ã. ŽR‰º—ŠGiŒ`ŠOj: ‘æ11‰ñÓ슙‘qŒöŠJuÀ i99.02.13j, ‘å‘D.


<<23 ”畆‰ÈŠw>>

2442. mŒ´’˜n Local Cytokine Expression in Steroid-Modified Tinea Faciei. ‘¾“cK‘¥CÄ“¡“T[C“cÀO”VC“¡‘º‹¿’jCŸ‰ªŒ›¶i”çj: J. Dermatol., 25(6): 362`366, 1998.

2443. mŒ´’˜n Current Topics in Diagnosis and Treatment of Tinea Unguium in Japan. “cÀO”Vi”çj: J. Dermatol., 26(2): 87`97, 1999.

2444. mŒ´’˜n ’܈ىh—{Çi’܉Šj. ‘¾“cK‘¥CŸ‰ªŒ›¶i”çj: Monthly Book Derma., 2(13): 43`48, 1998.

2445. mŒ´’˜n Efficacy of Oral Fluconazole in Tinea Pedis of the Hyperkeratotic Type; Stratum corneum levels. “cÀO”VC“yˆäŠó•¶C–îŒûŒúC‘¾“cK‘¥C¼ŽR–ΕvCSekiguchi, K.CŸ‰ªŒ›¶i”çj: Mycoses, 41: 153`162, 1998.

2446. mŒ´’˜n ‰ß‹Ž25”NŠÔ‚Ì–k—¢‘åŠw”畆‰È‚É‚¨‚¯‚é“]ˆÚ«”畆Šà48Ç—á‚ÌŒŸ“¢. “¡‰ª²C‚{”ŽC•‘ºr”VCóˆär–íC‹TŽRFˆê˜YC•ÄŒ³N‘ C¼ŽR–ΕvCŸ‰ªŒ›¶i”çj: ¼“ú–{”畆‰È, 60(5): 681`684, 1998.

2447. mŒ´’˜n ”畆‹Ø‰Š‚É‚¨‚¯‚éŠÔŽ¿«”x‰Š‚Ɣ畆Çó‚Æ‚ÌŠÖ˜A«‚ÌŒŸ“¢. ŽRã”ü]C‰q“¡ŒõCVˆätŽ}CŸ‰ªŒ›¶C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽ, 108(8): 1021`1029, 1998.

2448. m€Œ´’˜n Lichen Planus and Sjogren-type Sicca Syndrome in a Patient with Chronic Hepatitis C. Žíˆä—Ç“ñC‘¾“cK‘¥CŸ‰ªŒ›¶i”çj: Review Series Hepatitis, (3): 14`15, 1998.

2449. m€Œ´’˜n ‘½Ê‚ÈŠÖßÇó‚𔺂Á‚½ŠÖßÇ«Š£á‚Ì‚P—áiŠO‘l—á). ‘O“‡‰pŽ÷C²“¡’¼ÆCVˆä’BC‘¾“cK‘¥C‘åìŽiCŸ‰ªŒ›¶i”çj: ‘æ13‰ñ“ú–{Š£áŠw‰ï‹L˜^W(Proceedings of the 13th Annual Meeting of the Japanese Society for Psoriasis Research), 13: 68`69, 1998.

2450. m€Œ´’˜n ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€‚P; ”畆‰È¥“à‰È‡“¯ƒJƒ“ƒtƒ@ƒŒƒ“ƒX‚̉^‰c. ‰q“¡ŒõC¬—Ñ–LC‹ß“¡Œ[•¶i“àj: “ú–{”畆‰ÈŠw‰ï‰ïŽ, 108: 1621`1622. 1998.

2451. mÇ—á•ñn Pityriasis Versicolor with a Unique Clinical Appearance. ‰œ“c’·ŽO˜Yi϶‰ïŽOð•a‰@jCˆÉ“¡‰ëÍiVŠƒ‘åjC’‡–íC¼ì•“ñiŒc‘åjC“cÀO”Vi”çjC‹v•ÄŒõi•a—j: Medical Mycology, 36: 331`344, 1998.

2452. mÇ—á•ñn A Case of Tinea Barbae Successfully Treated with Terbinafine. “cÀO”VC“yˆäŠó•¶C¼ŽR–ΕvCŸ‰ªŒ›¶i”çj: Mycoses, 41: 77`81, 1998.

2453. mÇ—á•ñn ƒŠƒ“ƒp•‚Žî‚ð‚«‚½‚µ‚½“û–[ŠOPaget•a. •y“c¹GC‚{”ŽC²“¡’¼ÆC–îŒûŒúC‘¾“cK‘¥C•ÄŒ³N‘ CŸ‰ªŒ›¶i”çjCão—Ljêi“ŒŽœˆã‘åj: Skin Cancer, 12(3): 335`339, 1998.

2454. mÇ—á•ñn •¡”­«‘Ñóáv]. ‚{”ŽC“¡‰ª²CŽR–{’B—Yi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽ, 108(11): 1419`1425, 1998.

2455. mÇ—á•ñn Sister Mary Joseph's Nodule‚Ì1—á. ‚{”ŽC–îŒûŒúC’؈äL”üC‰H‹àdŠìC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: ”畆‰È‚Ì—Õ°, 40(10): 1684`1685, 1998.

2456. mÇ—á•ñn “ª•”‚É‚Q‚‚̊®‘S’E–Ñ”Á‚ð”F‚ß‚½æ“V«”畆Œ‡‘¹Ç‚Ì1—á. “V‰HN”Vi”çjC¬•û“~Ž÷CŠÔ’†òC‰ª•”ÈŒái“¯ˆ¤‹L”O•a‰@j: ”畆‰È‚Ì—Õ°, 40(11): 1720`1721, 1998.

2457. mÇ—á•ñn Žð¸—l”ç]‚𔺂Á‚½”畆Œ´”­Anaplastic Large Cell Lymphoma‚Ì1—á. “V‰HN”VC‹àŽq‘C‚{”ŽC‘¾“cK‘¥C•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: ”畆‰È‚Ì—Õ°, 40(11): 1801`1804, 1998.

2458. mÇ—á•ñn ƒAƒ“ƒsƒƒLƒVƒJƒ€iƒtƒ‹ƒJƒ€R)‚É‚æ‚éŒõü‰ß•qŒ^–ò]. ’†–ì•q–¾C‹{“c‘ŽqC“V–ì—²•¶C‘¾“cK‘¥CŸ‰ªŒ›¶i”çj: ”畆‰È‚Ì—Õ°, 40(11): 1817`1820, 1998.

2459. mÇ—á•ñn ‹}‘¬‚Éis‚·‚é’×ᇫ‘å’°‰Š‚ɇ•¹‚µ‚½‰óás«”^”çÇ‚Ì1—á. “V‰HN”VC‘¾“cK‘¥C‹ÀêLìC‹àŽq‘C–îŒûŒúCŸ‰ªŒ›¶i”çj: ”畆‰È‚Ì—Õ°, 40(5): 813`816, 1998.

2460. mÇ—á•ñn ‘½‘ŸŠíáŠQ«–ò܃AƒŒƒ‹ƒM[‚𶂶‚½¬lStill•a. ‚{”ŽC´–ì‚Ý‚«CŽRã”ü]Cóˆär–íC•ÄŒ³N‘ i”çj: ”畆‰È‚Ì—Õ°, 40(7): 1117`1121, 1998.

2461. mÇ—á•ñn Amblyomma Americanum‚É‚æ‚éƒ}ƒ_ƒj™ùÇ. VŽRŽj˜NC‘‘òŠ²’jCŸ‰ªŒ›¶i”çjCˆÉ“¡—mˆêiŠñjCŠpâÆ‹Miˆ¤’mˆã‰È‘åj: ”畆‰È‚Ì—Õ°, 40(8): 1188`1189, 1998.

2462. mÇ—á•ñn ‚—îŽÒ‚Ì…“—‚Ì1—á. ’·£²•vC‚‹´¸ŽiC“¡‰ª²CŽR–{’B—Yi”çj: ”畆‰È‚Ì—Õ°, 40(9): 1451`1453, 1998.

2463. mÇ—á•ñn 4Ží—Þ‚Ì–òÜ‚ÌDrug combination‚É‚æ‚éŒÅ’è–ò]‚Ì1—á. ´–ì‚Ý‚«C‹{èçtC’·£²•vCVˆä’BC•½¼³_CŒüˆäGŽ÷i”çj: ”畆‰È‚Ì—Õ°, 41(1): 41`45, 1999.

2464. mÇ—á•ñn ƒAƒgƒs[«”畆‰Š‚ÌŒûO•a•Ï. •ÄŒ³N‘ C–îŒûŒúi”çj: ”畆•af—Ã, 20(4): 327`330, 1998.

2465. mÇ—á•ñn ‰ºŽˆ‚ɶ‚¶‚½Stewart-TrevesÇŒóŒQ. ]ŠÔ‘CŒ´®“¹CŽíˆä—Ç“ñC‘‘òŠ²’jCŸ‰ªŒ›¶i”çj: ”畆•af—Ã, 20(5): 415`418, 1998.

2466. mÇ—á•ñn ‚bŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXŠ´õÇ‚É”º‚¤erythema multiforme. ’؈äL”üCŸ‰ªŒ›¶i”çj: ”畆•af—Ã, 21(3): 231`234, 1999.

2467. mÇ—á•ñn ŒŸf‚É‚Ä”x‚É‘½”­‰A‰e‚ð”F‚ß‚½‚±‚Æ‚É‚æ‚è‹C•t‚©‚ꂽBowen carcinoma‚Ì1—á. Ä“¡“T[i”çjC–ö–{–M—Yi•a—jC•ÄŒ³N‘ i”çj: –k—¢ˆãŠw, 28(4): 394`397, 1998.

2468. mÇ—á•ñn ‘½”­‚·‚é“`õ«“î‘®Žî‚©‚çf’f‚µ‚½HIVŠ´õÇ. VŽRŽj˜NC‰ª–{Œ‰C‰¹ŽR˜aéi”çj: —Õ°”畆‰È, 52(12): 1034`1036, 1998.

2469. mÇ—á•ñn ‚¢‚í‚ä‚é”畆¬‡Žîᇂ̑gD‰»Šw“IŒŸ“¢. ‚{”ŽC“¡‰ª²CŒË“c~CŽR–{’B—Yi”çj: —Õ°”畆‰È, 52(7): 553`556, 1998.

2470. mÇ—á•ñn ƒRƒ‹ƒqƒ`ƒ“‚ª‘tŒø‚µ‚½¬lStill•a‚Ì1—á. VŽRŽj˜NC´–ì‚Ý‚«C“V–ì—²•¶C‚{”ŽC‘¾“cK‘¥CŸ‰ªŒ›¶i”çj: —Õ°”畆‰È, 52(9): 721`723, 1998.

2471. mÇ—á•ñn ‰t‘Ì’‚‘f—Ö@‚ª—LŒø‚Å‚ ‚Á‚½Laugier-Hunziker-BaranÇŒóŒQ. VŽRŽj˜NC‰ª–{Œ‰C‰¹ŽR˜aéi”çj: —Õ°”畆‰È, 53(1): 56`58, 1999.

2472. m—Õ°Ž¡Œ±n ƒAƒgƒs[«”畆‰Š, ”玉Œ‡–R«”畆‰Š‚È‚Ç‚ÉŒ©‚ç‚ê‚銣‘‡«”畆Çó‚ɑ΂·‚é–û«•ÛŽ¼Ü”z‡——pÜiƒmƒu–ò—pƒoƒXƒGƒbƒZƒ“ƒXRj‚ÌŽg—pŒoŒ±. ‘¾“cK‘¥CŸ‰ªŒ›¶i”çj: ”畆, 41(1): 97`102, 1999.

2473. muÀn œ‘«ƒ|ƒ‹ƒtƒBƒŠƒ“Ç. •ÄŒ³N‘ i”çj: Œ’, 27(4): 8`10, 1998.

2474. muÀn Ž¿‹^‰ž“š, ”畆‰È; ‘«’ê‚̈ÙL‚Æ‚»‚Ì‘Îô. ‘¾“cK‘¥i”çj: “ú–{ˆãŽ–V•ñ, (3905): 106`107, 1999.

2475. mŠwp‘n i•ª’SŽ·•Mj ”畆‰Èf—Ãvƒ‰ƒNƒeƒBƒX(5)|ƒXƒLƒ“ƒPƒA‚ÌŽÀÛ; –Ñ|–Ñ‚ÍĶ‚Å‚«‚é‚©? –тͶ‚¦‚é‚©? •a‘Ô¥ƒƒJƒjƒYƒ€|‚È‚ºŽá‚Í‚°‚ª‹N‚±‚é‚©?, p.54`55, ‘¾“cK‘¥CŸ‰ªŒ›¶i”çj. •ÒW “c㔪˜Ni“Œ–k‘åjC‹{’n—ÇŽ÷i‹ž‘åjC‘ëì‰ë_i•l¼ˆã‘åjC•ÒC •¶Œõ“°, 98.00.00”­s.

2476. mŠwp‘n i•ª’SŽ·•Mj …’ŽQ&A; Q.22: ‚µ‚ç‚­‚à‚ƃPƒ‹ƒXƒX“ÃáŒ, p.56`57, Q.43: ƒPƒ‹ƒXƒX“ÃáŒ, ”’á‹Û«–Ñጂ̎¡—ÂÍ, p.104`105, ‘¾“cK‘¥CŸ‰ªŒ›¶i”çj. •ÒW ‹{’n—ÇŽ÷i‹ž‘åjC•ÒC ˆã–òƒWƒƒ[ƒiƒ‹, 98.04.10”­s.

2477. mŠwp‘n i•ª’SŽ·•Mj …’ŽQ & A; ”’á‹Û«–Ñጂ̎¡—ÂÍ, p.104`105, ‘¾“cK‘¥CŸ‰ªŒ›¶i”çj. •ÒW ‹{’n—ÇŽ÷i‹ž‘åjC•ÒC ˆã–òƒWƒƒ[ƒiƒ‹, 98.04.10”­s.

2478. mŠwp‘n i•ª’SŽ·•Mj ”畆‰Èƒvƒ‰ƒCƒ}ƒŠƒPƒA; ‰~Œ`’E–ÑÇ, p.125`130, Ÿ‰ªŒ›¶i”çj. •ÒW ‹{’n—ÇŽ÷i‹ž‘åjC•ÒC f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 98.05.20”­s.

2479. mŠwp‘n i•ª’SŽ·•Mj ”畆Ž¾Š³ÅV‚ÌŽ¡—Ãg1999-2000"; ƒTƒ‹ƒRƒCƒh[ƒVƒX, p.87`88, Ÿ‰ªŒ›¶i”çj. •ÒW V‘º^lC‘ëì‰ë_C•ÒC “ì]“°, “Œ‹ž, 99.02.20”­s.

2480. mŠwp‘n i•ª’SŽ·•Mj ‹«ŠE—̈æ‚̔畆•a•Ï|‘¼‘ŸŠíŽ¾Š³‚Ɣ畆|; “à•ª”å“à‰È‚Ɣ畆Ž¾Š³, p.30`39, Žíˆä—Ç“ñCŸ‰ªŒ›¶i”çj. •ÒW ‹{’n—ÇŽ÷i‹ž‘åjC•ÒC ’†ŠOˆãŠwŽÐ, “Œ‹ž, 98.06.10”­s.

2481. mŠwp‘n i•ª’SŽ·•Mj Methods in Molecular Medicine: Therapeutic Applications of Ribozymes; Tissue-Specific Delivery of an Anti-H-ras Ribozymes Against Malignant Melanoma, p.169`192, ‘åìŽii”çjCMohammed Kashani-SabetiƒJƒŠƒtƒHƒ‹ƒjƒA‘åj. •ÒW Kevin J. Scanloni•Ä‘ Berlex BiosciencesjC•ÒC Humana Press Inc., Totowa, New Jersey, USA, 98.00.00”­s.

2482. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ^‹ÛŒŸ¸–@, 1. ŽŽ—¿‚ÌÌ‚è•û, p.6`7, “cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2483. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ^‹ÛŒŸ¸–@, 2. ’¼Ú‹¾ŒŸ¸–@, p.8`11, “cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2484. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ^‹ÛŒŸ¸–@, 3. •a—‘gDŠw“If’f–@, p.12`17, “cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2485. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 9. Žè”’á, p.80`81, “cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2486. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 15. ƒJƒ“ƒWƒ_«ŽwæäŠÔ‚Ñ‚ç‚ñÇ, p.92`93, “cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2487. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 16. ƒJƒ“ƒWƒ_«ŠÔŽC], p.94`95, “cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2488. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 36. tˆÚA‚É”º‚¤”畆^‹ÛÇ, p.142`143, “cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2489. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚ÌŠT—v, 2. •\Ý«ƒJƒ“ƒWƒ_Ç, p.38, ‹àŽq‘C“cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2490. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 17. ”S–ŒƒJƒ“ƒWƒ_Ç, p.96`99, ‹àŽq‘C“cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2491. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚ÌŠT—v, 10. ”’á«“÷‰èŽî, p.46, ‰H‹àdŠìC“cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2492. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 28. ”’á«“÷‰èŽî, p.124`125, ‰H‹àdŠìC“cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2493. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚ÌŠT—v, 11. •úü‹ÛÇ, p.47, ‘¾“cK‘¥C“cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2494. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 29. •úü‹ÛÇ, p.126`127, ‘¾“cK‘¥C“cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2495. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 6. Šç–Ê‚Ì”’á, p.70`71, ‘¾“cK‘¥i”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2496. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 7. ŒÒ•””’á, p.72`75, “yˆäŠó•¶C“cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2497. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 8. ‘«”’á, p.76`79, –îŒûŒúC“cÀO”Vi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2498. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ”畆^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã, 11. ”Ä”­«”’á, p.84`85, ‰Í–ìŒoŽqi”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2499. mŠwp‘n i•ª’SŽ·•Mj ”畆^‹ÛǃJƒ‰[ƒAƒgƒ‰ƒX; ^‹ÛŒŸ¸–@, 5. –ƉuŠw“If’f–@, p.20`22, “cÀO”Vi”çjCˆ¢•””ü’mŽqiˆã—Éq¶j. •ÒW ¼ŽR–Εvi”çjC•ÒC ˆã‰ÈŠwo”Å, 99.02.00”­s.

2500. mŠwp‘n i•ª’SŽ·•Mj Gene Therapy (Advances in Pharmacology); Anti-oncogene Ribozymes for Cancer Gene Therapy, 40: 207`257, Irie, A.CKijima, H.C‘åìŽii”çjCBouffard, David Y.CSuzuki, T.CCurdio, Lisa D.CHolm, Per SonneCSassani, AlexCScanlon, Kevin J.iCity of Hope national Medical Centerj. •ÒW August, J. ThomasiJohns Hopkins UniversityjC•ÒC Academic Press, Tokyo, 97.00.00”­s.

2501. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj NHK¡“ú‚ÌŒ’N; “~‚Ì”§‚ ‚ê, p.78`81, Ÿ‰ªŒ›¶i”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC “ú–{•ú‘—o”Å‹¦‰ï, “Œ‹ž, 98.12.01”­s.

2502. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj NHK¡“ú‚ÌŒ’N; ÚG”畆‰Š, p.82`85, Ÿ‰ªŒ›¶i”çj. •ÒW ¼ŽR–Εvi”çjC•ÒC “ú–{•ú‘—o”Å‹¦‰ï, “Œ‹ž, 98.12.01”­s.

2503. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj Dermatopics; Latex allergy, Ÿ‰ªŒ›¶i”çj. ƒG[ƒUƒCŠ”Ž®‰ïŽÐ, “Œ‹ž, 98.08.00”­s.

2504. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Herpes Zoster in Infancy. –îŒûŒúC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: ‘Û¬Ž™”畆‰ÈŠw‰ï i98.05.18`20j, ƒtƒ‰ƒ“ƒX.

2505. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒXƒgƒŒƒX‚Ɣ畆áŠQ. •ÄŒ³N‘ i”çj: “ú–{Ï•iŠw‰ï‘æ27‰ñŠwp‘å‰ï i98.06.05j, “Œ‹ž.

2506. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŒŒŠÇ“÷Žî‚ɑ΂·‚é1L-12—Ö@‚ÌŠî‘bŒ¤‹†. ‘‘òŠ²’ji”çj: ‘æ63‰ñ“ú–{”畆‰ÈŠw‰ï“Œ•”Žx•”Šwp‘å‰ï i98.10.31j, •l¼.

2507. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –Ô–Œ’†S“®–¬•ÂÇǂɈø‚«‘±‚¢‚Ä”­Ç‚µ‚½SLE. “c•Ó˜a”üC’†‘º˜aÆCŽRã”ü]C‘åìŽii”çjCŽR“cGš¤i‘—§‰¡•lj: ‘æ61‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”‘‰ï i98.02.21j, ‰¡•l.

2508. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰©FŽî‚Æ‘½–т𔺂Á‚½Œ´”­«’_`«ŠÌd•Ï. “V‰HN”Vi”çjC¬•û“~Ž÷CŠÔ’†òC‰ª•”ÈŒái“¯ˆ¤‹L”O•a‰@j: ‘æ61‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”‘‰ï i98.02.21j, ‰¡•l.

2509. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”畆¥‹ØZ‚Æ––½«”]_ŒoáŠQ‚𔺂Á‚½‚a×–E«ƒŠƒ“ƒpŽî. “V‰HN”VCŽíˆä—Ç“ñC“c•Ó˜a”üC“¡ˆäMLi”çjCX^—R”üi“Œ‹ž“s˜Vlˆã—ÃZƒ“j: ‘æ98‰ñ“ú–{”畆‰ÈŠw‰ï‘‰ï i98.04.11j, “Œ‹ž.

2510. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”畆‰ÈE“à‰È‡“¯ƒJƒ“ƒtƒ@ƒŒƒ“ƒX‚̉^‰c. ‰q“¡Œõi”çjC‹ß“¡Œ[•¶C¬—Ñ–Li“àj: ‘æ97‰ñ“ú–{”畆‰ÈŠw‰ï i98.05.29`31j, ‘åã.

2511. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒNƒ‰ƒrƒbƒgRiƒŒƒ{ƒtƒƒLƒTƒVƒ“j‚É‚æ‚éŒÅ’è–ò]. ŽsìŒOC“V–ì—²•¶C‹´–{–¾•FC¼“‡”ü‰ÄC‘åìŽiC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: “ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ï i98.07.11j, ‚¼, “ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ïŽGŽ, 6(2): 56, 1998.

2512. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘½Ê‚ÈŠÖßÇó‚𔺂Á‚½ŠÖßÇ«Š£á‚Ì1—áiŠO‘l—áj. ‘O“‡‰pŽ÷C²“¡’¼ÆCVˆä’BC‘¾“cK‘¥C‘åìŽiCŸ‰ªŒ›¶i”çj: ‘æ13‰ñ“ú–{Š£áŠw‰ï i98.11.20j, ‚¼, ‘æ13‰ñ“ú–{Š£áŠw‰ï‹L˜^W, p.68`69, 1998.

2513. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒŠÇ“÷Žî‚ɑ΂·‚éHEW-3 XOKT-3 bispecificR‘Ì•¹—pIL-2/LAK–Ɖu—Ö@‚ÌŒŸ“¢|ƒqƒgŒŒŠÇ“÷ŽîˆÚASCIDƒ}ƒEƒXƒ‚ƒfƒ‹‚ð—p‚¢‚Ä|. ‘‘òŠ²’ji”çjC•l“c—SŽqi¶‰»ŒnjC’Ë–{G—Yi“ŒŠC‘åjC“¡‘º‹¿’jCŸ‰ªŒ›¶i”çjC‹Ê“àGˆêi”÷jC÷ˆä”ü“Tiˆã—Éq¶jCŠ_¶‰€Žqi“ŒŠC‘åj: ‘æ28‰ñ“ú–{–ƉuŠw‰ï‘‰ï i98.12.03j, _ŒË.

2514. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j œZ‚𶂶“ªŠW“à‚ÖŠg‘債‚½ˆ««ŒŒŠÇ“à”ç×–EŽî. Œ´®“¹CVŽRŽj˜NCŽRŒû‹ž”üC’·£²•vCVˆä’BC‹¿êLìC‘‘òŠ²’jCŸ‰ªŒ›¶i”çj: ‘æ22‰ñ”畆–¬ŠÇ§˜b‰ï i99.01.28j, “È–Ø.

2515. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì2—á. –îŒûŒúC•ÄŒ³N‘ i”çj: ‘æ61‰ñ“Œ‹žŽx•”Šwp‘å‰ï i99.02.21j, ‰¡•l.

2516. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j –Ñ”¯‚ÌŠî‘b‚Æ—Õ°. Ÿ‰ªŒ›¶i”çj: –k‹ãBŽs”畆‰Èˆã‰ï i98.06.25j, –k‹ãB.

2517. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ‰óŽ€«ŒŒŠÇ‰Š‚Æ—Þ‰Ž¾Š³. Ÿ‰ªŒ›¶i”çj: ‘æ46‰ñ•ºŒÉŒ§”畆‰Èˆã‰ï i98.11.28j, _ŒË.

2518. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j Žq‹Ÿ‚Ì“ª”¯|’E–Ñ‚ð’†S‚É|. Ÿ‰ªŒ›¶i”çj: ¬Ž™”畆‰ÈŠw‰ïƒZƒ~ƒi[ i99.02.04j, “Œ‹ž, “ú–{¬Ž™”畆‰ÈŠw‰ïŽ, 18(1): 1999.

2519. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ”畆’×á‡, Œ´ˆö‚ÆŽ¡—Âð‚ß‚®‚éŋ߂̘b‘è. Ÿ‰ªŒ›¶i”çj: ‘æ62‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”‘‰ï i99.02.13j, “Œ‹ž.

2520. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j ‚—îŽÒ‚Ì‚©‚ä‚Ý. •ÄŒ³N‘ i”çj: ‘æ57‰ñ_“Þì“à‰ÈˆãŠw‰ïŠwpu‰‰‰ï i98.11.07j, ‰¡•l.

2521. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’_”XŠà‚ð‡•¹‚µ‚½”畆‹Ø‰Š. “c•Ó˜a”üC’†‘º˜aÆCŽRã”ü]C‘åìŽii”çjC¬¼’BŽii‘—§‰¡•lj: ‘æ735‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.01.17j, ìè.

2522. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ãŠááÙ‚Ì”Á󎇔Á‚©‚çf’f‚µ‚½‘Sg«ƒAƒ~ƒƒCƒh[ƒVƒX. ]ŠÔ‘C²“¡’¼ÆCóˆär–íCŽR–{’B—Yi”çj: ‘æ735‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.01.17j, ìè.

2523. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŽèŽwF‘f’¾’…‚ÆAcral erythema‚ðl‚¦‚½‰–Ž_ƒuƒŒƒIƒ}ƒCƒVƒ“‚É‚æ‚é–ò]. ’؈äL”üC–îŒûŒúC•ÄŒ³N‘ i”çjC²“¡ˆÐ•¶i”åj: ‘æ735‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.01.17j, ìè.

2524. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “û“ª‹y‚Ñ“û—Ö•”‚É’˜‚µ‚¢F‘f’¾’…‚𔺂Á‚½•F•\”çŽî‚Ì1—á. “V‰HN”Vi”çjCŠÔ’†òC¬•û“~Ž÷C‰ª•”ÈŒáCŽè“‡Lˆêi“¯ˆ¤‹L”O•a‰@j: ‘æ735‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.01.17j, ìè.

2525. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ã”ç«ŽîᇗR—ˆ”|—{×–EŠ”‚É‚¨‚¯‚éCD40”­Œ»‚ɂ‚¢‚Ä. “V‰HN”VC‘¾“cK‘¥CŸ‰ªŒ›¶i”çjC‹Ê“àGˆêi”÷jC“y‰®gC²“¡—Yˆêi•a—j: ‘æ736‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.03.28j, “Œ‹ž.

2526. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰ŠÇ«•Ó‰—²‹N«”’”Á. ’؈äL”üC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: ‘æ738‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.06.20j, ‰¡•l.

2527. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒAƒŠƒ‹ƒCƒ\ƒvƒƒsƒ‹ƒAƒZƒ`ƒ‹”A‘f‚É‚æ‚鑽”­Œ^ŒÅ’è–ò]. ‘O“‡‰pŽ÷CVˆä’BC‘åìŽiC‹´–{–¾•FCƒTƒ“ƒeƒBƒX’qŒbCŸ‰ªŒ›¶i”çj: ‘æ738‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.06.20j, ‰¡•l, “ú–{”畆‰ÈŠw‰ïŽGŽ, 109(2): 218, 1999.

2528. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Angiolymphoid hyperplasia with eosinophilia. “c•Ó˜a”üC¼ˆä–îŽõŒbC’†‘º˜aÆC‘åìŽiC•‘ºr”Vi”çjC¼ŽRkˆê˜YiŽ¨•@j: ‘æ738‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.06.20j, ‰¡•l, “ú–{”畆‰ÈŠw‰ïŽGŽ, 109(2): 218, 1999.

2529. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Šç–Ê‚ÌŠÂóg”Á‚ð‰”­Çó‚Æ‚µ‚½SLE. ‹´–{–¾•FCŸ‰ªŒ›¶i”çj: ‘æ739‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.07.18j, “Œ‹ž.

2530. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Angiolymphoid hyperplasia with eosinophilia. ’؈äL”üC‘‘òŠ²’jCŸ‰ªŒ›¶i”çj: ‘æ740‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.09.18j, _“Þì.

2531. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j dÇ‹Ø–³—ÍÇŒo‰ß’†‚É‘«æä‚ɉóás‚𶂶‚½RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ‚Ì1—á. ˆî‘º•‘CVˆä’BC•y“c¹GC–îŒûŒúC‹´–{–¾•FCŸ‰ªŒ›¶i”çj: ‘æ740‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.09.19j, _“Þì.

2532. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘¤“ª“®–¬‰Š‚Ì1—á. Žíˆä—Ç“ñC“c•Ó˜a”üC“V‰HN”VC“¡ˆäMLi”çjC•Hì—²Žji“s˜Vˆãj: ‘æ740‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.09.19j, _“Þì.

2533. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹‘åŽîᎂð’悵‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ‚𔺂Á‚½“ª•”—Lž™×–EŠà‚Ì1—á. ´–ì‚Ý‚«CŽsìŒOCVˆä’BC‹´–{–¾•FC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: ‘æ741‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.10.17j, “¡‘ò.

2534. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j L”͈͂ɋy‚Ô”ç]‚Æ’E–т𗈂µ‚½DŽ_‹…«”X–E«–Ñ”¯. “n•Ó—S”üCVˆä’BC²“¡’¼ÆC‹´–{–¾•FC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: ‘æ741‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.10.17j, “¡‘ò.

2535. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j episodic angioedema associated with eosinophilia. –îŒûŒúC•ÄŒ³N‘ i”çj: ‘æ741‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.10.17j, “¡‘ò.

2536. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”畆Z‚𔺂Á‚½–«œ‘’P‹…«”’ŒŒ•a. “V‰HN”VC“¡ˆäMLC“c•Ó˜a”üCŽíˆä—Ç“ñi”çjCŒäŽqŽÄ˜H–¾i“s˜Vˆãj: ‘æ741‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.10.17j, “¡‘ò.

2537. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. _èrˆêC“¡“c—T‰îi”çjCÄ“¡N‰hC‹àŽqŒ˜‘¾˜YiŽ­“‡˜JЕa‰@j: ‘æ38‰ñ“ú–{”畆‰ÈŠw‰ïˆïé’n•û‰ï i98.10.25j, …ŒË.

2538. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “ª•”‚Ég”Á¥…áv‚ª‘½”­‚µ‚½Œã“V«•\”ç…ávÇ. Œ´®“¹C•y“c¹GC_èrˆêCÄ“¡“T[C’·£²•vCŽíˆä—Ç“ñC‹´–{–¾•FCŸ‰ªŒ›¶C‹´–{—²i”çj: ‘æ50‰ñ“ú–{”畆‰ÈŠw‰ï¼•”Žx•”‘‰ïŠwp‘å‰ï i98.11.14j, ’¹Žæ.

2539. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”^áv«Š£á‚É”­Ç‚µ‚½…áv«—Þ“VáváŒ. “c•Ó˜a”üC“¡ˆäMOC“V‰HN”VCŽíˆä—Ç“ñCóˆär–íCŽR–{’B—Yi”çj: ‘æ742‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.11.21j, ìè.

2540. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j multiple desmoplastic trichoepitheliomas. ¬’†—‰ïC²“¡’¼ÆCVˆä’BC‹ÀêLìC‹´–{–¾•FC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: ‘æ742‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.11.21j, ìè.

2541. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “\•tŽŽŒ±ŒãŠO—p•”ˆÊ‚Ɉê’v‚µ‚Äg”Á‚ªÄ”R‚µ‚½ƒAƒ‹ƒƒ^R“îp‚É‚æ‚éÚG”畆‰Š. ˆî‘º•‘CVˆä’BC‹´–{–¾•FC‘åìŽiCŸ‰ªŒ›¶i”çj: ‘æ742‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.11.21j, ìè.

2542. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒŒŠÇ“÷Žî‚ɑ΂·‚éTNP-470‚Æetoposide‚Ì—LŒø«‚ÌŒŸ“¢. ”n„C‘‘òŠ²’jC‰H‹àdŠìi”çjC•l“c—SŽqi¶‰»ŒnjCŒ´Œû•‡ŽÑŽqCŸ‰ªŒ›¶i”çjC÷ˆä”ü“Tiˆã—Éq¶j: ‘æ743‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.12.19j, “Œ‹ž.

2543. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j …áv«—Þ“VáváŒ‚ð‡•¹‚µ‚½d‰»«ˆÞk«‘Ûá. ¬’†—‰ïC²“¡’¼ÆC•y“c¹GCVˆä’BC‹´–{–¾•FC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: ‘æ744‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i99.01.16j, “¡‘ò.

2544. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j æ“V«F‘f«•ê”Á‚æ‚趂¶‚½ˆ««•FŽî. ŠÃ—˜~Cˆî‘º•‘C²“¡’¼ÆC‹´–{–¾•FC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: ‘æ744‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i99.01.16j, “¡‘ò.

2545. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”~“Å‚QŠú]iHIVŠ´õŽÒj‚Ì1—á. ‘åìŽiCŸ‰ªŒ›¶i”çjCŠâŸºŒ[ˆêi•a—j: ‘æ744‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i99.01.16j, “¡‘ò, ”畆•af—Ã, 21(5): 1999.

2546. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠÔŽ¿«”x‰Š‚𔺂Á‚½SLE. VŽRŽj˜NCVˆä’BC‹´–{–¾•FC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çj: ‘æ62‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”‘‰ï i99.02.13j, “Œ‹ž.

2547. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒ{[ƒGƒ“•a, —Lž™×–EŠà‚É‚¨‚¯‚éCD40”­Œ»‚ÆZ×–E‚ÌCD40 ligand”­Œ»‚ɂ‚¢‚Ä. “V‰HN”VC‘¾“cK‘¥CŸ‰ªŒ›¶i”çjC‹Ê“àGˆêi”÷jC—§“c”ü“ÞŽqi—ÕŒŸjC•l“c—SŽqi¶‰»Œnj: ‘æ745‰ñ“Œ‹ž’n•û‰ïiŒ¤‹†’n•û‰ïj i99.02.23j, “Œ‹ž.

2548. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒCƒgƒ‰ƒRƒiƒ][ƒ‹‚ÅŽ¡—µ‚½¬Ž™ƒXƒ|ƒƒgƒŠƒR[ƒVƒX‚Ì1—á. _èrˆêC“¡“c—T‰îCVŽRŽj˜Ni”çj: ‘æ308‰ñ“ú–{”畆‰ÈŠw‰ï•Ÿ‰ª’n•û‰ï i99.03.21j, •Ÿ‰ª.

2549. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j TNP-470, etoposide, prednisolone‚É‚æ‚錌ŠÇ“÷Žî—}§Œø‰Ê‚ÌŒŸ“¢. ‘‘òŠ²’jC”n„C‰H‹àdŠìi”çjC•l“c—SŽqi¶‰»ŒnjCŒ´Œû•‡ŽÑŽqCŸ‰ªŒ›¶i”çjC÷ˆä”ü“Tiˆã—Éq¶j: ‘æ745‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ïiŒ¤‹†j i99.03.28j, “Œ‹ž.

2550. mŒ¤‹†‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Anagen Induction by Contact Hypersensitivity in C3H Mice. ‘¾“cK‘¥C’؈äL”üCVŽRŽj˜NCŽsìŒOC•y“c¹GCƒTƒ“ƒeƒBƒX’qŒbC“¡‘º‹¿’jCŸ‰ªŒ›¶i”çj: 3rd International Research Workshop on Alopecia areata i98.11.05j, Washington D.C..

2551. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j multicentiric Castleman's disease—ÞŽ—‚Ì‘SgÇó‚𔺂Á‚½CD56+ Cutaneous T-cell Lymphome. “V‰HN”Vi”çjCŽžŒõ—æŽqC¬•û“~Ž÷C‰ª•”ÈŒái“¯ˆ¤‹L”O•a‰@j: ‘æ17‰ñ”畆ƒŠƒ“ƒtƒH[ƒ}Œ¤‹†Šw‰ï i98.07.11j, ‰¡•l.

2552. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒXƒeƒƒCƒh‚É‚æ‚錌ŠÇ“÷Žî—}§Œø‰Ê‚ÌŒŸ“¢. ‘‘òŠ²’jC”n„C‰H‹àdŠìi”çjC•l“c—SŽqi¶‰»ŒnjCŒ´Œû•‡ŽÑŽqCŸ‰ªŒ›¶i”çjC÷ˆä”ü“Tiˆã—Éq¶j: ‘æ22‰ñ”畆–¬ŠÇ§˜b‰ï i99.01.28j, ‰F“s‹{.

2553. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠÔŽ¿«”x‰Š‚ð‡•¹‚µ‚½”畆‹Ø‰ŠŠ³ŽÒ¶‘¶—á‚ÌŒŸ“¢. Vˆä’BCŒ´®“¹C‹´–{–¾•FCŸ‰ªŒ›¶CŠÖª“ÖŽqCVˆätŽ}C‰q“¡Œõi”çj: ‘æ13‰ñäPŒ´•aŒ¤‹†‰ï i99.01.29j, ‰F“s‹{.

2554. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “à‰ÈŽ¾Š³‚Ɣ畆Çó|Žå‚É“œ”A•a‚ɂ‚¢‚Ä|. Ÿ‰ªŒ›¶i”çj: MB–k—¢ˆãŠw‰ï i98.08.01j, ’·–ì.

2555. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ’E–ÑÇ‚Æ‚»‚̃PƒA. Ÿ‰ªŒ›¶i”çj: ƒXƒLƒ“ƒPƒAŒ¤‹†‰ï i99.03.23j, ɪ.

2556. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éƒJƒ|ƒW…“——l”­]Ç‚Ì‚Ü‚Æ‚ß. ‘¾“cK‘¥C²“¡’¼ÆCŸ‰ªŒ›¶i”çj: ‘æ5‰ñ_“Þ쌧ƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï i98.11.12j, ‰¡•l.

2557. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŒŒŠÇ“÷ŽîIL-2/LAK–Ɖu—Ö@-HEW-3XOKT-3 bispecificR‘Ì•¹—pŒø‰Ê‚ÌŒŸ“¢. ‘‘òŠ²’ji”çjC•l“c—SŽqi¶‰»ŒnjCŒ´®“¹C“¡‘º‹¿’jCŸ‰ªŒ›¶i”çjC‹Ê“àGˆêi”÷jC÷ˆä”ü“Tiˆã—Éq¶jC’Ë–{G—YCŠ_¶‰€Žqi“ŒŠC‘åj: ‘æ743‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i98.12.19j, “Œ‹ž.


<<24 ”å”AŠí‰ÈŠw>>

2558. mŒ´’˜n Effect of probucol on serum lipoprotein abd apoprotein profiles in renal transplant patients. ‘å‹v•Û[lC–xˆä‚ ‚«‚çCŠ™“cvŽõC’|“àN—YC’Ë–{—Y‰îi“àjC¬—ÑLsC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC‰““¡’‰—Yi”åj: Am. J. Kidney. Dis., 31(2): 356`359, 1998.

2559. mŒ´’˜n Distribution and significance of microcalcifications in the neoplastic and nonneoplastic prostate. Woods, J.E.C‘v¬_i”åjCWheeler, T.M.iƒxƒCƒ‰[ˆã‘åj: Arch. Pathol. Lab. Med., 122: 152`155, 1998.

2560. mŒ´’˜n Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Wilcox GeorgeiƒxƒCƒ‰[ˆã‘åjC‘v¬_i”åjCChakraborty SubhenduCScardino Peter T.CWheeler, Thomas M.iƒxƒCƒ‰[ˆã‘åj: Hum. Pathol., 29(10): 1119`1123, 1998.

2561. mŒ´’˜n Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Wheeler, T.M.CDillioglugil, O.CKattan, W.M.CArakawa, A.C‘v¬_C{ŽRˆê•äC‘å–x—i”åj: Hum. Pathol., 29(8): 856`8625, 1998.

2562. mŒ´’˜n BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer. “à“c–LºC‰¤tŠìC²“¡ˆÐ•¶C‚]•½C‚“ˆ—Í–íC“ü]Œ[C‘å–x—C¬ŽÄŒ’i”åj: Int. J. Cancer (Pred. Oncol.): 84, 19`23, 1999.

2563. mŒ´’˜n Pathophysiology of clinical varicoceles in infertile men. Cockett, A.T.CTakihara, H.iƒxƒCƒ‰[ˆã‘åjCŠâ‘º³ŽkC¬ŽÄŒ’i”åj: Int. J. Urol., 5(2): 113`115, 1998.

2564. mŒ´’˜n Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer. Œã“¡NŽ÷iŠâŽèˆã‘åjC‘å–x—i”åjC™‘º~C“¡‘òGŒõC“¡‰ª’mºiŠâŽèˆã‘åj: Int. J. Urol., 5: 334`337, 1998.

2565. mŒ´’˜n Current and future trends in interventional therapy for benign prostatic hyperplasia in Japan. ‰oìWC“à“c–LºC¬ŽÄŒ’i”åj: J. Urol., 159: 1958`1960, 1998.

2566. mŒ´’˜n Impact of life expectancy and tumor doublig time on the clinical significance of prostate cancer in Japan. ‰oìWC¼–{˜a«CŠâ‘º³ŽkC“à“c–Lºi”åjCŒK”ö’èmi•a—jC¬ŽÄŒ’i”åj: Jpn. J. Clin. Oncol., 27(6): 394`400, 1997.

2567. mŒ´’˜n Zonal biopsy in the detection of prostate cancer in Japanese men. ‰oìWC¼–{˜a«CŠâ‘º³ŽkC“à“c–Lºi”åjCŒK”ö’èmi•a—jC¬ŽÄŒ’i”åj: Jpn. J. Clin. Oncol., 28(1): 20`26, 1997.

2568. mŒ´’˜n Results of transrectal ultrasound-guided biopsies and clinical significance of Japanese prostate cancer. ‰oìWC¼–{˜a«C‹g“cˆê¬CŠâ‘º³Žki”åjCŒK”ö’èmi•a—jC¬ŽÄŒ’i”åj: Jpn. J. Clin. Oncol., 28(11): 666`672, 1998.

2569. mŒ´’˜n •›t‚Ö‚Ì“àŽ‹‹¾“I“ž’B–@‚Ì‘I‘ð. ¼“cŒöŽuiŠÖ¼ˆã‘åjC”nêŽu˜Yi”åj: Jpn. J. Endourol. ESWL, 11: 132`133, 1998.

2570. mŒ´’˜n Œã• –Œ‹¾Œã•û“ž’B–@. ”nêŽu˜Yi”åjCç—t—Ti“Œ–k‘åjC“à“¡½“ñi‹ã‘åj: Jpn. J. Endourol. ESWL, 11: 161`168, 1998.

2571. mŒ´’˜n Laparoscopic adrenalectomy for pheochromocytoma: Transperitoneal and extraperitoneal approach. ”nêŽu˜Yi”åjCHoriguchi, A.CNonaka, S.CMurai, M.iŒc‘åj: Jpn. J. Endourol. ESWL, 11: 35`40, 1998.

2572. mŒ´’˜n Adenoviral-mediated anti-H-ras ribozyme for the treatment of bladder cancer. “ü]Œ[i”åjCJerry TsaiCMohammed Kashani-Sabet: Methods in Molecular Medicine, 11.

2573. mŒ´’˜n Receptors for BPH growth factors are located in some neuroendocrine cells. Šâ‘º³ŽkC¬ŽÄŒ’i”åjCAbraham T.K. Cockettiƒƒ`ƒFƒXƒ^[‘åj: The Prostate, 8(Suppl.): 14`17, 1998.

2574. mŒ´’˜n Protective effect of nicaraven against prolonged cold kidney preservation and reperfusion injury. ^è‹`•FiŽÀ“®ŒnjCŒF–ì˜a—YC‰““¡’‰—YCŠâ‘º³ŽkC¬ŽÄŒ’i”åjC‰¡“c˜a•FiŽ™jC‘å‹v•Û[li²–ìŒú¶•a‰@j: Transplant. Proc., 30: 3758`3760, 1998.

2575. mŒ´’˜n T-cell receptor variable gene analysis of renal allograft-infiltrating cells in biopsy specimens using a nonradioisotopic micromethod. ¬”¦•¶–íiˆã—Éq¶jCŒF–ì˜a—YC‰““¡’‰—Yi”åjC’|“àN—Yi“àjC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjCŠp“c‚Ý‚³‚¨i–Ɖuj: Transplantation, 66(10): 1389`1392, 1998.

2576. mŒ´’˜n Suppression of the growth and invasiveness of human prostate cancer cells in vitro by neuropeptide antagonist substance panalogues. Šâ‘º³ŽkC‰oìWC“à“c–LºC¬ŽÄŒ’i”åjCAbraham T.K. CockettCSten Gershageniƒƒ`ƒFƒXƒ^[‘åj: Urologic Oncology, 4(1): 24`28, 1998.

2577. mŒ´’˜n Characterization of the cell-specific expression of parathyroid hormone-related protein in normal and neoplastic prostate tissue. Guan Wuiƒƒ`ƒFƒXƒ^[‘åjCŠâ‘º³Žki”åjCP. Anthony Di Sant'AgneseCLeonard, J. DeftosCAbraham, T.K. CockettCSten Gershageniƒƒ`ƒFƒXƒ^[‘åj: Urology, 51(Suppl. 5A): 110`120, 1998.

2578. mŒ´’˜n Clinical outcome of high-intnesity focused ultrasound for treating benign prostatic hyperplasia: Preliminary report. “à“c–LºC‘º–{«rC‹v”\‹v—²CŠâ‘º³ŽkC‰oìWC¬ŽÄŒ’i”åj: Urology, 52(1): 66`71, 1998.

2579. mŒ´’˜n Inadequacy of free prostate-specific antigen parameters in the prediction of pathologic extent of prostate cancer in Japanese men. ‰oìWC{ŽRˆê•äC‘v¬_i”åjCŒK”ö’èmi•a—jC“à“c–LºC¬ŽÄŒ’i”åj: Urology, 52(2): 230`236, 1998.

2580. mŒ´’˜n Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men. ‰oìWC{ŽRˆê•äC¼–{˜a«C²“¡ˆÐ•¶C“à“c–Lºi”åjCŒK”ö’èmi•a—jC¬ŽÄŒ’i”åj: Urology, 52(3): 433`440, 1998.

2581. mŒ´’˜n Limited suppression of prostate-specific antigen after salvage radiotherapy for its isolated elevation after radical prostatectomy. ‰oìWC¼–{˜a«C{ŽRˆê•äC‘v¬_i”åjCŒK”ö’èmi•a—jCŠâ‘º³Žki”åj: Urology, 53(1): 148`154, 1999.

2582. mŒ´’˜n Factors influencing morbidity in patients undergoing transrethral resection of the prostate. “à“c–LºC‘å–x—C‘v¬_C²“¡ˆÐ•¶CŠâ‘º³ŽkC‹PºC¬ŽÄŒ’i”åj: Urology, 53(1): 98`104, 1999.

2583. mŒ´’˜n –{–M‚É‚¨‚¯‚é‘O—§‘BŠà‚̈ӎ¯’²¸|lŠÔƒhƒbƒOŽófŽÒ‚Å‚ÌŒŸ“¢. ‰oìWi”åj: ‹¦‰h¶–½Œ¤‹†•¬˜_•¶W, 13(11ŒŽ), 1997.

2584. mŒ´’˜n ’Pt‚¨‚æ‚Ñ‹@”\“I’PtŠà‚ɑ΂·‚ét•Û‘¶Žèp‚ÌŒoŒ±. ’·’J쓹•FiŠâŽèˆã‘åjC‘å–x—i”åjC™‘º~C“¡‘òGŒõC“¡‰ª’mºiŠâŽèˆã‘åj: tˆÚA¥ŒŒŠÇŠO‰È, 9(1): 12`17, 1998.

2585. mŒ´’˜n ‹L–¼•ûŽ®‚É‚æ‚éKDQOLTM(Kidney Disease Quality of Life, “§ÍŠ³ŽÒŠÖ˜AQOL)‚ÆŽ©ŒÈŒˆ’èŽÚ“x‚Ì‘ª’èŽÚ“x‚ð—p‚¢‚½Š³ŽÒŽx‰‡ƒVƒXƒeƒ€‚ÌŠm—§‚ÉŠÖ‚·‚é1lŽ@. •º“¡“§CX—²Žii”åjC•½—Ç—²•ÛCç—t“N’jC“ú‘ä‰p—YC–ö‹žŽqC‰ª“cD”üCŒü‚—˜ŽqCŒF’J–LŽqC“Œ•Ÿ^—R”üC²“¡–FŽqi‰¡•l‘æˆêjC‰ª”ü’q‘ãi’}”g ‘åj: ‘Pm‰ïŒ¤‹†”N•ñ, 19: 106`109, 1998.

2586. mŒ´’˜n ON-LINE HDF‚Ìœ‘ãŽÓ‚É—^‚¦‚é‰e‹¿(‘æ1•ñ). •º“¡“§CX—²Žii”åjCç—t“N’jC“ú‘ä‰p—YC•’qC‹g‰ª”üDCŸŽRŒb—˜CÖ“¡F—YCŽR–{O”üCXˆä—TŽÀŽqC‰ª–{’qKC–{ŠÔ’C’|‘ò^Œái‰¡•l‘æˆêj: ‘Pm‰ïŒ¤‹†”N•ñ, 19: 36`37, 1998.

2587. mŒ´’˜n • o‹¾‰º•›t“Eœp|ŒoŒã• –Œo¥Œã•û“ž’B–@|. ”nêŽu˜Yi”åj: “à•ª”åŠO‰È, 15(3): 177`180, 1998.

2588. mŒ´’˜n t×–EŠà”]“]ˆÚ‚Ì—Õ°“I”wŒi‚ÆŽ¡—Ã. Z—F½CŠÛ–ÎŒ’C’†‘ºŒOC‹k­ºiŒc‘åjC”nêŽu˜Yi”åjC‘ºˆäŸiŒc‘åj: “ú”å”A‰ïŽ, 89(8): 705`711, 1998.

2589. mŒ´’˜n ¸‘ƒŽîᇂɂ¨‚¯‚ép53ˆâ“`Žq‚¨‚æ‚уQƒmƒ€•sˆÀ’諂̉ðÍ. ‰¤tŠìC“à“c–LºC²“¡ˆÐ•¶C“ü]Œ[C‘v¬_CŠâ‘º³ŽkC‘å–x—C¬ŽÄŒ’i”åj: “ú”å”A‰ïŽ, 89(9): 780`787, 1998.

2590. mŒ´’˜n ‰A«¶ŒŸŒã‚Ì‘O—§‘BĶŒŸ“K‰žðŒŒˆ’è‚ÌŒŸ“¢. ¼–{˜a«C‰oìWC{ŽRˆê•äC²“¡ˆÐ•¶CŠâ‘º³Žki”åjCŒK”ö’èmi•a—jC¬ŽÄŒ’i”åj: “ú”å”A‰ïŽ, 90(1): 41`48, 1998.

2591. mŒ´’˜n ¸‘ƒŽîᇂɂ¨‚¯‚éloss of heterozygosity‚ƃQƒmƒ€•sˆÀ’諂̉ðÍ. ˜ZŠpŽüC‰¤tŠìC“à“c–Lºi”åj: –k—¢ˆãŠw, 27(6): 333`339, 1997.

2592. mŒ´’˜n ƒ}ƒEƒX‘O—§‘BŠà”­¶‚ɉ—‚¯‚éƒAƒ|ƒg[ƒVƒX‚Ì㸋y‚уAƒ|ƒg[ƒVƒXŠÖ˜Aˆâ“`Žq‚Ì”­Œ». ‹g“cˆê¬C‘ŠŒ´³Oi”åjCSang H., Park.CTimothy C., ThompsoniƒxƒCƒ‰[ˆã‘åj: –k—¢ˆãŠw, 28(1): 15`24, 1998.

2593. mŒ´’˜n ¬Ž™”A˜HŒ‹ÎÇ52—á‚ÌŒoŒ±|“Á‚É‘ÌŠOÕŒ‚”gŒ‹Î”jÓp(ESWL)‚ð’†S‚É|. ˆÉ“¡Œ[ˆêC^‰ºß•vCŽu‘º“NC‹v•Û¯ˆêCrìFi”åj: –k—¢ˆãŠw, 28(1): 81`90, 1998.

2594. mŒ´’˜n äNã÷Šà‚É‚¨‚¯‚ép53Šà—}§ˆâ“`Žq‚̈Ùí|•a—‘gDŠw“IˆöŽq‚Æ—\Œã‚Æ‚ÌŠÖŒW. Œ´–ì—TŽiC‰¤tŠìC“à“c–Lºi”åj: –k—¢ˆãŠw, 28(3): 280`286, 1998.

2595. mŒ´’˜n V‚µ‚¢•LŒ^Øœƒ‹[ƒv‚ð—p‚¢‚½Œo”A“¹“I‘O—§‘BØœp‚Ì—Õ°¬Ñ. “à“c–LºC‘åì–ƒŽqCŽÄ“c—Y“ñCÝŠy•q–çC‰–ì‰pŽjCŠâ‘º³ŽkC‰oìWC‰““¡’‰—YC¬ŽÄŒ’i”åj: —Õ°”å”AŠí‰È, 51(13): 1013`1017, 1997.

2596. m€Œ´’˜n Frameshift somatic mutations of the microsatellite mutator phenotype in primary prostate cancer. ‰©‰p–ÎC“à“c–LºC‰¤tŠìC“ü]Œ[C²“¡ˆÐ•¶C‚“ˆ—Í–íCŒ´–ì—TŽiC‰–ì‰pŽji”åj: Proceedings of the Ninth Workshop on prostate Cancer, p.24`27, 1998.

2597. m€Œ´’˜n ‘O—§‘BŠà‚Ì•aŠúf’f‚É‚¨‚¯‚éTRUS (transrectal ultrasound)‚Ì—L—p«‚ÆŒÀŠE‚ɂ‚¢‚Ä. ‘v¬_C‰oìWi”åj: “ú–{—Õ°, 56(8): 2036`2041, 1998.

2598. m€Œ´’˜n —Õ°“I‚ɈӖ¡‚Ì‚È‚¢‘O—§‘BŠà‚Ì”»’èŠî€, •p“x‚Æ‘O—§‘B‘S“Ep‚̉”Û. ‘å–x—i”åj: “ú–{—Õ°, 56(8): 2092`2097, 1998.

2599. m€Œ´’˜n t‘ŸÇŒóŒQ: ‚»‚Ì‘¼‚Ìt‘ŸŽ¾Š³‚ðŠÜ‚ß‚Ä. “¡‰ª’mºC—é–Ø‘×iŠâŽèˆã‘åjC‘å–x—i”åj: “ú–{—Õ°•Êû(—̈æ•ÊÇŒóŒQƒVƒŠ[ƒYNo.16): 488`490, 1998.

2600. m€Œ´’˜n ªŽ¡“I‘O—§‘B‘S“Eœp. “¡‰ª’mºC’OŽ¡iiŠâŽèˆã‘åjC‘å–x—i”åj: ”å”AŠíŠO‰È, 10(9): 927`931, 1998.

2601. mŒ¤‹†•ñi•¶•”Èjn ”A˜Hˆ««Žîᇂ̔­¶¥i“W‚ÉŠÖ—^‚·‚éŠàŠÖ˜Aˆâ“`Žq‰ð͂̉ðÍ. “à“c–Lºi”åj: •½¬8, 9”N“x•¶•”ȉȊwŒ¤‹†”ï•â•‹àŠî”ÕŒ¤‹†(C), 1998.04.

2602. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ”A˜Hˆ««Žîᇂ̔­¶¥i“W‚ÉŠÖ—^‚·‚éŠàŠÖ˜Aˆâ“`Žq‰ð͂̉ðÍ. “à“c–Lºi”åj: —é–Ø”å”AŠí‰Èà’c, Œ¤‹†¬‰Ê•ñ‘, 1998.04.

2603. mÇ—á•ñn Port site recurrence after laparoscopic resection of retroperitoneal liposarcoma. Horiguchi, A.CSaito, S.C”nêŽu˜Yi”åjCMurai, M.CMukai, M.i”åj: J. Urol., 159: 1296`1297, 1998.

2604. mÇ—á•ñn Vitamine D3 withdrawal in hemodialysis patients with a dynamic bone disease. ‹ß“¡Œõ—miŒú–؃NƒŠƒjƒbƒNjC•º“¡“§CŽðˆä‹Ši”åj: Nephron: 80`90, 1998.

2605. mÇ—á•ñn ”AŠÇŽ©‘R”j—ô‚Ì‚P—á. Œ´–ì—TŽiC‘º–{«rC²“¡ˆÐ•¶C‰©‰p–ÎCŽÄ“c—Y“ñC‹y”\‹v—²CŠâ‘º³ŽkC“à“c–Lºi”åj: ¼“ú–{”å”AŠí‰È, 60(9): 666`668, 1998.

2606. mÇ—á•ñn HDŠ³ŽÒ‚Ì”ñƒVƒƒƒ“ƒg•”‚É”­¶‚µ‚½‰¼«“®–¬áŽ‚Ì‚P—á. Œã“¡NŽ÷C“c‘ºŒ’C—é–Ø“OiŠâŽèˆã‘åjC‘å–x—i”åjC‰ª–{’mŽmC“¡‰ª’mºiŠâŽèˆã‘åj: “§Í‰ïŽ, 30(9): 1155`1157, 1997.

2607. mÇ—á•ñn ‘½”X–E«ˆÞkt‚É”­¶‚µ‚½tƒIƒ“ƒRƒTƒCƒg[ƒ}‚Ì‚PÇ—á. ²“¡ˆÐ•¶i”åjC‰i“cŠ²’jCŠÑˆä•¶•FC•ìƒC‰ª–{dâXC•Ÿˆä€”V‰îi¹˜H‰Áj: ”å”AŠí‰È‹I—v, 44: 493`496, 1998.

2608. mÇ—á•ñn ÔŒŒ‹…‘‘½Ç‚𔺂Á‚½tŠà‚Ì‚PÇ—á. ²“¡ˆÐ•¶i”åjC•Ÿˆä€”V•C•ìƒC‰i“cŠ²’jCŠÑˆä•¶•FC‰ª–{dâXC“c’†^lC‘命˜a³Ž÷i¹˜H‰Áj: ”å”AŠíŠO‰È, 11(1): 85`87, 1998.

2609. mÇ—á•ñn æ“V«‰AŒsœ]‹ÈÇ‚Ì‚PÇ—á. ²“¡ˆÐ•¶i”åjCŠÑˆä•¶•FC•ìƒC‰i“cŠ²’jC‰ª–{dâXC•Ÿˆä€”V‰îi¹˜H‰Áj: ”å”AŠíŠO‰È, 11(11): 1391`1393, 1998.

2610. mÇ—á•ñn ŒúŒ^Øœƒ‹[ƒv‚ð—p‚¢‚½Œo”A“¹“I‘O—§‘BØœp‚Ì—Õ°¬Ñ. “à“c–LºC‘º–{«rC¬—ѹ“ñC²“¡ˆÐ•¶C“c‘º–ƒŽqCÝŠy•q–çCŠâ‘º³ŽkC‰oìWi”åj: ”å”AŠíŠO‰È, 11(7): 859`862, 1998.

2611. m—Õ°Ž¡Œ±n ‘O—§‘B”ì‘åÇŠ³ŽÒ‚ɑ΂·‚éTestosterone-5ƒ¿-Reductase‘jŠQ–òFK143‚Ì—Õ°•]‰¿|ƒvƒ‰ƒZƒ{‚ð‘ÎÆ‚Æ‚µ‚½“ñd–ÓŒŸŒQŠÔ”äŠrŽŽŒ± iŒãŠú‘æ“ñ‘ŠŽŽŒ±j|. ‰Í粌Ži“Œ‘åjC–{ŠÔá•viã‘åjC¼Š_Ži“Œ‘åjC“¡“cŒö¶i•l¼ˆã‘åjC‰eŽRT“ñC‰œŽR–¾•FCŽO–ØPŽ¡iã‘åjC“‡è~iç—t‘åjCHŒ³Wiã ‘åjCŒI“cFi‹ß‘åjC–p‰p“Niã‘åjC¬ŽÄŒ’i”åjC‰¡ŽR‰p“ñiã‘åjCŽç“a’å•vi_ŒË‘åjCåÎ~iã‘åj: ”å”AŠíŠO‰È, 11(4): 505`525, 1998.

2612. m‘àn ƒ}ƒCƒNƒƒTƒeƒ‰ƒCƒg•sˆÀ’諂ƃ~ƒXƒ}ƒbƒ`C•œ‹@\. “à“c–Lºi”åj: “ú”å”A‰ïŽ, 89(12): 917`930, 1998.

2613. m‘àn • o‹¾‰º•›t“Eœp: ŽèpNP‚ƃRƒXƒg‚©‚ç‚Ý‚½ŠJ•úŽèp‚Æ‚Ì”äŠr. ”nêŽu˜Yi”åjC‘ºˆäŸiŒc‘åj: ”å”AŠíŠO‰È, 11(—Õ‘): 369`371, 1998.

2614. m‘àn “ÁW: ¬l•aŽ¡—Âւ̒§í|mˆÚAn”]Ž€‰º‚ÌtˆÚA|. ‰““¡’‰—Yi”åj: —Õ°¬l•a, 28(1): 33`36, 1998.

2615. m‘àn Œã• –Œ‹¾‰ºŽèp‚Æ• –ŒŠOœ”Õ‹¾‰ºŽèp. ”nêŽu˜Yi”åj: —Õ°”å”AŠí‰È, 52(8): 547`556, 1998.

2616. muÀn ŒoŒã• –Œ“IƒAƒvƒ[ƒ`. ”nêŽu˜Yi”åj: JSES“àŽ‹‹¾ŠO‰È, 3(2): 150`152, 1998.

2617. muÀn Œ»‘ãˆã—Âɂ¨‚¯‚銿•ûŽ¡—Ã‚Ì–ðŠ„‚Æ—L—p«. ΋´Wi”åj: Medicament News, (4ŒŽ25“ú), 1998.

2618. muÀn À’k‰ïuˆã—×pŠ¿•û»Ü‚ÌŽg‚¢•ûvŠ³ŽÒ‚ÌQuality of Life‚ÆŠ¿•ûŽ¡—Ã. ΋´Wi”åj: Medicament news (99.01.05).

2619. muÀn Š¿•û‹³Žº. ΋´Wi”åj: Modern Physician, 18(3): 328, 1998.

2620. muÀn ’jŽq”AŽ¸‹Ö‚ÌÅV‚ÌŽ¡—Ã. ΋´Wi”åj: Therapeutic Research, 18(12): 19`25, 1997.

2621. muÀn Ž„‚ÌŽèp|TURP. ¬ŽÄŒ’C“à“c–Lºi”åj: Video Journal of JUA, 5(1): 1999.

2622. muÀn Š¿•û: ˆÀ‘S, “KØ‚ÈŠ¿•û»Ü‚ÌŽg‚¢•û. ΋´Wi”åj: ‚³‚Û[‚Æ(98.02.25).

2623. muÀn Š¿•û: ”å”AŠíŽ¾Š³‚ÆŠ¿•û»Ü. ΋´Wi”åj: ‚³‚Û[‚Æ(98.04.25).

2624. muÀn Š¿•û: •úŽËüäNã÷‰Š‚ÆŠ¿•û. ΋´Wi”åj: ‚³‚Û[‚Æ(98.11.10).

2625. muÀn Š¿•û: ”A˜HŒ‹Î‚ÆŠ¿•û. ΋´Wi”åj: ‚³‚Û[‚Æ(99.01.10).

2626. muÀn Š¿•û: ”å”AŠíŽ¾Š³‚ÆŠ¿•û»Ü. ΋´Wi”åj: ‚³‚Û[‚Æ, (98.06.25).

2627. muÀn ‘O—§‘B”ì‘åÇ‚Æ‚»‚ÌŽ¡—ÃBŠ¿•ûu‚킽‚µ‚ÌŽ¡—ÃŽwjv‚U. ΋´Wi”åj: ƒƒfƒBƒJƒ‹’©“ú, (3ŒŽ†): 38`40, 1999.

2628. muÀn u¬ŽÄŒÓ“’v‚Ì•›ì—p•ñ“¹‚ɂ‚¢‚Ĉꌾ. ΋´Wi”åj: ƒƒfƒBƒJƒ‹’©“ú, 1998”N6ŒŽ†.

2629. muÀn ‘æ31‰ñ“ú–{tˆÚA—Õ°Œ¤‹†‰ï‹L˜^. ‰““¡’‰—Yi”åj: ˆÚA, 33(3): 199`268, 1998.

2630. muÀn ‹}«‘O—§‘B‰Š‚ÌŽ¡—Ã. ΋´Wi”åj: ŠO‰ÈŽ¡—Ã, 78(4): 501`502, 1998.

2631. muÀn ‹}«‘O—§‘B‰Š‚ÌŽ¡—Ã. ΋´Wi”åj: ŠO‰ÈŽ¡—Ã, 78(4): 501`502, 1998.

2632. muÀn “ú–{—Õ°Š¿•û. ΋´Wi”åj: Š¿•ûŒ¤‹†, (8ŒŽ), 1999.

2633. muÀn Š¿•û–ò‚Ƽ—m–ò‚Ì•¹—p: ‘O—§‘BŽ¾Š³‚É‚¨‚¯‚镹—p, ”z‡‚Ì—¯ˆÓ“_. ΋´Wi”åj: Š¿•û’²ÜŒ¤‹†, 6(4): 99`101, 1998.

2634. muÀn ‡V. ”å”AŠí‰È—̈æ, ”A•Â. “à“c–Lºi”åj: ‹~‹}ˆãŠw, 22(12): 1816`1819, 1998.

2635. muÀn ‚—îŽÒ‚Ì”r”AáŠQ. ΋´Wi”åj: u‰‰‰ï: ‚—îŽÒ‚Ì”r”AáŠQ(98.11.20).

2636. muÀn tˆÚAu‰‰‰ï. ‰““¡’‰—Yi”åj: u‰‰‰ï: tˆÚAu‰‰‰ï(98.07.26).

2637. muÀn “ÁW:u‘O—§‘B‚ª‚ñ|‘Šú”­Œ©‚ÆŽ¡—Ẫ|ƒCƒ“ƒg|v: ‘O—§‘B‚ª‚ñW’cŒŸf‚ÌŽÀÛ|lŠÔƒhƒbƒOŽófŽÒ‚ð‘ÎÛ‚Æ‚µ‚½ê‡|. ‰oìWi”åj: ŽÀŒ±Ž¡—Ã, (651): 71`73, 1998.

2638. muÀn “ÁW: ”å”AŠíŽ¾Š³ƒŠT˜_„. ΋´Wi”åj: ŽÀ’nˆã‰Æ‚Ì‚½‚ß‚ÌTHE KAMPO, (2): 8`13, 1999”N1ŒŽ.

2639. muÀn “ÁW: t¥”å”AŠí—̈æ‚ÌŠ¿•û—Ö@‚Ì“®Œü, ŠeŽí•a‘Ô‚É‚¨‚¯‚éŽg—pŒoŒ±|”r”AáŠQ. ΋´Wi”åj: t‚Æ“§Í, 45(3): 357`360, 1998.

2640. muÀn ”å”AŠí¥t¥˜Vl. ΋´Wi”åj: ‘æ7‰ñ“ú–{‘åŠwŠ¿•ûƒZƒ~ƒi[(98.04.24).

2641. muÀn ‘Î’ku21¢‹I‚̈ã—ÂƊ¿•ûvŠ³ŽÒ‚³‚ñ‚Ɉê”Ô‚¢‚¢‚à‚Ì‚ð’ñ‹Ÿ‚·‚é|‚—îŽÒ‚Ì—ÇD‚ÈQOL‚ÉŠú‘Ò‚³‚ê‚銿•û. ΋´Wi”åj: “úŠ¿‹¦‰ï•ñ, 14(3): 4`9, 1998.

2642. muÀn À’k‰ï: ‘½‘ŸŠíáŠQ‚ÆŠ¿•û‘½‘ŸŠíáŠQ‚É—L—p«‚ª‚‚¢Š¿•û–ò|–òŒø‚Æ, ƒRƒXƒg–Ê‚©‚ç‚àŠú‘Ò‚³‚ê‚é. ΋´Wi”åj: “úŒoƒƒfƒBƒJƒ‹, (4ŒŽ†): 20`27, 1998.

2643. muÀn Žs–¯ŒöŠJuÀ. ΋´Wi”åj: “ú–{ˆãŽ–V•ñ, (3897), 1999.01.02.

2644. muÀn ‚—îŽÒ‚ւ̃Rƒ“ƒT[ƒg. ΋´Wi”åj: “ú–{ˆãŽ–V•ñ, 3874, 1998.

2645. muÀn “ÁW: ”AŽ¸‹Ö‚Æ“Œ—mˆãŠw—Ö@|”AŽ¸‹Ö‚ÌÅV‚ÌŽ¡—Ã. ΋´Wi”åj: ”r”AáŠQƒvƒ‰ƒNƒeƒBƒX, 7(1): 7`11, 1999.

2646. muÀn ”å”AŠíŽ¾Š³. ΋´Wi”åj: –ˆ“úƒ‰ƒCƒt, 1ŒŽ†: 34`36, 1998.

2647. muÀn •ÛŒ¯f—©‚ç‚Ý‚½Š¿•û–ò‚Æ‘Q‚­‚Ì—m–ò‚ðl‚¦‚é. ΋´Wi”åj: –òŽ–“ú•ñ, (4ŒŽ24“ú), 1998.

2648. muÀn Ž„‚Ì‘I‚ñ‚¾í”õ–ò, ”r”AáŠQŽ¡—Öò. “à“c–Lºi”åj: —Õ°‚Æ–ò•¨Ž¡—Ã, 18(1): 109`109, 1999.

2649. muÀn “ÁW: ‘O—§‘Bf—Â̂·‚ׂÄ: ‘O—§‘B”ì‘åÇ|‘O—§‘B”ì‘åÇ‚ÌV‚µ‚¢Ž¡—Ö@|. “à“c–Lºi”åj: —Õ°‰ÈŠw, 33(12): 1554`1560, 1997.

2650. muÀn ‘æ1‰ñ“ú’†”å”AŠí‰ÈŠw‰ï‹c. Šâ‘º³Žki”åj: —Õ°”å”AŠí‰È, 51(10): 784`785, 1997.

2651. muÀn —‘z“I‚È“ŒvŠwƒRƒ“ƒsƒ…[ƒ^ƒ\ƒtƒg‚ÌЉî. ‘å–x—i”åj: —Õ°”å”AŠí‰È, 51(10): 794`795, 1997.

2652. muÀn À’k‰ïuƒAƒƒŠƒJ‚ɂ̓I[ƒvƒ“‚È‹³ˆç‚ª‚ ‚év: ƒAƒƒŠƒJ‚É‚¨‚¯‚鑲Œã—Õ°Œ¤C§“x|Œ»ó‚Æ‚»‚ÌŠî–{¸_|. Cockett, Abraham T.K.iƒƒ`ƒFƒXƒ^[‘åjCCarlton Jr., C.EugeneCScardino, Peter T.iƒxƒCƒ‰[ˆã‘åjCHŒ³¬‘¾i“úˆã‘åjC‘å–x—C‘v¬_i”åj: —Õ°”å”AŠí‰È, 51(11): 871`876, 1997.

2653. muÀn ”å”AŠí‰Èˆã‚ÌŒ»ó‚Æ’¼–Ê‚·‚é”–â‘è|ŽáŽèˆãŽt‚Í‚¢‚Ü‚±‚¤l‚¦‚Ä‚¢‚é|. ²“¡ˆÐ•¶i”åj: —Õ°”å”AŠí‰È, 52(2): 155`164, 1998.

2654. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj1999; Ž„‚Í‚±‚¤Ž¡—µ‚Ä‚¢‚é|—V‘–t(t‰º‚), p.494`495, “à“c–Lºi”åj. •ÒW ‘½‰ê{K’jC”öŒ`‰x˜YC•ÒC ˆãŠw‘‰@, “Œ‹ž, 99.00.00.”­s.

2655. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i’P’˜j ‘O—§‘B’´‰¹”gf’fƒAƒgƒ‰ƒX(1500”»); ‘å–x—i”åj. ƒxƒNƒ‹ƒgƒRƒAŽÐ, “Œ‹ž, 98.00.00”­s.

2656. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Glenn's Urologic Surgery(5th ed.); Endoscopic Laser Surgery, p.933`940, ¬ŽÄŒ’C“à“c–Lºi”åj. •ÒW San D. Graham Jr.CJames F. J.B.C•ÒC Lippincott-Raven Co.CPhiladelphia, 98.00.00.”­s.

2657. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Pathological features of prostate cancers with a normal serum PSA levels (ƒ4.0 ng/ml) in patients with radical retropubic prostatectomy. ‘å–x—i”åjC“¡‰ª’mºCŒã“¡NŽ÷iŠâŽèˆã‘åjC‘v¬_i”åjCWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆã‘åj: 24th Society International Urology i97.09.09j Montreal, Canada.

2658. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Peripheral zone and transition zone prostate cancers have a different prognosis. ‘å–x—i”åjC“¡‰ª’mºCŒã“¡NŽ÷iŠâŽèˆã‘åjC‘v¬_i”åjCWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆã‘åj: 24th Society International Urology i97.09.09j Montreal, Canada.

2659. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Inhibition of tumor-growth and angiogenesis by vitamin D3 in murine renal cell carcinoma. “¡‰ª’mºC’·’J쓹•FCIchikawa, K.CMatsushita, Y.CSato, M.iŠâŽèˆã‘åjC‘å–x—i”åjCTanji, S.: 24th Society International Urology i97.09.09j Montreal, Canada.

2660. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Prognostic significance of tumor volume in patients with clinically localized prostate cancer. Œã“¡NŽ÷iŠâŽèˆã‘åjC‘å–x—i”åjC“¡‰ª’mºiŠâŽèˆã‘åjCWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆã‘åj: 24th Society International Urology i97.09.09j Montreal, Canada.

2661. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Pathologic features and prognosis of prostate cancer with seminal vesicle involvement. ‘v¬_CŠÛ“T•vi”åjCPeter, Kattan M.W.CScardino, Peter T.CWheeler, Thomas M.iƒxƒCƒ‰[ˆã‘åj: 86th Annual Meeting United States and Canadian Academy of Pathology i98.00.00j Boston.

2662. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The reduction of tumoral calcinosis in CAPD patients by administration of diphosphonate. •º“¡“§CŒF–ì˜a—YC‰¡“c^“ñCr–ØrsCŽðˆä‹Ši”åj: Annual Meeting of American Society of Peritoneal Dialysis i98.00.00j Nashville.

2663. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Dialysate hyaluronan (HA)/IgG/CA125 ratio in CAPD patients - A possible marker of sclerosing encapsulating sclerosis - A preliminary report. •º“¡“§CŒF–ì˜a—YC”nŸÁC‰¡“c^“ñCŽðˆä‹Ši”åjCŒE“cŽÀi‹M—F‰ï‰¤Žq•a‰@jC‹÷“cN—mi‚·‚Ý‚¾“à‰Èj: 8th Meeting of Intrenational Society of Peritoneal Dialysis i98.00.00j Seoul.

2664. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Clinical significance of vitamin D3 withdrawal in hemodialysis patients with a dynamic bone disease: One year prospective study. •º“¡“§C‹ß“¡Œõ—miŒú–؃NƒŠƒjƒbƒNjC–{ŠÔääC•½—Ç—²•ÛC“ú‘ä‰p—Yi‰¡•l‘æˆêjCŽðˆä‹Ši”åj: American Society of Nephrology, 31st Annual Meeting i98.00.00j Philadelphia.

2665. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Adenoviral mediated anti-H-ras ribozyme for the treatment of bladder cancer. “ü]Œ[i”åjCOlav EngebraatenCBirgit AndereggCAndrea FlorlCMeredith Halks-MillerCKevin J., ScanloniCity of Hopej: ‘æ93‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï i98.05.30`06.04j, ƒTƒ“ƒfƒBƒGƒS, J. Urol., 159(Suppl.5): 1106, 1998.

2666. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The prognosis of patients with seminal vesicle involvement (SVI) depends upon the level of extraprostatic extension (EPE). ‘v¬_i”åjCrì“ÖiƒxƒCƒ‰[ˆã‘åjC{ŽRˆê•äi”åjCPeter T. ScardinoCThomas M. WheeleriƒxƒCƒ‰[ˆã‘åj: ‘æ93‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï i98.05.30`06.04j, ƒTƒ“ƒfƒBƒGƒS, J. Urol., 159(Suppl.5): 1141, 1998.

2667. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The prevalence of benign prostatic hyperplasa (BPH) and mean prostate volume in Asians and Europeans at autopsy in Kazakstan. ŠÛ“T•vi”åjCSlawin, Kevin M.CWheeler, Thomas M.iƒxƒCƒ‰[ˆã‘åj: ‘æ93‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï i98.05.30`06.04j, ƒTƒ“ƒfƒBƒGƒS, J. Urol., 159(Suppl.5): 420, 1998.

2668. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Parathyroid hormone-related protein is an independent prognostic marker in renal cell carcinoma. Šâ‘º³ŽkC‰oìWCÝŠy•q–çC“à“c–LºC¬ŽÄŒ’C‘å–x—i”åj: ‘æ93‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï i98.05.30`06.04j, ƒTƒ“ƒfƒBƒGƒS, J. Urol., 159(Suppl.5): 745, 1998.

2669. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Retroperitoneoscopic adrenalectomy by a posterior lumbar approach: Feasibility of the use of a robotic arm for solo-surgery. ”nêŽu˜Yi”åjCYanaihara, H.CNagata, H.CItoh, K.CMurai, M.iŒc‘åj: 94th American urological Association, Annual Meeting i98.06.02j, San Diego, USA.

2670. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Histological characteristics and significance of Japanese prostate cancer with low levels of prostate specific antigen 4.0 ng/ml less. ²“¡ˆÐ•¶C‰oìWC‘å–x—i”åjCŒK”ö’èmi•a—j: 4th Seminar of the international Cooperative Study of Diagnostic Ultrasound and Prostate Cancer i98.07.03`04j, “Œ‹ž.

2671. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The utility of free to total PSA ratio for detecting prostate cancer in Japanese men with total PSA between 2.1 and 10 ng/ml. ‘å–x—C‰oìWC¬ŽÄŒ’i”åj: 4th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer i98.07.03`04j, “Œ‹ž.

2672. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The prognostic significance of prostatic capsular invasion (PCI) level. ‘v¬_C‘å–x—C‹y”\‹v—²i”åjCŒK”ö’èmi•a—jC‰oìWi”åj: 4th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer i98.07.03`04j, “Œ‹ž.

2673. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Systematic biopsy assess Gleason grade more accuracy in palpable cancers and when multiple („4) cores are positive. Žu‘º“NC{ŽRˆê•äi”åj: 4th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer i98.07.03`04j, “Œ‹ž.

2674. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j ƒuƒ‰ƒbƒhƒAƒNƒZƒX‚Ì”–â‘è. ‰““¡’‰—Yi”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï, 1998”N‘²Œã¥¶ŠU‹³ˆç i98.04.11j, Ž­Ž™“‡.

2675. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Watchful waiting‚Æ‘O—§‘BŠà‚Ìu—Õ°“Id—v«£. ‰oìWi”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2676. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j t×–EŠà‚ɑ΂·‚ét•”•ªØœp‚Ì“K‰ž‚ÆŒÀŠE|‘I‘ð“It‹@”\‰·‘¶Žèp‚Ì“K‰ž”͈͂ɂ‚¢‚Ä. ”nêŽu˜Yi”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.25j, ‘O‹´.

2677. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j TURP, TVP. “à“c–Lºi”åjC“ß{•Û—Fi‰ª‘åj: ‘æ12‰ñ“ú–{Endourology¥ESWLŠw‰ï‘‰ï i98.10.24j •l¼.

2678. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j is«‘O—§‘BŠà‚Ì‘ÎǗÖ@‚Æ‚µ‚Ä‚ÌŒo”A“¹“I‘O—§‘BØœp‚ÌŒŸ“¢. ‘v¬_C“à“c–LºCÄ“¡‹BC¬—ѹ“ñCŠâ‘º³ŽkC‰oìWC‰““¡’‰—Yi”åj: ‘æ12‰ñ“ú–{Endourology¥ESWLŠw‰ï‘‰ï i98.10.24j •l¼.

2679. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj Œã• –Œ“IŒã•û“ž’B–@|• o‹¾‰º•›t“Eœp‚Ì•W€pŽ®. ”nêŽu˜Yi”åj: ‘æ12‰ñ“ú–{Endourology¥ESWLŠw‰ï‘‰ï i98.10.23j, •l¼, Jpn. J. Endourol. ESWL, 11: 161`168, 1998.

2680. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ”å”AŠí‰È—̈æ‚Å‚ÌAESOPTM‚ÌŽg—pŒoŒ±. ”nêŽu˜Yi”åjC’·ÈŽŒÈC¬ŽR­ŽjC‹e’n‰hŽŸC‘ºˆäŸ: ‘æ11‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï i98.12.10j “Œ‹ž.

2681. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ESWL‚É‚æ‚étŒ‹Î”jÓpŒã‚ÌŒŒ”A‚Æt¶ŒŸŒã‚ÌŒŒ”A‚Ì—R—ˆ. •º“¡“§i”åjC”nŸÁC•½—Ç—²•Ûi‰¡•l‘æ‚PjC‰¡“c^“ñi”åjCŠ™“cvŽõi“àjC“ú‘ä‰p—Yi‰¡•l‘æˆêjCŽðˆä‹Ši”åj: “ú–{t‘ŸŠw‰ï i98.00.00j “Œ‹ž.

2682. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ON-LINE HDF‚Ì•›bó‘BŽhŒƒŒø‰Ê‚ÌŒŸ“¢. •º“¡“§i”åjCŸŽRŒb—˜C•’qCÄ“¡F—YCŽR–{O”üCXˆä—TŽÀŽqC‰ª–{’q”VC–{ŠÔ’C’|‘ò^ŒáC“ú‘ä‰p—Yi‰¡•l‘æˆêj: “ú–{“§ÍˆãŠw‰ï i98.00.00j ‰¡•l.

2683. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ΊD‰»‚𔺂Á‚½Lymphangioma‚Ì1Ç—á. ‰œ–ì‹I•FC‘v¬_CŠâ‘º³ŽkC‘º–{«rC•½ˆäËŽiCŸ“c^sC“c‘º–ƒŽqC‰oìWC‰““¡’‰—YC¬ŽÄŒ’C–{“c’¼NC¼‘º´Žui”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.09j, Ž­Ž™“‡.

2684. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@”å”AŠí‰È‚É‚¨‚¯‚é’´‰¹”gƒKƒCƒh‰º‘O—§‘Bj¶ŒŸ‚ÌŒŸ“¢. ‹g“cˆê¬C‰oìWCÝŠy•q–çC‘v¬_CŸ“c^sC–]ŒŽ‰pŽ÷CaŒûG”VC•½ˆäËŽiC‘º–{«rC“à“c–LºC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.09j, Ž­Ž™“‡.

2685. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Γc•a‰@‚É‚¨‚¯‚铧͊³ŽÒ‚É”­¶‚µ‚½t×–EŠà‚Ì—Õ°“IŒŸ“¢. “¿Œõ³sC‘ˆä‘¥ºCˆî“c•¶‰qCΓc—T‘¥i”åjCΓc‰ˆêiΓc•a‰@jC”ª’|’¼iˆ®ˆã‘åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2686. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B¶ŒŸ‘gD•W–{‚É‚¨‚¯‚éHigh Grade Prostatic Intraepithelial Neoplasia (PIN)‚ÆAtypical Adenomatous Hyperplasia (AAH)‚Ì•p“x. ‘v¬_C‰oìWCŠâ‘º³ŽkC“à“c–LºC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2687. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒ´PSA 4.0 gm/mlˆÈ‰º‚É‚¨‚¯‚é‘O—§‘BŠàªŽ¡p‚Ì•a—ŠŒ©. •½ˆäËŽiC‰oìWC²“¡ˆÐ•¶CŠâ‘º³ŽkC“à“c–LºC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2688. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠà”í–ŒZ‚Ì’ö“x(Prostatic Capsular Invasion Level)‚Æ•a—•aŠú, —\Œã‚Æ‚ÌŠÖŒW. ‹y”\‹v—²C‘v¬_C‘º–{«rC‰oìWCŠâ‘º³ŽkC“à“c–LºC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2689. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠà‚ɑ΂·‚éLH-RH analogue“Š—^Œã‚Ìflare-up‚ÌŒ¤‹†: apoptosis‚ÌoŒ»•p“x‚ÆŽžŠú. ‘ŠŒ´³OC–]ŒŽ‰pŽ÷C•½ˆäËŽiCÄ“¡‹BC²X–Ø–M–¾C“à“c–LºC^‰ºß•vC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2690. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÚAt‚Ì—â‹p•Û‘¶ŒãÄŠÁ—¬‚É‚¨‚¯‚éNicaraven (AVS)‚Ìt•Û‘¶•ÛŒìŒø‰Ê. “c‘º–ƒŽqC‹g“cˆê¬i”åjC^è‹`•FiŽÀ“®ŒnjCŠâ‘º³ŽkC‹y”\‹v—²C‘º–{«rC‰““¡’‰—Yi”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2691. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äNã÷ŒeŽºŽîᇂ̂Q—á. “¡“c“N•vC‘ˆä‘¥ºC{ŽRˆê•äC‹PºC¬ŽÄŒ’CŒüˆäLÆi”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2692. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ho: YAƒŒ[ƒU[‚É‚æ‚éTUL‚ÌŒoŒ±. ’·‘q˜a•Fi¼ŒE•a‰@jC‰F“s‹{‘ñŽ¡i”åjC—Ñ‹ÅCŽR“¡­•vC’†–ìŠÔ—²ié‹Êˆã‘åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2693. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ESWL‚É‚æ‚étŒ‹Î”jÓpŒã‚ÌŒŒ”A‚Ì—R—ˆ. •º“¡“§C”näÊi”åjCã“c³Liã“cƒNƒŠƒjƒbƒNjC‰¡“c^“ñCrìFC‹v•Û¯ˆêC^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2694. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Replication error—z«‘O—§‘BŠà‚É‚¨‚¯‚éBax, TGFƒÀ receptor type ‡Uˆâ“`ŽqˆÙí. ‰©‰p–ÎC‰¤tŠìC‘º–{«rC–{“c’¼NC‰oìWC¬–““ñ–çCa’J@‘¥C“à“c–LºC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2695. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Tlc‘O—§‘BŠà‚É‚¨‚¯‚éorgan-confined disease‚ÆŠÖ˜A‚·‚ép‘O—Õ°•a—Šw“Iƒpƒ‰ƒ[ƒ^[‚ÌŒŸ“¢. ¬ìCiH“c‘åjC‰oìWi”åjCVˆä—zˆêi‘q•~’†‰›•a‰@jC“ΑƒŒ«ˆêi‘—§‚ª‚ñƒZƒ“jC‰Á“¡“N˜YiH“c‘åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2696. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BĶŒŸ‚ÌŒŸ“¢. ¼–{˜a«C‰oìWC‰©‰p–ÎC‘º–{«rC‹y”\‹v—²C‰–ì‰pŽji”åjCŒK”ö’èmi•a—jC¯Ži´ŽuC΋´WC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2697. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j p‘O—Õ°ŠŒ©, ¶ŒŸ•a—ŠŒ©‚É‚æ‚épT3‘O—§‘BŠà‚Ì—\‘ª. ‰oìWC{ŽRˆê•äCŸ“c^sC¼–{˜a«C²“¡ˆÐ•¶CŠâ‘º³ŽkCò”ŽˆêC‰¡“c^“ñC“à“c–LºC΋´WC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2698. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j t×–EŠà‚Ì×–EŒ`‘ÔŠw“I•ªÍ: —Õ°•a—Šw“IŠŒ©‚Æ‚Ì”äŠrŒŸ“¢. Šâ‘º³ŽkC‘v¬_C‰oìWC¬—ѹ“ñC‘ºŽR‰ëˆêC¼‘º´ŽuC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2699. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠà‚Ì•aŠú‹y‚Ñaggressiveness‚Ì—\‘ª‚É‚¨‚¯‚éfree to total PSA ratio‚Ì—L—p«. ÝŠy•q–çC‰oìWCaŒûG”VC¬—ѹ“ñC‘º–{«rCò”ŽˆêC‰¡“c^“ñC{ŽRˆê•äC΋´WC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.10j, Ž­Ž™“‡.

2700. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B‘S“EœÇ—á‚Ì—Õ°f’f(Žå‚É6•ªŠ„–@‘O—§‘B¶ŒŸ, PSA’l)‚Æ•a—‘gDŠw“IŒŸ“¢. ‰i“cŠ²’jCŠÑˆä•¶•FC‰©‰p–ÎC•ìƒi”åjC•Ÿˆä€”V•C‰ª–{dâXi¹˜H‰Áj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.11j, Ž­Ž™“‡.

2701. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆê”Êl‚É‚¨‚¯‚é‘O—§‘BŠà‚Ì”F’m“x‚ɂ‚¢‚Ä. Ÿ“c^sC‰oìWC¬—ѹ“ñC“¡“c“N•vC–]ŒŽ‰pŽ÷C‰¡“c^“ñCìã’B•vC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.11j, Ž­Ž™“‡.

2702. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B”ì‘åǂɑ΂·‚éminimum invasive surgery‚Ì—Õ°Œø‰Ê. “à“c–LºC²“¡ˆÐ•¶C‘º–{«rC‘åì–ƒŽqC‰oìWC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.11j, Ž­Ž™“‡.

2703. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B”ì‘åǂɑ΂·‚éŒo”A“¹“I‘O—§‘BØœ4,238—á‚Ì—Õ°“Œv. ²“¡ˆÐ•¶C“à“c–LºC‘º–{«rC‘åì–ƒŽqCŠâ‘º³ŽkC‰oìWC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.11j, Ž­Ž™“‡.

2704. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠà”í–ŒZ‚Ì’ö“x‚Æ•a—•aŠú—\Œã‚Æ‚ÌŠÖŒW. ‹y”\‹v—²C‘v¬_C‘º–{«rC‰oìWCŠâ‘º³ŽkC“à“c–LºC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.11j, Ž­Ž™“‡, “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 88: 243, 1998.

2705. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¸‘ƒŽîᇂɂ¨‚¯‚ép53ˆâ“`Žq‚ƃQƒmƒ€•sˆÀ’諂̉ðÍ. —äˆä’è‹IC˜ZŠpŽüC‰¤tŠìC‰©‰p–ÎCŒ´–ì—TŽiC¼‘º´ŽuC¬–““ñ–çC‹PºC“à“c–LºC¬ŽÄŒ’i”åj: ‘æ86‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i98.04.11j, Ž­Ž™“‡, “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 89(9): 780`787, 1998.

2706. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”DŽYåñ•w‚Ì”AŽ¸‹Ö—LÇ—¦‚Æ‚»‚̈ӎ¯. ¼‘º‚©‚¨‚éi“ú–{ƒRƒ“ƒ`ƒlƒ“ƒX‹¦‰ïjC²“¡^’qŽqCH“¡‚µ‚Æ‚ÝC–––Ø^“Þ”üC‚âˆçŽqCŠâØ–FŽqiŠÅŒìjC‰¡ŽR‰p“ñi”åj: ‘æ8‰ñ—«”r”AáŠQŒ¤‹†‰ïŠwpW‰ï i98.05.30j, ‹v—¯•Ä.

2707. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —«—p”AŽ¸‹Ö–hŽ~ƒvƒ‰ƒO "ƒAƒrƒi"Žg—p‚ðŽŽ‚Ý‚Ä. 죗R”üŽqi“ú–{ƒRƒ“ƒ`ƒlƒ“ƒX‹¦‰ïjC‰¡ŽR‰p“ñi”åjC¼‘º‚©‚¨‚éi“ú–{ƒRƒ“ƒ`ƒlƒ“ƒX‹¦‰ïj: ‘æ8‰ñ—«”r”AáŠQŒ¤‹†‰ïŠwpW‰ï i98.05.30j, ‹v—¯•Ä.

2708. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j æ“V«”AŠÇŠà‚ɑ΂·‚éŒo”A“¹“IŠàØŠJp‚ÌŒoŒ±. Šâ‘º³ŽkC‘º–{«rC“c‘º–ƒŽqCÝŠy•q–çC‘v¬_C‰““¡’‰—Yi”åj: ‘æ7‰ñ“ú–{¬Ž™”å”AŠí‰ÈŠw‰ï‘‰ï i98.07.03j, ŽD–y.

2709. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠà‚É‚¨‚¯‚éƒQƒmƒ€•sˆÀ’è«‚ÆDNAC•œŠÖ˜Aˆâ“`Žq‚ÌFrameshift Somatic Mutation‚ÌŒŸ“¢. ‰©‰p–ÎC“à“c–Lºi”åj: ‘æ9‰ñ‘O—§‘BŠàƒ[ƒNƒVƒ‡ƒbƒv i98.09.18j, “Œ‹ž.

2710. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž©‘RŽj‚æ‚茩‚½‘O—§‘BŠà‚Ì—Õ°“Id—v«. ‰oìWi”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2711. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B”ì‘åǂɑ΂·‚éŒúŒ^ƒ‹[ƒv‚ð—p‚¢‚½New TURP‚Ì—Õ°Œø‰Ê. ‰©‰p–ÎC²“¡ˆÐ•¶C¬—ѹ“ñC‘º–{«rC‹y”\‹v—²C“c‘º–ƒŽqCŠâ‘º³ŽkC“à“c–Lºi”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2712. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰E‘¤• •”ál’É‚ðŽå‘i‚É”­Œ©‚³‚ꂽœ”Õ“àprimitive neuroectodermal tumor (PNET)‚Ì1Ç—á. —äˆä’è‹ICŠâ‘º³ŽkC‰œ–ì‹I•FC‘º–{«rC‘v¬_C¬ŽÄŒ’i”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2713. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 15Έȉº‚̬Ž™tˆÚA|20”NˆÈãŒo‰ß‚µ‚½Ç—á‚ÌŒŸ“¢. “c‘º–ƒŽqC‰““¡’‰—YC‘º–{«rC‹y”\‹v—²C‹g“cˆê¬CŠâ‘º³ŽkCŽðˆä‹ŠC¬ŽÄŒ’i”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2714. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B“û“ªó‘BŠà‚Ì1—á. Ÿ“c^sC‰i“cŠ²’jC‰©‰p–Îi”åjCŠÑˆä•¶•FC•ìƒC‰ª–{dâXC•Ÿˆä€”V‰îi¹˜H‰Áj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2715. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’´‰¹”g¶ŒŸŒ‹‰Ê‚ÉŠî‚¢‚½‘O—§‘BŠà‚Ìu—Õ°“Id—v«v. ‚“ˆ—Í–íC‰oìWCÝŠy•q–çC¬—ѹ“ñCaŒûG”VCÄ“¡‹BCò”ŽˆêC‰¡“c^“ñC{ŽRˆê•äC“à“c–LºC¬ŽÄŒ’i”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2716. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠàƒzƒ‹ƒ‚ƒ“’ïR«”­Œ»‚̊댯ˆöŽq‚ÌŒŸõ. ‰œ–ì‹I•FC{ŽRˆê•äC“¡“c“N•vC‹PºC‘ˆä‘¥ºCŒüˆäLÆC¬ŽÄŒ’i”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2717. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “«¸‘ƒŽîᇂɑ΂·‚éƒpƒNƒŠƒ^ƒLƒZƒ‹‚ÌŽg—pŒoŒ±. ²“¡ˆÐ•¶CŠâ‘º³ŽkC–]ŒŽ‰pŽ÷CΈä~ˆê˜YC‰©‰p–ÎCÄ“¡‹BC‘º–{«rC‰oìWC“à“c–LºC‰““¡’‰—Yi”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2718. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠà“Eo•W–{‚É‚¨‚¯‚éProstatic intraepitherial neoplasia‚Ì“Á’¥. ‹y”\‹v—²C‘v¬_C‰©‰p–ÎC‘º–{«rC‰oìWC“à“c–LºC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2719. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j t×–EŠà×–E–—•W–{‚É‚æ‚éDNA ploidy‚̉ðÍ. Šâ‘º³ŽkCaŒûG”VC²“¡ˆÐ•¶C‘º–{«rC‰oìWC“à“c–LºC^‰ºß•vC‰““¡’‰—Yi”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.24j, ‘O‹´.

2720. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éŒo’¼’°“I’´‰¹”gƒKƒCƒh‰º‘O—§‘B¶ŒŸ‚ɂ‚¢‚Ä. ¼–{˜a«C‰oìWC–]ŒŽ‰pŽ÷C¬—ѹ“ñC“c‘º–ƒŽqi”åjCŒK”ö’èmi•a—jC¯Ži´ŽuC¬ŽÄŒ’i”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.25j, ‘O‹´.

2721. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Humoral hypercalcemia of malignancy (HHM)‚Å‚CaŒŒÇ‚𗈂µ‚½“§ÍÇ—á‚Ö‚ÌpamidronateŽg—pŒoŒ±. ‰¡“c^“ñC²“¡ˆÐ•¶CŸ“c^sCÝŠy•q–çi”åjC‘åŒIŒ’•Fi“àj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.25j, ‘O‹´.

2722. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”r”A¢“ï‚𔺂¤is‘O—§‘BŠà‚ɑ΂·‚éŒo”A“¹“I‘O—§‘BØœp. Ä“¡‹BC¬—ѹ“ñC‘º–{«rC‰©‰p–ÎC‹y”\‹v—²C“c‘º–ƒŽqC‰oìWC“à“c–Lºi”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.25j, ‘O‹´.

2723. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –k—¢‘åŠwˆãŠw•””å”AŠí‰È‚É‚¨‚¯‚é• o‹¾‰ºŽèp‚ÌŒŸ“¢. ‘º–{«rCŠâ‘º³ŽkC‰œ–ì‹I•FCÄ“¡‹BC¬—ѹ“ñC“c‘º–ƒŽqC‰oìWC‹PºC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.25j, ‘O‹´.

2724. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’jŽq”A“¹‚ÉŒ´”­‚µ‚½ˆ««ƒŠƒ“ƒpŽî‚Ì‚P—á. “¡“c“N•vC{ŽRˆê•äC‹PºC¬ŽÄŒ’i”åjC–{‹§i•a—jCŒüˆäLÆi”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.25j, ‘O‹´.

2725. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒ‰t“§ÍŠ³ŽÒ‚ÌtŠà‚ɑ΂·‚éŒã• –Œ‹¾‰ºªŽ¡“It“EœpiƒrƒfƒI). ”nêŽu˜Yi”åj: ‘æ63‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i98.09.25j, ‘O‹´.

2726. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äNã÷Šà‚É‚¨‚¯‚ép53Šà—}§ˆâ“`Žq‚̈Ùí‚Æ—\Œã. “à“c–LºC²“¡ˆÐ•¶C‰©‰p–ÎC¬–““ñ–çCŠâ‘º³ŽkC‰oìWi”åj: ‘æ36‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i98.10.07`09j, •Ÿ‰ª.

2727. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŋ߂̈ã—Ã̖â‘è“_‚ɂ‚¢‚Ä. ΋´Wi”åj: ‘æ51‰ñ“ú–{”å”AŠí‰ÈˆãŽt‰ïÝ—§‹L”OˆãŠw‰ï i98.11.03j •ºŒÉ.

2728. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äNã÷Z‚𔺂Á‚½œ”Õ“àaggressive angiomyxoma‚Ì1—á. –]ŒŽ‰pŽ÷C–å˜e˜abC‰–ì‰pŽjCΈä~ˆê˜YC—›Š¿‰hC‚‹´—Tˆê˜YC‹g“cˆê¬i”åjC‘qŽ–ÎCX‰i³“ñ˜Yi϶‰ïj: ‘æ50‰ñ“ú–{”å”AŠí‰ÈŠw‰ï¼“ú–{‘‰ï i98.11.07j ‰ºŠÖ.

2729. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’P—£ŠÁ—¬t‚ð—p‚¢‚½ƒ‰ƒbƒgt‚Ì—â‹p•Û‘¶‚É‚¨‚¯‚éŒÜ—èŽU‚Ìt•Û‘¶Œø‰Ê‚ÌŒŸ“¢. ^è‹`•FiŽÀ“®ŒnjC“c‘º–ƒŽqC‰““¡’‰—Yi”åjCÔ£•üGC‰Á‰ê’J”£i–òÜj: ‘æ34‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i98.12.01j “Œ‹ž.

2730. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j t•Û‘¶‚É‚¨‚¯‚é×–E“à‰t‚Æ×–EŠO‰t‚Ìt‹@”\‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä. ^è‹`•FiŽÀ“®ŒnjC“c‘º–ƒŽqC‹g“cˆê¬C‰““¡’‰—Yi”åjC‰Á‰ê’J”£i–òÜjC‰ÍŒ´Ž‰ëi¶—j: ‘æ76‰ñ“ú–{¶—Šw‰ï i99.03.28`30j ’·è, ‘æ76‰ñ“ú–{¶—Šw‰ï‘å‰ï—\eW, p.252, 1999.

2731. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Fabry•a‚Ì3—á. —é–Ø‘×C‘å–x—i”åjC“¡‰ª’mºC´–ìkŽ¡C’·ª—TC–åŠÔM”ŽiŠâŽèˆã‘åj: ‘æ8‰ñ“Œ–ktƒtƒ@[ƒ‰ƒ€ i97.06.28j •Ÿ“‡.

2732. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘O—§‘BŠà‚Ì—Õ°“IˆÓ‹`‚É‚¨‚¯‚é“ú•Ä‚Ì”äŠrŒŸ“¢. ‘å–x—i”åjC’·’J쓹•FCŒã“¡NŽ÷C“¡‰ª’mºiŠâŽèˆã‘åjCScardino, P.T.iƒxƒCƒ‰[ˆã‘åj: ‘æ10‰ñŠâŽèŠà’k˜b‰ï i97.07.19j ·‰ª.

2733. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚é‘O—§‘B¶ŒŸ‚ÌŒŸ“¢. “¡àVGŒõiŠâŽèˆã‘åjC‘å–x—i”åjC¬Œ´qCŒã“¡NŽ÷C¬’r”Ž”VC“¡‰ª’mºiŠâŽèˆã‘åj: ‘æ217‰ñ“Œ–k’n•û‰ï i97.09.20j •Ÿ“‡.

2734. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠâŽèŒ§‹{ŒÃŽs‚É‚¨‚¯‚é‘O—§‘B‚ª‚ñW’cŒŸf‚ÌŒŸ“¢. Œã“¡NŽ÷iŠâŽèˆã‘åjC‘å–x—i”åjC“¡‰ª’mºiŠâŽèˆã‘åj: “ú–{ŠàŽ¡—Êw‰ï i97.10.00j ‹ž“s.

2735. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠâŽèŒ§‹{ŒÃŽs‚É‚¨‚¯‚é‘O—§‘B‚ª‚ñW’cŒŸf‚ÌŒŸ“¢. ‘å–x—i”åjCŒã“¡NŽ÷C“¡‰ª’mºiŠâŽèˆã‘åj: ‘æ62‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i97.10.14j b•{.

2736. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”r”A¢“ï‚ðŽå‘i‚Æ‚µ‚Ä”­Œ»‰ï‰A•”–ü’…Ç‚Ì1—á. ‰œ–ì‹I•FC‘ºŽR‰ëˆêC{ŽRˆê•äC‹PºCŒüˆäLÆC¬ŽÄŒ’i”åj: “ú–{”å”AŠí‰ÈŠw‰ïé‹Ê’n•û‰ï i98.00.00j é‹Ê.

2737. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j LH-RHƒAƒSƒjƒXƒgÜ“Š—^•û–@‚ªŒ´ˆö‚ÆŽv‚í‚ꂽ‘O—§‘BŠàƒRƒ“ƒgƒ[ƒ‹•s—ÇÇ—á‚ÌŒoŒ±. ²“¡ˆÐ•¶C‰oìWCaŒûG”VC•½ˆäËŽiCÝŠy•q–çC“à“c–LºC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ17‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i98.02.12j V‰¡•l.

2738. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j f’f‚É‹ê—¶‚µ‚½—«”A“¹ŒeŽº‚Ì‚P—á. ‚“ˆ—Í–íCÝŠy•q–çCŠâ‘º³ŽkC‘º–{«rC¬—ѹ“ñC‰©‰p–ÎC“à“c–Lºi”åj: ‘æ54‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï i98.06.13j, “Œ‹ž.

2739. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œo”A“¹“IØœp(TUR)‚É‚æ‚莡—³‚ꂽUtricular Cyst‚Ì‚QÇ—á. ‘v¬_C‰oìWC‘å–x—C‹y”\‹v—²C‘åì–ƒŽqC‰““¡’‰—Yi”åj: ‘æ54‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï i98.06.13j, “Œ‹ž.

2740. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •a—‘gDŠw“If’f‚ª¢“ï‚Èis«”A“¹Žîᇂ̂P—á. ¬Œ´qC’·’J쓹•FC‘å–x—i”åjC“¡‰ª’mºCâוŸ•¶•F: ‘æ216‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ–k’n•û‰ï i98.06.21j, å‘ä.

2741. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j t”AŠÇd•¡Šà‚Ì1Ç—á. “¡é‹M‹³CŠâ‘º³ŽkC—äˆä’è‹IC‘º–{«rC‘v¬_C‰oìWC‰““¡’‰—YC”nêŽu˜Yi”åj: ‘æ55‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï i98.11.28j ìè.

2742. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠO«¸ŠÇ’f—ô‚ɑ΂·‚évasostomy‚ÌŒoŒ±. Έä‘å•ãCŠâ‘º³ŽkC¼–{˜a«C²“¡ˆÐ•¶C‘å–x—C‹g“cˆê¬C‰““¡’‰—YC”nêŽu˜Yi”åj: ‘æ55‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï i98.11.28j ìè.

2743. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”A“¹oŒŒ‚ðŽå‘i‚É”­Œ©‚³‚ꂽ¸”X‘BG•½ã”çŠà‚Ì1—á. “c”¨Œ’ˆêCŠâ‘º³ŽkC‚“ˆ—Í–íCΈä~ˆê˜YC“c‘º–ƒŽqC“à“c–LºC‰““¡’‰—YC”nêŽu˜Yi”åj: ‘æ55‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï i98.11.28j ìè.

2744. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”­”M‚ðŽå‘i‚Æ‚µ‚½‘O—§‘BŠà‚Ì1—á. “c”¨Œ’ˆêC‰oìWCΈä‘å•ãC—äˆä’è‹IC¼–{˜a«C²“¡ˆÐ•¶C“c‘º–ƒŽqC‘v¬_C”nêŽu˜Yi”åj: ‘æ19‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i99.02.04j V‰¡•l.

2745. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒgƒ‰ƒjƒ‰ƒXƒg‚É‚æ‚é‚ÆŽv‚í‚ꂽŠÌ‹@”\áŠQ‚𔺂Á‚½–³‹Û«äNã÷‰Š‚Ì1—á. ‰©‰p–ÎC‰¡“c^“ñCÝŠy•q–çi”åj: ‘æ19‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i99.02.04j V‰¡•l.

2746. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆ««•FŽî‚ÌL”͂Ȍ㕠–ŒZ‚É‚æ‚ét•s‘S‚ð’悵‚½1—á. ‚“ˆ—Í–íC‹g“cˆê¬C“¡é‹M‹³CΈä~ˆê˜YC‘º–{«rC”nêŽu˜Yi”åjC“n•Ó–€–çCtŽR”üi“àjCŒK”ö’èmi•a—j: ‘æ19‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i99.02.04j V‰¡•l.

2747. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ªŽ¡“I‘O—§‘B‘S“Eœp‚Å“Eo‚³‚ꂽ‘O—§‘BŠà‚Ì•a—Šw“Iƒvƒƒtƒ@ƒCƒ‹. ‘å–x—i”åjCŒã“¡NŽ÷C’·’J쓹•FC—é–Ø“OC“¡‰ª’mºCScardino, P.T.: ‘æ480‰ñŠâŽèˆãŠw‰ï i99.03.13j ·‰ª.

2748. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j tŒŒŠÇŽèp: tˆÚA‚ð’†S‚É. ‰““¡’‰—Yi”åj: ‘æ21‰ñ”å”AŠí‰ÈŽèpŽè‹Z i98.07.26j, “Œ‹ž.

2749. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “ñŽŸ«•›bó‘B‹@”\˜´iǂɑ΂·‚étˆÚA‚ÌŒø‰Ê‚ÌŒÀŠE. •º“¡“§C‰¡“c^“ñC‹y”\‹v—²CX‰º“N•vC‹g“cˆê¬CŠâ‘º³ŽkC^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åj: ‘æ31‰ñtˆÚA—Õ°Œ¤‹†‰ï i98.00.00j ‰¡•l.

2750. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j œ‘ãŽÓƒpƒ‰ƒ[ƒ^‚©‚猩‚½–³Œ`¬œ‚ɑ΂·‚銈«Œ^ƒrƒ^ƒ~ƒ“D3‚Ì’†Ž~Œø‰Ê(—\•ñ). •º“¡“§i”åjC‹ß“¡Œõ—miŒú–؃NƒŠƒjƒbƒNjCŽðˆä‹Ši”åj: t‚ƃrƒ^ƒ~ƒ“‚cŒ¤‹†‰ï i98.00.00j “Œ‹ž.

2751. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –³‹@”\t‚©, ‹}«‹‘┽‰ž‚©•s–¾‚¾‚Á‚½Ž€‘ÌtˆÚA‚Ì‚P—á. X‰º“N•vC‹y”\‹v—²CÝŠy•q–çC^‰ºß•vC‰““¡’‰—Yi”åjCŒK”ö’èmi•a—j: ‘æ14‰ñtˆÚA¥ŒŒŠÇŠO‰ÈŒ¤‹†‰ï i98.06.05j, ‹{è.

2752. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j 1. ”A˜H•s’èD‘i‚ɑ΂·‚銿•û—Ö@, 2. ˆã—ÃŒoÏ‚ÆŠ¿•û. ΋´Wi”åj: ŒQ”n“Œ—mˆãŠw—Õ°Œ¤‹†‰ï, Š¿•ûŠwpu‰‰‰ï i98.05.14j, ‘O‹´.

2753. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j 1. ”A˜H•s’èD‘i‚ɑ΂·‚銿•û—Ö@, 2. ˆã—ÃŒoÏ‚ÆŠ¿•û. ΋´Wi”åj: ‘æ11‰ñˆ¤’m“Œ—mˆãŠwŒ¤‹†‰ï i99.01.18j ˆ¤’m.

2754. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠâŽèŒ§‹{ŒÃŽs‚É‚¨‚¯‚é‘O—§‘B‚ª‚ñW’cŒŸf‚ÌŒŸ“¢. ‘å–x—i”åjCŒã“¡NŽ÷C쑺”É”üCŒã“¡N•¶C“¡‰ª’mºiŠâŽèˆã‘åj: —\–hˆãŠwŒ¤‹†‰ï i97.00.00j å‘ä.

2755. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŒŒ´PSAƒŒƒxƒ‹2`10 ng/ml‚É‚¨‚¯‚éFree/TotA1 PSA ratio(%)‚Ì‘O—§‘BŠà‚Ìf’f”\—Í‚ÌŒŸ“¢. ‘å–x—i”åjC“¡‰ª’mºiŠâŽèˆã‘åjC‰oìWC¬ŽÄŒ’i”åj: ‘æ2‰ñ“Œ–k”å”AŠíˆ««Žîᇌ¤‹†‰ï i97.11.15j ·‰ª.

2756. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j pŒã‘O—§‘BŠà‚É‚¨‚¯‚éSalvage Radiotherapy‚Ì—L—p«. ‘v¬_C“c”¨Œ’ˆêC“¡é‹M‹³C—äˆä’è‹IC¬—ѹ“ñC‰©‰p–Îi”åj: ‘æ15‰ñ_“Þ쌧—§‘O—§‘BŽîᇌ¤‹†‰ï i98.07.11j, ‰¡•l.

2757. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‰»Šw—Ö@Œã’·ŠúŠÔ‚ɂ킽‚Á‚Ädisease control‚ª‰Â”\‚Å‚ ‚Á‚½is«‘O—§‘BŠà‚Ì1—á. ‚“ˆ—Í–íC‘v¬_C‰oìWCΈä‘å•ãCŠâ‘º³ŽkC“à“c–LºC^‰ºß•vi”åj: ‘æ15‰ñ_“Þ쌧—§‘O—§‘BŽîᇌ¤‹†‰ï i98.07.11j, ‰¡•l.

2758. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒCƒŒƒEƒXÇ󂪎‘±‚·‚éd‰»«”í”X«• –Œ‰Š(SEP)‚ɑ΂·‚éhome IVH—Ö@. ‹g“cˆê¬C‘º–{«rC‚“ˆ—Í–íC‹y”\‹v—²C“c‘º–ƒŽqC‰““¡’‰—YC”nêŽu˜YC‰¡“c^“ñi”åj: ‘æ56‰ñ_“Þ쌧tŒ¤‹†‰ï‡“¯Œ¤‹†‰ï i98.11.15j ‰¡•l.

2759. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”r”AáŠQ‚Ìf’f‚ÆŽ¡—Ã. Šâ‘º³Žki”åj: ‘æ46‰ñPharmaceutical CareŒ¤C‰ï i98.11.15j ŠC˜V–¼.

2760. mŠwpÜi‘ÛÜjn ùìˆãŠw§Šw‹à§“xvŒ£§, ùìˆãŠw§Šw‹à§“x10Žü”N‹L”OsŽ–i97.12.05jC–k‹ž, ¬ŽÄŒ’i”åj.


<<25 Šá‰ÈŠw>>

2761. mŒ´’˜n Up-to-date management to prevent and control optic nerve diseases. Žá‘q‰ë“oiŠáj: Asian Med. J., 41(7): 353`361, 1998.

2762. mŒ´’˜n Inflammatory reaction via arachidonic acid cascade after intravitreal injection of endothelin-1. ¯ŽiMsCOshika, T.CMasuda, K.iŠáj: Curr. Eye Res., 17: 205`210, 1998.

2763. mŒ´’˜n Spectrum of pathogenic mitochondrial DNA multations and clinical features in Japanese families with Leber's hereditary optic neuropathy. Mashima, Y.CYamada, K.CŽá‘q‰ë“oiŠájCKigasawa, K.CKudoh, J.CShimizu, N.COguchi, Y.: Current Eye Res., 17: 403`408, 1998.

2764. mŒ´’˜n Detection of melatonin, its precursors and related enzyme activities in rabbit lens. ˆ¢•”[ŽuCˆÉ“¡³‘¥C‹{“cŠ²•vCÎì“NCSumi, Y.iŠáj: Exp. Eye Res., 68: 255`262, 1999.

2765. mŒ´’˜n Rapid increase in systolic calcium ion concentration mediated by acetylcoline receptors in cultured retinal neurons and Muller cells. Žá‘q‰ë“oCìè‚¢‚ÂÝCÎì“NiŠáj: Graefes Arch. Clin. Exp. Ophthalmol., 236: 934`939, 1998.

2766. mŒ´’˜n Mini-RKpŒãƒRƒ“ƒgƒ‰ƒXƒgŠ´“x‚ÌŒŸ“¢. ‹´–{sOi•‘ –ì“úÔjC´…Œö–çiŠáj: IOL & RS, 12(2): 70`73, 1998.

2767. mŒ´’˜n Mini-RKpŒãŠá‚̃Rƒ“ƒgƒ‰ƒXƒgŠ´“x‚̗݉Á. ‰œŽR˜aŽqi•‘ –ì“úÔjC¯ŽiMsC´…Œö–çiŠáj: IOL & RS, 12(4): 264`268, 1998.

2768. mŒ´’˜n Laser in situ keratomileusis (LASIK)‚É‚æ‚é‹ßŽ‹‹¸³. ‰|–{Šì‹vŽqC´…Œö–çC‹´–{sOC“c’†rˆêiŠáj: IOL & RS, 12: 269`273, 1998.

2769. mŒ´’˜n ƒVƒŠƒR[ƒ“ƒŒƒ“ƒY‘}“üŠá‚É‚¨‚¯‚é‘O”XØŠJƒTƒCƒY‚ÌŒŸ“¢|‘O”XØŠJƒTƒCƒY‚É‚æ‚é”äŠr|. •l“c–ƒ”üC´…Œö–çiŠájCŽOŒË‰ªŽÆiŽœŒbˆã‘åjCŒÃ‰ê‹M‹vC¬¼^—i•‘ –ì“úÔj: IOL & RS, 13(1): 11`14, 1999.

2770. mŒ´’˜n Effect of horizontal vergence on the motor and sensory components of vertical fusion. Œ´’¼liŠájCSteffen, H.CRoberts, D.C.CZee, D.S.: Invest. Ophthalmol. Vis. Sci., 39(12): 2268`2276, 1998.

2771. mŒ´’˜n Effect of ƒÀ-blocker on the rabbit ciliary artery. X–{—ÇŽqC‹g•xŒ’ŽuC—щl—CÎì‹ÏCÎì“NiŠáj: Invest. Ophthalmol. Vis. Sci., 39(4): 270`270, 1998.

2772. mŒ´’˜n Pharmacological characterization of pre- and post-synaptic endothelial receptors in the albino rabbit iris dilator muscle. Îì‹ÏC²“¡–í¶C‹g•xŒ’ŽuiŠájCŒ´“c–FÆi–ò—jCÎì“NiŠáj: Invest. Ophthalmol. Vis. Sci., 39(4): 800, 1998.

2773. mŒ´’˜n Selectivity of muscarinic agonists including (})-aceclidine and antimuscarinics on the human. Îì“NiŠájCDesantis, L.CPatil, P.N.: J. Ocul. Pharmacol. Ther., 14(4): 363`373, 1998.

2774. mŒ´’˜n Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Žá‘q‰ë“oC—äˆä—˜¹ŽqiŠájCOono, S.CMatsui, Y.i²‰êˆã‘åjCTabuchi, A.iìèˆã‘åjCKani, K.iŽ ‰êˆã‘åjCShikishima, K.CKawai, K.iŽœŒbˆã‘åjCNakao, Y.iŠâŽèˆã‘åjCTazawa, Y.i‹ß‹Eˆã‘åjCKiyosawa, M.i“ŒˆãŽ•‘åjCAbe, H.iVŠƒ‘åjCOhba, N.iŽ­‘åjCYago, K.i•Ÿ“‡Œ§—§ˆã‘åjCMaeda, S.iO‘Oˆã‘åjCSugita, M.i“Œ–Mˆã‘åjCÎì“NiŠájCOptic Neuritis Treatment Trial Multicenter Cooperative Research Group: Jpn. J. Ophthalmol., 43: 127`132, 1999.

2775. mŒ´’˜n Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Žá‘q‰ë“oC^‰º‹I”ü‘ãiŠájCOono, S.CMatsui, Y.CTabuchi, A.CKani, K.CShikishima, K.CKawai, K.CNakao, Y.CTazawa, Y.CKiyosawa, M.CAbe, H.COhba, N.CYago, K.CMaeda, S.CSugita, M.CÎì“NiŠájCOptic Neuritis Treatment Trial Multicenter Cooperative Research Group: Jpn. J. Ophthalmol., 43: 133`138, 1999.

2776. mŒ´’˜n Radioligand binding characteristics of the endothelin receptor in the rabbit iris. Nosaka, C.CÎì‹ÏCt–ìŒ÷C‹g•xŒ’ŽuCKase, H.CÎì“NiŠájCŒ´“c–FÆi–ò—j: Jpn. J. Pharmacol., 76: 289`296, 1998.

2777. mŒ´’˜n ƒnƒ“ƒtƒŠ[Ž©“®Ž‹–ìŒv‚É‚¨‚¯‚éM—ŠŒW”‚ÌŒŸ“¢. ¬“‡‹±ŽqC¼ˆäFŽqC‹g•xŒ’ŽuCÎì“NiŠáj: Jpn. Orthopt. J., 26: 173`177, 1998.

2778. mŒ´’˜n Adenovirus vector-mediated gene transfer into rat retinal neurons and Muller cells vitro and in vivo. •ŸŒ´‰ë”ViŠájCSuzuki, A.CFukuda, Y.CKosaka, J.: Neurosci. Lett., 242(2): 93`96, 1998.

2779. mŒ´’˜n Histopathological study of the effect of phacoemulsification-aspiration on iris muscles. ¬¼^—i•‘ –ì“úÔjC‰F‰ê–ÎŽOiˆã—Éq¶jC‘å–ìVŽ¡i²‰êˆã‘åjC´…Œö–çiŠájC¬Œ´^Ž÷•vi•‘ –ì“úÔj: Ophthalmologica, 212: 169`174, 1998.

2780. mŒ´’˜n Šá‚ɉe‹¿‚ð—^‚¦‚é–òÜE•úŽËü. Îì‹ÏCŽá‘q‰ë“oiŠáj: Pharma Medica, 16: 69`73, 1998.

2781. mŒ´’˜n Žº“à‰˜õ‚É‚æ‚é_Œo“Å‚Ì‘Îô. ‹{“cŠ²•vC“ï”g—´lC¼–{_”VCŽs•Ó‹`ÍiŠáj: The Lung, 6: 374`377, 1998.

2782. mŒ´’˜n Development of Myopia Due to Environmental Problems; A possible interaciton of anti-cholinesterase compounds examined by accomodative adaptation. Îì“NC“y‰®–M•FC‘å’Ë‹I‰ÀC‰LŽ”ˆê•FiŠáj: The Vision Care, p.108`111, 1998.

2783. mŒ´’˜n ‹ßŽ‹‚Ì”­¶‚Ɗ‹«ˆöŽq. Îì“NC“y‰®–M•FC‘å’Ë‹I‰ÀC‰LŽ”ˆê•FiŠáj: The Vision Care, p.109`118, 1998.

2784. mŒ´’˜n MTI PhotoscreenerTM‚Ì“àŽÎŽ‹Š³ŽÒ‚ւ̉ž—p. ¯Ži—ÏŽqC–ؔÉC“¡ŽR—R‹IŽqCVˆä“cF—TCŒü–ì˜a—YCÎì“NiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 15(11): 1623`1628, 1998.

2785. mŒ´’˜n ƒAƒZƒNƒŠƒWƒ“, ƒvƒƒJƒ‹ƒsƒ“‚̃qƒgŠá“à•½ŠŠ‹Ø‚ɑ΂·‚é–ò—Šw“Iì—p. Îì‹ÏC‹g•xŒ’ŽuCÎì“NiŠájCPatil, P.N.iOhio State Univ.jCDe SantisiAlcon Lab.j: ‚ ‚½‚炵‚¢Šá‰È, 15(7): 983`985, 1998.

2786. mŒ´’˜n ‘½”—á‚É‚¨‚¯‚éƒRƒ“ƒgƒ‰ƒXƒgŠ´“x‹óŠÔŽü”g”“Á«‚ÌŒŸ“¢|³íŽÒ‚Ì”N—㎋ŽÒ‚ÌŽ‹—Í|. ‰LŽ”ˆê•Fi“ú–{•ŸŽƒ‘åjC¼–ìÊŽqC‘å–Øç‰ÀCA¼iŽqC¼ˆäFŽqC¼“‡Ø•äŽqCÎì“NiŠáj: Šá‰È—Õ°ˆã•ñ, 92(6): 756`760, 1998.

2787. mŒ´’˜n Dissociated Horizontal Deviaiton‚Ì‚RÇ—á. ¯Ži—ÏŽqC–ؔÉC“¡ŽR—R‹IŽqCVˆä“cF—TCŒü–ì˜a—YiŠáj: Šá‰È—Õ°ˆã•ñ, 92(7): 950`954, 1998.

2788. mŒ´’˜n Cover-uncover‚É‚¨‚¯‚éŠá‹…‰^“®‚Ì’è—Ê“I•ªÍ. ™–{’©ŽqCŽR“c“OlCŽO‹´—S”üŽqC¼–ìÊŽqCª–{“OCÎì“NiŠáj: Šá‰È—Õ°ˆã•ñ, 92(7): 963`967, 1998.

2789. mŒ´’˜n TVƒXƒNƒŠ[ƒ“‰æ‘œ‚ÌŠááŠQ«‚Ì”äŠr. “ï”g—´lC¼–{_”VCŽs•Ó‹`ÍC•y‰ª•q–çC²“¡”ü“ÞŽqC‹{“cŠ²•viŠáj: Šá‰È—Õ°ˆã•ñ, 92: 279`281, 1998.

2790. mŒ´’˜n RƒRƒŠƒ“ƒGƒXƒeƒ‰[ƒ[‚Ì–«“Å«|“Á‚É—L‹@—Ó‚ÌŽ‹Šo“Å«‚ɂ‚¢‚Ä|. Îì“NiŠáj: Ž©—¥_Œo, 35(1): 1`17, 1998.

2791. mŒ´’˜n •s’èD‘i‚Æ”÷—ʉ»Šw•¨Ž¿. Îì“NiŠáj: SgˆãŠw, 38(10): 96`102, 1998.

2792. mŒ´’˜n Ž‹_Œo‰ŠŽ¡—ѽŽ{݃gƒ‰ƒCƒAƒ‹Œ¤‹†‚ÌŠT—v. Žá‘q‰ë“oiŠáj: _ŒoŠá‰È, 15: 10`14, 1998.

2793. mŒ´’˜n ‰ü—ÇŒ^úŽh¶ŒŸj‚É‚æ‚é•a—‘gDf’f. ŒÃ–ì‹v”üŽqC”Ñ“cä݈êC‹T“c—zˆêCŽRŒû³’¼C‘Ÿº—mŽqC¬¼—SŽqCŠâ•¬ŽqC²X–ØG‹MC’†‘º–ž”üŽqC–ؔÉC¯Ži—ÏŽqCˆ¢‘]ŽqiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 10(—Õ‘): 183, 1998.

2794. mŒ´’˜n ”’F‰Æ“e…»‘Ì‚É‚¨‚¯‚郃‰ƒgƒjƒ“ŽY¶. ˆ¢•”[ŽuC‹{“cŠ²•vCÎì“NCˆÉ“¡³‘¥iŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 102: 238, 1998.

2795. mŒ´’˜n ‘¼ŠoŽ‹–ìŒv|“µEŽ‹–ìŒv|. ‹g•xŒ’ŽuC¼ˆäFŽqiŠájC“c’†ŠÙ–¾”Žiˆã—Éq¶jCÎì“NiŠáj: “ú–{Šá‰È‹I—v, 49: 733`737, 1998.

2796. mŒ´’˜n ãŽÎ‹Ø–ƒáƒ‚ɑ΂·‚鉺’¼‹Ø…•½ˆÚ“®p. –쓇ˑãC¬Œ´^Ž÷•vC´…Œö–çiŠáj: “ú–{ŽÎ”\ŒP—ûŽm‹¦‰ïŽ, 26: 249`253, 1998.

2797. mŒ´’˜n cover-uncover‚É‚¨‚¯‚éŠá‹…‰^“®‚Ì’è—Ê“I‰ðÍ. ™–{’©ŽqCŽR“c“OlCŽO‹´—S”üŽqC¼–ìÊŽqCª–{“OCÎì“NiŠáj: “ú–{ŽãŽ‹ŽÎŽ‹Šw‰ÈŽ, 25: 200`204, 1998.

2798. mŒ´’˜n I––ˆÊŠáUiend-point nystagmus)‚Ì‹­–ŒƒT[ƒ`ƒRƒCƒ‹–@‚É‚æ‚錤‹†. –]ŒŽˆêC‹g“cŠ°Cª–{“OCÎì“NiŠáj: –k—¢ˆãŠw, 28: 254`259, 1998.

2799. mŒ´’˜n ’áŽü”g“dŽ¥”g‚̃}ƒEƒX‚ւ̉e‹¿. •y‰ª•q–çC¼èL‰hC‹{“cŠ²•vC‰F‰ê–ÎŽOCÎì“NiŠáj: —Õ°ŠÂ‹«ˆãŠw, 7(2): 80`86, 1998.

2800. mŒ´’˜n ƒGƒLƒVƒ}ƒŒ[ƒU[‹üÜ‹¸³ŽèpŒã‚̊ሳ•]‰¿. ‘“c‚ ‚±i•‘ –ì“úÔjC´…Œö–çC¯ŽiMsC‰|–{Šì‹vŽqiŠáj: —Õ°Šá‰È, 52(3): 323`326, 1998.

2801. mŒ´’˜n ‹üÜŽèpŽ{sŠá‚É‚¨‚¯‚éŠáˆ³‚̉߬•]‰¿. ¯ŽiMsiŠájC‘“c‚ ‚±i•‘ –ì“úÔjC´…Œö–çiŠájC‹´–{sOi•‘ –ì“úÔj: —Õ°Šá‰È, 52(3): 365`368, 1998.

2802. mŒ´’˜n Šp–ŒØŠJ’´‰¹”g”’“àáŽèp‚̘_“_|pŒãŠá“à‰Š, p’†‡•¹Ç‚ɂ‚¢‚Ä|. ŒÃ‰ê‹M‹vi•‘ –ì“úÔjC´…Œö–çiŠájC¬¼^—i•‘ –ì“úÔjCŽOŒË‰ªŽÆiŽœŒbˆã‘åj: —Õ°Šá‰È, 52(4): 603`606, 1998.

2803. mŒ´’˜n Minimally invasive radial keratotomy‚Ì“K‰žŠî€. ‹´–{sOi•‘ –ì“úÔjC´…Œö–çiŠáj: —Õ°Šá‰È, 52(5): 727`730, 1998.

2804. mŒ´’˜n ‘O–[“à–ƒŒ‚Ì—LŒø«‚ƈÀ‘S«‚ÌŒŸ“¢. ŽOŒË‰ªŽÆiŽœŒbˆã‘åjC´…Œö–çiŠájCŒÃ‰ê‹M‹vC¬¼^—i•‘ –ì“úÔj: —Õ°Šá‰È, 52(5): 925`928, 1998.

2805. mŒ´’˜n ƒGƒLƒVƒ}ƒŒ[ƒU[‹üÜ‹¸³Žèp‚É‚¨‚¯‚éƒAƒ‹ƒR[ƒ‹Šp–Œã”ç”—£. ‰|–{Šì‹vŽqi•‘ –ì“úÔjC´…Œö–çC‹´–{sOC“c’†rˆêiŠáj: —Õ°Šá‰È, 52(5): 933`936, 1998.

2806. mŒ´’˜n V‚µ‚¢—Ž‹‹¸³p. ‘Δnˆêmi•‘ –ì“úÔjC´…Œö–çiŠáj: —Õ°Šá‰È, 52(6): 1035`1038, 1998.

2807. mŒ´’˜n ƒGƒLƒVƒ}ƒŒ[ƒU[‹ßŽ‹‹¸³Šp–ŒØœŒã‚T”N‚Ì—Õ°¬Ñ. ‹´–{sOi•‘ –ì“úÔjC´…Œö–çiŠájC“V–ìŽj˜Yi“Œ‘åj: —Õ°Šá‰È, 52(7): 1745`1748, 1998.

2808. mŒ´’˜n ‹üÜŒ^‘½Å“_Šá“àƒŒƒ“ƒY‚ÌpŒã¬Ñ‚Æ“K‰ž. ¯ŽiMsC´…Œö–çiŠáj: —Õ°Šá‰È, 53(3): 259`263, 1999.

2809. mŒ´’˜n ”’“àáŽèpŒãŠá“à‰Š‚Ì”­¶•p“x‚Æ—\–h. ŒÃ‰ê‹M‹vi•‘ –ì“úÔjC´…Œö–çC¬¼^—iŠáj: —Õ°Žèp, 11(2): 175`178, 1998.

2810. m€Œ´’˜n Multiple chemical sensitivity (MCS) patients in Japan. ‹{“cŠ²•vCÎì“NC“ï”g—´liŠáj: Japan-France Joint Workshop on Health and Building Proceedings, p.47`56, 1999.

2811. mŒ¤‹†•ñn ‚RŽŸŒ³‰f‘œ‚̶‘Ô‰e‹¿‘‡•]‰¿ƒVƒXƒeƒ€‚ÌŠJ”­‚ÉŠÖ‚·‚éƒtƒB[ƒWƒrƒŠƒeƒBƒ^ƒfƒB. Îì‹ÏiŠáj: “µEŒa‚É‚æ‚鎩—¥_ŒoŠˆ“®‚Ì•]‰¿, p.219`250, 1998.

2812. mŒ¤‹†•ñiŒú¶Èjn ƒŒ[ƒxƒ‹ˆâ“`«Ž‹_Œoǂɑ΂·‚é–ò•¨Ž¡—Â̎Ž‚Ý. ^“‡s•FC¬Œû–F‹viŒc‘åjCŽá‘q‰ë“oiŠáj: Œú¶È“Á’莾Š³–Ô–Œ–¬—–ŒEŽ‹_ŒoˆÞkÇ’²¸Œ¤‹†”Ç•ñ‘, p.4`11, 1998.

2813. mŒ¤‹†•ñiŒú¶Èjn Ž‹_Œo‰ŠŽ¡—ѽŽ{݃gƒ‰ƒCƒAƒ‹‚ÌÅIŒ‹‰Ê‚ɂ‚¢‚Ä. Žá‘q‰ë“oCÎì“NiŠáj: Œú¶È“Á’莾Š³–Ô–Œ–¬—–ŒEŽ‹_ŒoˆÞkÇ’²¸Œ¤‹†”Ç•ñ‘, p.12`14, 1998.

2814. mŒ¤‹†•ñiŒú¶Èjn _Œo×–EŽ€‚̊댯ˆöŽqƒAƒ|ƒŠƒ|ƒvƒƒeƒCƒ“‚d‚Ì–Ô–ŒF‘f•Ï«Ç‚Ö‚ÌŠÖ—^‚ɂ‚¢‚Ä. ‹e’r—T”üC•½“cåCŽs•Ó‹`ÍCŽá‘q‰ë“oiŠáj: Œú¶È“Á’莾Š³–Ô–Œ–¬—–ŒEŽ‹_ŒoˆÞkÇ’²¸Œ¤‹†”Ç•ñ‘, p.51`54, 1998.

2815. mŒ¤‹†•ñiŒú¶Èjn ŠázŠÂ‚ɉe‹¿‚ð‹y‚Ú‚·ŒŒŠÇ•½ŠŠ‹Ø‚ɑ΂·‚鶗–ò—Šw“IŒ¤‹†. ‹g•xŒ’ŽuCÎì‹ÏCt–ìŒ÷C‘å’Ë‹I‰ÀiŠáj: •½¬8`10”N“x‰ÈŠwŒ¤‹†”ï•â•‹àŠî”ÕŒ¤‹†‚b, Œ¤‹†¬‰Ê•ñ‘, p.1`29, 1999.

2816. mÇ—á•ñn Œ´”­‘ƒ‚ªŠÌŽîᇂł ‚Á‚½“]ˆÚ«“àˆö«Šá“à‰Š‚Ì‚P—á. Ž™‹ÊˆÀ‘ãC‹g•xŒ’ŽuC—Ñ—ÇŽqC’†ì—¢ŠGCÎì“NiŠáj: Šá‰È, 40(5): 743`747, 1998.

2817. mÇ—á•ñn Œ´”­«RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ‚É‚æ‚é–«‹•ŒŒ«Ž‹_ŒoÇ‚Ì‚P—á. Ž™‹ÊˆÀ‘ãCŽá‘q‰ë“oC‹g•xŒ’ŽuC¯ŽiŽ¡‘ãCÎì“NiŠáj: “ú–{Šá‰È‹I—v, 49(4): 346`354, 1998.

2818. m‘àn “ÁW; Ž‹_Œo‰Š‚Ìf’f‚ÆŽ¡—Ã. Žá‘q‰ë“oiŠáj: Ophthalmology Update, 13(3): 3`10, 1998.

2819. m‘àn ‰ä‚ª‘‚É‚¨‚¯‚鉻Šw•¨Ž¿‰ß•qÇ‚ÌŒ»ó‚Æ–â‘è“_. ‹{“cŠ²•vC“ï”g—´lCŽs•Ó‹`ÍCÎì“NiŠáj: ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 18: 977`980, 1998.

2820. m‘àn ‹ü܎㎋‚Æ•s“¯Ž‹ŽãŽ‹‚ÌŽ¡—Éߒö‚É‚¨‚¯‚鎋—͉ü‘PŠúŠÔ. ¼ˆäFŽqC¼“‡Ø•äŽqC™ŽR—R‹IŽqCŽR“c“OlCÎì“NiŠájC‰LŽ”ˆê•Fi“ú–{•ŸŽƒ‘åj: Šá‰È—Õ°ˆã•ñ, 92(6): 751`755, 1998.

2821. m‘àn ˜˜_; Ž©—¥_Œoŋ߂̘b‘è‚æ‚è. Îì“NiŠáj: _ŒoŠá‰È, 15(2): 123, 1998.

2822. m‘àn ‰»Šw•¨Ž¿‰ß•qÇ‚Æ_ŒoŠá‰È‚ÌŠÖ‚í‚è. “ï”g—´liŠáj: _ŒoŠá‰È, 15(2): 162`169, 1998.

2823. m‘àn ŠázŠÂ‚Ì–ò—Šw. ‹g•xŒ’ŽuiŠáj: _ŒoŠá‰È, 15(2): 212`218, 1998.

2824. m‘àn The optic nerve in clinical practice. Žá‘q‰ë“oiŠáj: _ŒoŠá‰È, 15: 226, 1998.

2825. m‘àn R‚Ä‚ñ‚©‚ñ–ò‚ÆŽ‹‹@”\áŠQ. Žá‘q‰ë“oiŠáj: _ŒoŠá‰È, 15: 47`50, 1998.

2826. m‘àn “ªŠW“àŽ¾Š³‚Ì_ŒoŠá‰È“I‚ÈŒ©•û. Žá‘q‰ë“oiŠáj: “¡‘òŽsˆãŽt‰ï•ñ, 273: 3`6, 1998.

2827. m‘àn ”MƒVƒ‡ƒbƒN’`”’Ž¿‚ÆŠá|‘P‹Ê‚ƈ«‹Ê|Heat-shock Proteins in the Eye. Žá‘q‰ë“oiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 102(7): 409`410, 1998.

2828. muÀn ‰»Šw•¨Ž¿‰ß•qÇ; Šá‰Èˆã‚Ì—§ê‚©‚ç. Žs•Ó‹`ÍC‹{“cŠ²•viŠáj: Current Therapy, 17(3): 97`103, 1999.

2829. muÀn ƒƒ“ƒ|ƒCƒ“ƒgƒAƒhƒoƒCƒX; mini-RK‚Ì—˜“_. ´…Œö–çiŠáj: Practical Ophthalmology, 1(4): 64`65, 1998.

2830. muÀn ³íŠáˆ³—Γàá‚ð‚Ç‚¤f‚é‚©. ‹g•xŒ’ŽuiŠáj: Practical Ophthalmology, 1(5): 18`21, 1998.

2831. muÀn Ž„‚ÌD‚«‚Ȭ“¹‹ï|ƒfƒBƒXƒ|[ƒUƒuƒ‹”’“àáŽèpƒLƒbƒg|. ´…Œö–çiŠáj: Practical Ophthalmology, 1(6): 145, 1998.

2832. muÀn ŠÂ‹«‚ÆŠá|‰»Šw•¨Ž¿‚È‚Ç|. Žs•Ó‹`ÍC‹{“cŠ²•viŠáj: Practical Ophthalmology, 1(7): 50`55, 1998.

2833. muÀn –Ô–ŒMuller×–E‚Ì–ðŠ„. Žá‘q‰ë“oiŠáj: Practical Ophthalmology, 1(8): 110`118, 1998.

2834. muÀn Šp–ŒØŠJ. ´…Œö–çiŠáj: Practical Ophthalmology, 1(8): 20`23, 1998.

2835. muÀn “ª’É‚Ì\‘¢39; ‘M‹P«ˆÃ“_. Îì‹ÏCŽá‘q‰ë“oiŠáj: Scope, 37: 18`19, 1998.

2836. muÀn ŠááÙáz¹‚ÌŒ´ˆö‚Æ‚»‚̃{ƒcƒŠƒkƒXŽ¡—Ã(BOTOX)‚ÌŒ»ó‚ð‹³‚¦‚ĉº‚³‚¢. Îì‹ÏiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 15(‘): 182`184, 1998.

2837. muÀn —L‹@ƒŠƒ“’†“Å, ƒTƒŠƒ“’†“ÅŠ³ŽÒ‚Ì‹~‹}ˆ’u–@‚ð‹³‚¦‚Ä‚­‚¾‚³‚¢. Žs•Ó‹`ÍiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 15(‘): 73`76, 1998.

2838. muÀn “µEŽ‹–ìŒv. ‹g•xŒ’ŽuiŠáj: _ŒoŠá‰È, 15(3): 288`293, 1998.

2839. muÀn “dŽq“µEŒv‹L˜^–@EÔŠOüƒrƒfƒI“µEŒv‹L˜^–@. Œü–ì˜a—YiŠáj: ¶‘ÌE‹@”\ŒŸ¸‚ÌABC, 120(8): 313`314, 1998.

2840. muÀn ŠááÙ‰º‚‚ðf‚½‚ç. Œü–ì˜a—YiŠáj: “ú–{‚ÌŠá‰È, 69(7): 741`745, 1998.

2841. muÀn VDTŒŸf‚Ì—v“_. –ؔÉiŠáj: “ú–{‚ÌŠá‰È, 70(1): 13`17, 1999.

2842. muÀn ‹üÜ‹¸³Žèp‚ði‚ß‚Ä‚ä‚­‚É“–‚½‚èŠá‰Èê–åˆã‚É‹‚ß‚ç‚ê‚邱‚Æ|‘åã’nÙ–¯Ž–•”•½¬10”N9ŒŽ28“ú”»Œˆ‘S•¶‚ð“Ç‚ñ‚Å|. Šâ£ŒõC´…Œö–çiŠáj: “ú–{‚ÌŠá‰È, 70(3): 317`318, 1999.

2843. muÀn ‹üÜ‹¸³Žèp‚É—p‚¢‚éŠá“àƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY. ´…Œö–çiŠáj: “ú–{ˆãŽ–V•ñ, (3881): 110`111, 1998.

2844. muÀn ‰»Šw•¨Ž¿‰ß•qÇ‚Ì’†˜a—Ö@. Žs•Ó‹`ÍiŠáj: “ú–{ˆãŽ–V•ñ, (3893): 109`111, 1998.

2845. muÀn Šá“àƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚Ì“Eo, ŒðŠ·. ´…Œö–çiŠáj: “ú–{ˆãŽ–V•ñ, (3894): 130, 1998.

2846. muÀn RKŽèp‚ƃCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg. ´…Œö–çiŠáj: “ú–{ˆãŽ–V•ñ, (3903): 118`119, 1998.

2847. muÀn ‘O•”‹•ŒŒ«Ž‹_ŒoÇ. Žs•Ó‹`ÍiŠáj: “ú–{Šá‰ÈŠw‰ï¶ŠU‹³ˆç’ÊMuÀ, 23: 1998.

2848. muÀn ƒhƒCƒc‚É‚¨‚¯‚鉻Šw•¨Ž¿‰ß•qÇ(MCS)Œ’N•ÛŒ’ˆã—ËƖ±‚ÅMCS‚ª•ÛŒ’“K‰ž‚³‚ê‚邽‚ß‚Ì•û–@|‚±‚ê‚܂ł̈ãŠw펯‚ð‘å‚«‚­‰z‚¦‚½ƒAƒ‹ƒeƒ“ƒLƒ‹ƒq‹³Žö‚̘_•¶(–|–ó). ˆ¢‘]ŽqiŠáj: —Õ°ŠÂ‹«ˆãŠw, 7(2): 93`94, 1998.

2849. muÀn ˜V”NŽÒ‚ÌŠá‰Èf—ẪRƒc. ‹{“cŠ²•viŠáj: ˜V‰»‚ÆŽ¾Š³, 11: 103`104, 1999.

2850. m•ÒWŽÒ‚ւ̎莆i‰p•¶jn At Issue: What is the most benefitial incision location for the patient? ´…Œö–çiŠáj: Ocular Surgery News International, 9(4): 1998.

2851. mŠwp‘n i•ª’SŽ·•Mj Šá‰È—Õ°ƒƒ‚(‰ü’ù‘æ‚Q”Å); ‹üÜŽèp, p.281`285, ´…Œö–çiŠáj. •ÒW àV“c“ÕC–{“cEŽmC猴‰x•vC•ÒC “ì]“°, “Œ‹ž, 98.06.20”­s.

2852. mŠwp‘n i•ª’SŽ·•Mj ES Now Illustrated 9; “ÁŽê—áE“ïÇ—á‚Ì”’“àáŽèp|—ΓàáŽèp‘O‚¨‚æ‚ÑŒã, ¯ŽiMsiŠáj. •ÒW ‘厭“N˜YC‘¼C•ÒC ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 98.00.00”­s.

2853. mŠwp‘n i•ª’SŽ·•Mj VŠá‰ÈŠw; ŠOŠá‹Ø, p.1`10, Žá‘q‰ë“oC—Ñ—ÇŽqiŠáj. “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 98.00.00”­s.

2854. mŠwp‘n i•ª’SŽ·•Mj VŠá‰ÈŠw; Ž‹_ŒoEŽ‹˜H, p.105`109, Žá‘q‰ë“oC¼èL‰hiŠáj. “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 98.00.00”­s.

2855. mŠwp‘n i•ª’SŽ·•Mj V}à—Õ°Šá‰ÈuÀ6: ‰Á—î‚Æ“µE; “µE, p.38`39, Îì‹ÏiŠáj. ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 98.00.00”­s.

2856. mŠwp‘n i•ª’SŽ·•Mj V}à—Õ°Šá‰ÈuÀ9: Šá•”‹~‹}ˆã—Ã/Žîá‡; Šáâ|“]ˆÚ«Žîá‡, p.135`141, ŒÃ–ì‹v”üŽqiŠáj. ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 99.00.00”­s.

2857. mŠwp‘n i•ª’SŽ·•Mj “ïÇ”’“àá‚Ö‚ÌPEA-IOLŽèp; ‚a. p’†‡•¹Ç‚ւ̑Έ|Žå‚ȃŒƒ“ƒY‘¹‚Æ‚»‚̑Έ, p.149`151, ¯ŽiMsiŠáj. •ÒW ã–ì‘Ž÷i¹ƒ}ƒŠ‘åjC’JŒûd—Yiº˜a‘åjC•ÒC ‹àŒ´o”Å, “Œ‹ž, 98.10.20”­s.

2858. mŠwp‘n i•ª’SŽ·•Mj “ïÇ”’“àá‚Ö‚ÌPEA-IOLŽèp; p‘O‚©‚ç—\‘ª‰Â”\‚È“ïÇ—á|d‚¢Šj‚ÌPEA‚É‚¨‚¯‚éƒ|ƒCƒ“ƒg, p.19`23, ´…Œö–çiŠáj. •ÒW ã–ì‘Ž÷i¹ƒ}ƒŠ‘åjC’JŒûd—Yiº˜a‘åjC•ÒC ‹àŒ´o”Å, “Œ‹ž, 98.10.20”­s.

2859. mŠwp‘n i•ª’SŽ·•Mj “ïÇ”’“àá‚Ö‚ÌPEA-IOLŽèp; p‘O‚©‚ç—\‘ª‰Â”\‚È“ïÇ—á|¬“µE‚Ì”’“àáŽèp, p.1`5, ´…Œö–çC¬¼^—iŠáj. •ÒW ã–ì‘Ž÷i¹ƒ}ƒŠ‘åjC’JŒûd—Yiº˜a‘åjC•ÒC ‹àŒ´o”Å, “Œ‹ž, 98.10.20”­s.

2860. mŠwp‘n i•ª’SŽ·•Mj V}à—Õ°Šá‰ÈuÀ; 1. Žå‘i, ŠŒ©‚©‚ç‚̃Aƒvƒ[ƒ`. _ŒoüˆÛŒ‡‘¹, p.210`211; 4. —Γàá, Žá‘q‰ë“oiŠáj. •ÒW V‰Æ^C΋´’B˜NC¬Œû–F‹vC–؉º–ÎC’†‘º‘׋vC–]ŒŽŠwCŽá‘q‰ë“oiŠájC•ÒC ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 98.11.05”­s.

2861. mŠwp‘n i•ª’SŽ·•Mj ‹üÜ‹¸³‚̃vƒƒZƒX‚ÆŽÀÛ; ‘æ‚TÍ: ‹üÜ‹¸³Žèp3 mini-RK|(1)mini RK‚Ìì—p‹@˜¥“Á’¥, (2)Žè‹Z, (5)“K‰ž‚Æ–â‘è“_, p.105, p.109, p.112`114, ´…Œö–çiŠáj. •ÒW ‹›—¢”Ži“ޗLjã‘åjC´…Œö–çi–k—¢‘åjC•ÒC ‹àŒ´o”Å, “Œ‹ž, 98.10.20”­s.

2862. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—ÃQ & A; “µEŽ‹–ìŒviPupil Perimentry)‚ɂ‚¢‚Ä‚²‹³Ž¦‚­‚¾‚³‚¢, 151: 4`7, ‹g•xŒ’ŽuiŠáj.

2863. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈƒuƒŒ[ƒNƒXƒ‹[—ΓàᎡ—Ã; –ò•¨‚Ŋሳ‰º~‚ª“¾‚ç‚ê‚È‚¢³íŠáˆ³—Γàá, p.80; ”’“àá‚É‚ ‚éPOAGŠ³ŽÒ‚ÌŽèp, p.110; ƒŒ[ƒU[‘@ˆÛ’Œ‘ÑŒ`¬p‚ðd‚Ë‚Ä‚æ‚¢‚©, p.124; Overfitaration, p.155; Ž‹–ì‚̈«‰»‚µ‚‚‚ ‚é˜Vl‚ÌŽèp“K‰ž, p.199, ‹g•xŒ’ŽuiŠáj.

2864. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈƒuƒŒ[ƒNƒXƒ‹[—ΓàᎡ—Ã; Š³ŽÒ‚̃‰ƒCƒtƒXƒ^ƒCƒ‹‚ÌŽw“±, p.188`189, ‹g•xŒ’ŽuC¼Œ³riŠáj.

2865. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈƒIƒsƒjƒIƒ“(5) Šp–Œ‹üÜ‹¸³Žèp; ƒ~ƒjRK‚ð—p‚¢‚½Ž©Œ±—á‚̉ðÍ, p.143`153, ´…Œö–çiŠáj. •ÒW ‘“cŠ°ŽŸ˜YCàV[C•ÒC ’†ŽR‘“XC“Œ‹žC98.10.30”­s.

2866. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈƒIƒsƒjƒIƒ“6 ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg10Í; ”’“àá‚ɑ΂µ‚Ä|ŽèpŽžŠú, p.152`155, ´…Œö–çiŠáj. 99.02.01”­s.

2867. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈƒIƒsƒjƒIƒ“6 ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg13Í; Ž‹_Œo‰Š, p.242`245, Žá‘q‰ë“oiŠáj. 99.02.01”­s.

2868. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈƒIƒsƒjƒIƒ“6 ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg13Í; ‹•ŒŒ«Ž‹_ŒoÇ, p.250`253, Žs•Ó‹`ÍiŠáj. 99.02.01”­s.

2869. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—Õ֗˜Žè’ ; Ž¾Š³‚¨‚æ‚ÑŠŒ©|C.ŒŸ¸, “d‹CŠáU}, p.274`275; J.Šá‹…‰^“®áŠQCŠáU, p.190`191, Žá‘q‰ë“oiŠáj.

2870. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈŠw‘ÌŒn; ƒGƒAƒoƒbƒN‚É‚æ‚éŠáŠOi·‚µ‘Ö‚¦”Å), p.58(2)`58(4), Œ´’¼liŠáj.

2871. mŠwp‘n i•ÒWj ‹üÜ‹¸³‚̃vƒƒZƒX‚ÆŽÀÛ; •ÒW ‹›—¢”Ži“ޗLjã‘åjC´…Œö–çiŠájC•ÒC ‹àŒ´o”Å, “Œ‹ž, 98.00.00”­s.

2872. mŠwp‘n i•ÒWj Šá‰Èf—ÃKƒCƒhƒuƒbƒN; •ÒW ‘“cŠ°ŽŸ˜YCŽá‘q‰ë“oiŠájC•ÒC ˆãŠw‘‰@, “Œ‹ž, 98.10.15”­s.

2873. mŠwp‘n i•ÒWj V}à—Õ°Šá‰ÈuÀ; •ÒW V‰Æ^C΋´’B˜NC¬Œû–F‹vC–؉º–ÎC’†‘º‘׋vC–]ŒŽŠwCŽá‘q‰ë“oiŠájC•ÒC ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 98.11.05”­s.

2874. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj NHK‚«‚傤‚ÌŒ’N; –Ú‚Ì•a‹CE”’“àá, 127: 52`55, ´…Œö–çiŠáj. “ú–{•ú‘—o”Å‹¦‰ï, “Œ‹ž, 98.10.01”­s.

2875. mŠw‰ïi‘Ûjn i‹³ˆçu‰‰j Exchanging Torn Silicone IOL. ´…Œö–çiŠáj: American Society of Cataract and Refractive Surgery 1998 Annual Meeting i98.04.18`22j, San Diego, USA.

2876. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Development of myopia due to environmental problems: A possible interaction of anti-cholinesterase compounds examined by accommodative adaptation. Îì“NC“y‰®–M•FC‘å’Ë‹I‰ÀC‰LŽ”ˆê•FiŠáj: 1st Asia-Pacific International Conference of the Vision Care i98.04.15`18j, “Œ‹ž.

2877. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Multicenter clinical trial in the treatment of idiopathic optic neuritis in Japan. Žá‘q‰ë“oCÎì“NiŠájCOhno, S.CMatsui, Y.CKani, K.CShikishima, K.CKawai, K.CTabuchi, A.CNakao, Y.CTazawa, Y.Cand Japanese Optic Neuritis Treatment Multicenter Trial Research Group: International Neuro-ophthalmology Society Meeting i98.07.19`23j, Dublin, Ireland.

2878. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Anterior shift of posterior corneal surface after LASIK. ´…Œö–çiŠáj: 1998 World Refractive Surgery Symposium i98.07.25`28j, USA.

2879. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Refractive surgery around the world. ´…Œö–çiŠáj: 1998 World Refractive Surgery Symposium i98.07.25`28j, USA.

2880. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Corneal barrier index in ocular pharmacotherapeutics. Paril, P.N.CÎì‹ÏiŠáj: 31st Indian Pharmacological Society i98.00.00j, India.

2881. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Comparison of foldable IOLs. ¬¼^—C´…Œö–çiŠáj: American Society of Cataract and Refractive Surgery 1998 Annual Meeting i98.04.18`22j, San Diego, USA.

2882. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Advantages of small optic sillicone IOLs. ¬¼^—i•‘ –ì“úÔjC´…Œö–çiŠáj: American Society of Cataract and Refractive Surgery (ASCRS) 1998 Annual Meeting i98.04.18`22j, San Diego, USA.

2883. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Underestimation of intraocular pressure after refractive surgery. ‘“c‚ ‚±i•‘ –ì“úÔjC´…Œö–çC¯ŽiMsC‹´–{sOiŠáj: American Society of Cataract and Refractive Surgery 1998 Annual Meeting i98.04.18`22j, San Diego, USA.

2884. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Effects of diluted ethanol on cornea in rabbits. ‰|–{Šì‹vŽqi•‘ –ì“úÔjC´…Œö–çiŠájC…—¬’‰•Fi“Œ‘åj: American Society of Cataract and Refractive Surgery 1998 Annual Meeting i98.04.18`22j, San Diego, USA.

2885. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Pharmacological characterization of pre- and post-synaptic endothelin receptors in the albino rabbit iris dilator muscle. Îì‹ÏC²“¡–í¶C‹g•xŒ’ŽuiŠájCŒ´“c–FÆi–ò—jCÎì“NiŠáj: ARVO Annual Meeting 1998 i98.05.12j, Florida.

2886. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Torsional orientation of the paretic and nonparetic eye under monocular viewing conditions in forth nerve palsies. Steffen, H.CStraumann, D.CRepka, M.CGuyton, D.L.CMiller, N.R.CŒ´’¼liŠájCRober, D.D.CZee, D.S.: ARVO Annual Meeting 1998 i98.05.12j, Florida.

2887. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Multicenter clinical trial of megadose methylprednisolone in the treatment of idiopathic optic neutitis in Japan. Žá‘q‰ë“oC‘å–ìVŽ¡C¼ˆäFŽqCKani, K.CShikishima, K.CKawai, A.CTabuchi, Y.CNakao, Y.CTazawa, Y.CKiyosawa, M.CÎì“NiŠáj: ARVO Annual Meeting 1998 i98.05.15j, Florida.

2888. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of ƒÀ-blocker on the rabbit clliary artery. X–{—ÇŽqC‹g•xŒ’ŽuC—щl—CÎì“NCÎì‹ÏiŠáj: ARVO Annual Meeting i98.05.11j, Florida.

2889. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The extrastriate cortex plays different roles in controlling convergence eye movement to slow and fast target speeds. Takada, R.CŒ´’¼liŠájCŒË“c”£iŠÅŒìŠw•”jCHasebe, H.CTakagi, M.CAbe, H.CBando, T.iŠáj: ARVO Annual Meeting i98.05.11j, Florida.

2890. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effects of a new excitotoxic amino acid, dysiherbaine on cultured Muller vells. —äˆä—˜¹ŽqiŠájC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjCŽá‘q‰ë“oiŠájCŽðˆä—²ˆêi…ŽYŠw•”j: ARVO Annual Meeting 1998 i98.05.13j, Florida.

2891. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Comparison of threshold visual perimetry and objective pupil perimetry in clinical patients. ‹g•xŒ’ŽuC¼ˆäFŽqiŠájC“c’†ŠÙ–¾”Žiˆã—Éq¶jCÎì“NiŠáj: ARVO Annual Meeting 1998 i98.05.14j, Florida.

2892. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j ƒXƒeƒƒCƒh܈ˑ¶Ç‚ðŽ¦‚·Ž‹_ŒoÇ. Žá‘q‰ë“oiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2893. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ¬ØŠJ‘ΉžIOL‚ÌÅV•]‰¿; 2)ƒVƒŠƒR[ƒ“ƒŒƒ“ƒY. ¬¼^—C´…Œö–çiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2894. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‚RŽŸŒ³‰f‘œ‚ÌŽ©—¥_ŒoŒn‚É‹y‚Ú‚·‰e‹¿. ŽR“c“OliŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2895. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’®ŠoŽhŒƒ‚ð—p‚¢‚½‰“S«Ž‹_Œo‘@ˆÛ‚Ì—}§‹@”\‚ÌŒŸ“¢. Vˆä“cF—TiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01j, •Ÿ‰ª.

2896. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “Eo‰Æ“eŒã–Ñ—l“®–¬‚É‹y‚Ú‚·ŠeŽíƒÀŽÕ’f–ò‚̉e‹¿. X–{—ÇŽqC‹g•xŒ’ŽuC—щl—CÎì‹ÏCÎì“NiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01`04j, •Ÿ‰ª.

2897. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “Eo‰Æ“eŒã–Ñ—l“®–¬‚Ì_ŒoŽx”z‚ƃvƒƒJƒ‹ƒsƒ“‚̉e‹¿. ‹g•xŒ’ŽuCX–{—ÇŽqC—щl—CÎì‹ÏCÎì“NiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01`04j, •Ÿ‰ª.

2898. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “Eo‰Æ“eŒã–Ñ—l“®–¬‚É‹y‚Ú‚·ƒCƒ\ƒvƒƒsƒ‹ƒEƒmƒvƒƒXƒgƒ“‚̉e‹¿. —щl—C‹g•xŒ’ŽuCX–{—ÇŽqCÎì‹ÏCÎì“NiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01`04j, •Ÿ‰ª.

2899. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒTƒM“µEŽU‘å‹Ø‚É‚¨‚¯‚éƒGƒ“ƒhƒZƒŠƒ“, ƒTƒ‰ƒtƒHƒgƒLƒVƒ“‚Ì–ò—ì—p‚ÆŽó—e‘Ì‚Ì«Ž¿. ²“¡–í¶CÎì‹ÏC‹g•xŒ’ŽuCÎì“NiŠájCŒ´“c–FÆi–ò—j: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01`04j, •Ÿ‰ª.

2900. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ{ƒcƒŠƒkƒX“Š—^‘OŒã‚ÌŽ©—¥_Œo‹@”\‚Ì”äŠr. ’†Œ´‰xŽqCÎì‹ÏCVˆä“cF—TCŒü–ì˜a—YiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01`04j, •Ÿ‰ª.

2901. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’´‰¹”g”’“àáŽèp‚ª“µE‚É‚¨‚æ‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä. ¬¼^—C´…Œö–çiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01`04j, •Ÿ‰ª.

2902. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’´‰¹”g”’“àáŽèp‚ª“øÊ‘gD‚É‚¨‚æ‚Ú‚·‰e‹¿. ‰F‰ê–ÎŽOiˆã—Éq¶jC¬¼^—C´…Œö–çiŠájC‘å–ìVŽ¡i²‰êˆã‘åj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01`04j, •Ÿ‰ª.

2903. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V‚µ‚¢_Œo“Å«ƒOƒ‹ƒ^ƒ~ƒ“Ž_ƒAƒSƒjƒXƒg‚Ì”|—{–Ô–Œ×–E‚ɑ΂·‚éŒø‰Ê. —äˆä—˜¹ŽqiŠájC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjCŽá‘q‰ë“oiŠájCŽðˆä—²ˆêi…ŽYŠw•”j: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01`04j, •Ÿ‰ª.

2904. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ü—ÇŒ^úŽh¶ŒŸj‚É‚æ‚é•a—‘gDf’f. ŒÃ–ì‹v”üŽqC”Ñ“cä݈êC‹T“c—zˆêCŽRŒû³’¼C‘Ÿº—mŽqC¬¼—SŽqCŠâ•¬ŽqC²X–ØG‹MC’†‘º–ž”üŽqC–ؔÉC¯Ži—ÏŽqCˆ¢‘]ŽqiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.03j, •Ÿ‰ª.

2905. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œã”X”j—ô‚ð‚«‚½‚·RCLƒ}ƒEƒX”’“àá‚Ì”­¶‹@˜. ‰F‰ê–ÎŽOiˆã—Éq¶jC¼“‡–F•¶ié‹Ê‚ª‚ñƒZƒ“jCŒ´–¾ŽqiŠájC“ú‡Oi‹ž‘åj: ‘æ37‰ñ“ú–{”’“àáŠw‰ï i98.05.20j, å‘ä.

2906. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j LASIKŒã‚̊ሳ‰ß¬•]‰¿. ‘“c‚ ‚±C´…Œö–çC¯ŽiMsC‰|–{Šì‹vŽqiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2907. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒVƒŠƒR[ƒ“ƒŒƒ“ƒY‘}“üŠá‚É‚¨‚¯‚é‘O”XØŠJƒTƒCƒY‚ÌŒŸ“¢. •l“c–ƒ”üC´…Œö–çiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2908. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Å‹­“x‹ßŽ‹‚Ö‚ÌŠá“àƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‘}“üp. ‹´–{sOC´…Œö–çiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2909. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘ãŽÓhRÜ‚ðŽg—p‚µ‚È‚¢”’“àáE—ΓàᓯŽžŽèp. ‘ΔnˆêmC¯ŽiMsC´…Œö–çiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2910. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒVƒŠƒR[ƒ“ƒg[ƒŠƒbƒNIOL‘}“ü”’“àáŽèp‚Ì‘Šú¬Ñ. ‘ΔnˆêmC´…Œö–çiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2911. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j LASIK‚É‚æ‚éŠp–ŒŒã–Ê‚ÌŒ`ó•Ï‰». “c’†rˆêC´…Œö–çiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2912. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Intraocular Contact Lens‘}“üp. ´…Œö–çiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2913. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰SŽÒ‚É‚æ‚éŠp–Œ¬ØŠJ’´‰¹”g”’“àáŽèp. ŒÃ‰ê‹M‹vC¬¼^—C‘“c‚ ‚±C‰|–{Šì‹vŽqC´…Œö–çiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2914. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j LASIK‚Ì—Õ°¬Ñ. ‰|–{Šì‹vŽqC´…Œö–çC‹´–{sOC“c’†rˆêiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2915. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹üÜŒ^‘½Å“_Šá“àƒŒƒ“ƒY‘}“üp‚Ì‚T”NŒo‰ß. ¯ŽiMsC´…Œö–çiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2916. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒŠÇV¶—Γàá|”­ÇƒƒJƒjƒYƒ€‚ƑΈ–@. ‹g•xŒ’ŽuiŠáj: ‘æ21‰ñ“ú–{Šá‰ÈŽèpŠw‰ï i98.05.23j, å‘ä.

2917. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Šá‰ŠÇ«Ž¾Š³‚ÌV‚µ‚¢Ž¡—Ã|Ž‹_Œo‰Š. Žá‘q‰ë“oiŠáj: ‘æ32‰ñ“ú–{Šá‰ŠÇŠw‰ï i98.06.07j, ‹ž“s.

2918. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”_–ò‚Ɗ‹«. Îì“NiŠáj: ‘æ‚V‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï i98.06.11j, ˆ®ì.

2919. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰»Šw•¨Ž¿‰ß•qó‘Ԃɂ‚¢‚Ä‚Ì’²¸. ‹e’r—T”üCŽ™‹ÊˆÀ‘ãC“ï”g—´lCŽs•Ó‹`ÍC‹{“cŠ²•vCÎì“NiŠáj: ‘æ‚V‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï i98.06.11j, ˆ®ì.

2920. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰»Šw•¨Ž¿‰ß•qÇŽ¡—ÃŽ{Ý‚ÌŠJ”­ (‚»‚Ì‚R)ŠeŽíÞ—¿‚©‚ç‚̉»Šw•¨Ž¿”­¶—Ê‚Ì‘ª’è. ŽOãGliŽO•H—â”MjC—é–غC•lè‚Í‚ÂŽqiV•H—â”MH‹ÆjCÎì“NC‹{“cŠ²•vC“ï”g—´liŠájC––‹gˆê¬iŽO•H‘Œ¤jC–åL”ÉKiŠáj: ‘æ‚V‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï i98.06.12j, ˆ®ì.

2921. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒIƒ]ƒ“EƒCƒIƒ“ŒOö–@‚ɂ‚¢‚Ä: ƒIƒ]ƒ“EƒCƒIƒ“ŒOö–@‚ÌZ‘î‰îŒì—pƒ}ƒbƒgƒŒƒX–ŋۂւ̉ž—p. •lè‚Í‚ÂŽqiV•H—â”MjC—é–غCŽOãGliŽO•H‘Œ¤jCÎì“NC‹{“cŠ²•vC“ï”g—´liŠájC––‹gˆê¬iŽO•H‘Œ¤j: ‘æ‚V‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï i98.06.12j, ˆ®ì.

2922. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰»Šw•¨Ž¿‰ß•qÇŠ³ŽÒ‚Ì“µEŒŸ¸; ‚»‚ÌŒ»ó‚Æ«—ˆ. Žs•Ó‹`ÍiŠáj: ‘æ‚V‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï i98.06.12j, ˆ®ì.

2923. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒTƒM“µEŠ‡–ñ‹Ø‚ɑ΂·‚éƒ{ƒcƒŠƒkƒX‚`Œ^“Å‘f‚Ìì—p. ŽOˆä‹`‹vCÎì‹ÏC‹g•xŒ’ŽuC^‰º‹I”ü‘ãCŒü–ì˜a—YCVˆä“cF—TiŠáj: ‘æ18‰ñ“ú–{Šá–ò—Šw i98.09.18`19j, ‘åã.

2924. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹üÜŒ^‘½Å“_Šá“àƒŒƒ“ƒY‚ÌpŒã¬Ñ‚Æ“K‰ž. ¯ŽiMsi•‘ –ì“úÔjC´…Œö–çiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2925. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹U—Ž‹ûÇŒóŒQ‚Ì’´‰¹”g”’“àáŽèp. ŒÃ‰ê‹M‹vC´…Œö–çiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2926. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒVƒŠƒR[ƒ“ƒg[ƒŠƒbƒNIOL‘}“ü”’“àáŽèp. ‘ΔnˆêmC´…Œö–çiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2927. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Mini-RKpŒã‚R”N‚Ì—Õ°Œo‰ß. ‹´–{sOC´…Œö–çiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2928. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —¼Šá“¯Žž”’“àáŽèp‚ÌŒŸ“¢. ´…Œö–çC•l“c–ƒ”üiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2929. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ^‹ÛŒŒÇ‚É”º‚¤^‹Û«Šá“à‰Š‚ÌŒŸ“¢. ²“¡”üØŽqC‹T’J—CŽR“c“OlC”’ìTŽ¢C–ؔÉiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2930. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j VDTì‹ÆŽÒ‚̋ߎ‹‰»ŒXŒü. ¬ì‘דTC¼–{”ü•ÛC¯Ži—ÏŽqC–ؔÉCÎì“NiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2931. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j VŒ^ÔŠOü“dŽq“µEŒv‚ÌЉîiC7364). ŒÑ“c’¼ri•l¼ƒtƒHƒgƒjƒNƒXjC–ؔÉCÎì“NC匴ŽµdiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2932. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹S«Ž‹–ì‹·ó‚ð‚«‚½‚µ‚½—¼Šá«‚ÌŽ‹_ŒoÇ. ’†ì—¢ŠGC”µ–ì’·•¶CŽá‘q‰ë“oiŠájC‹{‰i‰Ã—²C•ìˈêi—Žqˆã‘åj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2933. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž©“®“µEŽ‹–ìŒv‚É‚¨‚¯‚éƒpƒ‰ƒ[ƒ^[‚ÌŒŸ“¢. ¼ˆäFŽqC‹g•xŒ’ŽuC¬“‡‹±ŽqCÎì“NiŠájCŠ–ˆßŽqC“c’†ŠÙ–¾”Žiˆã—Éq¶j: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2934. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Space Saving Chart|300 Type ‡U‚ÌŽg—pŒoŒ±. ŠÔìŒ\ŽqCŒ´’¼lCŒj–¢“ÞiŠájC²X–Ø”Éiƒ†ƒjƒnƒCƒgj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2935. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž‹_Œo‰ŠŽ¡—ѽŽ{݃gƒ‰ƒCƒAƒ‹; Ž¡—ÂP”NŒã‚Ü‚Å‚ÌŽ‹‹@”\‚Ì„ˆÚ. Žá‘q‰ë“oC^‰º‹I‘ã”üiŠájC‘å–ìVŽ¡C¼ˆäi]i²‰êˆã‘åjC‰ÂŽ™ˆêFiŽ ‰ê‘åjC•~“‡ŒhŒáC‰Í‡ˆêdiŽœŒbˆã‘åjC“c•£º—Yiìèˆã‘åjC’†”ö—YŽO i‹ß‹E‘åjC“c‘ò–LiŠâŽèˆã‘åjC´‘òŒ¹Oi“Œ‹žˆãŽ•‘åjC‘O“cCŽiiO‘O‘åjC‘å’ë‹I—YiŽ­Ž™“‡‘åjCˆ¢•”tŽ÷iVŠƒ‘åjC”ªŽqŒbŽqi•Ÿ“‡ˆã‘åjC™“c –«i“Œ–M‘åjCÎì“NiŠájCŽ‹_Œo‰ŠŽ¡—ѽŽ{݃gƒ‰ƒCƒAƒ‹Œ¤‹†ƒOƒ‹[ƒv: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2936. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰Á—”Á•Ï«‚ɑ΂·‚é•úŽËüŽ¡—Ã|‘½Ž{Ý–³ìˆ×—Õ°ŽŽŒ±|. ¬–¸—Sˆê˜Yi–¼ŒÃ‰®‘åjC‹ÊˆäMi“Œ–k‘åjC‘å•_iŽD–yˆã‘åjC’†‘ò–žiO‘O‘åjC“’‘ò”ü“sŽqi“ú‘åjC–x“cŠì—Ti‡“V‘åjCŽá‘q‰ë“oiŠájC–œ‘㓹Žq i‹ž‘åjC‚‹´Š°“ñiŠÖ¼ˆã‘åjC΋´’B˜Ni‹ã‘åjCùˆäŒ[Ž‘i‹ž‘åjC’Òˆê˜Yi“Œ–k‘åj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2937. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œy”÷‚ÈŠá‹…‰^“®áŠQ‚ÌŒŸo‚É—L—p‚ÈV‚µ‚¢Electro-OculogramŒŸo–@. _Š_‹v”üŽqiˆã—Éq¶jCŽO‹´—S”üŽqC™–{’©ŽqC¼–ìÊŽqCŽR“c“OliŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.24j, _ŒË.

2938. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚RŽŸŒ³ƒT[ƒ`ƒRƒCƒ‹–@‚É‚æ‚é㉺•ûŒü‚Ì—Z‘œ‚Ì‘ª’èi‘æ‚P•ñjçtçs‚̉e‹¿‚ÆŠ´Šo«E‰^“®«¬•ª‚ÌŒŸ“¢. Œ´’¼liŠájCSteffen, H.CRoberts, D.C.CZee, D.S.: ‘æ46‰ñ“ú–{—Õ°Ž‹Šo“d‹C¶—Šw‰ï i98.11.13`15j, •Ê•{.

2939. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “Á”­«Ž‹_Œo‰Š‚É‚¨‚¯‚錒Šá‚ÌŽ‹‹@”\•]‰¿. Ž™‹ÊˆÀ‘ãC—äˆä—˜¹ŽqCŽá‘q‰ë“oiŠájC‘å–ìVŽ¡i²‰êˆã‘åjC‰ÂŽ™ˆêFiŽ ‰êˆã‘åjC‰Í‡ˆêdC•~“‡ŒhŒáiŽœŒbˆã‘åjC“c•£º—Yiìèˆã‘åjC’†”ö—YŽO i‹ß‹E‘åjC“c‘ò–LiŠâŽèˆã‘åjCÎì“NiŠájCŽ‹_Œo‰Š‘½Ž{݃gƒ‰ƒCƒAƒ‹Œ¤‹†ƒOƒ‹[ƒv: ‘æ36‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i98.11.26`28j, ç—t.

2940. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘½”­«d‰»Ç‚É‚¨‚¯‚鎋_ŒoáŠQ‚ÆŠá‹…‰^“®áŠQ‚ÌoŒ»‚Æ‚ÌŽžŠÔ“IŠÖŒW‚ɂ‚¢‚Ä. ‹T’J—CŽá‘q‰ë“oC–ؔÉiŠájCÄ“¡–L˜aCâˆä•¶•Fi“àj: ‘æ36‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i98.11.26`28j, ç—t.

2941. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž‹_Œo“û“ª‰Š‚ð‡•¹‚µ‚½ƒŒ[ƒxƒ‹ˆâ“`«Ž‹_Œoǂ̬Ž™—á. ’O‰H‘×—mC’–“c‚³‚ð‚èC²“¡”üØŽqCŽá‘q‰ë“oiŠáj: ‘æ36‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i98.11.26`28j, ç—t.

2942. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒTƒM“µEŠ‡–ñ‹Ø, ŽU‘å‹Ø‚ɑ΂·‚éƒ{ƒcƒŠƒkƒX‚`Œ^“Å‘f‚Ì–ò—ì—p. Îì‹ÏCŽOˆä‹`‹vC‹g•xŒ’ŽuC^‰º‹I”ü‘ãCVˆä“cF—TCŒü–ì˜a—YiŠáj: ‘æ36‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i98.11.27j, ç—t.

2943. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žá”NŽÒ‚Ì‹•ŒŒ«Ž‹_ŒoÇ‚ÌŒo‰ß‚Ɗ댯ˆöŽq‚ɂ‚¢‚Ä. ‘q’m—²CX“c“N–çCŽá‘q‰ë“oiŠáj: ‘æ36‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i98.11.27j, ç—t.

2944. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘½”­«d‰»Ç; Šá‹…‰^“®áŠQ‚ð’†S‚É. Žá‘q‰ë“oiŠáj: ‘æ36‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i98.11.27j, ç—t.

2945. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒtƒH[ƒ_ƒuƒ‹ƒŒƒ“ƒY‚Ö‚Ì‹Û•t’…. ¬¼^—C´…Œö–çCŒÃ‰ê‹M‹vC–å‘q—˜ŽçC‚–ìT–çiŠáj: ‘æ22‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï i99.01.29`31j, “Œ‹ž.

2946. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹U—Ž‹ûÇŒóŒQ‚Ì’´‰¹”g”’“àáŽèp. ŒÃ‰ê‹M‹vC¬¼^—C´…Œö–çiŠáj: ‘æ22‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï i99.01.29`31j, “Œ‹ž.

2947. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V‚µ‚¢—Ž‹‹¸³”’“àᓯŽžŽèp. ‘ΔnˆêmC´…Œö–çC¬¼^—iŠáj: ‘æ22‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï i99.01.29`31j, “Œ‹ž.

2948. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Šá“àƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚Ì—Õ°Œo‰ß. ‹´–{sOC´…Œö–çC‰|–{Šì‹vŽqC“c’†rˆêiŠáj: ‘æ22‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï i99.01.29`31j, “Œ‹ž.

2949. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹ßŽ‹‹­“x•Ê‚É‚Ý‚½LASIK‚̬Ñ. ‰|–{Šì‹vŽqC´…Œö–çC‹´–{sOC“c’†rˆêiŠáj: ‘æ22‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï i99.01.29`31j, “Œ‹ž.

2950. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”’F‰Æ“e…»‘Ì‚É‚¨‚¯‚郃‰ƒgƒjƒ“ŽY¶. ˆ¢•”[ŽuC‹{“cŠ²•vCÎì“NCˆÉ“¡³‘¥iŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01`04j, •Ÿ‰ª.

2951. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –Ô–ŒF‘f•Ï«Ç‚É‚¨‚¯‚éƒAƒ|ƒŠƒ|ƒvƒƒeƒCƒ“‚d‚̈â“`Žq‘½Œ^. ‹e’r—T”üC•½“cåCŽs•Ó‹`ÍCŽá‘q‰ë“oiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.01`04j, •Ÿ‰ª.

2952. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “«‚Ô‚Ç‚¤–Œ‰Š‚ɑ΂·‚é–[…‚Å‚ÌPCR–@‚É‚æ‚é’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‡UŒ^‚ÌŒŸo. ’–“c‚³‚ð‚èC•½“cåC—äˆä—˜¹ŽqCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.02j, •Ÿ‰ª.

2953. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž‹•W’ñŽ¦‰Û‘è‚̈Ⴂ‚É‚æ‚éÕ“®«Šá‹…‰^“®‚̃pƒ‰ƒ[ƒ^‚̕ω». ¼èL‰hiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.03j, •Ÿ‰ª.

2954. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j VDTì‹Æ‚Ƌߎ‹‰». ¬ì‘דTC¼–{”ü•ÛCÄ“¡ŒbC¯Ži—ÏŽqC–ؔÉiŠáj: ‘æ102‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï i98.04.03j, •Ÿ‰ª.

2955. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹üÜ‹¸³ŽèpŠó–]Š³ŽÒ‚Ì«ŠiŒXŒü. •Ðƒmâ—ŒbC´…Œö–çC“c’†rˆêiŠáj: Ophthalmic Surgeon's Week in Sendai i98.05.20`24j, å‘ä.

2956. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ÉŽq‘ÌŽèp`pŒãŽ‹—͒ቺ—á‚ÌŒŸ“¢. ¼–{”ü•ÛC²“¡”üØŽqC”’ìTŽ¢C¯ŽiŽ¡‘ãC“¡“c“NC”µ–ì’·•¶iŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2957. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “øÊ‚É“]ˆÚ‚µ‚½‰ºˆô“ªŽîᇂ̂P—á. ‹e’r—T”üC•y‰ª•q–çC”’ìTŽ¢C‹g•xŒ’ŽuCŽá‘q‰ë“oiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2958. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Parry-RombergÇŒóŒQ‚Ì‚P—á. “c’†˜HŽqC‰|–{”ü’qŽqC–x’å•vC”’ì´ŒáC¡ˆäŒOC‘å‘ò^–ØŽqi—Žqˆã‘åjC¯ŽiŽ¡‘ãiŠáj: ‘æ52‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i98.10.23`25j, _ŒË.

2959. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆ³”—«Ž‹_ŒoÇ‚Ì‚Q—á. ’†‘ò³”ŽC¼èL‰hC‹g“cŠ°iŠáj: ‘æ36‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i98.11.26`28j, ç—t.

2960. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÙ‚Ȃ鎋•W‘¬“x‚Å—U”­‚³‚ꂽçtçs‰^“®‚Ì‚ŽŸŽ‹Šo—Ì”j‰ó‚É‚æ‚é•Ï‰». ‚“c—¥ŽqiVŠƒ‘åjCŒ´’¼liŠájC’·’J•”“úC‚–Ø•ô•vCˆ¢•”tŽ÷CŒË“ct’jCâ“Œ••FiVŠƒ‘åj: ‘æ36‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i98.11.26`28j, ç—t.

2961. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚É‚æ‚é‘–Œ”]‰Š‚ªŒ´ˆö‚ÆŽv‚í‚ꂽMIÇŒóŒQ. ’†Œ´‰xŽqCŽOˆä‹`‹vCŽR“c“OlCŽá‘q‰ë“oiŠáj: ‘æ36‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i98.11.26`28j, ç—t.

2962. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”畆Œ‹ß«“®–¬ŽüˆÍ‰Š‚É”º‚Á‚½“®Šá_Œo–ƒáƒ‚Ì‚P—á. ¼–{”ü•ÛC‹g•xŒ’ŽuCŒ´–¾ŽqiŠájC”Ñ’Ë‚_i“àjC‘‘òŠ²’jCŒ´®“¹i”çj: ‘æ36‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i98.11.26`28j, ç—t.

2963. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j PTKŒã‚Ì’´‰¹”g”’“àáŽèp. ŒÃ‰ê‹M‹vC¬¼^—C‰|–{Šì‹vŽqC‹´–{sOC´…Œö–çiŠáj: ‘æ23‰ñŠp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX‘æ15‰ñ“ú–{Šp–ŒˆÚAŠw‰ï i99.02.12j, ‰F•”.

2964. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹­“x—Ž‹Ç—á‚Ì—Ž‹‹¸³E”’“àᓯŽžŽèp. ‘ΔnˆêmC´…Œö–çiŠáj: ‘æ68‰ñ‹ãBŠá‰ÈŠw‰ï i98.05.29`31j, ²‰ê.

2965. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Šp–Œ¬ØŠJ”’“àáŽèp‚ÌŽä‹NŠp–Œ—Ž‹. ŒÃ‰ê‹M‹vC¬¼^—C•l“c–ƒ”üC´…Œö–çiŠáj: ‘æ68‰ñ‹ãBŠá‰ÈŠw‰ï i98.05.29`31j, ²‰ê.

2966. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ARRAY‹üÜŒ^‘½Å“_Šá“àƒŒƒ“ƒY‚ÌpŒã¬Ñ. ¯ŽiMsC´…Œö–çiŠáj: ‘æ68‰ñ‹ãBŠá‰ÈŠw‰ï i98.05.29`31j, ²‰ê.

2967. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŋߌoŒ±‚µ‚½‚ŒŒˆ³«“û“ª•‚Žî‚̬ˆö‚ÆlŽ@. ’†—¢éKCŽá‘q‰ë“oCÎì“NCŒü–ì˜a—YiŠáj: ‘æ15‰ñŠÖ“ŒŠá‰ÈŠw‰ï i98.06.06`07j, “Œ‹ž.

2968. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “ªŠWˆô“ªŽî“EoŒã‚ÌŽü•ÓŽ‹–ì‰ü‘P‚É”º‚¢‰ñù•¡Ž‹‚ðŽ©Šo‚µ‚½‚P—á. Œ´’¼lCŒj–¢“ÞC”öèŒõ‘ãiŠájC‘å‚O–«i”]ŠOj: ‘æ47‰ñŽl‘Šá‰ÈŠw‰ï i98.07.05j, ‚’m.

2969. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž‹_Œo“û“ª‰ðÍ‘•’uTopss‚É‚¨‚¯‚é“û“ª‹«ŠEü‚ÌŒŸ“¢. ¯ŽiMsCV‰Æ^C—é–ØN”VC¬ŠÖM”VC”’“yéÆiŠáj: ‘æ36‰ñ–k“ú–{Šá‰ÈŠw‰ï i98.07.25j, VŠƒ.

2970. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¬Šá‹…‚ɇ•¹‚µ‚½Šáâ|”XŽî‚Ì‚P—á. X“c“N–çC”–ØLÆCŽá‘q‰ë“oiŠáj: ‘æ64‰ñ’†•”Šá‰ÈŠw‰ïŠá•a—Œ¤‹†‰ï i98.10.02`04j, ŽOd.

2971. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž©—¥_Œoì“®–ò‚Ì’²ßŽcŒø‚ɑ΂·‚é‰e‹¿. ’†ì—¢ŠGC™ŽR—R‹IŽqC‘å–Øç‰ÀC²“¡”üØŽqC“y‰®–M•FC‰LŽ”ˆê•FCÎì“NiŠáj: ‘æ64‰ñ’†•”Šá‰ÈŠw‰ïŠá•a—Œ¤‹†‰ï i98.10.02`04j, ŽOd.

2972. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “û“ªŽîᇂª‘O–Ê‚Éo‚½Œã•”‹­–Œ‰Š. ‘q’m—²C—Ñ—ÇŽqCŽá‘q‰ë“oiŠáj: ‘æ64‰ñ’†•”Šá‰ÈŠw‰ïŠá•a—Œ¤‹†‰ï i98.10.04j, ŽOd.

2973. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ‹üÜ‹¸³Žèp‚ÌŒ»ó. ´…Œö–çiŠáj: ‘æ10‰ñÅVŠá‰ÈŠÅŒìŒ¤C i98.07.12j, _ŒË.

2974. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j LASIC vs PRK. ´…Œö–çiŠáj: ‘æ2‰ñJFC/VISXƒZƒ~ƒi[i“Á•Êu‰‰j i99.01.28j, “Œ‹ž.

2975. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Implantable Contact Lens‚Ì—Õ°ŒoŒ±. ´…Œö–çiŠáj: Seminar on Cataract, IOL & Refractive Comeal SurgeryiˆÀ”äƒNƒŠƒXƒ^ƒ‹‹äŠy•”99) i99.02.26`28j, ŠâŽè.

2976. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ¬n‰Æ“eƒ~ƒ…ƒ‰[×–E‚É‚¨‚¯‚éNMDAŒ^ƒOƒ‹ƒ^ƒ~ƒ“Ž_Žó—e‘̂̈â“`Žq’P—£. ’–“c‚³‚ð‚èC•½“cåC“n•Ó^—ŽqiŠájC‚Š_—m‘¾˜Yi•ª¶jCŽá‘q‰ë“oiŠáj: Ž‹Šo‰ÈŠwƒtƒH[ƒ‰ƒ€‘æ‚Q‰ñŒ¤‹†‰ï i98.08.05j, ‰ªè.

2977. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j V‚µ‚¢_Œo“Å«ƒAƒ~ƒmŽ_Dyshiherbaine‚Ì”|—{ƒ~ƒ…[ƒ‰[×–E. —äˆä—˜¹ŽqiŠájC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjCŽá‘q‰ë“oiŠájCŽðˆä—²ˆêi…ŽYŠw•”j: Ž‹Šo‰ÈŠwƒtƒH[ƒ‰ƒ€‘æ‚Q‰ñŒ¤‹†‰ï i98.08.05j, ‰ªè.

2978. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ”’“àápŒã‚ÉPRK‚ðŽ{s‚µ‚½è÷—±óŠp–Œ•Ï«Ç‚Ì‚P—á. ´…Œö–çiŠájC‰|–{Šì‹vŽqi•‘ –ì“úÔj: ‘æ13‰ñAMIS‚̉ï i98.10.22j, “Œ‹ž.

2979. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŒõŠ´Žó«”­ìiƒ|ƒPƒ‚ƒ“j‚Ì’²¸Œ¤‹†|Šá‰ÈŒŸ¸‚ð’†S‚É|. Îì‹ÏiŠájC»‰ŸÂiŽ™jCÎì“NiŠáj: •½¬10”N“xŒú¶È¸_¥_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ï@V‹Zp‚ð—p‚¢‚½“‚Ä‚ñ‚©‚ñ‚Ìf’f–@‚ÆŽ¡—Ö@‚ÌŠJ”­Œ¤‹†•ñ‰ï i98.12.15j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.39, 1998.

2980. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘¹–ÊÏ‚Ì‘å‚«‚³‚̈Ⴂ‚É‚æ‚é…»‘Ì‚Ì”½‰ž‚ɂ‚¢‚Ä. Žá™ˆÀŠó”TC¼–{”ü•ÛC‰F‰ê–ÎŽOiŠáj: ‘æ25‰ñ…»‘ÌŒ¤‹†‰ï i99.01.22j, •Ÿˆä.

2981. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒŒ[ƒxƒ‹•a‚Ìmt DNA•ÏˆÙŽü•Ó•”‚ÉŒ©‚ç‚ê‚é³íŽÒ‚É‚¨‚¯‚é•ÏˆÙ. –L‰ª—TŽqCŽR•Ó°”üiŠájC‘å’J‰pŽ÷i—Õ•a—jCŽá‘q‰ë“oiŠáj: Œú¶È“Á’莾Š³–Ô–Œ–¬—–ŒŽ‹_ŒoˆÞkÇ’²¸Œ¤‹†”Ç1998”N“x”ljï‹c i99.01.27j, “Œ‹ž.

2982. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒXƒeƒƒCƒh܈ˑ¶«‚ðŽ¦‚·“Ë”­«Ž‹_Œo‰Š‚Æ‹æ•Ê‚·‚ׂ«Ž‹_ŒoÇ‚Ì‘¶Ý. Žá‘q‰ë“oiŠáj: Œú¶È“Á’莾Š³–Ô–Œ–¬—–ŒŽ‹_ŒoˆÞkÇ’²¸Œ¤‹†”Ç1998”N“x”ljï‹c i99.01.27j, “Œ‹ž.

2983. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “Ë”­«Ž‹_Œo‰Š‚¨‚æ‚Ñ‘O•”‹•ŒŒ«Ž‹_ŒoÇ‚Ìf’fŠî€ì¬‚ɂ‚¢‚Ä. Žá‘q‰ë“oiŠáj: Œú¶È“Á’莾Š³–Ô–Œ–¬—–ŒŽ‹_ŒoˆÞkÇ’²¸Œ¤‹†”Ç1998”N“x”ljï‹c i99.01.27j, “Œ‹ž.

2984. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj LASIKƒ‰ƒCƒuƒT[ƒWƒFƒŠ[. ´…Œö–çiŠáj: ‘æ‚R‰ñISRS JAPAN Meeting i98.04.02j, •Ÿ‰ª.

2985. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Ž‹_ŒoŠá‰È“ü–å. Žá‘q‰ë“oiŠáj: ‡“V“°‘åŠwŠá‰ÈƒZƒ~ƒi[ i98.07.03j, “Œ‹ž.

2986. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‹ßŽ‹‹¸³Žèp‚ɂ‚¢‚Ä. ´…Œö–çiŠáj: ‘æ‚S‰ñSSCRSiSetouchi Society of Cornea and Refractive Surgery) i98.08.29`30j, L“‡.

2987. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‹ßŽ‹‹¸³Žèp. ´…Œö–çiŠáj: CANONŽÐ“àu‰‰‰ï i98.09.10j, “Œ‹ž.

2988. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j —Γàá‚ÌŽ¡—ÂÆV‚µ‚¢ŒŸ¸|ŠJ•ú‹÷Šp—Γàá, ‚Æ‚­‚ÉNTG|. ¯ŽiMsC´…Œö–çiŠáj: ¼‘½–€’n‹æˆãŽt‰ïu‰‰‰ï i98.09.18j, “Œ‹ž.

2989. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j _ŒoŠá‰ÈŒŸ¸–@|_ŒoŽ¾Š³‚Ì•â•f’f‚Æ‚µ‚Ä|. Îì“NiŠáj: ‘æ‚S‰ñ_“Þì—Õ°_Œo¶—ƒZƒ~ƒi[ i98.10.30j, ‰¡•l.

2990. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‹üÜ‹¸³Žèp‚Í•K—v‚©H ´…Œö–çiŠáj: ‘æ104‰ñ˜a‰ÌŽRŠá‰ÈW’k‰ï i99.02.18j, ˜a‰ÌŽR.

2991. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ”’“àáŽèp‚©‚ç‹üÜ‹¸³Žèp‚Ü‚Å. ´…Œö–çiŠáj: ‘æ31‰ñ“Œ‹ž‘½–€’n‹æŠá‰ÈW’k‰ï i99.03.13j, “Œ‹ž.

2992. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j _ŒoŠá‰È‚Ì펯‚Æ”ñ펯. Žá‘q‰ë“oiŠáj: “¡“c•ÛŒ’‰q¶‘åŠw_ŒoƒAƒJƒfƒ~[ i99.03.18j, ˆ¤’m.

2993. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ’m‚Á‚Ä“¾‚·‚é_ŒoŠá‰È‚ÌŽÀ‘H“I’mŽ¯. Žá‘q‰ë“oiŠáj: ‘æ41‰ñé‹ÊŠá‰ÈuK‰ï i99.03.19j, ì‰z.

2994. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ”’“àáŽèp‚Ì—ðŽj. ´…Œö–çiŠáj: ‘å–ìVŽ¡æ¶‘Þ”C‹L”Ou‰‰‰ï i99.03.20j, ²‰ê.

2995. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‹üÜ‹¸³Žèp‚ÌŒ»‹µ‚Æ«—ˆ. ´…Œö–çiŠáj: üŠá‰Èˆã‰ïŠwpu‰‰‰ï i99.03.27j, _“Þì.

2996. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‰Á—î‚ÆŽ‹Šo‹@”\|“Á‚É”’“àá. Œ´’¼liŠáj: ‘æ‚V‰ñ“Œ‘å˜aŽsˆãŽt‰ï—Õ°ŒŸ“¢‰ï i98.06.05j, “Œ‘å˜aŽs.

2997. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ƒ~ƒX‚Í”ð‚¯‚«‚ê‚é‚©; ƒ~ƒX‚̶‚¸‚郃JƒjƒYƒ€‚Æ‚»‚Ì–hŽ~ô. “ï”g—´liŠáj: ‘æ30‰ñ–k—¢‘åŠw|_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i98.10.08j, ‘Š–ÍŒ´.

2998. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j —Γàá‚Ì–ò•¨Ž¡—Ã. ¯ŽiMsiŠáj: ‘æ81‰ñ_“Þ쌧Šá‰ÈW’k‰ï i99.02.20j, ‰¡•l.

2999. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ”’“àáŽèp‚Ì—ðŽj. ´…Œö–çiŠáj: ‘æ‚T‰ñ_“Þ쌧Šá‰ÈŽèp§˜b‰ï i99.03.07j, ‰¡•l.

3000. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Šp–ŒØŠJ”’“àáŽèp. “c’†rˆêiŠáj: ‘æ‚T‰ñ_“Þ쌧Šá‰ÈŽèp§˜b‰ï i99.03.07j, ‰¡•l.

3001. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‹ßŽ‹‹¸³‚É‚¨‚¯‚épŽ®‚ÌŒˆ’è‚Æ‘I‘ð. ´…Œö–çiŠáj: ‘æ31‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i99.03.25j, ’¬“c.

3002. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “à•ª”å«ŠáÇ‚É‚æ‚鎋—͒ቺ‚ð‚«‚½‚µ‚½‚P—á. ’O‰H‘×—mC’–“c‚³‚ð‚èC²“¡”üØŽqCÎì‹ÏCŽá‘q‰ë“oCŒü–ì˜a—YiŠáj: ‘æ79‰ñ_“Þ쌧Šá‰ÈW’k‰ï i98.09.03j, ‰¡•l.

3003. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒEƒTƒM“µEŠ‡–ñ‹Ø‚ɑ΂·‚éƒ{ƒcƒŠƒkƒX‚`Œ^“Å‘f‚Ìì—p. ŽOˆä‹`‹vCÎì‹ÏC‹g•xŒ’ŽuiŠájC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjCŒü–ì˜a—YCVˆä“cF—TiŠáj: ‘æ14‰ñ^’߃Zƒ~ƒi[in“’‘ò i98.09.06j, “’‘ò.

3004. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “®—hŽ‹‚ð‘i‚¦‚½æ“VŠáU‚Ì‚P—á. •y‰ª•q–çiŠájC匴ŽµdiX‰º‹L”O•a‰@jCVˆä“c–MŽqCÎì“NCÎì‹ÏC¼ˆäFŽqiŠáj: ‘æ30‰ñ–k—¢‘åŠw|_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i98.10.08j, ‘Š–ÍŒ´.

3005. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j P-ANCA㸂ð’悵‚½Ž©ŒÈ–Ɖu«Ž‹_Œo‰Š‚Ì‚P—á. •“¡–F“¿C’†Œ´‰xŽqC—äˆä—˜¹ŽqCt–ìŒ÷CŽá‘q‰ë“oiŠáj: ‘æ30‰ñ–k—¢‘åŠw|_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i98.10.08j, ‘Š–ÍŒ´.

3006. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Šáâ|–I‘ƒ‰Š‚ªCAO‚𗈂µ‚½‚PÇ—á. ’†¼ŠîC’†Œ´‰xŽqCt–ìŒ÷iŠáj: ‘æ30‰ñ–k—¢‘åŠw|_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i98.10.08j, ‘Š–ÍŒ´.

3007. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j laser peripheral iridotomy‚ÌŽ{s•û–@‚ɂ‚¢‚Ä; Fuchs' endothelial dystrophy‚ÌÇ—á‚ðŽQl‚É. â–{‘¥•qiŠáj: ‘æ30‰ñ–k—¢‘åŠw|_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i98.10.08j, ‘Š–ÍŒ´.

3008. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”ñ’èŒ^“IŒ´“c•a‚ª‹^‚í‚ꂽ‚PÇ—á. ŒË‘qƒC’–“c‚³‚ð‚èC²“¡”üØŽqCÎì‹ÏC‹{“cŠ²•viŠáj: ‘æ30‰ñ–k—¢‘åŠw|_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i98.10.08j, ‘Š–ÍŒ´.

3009. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Šp–ŒØŠJ‚©‚çŽn‚ß‚½‰SŽÒ‚Ì”’“àáŽèp. ŒÃ‰ê‹M‹vC‰|–{Šì‹vŽqC‘“c‚ ‚±C¬¼^—i•‘ –ì“úÔjC´…Œö–çiŠáj: ‘æ30‰ñ“Œ‹ž‘½–€’n‹æŠá‰ÈW’k‰ï i98.10.17j, “Œ‹ž.

3010. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒlƒRLSiŠO‘¤ƒVƒ‹ƒrƒEƒXj–ì‚©‚çã‹u‚¨‚æ‚Ñü𓊎˃jƒ…[ƒƒ“Ž‹ŠoŽó—e‚Ì“Á«. Vˆä“cF—TiŠáj: ‘æ‚S‰ñ_“Þì—Õ°_Œo¶—ƒZƒ~ƒi[ i98.10.30j, ‰¡•l.

3011. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œõ‹ÃŒÅ‚É‚æ‚é–Ô–ŒÃ–¬•ªŽ}•ÂÇÇ‚ÌŽ¡—Ã. ’†¼ŠîC²“¡”üØŽqCŽs•Ó‹`ÍC”’ìTŽ¢iŠáj: ‘æ81‰ñ_“Þ쌧Šá‰ÈW’k‰ï i99.02.20j, ‰¡•l.

3012. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹ßŽ‹‹¸³ŽèpŒã‚ɶ‚¶‚½Šp–Œ¬‘÷‚ɑ΂µ‚Äs‚í‚ꂽDeep Lamellar KeratoplastryiDLK). —щl—C•ŸŒ´‰ë”VC¯ŽiMsC´…Œö–çC‰F‰ê–ÎŽOC™“c‘¾˜YiŠáj: ‘æ81‰ñ_“Þ쌧Šá‰ÈW’k‰ï i99.02.20j, ‰¡•l.

3013. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j V‚µ‚¢—Ž‹‹¸³”’“àᓯŽžŽèp. “c’†rˆêC´…Œö–çiŠáj: ‘æ81‰ñ_“Þ쌧Šá‰ÈW’k‰ï i99.02.20j, ‰¡•l.

3014. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒGƒAƒoƒbƒO‚É‚æ‚éŠáŠO. Œ´’¼liŠáj: ‘æ81‰ñ_“Þ쌧Šá‰ÈW’k‰ï i99.02.20j, ‰¡•l.

3015. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹U—Ž‹ûÇŒóŒQ‚Ì”’“àáŽèp. ŒÃ‰ê‹M‹vC¬¼^—C¬Œ´^Ž÷•vC´…Œö–çiŠáj: ‘æ31‰ñ“Œ‹ž‘½–€’n‹æŠá‰ÈW’k‰ï i99.03.13j, “Œ‹ž.

3016. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Lipid degeneration‚Ì¡“ú“IŽ¡—Õûj. â–{‘¥•qC‹e’r—T”üCŒü–ì˜a—YC‰F‰ê–ÎŽOC´…Œö–çiŠáj: ‘æ31‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i99.03.25j, ’¬“c.

3017. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒŒ[ƒU[‘–¸Œ^‰ðÍ‘•’u‚É‚æ‚鎋_Œo“û“ªŒ`ó‚Ì‘ª’è. ¯ŽiMsC“¡“c“NC‹e’r—T”üC’†ì—¢ŠGiŠáj: ‘æ31‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i99.03.25j, ’¬“c.

3018. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘åŠw•a‰@‚É‚¨‚¯‚é“ú‹A‚èŠO—ˆ”’“àáŽèp. •ŸŒ´‰ë”VC“c’†rˆêC¯ŽiŽ¡‘ãCŽOˆä‹`‹vC—äˆä—˜¹ŽqC´…Œö–çiŠáj: ‘æ31‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i99.03.25j, ’¬“c.

3019. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éÉŽq‘ÌŽèp¬Ñ‚ÌŒŸ“¢. ¼–{”ü•ÛC’–“c‚³‚ð‚èCX“c“N–çCŽá—Ñ~ŽqC²“¡”üØŽqC”’ìTŽ¢C´…Œö–çiŠáj: ‘æ31‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i99.03.25j, ’¬“c.

3020. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@E“Œ•a‰@Šá‰È‚É‚¨‚¯‚éƒ{ƒcƒŠƒkƒXŽ¡—Â̌»ó. Îì‹ÏCŽOˆä‹`‹vC–ؔÉCVˆä“cF—TCŒü–ì˜a—YiŠáj: ‘æ31‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i99.03.25j, ’¬“c.


<<26 Ž¨•@ˆôA‰ÈŠw>>

3021. mŒ´’˜n What kind of patients are suitable for evaluating the therapeutic effect of sudden deafness? ²–씣C‰ª–{–qlCÝŠy“N–çC•½ŽR•ûriŽ¨•@j: Am. J. Otol., 19(5): 579`583, 1998.

3022. mŒ´’˜n “Ë”­«“ï’®‚Ì’®—͉ü‘P‚Ì•]‰¿|Ž¿“I”»’è–@‚ɂ‚¢‚Ä|. ²–씣C‰ª–{–qlC•½ŽR•ûrCV“cŒõ–MC¬–ì—YˆêiŽ¨•@j: Audiology Japan, 41: 124`129, 1998.

3023. mŒ´’˜n ƒqƒg‹…Œ`”X”ÁŒ`‘Ô‚Ì‚RŽŸŒ³Œv‘ªi‘æ‚P•ñj. ’·À‰p–¾iŽ¨•@jCKohut, R.I.CRyu, J.H.iWake Forest Univ.jC‰ª–{–qlC“¿‘Œú“ñC“¡–ì–¾lC¯–ìŒ÷iŽ¨•@j: Equilibrium Res., 57(4): 421`427, 1998.

3024. mŒ´’˜n Physiologic assessment of botulinum toxin effects in the rat larynx. ˆî–ØŸ‰piŽ¨•@jCConnor, N.P.CFord, C.N.CSchultz, E.CRodriquez, A.A.CBless, D.M.CPasic, T.CHeisey, D.M.: Laryngoscope, 108: 1048`1054, 1998.

3025. mŒ´’˜n Increased acute and mitotic activity in rat laryngeal muscles after botulinum toxin injection. ˆî–ØŸ‰piŽ¨•@jCConnor, N.P.CSchultz, E.CFord, C.N.CCook, C.H.CBless, D.M.CHeisey, D.M.: Laryngoscope, 108: 1055`1061, 1998.

3026. mŒ´’˜n An anatomic study of the rat larynx: Establishing the rat model for neuromuscular function. ˆî–ØŸ‰piŽ¨•@jCSchultz, E.CFord, C.N.CBless, D.M.: Otolaryngol. Head Neck Surg., 118(1): 74`81, 1998.

3027. mŒ´’˜n Relationship of clinical observations and objective measures in the assessment of medialization thyroplasty. ˆî–ØŸ‰piŽ¨•@jCFord, C.N.CBless, D.M.CConnor, N.P.CKhidr, A.A.CHeisey, D.M.: Phonoscope, 1: 85`96, 1998.

3028. mŒ´’˜n ƒXƒM‰Ô•²Ç‚ɑ΂·‚éChemosurgery‚Ì“K‰ž‚Æ‚»‚ÌŽ¡—ìÑ. ”ª”ö˜a—YiŽ¨•@j: ƒAƒŒƒ‹ƒM[‰È, 5: 185`194, 1998.

3029. mŒ´’˜n ãŠ{“´ŠàŽ¡—Ã|–k—¢•ûŽ®|. ”ª”ö˜a—YC‚‹´LbC‰ª–{–qliŽ¨•@j: “ªŒz•”Žîá‡, 24: 311`315, 1999.

3030. mŒ´’˜n •@o‚Ìhaemangiopericytome-like tumor‚Ì—Õ°‘œ, •a—‘gD‘œ‚Ì“Á’¥. ˆäŒû–F–¾C¬ìŽ“ñCŽR–{ˆê”ŽCˆÉ“¡º•FiŽ¨•@jCŠâŸºŒ[ˆêi•a—jC‰ª–{–qlC‰z–ìŽ÷“TC–]ŒŽKŽqiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 101(9): 1082`1087, 1998.

3031. mŒ´’˜n ƒXƒM‰Ô•²Ç‚Ì•@o—â…ŽhŒƒ‚ɑ΂·‚锽‰ž«. ˆäŒû–F–¾C”ª”ö˜a—YC‰ª–{–qliŽ¨•@jC”n“ˆ³—²i–ò—j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 101: 814`820, 1998.

3032. mŒ´’˜n ‚낤, ‚낤Œ^“Ë”­«“ï’®‚Ì’®—͉ñ•œ. ²–씣C‰ª–{–qlC•½ŽR•ûrC¬–ì—YˆêCV“cŒõ–MiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 101: 836`840, 1998.

3033. mŒ´’˜n Ž‹‰^“®«ŠáU(OKN), Ž‹‰^“®«ŒãŠáU(OKAN)‚É‚¨‚¯‚é‘̈ʂ̉e‹¿. VˆäŠî—miŽ¨•@jCCohen Bernard: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 102(2): 199`207, 1999.

3034. mŒ´’˜n ‰ºb‰î”S–Œ‰»ŠwÜŽèp. ”ª”ö˜a—YC—é–Ø—§rCˆäŒû–F–¾C¼ŽRkˆê˜YCŽR–{ˆê”ŽC‰ª–{–qliŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ïŽ, 38(4): 1`5, 1999.

3035. mŒ´’˜n Ž¨•@ˆôA‰È—̈敪—£‹Û‚Ì–òÜ‘Ï«‚ÌŒŸ“¢. —é–Ø—§rC‰ª–{–qlC”ª”ö˜a—YCŽRèŒö‹`iŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠ´õÇŒ¤‹†‰ï‰ïŽ, 16(1): 124`129, 1998.

3036. mŒ´’˜n “–‰È‚É‚¨‚¯‚é”x‰Š‹…‹ÛŒŸo—á‚Ì—Õ°“IŒŸ“¢. ŽRèŒö‹`C—é–Ø—§rC”ª”ö˜a—YC‰ª–{–qliŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠ´õÇŒ¤‹†‰ï‰ïŽ, 16(1): 35`39, 1998.

3037. mŒ¤‹†•ñi•¶•”Èjn dS“®—hŒv‚É‚æ‚é•às¥‘«“¥ŒP—û‚Ì•]‰¿‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†. “¿‘Œú“ñC“¡–ì–¾lC’·À‰p–¾C¯–ìŒ÷C‹´–{Wˆê˜YiŽ¨•@jC•Ä“c•qi¶•¨•¨—ŒnjCˆÉ•Û´ŽqCó–ì˜a]C‘ºŽR^‹|C‹“‡mi—ÕŒŸj: •½¬5, 6, 7”N“x‰ÈŠwŒ¤‹†”ï•â•‹àˆê”ÊŒ¤‹†‚bŒ¤‹†¬‰Ê•ñ‘, p.1`32, 1998.

3038. mŒ¤‹†•ñiŒú¶Èjn ƒGƒCƒY‚É‚¨‚¯‚鎨•@ˆôA‰È—̈懕¹Ç‚Å‚ ‚é•›•@o‰Š‚ÌŽ¡—Ö@‚ÌŒŸ“¢. ¼ŽRkˆê˜YiŽ¨•@j: Œú¶ÈƒGƒCƒYˆã—ˤ“¯Œ¤‹†Œ¤‹†•ñW, p.58`59, 1998.

3039. mŒ¤‹†•ñiŒú¶Èjn ‚—îŽÒ‚Ì’®ŠoáŠQ‚Ìis‚¨‚æ‚Ñ‚»‚ÌŒŸ¸–@‚ÉŠÖ‚·‚錤‹†. ‰ª–{–qlC¬–ì—YˆêiŽ¨•@jCŒ´—R‹Iiˆã—Éq¶j: ’·Žõ‰ÈŠw‘‡Œ¤‹†•½¬‚X”N“xŒ¤‹†•ñ˜V”N•aŠe˜_‡T, 3: 348`354, 1998.

3040. mÇ—á•ñn •@•›•@oˆ««•FŽî‚ð‡•¹‚µ‚½ƒEƒFƒ‹ƒi[ÇŒóŒQ‚Ì1—á. ŽR–{ˆê”ŽC¬ìŽ“ñCˆäŒû–F–¾C‰z–ìŽ÷“TCˆÉ“¡º•FiŽ¨•@j: Ž¨•@ˆôA‰È, “ªŒz•”ŠO‰È, 70(12): 790`791, 1998.

3041. mÇ—á•ñn “àŽ¨“¹“àˆ««ƒŠƒ“ƒpŽî‚Ì1—á. ‹´–{Wˆê˜YC“¡–ì–¾lC’†‘º—viŽ¨•@jC’†ìçqC–k‘º‰À‹vi‰¡•l‰h‹¤Ï•a‰@j: Ž¨•@ˆôA‰È, “ªŒz•”ŠO‰È, 70(6): 339`343, 1998.

3042. mÇ—á•ñn Šá‚Ì“®‚«‚ɂ‚¢‚Ä. “¿‘Œú“ñiŽ¨•@j: Ž¨•@ˆôA‰È, “ªŒz•”ŠO‰È, 70(6): 360`362, 1998.

3043. mÇ—á•ñn ŋߌoŒ±‚µ‚½ƒwƒ‹ƒyƒXˆô“ª‰ŠÇ—á. –]ŒŽ‚sCΈä–L‘¾C—é–Ø“OiŽ¨•@j: Ž¨•@ˆôA‰È, “ªŒz•”ŠO‰È, 70(7): 386`387, 1998.

3044. mÇ—á•ñn ƒT[ƒtƒ@[‚É‚Ý‚ç‚ꂽŠOŽ¨“¹Š®‘Sœ«•Â½‚Ì1—á. ŽR–{ˆê”ŽC¬ìŽ“ñCˆäŒû–F–¾CˆÉ“¡º•FC‰z–ìŽ÷“TC‰Á“¡KŽqiŽ¨•@j: Ž¨•@ˆôA‰È, “ªŒz•”ŠO‰È, 71(2): 109`112, 1999.

3045. mÇ—á•ñn ŒÄ‹z¢“ï‚ð’悵‚½ˆôŒã”^ᇂÌ1—á. ‰z–ìŽ÷“TC¬ìŽ“ñCˆäŒû–F–¾CŽR–{ˆê”ŽiŽ¨•@j: Ž¨•@ˆôA‰È, “ªŒz•”ŠO‰È, 71(2): 131`133, 1999.

3046. mÇ—á•ñn Ž¨•@ˆôA‰È—̈æ‚ÌŽ¾Š³. ¼ŽRkˆê˜YC”ª”ö˜a—YiŽ¨•@j: •ÊûŽ¡—Öò, ”ñƒXƒeƒƒCƒh«R‰ŠÇ–ò‚Ì‘I‘ð‚Æ“K«Žg—p, p.98`101.

3047. m‘àn “«ˆô“ª’×ᇂ̃XƒeƒƒCƒhŽ¡—Ã. ‚‹´LbiŽ¨•@j: JOHNS, 14(10): 1449`1452, 1998.

3048. m‘àn •½táŠQ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. “¿‘Œú“ñiŽ¨•@j: JOHNS, 14(6): 869`873, 1998.

3049. m‘àn •@ƒAƒŒƒ‹ƒM[‚ÌŽ¡—Ã|ƒgƒŠƒNƒ[ƒ‹|Ž_‚ð—p‚¢‚½‰ºb‰î‰»ŠwÜŽèp|. ”ª”ö˜a—YC‰ª–{–qliŽ¨•@j: Medicament News, 1602(2): 2`4, 1998.

3050. m‘àn º‘ÑŠàT3Ç—á‚Ì•Û‘¶“IŽ¡—Ç@–k—¢‘åŠw•a‰@‚Ìê‡. ’†ŽR–¾mC‚‹´LbiŽ¨•@j: Ž¨•@ˆôA‰È, “ªŒz•”ŠO‰È, 70(12): 793`797, 1998.

3051. m‘àn Œûo¥ˆô“ªŽ¾Š³‚ÌfŽ@‚̃Rƒc. ‚‹´LbiŽ¨•@j: Ž¨•@ˆôA‰È, “ªŒz•”ŠO‰È, 70(4): 283`288, 1998.

3052. m‘àn ‚—îŽÒ‚Ì’®ŠoáŠQ‡@˜Vl«“ï’®. ‰ª–{–qliŽ¨•@j: Ž¨•@ˆôA‰È, “ªŒz•”ŠO‰È, 70(5): 7`11, 1998.

3053. m‘àn ƒVƒF[ƒo[ƒVƒXƒeƒ€‚É‚æ‚èŠO—ˆ‚Ås‚Á‚½•@‘ùØœp. ”óŒû²GCVˆäŠî—mCÄ“¡‘åiŽ¨•@j: Ž¨•@ˆôA‰È, “ªŒz•”ŠO‰È, 71(1): 69`72, 1999.

3054. m‘àn º‘Ñ–ü’…Ç. •½ŽR•ûriŽ¨•@j: “ú–{ˆãŽ–V•ñ, (3876): 37`37, 1998.

3055. m‘àn ƒAƒŒƒ‹ƒM[«•@‰Š‚ÌŽ¡—Ã|‰ºb‰î‰»ŠwÜŽèp|. ”ª”ö˜a—YiŽ¨•@j: •ÛŒ¯ˆã‚Ì—Õ°, 380: 21`23, 1999.

3056. muÀn }‰ð‹~‹}¥‰ž‹}ˆ’uƒKƒCƒh; ‹~‹}‰ž‹}Žž‚É•K‚¸–𗧂Šî–{Žè‹Z‚ƈ’u‚Ì‚·‚ׂÄ, ‡T. “úíf—ÂɕK—v‚ȉž‹}ˆ’u|æ‚蕨Œ‚¢. “¿‘Œú“ñiŽ¨•@j: Medical Practice, 15(—Õ‘): 22`24, 1998.

3057. muÀn ‹C‚ɂȂ釖°Žž–³ŒÄ‹zÇŒóŒQ. ‰ª–{–qliŽ¨•@j: ŒŽŠ§—Õ°‚ÆŒ¤‹†, 75(10): 129`134, 1998.

3058. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj1999; •@oŒŒ, p.869`870, ”ª”ö˜a—YiŽ¨•@j. •ÒW ‘½‰ê{K’ji‘½‰êÁ‰»Ší‰È“à‰ÈƒNƒŠƒjƒbƒNjC”öŒ`‰x˜YiŠàŒ¤jC•ÒC ˆãŠw‘‰@, “Œ‹žC99.01.15”­s.

3059. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj|Ž„‚Í‚±‚¤Ž¡—µ‚Ä‚¢‚é; ‰ºˆô“ªŠà, p.875`876, ‰ª–{–qliŽ¨•@j. •ÒW ‘½‰ê{K’ji‘½‰êÁ‰»Ší‰È“à‰ÈƒNƒŠƒjƒbƒNjC”öŒ`‰x˜YiŠàŒ¤jC•ÒC ˆãŠw‘‰@, “Œ‹žC99.01.15”­s.

3060. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Horizontal positional nystagmus towards the upper ear of peripheral vestibular origin. “¿‘Œú“ñC’·À‰p–¾C¯–ìŒ÷C“¡–ì–¾liŽ¨•@j: 20th Regular Meeting of the Barany Society i98.09.12`15j, Wuerzburg, Germany, Inernat. Tinnitus J., 4(Suppl.1): 75, 1998.

3061. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Chemosurgery with trichloroacetic acid for allergic rhinitis. ”ª”ö˜a—YC—é–Ø—§rCŽR–{ˆê”ŽC’|“à‹`•vCL“‡‰®FCŽRèŒö‹`C‰ª–{–qliŽ¨•@j: ‘æ1‰ñƒAƒŒƒ‹ƒM[“àŽ‹‹¾Šw‰ï i98.06.25j, ƒMƒŠƒVƒƒ.

3062. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Chemosurgery with trichloroacetic acid for allergic rhinitis - Evaluation of trichloroacetic acid treatment effects according to classified most cells with double immunohistochemical method -. ”ª”ö˜a—YC—é–Ø—§rC¼ŽRkˆê˜YCˆäŒû–F–¾CŽRèŒö‹`CL“‡‰®FC‰ª–{–qliŽ¨•@j: ‘æ1‰ñƒAƒŒƒ‹ƒM[“àŽ‹‹¾Šw‰ï i98.06.26j, ƒMƒŠƒVƒƒ.

3063. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Neurological change after repeated botulinum toxin injections in the rat larynx. ˆî–ØŸ‰piŽ¨•@jCConnor, N.P.CSchultz, E.CFond, C.N.CCook, C.H.CBless, D.M.C²“¡Œ«‘¾˜YiŽ¨•@j: 102nd Meeting of the American Academy of Otolaryngology, Head and Neck Surgery i98.08.09j.

3064. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Case report of nystagmus alternans. ‘ºŽR^‹|i—ÕŒŸjC“¿‘Œú“ñiŽ¨•@jCˆÉ•Û´ŽqCó–ì˜a]C‹“‡mi—ÕŒŸjC’·À‰p–¾C¯–ìŒ÷Cèc“cW‹vC‹´–{Wˆê˜YiŽ¨•@j: 20th Regular Meeting of the Barany Society i98.09.11`12j, Wuerzburg, Germany.

3065. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Comparison between nystagmus alternans and congenital nystagmus of jerky type. ‹´–{Wˆê˜YC“¿‘Œú“ñC’·À‰p–¾C¯–ìŒ÷iŽ¨•@jC‘ºŽR^‹|i—ÕŒŸj: 20th Regular Meeting of the Barany Society i98.09.11`12j, Wuerzburg, Germany.

3066. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Effect of sound pressure level in human excised laryngeal studies. ˆî–ØŸ‰piŽ¨•@jCConnor, N.P.CBless, D.M.CFord, C.N.CHetsey, D.M.: Annual Meeting of the American Speech-Language-Hearing Assocciation i98.11.00j.

3067. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Detection of Epstein-barr virus in cerrical lymph node metastasis with head and neck tumor. ‰iˆä_–¤C‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_C‰ª–{–qliŽ¨•@jC²“¡—Yˆêiˆã—Éq¶j: 1st World Congress on Head and Neck Oncology i98.11.29j, Spain, Madrid.

3068. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j 3D analysis of supracricoid hemilaryngo-pharyngectomized hypopharyngeal cancer. ’†ŽR–¾mC‰ª–{–qlC‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC”n‰z’q_C‰iˆä_–¤C¼ŽR‹MŽqiŽ¨•@j: 1st World Congress on Head and Neck Oncology i98.11.29j, Spain, Madrid.

3069. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Cerrical lymph node metastasis from unknown primary sites. ŽRèŒö‹`C‚‹´LbC‰ª–{–qlC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_C‰iˆä_–¤C¼ŽR‹MŽqiŽ¨•@j: 1st World Congress on Head and Neck Oncology i98.11.29j, Spain, Madrid.

3070. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Clinical review of metastatic tumors of the head and neck region. ¼ŽR‹MŽqC‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_C‰iˆä_–¤C‰ª–{–qliŽ¨•@j: 1st World Congress on Head and Neck Oncology i98.11.29j, Spain, Madrid.

3071. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The Clinical impact of using chemo-radio-therapy as a primary treatment for hypopharyngeal cancer. ‰ª–{–qlC‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC’†ŽR–¾mC”n‰z’q_C‰iˆä_–¤iŽ¨•@j: 1st World Congress on Head and Neck Oncology i98.11.29j, Spain, Madrid.

3072. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Existence of EBV and expression of E-cadherin in nasal T cell lymphomas. ”n‰z’q_C‚‹´LbC‰ª–{–qlC”ª”ö˜a—YCˆî–ØŸ‰pC’†ŽR–¾mC‰iˆä_–¤iŽ¨•@jC²“¡—YˆêC“y‰®giˆã—Éq¶j: 1st World Congress on Head and Neck Oncology i98.11.29j, Spain, Madrid.

3073. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of both strong and weak vestibular stimulations on body balance. ¯–ìŒ÷C“¿‘Œú“ñC“¡–ì–¾lC’·À‰p–¾CŽRèŒö‹`C‹´–{Wˆê˜YiŽ¨•@j: 20th Regular Meeting of the Barany Society i98.09.12`15j, Wuerzburg, Germany, Internat. Tinnitus J., 4(Suppl.1): 23, 1998.

3074. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Three-dimensional analysis of the morphological aspect of saccular maculae. ’·À‰p–¾iŽ¨•@jCKohut, Robert I.CRyu, Jai H.iWake Forest Univ.jC“¿‘Œú“ñC‰ª–{–qlC“¡–ì–¾lC¯–ìŒ÷C‹´–{Wˆê˜YiŽ¨•@j: 20th Regular Meeting of the Barany Society i98.09.12`15j, Wuerzburg, Germany, Internat. Tinnitus J., 4(Suppl.1): 51, 1998.

3075. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒAƒŒƒ‹ƒM[«•@‰Š‚ÌÅVŽ¡—Ã|‰ºb‰î”S–Œ‰»Šw‹ÃŒÅp. ”ª”ö˜a—YC—é–Ø—§rCˆäŒû–F–¾C¼ŽRkˆê˜YCŽR–{ˆê”ŽC‰ª–{–qliŽ¨•@j: ‘æ10‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï i98.04.23j, –¼ŒÃ‰®.

3076. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒrƒfƒIƒVƒ“ƒ|ƒWƒEƒ€; ãŠ{Šà‚ÌŽ¡—Ã|ãŠ{Šà‚ÌŽ¡—Ã: –k—¢•ûŽ®. ”ª”ö˜a—YiŽ¨•@j: ‘æ19‰ñ“ªŒz•”ŽèpŽè‹ZŒ¤‹†‰ï i98.06.10j, –¼ŒÃ‰®, “ú–{“ªŒz•”Žîá‡, p.130, 1998.

3077. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ãŠ{Šà‚ÌŽ¡—Ã|ŽOŽÒ•¹—p—Ö@‚©‚çŠg‘åØœ, “ªŠW’êŠO‰È, Š{Šç–ÊÄŒš¥•â’Ô‚Ü‚Å|–k—¢•ûŽ®. ”ª”ö˜a—YC‚‹´LbiŽ¨•@j: ‘æ22‰ñ“ú–{“ªŒz•”Žîᇊw‰ï, ‘æ19‰ñ“ªŒz•”ŽèpŽè‹ZŒ¤‹†‰ï i98.06.11j, –¼ŒÃ‰®.

3078. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰ºb‰î”S–Œ‰»Šw‹ÃŒÅp. ”ª”ö˜a—YiŽ¨•@j: ‘æ37‰ñ“ú–{•@‰ÈŠw‰ï, ‘æ27‰ñ•@‰ÈŠw—Õ°–â‘觘b‰ï i98.10.01j.

3079. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ’†ˆô“ªŠà‚ÌŽ¡—Ã|’†ˆô“ªŠà‚ɑ΂·‚é•úŽËü—Ö@‚ÌŒø‰Ê‚ÆŒÀŠE. ˆî–ØŸ‰pC‚‹´LbiŽ¨•@jC¼—Ñ—²i•újC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_C‰iˆä_–¤C‰ª–{–qliŽ¨•@j: ‘æ22‰ñ“ú–{“ªŒz•”Žîᇊw‰ï i98.06.11j, –¼ŒÃ‰®, “ú–{“ªŒz•”Žîá‡, p.148, 1998.

3080. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j T4ãŠ{“´ŠàŽ¡—ÃŒoŒ±‚ÌŒŸ“¢. ”ª”ö˜a—YC‚‹´LbCˆî–ØŸ‰pC’†ŽR–¾mC”n‰z’q_C‰ª–{–qliŽ¨•@j: ‘æ8‰ñ“ú–{“ªŒz•”ŠO‰ÈŠw‰ï i98.01.23j, ‘åã.

3081. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •@oôò‰t‚É‚¨‚¯‚éRƒAƒŒƒ‹ƒM[–ò‚Ì•]‰¿–@|•@oôò‰t’†‚ÆŒŒ´’†‚ÌECP‚ɂ‚¢‚Ä. ¼ŽRkˆê˜YC”ª”ö˜a—YCˆäŒû–F–¾CŽR–{ˆê”ŽC—é–Ø—§riŽ¨•@j: ‘æ10‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï i98.04.24j, –¼ŒÃ‰®.

3082. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ºˆô“ªŠà‚ƃCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg. ‰ª–{–qlC‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_CˆÉ“¡”\¬Cˆî–ØŸ‰pC‰iˆä_–¤iŽ¨•@j: ‘æ22‰ñ“ú–{“ªŒz•”Žîᇊw‰ï i98.06.11j, –¼ŒÃ‰®, “ú–{“ªŒz•”Žîá‡, p.160, 1998.

3083. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ºˆô“ªŠà‚ɑ΂·‚é•”•ªØœ‚Ì“K‰ž‚ÆŒÀŠE. ’†ŽR–¾mC‰ª–{–qlC‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC”n‰z’q_CˆÉ“¡”\¬iŽ¨•@j: ‘æ22‰ñ“ú–{“ªŒz•”Žîᇊw‰ï i98.06.11j, –¼ŒÃ‰®, “ú–{“ªŒz•”Žîá‡, p.206, 1998.

3084. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Waldeyerˆô“ª—Ö‚Ü‚½‚ÍŒz•”ƒŠƒ“ƒpߌ´”­‚̈««ƒŠƒ“ƒpŽî‚ɑ΂·‚épirarubicin‚Ì—L—p«‚ÌŒŸ“¢. ”n‰z’q_C‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC’†ŽR–¾mC‰iˆä_–¤CˆÉ“¡”\¬C‰ª–{–qliŽ¨•@j: ‘æ60‰ñŽ¨•@ˆôA‰È—Õ°Šw‰ï i98.06.26j, ‰ªŽR.

3085. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¨‰º‘Bepithelial-myoepithelial carcinoma‚Ì1—á. ˆÉ“¡”\¬C‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC‰iˆä_–¤C—é–Ø—§riŽ¨•@j: ‘æ60‰ñŽ¨•@ˆôA‰È—Õ°Šw‰ï i98.06.26j, ‰ªŽR.

3086. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ³’†ŒûŠW”XŽî‚Ì1—á. V“cŒõ–MC‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC‰iˆä_–¤CŽRèŒö‹`C‰ª–{–qliŽ¨•@j: Œûo¥ˆô“ª‰ÈŠw‰ï i98.09.18j, ‹ž“s.

3087. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒgãƒGƒuƒlƒ‹‘B‚ÌŽOŽŸŒ³‰ðÍ. L“‡‰®FC‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mCˆÉ“¡”\¬C‰ª–{–qliŽ¨•@j: Œûo¥ˆô“ª‰ÈŠw‰ï i98.09.18j, ‹ž“s.

3088. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒgãˆô“ª‚É‚¨‚¯‚é‘B‘gD‚Ì•ª•z‚ɂ‚¢‚Ä. ‰iˆä_–¤C‚‹´LbC”ª”ö˜a—YCˆî–ØŸŽC’†ŽR–¾mC”n‰z’q_C‰ª–{–qliŽ¨•@j: Œûo¥ˆô“ª‰ÈŠw‰ï i98.09.18j, ‹ž“s.

3089. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ãŠà‚ÆŠÓ•Ê‚ð—v‚·‚éã•a•Ï‚ÌŒŸ“¢: “–‘åŠw‰ß‹Ž10”NŠÔ‚ÌÇ—á‚©‚çŠw‚Ô. ’†ŽR–¾mC‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC”n‰z’q_C‰iˆä_–¤iŽ¨•@j: Œûo¥ˆô“ª‰ÈŠw‰ï i98.09.18j, ‹ž“s.

3090. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ºŒûOŠàØœŒã‚ÌDouble cross lip fleys‚É‚æ‚éˆêÄŒš—á. ¼ŽR‹MŽqC‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_C‰ª–{–qliŽ¨•@j: Œûo¥ˆô“ª‰ÈŠw‰ï i98.09.18j, ‹ž“s.

3091. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒFƒQƒi[“÷‰èŽîÇ‚Ì—Õ°Œo‰ß‚ÆŽ¡—Ã. ‰iˆä_–¤C‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_C‰ª–{–qliŽ¨•@j: ‘æ37‰ñ“ú–{•@‰ÈŠw‰ï, ‘æ27‰ñ•@‰ÈŠw—Õ°–â‘觘b‰ï i98.10.03j, •Ÿˆä, —\eW, 37(3): 231, 1998.

3092. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒAƒŒƒ‹ƒM[«•@‰Š‚Ì•@”S–Œ”½‰ž«‚ɂ‚¢‚Ä. ˆäŒû–F–¾C”ª”ö˜a—YC¼ŽRkˆê˜YCŽR–{ˆê”ŽC—é–Ø—§rC‰ª–{–qliŽ¨•@j: ‘æ37‰ñ“ú–{•@‰ÈŠw‰ï‘‰ï i98.10.03j, •Ÿˆä, —\eW, 37(3): 243, 1998.

3093. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒpƒ[ƒCƒ“ƒXƒgƒ‹ƒƒ“ƒgiƒVƒF[ƒo[j‚ðŽg—p‚µ‚½“àŽ‹‹¾‰º•@“àŽèp. ”óŒû²GCVˆäŠî—mCÄ“¡‘åC‰ª–{–qlC”ª”ö˜a—YiŽ¨•@j: ‘æ37‰ñ“ú–{•@‰ÈŠw‰ï‘‰ï i98.10.03j, •Ÿˆä, —\eW, 37(3): 257, 1998.

3094. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒgƒŠƒNƒ[ƒ‹|Ž_‚É‚æ‚鉺b‰î‰»ŠwÜŽèp|”ì–ž×–E‚ÉŠÖ‚·‚錟“¢|. —é–Ø—§rC”ª”ö˜a—YC¼ŽRkˆê˜YCˆäŒû–F–¾CŽR–{ˆê”ŽC‰ª–{–qliŽ¨•@j: ‘æ37‰ñ“ú–{•@‰ÈŠw‰ï‘‰ï i98.10.03j, •Ÿˆä, —\eW, 37(3): 263, 1998.

3095. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ºb‰î‰»ŠwÜŽèp‚ª‰ºb‰îäC• ‚ÌŒŒŠÇ‚É‹y‚Ú‚·Œ`‘Ô“I•Ï‰». ŽR–{ˆê”ŽC”ª”ö˜a—YC¼ŽRkˆê˜YCˆäŒû–F–¾C—é–Ø—§riŽ¨•@j: ‘æ37‰ñ“ú–{•@‰ÈŠw‰ï‘‰ï i98.10.03j, •Ÿˆä, —\eW, 37(3): 264, 1998.

3096. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒXƒs[ƒ`ƒI[ƒWƒIƒOƒ‰ƒ€‚̃[ƒ‹ƒI[ƒo[‚ÌŒŸ“¢. ó–ì˜a]i—ÕŒŸjC’|“à‹`•viŽ¨•@jCˆÉ•Û´ŽqC‘ºŽR^‹|i—ÕŒŸjC‰ª–{–qliŽ¨•@j: ‘æ43‰ñ“ú–{’®ŠoˆãŠw‰ï i98.10.08j, “Œ‹ž, Audiology Japan, 41(5): 367`368, 1998.

3097. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j œ“±Œê‰¹—¹‰ð“xˆæ’l‚̊Œƒxƒ‹‚ÌŒŸ“¢. ¼•½“oŽu³iˆã—Éq¶jCˆÉ•Û´ŽqCó–ì˜a]i—ÕŒŸjC’|“à‹`•vC‰ª–{–qliŽ¨•@j: ‘æ43‰ñ“ú–{’®ŠoˆãŠw‰ï i98.10.08j, “Œ‹ž, Audiology Japan, 41(5): 369`370, 1998.

3098. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “Ë”­«“ï’®‚ÆŠÓ•Ê‚ð—v‚µ‚½‹@”\«“ï’®‚ÌŒŸ“¢. ‰z–ìŽ÷“TC²–씣CV“cŒõ–MC‰ª–{–qliŽ¨•@j: ‘æ43‰ñ“ú–{’®ŠoˆãŠw‰ï i98.10.08j, “Œ‹ž, Audiology Japan, 41(5): 379`380, 1998.

3099. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “Ë”­«“ï’®, ”N‘ãŠÔ‚ÌŒŸ“¢. ¬–ì—YˆêC‰ª–{–qlC²–씣C•½ŽR•ûriŽ¨•@j: ‘æ43‰ñ“ú–{’®ŠoˆãŠw‰ï i98.10.08j, “Œ‹ž, Audiology Japan, 41(5): 547`548, 1998.

3100. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽÀ—p“IŽÀŽ¨‘}“ü—˜“¾‘ª’è–@‚̑Ó–«‚ÆM—Š«‚ÌŒŸ“¢. ²–씣C’|“à‹`•vC¼•½“oŽu³C‰ª–{–qliŽ¨•@j: ‘æ43‰ñ“ú–{’®ŠoˆãŠw‰ï i98.10.09j, “Œ‹ž, Audiology Japan, 41(5): 673`674, 1998.

3101. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹[Ž—êƒI[ƒWƒIƒ[ƒ^‚ÌŽg—pŒoŒ±. ’|“à‹`•vC²–씣iŽ¨•@jC¼•½“oŽu³iˆã—Éq¶jCŽÄè“ÖŽqCŒ´—R‹IC‰ª–{˜NŽqiŽ¨•@jC—é–ØŒbŽqiŠÅŒì•”jC‰ª–{–qliŽ¨•@j: ‘æ43‰ñ“ú–{’®ŠoˆãŠw‰ï i98.10.09j, “Œ‹ž, Audiology Japan, 41(5): 675`676, 1998.

3102. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÚAp‚ðŽ{s‚µ‚½ˆÙŠ«bó‘BŽî. ¼ŽRkˆê˜YCŽR’†‚C‰¡–xŠwiŽ¨•@j: ‘æ53‰ñ‘—§•a‰@—×{Š‘‡ˆãŠw‰ï i98.10.22j, ‹à‘ò.

3103. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒnƒ“ƒmƒL‰Ô•²Ç‚ƉʎÀƒAƒŒƒ‹ƒM[‚ɂ‚¢‚Ä. Έä–L‘¾C—é–Ø—§rC–]ŒŽKŽqC¼ŽR‹MŽqiŽ¨•@j: ‘æ53‰ñ‘—§•a‰@—×{Š‘‡ˆãŠw‰ï i98.10.22j, ‹à‘ò.

3104. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚é’®—ͳí‚È’®_ŒoŽîᇂ̌Ÿ“¢. èc“cW‹vC‰ª–{–qlC’·À‰p–¾C²–씣C¯–ìŒ÷C“¡–ì–¾lC“¿‘Œú“ñiŽ¨•@j: ‘æ8‰ñ“ú–{Ž¨‰ÈŠw‰ï‘‰ïŠwpu‰‰‰ï i98.10.22`24j, å‘ä, Otl. Jpn., 8(4): 361, 1998.

3105. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j º–å‹·ó‚𗈂µ‚½“«ˆô“ª’×ᇂÌ1—á. ŽRèŒö‹`C”ª”ö˜a—YCˆî–ØŸ‰pC•½ŽR•ûrC”n‰z’q_C‰iˆä_–¤C—é–Ø—§rC‰ª–{–qliŽ¨•@j: ‘æ50‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï i98.11.05j, _ŒË.

3106. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j üð‘Ì•Ž¿•Ï«Ç‚É‚¨‚¯‚éš‹‰ºáŠQ‚ÌŒŸ“¢. ‰Í‡•qC’ÏŽçCŽ¼‚¢‚ÂÝC‰|–{_KC‰Á‰ê“c”ŽŽqC‰A—¢‚䂤‚Ýi‰¡•lŽs‘åjCL£”£iŽ¨•@j: ‘æ50‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï i98.11.05j, _ŒË.

3107. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆôA“ªˆÙ튴‚ðŽå‘i‚Æ‚µ‚½‘Œz“®–¬ŽÖ’JÇ‚Ì1—á. ŽR–{ˆê”ŽC¬ìŽ“ñCˆäŒû–F–¾CˆÉ“¡º•FiŽ¨•@j: ‘æ50‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï i98.11.05j, _ŒË.

3108. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j A“ªŠà‚Æf’f‚Å‚«‚È‚©‚Á‚½3Ç—á‚ɂ‚¢‚Ä. Έä–L‘¾C—é–Ø—§rC–]ŒŽKŽqC¼ŽR‹MŽqiŽ¨•@j: ‘æ50‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï i98.11.05j, _ŒË.

3109. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆê‘¤A“ª–ƒáƒ‚ɑ΂·‚鉹ºŽ¡—Â̌Ÿ“¢. •½ŽR•ûrCŽR’†‚CV“cŒõ–MCL“‡‰®FCŽRèŒö‹`Cèc“cW‹vC‰ª–{–qlCL£”£iŽ¨•@j: ‘æ50‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï i98.11.05j, _ŒË.

3110. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘½”­«A“ªŠW”X–E‚Ì1Ç—á. ŽR’†‚C¼ŽRkˆê˜YC‰¡–xŠwiŽ¨•@j: ‘æ50‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï i98.11.05j, _ŒË.

3111. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«A“ªŠW‰Š‚ÌŒŸ“¢|¬Ž™Ç—á‚ð’†S‚É|. ‰¡–xŠwC•½ŽR•ûrCL“‡‰®FCŽRèŒö‹`C‰ª–{–qlC¼ŽRkˆê˜YCŽR’†‚iŽ¨•@j: ‘æ50‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï i98.11.05j, _ŒË.

3112. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j A“ªŠàÇ—á‚É‚Ý‚ç‚ꂽº‘ÑU“®. ’†‘ºˆê”ŽCŽRŒûG–çC‘å’ËNŽiC‹“‡’BŽŸ˜YC‹e’n–ÎCV”ü¬“ñC‘º–ìŒb”üi“Œ‹žê”„•a‰@jCL£”£iŽ¨•@j: ‘æ50‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï i98.11.05j, _ŒË.

3113. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j E‹Æ‰ÌŽè‚̉¹ºáŠQ‚ÌŽæ‚舵‚¢. ’†‘ºˆê”ŽCŽRŒûG–çC‘å’ËNŽii“Œ‹žê”„•a‰@jCL£”£iŽ¨•@j: ‘æ43‰ñ‰¹ºŒ¾ŒêˆãŠw‰ï i98.11.19j, “Œ‹ž.

3114. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž©“®‰^“®‚ª‘Ì•½t‚É—^‚¦‚é‰e‹¿‚ÌŒŸ“¢i‘æ2•ñj. ¯–ìŒ÷C“¿‘Œú“ñC“¡–ì–¾lC’·À‰p–¾C—Ž‡“ÖiŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: ‘æ57‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ïŠwpu‰‰‰ï i98.11.26`27j, Šò•Œ, —\eW, p.124, 1998.

3115. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž©”­«ãŠááÙŒü‚«ŠáU, ’ZŠú•ûŒüŒð‘ã‚’¼«ŠáU‚ð’悵‚½CNSƒOƒ‹[ƒvƒX—á. “¡–ì–¾lC‹´–{Wˆê˜YC¯–ìŒ÷C’·À‰p–¾C“¿‘Œú“ñiŽ¨•@j: ‘æ57‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ïŠwpu‰‰‰ï i98.11.26`27j, Šò•Œ, —\eW, p.168, 1998.

3116. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚ß‚Ü‚¢ÇŠ³ŽÒ‚ɑ΂·‚é‰^“®—Ö@‚ÌŒø‰Ê. ‹´–{Wˆê˜YC“¿‘Œú“ñC’·À‰p–¾C¯–ìŒ÷iŽ¨•@jC•Ä“c•qi¶•¨•¨—ŒnjC‰ª–{–qliŽ¨•@j: ‘æ57‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ïŠwpu‰‰‰ï i98.11.26`27j, Šò•Œ, —\eW, p.178, 1998.

3117. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¨‰º‘BLymphadenoma‚Ì1—á. ‹´–{Wˆê˜YC‰ª–{–qlC‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_C‰iˆä_–¤iŽ¨•@j: ‘æ9‰ñ“ú–{“ªŒz•”ŠO‰ÈŠw‰ï i99.01.22j, ç—t, —\eW1999, p.105, 1999.

3118. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚鎨‰º‘BŽîᇂÌpŒã‡•¹Ç‚ÌŒŸ“¢. èc“cW‹vC‰ª–{–qlC‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_C‰iˆä_–¤iŽ¨•@j: ‘æ9‰ñ“ú–{“ªŒz•”ŠO‰ÈŠw‰ï i99.01.22j, ç—t, —\eW1999, p.105, 1999.

3119. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽèpŒã‚Ì‘n•”ˆ’u‚ÌŒŸ“¢. ‰iˆä_–¤C‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC’†ŽR–¾mC”n‰z’q_C‰ª–{–qliŽ¨•@j: ‘æ9‰ñ“ú–{“ªŒz•”ŠO‰ÈŠw‰ï i99.01.22j, ç—t, —\eW1999, p.91, 1999.

3120. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j A“ª‚É”­¶‚µ‚½•½ŠŠ‹Ø“÷Žî‚Ì1—á. ‰iˆä_–¤C‚‹´LbC’†ŽR–¾mC•½ŽR•ûrCL“‡‰®FCŽRèŒö‹`C‰ª–{–qliŽ¨•@j: ‘æ11‰ñ“ú–{A“ª‰ÈŠw‰ï i99.03.19j, L“‡.

3121. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Supracricoid hemilaryngopharyngectomy•”•ªØœŒãŽc‘¶A“ª‚Ì‘gDŠw“IŒŸ“¢: Ç—á•ñ. ’†ŽR–¾mC‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC”n‰z’q_C‰iˆä_–¤C‰ª–{–qliŽ¨•@j: ‘æ11‰ñ“ú–{A“ª‰ÈŠw‰ï i99.03.19j, L“‡.

3122. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚é”â—ô“à“]p‚̬Ñ. ŽR“c¹GC‘åÎŒö’¼C‰A—¢‚䂤‚ÝC‹ïŽuŒ«—²C’rŠÔ—zŽqCŽ¼‚¢‚ÂÝC’ÏŽçCL£”£iŽ¨•@j: ‘æ11‰ñ“ú–{A“ª‰ÈŠw‰ï i99.03.19j, L“‡.

3123. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ºˆô“ª_ŒoâŽî‚Ì1—á. •½ŽR•ûrC‚‹´LbC’†ŽR–¾mC‰iˆä_–¤CŽR’†‚CL“‡‰®FCŽRèŒö‹`C‰ª–{–qliŽ¨•@j: ‘æ11‰ñ“ú–{A“ª‰ÈŠw‰ï i99.03.20j, L“‡.

3124. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “ªŒz•”‚É“]ˆÚ‚𗈂µ‚½‘¼‘ŸŠíˆ««Žîᇂ̌Ÿ“¢. ¼ŽR‹MŽqC‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC’†ŽR–¾mC”n‰z’q_CˆÉ“¡”\¬C‰ª–{–qliŽ¨•@j: ‘æ22‰ñ“ú–{“ªŒz•”Žîᇊw‰ï i98.06.11j, –¼ŒÃ‰®, “ú–{“ªŒz•”Žîá‡, p.259, 1998.

3125. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •@oŒ´”­ƒŠƒ“ƒpŽî‚É‚¨‚¯‚é×–EŠÔÚ’…•ªŽq‚Ì”­Œ»‚ÌŒŸ“¢. ”n‰z’q_C‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC’†ŽR–¾mC‰ª–{–qliŽ¨•@j: ‘æ22‰ñ“ú–{“ªŒz•”Žîᇊw‰ï i98.06.11j, –¼ŒÃ‰®, “ú–{“ªŒz•”Žîá‡, p.286, 1998.

3126. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”½‘Α¤‚ÉŠ´‰¹“ï’®‚Ì‚ ‚é“Ë”­«“Ǘá‚ÌŒŸ“¢. ²–씣CV“cŒõ–MC‰z–ìŽ÷“TC¬–ì—YˆêC•½ŽR•ûrC‰ª–{–qliŽ¨•@j: ‘æ8‰ñ“ú–{Ž¨‰ÈŠw‰ï‘‰ï i98.10.22j, å‘ä, Otl. Jpn., 8(4): 313, 1998.

3127. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒg‹…Œ`”X”Á—L–Ñ×–E–§“x‚ÌŒŸ“¢i‘æ3•ñj. ’·À‰p–¾iŽ¨•@jCKohut, Robert I.CRyu, Jai H.iWake Forest University School of MedicinejC“¿‘Œú“ñC‰ª–{–qlC¯–ìŒ÷iŽ¨•@j: ‘æ8‰ñ“ú–{Ž¨‰ÈŠw‰ï‘‰ïŠwpu‰‰‰ï i98.10.22`24j, å‘ä, Otl. Jpn., 8(4): 390, 1998.

3128. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒg—‘Œ`”X”ÁŒ`‘Ô‚Ì3ŽŸŒ³Œv‘ª. ’·À‰p–¾iŽ¨•@jCKohut, Robert I.CRyu, Jai H.iWake Forest Univ.jC‰ª–{–qlC“¿‘Œú“ñC¯–ìŒ÷C‹´–{Wˆê˜YiŽ¨•@j: ‘æ57‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ïŠwpu‰‰‰ï i98.11.26`27j, Šò•Œ, —\eW, p.204, 1998.

3129. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ”¼‹KŠÇD‰–Šî«’¾’…‚Æ“ªˆÊ«‚ß‚Ü‚¢. ’·À‰p–¾C‰ª–{–qlC“¿‘Œú“ñC¯–ìŒ÷C‹´–{Wˆê˜YiŽ¨•@j: ‘æ52‰ñ‘Š•Ž¨•@‰ÈŒ¤‹†‰ï i98.07.18j, ‘Š–ÍŒ´.

3130. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¶‰ºŽž‚É‹CŠÇØŠJ‚ð•K—v‚Æ‚µ‚½ŠïŒ`Žî‚Ì1—á. ‹´–{Wˆê˜YC‚‹´LbC’†ŽR–¾mC•½ŽR•ûrCŽR’†‚CL“‡‰®FCŽRèŒö‹`C–]ŒŽKŽqC¼ŽR‹MŽqC‰¡–xŠwC‰ª–{–qliŽ¨•@j: ‘æ104‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.06.06j, ìè.

3131. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j –Ñã(Hairy Tongue)‚Ì1Ç—á. ŽRèŒö‹`C‚‹´LbC•½ŽR•ûrCL“‡‰®FC‰z–ìŽ÷“TC‰ª–{–qliŽ¨•@j: ‘æ104‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.06.06j, ìè.

3132. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŋߌoŒ±‚µ‚½’±Œ`“´‰ŠÇ—á. ˆÉ“¡º•FC¬ìŽ“ñCˆäŒû–F–¾CŽR–{ˆê”ŽiŽ¨•@j: ‘æ104‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.06.06j, ìè.

3133. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž¨‰º‘B‚É”­¶‚µ‚½DŽ_‘BŽî(oxiphilic adenoma)‚Ì1—á. ‰¡–xŠwC¼ŽRkˆê˜YCŽR’†‚C‚‹´LbiŽ¨•@j: ‘æ104‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.06.06j, ìè.

3134. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Epstein-Barr Virus‚Æãˆô“ªŽ¾Š³. ‰iˆä_–¤C‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_C‰ª–{–qliŽ¨•@j: ‘æ52‰ñ‘Š•Ž¨•@‰ÈŒ¤‹†‰ï i98.07.18j, ‘Š–ÍŒ´.

3135. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œûo’ê‚É”­¶‚µ‚½_ŒoâŽî—á. ‰¡–xŠwC¼ŽRkˆê˜YCŽR’†‚iŽ¨•@j: ‘æ105‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.09.19j, “¡‘ò.

3136. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “àŽ‹‹¾‚ð—p‚¢‚½A“ª–ƒáƒÇ—á‚Ì”j—ô“Eop. ˆäŒû–F–¾C¬ìŽ“ñCŽR–{ˆê”ŽCˆÉ“¡º•FiŽ¨•@j: ‘æ105‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.09.19j, “¡‘ò.

3137. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠOŽ¨“¹Šî’ê×–EŠà‚Ì1—á. ¬–ì—YˆêC“¡–ì–¾lC‹´–{Wˆê˜YC–àŽRˆÀOiŽ¨•@j: ‘æ105‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.09.19j, “¡‘ò.

3138. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠOŽ¨“¹‚ÌAngiolympho hyperplasia with eosinophilia‚Ì1—á. ŽR’†‚C¼ŽRkˆê˜YC‰¡–xŠwiŽ¨•@j: ‘æ105‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.09.19j, “¡‘ò.

3139. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚—îŽÒ‚Ì’®Šoã‚̃nƒ“ƒfƒLƒƒƒbƒvi‘æ2•ñj|•â’®Ší‘•—p‘OŒã‚ÌŒŸ“¢|. èc“cW‹vC‰ª–{–qlC²–씣C•½ŽR•ûrCŽRèŒö‹`iŽ¨•@jC•Ä“c•qi¶•¨•¨—ŒnjC¼•½“oŽu³iˆã—Éq¶j: ‘æ105‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.09.19j, “¡‘ò.

3140. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Š´‰¹“ï’®‚𔺂Á‚½dœ‘–Œ‰Š‚Ì1Ç—á. ‰z–ìŽ÷“TC‰ª–{–qlC²–씣C•½ŽR•ûrCŽRèŒö‹`CV“cŒõ–MiŽ¨•@j: ‘æ105‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.09.19j, “¡‘ò.

3141. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Thyroplasty Type ‡T|—Õ°‚ÆŽÀŒ±ƒ‚ƒfƒ‹|. ˆî–ØŸ‰pC²“¡Œ«‘¾˜YiŽ¨•@jCFord, C.N.CBless, D.M.: “ú–{Ž¨•@ˆôA‰ÈŠw‰ïé‹Ê’n•û•”‰ï i98.10.00j, ‰Y˜a.

3142. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “Ë”­«“ï’®‚Ì—Õ°“IŒŸ“¢. ²“¡Œ«‘¾˜YCˆî–ØŸ‰pC‰iˆä_–¤C–ö‘C‹àŽqŒ÷CŒ´“cGˆêiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ïé‹Ê’n•û•”‰ï i98.10.00j, ‰Y˜a.

3143. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆÙŠ«bó‘B‚É”­Ç‚µ‚½“û“ªŠà‚Ì1Ç—á. ’|“c¹•FC‚‹´LbC”ª”ö˜a—YC’·À‰p–¾Cèc“cW‹vC‹´–{Wˆê˜YC‰ª–{–qliŽ¨•@j: ‘æ106‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.12.05j, ‰¡•l.

3144. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j KTPƒŒ[ƒU[‚ð—p‚¢‚½ƒ|ƒŠ[ƒv—lº‘Ñ‚ÌŽ¡—Âɂ‚¢‚Ä. ŽR–{ˆê”ŽC¬ìŽ“ñCˆäŒû–F–¾CˆÉ“¡º•FC‰z–ìŽ÷“TiŽ¨•@j: ‘æ106‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.12.05j, ‰¡•l.

3145. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”½‰ñ‚µ‚È‚¢”½‰ñ_Œo‚Ì1Ç—á. —Ž‡“ÖC‚‹´LbC’†ŽR–¾mC‰iˆä_–¤Cèc“cW‹vC‰z–ìŽ÷“TC‰ª–{–qliŽ¨•@j: ‘æ106‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.12.05j, ‰¡•l.

3146. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘½”­«‚ÌA“ªŠW”X–E‚Ì1Ç—á. ŽR’†‚C¼ŽRkˆê˜YC‰¡–xŠwiŽ¨•@j: ‘æ106‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i98.12.05j, ‰¡•l.

3147. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •@¥â¿œŠç—ô”X–E‚Ì1—á. L“‡‰®FC¼ŽRkˆê˜YC‰¡–xŠwiŽ¨•@j: ‘æ107‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i99.03.13j, ‰¡•l.

3148. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠOŽ¨“¹—L¶ˆÙ•¨iƒ}ƒ_ƒjj‚Ì1—á. ³—ˆ—²C‰ª–{–qlC¯–ìŒ÷C‰z–ìŽ÷“TiŽ¨•@j: ‘æ107‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i99.03.13j, ‰¡•l.

3149. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œz•”Žîᇂª‹^‚í‚ꂽŠç–Ê“®–¬”ìŒú«•a•Ï‚Ì1—á. ˆÉ“¡º•FC¬ìŽ“ñCˆäŒû–F–¾CŽR–{ˆê”ŽiŽ¨•@j: ‘æ107‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i99.03.13j, ‰¡•l.

3150. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j T1bº‘ÑŠà‚©‚ç‘Šú‚Éœ“]ˆÚ‚𗈂µ‚½1Ç—á. ’†“‡³ŒÈC‚‹´LbC”ª”ö˜a—YC’†ŽR–¾mC”n‰z’q_C‰iˆä_–¤C‰ª–{–qliŽ¨•@j: ‘æ107‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i99.03.13j, ‰¡•l.

3151. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j L‘шæŽG‰¹«Ž¨–‚̌Ÿ“¢. ¼•½“oŽu³iˆã—Éq¶jC²–씣C•½ŽR•ûrCV“cŒõ–MC‰ª–{–qliŽ¨•@jCŽR‰ºŒöˆêi‹à‘òˆã‘åj: ‘æ18‰ñŽ¨•@Œ¤‹†‰ï i98.07.11j, “Œ‹ž.

3152. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‚—îŽÒ’®Šoƒnƒ“ƒfƒLƒƒƒbƒvi‘æ‚P•ñj|•â’®Ší‘•—p‘OŒã‚ÌŒŸ“¢|. èc“cW‹vC‰ª–{–qlC²–씣iŽ¨•@jC•Ä“c•qi¶•¨•¨—ŒnjC¼•½“oŽu³iˆã—Éq¶jC—é–ØŒbŽqC–Ø‘º—R‹IC‰ª–{˜NŽqCŽÄè“ÖŽqiŒ¾ŒêŽ¡—ÃŽmj: ‘æ9‰ñŽ¨•@‰È‚ƘV‰»‚ÌŒ¤‹†‰ï i98.07.25j, “Œ‹ž.

3153. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j MRSAŒŸo—á‚ÌŒŸ“¢. —é–Ø—§rC‰ª–{–qliŽ¨•@j: ‘æ28‰ñ“ú–{Ž¨•@ˆôA‰ÈŠ´õÇŒ¤‹†‰ï i98.09.05j, ìè.

3154. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ƒAƒŒƒ‹ƒM[«•@‰Š‚ɑ΂·‚éƒgƒŠƒNƒ[ƒ‹|Ž_‰»ŠwŽèp. ”ª”ö˜a—YiŽ¨•@j: ‘æ4‰ñ‰Ô•²ÇŒ¤‹†‰ï‰F“s‹{ i98.02.26j, ‰F“s‹{.

3155. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ƒAƒŒƒ‹ƒM[«•@‰Š‚ÌŽ¡—Ã, ƒgƒŠƒNƒ[ƒ‹|Ž_‚É‚æ‚鉺b‰î‰»ŠwÜŽèp. ”ª”ö˜a—YiŽ¨•@j: “ú–{ˆãŽt‰ï¶ŠU‹³ˆçuÀ¬Œ§ŒSˆãŽt‰ïŠwpu‰‰‰ï i98.07.22j, ã“c.

3156. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‡–°Žž–³ŒÄ‹zÇŒóŒQ‚ÆŽ¨•@ˆôA‰È. ‰ª–{–qliŽ¨•@j: ‘æ161‰ñ–k‹ãBŽ¨•@‰È—Õ°§˜b‰ï i98.09.11j, –k‹ãB.

3157. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ƒAƒŒƒ‹ƒM[«•@‰Š‚ÌŽ¡—Ã|ƒgƒŠƒNƒ[ƒ‹|Ž_‚É‚æ‚鉺b‰î‰»ŠwÜŽèp|. ”ª”ö˜a—YiŽ¨•@j: Š™‘qŽsˆãŽt‰ï“à‰Èˆã‰ïŠwpu‰‰‰ï i98.10.12j, Š™‘q.

3158. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “ªŒz•”Šà‚ÌÅ‹ß‚Ì“®Œü. ‰ª–{–qliŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ïVtŠwpu‰‰‰ï i99.01.30j, ‰¡•l.

3159. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‰äX‚Ì‹³Žº‚Ås‚Á‚Ä‚¢‚éƒAƒŒƒ‹ƒM[«•@‰Š‚ÌŽ¡—Ã|ƒXƒM‰Ô•²Ç‚ð’†S‚É|. ”ª”ö˜a—YiŽ¨•@j: ‘Š–ÍŒ´ˆãŽt‰ïŠwpu‰‰‰ï i99.01.30j, ‘Š–ÍŒ´.

3160. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ƒAƒŒƒ‹ƒM[«•@‰Š‚ÌŽ¡—Ã|ŠO‰È“IŽ¡—ÂàŠÜ‚ß‚Ä|. ”ª”ö˜a—YiŽ¨•@j: _“Þ쌧•ÛŒ¯ˆã‹¦‰ïŒŽ—ጤ‹†‰ï i99.02.21j, ‰¡•l, _“Þ쌧•ÛŒ¯ˆã‹¦‰ïŒ¤‹†‰ïŽ.

3161. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j 1)•â’®Ší‚Ì“Á«‘ª’è, 2)ƒCƒ„[ƒ‚[ƒ‹ƒh‚ɂ‚¢‚Ä. ‰ª–{–qlC²–씣C•½ŽR•ûriŽ¨•@j: ‘æ1‰ñ–k—¢‘åŠwŽ¨•@‰ÈŒ¤‹†‰ï i98.10.17j, ‘Š–ÍŒ´.

3162. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Љ‚ꂽŠ³ŽÒ‚ÌŽ¡—Ë‘”Û. ‰ª–{–qliŽ¨•@j: ‘æ1‰ñ–k—¢‘åŠwŽ¨•@‰ÈŒ¤‹†‰ï i98.10.17j, ‘Š–ÍŒ´.

3163. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ––Šú‚ª‚ñ‚ÆÝ‘îƒPƒA. ‰iˆä_–¤iŽ¨•@j: ‘æ1‰ñ–k—¢‘åŠwŽ¨•@‰ÈŒ¤‹†‰ï i98.10.17j, ‘Š–ÍŒ´.

3164. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ㉊ú‚ª‚ñ‚ÆŠÓ•Êf’f. ’†ŽR–¾miŽ¨•@j: ‘æ1‰ñ–k—¢‘åŠwŽ¨•@‰ÈŒ¤‹†‰ï i98.10.17j, ‘Š–ÍŒ´.

3165. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‚ª‚ñ‚©—Ç«Ž¾Š³‚©, ‚í‚©‚ç‚È‚¢ê‡‚ÌЉî‚ÆŠ³ŽÒ, ‰Æ‘°‚Ö‚Ìà–¾. –àŽRˆÀOiŽ¨•@j: ‘æ1‰ñ–k—¢‘åŠwŽ¨•@‰ÈŒ¤‹†‰ï i98.10.17j, ‘Š–ÍŒ´.

3166. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j is‚ª‚ñ‚ÌЉî‚ÆŠ³ŽÒ, ‰Æ‘°‚Ö‚Ìà–¾. Έä–L‘¾iŽ¨•@j: ‘æ1‰ñ–k—¢‘åŠwŽ¨•@‰ÈŒ¤‹†‰ï i98.10.17j, ‘Š–ÍŒ´.

3167. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ž„‚Ìf—ÃŒoŒ±‚©‚ç|‹C‚ɂȂ釖°Žž–³ŒÄ‹zÇŒóŒQ. ‰ª–{–qliŽ¨•@j: ‘æ40‰ñˆ¤Œõˆã‰ï i98.06.06j, ¼ŽR.

3168. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŽwŠÖß‹­’¼‚𔺂Á‚½ƒAƒuƒ~œŒÅ’…Ç. •½ŽR•ûriŽ¨•@j: ‘æ11‰ñ_“Þ쌧Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰ÈŽèpŽè‹ZŒ¤‹†‰ï i98.07.10j, ‰¡•l.

3169. mŠw‰ïŽåÃi‚»‚Ì‘¼jn ‘æ1‰ñ–k—¢Ž¨•@ˆôA‰ÈŒ¤‹†‰ï, •â’®ŠíŽÀ‹ZuÀƒZƒ~ƒi[, ŠàŠ³ŽÒ‚ƃCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒgƒVƒ“ƒ|ƒWƒEƒ€. ‰ª–{–qliŽ¨•@j:


<<27 ¸_‰ÈŠw>>

3170. mŒ´’˜n Œü¸_–ò‚É‚¨‚¯‚é‹K–ñˆá”½—á‚ÌŽæ‚舵‚¢‚ɂ‚¢‚Ä. ‘ºèŒõ–Mi¸j: Jpn. J. Biomet., 18: 125`138, 1997.

3171. mŒ´’˜n Effects of washing procedure on platelets pretreated with serotonin uptake inhibitors in vitro: Low Ki values predict long-lasting inhibition of serotonin uptake in vivo. ΋½‰ªƒCŠ}Œ´—FKi¸jC‰i“c‰xŽqi¶‰»ŒnjC‘ºèŒõ–MCŽO‰Y’å‘¥i¸j: Jpn. J. Psychopharmacol., 18: 19`21, 1998.

3172. mŒ´’˜n Study on the suitability of a rat model for tardive dyskinesia and the preventive effects of various drugs. ’|“எqi–òÜjC΋½‰ªƒC¬—шêLi¸jC“n•ÓŽ i¶•¨•¨—ŒnjCŽO‰Y’å‘¥i¸j: Prog. Neuro psychopharmacol. Biol. Psychiatry, 22: 679`691, 1998.

3173. mŒ´’˜n Demographic features of patients seeking cosmetic surgery. ΋½‰ªƒCŠâ”öŒõ_C—é–Ø–q•Fi¸jC•ŸŽR‰Ãji‘‡‘Š’k•”jC‘ºèŒõ–MCŽO‰Y’å‘¥i¸j: Psychiatry Clin. Neurosci., 52: 283`287, 1998.

3174. mŒ´’˜n Survival analytic approach to long-term prescription of benzodiazepine hypnotics. ΋½‰ªƒC™ŽRˆêC—é–Ø–q•FC¬—шêLi¸j: Psychiatry Clin. Neurosci., 52: 541`545, 1998.

3175. mŒ´’˜n R•sˆÀ–ò¥‡–°–òŠJ”­‚ÌÅ‘Oü. ‘ºèŒõ–Mi¸j: ¸__Œo–ò—ƒVƒ“ƒ|ƒWƒEƒ€, 24(1): 23`37, 1998.

3176. mŒ´’˜n ŽOŽŸ‹~‹}ƒZƒ“ƒ^[‚É”À‘—‚³‚ꂽ¸_‰È’ʉ@’†‚ÌŽ©ŽEŠé}Š³ŽÒ‚Ì”wŒi. ÷ˆäO”Ti¸jC’ç–M•Fi‹~–½jC•x“c—TŽqC‘ºèŒõ–Mi¸j: —Õ°¸_ˆãŠw, 27(11): 1363`1370, 1998.

3177. mŒ´’˜n ”]ŒŒŠÇ«’s•ð‚Ì–ò•¨—Ö@|”]zŠÂ‘ãŽÓ‰ü‘P–ò‚ÌŒø‰Ê‚ɂ‚¢‚Ä|. ‘å’J‹`•vi¸j: —Õ°¸_–ò—, 1(10): 1037`1046, 1998.

3178. mŒ´’˜n MCI-186(Edaravone)‚Ì‘æ‡T‘Š—Õ°ŽŽŒ±|’P‰ñ‚¨‚æ‚Ñ”½•œ“Š—^ŽŽŒ±‚É‚¨‚¯‚éˆÀ‘S«‚Æ–ò•¨“®‘Ô‚ÌŒŸ“¢|. ŽÄ“c‹v—YCVˆäd‹ICˆä‘ò”ü•cC‘ºèŒõ–Mi¸jC‚¼N—YCˆä‘òCC‚‹´çŽõŽqC“c’†³•F: —Õ°–ò—, 29(6): 863`876, 1998.

3179. mŒ¤‹†•ñiŒú¶Èjn ‘‡•a‰@‚É‚¨‚¯‚é¸_‰È‚Ì–ðŠ„‚ÉŠÖ‚·‚錤‹†. ’†“‡ß•vC’ç–M•FC¬—шêLC•Ä‘ò—m‰îC”ò’¹ˆä–]C‹àŽqWˆêCŽR“cŒ˜ˆêCŽs‘º’ÓC‚–ì»CVˆä~ŽqCŽR‰º‚¦‚ÝŽqC“‡“cKŽqC“c’†²Žqi¸j: •½¬9”N“xŒú¶‰ÈŠwŒ¤‹†”ï•â•‹à¸_•ÛŒ¯ˆã—ÃŒ¤‹†Ž–‹Æ¸_ˆã—Â̋@”\•ª‰»‚ÉŠÖ‚·‚錤‹†, p.88`126, 1998.

3180. mÇ—á•ñn ‚¹‚ñ–Ï‚ð’悵‚½“SŒ‡–R«•nŒŒ‚Ì‚PÇ—á. Vˆä~ŽqCˆÀˆä³CÎì•qŽqC‚‹´–¾”äŒÃC΋½‰ªƒC‘ºèŒõ–Mi¸j: _“Þ쌧¸_ˆãŠw‰ïŽ, 48: 31`36, 1999.

3181. mÇ—á•ñn _“Þ쌧‚É‚¨‚¯‚鉞‹}“ü‰@‚ÌŽÀ‘Ô. ˆÀˆä³C‘º‰ª‰p—YC’†“‡ß•vi¸j: ¸_ˆãŠw, 41(1): 105`109, 1999.

3182. mÇ—á•ñn R‚Ä‚ñ‚©‚ñ–ò‚Ì‘½Ü•¹—p—Ö@‚É‚æ‚è”­ì•p“x‚Ƹ_Çó‚Ì‘ˆ«‚ð‚«‚½‚µ‚Ä‚¢‚½‚Ä‚ñ‚©‚ñ‚Ì‚P—á. ˆî“cŒ’C¬—шêLC‚‹´–¾”äŒÃi¸j: —Õ°¸_–ò—, 2(1): 81`84, 1999.

3183. mÇ—á•ñn ’á—p—ÊrisperidoneŽg—p‚ɂĉü‘P‚ðŽ¦‚µ‚½‘ÌŠO˜HÇó‚ðo‚µ‚â‚·‚¢¸_•ª—ô•a‚Ì‚P—á. Îì³”ŽC’å‘‘¾ŽuCˆÀˆä³i¸j: —Õ°¸_–ò—, 2(2): 183`186, 1999.

3184. mÇ—á•ñn ‘½Ü•¹—p‚É‚æ‚éƒCƒŒƒEƒX‚ðŒ_‹@‚É’Pƒ“Š—^‚É•ÏX‚Å‚«‚½¸_•ª—ô•a‚Ì1—á. ˆÀˆä³CÎì³”ŽC¬—шêLC‚‹´–¾”äŒÃC΋½‰ªƒi¸j: —Õ°¸_–ò—, 2(4): 407`409, 1999.

3185. m—Õ°Ž¡Œ±n ‘I‘ð“IƒZƒƒgƒjƒ“ÄŽæ‚èž‚Ý‘jŠQ–òSME3110 (fluroxamine maleate)‚Ì‚¤‚•a,‚¤‚Âó‘Ԃɑ΂·‚é‘OŠú—Õ°, ‘æ‡U‘ŠŽŽŒ±|‰–Ž_ƒCƒ~ƒvƒ‰ƒ~ƒ“‚ð‘ÎÆ‚Æ‚µ‚½—p—ʔ͈͂̌Ÿ“¢|. ‘ºèŒõ–MCX‰·—CŽO‰Y’å‘¥i¸jC‘¼: —Õ°ˆã–ò, 14(5): 1998.

3186. m—Õ°Ž¡Œ±n ‘I‘ð“IƒZƒƒgƒjƒ“ÄŽæ‚èž‚Ý‘jŠQ–òSME3110 (fluroxamine maleate)‚Ì‚¤‚•a,‚¤‚Âó‘Ԃɑ΂·‚éŒãŠú—Õ°, ‘æ‡U‘ŠŽŽŒ±. ‘ºèŒõ–MCX‰·—Cóˆä¹Oi¸jC‘¼: —Õ°¸_–ò—, 1(2): 185`198, 1998.

3187. m‘àn SgÇ‚©‚ç‚Ý‚½‚—îŽÒ‚̇–°áŠQ. ‘ºèŒõ–Mi¸j: Geriatric Medicine, 36(7): 1011`1019, 1998.

3188. m‘àn V‚µ‚¢R‚¤‚–òSSRI. ‘ºèŒõ–Mi¸j: Infection Now, 3: 8, 1999.

3189. m‘àn ‚—îŽÒ‡–°áŠQ‚ÌŽÀ‘ԂƑΉž. ‘ºèŒõ–MC‘å싧Žqi¸j: Medical Tribune, 5(5): 18`19, 1998.

3190. m‘àn ‚¤‚•af—Âð‚ß‚®‚éŋ߂̘b‘è. ‘ºèŒõ–Mi¸j: Medicament News, (1581): 10`11, 1998.

3191. m‘àn –ò•¨—Ö@¥ÅV‚̘b‘è: •s–°Ç. ‘ºèŒõ–Mi¸j: Medicament News, (1598): 22`24, 1998.

3192. m‘àn ƒMƒƒƒo‚©‚çƒZƒƒgƒjƒ“‚ÖR•sˆÀ–ò‚ÌV‚½‚È“WŠJ. ‘ºèŒõ–Mi¸j: Scias, '98-7: 54`56, 1998.

3193. m‘àn SSRI. ‘ºèŒõ–Mi¸j: ‚©‚炾‚̉Ȋw, 201(6): 89, 1998.

3194. m‘àn ‚¤‚•a‚Ì‘Šú”­Œ©. ‘ºèŒõ–Mi¸j: ‚«‚傤‚ÌŒ’N, 11: 98`101, 1998.

3195. m‘àn ‡–°áŠQ‚̃mƒ‹ƒAƒhƒŒƒiƒŠƒ“‰¼à. ‘ºèŒõ–Mi¸j: ‚±‚±‚ë‚Ì—Õ°‚ ‚ç‚©‚é‚Æ, 17(‘): 312`317, 1998.

3196. m‘àn ¸_•ª—ô•aŒ¤‹†Å‘Oüi‘æ3‰ñ). ΋½‰ªƒi¸j: ‚º‚ñ‚©‚ê‚ñ, 1998(10ŒŽ†): 28`31, 1998.

3197. m‘àn ¸_•ª—ô•aŒ¤‹†Å‘Oüi‘æ4‰ñ). ΋½‰ªƒi¸j: ‚º‚ñ‚©‚ê‚ñ, 1998(11ŒŽ†): 28`31, 1998.

3198. m‘àn ¸_•ª—ô•aŒ¤‹†Å‘Oüi‘æ5‰ñ). ΋½‰ªƒi¸j: ‚º‚ñ‚©‚ê‚ñ, 1998(12ŒŽ†): 26`29, 1998.

3199. m‘àn ¸_•ª—ô•aŒ¤‹†Å‘Oüi‘æ1‰ñ). ΋½‰ªƒi¸j: ‚º‚ñ‚©‚ê‚ñ, 1998(8ŒŽ†): 28`31, 1998.

3200. m‘àn ¸_•ª—ô•aŒ¤‹†Å‘Oüi‘æ2‰ñ). ΋½‰ªƒi¸j: ‚º‚ñ‚©‚ê‚ñ, 1998(9ŒŽ†): 28`31, 1998.

3201. m‘àn ¸_•ª—ô•aŒ¤‹†Å‘Oüi‘æ6‰ñ). ΋½‰ªƒi¸j: ‚º‚ñ‚©‚ê‚ñ, 1999(1ŒŽ†): 26`29, 1999.

3202. m‘àn ¸_•ª—ô•aŒ¤‹†Å‘Oüi‘æ7‰ñ). ΋½‰ªƒi¸j: ‚º‚ñ‚©‚ê‚ñ, 1999(2ŒŽ†): 32`35, 1999.

3203. m‘àn ¸_•ª—ô•aŒ¤‹†Å‘Oüi‘æ8‰ñ). ΋½‰ªƒi¸j: ‚º‚ñ‚©‚ê‚ñ, 1999(3ŒŽ†): 26`29, 1999.

3204. m‘àn –ò•¨ˆË‘¶‚Ì•a‘Ô‚ÆŽ¡—Ã. ΋½‰ªƒi¸j: ƒtƒ@ƒ‹ƒ}ƒVƒA, 34: 905`909, 1998.

3205. m‘àn ‡–°–òˆË‘¶‚Æ——p. ‘ºèŒõ–Mi¸j: Ž¡—Ã, 81(3): 1117`1122, 1999.

3206. m‘àn ‡–°–ò‚Ì—Õ°–ò—‚ÆŽg‚¢•û. ‘ºèŒõ–Mi¸j: _ŒoŽ¡—Êw, 15(2): 159`168, 1998.

3207. m‘àn ¸_•ª—ô•aŽ¡—Âɂ¨‚¯‚é–ò•¨—Ö@‚ƃŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Ì“‡. ΋½‰ªƒi¸j: ¸ƒŠƒnŽ, 2: 133`140, 1998.

3208. m‘àn Å‹ß‚ÌŒü¸_–ò‚Ì“®Œü. ‘ºèŒõ–Mi¸j: ¸_‰È‹~‹}, 1(1): 11`23, 1998.

3209. m‘àn çN‚¤‚•aŒ—‚Ì–ò•¨—Ö@‚ÌŽÀÛ. ‘ºèŒõ–Mi¸j: ¸_‰ÈŽ¡—Êw, 13(5): 557`565, 1998.

3210. m‘àn •¹—p—Ö@‚ÉŠÖ‚·‚é—¯ˆÓ“_. ‚‹´–¾”äŒÃC΋½‰ªƒi¸j: ¸_‰ÈŽ¡—Êw, 13: 258`261, 1998.

3211. m‘àn ‚¤‚•aŽ¡—Â̖¾“ú‚Ö‚ÌŠú‘Ò. ‘ºèŒõ–Mi¸j: ‘æ7‰ñ“ŒŠC–ò•¨Ž¡—ÃŒ¤‹†‰ïŽ, p.13`20, 1998.

3212. m‘àn ”ñ’èŒ^R¸_•a–ò|‚»‚Ì–ò—Šw“I“Á’¥‚ÆŽ¡—ÃŒ»ê‚É‚à‚½‚ç‚·‰e‹¿|. ΋½‰ªƒi¸j: “ú–{_Œo¸_–ò—ŠwŽGŽ, 18: 67`68, 1998.

3213. m‘àn ³‚µ‚¢u‡–°–òv‚̃XƒXƒ. ‘ºèŒõ–Mi¸j: •Êû•ó“‡¥–¼ˆã‚Éu‚¯, (404): 196`202, 1998.

3214. m‘àn R‚¤‚–ò‚Ì“®Œü. ΋½‰ªƒi¸j: –òŽ–“ú•ñ, (9043): 12, 1998.

3215. m‘àn ‡–°–ò‚ÌŽí—Þ‚Æì—p. ‘ºèŒõ–Mi¸j: —Õ°‚ÆŒ¤‹†, 76(2): 229`234, 1999.

3216. m‘àn Ž¡—Ã’ïR«¸_•ª—ô•a‚Ìf’f‚ÆŽ¡—ÃiÀ’k‰ïj. H“¡‹`—YC‘ºèŒõ–Mi¸jC”ª–Ø„•½C•½“ˆ–M–Ò: —Õ°ˆã–ò, 15(1): 31`51, 1998.

3217. m‘àn ‡–°–ò‚Ì——p. ‘ºèŒõ–Mi¸j: —Õ°¸_ˆãŠw, 27(4): 381`388, 1998.

3218. m‘àn –òÜ—U”­«‚ÌŒ¶Šo. ΋½‰ªƒi¸j: —Õ°¸_ˆãŠw, 27: 934`938, 1998.

3219. m‘àn ‡–°–ò‚Ì–ò•¨‘ŠŒÝì—p. ‘ºèŒõ–Mi¸j: —Õ°¸_–ò—, 1(12): 1309, 1998.

3220. m‘àn SNRIŠJ”­‚ÌŒ»ó. ‘ºèŒõ–Mi¸j: —Õ°¸_–ò—, 1(4): 419`430, 1998.

3221. m‘àn Moclobemide|‚¤‚•aŽ¡—Ã‚Ì‚à‚¤‚ЂƂ‚̓¹|. ˆä‘òŽu–¼–ìi¸j: —Õ°¸_–ò—, 1(8): 881`886, 1998.

3222. m‘àn ‡–°–ò‚ÆQuality of Life•]‰¿. ˆä‘òŽu–¼–ìi¸j: —Õ°¸_–ò—, 1(9): 947`954, 1998.

3223. m‘àn R‚Ä‚ñ‚©‚ñ‚Ì”F’máŠQ‚Æ‚»‚ÌŽ¡—Ã. ‚‹´–¾”äŒÃi¸j: —Õ°¸_–ò—, 1: 1135`1144, 1998.

3224. m‘àn R‚Ä‚ñ‚©‚ñ–ò‚Ì’ˆÓ‚·‚ׂ«•›ì—p. ‚‹´–¾”äŒÃi¸j: —Õ°¸_–ò—, 1: 603`613, 1999.

3225. m‘àn ”ñ’èŒ^R¸_•a–ò‚ª‚à‚½‚ç‚·Ž¡—Â̕ω». ΋½‰ªƒi¸j: —Õ°¸_–ò—, 1: 750`758, 1998.

3226. m‘àn ƒvƒ‰ƒZƒ{”äŠrŽŽŒ±‚Ì–â‘è“_. ΋½‰ªƒi¸j: —Õ°¸_–ò—, 2: 145`153, 1999.

3227. m‘àn ‚¤‚•a‚Ì•]‰¿ŽÚ“x. ‚‹´–¾”äŒÃi¸j: —Õ°¸_–ò—, 2: 27`33, 1999.

3228. m‘àn Multi-Acting Receptor Targeted Agent (MARTA)|dirty‚©rich‚©|. ΋½‰ªƒi¸j: —Õ°¸_–ò—, 2: 353`363, 1999.

3229. m‘àn ‚—îŽÒ‚Ì–ò•¨—Ö@ã‚Ì’ˆÓ“_. ‘ºèŒõ–Mi¸j: ˜V”NŠú’s•ð, 12(3): 332`334, 1998.

3230. m‘àn ”]zŠÂ‘ãŽÓ‰ü‘P–ò‚Ì—ðŽj, •ª—Þ, –ò—ì—p. ‚‹´–¾”äŒÃi¸j: ˜V”N¸_ˆãŠwŽGŽ, 9: 891`897, 1998.

3231. muÀn ’m‚Á‚Ä‚¨‚«‚½‚¢g‹ß‚ȇ–°áŠQ. ‘ºèŒõ–Mi¸j: Medical Tribune, 8: 17, 1998.

3232. muÀn S‚Ì‹~‹}ˆã—Ã. ‘ºèŒõ–Mi¸j: ‚«‚傤‚ÌŒ’N, 11: 102`105, 1998.

3233. muÀn –°‚ê‚È‚¢. ‘ºèŒõ–Mi¸j: ’©“ú‰Æ’ë•Ö—˜’ ¥•é‚炵‚Ì•—, 6(6): 26`27, 1998.

3234. mŠwp‘n i•ª’SŽ·•Mj ¸_ˆãŠw”N•ñ; V‹KR¸_•a–ò, 1998-'99, ‘ºèŒõ–Mi¸j. •ÒW ¼‰º³–¾i“s¸_ˆãŠwŒ¤jC‘¼5–¼C•ÒC æ’[ˆãŠwŽÐ, “Œ‹žC98.12.15”­s.

3235. mŠwp‘n i•ª’SŽ·•Mj ‚¤‚•a‚Ìf’f‚ÆŽ¡—Ã; ‚¤‚•a‚Ì‘Šú”­Œ©¥‘ŠúŽ¡—Ã, p.78`90, ‘ºèŒõ–Mi¸j. •ÒW ^‹»ŒðˆÕˆã‘o”Å•”C•ÒC ^‹»ŒðˆÕˆã‘o”Å•”, “Œ‹žC99.02.15”­s.

3236. mŠwp‘n i•ª’SŽ·•Mj •s–°Ç‚Ƈ–°áŠQiãj; •s–°Ç‚ÌŽ¡—Ã: –ò•¨—Ö@‚ÌŽÀÛ, p.135`147, ‘ºèŒõ–Mi¸j. •ÒW •Hì‘וviH“c‘åjC‘ºèŒõ–Mi¸jC•ÒC f—ÃVŽÐ, ‘åãC99.03.27”­s.

3237. mŠwp‘n i•ª’SŽ·•Mj •s–°Ç‚Ƈ–°áŠQi‰º); ‡–°áŠQŽ¡—Öò: ‡–°–ò, p.386`413, ‘ºèŒõ–Mi¸j. •ÒW •Hì‘וviH“c‘åjC‘ºèŒõ–Mi¸jC•ÒC f—ÃVŽÐ, ‘åãC99.03.27”­s.

3238. mŠwp‘n i•ª’SŽ·•Mj —Õ°¸_ˆãŠwuÀ14, ¸_‰È–ò•¨—Ö@; V‚µ‚¢R¸_•a–ò‚ÌŠJ”­‚Æ“WŠJ, p.96`108, ‘ºèŒõ–Mi¸j. •ÒW ‘ºèŒõ–Mi¸jC—tˆÀ—¢i¹ƒ}ƒŠˆã‘åj•ÒC ’†ŽR‘“X, “Œ‹žC99.03.31”­s.

3239. mŠwp‘n i•ª’SŽ·•Mj —Õ°¸_ˆãŠwuÀ14: ¸_‰È–ò•¨—Ö@; “K‰žã‚Ì–â‘è A.g‘Ì“I—L•aŽž‚̸_–ò•¨—Ö@, p.483`497, ‚‹´–¾”äŒÃi¸j. •ÒW ‘ºèŒõ–Mi¸jC—tˆÀ—¢C•ÒC ’†ŽR‘“X, “Œ‹žC99.03.31”­s.

3240. mŠwp‘n i•ª’SŽ·•Mj —Õ°¸_ˆãŠwuÀ9: ‚Ä‚ñ‚©‚ñ; —U”­ˆöŽq‚©‚ç‚Ý‚½”­ì”­Œ»‹@˜ A.”­ì—U”­ˆöŽq, p.375`381, ‚‹´–¾”äŒÃi¸j. •ÒW —é–Ø“ñ˜YCŽR“àr—YC•ÒC ’†ŽR‘“X, “Œ‹žC99.03.31”­s.

3241. mŠwp‘n i•ª’SŽ·•Mj ¸_‰ÈŽ¡—Êw: ‚Ä‚ñ‚©‚ñ˜_•¶W; ‚ÌdÏó‘Ô‚ÌŽ¡—Ã, p.125`136, ‚‹´–¾”äŒÃC‘ºèŒõ–Mi¸j. ¯˜a‘“X, “Œ‹žC98.00.00”­s.

3242. mŠwp‘n i•ª’SŽ·•Mj —Õ°¸_ˆãŠwuÀ‘æ14Šª¸_‰È–ò•¨—Ö@; R¸_•a–ò‚Ìì—p‹@˜, p.41`57, ΋½‰ªƒi¸j. •ÒW ¼‰º³–¾C‘ºèŒõ–Mi¸jC—tˆÀ—¢C•ÒC ’†ŽR‘“X, “Œ‹žC99.03.31”­s.

3243. mŠwp‘n i•ÒWj •s–°Ç‚Ƈ–°áŠQi㥉ºj; •ÒW •Hì‘וviH“c‘åjC‘ºèŒõ–Mi¸jC•ÒC f—ÃVŽÐ, ‘åãC99.03.27”­s.

3244. mŠwp‘n i•ÒWj —Õ°¸_ˆãŠwuÀ14, ¸_‰È–ò•¨—Ö@; •ÒW ‘ºèŒõ–Mi¸jC—tˆÀ—¢i¹ƒ}ƒŠˆã‘åj•ÒC ’†ŽR‘“X, “Œ‹žC99.03.31”­s.

3245. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ‡–°‚Æ‚»‚ÌáŠQ, ”]‚Æ_Œo‰ÈŠwƒVƒŠ[ƒY10; ‡–°ŠÖ˜A•¨Ž¿: ŠoÁ–ò‚Ƈ–°–ò, p.104`112, ‚‹´–¾”äŒÃC΋½‰ªƒi¸j. •ÒW ‚‹´“OCÝŠyMsC´…‹P•vC•ÒC ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹žC98.00.00”­s.

3246. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ‚Ä‚ñ‚©‚ñÇŒóŒQ; •¡ŽG•”•ª”­ì‚Ä‚ñ‚©‚ñdÏó‘Ô, p.150`163, ‚‹´–¾”äŒÃC‘ºèŒõ–Mi¸j. •ÒW ´–칈êC‘å“cŒ´r•ãC•ÒC ˆãŠw‘‰@, “Œ‹žC98.00.00”­s.

3247. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¸_Ž¾Š³100‚̉¼à; ¸_ˆãŠw‚É‚¨‚¯‚鉼à‚̈Ӌ`‚ÆŒÀŠE, p.1`4, ΋½‰ªƒi¸j. •ÒW ΋½‰ªƒi¸jC•ÒC ¯˜a‘“X, “Œ‹žC98.00.00”­s.

3248. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj V¸_‰È‘I‘‡E•s–°Ç‚Ƈ–°áŠQi‰ºj; ¸_ŽhŒƒ–ò, p.374`385, ΋½‰ªƒi¸j. •ÒW •Hì‘וvC‘ºèŒõ–Mi¸jC•ÒC f—ÃVŽÐ, ‘åãC99.03.27”­s.

3249. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ê–åˆã‚Ì‚½‚߂̸_ˆãŠwƒŒƒrƒ…['98|ÅVŽå—v•¶Œ£‚Ɖðà|; R•sˆÀ–ò‚Ƈ–°–ò, p.141`146, ΋½‰ªƒi¸j. ‘‡ˆãŠwŽÐ, “Œ‹žC98.00.00”­s.

3250. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj Central Nervous System Today-1 ‡–°áŠQ¥Š´îáŠQ|Šî‘b‚©‚ç—Õ°‚Ü‚Å|; ‡–°“±“üÜ‚Ì•›ì—p, p.14`20, ΋½‰ªƒi¸j. •ÒW ‘ºèŒõ–Mi¸jC㓇‘—˜C•ÒC ƒ‰ƒCƒtƒTƒCƒGƒ“ƒX, “Œ‹žC98.00.00”­s.

3251. m‚»‚Ì‘¼‚Ì’˜‘n i•ÒWj ¸_Ž¾Š³100‚̉¼à; •ÒW ΋½‰ªƒi¸jC•ÒC ¯˜a‘“X, “Œ‹žC98.00.00”­s.

3252. m‚»‚Ì‘¼‚Ì’˜‘n i•ÒWj Central Nervous System Today-1 ‡–°áŠQ¥Š´îáŠQ|Šî‘b‚©‚ç—Õ°‚Ü‚Å|; •ÒW ‘ºèŒõ–Mi¸jC㓇‘—˜C•ÒC ƒ‰ƒCƒtƒTƒCƒGƒ“ƒX, “Œ‹žC98.00.00”­s.

3253. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj ƒŠƒ^[ƒ“ƒ}ƒbƒ`¸_ˆãŠw; MAO‘jŠQ–ò‚Ì•œŠˆ, p.23`27, ‘ºèŒõ–Mi¸j. •ÒW –쑺‘ˆê˜Yi–h‰qˆã‘åjC•ÒC V‹»ˆãŠw, “Œ‹žC98.08.31”­s.

3254. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ª’SŽ·•Mj S‚̉ƒëˆãŠw; S‚Ì•a‹C‚ÌŽ¡—Ã: –ò•¨—Ö@, p.772`777, ‘ºèŒõ–Mi¸j. •ÒW ŽRèWŽ‘CŽR“àr—YC‰ºâKŽOC•ÒC •ÛŒ’“¯lŽÐ, “Œ‹žC99.01.20”­s.

3255. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ª’SŽ·•Mj Ž¡—ÖòƒKƒCƒh1999`2000; R‚¤‚–ò, p.22`30, ‘ºèŒõ–Mi¸j. •ÒW ˜a“cUC‘å‹v•ÛºsC‰i“c’¼ˆêC–îè‹`—YC•ÒC •¶Œõ“°, “Œ‹žC99.02.10”­s.

3256. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ–“T; ‚¤‚•a, p.27`28, ‘å’J‹`•vi¸j. 쓇‘“X, “Œ‹žC99.03.05”­s.

3257. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ª’SŽ·•Mj ŽY‹ÆƒJƒEƒ“ƒZƒŠƒ“ƒOŽ–“T; —}‚¤‚Â, p.400`401, ‘å’J‹`•vi¸j. 쓇‘“X, “Œ‹žC99.03.05”­s.

3258. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Pharmacokinetic investigation of clozapine in Japanese patients. ‘ºèŒõ–Mi¸jCKoyama, T.CYagi, G.CŽO‰Y’å‘¥i¸jC‘¼: 36th ACNPi‘æ36‰ñƒAƒƒŠƒJ_Œo¸_–ò—Šw‰ï) i97.12.09j, Hawaii, —\eW, p.171, 1997.

3259. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical optimum dose of LY 248686 (duloxetine) for treatment of depression and depressive state Ca double-blind inter-group comparison study using imipramine hydrochloride as a comparator product. ‘ºèŒõ–Mi¸j: ‘æ36‰ñƒAƒƒŠƒJ_Œo¸_–ò—Šw‰ï, 36th ACNP i97.12.09j, Hawaii, —\eW, p.264, 1997.

3260. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Preclinical and clinical studies on perospirone HCl, a novel antipsychotic: Review. ‘ºèŒõ–Mi¸j: 38th NCDEUi‘æ38‰ñV–ò—Õ°•]‰¿Šw‰ï) i98.00.00j, ƒAƒƒŠƒJ, —\eW, p.122, 1998.

3261. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Epileptic seizures observed at the time of EEG recording. ˆîŒ©ˆòºi¸jC‹g‘º‹vmŽqi“Œ•a‰@Œ¤‹†ŒnjC‚‹´–¾”äŒÃC‘º‰ª‰p—YC¬Œû“OC‘ºèŒõ–Mi¸j: ‘æ3‰ñƒˆ[ƒƒbƒp‚Ä‚ñ‚©‚ñŠw‰ï i98.05.25j, ƒƒ‹ƒVƒƒƒ, Epilepsia, 39(Suppl.2): 112, 1998.

3262. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Phase I study of nefazodone (BMY-13754). ΋½‰ªƒC—Ž‡ˆê‹vC“àŠCŒõ’©i¸jC•ŸŽR‰Ãji‘‡‘Š’k•”jC‘ºèŒõ–Mi¸j: 21st CINP Congress i98.07.13j, Glasgow, UK.

3263. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical effects of perospirone on schizophrenia; a double blind study with haloperidol. ‘ºèŒõ–Mi¸j: 21st CINP Congress i98.07.13j, Glasgow, UK., 21st CINP Congress, Final Programme, p.324, 1998.

3264. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Pharmacokinetic interaction among haloperidol, carteolol, and biperiden in healthy subjects. ˆä‘òŽu–¼–ìC‘ºèŒõ–MCŽO‰Y’å‘¥C‹g‰ª³ÆC“àŠCŒõ’©i¸jCŒF’J—YŽ¡i–ò—jC–ؔÉiŠájCKubo, S.i‘å’Ë»–òj: 21st CINP Congress i98.07.14j, Glasgow, UK, 21st CINP Congress, Final Programme, p.318, 1998.

3265. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Phase 1 study of multiple dose of levetiracetam in Japan subjects. ‚‹´–¾”äŒÃCˆä‘òŽu–¼–ìC¬—шêLi¸jCŒF’J—YŽ¡i–ò—jC‘ºèŒõ–Mi¸j: 21st International Neuropsychopharamacology Congress i98.07.15j, Glasgow, UK.

3266. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effects of intraventricular injection of low dose AF64A on working memory and brain ChAT activity in the rat. ìŒû‹BC‘å’J‹`•vC—é–Ø–q•Fi¸jC‰i“c‰xŽqi¶‰»ŒnjCˆä‘òŽu–¼–ìC‹g“c–FŽqi¸jC¬Œû“OiŠÅŒìŠw•”jCŽO‰Y’å‘¥i¸j: 6th International Conference on Alzheimer's Disease and Related Disorders i98.07.20j, ƒAƒ€ƒXƒeƒ‹ƒ_ƒ€.

3267. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Psychiatric emergency service in a university hospital in Japan. ˆÀˆä³C‘ŽR_ˆêC¬—шêLC‘º‰ª‰p—YC’†“‡ß•vC‘ºèŒõ–Mi¸j: 5th World Congress of the International Association for Emergency Psychiatry i98.10.15`17j, Brussels, Belgium.

3268. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j V‚µ‚¢R¸_•a–ò‚Ö‚ÌŠú‘Ò|SDAŒnR¸_•a–ò‚ð’†S‚É|. ‘ºèŒõ–Mi¸j: ‘æ94‰ñ“ú–{¸__ŒoŠw‰ï i98.05.21j, ‰«“ê, “ú–{¸__ŒoŠw‰ïŽ, 1998.

3269. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j ‡–°–ò‚Ì‘ŠŒÝì—p. ‘ºèŒõ–Mi¸j: ‘æ23‰ñ“ú–{‡–°Šw‰ï i98.06.05j, H“c.

3270. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Šú‘Ò‚³‚ê‚éV‹KR‚Ä‚ñ‚©‚ñ–ò. ‚‹´–¾”äŒÃi¸j: ‘æ32‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï i98.10.09j, ‰¡•l.

3271. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j V‚µ‚¢R¸_•a–òŠJ”­‚Ì“WŠJ; Clozapine-like agents. ΋½‰ªƒi¸j: ‘æ28‰ñ“ú–{_Œo¸_–ò—Šw‰ï i98.10.23j, “Œ‹ž, “ú–{_Œo¸_–ò—Šw‰ïŽ, 18: 255`256, 1998.

3272. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j V–òi”ñ’èŒ^R¸_•a–òj‚Ö‚ÌŠú‘Ò. ‘ºèŒõ–Mi¸j: ‘æ31‰ñ‘S‰Æ˜A“Œ‹ž‘å‰ï i98.11.16j, “Œ‹ž, —\eW, p.39`40, 1998.

3273. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å—Ê•ž–ò‚É‚æ‚鎩ŽEŠé}. ÷ˆäO”Ti¸jC’ç–M•Fi‹~–½jCŠâè“ÖŽqCX“c¶‹IŽqCÎì•qŽqC‘ºèŒõ–Mi¸j: ‘æ10‰ñ“ú–{‘‡•a‰@¸_‰ÈˆãŠw‰ï‘‰ï i97.11.01j, ‹à‘ò, ‘‡•a‰@¸_ˆãŠw, 9: 102, 1997.

3274. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j _“Þ쌧‚É‚¨‚¯‚鉞‹}“ü‰@‚ÌŒ»ó. ˆÀˆä³CÎì³”ŽC’†“‡ß•vi¸j: ‘æ94‰ñ“ú–{¸__ŒoŠw‰ï i98.05.21j, ‰«“ê.

3275. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “Ë”­«“ï’®‚ÌS—“Á«‚ɂ‚¢‚Ä. âE–{–¾•Fi¸jC‰’J—¯—¢ŽqiŠÅŒì•”jCVŠJiŽqC‰“æGŽ÷i‰qjC‰ª“cGri¸jCŽR“c­•vC‰ª–{–qliŽ¨•@j: ‘æ94‰ñ“ú–{¸__ŒoŠw‰ï i98.05.21j, ‰«“ê.

3276. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Paroxetine•ž—p’†‚Ì‚—îŽÒ‚¤‚•aŠ³ŽÒ‚É‚¨‚¯‚錌¬”Â5-HTŽæ‚èž‚Ý”\‚Æ‚¤‚Âó‘Ԃ̕ω». ¬—шêLCŠ}Œ´—FKi¸jC‰i“c‰xŽqi¶‰»ŒnjC’å‘‘¾ŽuC“à“c‘¾ˆêCˆÀˆä³C΋½‰ªƒC‘ºèŒõ–Mi¸j: ‘æ8‰ñ“ú–{—Õ°¸__Œo–ò—Šw‰ï i98.09.17`18j, ŽD–y, International Clinical Psychopharmacology, 14(1): 41`59, 1998.

3277. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j SŽ¾Š³‚ÅŽ€–S‚µ‚½¸_•ª—ô•aŠ³ŽÒ‚ÌS“d}ŠŒ©. ˆÀˆä³Cˆî“cŒ’C’†“‡ß•vi¸jCŠâ‰ºŠoC²“¡’‰•FCŽR“àˆÒŒõC‘ºã˜aŽqC²“¡´‹MC˜aò“Oi“àj: ‘æ41‰ñ“ú–{•a‰@’nˆæ¸_ˆãŠw‰ï‘‰ï i98.10.00j, VŠƒ.

3278. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žvl’†’f–@‚ª’˜Œø‚µ‚½‹­”—«áŠQ‚Ì‚P—á. ‰““¡‘ŽqC‘å’J‹`•vC“à“c‘¾ˆêCŽá“c•””Ž•¶C‘ºèŒõ–Mi¸j: ‘æ24‰ñ“ú–{s“®—Ö@Šw‰ï‘å‰ï i98.11.26j, “Œ‹ž.

3279. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ð—£«“¯ˆêáŠQiDSM-‡Wj‚ɑ΂·‚éÖ°‚ÌŽŽ‚Ý. ’†“‡ß•vCˆÀˆä³CŠâ–{Š°li¸j: ‘æ19‰ñ“ú–{ŽÐ‰ï¸_ˆãŠw‰ï i99.03.00j, •Ÿ“‡.

3280. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “Ë”­«“ï’®Š³ŽÒ‚̃XƒgƒŒƒX“Á«‚ÉŠÖ‚·‚錤‹†. âE–{–¾•Fi¸jCˆÉ“¡•¶ŽqiŠÅŒì•”jC‰’J—¯—¢ŽqiŠÅŒìŠw•”jCˆÉ“¡—SŽqi–òŠw•”jC’†ì®ŽqiŠÅŒì•”jC²–씣C‰ª–{–qliŽ¨•@j: ‘æ8‰ñ“ú–{Ž¨‰ÈŠw‰ï‘‰ï i98.10.22j, å‘ä, —\eW, 8(4): 314, 1998.

3281. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒnƒƒyƒŠƒh[ƒ‹, ƒJƒ‹ƒeƒIƒ[ƒ‹‚¨‚æ‚уrƒyƒŠƒfƒ“‚ÌŒoŒû•¹—p“Š—^Žž‚É‚¨‚¯‚é–ò—ÍŠw“I‘ŠŒÝì—p‚ÌŒŸ“¢. ˆä‘òŽu–¼–ìi¸jCŒF’J—YŽ¡i–ò—jC“àŠCŒõ’©C‹g‰ª³ÆCi¸jC–ؔÉiŠájCH“¡¯ŽŸi‘å’Ë»–òjCŽO‰Y’å‘¥C‘ºèŒõ–Mi¸j: ‘æ28‰ñ“ú–{_Œo¸_–ò—Šw‰ï i98.10.23j, “Œ‹ž, “ú–{_Œo¸_–ò—ŠwŽGŽ, 18(6): 384, 1998.

3282. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¸_•ª—ô•aŠ³ŽÒ‚É‚¨‚¯‚éclozapine‚Ì–ò•¨“®‘ÔŠw“IŒŸ“¢|Œø‰Ê‚ƈÀ‘S«‚ð‚Ó‚Ü‚¦‚Ä|. ‘ºèŒõ–Mi¸jC¬ŽRŽiCŽO‰Y’å‘¥i¸jC‘¼: ‘æ28‰ñ“ú–{_Œo¸_–ò—Šw‰ï i98.10.23j, “Œ‹ž, —\eW, p.188, 1998.

3283. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œü¸_–òŠJ”­‚ɂ܂‚í‚éŒoŒ±‚©‚ç. ‘ºèŒõ–Mi¸j: ‘æ28‰ñ“ú–{_Œo¸_–ò—Šw‰ï i98.10.23j, “Œ‹ž, —\eW, p.52`53, 1998.

3284. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒCƒ“ƒ^[ƒtƒFƒƒ““Š—^Š³ŽÒ‚É‚¨‚¯‚é’è—Ê”]”g‰ðÍ. ˆî“cŒ’C‚‹´–¾”äŒÃC‹g“c–FŽqi¸jC‹g‘º‹vmŽqi¶•¨•¨—ŒnjCˆîŒ©ˆòºC‘ºèŒõ–Mi¸j: ‘æ28‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ïŠwpW‰ï i98.11.12j, _ŒË.

3285. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¸_‰È’ʉ@’†‚ÌŠ³ŽÒ‚ÌŽ©ŽEŠé‰æ‚ɂ‚¢‚Ä. ÷ˆäO”TC’ç–M•Fi¸jC’ËŒ´“ÖŽqi‹î–Ø–ì•a‰@jC‰¡ŽR³@C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.12`14j, ‚¼.

3286. mŠw‰ïi‘S‘jn iŒöŠJuÀj R•sˆÀ–ò¥‡–°–ò‚̳‚µ‚¢Žg‚¢•û. ‘ºèŒõ–Mi¸j: ‘æ33‰ñ“ú–{ƒAƒ‹ƒR[ƒ‹¥–ò•¨ˆãŠw‘‰ï i98.08.29j, ¼‹{, “ú–{ƒAƒ‹ƒR[ƒ‹¥–ò•¨ˆãŠw‰ïŽ, 33(4): 332`333, 1998.

3287. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ‡–°“±“üÜ‚Ì•›ì—p‚ð’†S‚É. ΋½‰ªƒi¸j: ‘啪Œ§¸_‰Èˆã‰ï i98.06.24j, ‘啪.

3288. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ‚¤‚•aŽ¡—Â̖¾“ú‚Ö‚ÌŠú‘Ò. ‘ºèŒõ–Mi¸j: ‘æ7‰ñ“ŒŠC–ò•¨Ž¡—ÃŒ¤‹†‰ï i98.08.01j, –¼ŒÃ‰®, —\eW, p.13`20, 1998.

3289. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹‘åŽq‹{‹ØŽî‚É”º‚¤‚“x‚Ì•nŒŒ‚É‚æ‚è, ‚¹‚ñ–Ï‚ð’悵‚½‚P—á. Vˆä~ŽqCÎì•qŽqCˆÀˆä³C‚‹´–¾”äŒÃC΋½‰ªƒC‘ºèŒõ–Mi¸j: ‘æ126‰ñ_“Þ쌧¸_ˆãŠw‰ï—á‰ï i98.07.00j, ‰¡•l.

3290. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ‚킪‘‚É‚¨‚¯‚éŒü¸_–ò‚ÌŠJ”­‚ÌŒ»ó. ΋½‰ªƒi¸j: ‘æ30‰ñGeneral Hospital PsychiatryŒ¤‹†‰ï i98.06.20j, “Œ‹ž.

3291. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ¸_ˆãŠw“IŽ¾Š³‚É‚æ‚éƒZƒƒgƒjƒ“‚Ì–ðŠ„|V‚µ‚¢Œü¸_–ò‚ÌŠJ”­‚ð‚ß‚®‚Á‚Ä|. ‘ºèŒõ–Mi¸j: ‘æ2‰ñŠˆ«ƒAƒ~ƒ“‚ÉŠÖ‚·‚éƒ[ƒNƒVƒ‡ƒbƒv i98.08.21j, “Œ‹ž, —\eW, p.5, 1998.

3292. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j R¸_•a–ò‚ÌŠJ”­‚ÆŽ¡Œ±‚Ö‚ÌŠú‘Ò. ‘ºèŒõ–Mi¸j: “ú–{ˆã–ò•iî•ñŠwŒ¤‹†‰ï i99.01.23j, “Œ‹ž, —\eW, p.3`4, 1999.

3293. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‡–°áŠQ‘Û•ª—Þ‚ÆŒ´ˆö•]‰¿. ‚‹´–¾”äŒÃi¸j: CNS Symposium 1998 i98.10.03j, “Œ‹ž.

3294. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ¸_•ª—ô•aŽ¡—Öò‚Ì–¾“ú‚Ö‚ÌŠú‘Ò. ‘ºèŒõ–Mi¸j: Ž­Ž™“‡Œ§ˆãŽt‰ïŠwpu‰‰‰ï i98.00.00j, Ž­Ž™“‡.

3295. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j R•sˆÀ–ò, ‡–°–ò‚ÌŽg‚¢•û‚Æ•›ì—p‚ɂ‚¢‚Ä. ‘ºèŒõ–Mi¸j: •½¬9”N“x“Œ‹ž“s—Žq–òÜŽt‰ï‘æ‡VuÀ i98.02.21j, “Œ‹ž.

3296. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j R¸_•a–ò‚ɂ‚¢‚Ä. ΋½‰ªƒi¸j: _“Þ쌧•a‰@–òÜŽt‰ï‚SŒŽ–òŠwŒ¤C‰ï i98.04.18j, ‘Š–ÍŒ´.

3297. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‡–°“±“üÜ‚ÌŽg‚¢•û‚Æ•›ì—p. ΋½‰ªƒi¸j: ˆïé¸_ˆã‰ï i98.11.11j, …ŒË.

3298. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‚—îŽÒ‚̇–°áŠQ. ‘ºèŒõ–Mi¸j: ’©“úV•·ˆã—ÃZƒ~ƒi[ i98.12.19j, _ŒË, —\eW, 1998.

3299. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j •sˆÀ‚Æ‚¤‚‚̖ò•¨Ž¡—Ã. ‘ºèŒõ–Mi¸j: “Œ‹ž“sé–k’n‹æƒTƒCƒR¥ƒtƒBƒWƒIˆã—ç˜b‰ï i99.02.20j, “Œ‹ž.

3300. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‚¤‚•a‚ÌV‚µ‚¢–ò•¨Ž¡—Ã|SSRI‚ð’†S‚É‚µ‚Ä|. ΋½‰ªƒi¸j: _“Þ쌧¸__Œo‰Èf—Ê‹¦‰ïŠwpu‰‰‰ï i99.02.20j, ‰¡•l.

3301. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j R¸_•a–ò‚ÌŠJ”­‚ÆŽ¡Œ±‚Ö‚ÌŠú‘Ò. ‘ºèŒõ–Mi¸j: ‘æ8‰ñ–k—¢¸_ˆãŠw§˜b‰ï i99.03.13j, “Œ‹ž, —\eW, 1999.

3302. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j R¸_•a–ò‚ÌÅ‹ß‚Ì’mŒ©. ‘ºèŒõ–Mi¸j: —®‹…‘åŠwˆãŠw•”¸_‰ÈŒ¤‹†‰ï i97.10.27j, “ß”e.

3303. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j R‚¤‚–ò‚Ì–ò—ì—p‚ÆŠ³ŽÒ‚ɑ΂·‚éî•ñ’ñ‹Ÿ‚ÌŽd•û. ‘ºèŒõ–Mi¸j: ‰«“ꌧ–òÜŽt‰ï—á‰ï i97.10.27j, ‹X–ì˜p.

3304. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‚±‚ê‚©‚ç•K—v‚ÈR¸_•a–ò‚ÌŠJ”­Žv‘z. ΋½‰ªƒi¸j: R¸_•a–òŠJ”­ƒZƒ~ƒi[ i98.11.26j, “Œ‹ž.

3305. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‡–°–ò‚Ì—ðŽj‚Æ•Ï‘J. ˆä‘òŽu–¼–ìi¸j: ƒŒƒ“ƒhƒ‹ƒ~ƒ“ù10Žü”NŠwpu‰‰‰ï i98.12.17j, ‰¡•l.

3306. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j V–ò‚Ì‚à‚½‚ç‚·ˆã—Â̕ω». ΋½‰ªƒi¸j: ¸_•ÛŒ’•ŸŽƒu‰‰‰ï i99.03.25j, `–ì.

3307. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j SSRI‚Ö‚ÌŠú‘Ò‚ÆŒÀŠE. ΋½‰ªƒi¸j: CNS Symposium 1998; ‡V.‚¤‚•a‚ð‚ß‚®‚é¡“ú‚̘b‘è i98.10.03j, “Œ‹ž.


<<28 •úŽËü‰ÈŠw>>

3308. mŒ´’˜n •@o”ñƒzƒWƒLƒ“ƒŠƒ“ƒpŽî‚ÌCT‰æ‘œŠŒ©‚Æ—\Œã. –ؗR‹IC¼—Ñ—²C›MˆêC’r“crºC¼Œûˆèi•új: “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 59(3): 60`63, 1999.

3309. mŒ´’˜n ‚TΈȉº‚̬Ž™‚É‚¨‚¯‚é”]ŒŒ—¬SPECTŒŸ¸‚Ì—L—p«‚ÌŒŸ“¢. –ؗR‹ICΈ䟌ÈC–x’rdŽ¡C’r“crºC¼—Ñ—²i•új: “ú–{‰æ‘œˆãŠwŽGŽ, 17(3): 117`124, 1998.

3310. mÇ—á•ñn •Âǃoƒ‹[ƒ“•¹—p‰ºTAE‚ª‘tŒ÷‚µ‚½äB“®–¬áŽ”j—ô‚Ì‚P—á. ‘“c˜a‹MC¼Šª”Ži•újCÎ씎˜aiŠOjC•½“cŒõ”ŽC™–{Ÿ•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 9(7): 301`304, 1998.

3311. m‘àn MRA, 3D-CT, DSA, Angiography‚É‚æ‚é‰æ‘œŒŸ¸‚ÆNP«. ›Mˆêi•új: Brain Nursing, 14(10): 863`867, 1998.

3312. m‘àn ƒGƒfƒBƒgƒŠƒAƒ‹: ‹~‹}—̈æ‚É‚¨‚¯‚鋹•”CTf’fƒ}ƒjƒ…ƒAƒ‹. ˆé•”‹`Œ›i•új: ‹~‹}ˆãŠw, 22(3): 1998.

3313. m‘àn Á‰»ŠíŽ¾Š³‚ɑ΂·‚éIVR, H“¹Ã–¬áŽ; BRTO. ˆé•”‹`Œ›C¼‰iŒh“ñC‹g“c’¨Œ³i•új: Á‰»ŠíƒZƒ~ƒi[, 70: 41`50, 1998.

3314. m‘àn “ÁW|IVR30”N; ŽŸ‚È‚éƒXƒeƒbƒv‚Ö, IVR-ƒXƒeƒ“ƒg‚ÌŒ»ó‚Æ“W–]. ˆé•”‹`Œ›i•új: Vˆã—Ã, (6): 136`140, 1998.

3315. m‘àn Ò‘‰~[Ç|‰æ‘œf’f. ›Mˆêi•új: _Œo“à‰È, 49(1): 18`25, 1998.

3316. m‘àn ŠÌ‚ª‚ñ‚ÌŠÌ“®–¬Çðp(TAE). ˆé•”‹`Œ›C¼‰iŒh“ñC‘êì­˜aC²X–Ø^‹|C‹g“c’¨Œ³i•újC‘•ª–ΔŽC‚“c‰ë”Ži“àj: ‘‡—Õ°, 48(3): 458`467, 1999.

3317. m‘àn ”][ǂ̉摜f’f. ›Mˆêi•új: “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 58(12•t˜^): 1, 1998.

3318. m‘àn ‹¹•”‘å“®–¬áŽ‚ɑ΂·‚éŒoƒJƒe[ƒeƒ‹“IStent-grafts—¯’up. ¼Šª”ŽCˆé•”‹`Œ›C‘êì­˜aC¼‰iŒh“ñi•újC—Ñ@”ŽC’¬ˆä³li‹¹ŠOjC¡ˆäŠ°i–@ˆãjC¬Œ´–M‹`i‹¹ŠOj: “ú–{ŒŒŠÇ‘¢‰eƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒiƒ‹ƒ‰ƒWƒIƒƒW[Šw‰ïŽGŽ, 14(1): 34`40, 1999.

3319. m‘àn “ÁW: ‹¹¥• •”‹~‹}Ž¾Š³‚ÌIVR-‹¹•”; S¥‘匌ŠÇ. ˆé•”‹`Œ›C¼Šª”ŽC¼‰iŒh“ñC‘êì­˜aC²X–Ø^‹|i•újC‹à鳉ÀiŠOjC‘Š”nˆêˆåi‹~–½j: —Õ°‰æ‘œ, 15(1): 46`53, 1999.

3320. m‘àn ”’Ž¿“à‚ÌT2‹­’²‘œ‚Å‚ÌL”Ä‚È‚M†‚ðŽå‘Ì‚Æ‚·‚é•a•Ï. ›Mˆêi•új: —Õ°‰æ‘œ, 15(2): 156`165, 1999.

3321. muÀn ŽÀ–±ƒZƒ~ƒi[, •úŽËü–hŒì—pÝ”õ¥‹@Ší‚Ì—˜—p(3)ƒCƒ[ƒWƒ“ƒOƒvƒŒ[ƒg‚¨‚æ‚у}ƒCƒNƒƒvƒŒ[ƒg‚Ì—˜—p‚Æ’ˆÓŽ–€. ’†‘òŒ\Ž¡i•újC–؟ŒÈiRIŒnj: Isotope News, (527): 36`41, 1998.

3322. muÀn _Œo•úŽËü; Ò’Å. ›Mˆêi•új: ‰æ‘œf’f, 18(7): 762`763, 1998.

3323. muÀn _Œo•úŽËü; Žîá‡. ›Mˆêi•új: ‰æ‘œf’f, 19(1): 86`87, 1999.

3324. m‹³‰È‘n i•ª’SŽ·•Mj “ª•”‰æ‘œf’fŠw; ”][Ç, p.54`71, ›Mˆêi•új. •ÒW ‘OŒ´’‰sC•ÒC ’†ŠOˆãŠwŽÐ, “Œ‹žC98.04.01”­s.

3325. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j SPIO-enhanced MRI for well-differentiated hepatocellular carcinoma: Radiological-pathologic correlation. ²X–Ø^‹|Cˆé•”‹`Œ›C¼‰iŒh“ñC‘êì­˜aCŽR‰ºiC’†Œ´çqC¼—Ñ—²i•újCŽO•xO”Vi•a—jC‘•ª–ΔŽi“àj: International Symposium: Abdominal Imaging 1999 i99.01.22j, ŒF–{.

3326. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Asymmetrical position of the fornix with reference to mamillary body: MR image observation. ›MˆêC’r“crºC¼—Ñ—²i•új: ‘æ36‰ñ•Ä‘_Œo•úŽËüŠw‰ï i98.05.17`21j, ƒtƒBƒ‰ƒfƒ‹ƒtƒBƒA, —\eW, p.428, 1998.

3327. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Radiological intervention in 3 cases with chronic melena from variceal collaterals in the hepatico/pancreatico-jejunal anastomosis due to portalvein occlusion after pancreatoduodenectomy. ˆé•”‹`Œ›C¼‰iŒh“ñC‘êì­˜aC²X–Ø^‹|C‹g“c’¨Œ³i•új: ‰¢BIVRŠw‰ï i98.09.27j, ƒ”ƒFƒjƒX, Cardiovasc. Intervent. Radiol., 21(Suppl.): 1998.

3328. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j CT-guided celiac plexus and splanchnic nerve neurolysis for control of pancreatic cancer pain. ã–ìŒbŽqi“Œ—ˆã‘åjCˆé•”‹`Œ›i•újC–Ø‘ºC•Ÿ“cºC¡òrGC‚茒i“Œ—ˆã‘åj: ‰¢BIVRŠw‰ï i98.09.27j, ƒ”ƒFƒjƒX, Cardiovasc. Intervent. Radiol., 21(Suppl.): 1998.

3329. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical utility of T2 weighted fast recovery FSE (T2 FRFSE): Can it be used as a substitute for T2 weighted images. ¼‰iŒh“ñCˆé•”‹`Œ›C‹g“c’¨Œ³i•új: ‘æ84‰ñ–k•Ä•úŽËüŠw‰ï i98.11.29j, ƒVƒJƒS, Radiology, 209(Suppl.): 1998.

3330. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j V‚µ‚¢‰æ‘œf’f‚Æinterventional radiology‚Ì‹~‹}‰ž—p. ˆé•”‹`Œ›i•új: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.12j, ‚¼.

3331. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j B-RTO‚É‚æ‚éˆÝ֬᎓—á‚ÌŒŸ“¢‚Æ¡Œã‚Ì“W–]. ˆé•”‹`Œ›i•új: ‘æ5‰ñ“ú–{–å–¬ˆ³˜´iÇH“¹Ã–¬áŽŠw‰ï i98.09.03j, •Ÿ‰ª.

3332. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j MRI‚ÌÅVƒgƒsƒbƒNƒX; ”]Ò‘—̈æMRI‚̃gƒsƒbƒNƒX. ›Mˆêi•új: “ú–{Ž¥‹C‹¤–ˆãŠw‰ï i98.09.24j, ‹ž“s.

3333. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹~‹}ˆã—Â̌»ê‚Å•úŽËü‰Èˆã‚͉½‚ð‚·‚×‚«‚©H ¼Šª”Ži•új: ‘æ34‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G‘å‰ï i98.10.05`07j, “Œ‹ž, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 58(10): 333, 1998.

3334. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹~‹}Ž¾Š³‚É‚¨‚¯‚é’YŽ_ƒKƒXDSA‚Ì—L—p«‚ÉŠÖ‚·‚é—Õ°Œ¤‹†. ¼Šª”ŽC‘êì­˜aC‹g“c’¨Œ³C¼‰iŒh“ñC–k–ì‰ëŽjCˆé•”‹`Œ›C¼—Ñ—²i•új: ‘æ57‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï i98.04.09`11j, _ŒË, “ú–{ˆãŠw•úŽËüŠw‰ïŽ, 58(2): 128, 1998.

3335. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒCƒ[ƒWƒ“ƒOƒvƒŒ[ƒg‚É‚æ‚éŠjˆãŠw‰æ‘œŽB‘œ‚ÌŽŽ‚Ý. ’†‘òŒ\Ž¡C–x’rdŽ¡i•újC]“¡‰ëOi•xŽmƒtƒBƒ‹ƒ€¥ƒTƒCƒGƒ“ƒXjC_‹{ŽiŒö“ñC‹e’rŒhC‘¾“cK—˜i•úŽËü•”jC–؟ŒÈiRIŒnjC¼Šª”ŽCΈ䟌ÈC ¼—Ñ—²i•új: ‘æ57‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï i98.04.09j, _ŒË, “ú–{ˆãŠw•úŽËüŠw‰ïŽ, 58(2): 97, 1998.

3336. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “ªŒz•””ñƒzƒWƒLƒ“ƒŠƒ“ƒpŽî‚ÌŽ¡—ìÑ. –ؗR‹IC¼—Ñ—²C¼ŒûˆèC–k–ì‰ëŽji•újC”n‰z’q_C”ª”ö˜a—YC‚‹´LbiŽ¨•@j: ‘æ57‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï i98.04.11j, _ŒË.

3337. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j RI‚É‚æ‚éSŽ¾Š³Š³ŽÒ‚Ì‹ÇŠ”xŒŒ‰t—Ê‚Ì•]‰¿. ’†‘òŒ\Ž¡CΈ䟌Èi•új: ‘æ37‰ñ“ú–{MEŠw‰ï i98.05.14j, ‘q•~, ˆã—p“dŽq‚ƶ‘ÌHŠw, 36(Suppl.): 335, 1998.

3338. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j SPECT‘œ‚Ì3ŽŸŒ³•\Ž¦‚É‚æ‚é”]ŒŒŠÇáŠQŠ³ŽÒ‚Ì‹ÇŠ”]ŒŒ—¬—Ê‚Ì•]‰¿. ’†‘òŒ\Ž¡C–x’rdŽ¡CΈ䟌Èi•újC‹e’rŒhCV‹{ŽiŒö“ñC‘¾“cK—˜i•úŽËü•”jC¼—Ñ—²i•új: ‘æ17‰ñ“ú–{ˆã—p‰æ‘œHŠw‰ï i98.07.29j, “Œ‹ž, Medical Imaging Technology, 16(4): 475`476, 1998.

3339. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –å–¬ˆ³˜´iǂɑ΂·‚éTIPS‚Ì—L—p«‚ÉŠÖ‚·‚鑽Ž{Ý‹¤“¯Œ¤‹†. ˆé•”‹`Œ›i•újC‘•ª–ΔŽi“àjC‹à‘òG“TC¼“c‹ÏC‰““c÷C‰äÈ”ü‹vC“c’†Ž–¾C£ÝGˆê: ‘æ5‰ñ“ú–{–å–¬ˆ³˜´iÇH“¹Ã–¬áŽŠw‰ï i98.09.03j, •Ÿ‰ª.

3340. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌÖ¬•Âǂ𔺂¤Budd-ChiariÇŒóŒQ‚É‚¨‚¯‚éŠÌ“àŒŒs“®‘Ô‚ÌŒŸ“¢. ¼‰iŒh“ñCˆé•”‹`Œ›C‘êì­˜aC‹g“c’¨Œ³i•újC‘•ª–ΔŽC‚“c‰ë”Ži“àj: ‘æ5‰ñ“ú–{–å–¬ˆ³˜´iÇH“¹Ã–¬áŽŠw‰ï i98.09.03j, •Ÿ‰ª.

3341. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j q‹ó‹@“‹æ’†‚̉F’ˆü‚É‚æ‚é”픘ü—Ê‚Ì‘ª’è. ’†‘òŒ\Ž¡i•újC‰ª–ì^Ž¡i•úŽËü‰e‹¿‹¦‰ïjC–؟ŒÈiRIŒnjC¼—Ñ—²i•új: ‘æ76‰ñ“ú–{ˆãŠw•úŽËü•¨—Šw‰ï i98.09.20j, ˆïé, •úŽËüˆãŠw•¨—, 18(Suppl.): 271`272, 1998.

3342. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒðŠ´_ŒoŒnŽîᇂɑ΂·‚é123I-MIBGƒVƒ“ƒ`ƒOƒ‰ƒtƒB|Ž¡Œ±‘æ‡U,‡V‘Š‚ÌŽg—pŒoŒ±|. –ؗR‹IC–x’rdŽ¡CΈ䟌ÈC’†‘òŒ\Ž¡i•új: ‘æ38‰ñ“ú–{ŠjˆãŠwŠw‰ï‘‰ï i98.10.15j, ‚¼.

3343. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒŠÇŒ`¬p‚ª—L—p‚Å‚ ‚Á‚½‹}«‘å“®–¬‰ð—£‚É‚æ‚鉺Žˆ‹•ŒŒ‚Ì‚P—á. ¼Šª”ŽC‘êì­˜ai•újC—Ñ@”Ži‹¹ŠOjC¡ˆäŠ°i–@ˆãjCˆé•”‹`Œ›i•újC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ12‰ñS‘ŸŒŒŠÇ“àŽ‹‹¾ƒŒ[ƒU[Œ`¬pŒ¤‹†‰ï i98.10.24j, ‘åã, —\eW, p.45, 1998.

3344. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j dÇ‹}«äX‰Š‚ɑ΂·‚éäXy‘f‘jŠQ–ò, R¶ÜŽ‘±—Ö@‚Ì—L—p«‚ÉŠÖ‚·‚é—Õ°“IŒ¤‹†. ¼Šª”ŽC‘êì­˜ai•újC•½“cŒõ”Ži‹~–½jC¡òOi“àjCó—˜–õi‹~–½jC‘꓇í‰ëiŠOjC™–{Ÿ•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.12`14j, ‚¼, “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 9(9): 459.

3345. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒƒ‹ƒ_ƒCƒGƒ‹—Ö‚¨‚æ‚ÑŒz•”ƒŠƒ“ƒpߌ´”­”ñƒzƒWƒLƒ“ƒŠƒ“ƒpŽî‚ÌŽ¡—ìÑ. –ؗR‹IC¼—Ñ—²C¼ŒûˆèC–k–ì‰ëŽji•újC”n‰z’q_C”ª”ö˜a—YC‚‹´LbiŽ¨•@j: ‘æ11‰ñ“ú–{•úŽËüŽîᇊw‰ï i98.11.22j, ‘O‹´.

3346. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j SPECT‚É‚æ‚é‹•ŒŒ«SŽ¾Š³Š³ŽÒ‚Ì‹ÇŠtŒŒ‰t—Ê‚Ì‘ª’è. ’†‘òŒ\Ž¡C–x’rdŽ¡CΈ䟌ÈC¼Šª”Ži•újC‹e’rŒhC_‹{ŽiŒö“ñC‘¾“cK—˜CˆË“cˆêdi•úŽËü•”j: ‘æ38‰ñ“ú–{ŠjˆãŠw‰ï i98.10.15j, ‚¼, ŠjˆãŠw, 35(7): 634, 1998.

3347. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠjˆãŠw‚É‚æ‚é‹•ŒŒ«SŽ¾Š³Š³ŽÒ‚Ì‹ÇŠŠÌŒŒ‰t—Ê‚Ì‘ª’è. ’†‘òŒ\Ž¡C–x’rdŽ¡CΈ䟌Èi•új: ‘æ35‰ñ“ú–{—Õ°¶—Šw‰ï i98.10.23j, “ß{, “ú–{—Õ°¶—Šw‰ïŽ, 28(Suppl.): 122`123, 1998.

3348. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Sƒv[ƒ‹ƒVƒ“ƒ`‚ª•a‘Ô‚ð‚æ‚­Ž¦‚µ‚½cŠu“àŒŒŠÇŽî‚ÆŽv‚í‚ê‚é‚P—á. ‘“c˜a‹MC–x’rdŽ¡C¼ŒûˆèC’†‘òŒ\Ž¡Có–ì—Y“ñCΈ䟌Èi•új: ‘æ50‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i99.01.30j, “Œ‹ž.

3349. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ’†Ž¨‚¨‚æ‚Ñ“û“Ë“´‚É•a‘ƒ‚ÌŽå‘Ì‚ð”F‚ß‚½ƒEƒFƒQƒi[“÷‰èŽî‚Ì‚P—á. –ؗR‹IC›MˆêC–î“àŒ´‹vC¬“‡—¢‰›C¼—Ñ—²i•új: ‘æ11‰ñ“ªŒz•”•úŽËüŒ¤‹†‰ï i98.10.05j, “Œ‹ž.

3350. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j PIXE‚É‚æ‚éLECƒ‰ƒbƒgŠÌ‘ŸCu‚Ì“®‘Ô•ªÍ. ‘¾“cŒ°¬C¼—Ñ—²i•új: ‘æ16‰ñPIXEƒVƒ“ƒ|ƒWƒEƒ€ i98.10.30j, ”ª”¦•½, —vŽ|W, p.43, 1998.

3351. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒzƒ‹ƒ}ƒŠƒ“ˆ—‚É‚æ‚é‘ŸŠíŒ³‘f”Z“x‚Ì•Ï“®. ‘¾“cŒ°¬C¼—Ñ—²i•újC’†ŽR–ÎMCŽOŒ´°]iŽÀ“®ŒnjC¢—Çkˆê˜YiŠâŽèˆã‘åjC“ñƒcìÍ“ñC”©ŽR’qCÄ“¡‹`OiNMCCj: ‘æ4‰ñm‰È‹L”OƒTƒCƒNƒƒgƒƒ“ƒZƒ“ƒ^[‹¤“¯—˜—pŒ¤‹†¬‰Ê•ñ‰ï i98.05.09j, ŠâŽè, —vŽ|W‡X, 132, 1998.


<<29 –ƒŒ‰ÈŠw>>

3352. mŒ´’˜n Propofol-induced increase in vascular capacitance is do to inhibition of sympathetic vasoconstrictive activity. ŠO{”ü•vi–ƒjCŽR‰YŒ’i‹ã‘åjC’|’†’qºi–ƒjC‚‹´¬•ãi‹ã‘åj: Anesthesiology, 89: 1495`1500, 1998.

3353. mŒ´’˜n High predictive value of red cell volume measurement using carboxy-haemoglobin in a rabbit model of haemorrhage. Obata, H.CGoto, F.CNara, T.CKunimoto, F.COriuchi, N.iŒQ‘åjCŽOŽÄŠG—¢CNemoto, M.i–ƒj: Br. J. Anaesth., 81(6): 940`944, 1998.

3354. mŒ´’˜n Epidural saline solution prior to local anaesthetic produces differential nerve block. ‰œ•xr”VCŠO{”ü•vi–ƒj: Can. J. Anaesth., 45(11): 1091`1093, 1998.

3355. mŒ´’˜n Human eotaxin induces eosinophil extravasation through rat mesenteric venules: role of ƒ¿4 integlins and vascular cell adhesion molecule-1. ‰iˆäˆê¬i–ƒjCLarkin, S.CHartnell, A.CLarbi, K.CRaziaghaknani, M.CWindley, C.CDavis, D.CLobb, R.R.CWilliams, T.J.CNoursharg, S.: Immunology, 96(2): 176`183, 1999.

3356. mŒ´’˜n Consideration of the optimal equidural fentanyl doses in abdominal surgery. rì^”Vi‘æˆê¶–½jCŠO{”ü•vi–ƒj: J. Clin. Anesth., 10: 551`556, 1998.

3357. mŒ´’˜n ’鉤؊Jp’†‚Ìd–ŒŠOƒ‚ƒ‹ƒqƒl“Š—^‚ªŽYåñ‘Šú‚Ì“û`•ª”å‹y‚ÑŽ™‚Ì‘Ìd‘‰Á—¦‚É‹y‚Ú‚·‰e‹¿. ÎŽR—R—¢C‰œ•xr”VCŠO{”ü•vi–ƒj: “ú–{—Õ°–ƒŒŠw‰ïŽ, 18(6): 581`585, 1998.

3358. mŒ´’˜n ƒ‚ƒ‹ƒqƒl‚©‚çƒtƒFƒ“ƒ^ƒj[ƒ‹‚Ö‚Ì•ÏX‚É‚æ‚éisŠàŠ³ŽÒ‚̈ӎ¯ƒŒƒxƒ‹‚̉ü‘P. “IꌳOCŽO’J_”VCŠâŠ_ŽqC•Šâ­”VC²£Žõ”üCŠO{”ü•vi–ƒj: –k—¢ˆãŠw, 28(21): 53`57, 1998.

3359. m‘àn –ƒŒƒKƒX‚Í‚±‚ê‚©‚ç‚Ç‚¤‚È‚é‚©. ŠO{”ü•vi–ƒj: Medical Gas, 1(1): 96`98, 1998.

3360. m‘àn Ý‘î‚ÅŽn‚߂邪‚ñ‚Ì’É‚ÝŽ¡—Ã. “IꌳOi–ƒj: ƒ^[ƒ~ƒiƒ‹ƒPƒA, 8(2): 119`124, 1998.

3361. m‘àn Ráz¹–ò, R‚¤‚–ò, ƒXƒeƒƒCƒh‚ÌŠàáu’ɂɑ΂·‚é“K‰ž. “IꌳOi–ƒj: ƒyƒCƒ“ƒNƒŠƒjƒbƒN, 19(5): 687`694, 1998.

3362. m‘àn ‚ ‚½‚Ü‚Ì‚È‚©‚Ì‚­‚é‚¢‚²‚Æ. ŠO{”ü•vi–ƒj: ƒyƒCƒ“ƒNƒŠƒjƒbƒN, 19(8): 1107, 1998.

3363. m‘àn ƒhƒpƒ~ƒ“‚ƃhƒuƒ^ƒ~ƒ“‚ÌŽüpŠúzŠÂŠÇ—‚É‚¨‚¯‚éŽg‚¢•ª‚¯. ŠO{”ü•vi–ƒj: zŠÂ§Œä, 19(2): 160`164, 1998.

3364. m‘àn ƒ‚ƒjƒ^[‚ÌŠ×âv. ŠO{”ü•vi–ƒj: –ƒŒ, 47: 391, 1998.

3365. m‘àn ¬l‚ÌS‘Ÿ¥‘匌ŠÇ–ƒŒ‚É‚¨‚¯‚éÖ¬–ƒŒ–ò‚Ì’·Š‚Æ’ZŠ. ’|’†’qºCŠO{”ü•vi–ƒj: —Õ°–ƒŒ, 22(3): 337`341, 1998.

3366. m‘àn Neuropathic Pain‚Ì”­Œ»‹@˜. ˆÀ—¢•¶—YC’‡–ìLC¼èd”VC‹àˆäº•¶CŠÛŽRGCÎŽR—R—¢C’|˜Q–¯]C“IꌳOC‰œ•xr”VC’|’†’qºC‰iˆäˆê¬CŠO{”ü•vi–ƒj: —Õ°–ƒŒ, 22(4): 533`538, 1998.

3367. m‘àn ‘æ19‰ñ“ú–{zŠÂ§ŒäˆãŠw‰ï‘‰ïwˆóÛ‹Lx. ŠO{”ü•vi–ƒj: —Õ°–ƒŒ, 22(8): 1189, 1998.

3368. muÀn ƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^‚É‚æ‚é”MŽ–ŒÌ. ‰iˆäˆê¬i–ƒj: Clin. Eng., 9(9): 842`846, 1998.

3369. muÀn u–³’É•ª•Øv‰ŽY•w—á. ‰œ•xr”Vi–ƒj: Life Support and Anesthesia, 6(2): 134`139, 1999.

3370. muÀn ƒi[ƒX•KŒ©|ŽèpŽº‚Ì‹~‹}ˆ’u 2.S“d}ˆÙí. ’|’†’qºCŠO{”ü•vi–ƒj: OPE Nursing, 13(12): 1166`1170, 1998.

3371. muÀn ”ñƒXƒeƒƒCƒh«Á‰Š’Á’É–ò‚Ì‘I‘ð‚ÆŽg‚¢•û|–òÜ‚ÆÜŒ^‘I‘ð‚Ìl‚¦•û. “IꌳOi–ƒjC’r“c—R”üŽqi–òÜj: ‚ª‚ñŠÅŒì, 3(4): 297`302, 1998.

3372. muÀn “ÁWu¬ldÇšb‘§”­ì‚ÌŠÇ—v‹z“ü–ƒŒ–ò‚Ì“K‰ž‚ÆŽÀÛ|–ƒŒ‰Èˆã‚Ì—§ê‚©‚ç|. ‰iˆäˆê¬i–ƒj: ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 19(1): 37`41, 1999.

3373. muÀn ‹CŠÇŽxšb‘§‚ÌdÏ”­ì; –ƒŒ‰Èˆã‚Ì—§ê‚©‚ç. ‰iˆäˆê¬CŠO{”ü•vi–ƒj: —Õ°ˆã, 24(6): 836`841, 1998.

3374. muÀn Ž¿‹^‰ž“š; ƒy[ƒXƒ[ƒJ‘•’…Š³ŽÒ‚Ì–ƒŒ‚ɂ‚¢‚Ä. ’|’†’qºCŠO{”ü•vi–ƒj: —Õ°–ƒŒ, 22(12): 1746`1747, 1998.

3375. m‹³‰È‘n i•ª’SŽ·•Mj –ƒŒ‹Ù‹}u‚ ‚È‚½‚È‚ç‚Ç‚¤‚·‚év‚̃Rƒc‚ƃ|ƒCƒ“ƒg; –ƒŒ’†šb‘§”­ì, 2: 64`65, Š·‹C¢“ï, 2: 80`81, ‰iˆäˆê¬i–ƒjC‰Á“¡´Žii‘O‹´Ô\Žš•a‰@j. •ÒW ‰Ô‰ªˆê—Yi“Œ‘åjC•ÒC Ž½“°o”Å, “Œ‹ž, 98.04.08”­s.

3376. m‹³‰È‘n i•ª’SŽ·•Mj –ƒŒ‹Ù‹}u‚ ‚È‚½‚È‚ç‚Ç‚¤‚·‚év‚̃Rƒc‚ƃ|ƒCƒ“ƒg; d–ŒŠO–ƒŒ, d–ŒŠOúŽh¢“ï, p.132`133, ‰œ•xr”Vi–ƒjC‰Á“¡´Žii‘O‹´Ô\Žš•a‰@j. •ÒW ‰Ô‰ªˆê—Yi“Œ‘åjC•ÒC Ž½“°o”Å, “Œ‹žC98.04.08”­s.

3377. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj —Õ°ŒÄ‹z‹@”\ŒŸ¸1998‰ü’ù”Å; ‹CŠÇ“à‘}ŠÇ‚ÆlHŒÄ‹zŠíƒPƒA, p.388`394, ŠO{”ü•vi–ƒj. •ÒW ”x‹@”\ƒZƒ~ƒi[C•ÒC ”x‹@”\ƒZƒ~ƒi[, 98.00.00”­s.

3378. m–|–ón iŠÄCj ŽY‰È–ƒŒƒnƒ“ƒhƒuƒbƒN; ŠÄC ‰œ•xr”Vi–ƒjC•ÒC ˆãŠw‘‰@MYW, “Œ‹žC98.07.10”­s.

3379. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Histological evidence for neurotoxicity of intrathecal tetracaine: The posterior root nerve near the entry into the spinal cord is the target. ’|˜Q–¯]i–ƒjC–ö‰ºŽO˜Yi_“Þ샊ƒnƒrƒŠƒZƒ“jCˆÀ—¢•¶—YCŠO{”ü•vi–ƒj: American Society of Anesthesilogists i98.10.20j, Orlando, U.S.A.

3380. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Review of Cardiovascular Interactions. ŠO{”ü•vi–ƒj: 6th International Congress of Cardiothoracic and Vascular Anesthesia i98.09.02j, Santiago, Chile.

3381. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Quantitative analysis of left ventricular regional wall motion with color kinesis during abdominal aortic cross clamping. ŽR‰YŒ’i‹ã‘åjCŠO{”ü•vi–ƒjC‰ª–{_ŽkCŒ´‘ò‘×”äŒÃC‚‹´¬•ãi‹ã‘åj: American Society of Anesthesilogists i98.10.20j, Orlando, U.S.A.

3382. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Epidural epinephrine infusion combined with bupivacaine may increase blood loss during labor and delivery. ‰œ•xr”Vi–ƒjC–]ŒŽƒŽqC“V–슮iŽY•wjCŠO{”ü•vi–ƒj: 73rd International Anesthesia Research Society i99.03.13j, Los Angeles, U.S.A., Anesth. Analg., 88(2s): 1999.

3383. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The effect of saline volume with loss of resistance method on subsequent local anesthetic spread. ŠFì–ƒŠóŽqC‰œ•xr”VCŠO{”ü•vi–ƒj: 73rd International Anesthesia Research Society i99.03.13j, Los Angeles, U.S.A., Anesth. Analg., 88(2s): 1999.

3384. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –ƒŒƒKƒX‚Í‚±‚ê‚©‚ç‚Ç‚¤‚È‚é‚©|ƒnƒƒ^ƒ“|. ŠO{”ü•vi–ƒj: ‘æ2‰ñ“ú–{ˆã—ÃKƒXŠw‰ï‘‰ï i98.06.11j, “Œ‹ž.

3385. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å—Êd–ŒŠOƒtƒFƒ“ƒ^ƒj[ƒ‹“Š—^‚ª‘}ŠÇŽž‚ÌzŠÂ“®‘Ô‚É‹y‚Ú‚·‰e‹¿‚Æ‚»‚ÌŽž‚ÌŒŒ’†ƒtƒFƒ“ƒ^ƒj[ƒ‹”Z“x‚ɂ‚¢‚Ä. ‹àˆäº•¶C‰œ•xr”VCŠO{”ü•vi–ƒj: “ú–{–ƒŒ–ò—Šw‰ï‘‰ï i98.06.11j, “Œ‹ž.

3386. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚ª‚ñáu’ÉŽ¡—Âł̃‚ƒ‹ƒqƒl‚ƃtƒFƒ“ƒ^ƒj[ƒ‹‚É‚æ‚éŒX–°ŒXŒü‚Æ’Á’ÉŒø‰Ê‚Ì”äŠr. “IꌳOi–ƒjC‰Á‰ê’J”£C’r“c—R”üŽqi–òÜjC‹ß“¡‚Ü‚ä‚Ýi‘‡‘Š’k•”jC‹{–{ˆ»Žqi“Œ‹ž–ò‰È‘åjCŠO{”ü•vi–ƒj: ‘æ3‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï i99.03.20j, ‹ž“s, ‘æ3‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï‘‰ïƒvƒƒOƒ‰ƒ€¥u‰‰´˜^W, p.113, 1998.

3387. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’鉤؊Jp‚É‚¨‚¯‚éŽq‹{Žûk–òƒ}ƒŒƒCƒ“Ž_ƒƒ`ƒ‹ƒGƒ‹ƒSƒƒgƒŠƒ“‚ÌŽŠ“K—Ê. ŠâŠ_ŽqC‰œ•xr”VCÄ“¡”ü˜aŽqC‹àˆäº•¶CŠO{”ü•vi–ƒj: ‘æ45‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i98.04.16j, Ž­Ž™“‡.

3388. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j d–ŒŠO–ƒŒ‰ºŒoäT•ª•Ø‚̈ê”Ê—«‚Ö‚ÌZ“§“x. ‰œ•xr”VCŠO{”ü•vi–ƒj: ‘æ45‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i98.04.17j, Ž­Ž™“‡.

3389. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Tetracaine‚É‚æ‚é_Œo“Å«‚ÌŒ`‘ÔŠw“IŒŸ“¢. ’|˜Q–¯]CˆÀ—¢•¶—YCŠÛŽRGCŠO{”ü•vi–ƒj: ‘æ45‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i98.04.18j, Ž­Ž™“‡, J. Anesth., 12(Suppl.): 556, 1998.

3390. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒuƒvƒŒƒmƒ‹ƒtƒBƒ“‚©‚烂ƒ‹ƒqƒl‚Ö‚Ì•ÏX‚ªŠà«áu’É‚É‹y‚Ú‚·‰e‹¿. “IꌳOi–ƒjC‰Á‰ê’J”£i–òÜjC‘ŸºÊCŠO{”ü•vi–ƒj: ‘æ32‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŠwpW‰ï i98.07.24j, L“‡, “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ, 5(3): 324, 1998.

3391. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŒoH“¹SƒGƒR[‚©‚ç‹‚ß‚½S‘ŸŒŒŠÇ‘ŠŒÝŠÖŒW(Ea/Eas)‚ÆForrester•ª—Þ‚ÌŠÖŒW. ’|’†’qºCìèrGCˆÀÄŒ’C“y‰®ŸrCŠO{”ü•vi–ƒj: ‘æ18‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i98.10.28j, ¼ŽR.

3392. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”ñ”D•w‚ÌpŒã‘̉·ã¸‚É‚¨‚¯‚é–ƒŒ–@‚̈ٷ‚ɂ‚¢‚Ä|d–ŒŠO–ƒŒŒQ‚Æ‘Sg–ƒŒŒQ‚Ì”äŠr. Ä“¡”ü˜aŽqC‰œ•xr”VCŠO{”ü•vi–ƒj: ‘æ18‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i98.10.29j, ¼ŽR, “ú–{—Õ°–ƒŒŠw‰ïŽ, 18(8): 242, 1998.

3393. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j d–ŒŠOƒJƒe[ƒeƒ‹æ’[d“x‚Ì”äŠrŒŸ“¢. ŠFì–ƒŠóŽqC‰iˆäˆê¬CŠO{”ü•vi–ƒj: ‘æ18‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i98.10.30j, ¼ŽR.

3394. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”xŒŒŠÇ‘¹‚𔺂í‚È‚¢‹CŠÇŽx’f—ôÇ‚Ì‹Ù‹}–ƒŒ‚Ì‚P—á. ’‡–ìLC‰iˆäˆê¬C•Šâ­”VCŠO{”ü•vi–ƒj: ‘æ18‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i98.10.30j, ¼ŽR.

3395. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œz•”d–ŒŠO–ƒŒ‚ð—p‚¢‚½bó‘BŽèpŒã‚É‘J‰„«’†•_ŒoáŠQ‚𶂶‚½‚P—á. ‹´êLˆê˜YC‰iˆäˆê¬C‹àˆäº•¶CŠO{”ü•vi–ƒj: ‘æ18‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i98.10.30j, ¼ŽR.

3396. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j d–ŒŠO–ƒŒ‰º‚É•ª•Ø‚ðs‚Á‚½”D•w‚̑̉·iãüâ|‰·j㸂ɂ¨‚¯‚é‹ÇŠ–ƒŒ–ò‚Ì·‚ɂ‚¢‚Ä. ‰œ•xr”Vi–ƒjC“V–슮iŽY•wjCŠO{”ü•vi–ƒjC“cŒû‰ë”VCrˆä’‰ŽmiŽY•wj: ‘æ18‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i98.10.30j, ¼ŽR, “ú–{—Õ°–ƒŒŠw‰ïŽ, 18(8): 340, 1998.

3397. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™“Ý“I‹¹•”ŠOŒã‚Ì”ñú’Ê«SŽº’†ŠuúEÇ—á‚Ìp’†ŠÇ—. Vˆä³NC’|’†’qºi–ƒj: ‘æ3‰ñ“ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ïŠwp‘å‰ï‘‰ï i98.11.21j, ‰¡•l.

3398. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “Ý“I‹¹•”ŠO‚É‚æ‚éSƒ^ƒ“ƒ|ƒi[ƒf‚T—á‚ÌŒŸ“¢. Vˆä³Ni–ƒjC‹àŽqŒõ‘¾˜YC‰E“c‹MŽqC‹g“c¬”üC’†”ö”ü˜aŽqiŒ§—§L“‡•a‰@j: ‘æ3‰ñ“ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ïŠwp‘å‰ï‘‰ï i98.11.22j, ‰¡•l.

3399. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j S‘ŸŽèpŒã‚Ì‘Šú”²ŠÇ‚ɉe‹¿‚·‚éˆöŽq‚ÌŒŸ“¢. ‘ŸºÊC’|’†’qºCìèrGCŠO{”ü•vi–ƒj: ‘æ3‰ñ“ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ïŠwp‘å‰ï‘‰ï i98.11.22j, ‰¡•l.

3400. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹}«S‹Ø[ǂɇ•¹‚µ‚½SŽº’†ŠuúE•Â½p‚Ì–ƒŒŒoŒ±. “y‰®ŸrC’|’†’qºCìèrGCŠFì–ƒŠóŽqCŠO{”ü•vi–ƒj: ‘æ38‰ñ“ú–{–ƒŒŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i98.09.11j, b•{.

3401. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j TAE‚ÅŽ~ŒŒ‚µ“¾‚½•sˆÀ’è‹·SÇ‚ÌŽ¡—ÃŒo‰ß’†‚É”F‚ß‚ç‚ꂽ‹‘åˆÝ•Ç“àŒŒŽî‚Ì‚P—á. ²–ì—zŽqC¡òOCÂŽR’¼‘PC¼ŽR¬‘¾˜YCŒ´‰pKi“àjC¼Šª”Ži•újC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ46‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i99.02.20j, ‰¡•l, ´˜^W, p.23`23, 1999.

3402. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j D’†‹…ƒGƒ‰ƒXƒ^[ƒ[‘jŠQ–ò‚É‚æ‚é”’ŒŒ‹…Z—}§|”÷¬zŠÂƒŒƒxƒ‹‚Å‚ÌŠÏŽ@|. ‰iˆäˆê¬i–ƒj: ‘æ4‰ñHeterophilŒ¤‹†‰ï i98.12.10j, “Œ‹ž.

3403. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j –«’É¥Šà«áu’ɂɑ΂·‚éÅ‹ß‚Ì’Á’É–@. ŠO{”ü•vi–ƒj: ‘æ429‰ñˆãŠwŒ¤C‚Ì“ú i98.11.10j, ‰¡•l.

3404. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j ”ñƒIƒsƒIƒCƒh‚ÌŽg‚¢•û. “IꌳOi–ƒj: Œú¶È•ÛŒ’ˆã—ËǑ—§•a‰@•”•½¬10”N“x‚ª‚ñŠÉ˜aƒPƒA‚ÉŠÖ‚·‚éuK‰ï i99.01.29j, ç—t.

3405. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ud–ŒŠO–ƒŒ‚Ì‹ô”­Ç¥ŒãˆâÇvd–ŒŠO–ƒŒ‚¨‚æ‚Ñ‘Sg–ƒŒ‰º–³’É•ª•Ø‚Ƒ̉·ã¸. ‰œ•xr”Vi–ƒjC“V–슮iŽY•wjCŠFì–ƒŠóŽqi–ƒjC“cŒû‰ë”VCrˆä’‰ŽmiŽY•wj: ‘æ97‰ñ•ª•Ø‚Æ–ƒŒŒ¤‹†‰ï i98.12.26j, ‰¡•l.

3406. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ˆê”Ê—«‚Ìd–ŒŠO–ƒŒ‰º–³’É•ª•Ø‚Ì”F’m“x‚ɂ‚¢‚Ä. ŠFì–ƒŠóŽqC‰œ•xr”Vi–ƒj: ‘æ96‰ñ•ª•Ø‚Æ–ƒŒŒ¤‹†‰ï i98.06.13j, “Œ‹ž.

3407. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘æ‚PŽ™‚ÌoŽY“®Œü‚Æ–³’É•ª•Ø‚ª•‹y‚µ‚È‚¢——R‚ɂ‚¢‚Ä. ‰œ•xr”Vi–ƒj: ‘æ96‰ñ•ª•Ø‚Æ–ƒŒŒ¤‹†‰ï i98.06.13j, “Œ‹ž.

3408. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j šb‘§Š³ŽÒ‚Ì–ƒŒ. ‰iˆäˆê¬i–ƒj: ‘æ9‰ñ_“Þìšb‘§¥ƒAƒŒƒ‹ƒM[ƒtƒH[ƒ‰ƒ€ i98.06.27j, ‰¡•l.

3409. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‘O•‰‰×ŽwŒüŒ^zŠÂŠÇ—. ŠO{”ü•vi–ƒj: ‘æ2‰ñŒQ”nÖ¬–ƒŒŒ¤‹†‰ï i99.01.23j, ‘O‹´.

3410. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ƒ‚ƒ‹ƒqƒl‚ÆÝ‘îƒ^[ƒ~ƒiƒ‹ƒPƒA. “IꌳOi–ƒj: ‘æ218‰ñ’·–쌧²‹vˆãŽt‰ï—Õ°Œ¤C‰ï i98.04.24j, ’·–ì.

3411. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Šàáu’ÉŠÇ—‚ɂ‚¢‚Ä. “IꌳOi–ƒj: ‘æ8‰ñ–ò•¨Ž¡—ÃŒ¤‹†‰ï i98.08.26j, ‰¡•l.

3412. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ƒ‚ƒ‹ƒqƒl‚ÌŒø‚«‚É‚­‚¢Šà‚Ì’É‚Ý|‚»‚ÌŒ´ˆö‚Æ‘Îô|. “IꌳOi–ƒj: ‘æ769‰ñ“ú–{Ô\ŽšŽÐˆã—ÃZƒ“ƒ^[W’k‰ï i98.09.16j, “Œ‹ž.

3413. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŒÛ–Œ‰·“xƒZƒ“ƒT[‚É‚æ‚éŒÛ–ŒúE‚ª‹^‚í‚ꂽ‚PÇ—á. Œ³‘º–äŽqCìèrGCÎì—æŽqC’‡–ìLC’|’†’qºCŠO{”ü•vi–ƒj: _“Þì–ƒŒê–åˆã‰ï i99.02.06j, ‰¡•l.


<<30 —Õ°•a—Šw>>

3414. mŒ´’˜n Oxaprozin interference with urinary benzodiazepine immunoassays and noninterference with receptor assay. ¼ì—²i—Õ•a—jC㞊‹gli‹~–½jC‘å’J‰pŽ÷i—Õ•a—jCAlbert, D.: J. Anal. Toxicol., 23(2): 125`126, 1999.

3415. mŒ´’˜n Bilateral optic neuropathy with mitochondrial DNA9804 mutation detected by non-isotopic single-stand conformational polymorphism. Žá‘q‰ë“oC—щl—iŠájC–L‰ª—TŽqCŽR•Ó°”üi—ÕŒŸjC˜a“c’m‰vC‘å’J‰pŽ÷i—Õ•a—jCÎì“NiŠáj: Neuro-ophthalmology, 19(1): 7`12, 1998.

3416. mŒ´’˜n ”A’†ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨ŒŸo–@‚Ì•]‰¿; ‹àƒRƒƒCƒh•WŽ¯ƒCƒ€ƒmƒAƒbƒZƒC(Triage)–@‚Æ‘¼–@‚Æ‚Ì”äŠr. ¼ì—²i—Õ•a—jC‹ß“¡—¯”üŽqi–òÜjC‰œ“cF”Íi‘åŽè’¬•a‰@jC—é–Ø‘”üi¶‰»ŒnjC‘å’J‰pŽ÷i—Õ•a—j: TDMŒ¤‹†, 15(3): 243`250, 1998.

3417. mŒ´’˜n Changes of free light chains in urine in case of gammopathy. ‘å’JTˆêC‘å’J‰pŽ÷i—Õ•a—j: ¶•¨•¨—‰»Šw, 43(1): 27`30, 1999.

3418. mŒ´’˜n ƒ‹ƒ~ƒm[ƒ‹”½‰ž‚ÉŠî‚­ŠÒŒ³•¨Ž¿‚̉Ȋw”­Œõ. ‹v•Û”ŽºCÄ“¡‰ërCŽˆä—SŽqC’¹‰H—zi–òŠw•”jC¼ì—²i—Õ•a—jC’––“•üŽqC‹g‘º‹g”ŽC’†‘ò—T”Vi–òŠw•”j: •ªÍ‰»Šw, 47: 599`603, 1998.

3419. mŒ´’˜n ƒ‰ƒeƒbƒNƒX‹ÃW–Ɖu‘ª’è–@‚É‚æ‚é”A’†—V—£‚k½’è—Ê‚Ì—Õ°“IˆÓ‹`‚ɂ‚¢‚Ä. ‘å’JTˆêC‘å’J‰pŽ÷i—Õ•a—j: –k—¢ˆãŠw, 28(5): 435`445, 1998.

3420. mŒ´’˜n Left ventricular asynergy induced by elevated activity of noradrenergic nervous system: A study of 717 patients in acute phase of subarachnoid hemorrhage. ¼ŽRÄ‹vi—Õ•a—jC‘“c‘ìCŽR–{aˆê˜YC²“¡´‹Mi“àjC‘å˜a“c—²i‹~–½jC˜aò“Oi“àjC‘å’J‰pŽ÷i—Õ•a—j: –k—¢ˆãŠw, 28(6): 494`506, 1998.

3421. mŒ´’˜n ‘SŒŒ‚ð—p‚¢‚½S‹Øƒgƒƒ|ƒjƒ“‚s’è«ŽŽŒ±Ž†"ƒgƒƒbƒv‚s"‚Ì—Õ°“IŒŸ“¢. Žu‘º‰Ã•Fi—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—j: —Õ°ŒŸ¸, 42: 471`475, 1998.

3422. mŒ´’˜n —Õ°ˆãŠw‚É•K—v‚ȃRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“; —Õ°ŒŸ¸ˆãE—Õ°ŒŸ¸‹ZŽt‚Ì—§ê‚©‚ç|‘åŠw•a‰@‚Ìf—ÃŽx‰‡|. Y’J’¼li—Õ•a—j: —Õ°•a—, 46(10): 987`993, 1998.

3423. mŒ´’˜n ‘O—§‘BŠà‚̃¿2 macroglobulinŒ‡–RÇ‚É‚¨‚¯‚錌’†Prostate-specific antigen‚Ì‘¶Ý—lŽ®‚ɂ‚¢‚Ä. Žë–ì—LìC_•Û’qCa’JŽ÷ŽqC¼ŽRÄ‹vC‰vŽq‹MbC“c’†P”Ci—Õ•a—jC‰oìWi”åjC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—, 46(9): 923`929, 1998.

3424. mŒ´’˜n ‘–Œ‰Š‚É‚¨‚¯‚鑉t’†SAAiŒŒ´ƒAƒ~ƒƒCƒhA’`”’)‚Ì‘ª’è‚ɂ‚¢‚Ä. Y’J’¼li—Õ•a—jCŽsìŒbŽqi¶•¨‰»ŠwŒnjCa’JŽ÷ŽqC‰vŽq‹MbC¼ŽRÄ‹vCŽë–ì—LìC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—, 46(9): 930`935, 1998.

3425. muÀn ŒŒ´’`”’“d‹C‰j“®‚Ì‚l•ª‰æ. ‘å’JTˆêC‘å’J‰pŽ÷i—Õ•a—j: ŒŸ¸‚Æ‹Zp, 27(1): 69`74, 1999.

3426. muÀn ŒŒŸ÷’`”’|ŒŸ¸€–Ú‚ÌÄ•]‰¿|. ‘å’J‰pŽ÷i—Õ•a—j: —Õ°ŒŸ¸, 43(13): 1623`1625, 1998.

3427. mŠwp‘n i•ª’SŽ·•Mj —Õ°ŒŸ¸ƒKƒCƒh1999`2000; ŒŒ´’`”’‚Æ‚»‚Ì•ª‰æ, p.159`165, ‘å’J‰pŽ÷i—Õ•a—j. •ÒW Medical Practice•ÒWˆÏˆõ‰ïC•ÒC •¶Œõ“°, “Œ‹ž, 99.02.20”­s.

3428. mŠwp‘n i•ª’SŽ·•Mj ÅV“d‹C‰j“®ŽÀŒ±–@; ƒZƒ‹ƒ[ƒX–Œ“d‹C‰j“®–@i‘˜_j, p.13`17, Žë–ì—LìC‘å’J‰pŽ÷i—Õ•a—j. •ÒW “ú–{“d‹C‰j“®Šw‰ïC•ÒC ˆãŽ•–òo”Å, “Œ‹ž, 99.02.25”­s.

3429. mŠwp‘n i•ª’SŽ·•Mj ÅV“d‹C‰j“®ŽÀŒ±–@; ƒZƒ‹ƒ[ƒX–Œ“d‹C‰j“®–@: ‰ž—p, p.17`23, ‘å’J‰pŽ÷i—Õ•a—j. •ÒW “ú–{“d‹C‰j“®Šw‰ïC•ÒC ˆãŽ•–òo”Å, “Œ‹ž, 99.02.25”­s.

3430. mŠwp‘n i•ª’SŽ·•Mj —Õ°ŒŸ¸Year book '99|—Õ°‰»Šw: •a‰@ŒŸ¸‚Ì“¹‚µ‚é‚×|; ŒŸ¸•”‚Ì—Õ°Žx‰‡, —Õ°Žx‰‡‚ÌŽÀ‘H, p.81`90, Y’J’¼li—Õ•a—j. •ÒW ›–ì„Žji•l¼ˆã‘åjC•ÒC ‰F’ˆ“°, “Œ‹ž, 99.02.28”­s.

3431. mŠwp‘n i•ª’SŽ·•Mj “à‰ÈV‘; ŒŒŸ÷’`”’‚ÌŽí—Þ‚Æ‹@”\, p.410`413, ‘å’J‰pŽ÷i—Õ•a—j. •ÒW “‡“cŠ]i“Œ‹žê”„•a‰@jC•ÒC ’†ŽR‘“X, “Œ‹ž, 99.03.01”­s.

3432. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j Reversed CPC: ƒŠƒ“ƒpߎ‚ÌŽ¡—ÂP”NŒã‚ɉ苅‚ÌoŒ»‚ð”F‚ß‚½‚P—á. ‘å’JTˆêi—Õ•a—j: ‘æ45‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i98.11.11j, ‚’m, —Õ°•a—, 46(•â): 37, 1998.

3433. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŒŸ¸î•ñŽº‚É‚¨‚¯‚é—Õ°Žx‰‡. Y’J’¼li—Õ•a—j: ‘æ‚X‰ñ¶•¨ŽŽ—¿•ªÍ‰ÈŠw‰ï i99.02.27j, ‘Š–ÍŒ´, ¶•¨ŽŽ—¿•ªÍ, 22(1): 24, 1999.

3434. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j CRP‰A«EŠà“]ˆÚ(Œ´”­‘ƒ•s–¾)‚Ì•a‘Ô‰ðÍ. Žë–ì—Lìi—Õ•a—j: ‘æ‚X‰ñ¶•¨ŽŽ—¿•ªÍ‰ÈŠw‰ï i99.02.27j, ‘Š–ÍŒ´, ¶•¨ŽŽ—¿•ªÍ, 22(1): 42, 1999.

3435. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“‚ÌReceptor assay‚Ì—Õ°‰ž—p: –{–@Œ‹‰Ê‚É‚æ‚èí—p—ÊŽ‘±ÛŽæ’†“Å‚Æ”»–¾‚µ‚½Ç—á. ¼ì—²i—Õ•a—jC㞊‹gli‹~–½jC‘“c‘ìi“àjC’ç–M•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ118‰ñ“ú–{–òŠw‰ï i98.04.01j, ‹ž“s.

3436. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’·ŽžŠÔì—pŒ^ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“‚̘A—p‚É‚æ‚è’áˆÓŽ¯‚Æ‚È‚Á‚½‚RÇ—á: ƒŒƒZƒvƒ^[ƒAƒbƒZƒC‚Ì—Õ°‰ž—p. ¼ì—²i—Õ•a—jC㞊‹gli‹~–½jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ‚W‰ñ“ú–{•a‰@–òŠw‰ï i98.09.00j, ‰¡•l.

3437. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒuŒõ•WŽ¯“œ½•ªÍ‘•’u(FACE SE1000)‚ð—p‚¢‚½ŒŒ´IgG“œ½‚̉ðÍ. ‰vŽq‹Mbi—Õ•a—jCŽsìŒbŽqi¶•¨‰»ŠwŒnjCŽë–ì—LìCY’J’¼lC‘å’JTˆêC_•Û’qC‘å’J‰pŽ÷i—Õ•a—j: ‘æ49‰ñ“ú–{“d‹C‰j“®Šw‰ï‘‰ï i98.09.26j, ŽD–y, ¶•¨•¨—‰»Šw, 42(•âû): 43, 1998.

3438. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒ´ƒAƒ~ƒƒCƒh‚`’`”’(SAA)‚Ì‚Š´“x’è—Ê–@‚ÉŠÖ‚·‚éŠî‘b“IŒŸ“¢‚È‚ç‚Ñ‚É—Õ°“IˆÓ‹`|ä`‘ÑŒŒ‚¨‚æ‚Ñ—r…’†SAA‚Ì‘ª’è‚ɂ‚¢‚Ä|. ‘åê—Y‹gi—ÕŒŸjCY’J’¼li—Õ•a—jCŽsìŒbŽqi¶•¨‰»ŠwŒnjC”«‘º˜a’ji—ÕŒŸjC’Jº”ŽiŽY•wjC‘å’J‰pŽ÷i—Õ•a—j: ‘æ45‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i98.11.11j, ‚’m, —Õ°•a—, 46(•â): 122, 1998.

3439. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Šà“]ˆÚ‚𔺂¤‘O—§‘BŠà‚É‚¨‚¯‚éƒvƒƒeƒA[ƒ[‚ƃCƒ“ƒqƒrƒ^[‚ɂ‚¢‚Ä. Žë–ì—LìC_•Û’qi—Õ•a—jCŽsìŒbŽqi¶•¨‰»ŠwŒnjCa’JŽ÷ŽqC‘å’JTˆêC‘å’J‰pŽ÷i—Õ•a—j: ‘æ45‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i98.11.11j, ‚’m, —Õ°•a—, 46(•â): 58, 1998.

3440. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ventricular arrhythmias following subarachnoid hemorrhage are induced by dysregulation of autonomic venous system. ¼ŽRÄ‹vi—Õ•a—jC‘“c‘ìC²“¡´‹MC“y‰®’¼‹Mi“àjCŽR–{aˆê˜Yi‹~–½jC˜aò“Oi“àj: ‘æ23‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ï i99.03.28j, “Œ‹ž, “ú–{zŠÂŠíŠw‰ïŽ, 63(‘): 113, 1999.

3441. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒuƒƒ€ƒƒŒƒŠƒ‹”A‘f‚ÌŒõŠwˆÙ«‘Ì•ª—£HPLC‚ÌŠJ”­‚Æ’†“ÅŠ³ŽÒŽŽ—¿‚ւ̉ž—p. ¼ì—²C‘å’J‰pŽ÷i—Õ•a—jC㞊‹gli‹~–½jC‹ß“¡—¯”üŽqC’|“எqi–òÜj: “ú–{–òŠw‰ï‘æ119‰ñ”N‰ï i99.03.30j, “¿“‡.

3442. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŒŒ´IgG“œ½‚̉ðÍ‚Æ‚»‚Ì—Õ°“IˆÓ‹`. ‰vŽq‹Mbi—Õ•a—jCŽsìŒbŽqi¶•¨‰»ŠwŒnjC_•Û’qC‘å’J‰pŽ÷i—Õ•a—j: ‘æ45‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i98.11.11j, ‚’m, —Õ°•a—, 46(•â): 222, 1998.

3443. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “œ”A•a«tÇ‚ÌŒo‰ß’†‚Ɉ««ƒŠƒ“ƒpŽî‚Ì•¹”­‚µ‚½ƒÁ½•a‚Ì‚P—á. ‘å’JTˆêi—Õ•a—jCa’JŽ÷Žqi¶‰»ŒnjC_•Û’qC“c’†P”CCŽë–ì—LìCY’J’¼lC‘å’J‰pŽ÷i—Õ•a—j: ‘æ40‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï i98.11.13j, ‹à‘ò, —Õ°ŒŒ‰t, 39(10): 1040, 1998.

3444. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒŒ´IgG“œ½‚̉ðÍ‚Æ‚»‚Ì—Õ°“IˆÓ‹`. ‰vŽq‹Mbi—Õ•a—jCŽsìŒbŽqi¶•¨‰»ŠwŒnjC_•Û’qC“c’†P”CC¼ŽRÄ‹vC‘å’J‰pŽ÷i—Õ•a—j: ‘æ24‰ñ–k—¢ˆãŠw‰ï‘‰ï i98.11.07j, ‘Š–ÍŒ´, –k—¢ˆãŠw, 28: 521, 1998.

3445. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ŒŸ¸Žº‚Ì—Õ°ˆã‚ւ̃Rƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“‚ÌŽÀÛ. Y’J’¼li—Õ•a—j: ‘æ22‰ñ—Õ°‰»ŠwŒŸ¸Œ¤‹†”ÇŒ¤C‰ï i98.06.19j, ’·è, Œ¤C‰ïƒeƒLƒXƒg, p.16`28, 1998.

3446. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Šà“]ˆÚ‚𔺂¤‘O—§‘BŠà‚É‚¨‚¯‚éƒvƒƒeƒA[ƒ[‚ƃCƒ“ƒqƒrƒ^[‚ÉŠÖ‚·‚錟“¢. Žë–ì—LìC_•Û’qC‰vŽq‹MbC‘å’J‰pŽ÷i—Õ•a—j: ‘æ‚R‰ñ•a‘Ô‚ÆŽ¡—Âɂ¨‚¯‚éƒvƒƒeƒA[ƒ[‚ƃCƒ“ƒqƒrƒ^[Œ¤‹†‰ï i98.08.22j, –¼ŒÃ‰®.

3447. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒzƒ‹ƒ^[S“d}‰ðÍ‚É‚æ‚éƒNƒ‚–Œ‰ºoŒŒ‹}«Šú‚ÌŽ©—¥_ŒoŒnŠˆ“®‚ÆSŽº«•s®–¬‚ÌŠÖŒW‚ɂ‚¢‚Ä. ¼ŽRÄ‹vi—Õ•a—jC‘“c‘ìC²“¡´‹MCì’[M–íC˜aò“Oi“àjCŽR–{aˆê˜Yi‹~–½j: ‘æ21‰ñS‹Ø‘ãŽÓŒ¤‹†‰ï i98.10.24j, “Œ‹ž.


<<31 ‹~–½‹~‹}ˆãŠw>>

3448. mŒ´’˜n Management of unruptured intracranial aneurysm in Japan: A Markovian decision analysis with utility measurements based on the Glasgow outcome scale. –ؑ¥–¾C–kŒ´F—Yi‹~–½jCFukui, T.CBeck, J.R.C‘Š”nˆêˆåi‹~–½jCYamamoto, W.CKamae, I.C‘å˜a“c—²i‹~–½j: Med. Decis. Making, 18: 357`364, 1998.

3449. mŒ´’˜n Žá”NŽÒ‹y‚Ñ‘s”NŽÒ‚Ì“Ë‘RŽ€|–UŒŸ—á‚©‚çŽÀ‘Ô‚ð’T‚é|. ‘ŠèrÆi‹~–½jC’†”¨ˆêi•a—jC‘å˜a“c^‹IŽqi“àjC¯ˆä‚Ì‚èŽqCŒÃì—Fi–@ˆãjCó—˜–õC‘Š”nˆêˆåi‹~–½jCŒIŒ´Ž—Ri–@ˆãjC‘å˜a“c—²i‹~ –½jC˜aò“Oi“àj: S‹Ø‚Ì\‘¢‚Æ‘ãŽÓ, 20: 227`233, 1998.

3450. mŒ´’˜n ‘Û‹Ù‹}‰‡•‘àˆã—Ã`[ƒ€‚̃oƒ“ƒOƒ‰ƒfƒBƒVƒ…l–¯‹¤˜a‘—³ŠªÐŠQˆã—ɇ•‚Ì•]‰¿. ó—˜–õi‹~–½jC‹à“c³Ž÷i¹ƒ}ƒŠˆã‘åjCóˆäN•¶iŽD–yˆã‘åjCŽRè’BŽ}iÂŽR•a‰@jCŽ}¼³ŒPi‘åã‘åjC‹ß“¡‹v’õCŽR–{•Û”Ži“úˆã‘åj: “ú–{W’cЊQˆã—ÃŒ¤‹†‰ïŽ, 3(1): 47`52, 1998.

3451. m€Œ´’˜n ‹CŠÇŽx”x–Eôò–@‚É‚æ‚鎉–bÇðÇŒóŒQ‚Ìf’f. V“¡³‹PC“c’†Œ[Ži‚aC‘Š”nˆêˆåi‹~–½jC–kŒ©Œ\Žii®ŠOjC•½“cŒõ”ŽC‘å˜a“c—²i‹~–½jCŽ…–ž·Œ›i®ŠOj: œÜ, 20(2): 694`696, 1998.

3452. m€Œ´’˜n ŒÄ‹zŠíÇó‚Ü‚½‚Í’†•_ŒoÇó‚ð’悳‚È‚¢Ž‰–bÇðÇŒóŒQ. “c’†Œ[Ži‚aCV“¡³‹Pi‹~–½jC–kŒ©Œ\ŽiC¼‘º–¾li®ŠOjC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jCŽ…–ž·Œ›i®ŠOj: œÜ, 20(2): 697`700, 1998.

3453. m€Œ´’˜n Iliosacral screw‚É‚æ‚霔՜܂̎¡—Ã. V“¡³‹PC“c’†Œ[Ži‚ai‹~–½jC¼‘º–¾li®ŠOjC•½“cŒõ”ŽC‘å˜a“c—²i‹~–½j: “ú–{ŠOŠw‰ïŽGŽ, 12(4): 287`293, 1998.

3454. mŒ¤‹†•ñiŒú¶Èjn ‹~ŒìŠ‚É‚¨‚¯‚銈“®ƒ}ƒjƒ…ƒAƒ‹. ó—˜–õCV“¡³‹Pi‹~–½j: ЊQ‚̉“®Šú‚É‚¨‚¯‚銈“®ƒ}ƒjƒ…ƒAƒ‹‚Æ‚»‚̉^—p‚ÉŠÖ‚·‚錤‹†‚ÌŒ¤‹†•ñ‘, p.41`48, 1998.

3455. mÇ—á•ñn Fetal bilateral adrenal hemorrhage following acute toluene poisoning. 㞊‹glC‘Š”nˆêˆåi‹~–½jC’·’JìˆêŽqi“àjC‘å˜a“c—²i‹~–½j: J. Toxicol. Clin. Toxicol., 36(4): 365`368, 1998.

3456. mÇ—á•ñn Survival after massive arsenic poisoning self-treated by high fluid intake. 㞊‹glC‘Š”nˆêˆåCó—˜–õC‘å˜a“c—²i‹~–½j: J. Toxicol. Clin. Toxicol., 36: 27`29, 1998.

3457. mÇ—á•ñn ‹}«S‹Ø[Ç‚É‚¨‚¯‚é‘ãŽÓE‰h—{ó‘Ô‚Ì—Õ°“I•]‰¿. ™–{Ÿ•Fi‹~–½jC—L‰ê“Oiº˜a‘åjC‰Á“¡ƒ`ƒCC–ؖí¶C‹ß“¡‰{Žqi‰h—{‰ÈjCÂŽR’¼‘PCó—˜–õi‹~–½jC•‘ò—˜˜Yi“àjC‘å˜a“c—²i‹~–½j: ŠO‰È‚Æ‘ãŽÓ¥‰h—{, 32(6): 343`350, 1998.

3458. mÇ—á•ñn ‚±‚ñ‚ÈÇ—á, ‚±‚ñ‚ȉ摜; ‹¹•”’Pƒ‚wüŽÊ^‚ªf’f‚É—L—p‚Å‚ ‚Á‚½‹}«–ò•¨’†“Å‚Ì‚P—á. HŽR‹v®C‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 10: 1133, 1998.

3459. mÇ—á•ñn ‚±‚ñ‚ÈÇ—á, ‚±‚ñ‚ȉ摜; ˆÝ•Ç“à‹‘åŒŒŽî. ¡òOC‘ŠèrÆC‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 10: 1279, 1998.

3460. mÇ—á•ñn ‚±‚ñ‚ÈÇ—á, ‚±‚ñ‚ȉ摜; “Á”­«H“¹”j—ô. ¡ˆäŠ°C‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 10: 461, 1998.

3461. mÇ—á•ñn ‚±‚ñ‚ÈÇ—á, ‚±‚ñ‚ȉ摜; ŠO«SŽº’†ŠuúE. “à“¡„•FC¡ˆäŠ°C‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 10: 585, 1998.

3462. mÇ—á•ñn ‚±‚ñ‚ÈÇ—á, ‚±‚ñ‚ȉ摜; ”]“®–¬áŽ”j—ô‚É‚æ‚é”玿‰ºoŒŒ. HŽR‹v®C‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 10: 701, 1998.

3463. mÇ—á•ñn ‚±‚ñ‚ÈÇ—á, ‚±‚ñ‚ȉ摜; Angioedema. 㞊‹glC‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 10: 807, 1998.

3464. mÇ—á•ñn ‚±‚ñ‚ÈÇ—á, ‚±‚ñ‚ȉ摜; Terson syndrome. HŽR‹v®C‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 10: 921, 1998.

3465. mÇ—á•ñn ”]’ቷ—Ö@’†‚ÉÇŒó«”]ŒŒŠÇáz¹k‚𗈂µ‚½¬Ž™dÇ“ª•”ŠO‚Ì‚Q—á. ‚‹´Œ÷C–kŒ´F—YC‰““¡¹FC‘å˜a“c—²i‹~–½j: _ŒoŠO, 21(2): 174`178, 1998.

3466. mÇ—á•ñn Ž©ŽEŠé‰æ‚É‚æ‚é’Åœ“®–¬Š®‘S’f—ô‚Ì1—á. ƒ’r“Þ’ÃŽqCV‘ò”ŽŽqCŽR“c’¼liŒ`ŠOjC¼Šª”ŽCV“¡³‹PC“c’†Œ[Ži‚aC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 19(1): 122`123, 1998.

3467. mÇ—á•ñn ƒ}ƒCƒRƒvƒ‰ƒYƒ}, ƒŒƒWƒIƒlƒ‰‹Û‡•¹dÇ”x‰Š‚Ì‚P—á. aˆä‘˜NC㞊‹glC•½“cŒõ”ŽCHŽR‹v®C‘Š”nˆêˆåC‘å˜a“ci‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 19: 268`269, 1998.

3468. mÇ—á•ñn Œz•”‰s“I‘¹‚É‚æ‚Á‚Ä“àŒz“®–¬“Ý“I‘¹‚ð‚«‚½‚µ‚½1—á. –Ñ—˜–ƒ—¢CŽR“c’¼liŒ`ŠOjC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 19: 526`527, 1998.

3469. m‘àn ‹~–½Ž¡—Âð•K—v‚Æ‚·‚éS‹Ø‰Š. ÂŽR’¼‘Pi‹~–½j: Heart View, 2(6): 18`25, 1998.

3470. m‘àn “à‰ÈƒGƒ}[ƒWƒFƒ“ƒV[‚Æ‹~‹}Žè‹Z; ŒŒ‰tƒKƒX. ó—˜–õi‹~–½j: Medicina, 35(11): 60`61, 1998.

3471. m‘àn ‘ŸŠíˆÚA–@Ž{s‚É‚æ‚éˆÚAƒR[ƒfƒBƒl[ƒ^[‚Ì–ðŠ„‚ÆŠÅŒì•w‚Ì‚©‚©‚í‚è•û. –쑺’mŽqi‹~–½¥ˆÚAƒRjCŒÃ¯•x”üŽqiŠÅŒì•”jC‘å˜a“c—²i‹~–½j: ƒxƒbƒhƒi[ƒX, 13(2): 154`160, 1998.

3472. m‘àn “ÁW; ‘h¶‚ð‚ß‚®‚éV‚µ‚¢“WŠJ‚Æ–â‘è“_|V‚µ‚¢S”x‘h¶–@|. ó—˜–õC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ŒÄ‹z‚ÆzŠÂ, 46(4): 327`332, 1998.

3473. m‘àn Ø’fŽw‚Ì’f’[Œ`¬. V“¡³‹Pi‹~–½j: Ž¡—Ã, 80(11): 113`115, 1998.

3474. m‘àn W’†Ž¡—ÈãŠw|Åæ’[‚Ì“®Œü; ICU‚É‚¨‚¯‚é‰æ‘œf’f. ‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 10: 130`138, 1998.

3475. m‘àn ‚­‚à–Œ‰ºoŒŒ‹}«Šú‚Ì•Û‘¶“IŽ¡—Ã. –kŒ´F—Yi‹~–½jC“¡ˆä´Fi”]ŠOj: —Õ°‚ÆŒ¤‹†, 75: 1915`1917, 1999.

3476. muÀn ‹~–½ˆã—Â̒†‚̌ċzŠÇ—. ‘Š”nˆêˆåi‹~–½j: Clin. Eng., 9: 521`527, 1998.

3477. muÀn ‹}«ŒÄ‹z•s‘S. ‘Š”nˆêˆåi‹~–½j: Medicina, 35(11): 271`273, 1998.

3478. muÀn ‹~‹}ŠÅŒì‚ÌŽÀ‘HƒKƒCƒh; (ÅI‰ñ)”]_ŒoŒn‹@”\•s‘S‚Ì•a‘Ô. –kŒ´F—Yi‹~–½j: ŠÅŒì‚̃|ƒCƒ“ƒg(ŒŽŠ§ƒi[ƒVƒ“ƒOƒŒƒR[ƒh), (‚PŒŽ†): 51`56, 1999.

3479. muÀn ŒÄ‹zŠÇ—‚Ì‚·‚ׂÄ, ƒxƒ“ƒ`ƒŒ[ƒ^[‚ð—p‚¢‚½ŒÄ‹zŠÇ—‚ÌŽÀÛ. ‘Š”nˆêˆåi‹~–½j: ‹~‹}ˆãŠw, 22: 1298`1302, 1998.

3480. muÀn ŒÄ‹zŠÇ—‚Ì‚·‚ׂÄ, ŠÔŽ¿«”x‰Š. ‘Š”nˆêˆåi‹~–½j: ‹~‹}ˆãŠw, 22: 1323`1326, 1998.

3481. muÀn ‘h¶‚ð‚ß‚®‚éV‚µ‚¢“WŠJ‚Æ–â‘è“_; CPAŠ³ŽÒ‚Ì‚»‚ÌŒã. ‘Š”nˆêˆåi‹~–½j: ŒÄ‹z‚ÆzŠÂ, 46(4): 351`357, 1998.

3482. muÀn Çó‚©‚ç‚Ý‚½’†“Å; 3. zŠÂŠí. ‘Š”nˆêˆåi‹~–½j: ’†“ÅŒ¤‹†, 11(4): 399`403, 1998.

3483. muÀn ŒÄ‹CI––’YŽ_ƒKƒX”Z“x‘ª’è/Œo”ç“IŒŒ‰tƒKƒX‘ª’è. ‘Š”nˆêˆåi‹~–½j: “ú–{ˆãŽt‰ïŽGŽ, 120(8): 56, 1998.

3484. mŠwp‘n i•ª’SŽ·•Mj —Õ°¸_ˆãŠwuÀ, ‘æ17Šª: ƒŠƒGƒ]ƒ“¸_ˆãŠwE¸_‰È‹~‹}ˆã—Ã; ‹~‹}ˆã—Âɂ¨‚¯‚é¸_‰È“I‘Ήž|”MŠ³ŽÒ, p.271`277, 㞊‹gli‹~–½j. •ÒW ¼‰º³–¾i“s¸_Œ¤‹†ŠjC•‘ò®i“úˆã‘åjCŽR˜e¬liL‘åjC•ÒC ’†ŽR‘“X, “Œ‹ž, 98.10.30”­s.

3485. mŠwp‘n i•ª’SŽ·•Mj ŒÄ‹zŠíŽ¾Š³ÅV‚ÌŽ¡—Ã; ‹C“¹”M, p.138`140, ‘Š”nˆêˆåi‹~–½j. •ÒW H“¡ãÄ“ñC’†“chˆê˜YCŠÑ˜a•q”ŽC•ÒC “ì]“°, “Œ‹ž, 98.00.00”­s.

3486. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj1999; Ž_‘f“Š—^–@, p.54`55, ‘å˜a“c—²i‹~–½j. •ÒW ‘½‰ê{K’ji‘½‰ê{Á‰»ŠíƒNƒŠƒjƒbƒNjC”öŒ`‰x˜YiŠàŒ¤jC•ÒC ˆãŠw‘‰@, “Œ‹ž, 99.01.15”­s.

3487. mŠwp‘n i•ª’SŽ·•Mj ”]ŒŒŠÇáŠQŠ³ŽÒ‚ÌŽ¡—ÂƃPƒAi”]ŒŒŠÇáŠQ‚̇•¹Ç); ”x‡•¹Ç, p.272`276, ‘Š”nˆêˆåi‹~–½j. •ÒW ‹à’Jt”VC•ÒC ƒƒfƒBƒJo”Å, ‘åã, 99.02.00”­s.

3488. m‹³‰È‘n i‹¤’˜j ‹~‹}‹~–½Žm•W€ƒeƒLƒXƒg. ‘Š”nˆêˆåi‹~–½j. •ÒW Œú¶È‹~‹}‹~–½Žm‹³ˆçŒ¤‹†‰ïC•ÒC ƒwƒ‹ƒXo”Å, “Œ‹ž, 98.04.00”­s.

3489. m‹³‰È‘n i•ª’SŽ·•Mj —Õ°NPŠw; ŒÄ‹z•s‘S, p.461`470, ‘Š”nˆêˆåi‹~–½j. •ÒW ¬ì“¹—YCÖ“¡‰pºC•ÒC ƒwƒ‹ƒXo”Å, “Œ‹ž, 98.00.00”­s.

3490. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj zŠÂŠíŽ¾Š³: ÅV‚ÌŽ¡—Ã, '98-'99; S‹Ø‰Š, p.133`137, ÂŽR’¼‘Pi‹~–½jC˜aò“Oi“àj. •ÒW ŽÂŽRdˆÐi‹ž‘åjC–îè‹`—Yi“Œ‘åjC•ÒC “ì]“°, “Œ‹ž, 98.04.01”­s.

3491. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Ž¾Š³•ÊÅVˆ•û; ‹}«ŒÄ‹z•s‘S, p.24`25, ‘Š”nˆêˆåi‹~–½j. •ÒW –îè‹`—YCŒË“c„‘¾˜YC•ÒC ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 98.00.00”­s.

3492. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Ž¿‹^‰ž“š‚É‚æ‚é•s®–¬; ‹CŠÇŽxšb‘§”­ì‚É‚Æ‚à‚È‚¤•s®–¬, p.141`143, ‘Š”nˆêˆåi‹~–½j. “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 98.00.00”­s.

3493. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Pharmacokinetics of active metabolites of ethylloflazepate (LOF) in the aged. 㞊‹gli‹~–½jCLin, Z.B.C‹ß“¡—¯”üŽqi–òÜjC‘Š”nˆêˆåi‹~–½j: 8th International Congress of Toxicology i98.07.06j, Paris, Toxicol. Lett., 95(Suppl.1): 60, 1998.

3494. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j ŒÄ‹zŠí‹~‹}ˆã—Ã. ‘Š”nˆêˆåi‹~–½j: ‘æ‚P‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï i98.06.01`02j, ‘q•~.

3495. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j SIRS‚ÆARDS. ‘Š”nˆêˆåi‹~–½j: ‘æ38‰ñ“ú–{ŒÄ‹zŠíŠw‰ï‘‰ï i99.03.30j, ŒF–{.

3496. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Iliosacral screw‚É‚æ‚霔՜܂̎¡—Ã. V“¡³‹PC“c’†Œ[Ži‚ai‹~–½jC¼‘º–¾li®ŠOjC•½“cŒõ”ŽC‘å˜a“c—²i‹~–½jCŽ…–ž·Œ›i®ŠOj: ‘æ12‰ñ“ú–{ŠOŠw‰ï i98.05.07`08j, “Œ‹ž, “ú–{ŠOŠw‰ïŽ, 12(2): 131, 1998.

3497. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹~‹}ˆã—ÂƑŸŠíˆÚA; ”]Ž€‘ŸŠí’ñ‹Ÿ‚Ö‚Ì‹ï‘Ì“IŽè‡‚ÉŠÖ‚·‚錟“¢. ‘å˜a“c—²i‹~–½j: ‘æ‚P‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï i98.06.01`02j, ‘q•~.

3498. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹}«ŠúŒz‘‘¹‚ɑ΂·‚éMRIf’f‚Ì—L—p«‚ɂ‚¢‚Ä. ‚‹´Œ÷C‰““¡¹FC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ13‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï i98.06.11`12j, ‘å’Ã.

3499. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Œã“ªŠWâ|”j—ô”]“®–¬áŽ‚ÌŽ¡—ÑI‘ð. –kŒ´F—YC‚‹´Œ÷C‰““¡¹FC‘å˜a“c—²i‹~–½jC´…‹ÅC“’‘òòC‘å“ä’mCŽR“cŸC‹{â‰À’jC“¡ˆä´Fi”]ŠOj: 17th Mt. Fuji Workshop on CVD i98.08.29j, ·‰ª.

3500. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒ}ƒŒƒCƒVƒAƒNƒ`ƒ“‘Û‹ó`‚É‚¨‚¯‚éЊQ‰‰K. V“¡³‹Pi‹~–½j: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.12j, ‚¼.

3501. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«ŠúŒz‘‘¹‚ÌMRIf’f. ‚‹´Œ÷C‰““¡¹FC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ12‰ñ“ú–{ŠOŠw‰ï i98.05.07`08j, “Œ‹ž.

3502. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å‘Ú•”Non-cavitary hemorrhage‚ÌŽ¡—ÃŒoŒ±. “c’†Œ[Ži‚aCV“¡³‹PC¼Šª”ŽC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jCŽ…–ž·Œ›i®ŠOj: ‘æ12‰ñ“ú–{ŠOŠw‰ï i98.05.07j, “Œ‹ž, “ú–{ŠOŠw‰ïŽ, 12(2): 143, 1998.

3503. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é˜V”NŽÒ‚Ì“ü—’†‚ÌS”x’âŽ~Ç—á‚Ì•Ï‘J‚ɂ‚¢‚Ä‚ÌŒŸ“¢. HŽR‹v®CÂŽR’¼‘PC㞊‹glC•½“cŒõ”ŽCV“¡³‹PC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ‚P‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï i98.06.01`02j, ‘q•~.

3504. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚­‚à–Œ‰ºoŒŒÅdÇ—á‚ɑ΂·‚鑽–ÊŽ¡—Ãí—ª‚Ì•]‰¿. –kŒ´F—YCHŽR‹v®C‘å˜a“c—²i‹~–½jC²“¡ŸlC‰F’ÖؑC•½ŽRŽõC‹{â‰À’jC“¡ˆä´Fi”]ŠOj: ‘æ‚P‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï i98.06.01`02j, ‘q•~.

3505. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “àˆö«S”x’âŽ~Ç—á‚ÌŒ´ˆöŽ¾Š³‚ÌŒŸ“¢. ó—˜–õi‹~–½jC—é–ØŒ[‰îi“àjCŒüŽRŒMCÂŽR’¼‘PC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC¯ˆä‚Ì‚èŽqC¼ˆäG˜aCŒIŒ´Ž—Ri–@ˆãj: ‘æ‚P‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï i98.06.01`02j, ‘q•~.

3506. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —ˆ‰@ŽžS”x’âŽ~Š³ŽÒ‚Ì‚ƒAƒ“ƒ‚ƒjƒAŒŒÇ‚ÉŠÖ‚·‚錟“¢. ŒF’JŒªC㞊‹glCŒüŽRŒMC•½“cŒõ”ŽCó—˜–õC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ‚P‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï i98.06.01`02j, ‘q•~.

3507. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«S‹Ø[nj㶎ºŽ©—R•Ç”j—ôÇ—á‚S—á‚ÌŽ¡—ÃŒoŒ±. —Ñ@”ŽC¡ˆäŠ°C‹g“cTC—é–ØŒ[‰îCÂŽR’¼‘PC•½“cŒõ”ŽC㞊‹glC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ‚P‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï i98.06.01`02j, ‘q•~.

3508. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚­‚à–Œ‰ºoŒŒÇ—á‚É‚¨‚¯‚éS“d}‚¨‚æ‚ÑSƒGƒR[}‚̕ω»; —ˆ‰@Žž‚Æ‘Þ‰@Žž‚Ì”äŠr. ÂŽR’¼‘Pi‹~–½jC²X–Ø‹BC‹g“cTC—é–ØŒ[‰îi“àjC—Ñ@”ŽCHŽR‹v®i‹~–½jC‰F’ÖؑC•½ŽRŽõi”]ŠOjC‚‹´Œ÷C‰““¡¹FC–kŒ´F—YC‘Š”nˆêˆåC‘å ˜a“c—²i‹~–½j: ‘æ‚P‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï i98.06.01`02j, ‘q•~, “ú–{—Õ°‹~‹}ˆãŠw‰ïŽGŽ, 1(1): 101, 1998.

3509. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž‰–bÇðÇŒóŒQ‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰t‚É‚æ‚é‹}«”xáŠQ”­Ç‹@˜‚ÌŒŸ“¢. “c’†Œ[Ži‚aC‘Š”nˆêˆåCV“¡³‹Pi‹~–½jC¼‘º–¾li®ŠOjC㞊‹glC•½“cŒõ”ŽC‘å˜a“c—²i‹~–½jCŽ…–ž·Œ›i®ŠOj: ‘æ‚P‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï i98.06.01`02j, ‘q•~, “ú–{—Õ°‹~‹}ˆãŠw‰ïŽGŽ, 1(1): 111, 1998.

3510. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«ŠúŒz’ÅEŒz‘‘¹‚É‚¨‚¯‚鎡—Ãã‚Ì–â‘è“_|‘½”­ŠO, ‡•¹Ç”­¶—á‚ɂ‚¢‚Ä‚ÌŒŸ“¢|. ‚‹´Œ÷C‰““¡¹FC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ13‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï i98.06.11`12j, ‘å’Ã.

3511. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚­‚à–Œ‰ºoŒŒdÇ—á(GradeE 5)‚ɑ΂·‚鑽–ÊŽ¡—Ãí—ª. –kŒ´F—YC‚‹´Œ÷C‰““¡¹FC‘å˜a“c—²i‹~–½jC‰F’ÖؑC•½ŽRŽõC‘å“ä’mC‘q“c²C‹{â‰À’jC“¡ˆä´Fi”]ŠOj: ‘æ27‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï i98.06.24`25j, ŽD–y.

3512. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j dÇ”j—ô”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp‚̈Ӌ`. ‚‹´Œ÷C–kŒ´F—YC‰““¡¹FC‘å˜a“c—²i‹~–½jC‘q“c²C‘å“ä’mC“¡ˆä´Fi”]ŠOj: ‘æ27‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï i98.06.24`25j, ŽD–y.

3513. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”j—ô«‰ð—£«’Åœ“®–¬áŽ‚Ì—Õ°“I“Á’¥‚ÆŽ¡—Õûj. –kŒ´F—Yi‹~–½jCŽR“cŸi”]ŠOjC‚‹´Œ÷C‰““¡¹FC‘å˜a“c—²i‹~–½jC‰F’ÖؑC•½ŽRŽõC‘q“c²C‹{â‰À’jC“¡ˆä´Fi”]ŠOj: ‘æ23‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i98.06.25`26j, ŽD–y, ”]‘²’†, 20: 173, 1998.

3514. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠO«ŠÌ‘¹‚ɇ•¹‚µ‚½‰º‘åÖ¬ŒŒðÇ‚Ì‚P—á. ¯–ìOŽ÷C‹à鳉ÀiŠOjC¼Šª”ŽC•½“cŒõ”Ži‹~–½jC¼ŽR’¼‹vC²“¡ˆêŠìiŠOjC‘꓇í‰ëC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jCŠ`“cÍiŠOj: ‘æ4‰ñ“ú–{ŒŒŠÇ“àŽ¡—Êw‰ï i98.07.01`03j, ‘åã.

3515. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Stent—¯’u‚É‚æ‚éˆãŒ´«’°œ“®–¬‘¹Ž¡—Â̗L—p«. •½“cŒõ”ŽC¼Šª”Ži‹~–½jC‹à鳉ÀC¯–ìOŽ÷C¼ŽR’¼‹vC²“¡ˆêŠìC‘꓇í‰ëiŠOjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jCŠ`“cÍiŠOj: ‘æ‚S‰ñ“ú–{ŒŒŠÇ“àŽ¡—Êw‰ï i98.07.01j, ‘åã.

3516. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹CŠÇŽx”x–Eôò‰t•ªÍ‚É‚æ‚鎉–bÇðÇŒóŒQ‚Ì‹}«”xáŠQ”­Ç‹@˜‚ÌŒŸ“¢. “c’†Œ[Ži‚aCV“¡³‹Pi‹~–½jC¼‘º–¾li®ŠOjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jCŽ…–ž·Œ›i®ŠOj: ‘æ24‰ñ“ú–{œÜŽ¡—Êw‰ï i98.07.10j, ‘åã.

3517. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«—L‹@ƒŠƒ“’†“Å‚É‚¨‚¯‚éÓf‚ƈÝôò‚Ì—LŒø«‚ÉŠÖ‚·‚錟“¢. ó—˜–õCŒF’JŒªC㞊‹gli‹~–½jC‹ß“¡—¯”üŽqi–òÜjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC¯ˆä‚Ì‚èŽqCŒÃì—FC‰iˆä’q‹IC¼ˆäG˜aCŒIŒ´Ž—Ri–@ˆãj: ‘æ20‰ñ“ú–{’†“ÅŠw‰ï‘‰ï i98.07.10j, ŽRŒû.

3518. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PCPS‚É‚Ä‹~–½‚µ‚¦‚½dÇ—L‹@ƒŠƒ“’†“Å‚Ì‚P—á. “à‹{—çŽkC㞊‹gli‹~–½jC‹ß“¡—¯”üŽqi–òÜjCó—˜–õC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ20‰ñ“ú–{’†“ÅŠw‰ï‘‰ï i98.07.10j, ŽRŒû.

3519. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •…H«Á‰»ŠÇ‘¹‚Ì’´‰¹”g“àŽ‹‹¾‚É‚æ‚é•]‰¿. ŒF’JŒªi‹~–½jC‹ß“¡ˆê‰pi“àjC¡òOC㞊‹gli‹~–½jC‹ß“¡—¯”üŽqi–òÜjCó—˜–õC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ20‰ñ“ú–{’†“ÅŠw‰ï‘‰ï i98.07.10j, ŽRŒû.

3520. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž‰–bÇðÇŒóŒQÇ—á‚̜܂ɑ΂·‚鎡—ÃŽžŠú‚Æ•û–@. V“¡³‹PC“c’†Œ[Ži‚aC‘Š”nˆêˆåi‹~–½jC¼‘º–¾li®ŠOjC•½“cŒõ”ŽC‘å˜a“c—²i‹~–½jCŽ…–ž·Œ›i®ŠOj: ‘æ24‰ñ“ú–{œÜŠw‰ï i98.07.10j, ‘åã, ´˜^W, p.11, 1998.

3521. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”j—ô’Åœ“®–¬áŽ‚É‚¨‚¯‚鎡—ÑI‘ð|Ž¡—ìтɊî‚­ŒŸ“¢|. –kŒ´F—YC‚‹´Œ÷C‰““¡¹FC‘å˜a“c—²i‹~–½jC´…‹ÅC“’‘òòCŽR“cŸC‘q“c²C‹{â‰À’jC“¡ˆä´Fi”]ŠOj: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i98.10.14`16j, ŽD–y.

3522. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚­‚à–Œ‰ºoŒŒ‹}«Šú‚ÌW–ñ“IŽ¡—Ã. –kŒ´F—YC‰““¡¹FC‚‹´Œ÷C‰¡ŽR³@C‘å˜a“c—²i‹~–½jC“’‘òòC´…‹ÅC‘q“c²C‹{â‰À’jC“¡ˆä´Fi”]ŠOj: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.12`14j, ‚¼.

3523. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒNƒ‚–Œ‰ºoŒŒ‹}«Šú‚̶Žº•Ç‰^“®ˆÙí‚ɑ΂·‚éƒJƒeƒRƒ‰ƒ~ƒ“ƒT[ƒW‚̉e‹¿‚ÆŒŒ‰t‹ÃŒÅü—nŒnˆÙí‚ÌŠÖ—^‚ɂ‚¢‚Ä. ŽR–{aˆê˜YC‹e–ì—²–¾i‹~–½jCŽs—ˆèŒ‰C‘“c‘ìC²“¡´FC˜aò“Oi“àjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC¼ŽRÄ‹vi—Õ•a—jC’†‘º–FŽ÷CÄ“¡—Ljêi‘—§ “Œ‹ž•a‰@ˆã—ÃZƒ“j: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.12`14j, ‚¼.

3524. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž‰–bÇðÇŒóŒQ‚ɑ΂·‚鎡—Ãí—ª. V“¡³‹PC“c’†Œ[Ži‚aC•½“cŒõ”ŽC¡ˆäŠ°C‰““¡¹FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.12`14j, ‚¼, “ú–{‹~‹}ˆãŠw‰ïŽ, 9(9): 456, 1998.

3525. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”ñú’Ê«ŠO«S”j—ôÇ—á‚ÌŒŸ“¢. —Ñ@”ŽC¡ˆäŠ°i‹~–½jC’¬ˆä³lC¬Œ´–M‹`i‹¹ŠOjC‘Š”nˆêˆåi‹~–½jC‹g‘º”Ž–Mi‹¹ŠOjC‘å˜a“c—²i‹~–½j: ‘æ26‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i99.03.03j, –‹’£.

3526. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œ€ÇŒ^S‹Ø‰Š‚ɑ΂·‚éŒo”ç“IS”x•â•(PCPS)‚Ì—L—p«‚Æ“]‹A‚ɉe‹¿‚·‚é—vˆö. ¼ŽR¬‘¾˜YCÂŽR’¼‘Pi‹~–½jC’|’[‹ÏC‘ŠèrÆi“àjC—Ñ@”ŽC¡ˆäŠ°C•‘ò—˜˜YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC˜aò“Oi“àj: ‘æ26‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i99.03.03j, –‹’£.

3527. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j dÇ“ª•”ŠO‚ɑ΂·‚é’á‘̉·—Ö@‚ÌV‚½‚È–â‘è“_|”]ŒŒŠÇ¹k‚ɂ‚¢‚Ä|. ‚‹´Œ÷C–kŒ´F—YC‰““¡¹FC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{_ŒoŠOŠw‰ï i99.03.26`27j, •Ÿ‰ª.

3528. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠO«”]ŒŒŠÇ¹k‚Ì—Õ°“IŒŸ“¢. ‚‹´Œ÷C‰““¡¹FC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.12`14j, ‚¼.

3529. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚—ŽÒ‚ɑ΂·‚é‹~‹}ˆã—Âɂ‚¢‚Ä‚ÌŒŸ“¢. HŽR‹v®CŒF’JŒªC㞊‹glC•½“cŒõ”ŽC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.12`14j, ‚¼.

3530. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÚAƒR[ƒfƒBƒl[ƒ^[‚ÌŒ»‹µ‚ÆŒŸ“¢‰Û‘è. –쑺’mŽqC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ26‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i98.11.12`14j, ‚¼.

3531. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “ª•”ŠO‚É‚¨‚¯‚é”]ŒŒŠÇŽB‰e‚̈Ӌ`‚ɂ‚¢‚Ä. ‚‹´Œ÷C–kŒ´F—YC‰““¡¹FC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{_ŒoŠOŠw‰ï i99.03.26`27j, •Ÿ‰ª.

3532. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž©ŽEŠé‰æ‚É‚æ‚é’Åœ“®–¬Š®‘S’f—ô‚Ì1—á. ƒ’r“Þ’ÃŽqCV‘ò”ŽŽqCŽR“c’¼liŒ`ŠOjC¼Šª”Ži•újCV“¡³‹PC“c’†Œ[Ži‚aC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ44‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i98.02.14j, Š‘ò.

3533. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒ}ƒCƒRƒvƒ‰ƒYƒ}, ƒŒƒWƒIƒlƒ‰‹Û‡•¹dÇ”x‰Š‚Ì‚P—á. aˆä‘˜NC㞊‹glC•½“cŒõ”ŽCHŽR‹v®C–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ44‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i98.02.14j, Š‘ò.

3534. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —¼‘¤ãøœœÜ‚ÌŽ¡—ÃŒoŒ±. “c’†Œ[Ži‚aCV“¡³‹Pi‹~–½jC‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: ‘æ36‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï i98.05.23j, “Œ‹ž, ´˜^W, 29: 36, 1998.

3535. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œz•”‰s“I‘¹‚É‚æ‚Á‚Ä“àŒz“®–¬“Ý“I‘¹‚ð‚«‚½‚µ‚½1—á. –Ñ—˜–ƒ—¢CŽR“c’¼lC—јaOiŒ`ŠOjC‚‹´Œ÷Cã–{“Þ”üŽqC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ45‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i98.06.27j, “y‰Y.

3536. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠO«‹CŠÇŽx’f—ô‚Ì‚P—á. •Šâ­”Vi–ƒjC—Ñ@”ŽC¡ˆäŠ°CŒF’JŒªC•½“cŒõ”ŽC㞊‹glCó—˜–õC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ45‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i98.06.27j, “y‰Y.

3537. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘½‘ŸŠíáŠQ‚ðŽå’¥‚Æ‚µ‚½Hemophagocytic Syndrome (HPS)‚Ì‚P¬l—á. ‰Ž“c‹M”Vi“àjCó—˜–õC¼Šª”Ži‹~–½jC¡ˆäŠ°i–@ˆãjC—Ñ@”ŽCÂŽR’¼‘PC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ‚V‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i98.12.05j, “Œ‹ž.

3538. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j œÜ‚𔺂í‚È‚¢˜“®–¬‚¨‚æ‚Ñ“à’°œ“®–¬‘¹‚Ì‚P—á. –ØMˆêCŽ…–ž·Œ›i®ŠOjC‚•½®LCV“¡³‹PC“c’†Œ[Ži‚aC¼Šª”Ži‹~‹}j: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï, ‘æ592‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï i98.12.19j, “Œ‹ž.

3539. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰ºŽˆ–Iâ|‘l‰Š‚ðŽå’¥‚Æ‚µ‚½T cell malignant lymphoma‚Ì‚P—á. “c‘ºK•äiŠOjC‚•½®LCŒF’JŒªC“c’†Œ[Ži‚aCV“¡³‹PC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ46‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i99.02.20j, ‰¡•l.

3540. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j CTƒKƒCƒh‰ºŒo”ç“IcŠuƒhƒŒƒi[ƒW‚ª‘tŒø‚µ‚½H“¹ŠàpŒã‚ÌcŠu”^ᇂ̂PÇ—á. •½“cŒõ”ŽC¼Šª”ŽC—é–Ø“N‘¾˜YC—Ñ@”ŽC¡ˆäŠ°CŒF’JŒªC‘꓇í‰ëC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ46‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i99.02.20j, ‰¡•l.

3541. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ¬Ž™dÇ“ª•”ŠO‚ɑ΂·‚é’á‘̉·—Ö@‚ɂ‚¢‚Ä‚Ì—Õ°“IŒŸ“¢. ‚‹´Œ÷C‰““¡¹FC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ‚P‰ñ“ú–{”]’ቷ—Ö@Œ¤‹†‰ï i98.10.09j, “Œ‹ž.

3542. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‹H‚ÈÇ—á‚ÌŽ¡—ÂɊւ·‚é—Õ°Œˆ’f•ªÍ|d–ŒŒ^Ò’Å“®Ã–¬áŽ‚Ì‚P—á|. •“cºC–ؑ¥–¾C‘å–ì鑾˜YC–kŒ´F—Yi‹~–½jC‰i“cŽu’ÃŽqCŠŽR“OC•ŸˆäŽŸ–î: ‘æ‚T‰ñ‘‡—Õ°Œ¤‹†‰ï i97.02.01`02j, ²‰ê. ´˜^W, p.26, 1997.

3543. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒpƒvƒAEƒjƒ…[ƒMƒjƒA‘’ÔgЊQ‚É‚¨‚¯‚éˆã—ʈ“®•ñ. ¬ˆä“y—Yˆêi“úˆã‘åjCó—˜–õi‹~–½j: ‘æ‚S‰ñ“ú–{W’cЊQˆã—ÃŒ¤‹†‰ï i99.02.11j, ‹à‘ò.

3544. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒpƒvƒAEƒjƒ…[ƒMƒjƒA‘’ÔgЊQ‚É‚¨‚¯‚é…Ž¿ŒŸ¸‚ɂ‚¢‚Ä. ‹à‘ò–Li’·•lÔ\Žš•a‰@jCó—˜–õi‹~–½j: ‘æ‚S‰ñ“ú–{W’cЊQˆã—ÃŒ¤‹†‰ï i99.02.11j, ‹à‘ò.

3545. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒpƒvƒAEƒjƒ…[ƒMƒjƒA‘’ÔgЊQ”íÐŒã‚PTŠÔ–Ú‚Ìassessment. ó—˜–õi‹~–½jC¬ˆä“y—Yˆêi“úˆã‘åj: ‘æ‚S‰ñ“ú–{W’cЊQˆã—ÃŒ¤‹†‰ï i99.02.11j, ‹à‘ò.

3546. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒpƒvƒAEƒjƒ…[ƒMƒjƒA‘’ÔgЊQ‚É‚¨‚¯‚éЊQŠÅŒì‚ɂ‚¢‚Ä. ‘å’ËŒbi¹ƒ}ƒŠ‘åjCó—˜–õi‹~–½j: ‘æ‚S‰ñ“ú–{W’cЊQˆã—ÃŒ¤‹†‰ï i99.02.11j, ‹à‘ò.

3547. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –hÐŒP—û‚É‚¨‚¯‚錻ó•ªÍ‚ÆŒŸ“¢. Έä”üŒbŽqC“ˆ“cKŽqiŠÅŒì•”jCŒF’JŒªCó—˜–õCŽá—Ñ–õ‹vCV“¡³‹PC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ‚S‰ñ“ú–{W’cЊQˆã—ÃŒ¤‹†‰ï i99.02.11j, ‹à‘ò.

3548. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j _“Þ쌧–k•”‹y‚Ñ’†‰›•”’n‹æ‚É‚¨‚¯‚éSŒŒŠÇŽ¾Š³‚ÌŒ»ó‚Æ«—ˆ; CCUƒlƒbƒgƒ[ƒN‚Ì”­“W‚ÉŒü‚¯‚Ä. ¼ŽR¬‘¾˜Yi‹~–½j: ‘Š–ÍÓìƒn[ƒgƒJƒ“ƒtƒ@ƒŒƒ“ƒX i98.04.24j, Œú–Ø.

3549. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ”]Ž€‚ð‚ß‚®‚é”–â‘è‚Æ‘ŸŠíˆÚA. ‘å˜a“c—²i‹~–½j: ‘æ426‰ñ‰¡•lŽsˆãŽt‰ï¢ˆãŠwŒ¤C£ i98.05.12j, ‰¡•l.

3550. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒXƒeƒ“ƒg—¯’u‚É‚æ‚è—ÇD‚ÈŒ‹‰Ê‚𓾂½Š´õ«• •”‘å“®–¬áŽ. •½“cŒõ”Ži‹~–½jC‹à鳉ÀC¼ŽR’¼‹vCrˆä‹`FC“c‘ºK•äiŠOjC¼Šª”Ži‹~–½jCŠ`“cÍiŠOjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ99‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i98.10.17j, “Œ‹ž.

3551. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œ§‰›’n‹æ‚É‚¨‚¯‚éƒNƒ‚–Œ‰ºoŒŒŠ³ŽÒ”À‘—ã‚Ì–â‘è“_. –kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ‚P‰ñ–k—¢ƒuƒŒƒCƒ“ƒAƒ^ƒbƒNƒZƒ~ƒi[ i99.03.11j, ‘Š–ÍŒ´.


<<33 —Õ°–ò—ŠwE–òÜŠw>>

3552. mŒ´’˜n –«t•s‘SŠ³ŽÒ‚É‚¨‚¯‚étemocaprilat‚ÌŒŒ´’`”’Œ‹‡«‚ÉŠÖ‚·‚錤‹†. •ŽR­ˆêC¼ìkŽjC–{‹´–Îi–òÜjCŒF–ì˜a—Yi”åjC–îŒã˜a•vi–òÜjC¬‹{ŽR‹MŽqi–òŠw•”jCì’[´i–òÜj: TDMŒ¤‹†, 15(4): 314`322, 1998.

3553. mŒ´’˜n ƒAƒ~ƒm”z“œ‘̂Ɖ–Ž_ƒoƒ“ƒRƒ}ƒCƒVƒ“‚Ì“K³Žg—p‚Ì‚½‚߂̃‚ƒjƒ^ƒŠƒ“ƒOƒVƒXƒeƒ€‚Ì\’z. –Ø‘º—˜”üC’r“c—R”üŽqC‰Á‰ê’J”£C“‡“cŽœ•Fi–òÜj: TDMŒ¤‹†, 16(1): 33`42, 1999.

3554. mŒ´’˜n RNSAID’×ᇖòMisoprostol‚̈•û‚ÌŒ»ó‚Æ“K«Žg—p‚ÉŠÖ‚·‚錟“¢. ‘ò“cŽÀ‰ÔC•ŽR­ˆêC’Å’C–îŒã˜a•vC‰¡“cTˆêi–òÜjCŒF’J—YŽ¡i–ò—jC¬—Ñ–¾³i®Œ`j: “ú–{•a‰@–òÜŽt‰ïŽGŽ, 34(12): 59`63, 1998.

3555. mŒ´’˜n ƒAƒgƒs[«”畆‰Š‚ɑ΂·‚éƒXƒeƒƒCƒh“îp‚ƈŸ‰”‰Ø“îp‚¨‚æ‚Ñ”A‘f“îp‚Ƃ̬‡“îp‚Ì—L—p«‚ÉŠÖ‚·‚錤‹†. “y‰®‰À¢i–òŠw•”jC¼Œ´”£C²ìŒ«ˆêC“‡“cŽœ•Fi–òÜjC•ÄŒ³N‘ CŸ‰ªŒ›¶i”çjC¬‹{ŽR‹MŽqi–òŠw•”j: •a‰@–òŠw, 24(6): 629`641, 1998.

3556. mŒ´’˜n –{–M‚É‚¨‚¯‚é•ž–òƒRƒ“ƒvƒ‰ƒCƒAƒ“ƒX‚ÌŒ»ó‚Æ‚»‚Ì–â‘è“_. “uLKC•ŽR­ˆêC–îŒã˜a•vi–òÜj: •a‰@–òŠw, 25(1): 22`27, 1999.

3557. mŒ´’˜n V‹KÌ—pŽž‚É‚¨‚¯‚éˆã–ò•i‚Ì•]‰¿–@‚ÉŠÖ‚·‚錤‹†|5HT3Žó—e‘ÌhR–ò‚ð—á‚É‚Æ‚Á‚Ä|. ’¬“c[C‰Á‰ê’J”£C²ìŒ«ˆêC“‡“cŽœ•FC–]ŒŽ^‹|i–òÜj: –ò܉uŠw, 3(2): 95`102, 1998.

3558. m€Œ´’˜n ‘S‘‹K–Í‚ÅŽÀŽ{‚³‚ꂽŠ´Žó«ŽŽŒ±¬Ñ‚ÉŠÖ‚·‚é‚PlŽ@|ƒOƒ‰ƒ€—z«‹…‹Û, ƒOƒ‰ƒ€‰A«‹…‹Û‚ɂ‚¢‚Ä|. •ŽR­ˆêC‰ª–{Œb”üŽqC–îŒã˜a•vi–òÜj: Jpn. J. Antibiot., 51(12): 764`778, 1998.

3559. m€Œ´’˜n ƒ‚ƒmƒoƒCƒAƒ‹¥ƒXƒpƒCƒN‚ð“K—p‚µ‚½“_“HÃ’—pƒAƒVƒNƒƒrƒ‹ƒLƒbƒg‚Ì—L—p«‚ÉŠÖ‚·‚錤‹†|(‘æ1•ñ)ì‹ÆŒø—¦|. •ŽR­ˆêC•½ŽR•ŽiC–îŒã˜a•vi–òÜj: ˆãŠw‚Æ–òŠw, 39(6): 1249`1255, 1998.

3560. m€Œ´’˜n ƒ‚ƒmƒoƒCƒAƒ‹¥ƒXƒpƒCƒN‚ð“K—p‚µ‚½“_“HÃ’—pƒAƒVƒNƒƒrƒ‹ƒLƒbƒg‚Ì—L—p«‚ÉŠÖ‚·‚錤‹†|(‘æ2•ñ)Žc‘¶—Ê|. •ŽR­ˆêC•½ŽR•ŽiC–îŒã˜a•vi–òÜj: ˆãŠw‚Æ–òŠw, 39(6): 1257`1262, 1998.

3561. m€Œ´’˜n ƒ‚ƒmƒoƒCƒAƒ‹¥ƒXƒpƒCƒN‚ð“K—p‚µ‚½“_“HÃ’—pƒAƒVƒNƒƒrƒ‹ƒLƒbƒg‚Ì—L—p«‚ÉŠÖ‚·‚錤‹†|(‘æ3•ñ)—˜•Ö«|. •½ŽR•ŽiC•ŽR­ˆêC–îŒã˜a•vi–òÜj: ˆãŠw‚Æ–òŠw, 40(1): 109`117, 1998.

3562. m€Œ´’˜n ƒAƒVƒNƒƒrƒ‹’ŽËÜ‚Ì•iŽ¿”äŠrŽŽŒ±(‡T). •ŽR­ˆêC”ö’¹Ÿ–çC–îŒã˜a•vi–òÜj: V–ò‚Æ—Õ°, 47(9): 1392`1397, 1998.

3563. m€Œ´’˜n ƒAƒVƒNƒƒrƒ‹’ŽËÜ‚Ì•iŽ¿”äŠrŽŽŒ±(‡U). •ŽR­ˆêC”ö’¹Ÿ–çC–îŒã˜a•vi–òÜj: V–ò‚Æ—Õ°, 47(9): 1398`1403, 1998.

3564. m€Œ´’˜n ƒ‚ƒmƒoƒCƒAƒ‹‚ð“K—p‚µ‚½ƒƒVƒ‹Ž_ƒKƒxƒLƒT[ƒg’ŽË—pƒLƒbƒg»Ü‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. •ŽR­ˆêC•½ŽR•ŽiC–îŒã˜a•vi–òÜj: f—ÂÆV–ò, 36(2): 173`180, 1999.

3565. m’Z•ñ¥‘¬•ñn “ú–{ˆã–ò•iî•ñŠwŒ¤‹†‰ï”­‘«‹L”OƒVƒ“ƒ|ƒWƒEƒ€ƒŒƒ|[ƒg|•a‰@–òÜŽt‚Ì—§ê‚©‚ç|. Ô£•üGi–òÜj: ŒŽŠ§–òŽ–, 40(10): 2414`2416, 1998.

3566. mÇ—á•ñn _“Þ쌧•a‰@–òÜŽt‰ïŽs–¯uÀ‚É‚¨‚¯‚éu‚­‚·‚è‚Ì‘Š’kƒR[ƒi[v‚Ì•ñ. ²ŠÑ”ü’q—¯C÷ˆä–¯—YCŠâ“c—zŽqC‘å“à•¶LC²“¡NMCŽOa˜a’jCª’×ÇKC’¬“c[CŽR“c‰p‹IC•ŽR­ˆêi–òÜjC‹e’n—L“¹CˆË“cŒ[Ži: _“Þ쌧•a‰@–òÜŽt‰ïŽ, (87): 37`41, 1998.

3567. mÇ—á•ñn "‚­‚·‚è‚Ɖ»Ï‚·‚±‚â‚©ƒtƒFƒA"‚ÌŠJÃ, ‚¨‚æ‚Ñg‚­‚·‚è‘Š’k‚ÌŽÀŽ{"‚ɂ‚¢‚Ä. Šâ“c—zŽqC•ŽR­ˆêC‘å“à•¶LC÷ˆä–¯—YC²“¡NMC²ŠÑ”ü’q—¯CŽOa˜a’jCª’×ÇKC’¬“c[i–òÜjCŽR“c‰p‹IC‹e’n—L“¹: _“Þ쌧•a‰@–òÜŽt‰ïŽ, (87): 41`42, 1998.

3568. mÇ—á•ñn “’‰ÍŒ´’¬–¯‘åŠw‚É‚¨‚¯‚é"‚¨–ò‘Š’k". ÷ˆä–¯—YC•ŽR­ˆêCŠâ“c—zŽqC‘å“à•¶LC²“¡NMC²ŠÑ”ü’q—¯CŽOa˜a’jCª’×ÇKC’¬“c[i–òÜjCŽR“c‰p‹IC‹e’n—L“¹: _“Þ쌧•a‰@–òÜŽt‰ïŽ, (88): 41`42, 1998.

3569. mÇ—á•ñn •a‰@–òÜŽt‚ÌgŠÅŒì‚Ì“ú‚¨‚æ‚ÑŠÅŒìTŠÔ‚̵"‚Ö‚ÌŽQ‰Á‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸Œ‹‰Ê. ‘å“à•¶LCŠâ“c—zŽqC÷ˆä–¯—YC²“¡NMC²ŠÑ”ü’q—¯CŽOa˜a’jCª’×ÇKC’¬“c[CŽR“c‰p‹IC•ŽR­ˆêi–òÜjC‹e’n—L“¹: _“Þ쌧•a‰@–òÜŽt‰ïŽ, (89): 52`57, 1998.

3570. mÇ—á•ñn ‘æ3‰ñ_“Þ쌧•a‰@–òÜŽt‰ï"Žs–¯uÀ"ƒAƒ“ƒP[ƒgWŒvŒ‹‰Ê. ’¬“c[C•ŽR­ˆêi–òÜjCŠâ“c—zŽqC‘å“à•¶LC÷ˆä–¯—YC²“¡NMC²ŠÑ”ü’q—¯CŽOa˜a’jCª’×ÇKCŽR“c‰p‹IC‹e’n—L“¹: _“Þ쌧•a‰@–òÜŽt‰ïŽ, (89): 59`61, 1998.

3571. mÇ—á•ñn "‚­‚·‚èGet the Answers‚©‚È‚ª‚í„iˆÏˆõ‰ï"‚ÌŠˆ“®‚ÌŒ»ó|Œ§–¯Œü‚¯¬ûŽqg‚ ‚È‚½‚Ì‚­‚·‚è‚ÆŒ’N"‚Ì”­s. •ŽR­ˆêCŠâ“c—zŽqC‘å“à•¶LC÷ˆä–¯—YC²“¡NMC²ŠÑ”ü’q—¯CŽOa˜a’jCª’×ÇKC’¬“c[i–òÜjCŽR“c‰p‹IC‹e’n—L“¹: _“Þ쌧•a‰@–òÜŽt‰ïŽ, (89): 63`64, 1998.

3572. mÇ—á•ñn ¶ŠUŒ¤C‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸. ’†“‡Vˆê˜YCΎ˳‰pC’·’Jì–ž‹gC‰¬–ìŒb”üŽqC•—ŠÔKŽOC•ŽR­ˆêi–òÜjCŽÂ“¹OC’Jì_ŽiC–LìŽu•ÛŽqC¼ˆä—@‹gC“¡“cŒ’“ñC•½Œ´ŽÀCŒ¹ì“Þ•äCX ‰ë”üCŒ³‹gŠìM: “ú–{•a‰@–òÜŽt‰ïŽ, 34(5): 687`695, 1998.

3573. m‘àn –ò܉uŠw‚ÌŽè–@‚ð‰ž—p‚µ‚½Š¿•û–ò‚Ì•]‰¿. Ô£•üGi–òÜjC“c‘ã^ˆêiº˜a–ò‰È‘åj: Methods in Kampo Pharmacology, 3: 110`115, 1998.

3574. m‘àn V‚½‚È’iŠK‚ðŒ}‚¦‚½ˆã–ò•iî•ñ‚Ì‚ ‚è•û. ŽR芲•viç—t‘åjC镸ˆêi‰¡•lŽs‘åjC¬—Ñ‹P–¾CÔ£•üGi–òÜj: Pharmacist Journal, (2): 1`4, 1998.

3575. m‘àn ˆã—ÃŒoÏ‚©‚ç‚Ý‚½Š¿•ûŽ¡—Ã1. “SŒ‡–R«•nŒŒ‚ÌŽ¡—Âð’†S‚É. Ô£•üGC“‡“cŽœ•Fi–òÜj: Progress in Medicine, 18(4): 675`679, 1998.

3576. m‘àn –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚鎡Œ±ŽÀŽ{‘̧‚Æ–òÜŽt‚Ì–ðŠ„. •ŽR­ˆêC‰¡“cTˆêC–ì’†”ü˜aC•½ŽR•ŽiC–îŒã˜a•vi–òÜj: ŒŽŠ§–òŽ–, 40(10): 2271`2276, 1998.

3577. m‘àn ˆã–ò•i“K‰žŠOŽg—p‚Ö‚Ì–òÜŽt‚ÌŽæ‚è‘g‚Ý|“K‰žŠOŽg—p‚ÌŒ»ó. ’†‘º˜a•vi‰¡•l‘å‰YM•a‰@jC–Ø‘º—˜”üC²ìŒ«ˆêC’|“எqi–òÜjC‹–”ã‹áŽqi“ŒŠC‘åjC¬âD’ji“úˆã‘æ2•a‰@jC[’J^—Žqi¹ƒ}ƒŠjC¼‹½Ÿs i–]¯–ò‹Çj: ŒŽŠ§–òŽ–, 40(14): 3223`3234, 1998.

3578. m‘àn ƒZƒtƒFƒ€ŒnR¶•¨Ž¿‚É‚æ‚éoŒŒŒXŒüiŒŒ‰t‹ÃŒÅˆÙí). •ŽR­ˆêC–îŒã˜a•vi–òÜj: ŒŽŠ§–òŽ–, 40(4): 941`944, 1998.

3579. m‘àn ƒZƒtƒFƒ€R¶•¨Ž¿‚É‚æ‚éƒWƒXƒ‹ƒtƒBƒ‰ƒ€—lì—p. •ŽR­ˆêC–îŒã˜a•vi–òÜj: ŒŽŠ§–òŽ–, 40(4): 945`948, 1998.

3580. m‘àn —Õ°‚É‚¨‚¯‚銈—p‚̃|ƒCƒ“ƒg|»Ü‚ÉŠÖ‚·‚逖Ú. •ŽR­ˆêC¡ˆäLŒbC–îŒã˜a•vi–òÜj: ŒŽŠ§–òŽ–, 41(3): 509`516, 1999.

3581. m‘àn Œûo“à•ö‰óŒ^»Ü‚Ì“Á’¥‚Æ‚»‚Ì•]‰¿. ”ö’¹Ÿ–çC•ŽR­ˆêC–îŒã˜a•vC÷ˆäKŽqi–òÜj: •²‘Ì‚ÆH‹Æ, 30(11): 31`40, 1998.

3582. m‘àn ’m‚Á‚Ä‚¨‚­‚ׂ«OTC–ò‚Ì’mŽ¯|‚ŒŒˆ³ÇŠ³ŽÒ, ‚Ž‰ŒŒÇŠ³ŽÒ. ‚‹´Œ«¬i–òÜj: —Õ°‚Æ–ò•¨Ž¡—Ã, 17(6): 527`529, 1998.

3583. m‘àn OTC–ò•ž—pŠ³ŽÒ‚Ö‚Ì’ˆÓ; –«‹CŠÇŽx‰ŠŠ³ŽÒ, ‹CŠÇŽxšb‘§Š³ŽÒ. Vˆä–œ—Žqi–òÜj: —Õ°‚Æ–ò•¨Ž¡—Ã, 17(6): 530`533, 1998.

3584. m‘àn OTC–ò•ž—pŠ³ŽÒ‚Ö‚Ì’ˆÓ; Á‰»«’×ᇊ³ŽÒ, –«ˆÝ‰ŠŠ³ŽÒ. –ì’†”ü˜ai–òÜj: —Õ°‚Æ–ò•¨Ž¡—Ã, 17(6): 534`536, 1998.

3585. m‘àn ’m‚Á‚Ä‚¨‚­‚ׂ«OTC–ò‚Ì’mŽ¯|•s–°ÇŠ³ŽÒ, •s’èD‘i‚ÌŠ³ŽÒ. ’|“எqi–òÜj: —Õ°‚Æ–ò•¨Ž¡—Ã, 17(6): 542`546, 1998.

3586. muÀn ƒi[ƒX‚Ì‚½‚ß‚ÌNew Drug InformationgƒpƒŠƒGƒbƒg". Ô£•üGC‰Á‰ê’J”£i–òÜj: Expert Nurse, 14(10): 127, 1998.

3587. muÀn Š¿•û–ò; Š¿•û–ò‚ÌŠî‘b’mŽ¯ 3g–¯ŠÔ–ò‚ɂ‚¢‚Ä". Ô£•üGC•ŽR­ˆêC“‡“cŽœ•Fi–òÜj: ‚¨‚͂悤21, (4): 66`69, 1998.

3588. muÀn Š¿•û–ò; Š¿•û–ò‚ÌŠî‘b’mŽ¯ 4gÁ‰»ŠíŽ¾Š³‚ÌŠ¿•û—Ö@". Ô£•üGC•ŽR­ˆêC“‡“cŽœ•Fi–òÜj: ‚¨‚͂悤21, (5): 80`83, 1998.

3589. muÀn Š¿•û–ò; Š¿•û–ò‚ÌŠî‘b’mŽ¯ 5g˜V”NŠúŽ¾Š³‚ÌŠ¿•û—Ö@(‚»‚Ì1)". Ô£•üGC•ŽR­ˆêC“‡“cŽœ•Fi–òÜj: ‚¨‚͂悤21, (6): 72`75, 1998.

3590. muÀn Š¿•û–ò; Š¿•û–ò‚ÌŠî‘b’mŽ¯ 6g˜V”NŠúŽ¾Š³‚ÌŠ¿•û—Ö@(‚»‚Ì2)". Ô£•üGC•ŽR­ˆêC“‡“cŽœ•Fi–òÜj: ‚¨‚͂悤21, (7): 74`77, 1998.

3591. muÀn DI TOPICS DIŽÀ—áW(120) VGPMSP‚ւ̑Ήž. ²ìŒ«ˆêi–òÜj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 16(7): 137`139, 1998.

3592. muÀn “ÁW; ˆã–ò•i“K‰žŠOŽg—p‚ÌŒ»ó‚Ɖۑè|“K‰žŠOŽg—p‚ɂ‚¢‚Ẳ@“à‘gD‚̑Ήž|. ²ìŒ«ˆêC“‡“cŽœ•Fi–òÜj: ŒŽŠ§–òŽ–, 40(14): 27`31, 1998.

3593. muÀn “ÁW; ˆã–ò•i“K‰žŠOŽg—p‚ÌŒ»ó‚Ɖۑè|“K‰žŠOŽg—p‚ÌŒ»ó|. ’†‘º˜a•vC²ìŒ«ˆêC¬—Ñ‹P–¾C’|“எqC–Ø‘º—˜”üi–òÜj: ŒŽŠ§–òŽ–, 40(14): 39`50, 1998.

3594. muÀn •a‰@‚É‚¨‚¯‚éˆã–ò•iî•ñ‹Æ–±‚ÌŠî‘b’mŽ¯(‚»‚Ì1). •ŽR­ˆêi–òÜj: _“Þ쌧•a‰@–òÜŽt‰ïŽ, (88): 33`35, 1998.

3595. muÀn •a‰@‚É‚¨‚¯‚éˆã–ò•iî•ñ‹Æ–±‚ÌŠî‘b’mŽ¯(‚»‚Ì2). •ŽR­ˆêi–òÜj: _“Þ쌧•a‰@–òÜŽt‰ïŽ, (89): 31`34, 1998.

3596. muÀn “ÁW¢’m‚Á‚Ä‚¨‚­‚ׂ«OTC–ò‚Ì’mŽ¯£ OTC–ò•ž—pŠ³ŽÒ‚Ö‚Ì’ˆÓ|‚—îŽÒ|. ²ìŒ«ˆêi–òÜj: —Õ°‚Æ–ò•¨Ž¡—Ã, 17(6): 550`553, 1998.

3597. muÀn Šw‰ï”F’è–òÜŽt‚͉½‚ð‹‚ß‚ç‚ê‚Ä‚¢‚é‚©. ’†–ìáÁ”ÄiŒF–{‘åjC–x—¹•½i‹ß‹E‘åjCX˜a•FiŒú¶ÈjC”óŒûxi‹ã‘åjC‘êŒûË—ßi“¿“‡‘åjC•ûG‘×i–¾Ž¡–ò‰È‘åjC‰œ‘ºŸ•Fi_ŒË‘åjC•ŽR­ˆê i–òÜjC’†–ìdsi‘啪ˆã‘åjC•“c‹ÎiŽO–ØŽs–¯•a‰@jC‘å‘ò—F“ñié•lf—ÊjC••”‰ëli–kŒ¤jCˆ¢‘]—ºŽqi“úˆã‘åjC”öŒF—²‰Ãi‰––ì‹`»–òj: —Õ°ˆã–ò, 14(15): 2647`2682, 1998.

3598. m‹³‰È‘n i•ª’SŽ·•Mj ˆã–ò•iî•ñŠw“ü–å; •a‰@–ò‹Ç‚É‚¨‚¯‚éˆã–ò•iî•ñ’ñ‹ŸŠˆ“®‘æ3”Å, p.225`237, ˜Iè_ŽqC“‡“cŽœ•Fi–òÜj. •ÒW ”Â’JKˆêiŽD–yˆã‘åjC•ÒC “ìŽR“°, 99.03.31”­s.

3599. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ƒ‰ƒWƒI‚½‚ñ‚Ï–òÜŽt¶ŠUŒ¤CuÀƒeƒLƒXƒg; –ò‰¿Šî€ŽûÚV–ò‚̉ðà, 5: 171`181, ˜Iè_Žqi–òÜj. •ÒW “ú–{–òÜŽt‰ïC•ÒC –òŽ–“ú•ñŽÐ, 98.06.01”­s.

3600. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŒoÖ¬¥Œo’°‰h—{ƒ}ƒjƒ…ƒAƒ‹; lH‰h—{Ü‚Ì‘g¬‚Æ’²®–@, p.57`64, •½ŽR•ŽiC“‡“cŽœ•Fi–òÜj. •ÒW ‚–Ø—mŽ¡iã‘åjC•ÒC Æ—ÑŽÐ, “Œ‹ž, 98.10.10”­s.

3601. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ¡“ú‚̈ã–òî•ñ; DIŽÀ—áW(120)|VGPMSP‚ւ̑Ήž; ‘æ20W, p.227`231, ²ìŒ«ˆêi–òÜj. –òŽ–V•ñŽÐ, “Œ‹ž, 99.02.10”­s.

3602. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Successful treatment of Cibenzoline succinate poisoning using a charcoal hemoperfusion (DHP). ‹ß“¡—¯”üŽqi–òÜjCÂŽR’¼‘Pi‹~–½jC²X–Ø‹Bi“àjC‹g“cTC—é–ØŒ[‰îC˜aò“Oi“àjC㞊‹glC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: 8th International Congress of Toxicology i98.07.05`09j, ƒpƒŠ.

3603. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Evaluation of efficacy of Kampo Medicine by pharmaco-epidemiological method; Efficacy of Sho-Saiko-To in the patient with liver dysfunction. Ô£•üGi–òÜjC“c‘ãáÁˆêiº˜a–ò‰È‘åjC“‡“cŽœ•Fi–òÜj: 2nd International Symposium on Natural Medicine and Microflora i98.10.26j, “ú–{, Program, p.3, 1998.

3604. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Strategy of Proper Drug Use in Japanese Hospital Pharmacies. ’¬“c[C‰Á‰ê’J”£C²ìŒ«ˆêC–]ŒŽ^‹|C“‡“cŽœ•Fi–òÜj: 33rd Annual ASHP Midyear Clinical Meeting and Exhibits i98.12.08j, Las Vegas, Internal Pharmaceutical AB, p.2265, 1998.

3605. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j •a“Šˆ“®‚É‚¨‚¯‚éTDM‹Æ–±‚Ì„i|ƒAƒ~ƒmƒOƒŠƒRƒVƒhŒnR¶•¨Ž¿‚̃‚ƒjƒ^ƒŠƒ“ƒO|. –Ø‘º—˜”üi–òÜj: ‘æ15‰ñ“ú–{TDMŠw‰ïŠwp‘å‰ï i98.05.30j, _ŒË, —vŽ|W, p.34, 1998.

3606. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j •a‰@–òÜŽt‚ÆŽs”̌㒲¸. ²ìŒ«ˆêi–òÜj: ‘æ8‰ñ“ú–{•a‰@–òŠw‰ïƒTƒeƒ‰ƒCƒgƒVƒ“ƒ|ƒWƒEƒ€ƒpƒlƒŠƒXƒg i98.09.11j, ‰¡•l, —vŽ|W, p.8`9, 1998.

3607. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Œû“à‰ŠŽ¡—×p‰@“à»Ü‚ÌŠî‘b“I‚¨‚æ‚Ñ—Õ°“IŒ¤‹†. ¼Œ´”£C²ìŒ«ˆêC“‡“cŽœ•Fi–òÜjC˜h‘ƒçŠGC΋½‰ª‹Ïi‘—§‘Š–ÍŒ´•a‰@j: “ú–{–òÜŠw‰ï‘æ14”N‰ï i99.03.26j, ‰ªŽR, —\eW, p.22`23, 1999.

3608. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –ò܉uŠw‚ÌŽè–@‚ð‰ž—p‚µ‚½Š¿•û–ò‚Ì•]‰¿; ‡B ¬ŽÄŒÓ“’“Š—^’†Ž~Š³ŽÒ315—á‚ÌŠÌ‹@”\‚Ì•Ï“®‚ÌŒŸ“¢. Ô£•üGC“‡“cŽœ•Fi–òÜjC“c‘ã^ˆêiº˜a–ò‰È‘åj: ‘æ49‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï i98.05.24j, ŒF–{, —vŽ|W, p.121, 1998.

3609. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’†“ÅŠ³ŽÒŽ¡—Âɂ¨‚¯‚é’†“Å•¨Ž¿•ªÍ‚Ì—L—p«. ‹ß“¡—¯”üŽqi–òÜjC‘Š”nˆêˆåCó—˜–õC㞊‹glCŒüŽRŒMC•“cºi‹~–½jC“‡“cŽœ•Fi–òÜjC‘å˜a“c—²i‹~–½jC¼ì—²i—Õ•a—j: ‘æ1‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï i98.06.01`02j, ‘q•~, “ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï‰ïŽ, (1): 146, 1998.

3610. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —Õ°•ª—£‹Û‚ÌŠeŽíR¶•¨Ž¿‚ɑ΂·‚銴Žó«—¦‚Ì„ˆÚ [‡T]|ƒOƒ‰ƒ€—z«‹…‹Û, ƒOƒ‰ƒ€‰A«‹…‹Û‚ɂ‚¢‚Ä|. ‰ª–{Œb”üŽqC“ï”gº—YC•ŽR­ˆêC–îŒã˜a•vi–òÜj: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.05j, ˜a‰ÌŽR.

3611. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —Õ°•ª—£‹Û‚ÌŠeŽíR¶•¨Ž¿‚ɑ΂·‚銴Žó«—¦‚Ì„ˆÚ[‡U]|ƒOƒ‰ƒ€‰A«ž…‹Û‚ɂ‚¢‚Ä|. “ï”gº—YC‰ª–{Œb”üŽqC•ŽR­ˆêi–òÜj: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i98.06.05j, ˜a‰ÌŽR, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46S-A: 206, 1998.

3612. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j _“Þ쌧“à•a‰@‚É‚¨‚¯‚éˆã–ò•iî•ñ‚ÌŠÇ—‚ÉŠÖ‚·‚錻ó•ªÍ. Šâ“c­‘¥i‰¡•lŽs‘åjC²ìŒ«ˆêC–Ø‘º—˜”üi–òÜjC¬âD’ji“úˆã‘åjC‹–”ã‹áŽqi“ŒŠC‘åjC’|“எqi–òÜjC‰i–ìOŽqiº˜a‘åjC’†‘º˜a•vi‰¡•lŽs ‘åjC[’J^—ŽqCŽR茰i¹ƒ}ƒŠ‘åjC镸ˆêi‰¡•lŽs‘åj: ‘æ8‰ñ“ú–{•a‰@–òŠw‰ï”N‰ï i98.09.12j, ‰¡•l.

3613. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¡Œ±ŽÀŽ{‘̧‚Æ–òÜŽt‚Ì–ðŠ„|–k—¢‘åŠw“Œ•a‰@|. –ì’†”ü˜aC‰¡“cTˆêC•ŽR­ˆêC’íŽqŠÛ‹IŽqC‘ò“cŽÀ‰ÔC•½ŽR•ŽiC–îŒã˜a•vi–òÜj: ‘æ8‰ñ“ú–{•a‰@–òŠw‰ï”N‰ï i98.09.12j, ‰¡•l, —\eW, p.70, 1998.

3614. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆã–ò•i“K³Žg—p‚ւ̃Aƒvƒ[ƒ`‡W|t‹@”\’ቺŽž‚̃Jƒ‹ƒoƒyƒlƒ€ŒnR¶•¨Ž¿‚ƃqƒXƒ^ƒ~ƒ“H2Žó—e‘ÌhR–ò‚Ì„§—p—Ê‚Ö‚ÌŒŸ“¢. ’¬“c[i–òÜjCŠ‹ŽR°Žqi–òŠw•”jC˜Iè_ŽqC²ìŒ«ˆêC‰Á‰ê’J”£C‘º£¨’ÃŽqC–îŒã˜a•vC“‡“cŽœ•Fi–òÜj: ‘æ8‰ñ“ú–{•a‰@–òŠw‰ï”N‰ï i98.09.12j, ‰¡•l, —vŽ|W, p.76, 1998.

3615. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 19-norteestosterone—U“±‘Ì‚É‚¨‚¯‚錎ŒoŽüŠú‚É‚æ‚é–ò•¨“®‘Ԃւ̉e‹¿. ‘ò“cŽÀ‰Ôi–òÜjCŒF’J—YŽ¡i–ò—jC‰¡“cTˆêi–òÜjC“¡“c•üŒbi–ò—jCˆä‘òŽu–¼–ìC‘ºèŒõ–Mi¸j: ‘æ19‰ñ“ú–{—Õ°–ò—Šw‰ï i98.11.20`21j, •Ê•{.

3616. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j GPMSP‚ւ̉@“àŽx‰‡‘̧‚ÌŠm—§‚ÉŒü‚¯‚Ä. ²ìŒ«ˆêC˜Iè_ŽqC’¬“c[CÔ£•üGC’r“c—R”üŽqC‘Š‘ò­–¾C‹ß“¡—¯”üŽqC‰Á‰ê’J”£C‘º£¨’ÃŽqC“‡“cŽœ•Fi–òÜj: ‘æ19‰ñ“ú–{—Õ°–ò—Šw‰ï i98.11.24`25j, •Ê•{.

3617. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j TPN—A‰t’²»Žž‚É‚¨‚¯‚éƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒW‚Ì—L—p«i‘æ2•ñj. ¼Œ´”£C²ìŒ«ˆêC“‡“cŽœ•Fi–òÜj: ‘æ14‰ñ“ú–{Ö¬Œo’°‰h—{Šw‰ï i99.02.12j, Žl“úŽs, Ö¬¥Œo’°‰h—{, p.260`263, 1999.

3618. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆã–ò•i‚Ì“K‰žŠOŽg—p‚ɑ΂·‚é–òÜŽt‚Ì–ðŠ„. “y’J•¶lC¬‹{ŽR‹MŽqi–òŠw•”jC’|“எqC–îŒã˜a•vi–òÜjC΋½‰ªƒi¸j: ‘æ27‰ñ“ú–{¸_•a‰@‹¦‰ï¸_ˆãŠw‰ï i99.03.04j, •Ÿ‰ª.

3619. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž‘±“IŒŒ‰tàh‰ß(CHDF)Ž{sŽž‚ÉS•s‘SŽ¡—ÖòOlprinome‚ð“Š—^‚µ‚½‚PÇ—á. ‚‹´Œ«¬C“‡“cŽœ•Fi–òÜjC‰z‘OGri–¾Ž¡–ò‰È‘åjC‘å–ìˆÀŽÀC˜aò“Oi“àj: “ú–{–òŠw‰ï‘æ118”N‰ï i98.03.31j, ‹ž“s, —vŽ|W, 4: 154, 1998.

3620. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j R^‹Û–òƒCƒgƒ‰ƒRƒiƒ][ƒ‹‚Ì“K³Žg—p‚ÉŠÖ‚·‚錤‹†(2). 㔩’mŽqC¬‹{ŽR‹MŽqi–òŠw•”jC‘º£¨’ÃŽqC“‡“cŽœ•Fi–òÜjC‹v•ÄŒõi•a—j: “ú–{–òŠw‰ï‘æ118”N‰ï i98.04.02j, ‹ž“s.

3621. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –«t•s‘SŠ³ŽÒ‚É‚¨‚¯‚éRƒAƒŒƒ‹ƒM[–òoxatomide‚Ì‘Ì“à“®‘Ô‚ÉŠÖ‚·‚錤‹†. óˆä”ü—R‹IC•ŽR­ˆêC–îŒã˜a•vi–òÜjC‰¡“c^“ñi”åj: ‘æ43‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï i98.05.30j, ‰¡•l.

3622. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –ò•¨“®‘ÔƒVƒ…ƒ~ƒŒ[ƒVƒ‡ƒ“ƒvƒƒOƒ‰ƒ€; Clinkinetics-K‚ÌŠJ”­. ‘•ªG–çC–Ø‘º—˜”üC‘º£¨’ÃŽqC“‡“cŽœ•Fi–òÜj: ‘æ15‰ñ“ú–{TDMŠw‰ïŠwp‘å‰ï i98.05.31j, _ŒË.

3623. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ®Œ`ŠO‰È—̈æ‚É‚¨‚¯‚éƒIƒLƒTƒZƒtƒFƒ€ŒnR¶•¨Ž¿‚ÌpŒãŠÌ‹@”\ŒŸ¸’lˆÙí‚ÉŠÖ‚·‚é–ò܉uŠw“IŒ¤‹†. •ŽR­ˆêC”ö’¹Ÿ–çC“uLKC‘ò“cŽÀ‰ÔC–îŒã˜a•vC‰¡“cTˆêCŒF’J—YŽ¡C“n•Ó•üŒbi–ò—j: ‘æ46‰ñ“ú–{‰»Šw—Ö@Šw‰ï i98.06.04`05j, ˜a‰ÌŽR.

3624. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒVƒxƒ“ƒ]ƒŠƒ““K³Žg—p•]‰¿‚ÆŒŒ’†”Z“x. ‚‹´Œ\ŽqC‘•ªG–çC’¬“c[C‚‹´Œ«¬C‹ß“¡—¯”üŽqC‘º£¨’ÃŽqC“‡“cŽœ•Fi–òÜjCÂŽR’¼‘Pi‹~–½jC‹g“cTC—é–ØŒ[‰îi“àjC㞊‹gli‹~–½jC²X –Ø‹BC˜aò“Oi“àj: ‘æ7‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ i98.06.25j, ‘O‹´, —vŽ|W, p.163`164, 1998.

3625. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆã–ò•i“K³Žg—p‚É‚¨‚¯‚é–òÜŽt‚ÌŠÖ‚í‚è|ˆã–ò•i“K³Žg—p„iˆÏˆõ‰ï‚Ì‹@”\‚ÆŽÀ‘H“à—e‚ɂ‚¢‚Ä|. ’¬“c[C˜Iè_ŽqC‰Á‰ê’J”£C²ìŒ«ˆêC‘º£¨’ÃŽqC“‡“cŽœ•FC–]ŒŽ^‹|i–òÜj: ‘æ7‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ i98.06.25j, ‘O‹´, —vŽ|W, p.95`96, 1998.

3626. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j t‹@”\’ቺ‚ª‚ñŠ³ŽÒ‚É‚¨‚¯‚éƒIƒsƒIƒCƒh‚Ì“K³Žg—p‚ÉŠÖ‚·‚錤‹†. ‹{–{ˆ»ŽqCX쳎qi“Œ‹ž–ò‰È‘åjC‰Á‰ê’J”£C‘º£¨’ÃŽqC“‡“cŽœ•Fi–òÜjC“IꌳOCŠO{”ü•vi–ƒj: ‘æ7‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ i98.06.26j, ‘O‹´, —vŽ|W, p.123`124, 1998.

3627. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘¢ŒŒŠíŽîᇂ̉»Šw—Ö@‚É”º‚¤Œû“à‰Š‘Îô‚ɂ‚¢‚Ä`‰@“à»ÜgŒûo—pƒvƒƒXƒ^ƒOƒ‰ƒ“ƒfƒBƒ““îph‚Ì—Õ°Œø‰Ê‚ÌŒŸ“¢`. Ô£•üGC‘å‰Í“à‹M_C‰Á‰ê’J”£C¼Œ´”£C²ìŒ«ˆêC“‡“cŽœ•Fi–òÜjCŒS”ü‰ÀCHŽR’¨C’hŒ´Š²¶C‹àŽq‘½ŽqC‰–’J–ÎC“ŒŒ´³–¾i“àj: ‘æ7‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ i98.06.26j, ‘O‹´, —vŽ|W, p.181`182, 1998.

3628. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éÝ‘îˆã—ÂƖòÜŽt‚ÌŒW‚í‚èi‘æ1•ñj. Vˆä–œ—ŽqC‰Á‰ê’J”£C“‡“cŽœ•Fi–òÜj: ‘æ8‰ñ“ú–{•a‰@–òŠw‰ï”N‰ï i98.09.12j, ‰¡•l, —\eW, p.186, 1998.

3629. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰ŠÇ«’°Ž¾Š³Š³ŽÒ‚ÌŒŒ‰t’†”÷—ÊŒ³‘f”Z“x‚Ì„ˆÚ|‚¨‚à‚ɃZƒŒƒ“‚ƃZƒŒƒ“ˆË‘¶y‘f‚ɂ‚¢‚Ä|. ¬¼ºŽqC¼–{Œªˆê˜YC‰““¡˜a–Liº˜a–ò‰È‘åjC¬ìK—YC–îŒã˜a•vi–òÜjC‰¡ŽRŒOCŸ–””º‰hi“àj: ‘æ8‰ñ“ú–{•a‰@–òŠw‰ï”N‰ï i98.09.12j, ‰¡•l, —vŽ|W, p.347, 1998.

3630. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Basic Clinical Pharmacokinetics‚Ì•êW’cƒpƒ‰ƒ[ƒ^‚É‚æ‚錌´’†ƒŠƒ`ƒEƒ€(Li)”Z“x‚Ì—\‘ª«‚ÉŠÖ‚·‚錤‹†. ’Å’C’|“எqC¡ˆäLŒbC¬—Ñ—TŽqCŠ‹ˆä^‹|CL£”ü‹IC–îŒã˜a•vi–òÜjCŽÂèŒöˆêi–òŠw•”jCŽá“c•””Ž•¶i¸j: ‘æ8‰ñ“ú–{•a‰@–òŠw‰ï”N‰ï i98.09.13j, ‰¡•l, —vŽ|W, p.358, 1998.

3631. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’P—£ŠÁ—¬t‚ð—p‚¢‚½ƒ‰ƒbƒgt‚ÌŽ¡•”•Û‘¶‚É‚¨‚¯‚éŒÜ—èŽU‚Ìt•Û‘¶Œø‰Ê. Ô£•üGC‰Á‰ê’J”£C“‡“cŽœ•Fi–òÜjC^è‹`•FiŽÀ“®ŒnjC“c‘ãáÁˆêiº˜a–ò‰È‘åj: ‘æ8‰ñ“ú–{•a‰@–òŠw‰ï”N‰ï i98.09.13j, ‰¡•l, —vŽ|W, p.371, 1998.

3632. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Vˆã–ò•i”­”„Žž‚É“üŽè‚Å‚«‚éˆã–ò•iî•ñŒ¹‚Ì•]‰¿. ¡ˆäLŒbC•ŽR­ˆêC•½ŽR•ŽiC’|“எqC–îŒã˜a•vi–òÜj: ‘æ13‰ñ“ú–{–òÜŽt‰ïŠwp‘å‰ï i98.09.20j, –kŠC“¹.

3633. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒW‚Ì—L—p«‚ÉŠÖ‚·‚錤‹†. ’‡ì‹`lC“ŒŠC—Ñ“OC–LŒû‹`•viŽRŒ`‘åjC“‡“cŽœ•FC¼Œ´”£C–îŒã˜a•vC¬ìK—Yi–òÜjC•½–ìŒöîC‘º“c˜a–çi“úˆã‘åj: “ú–{–òŠw‰ï‘æ119”N‰ï i99.03.30j, “¿“‡.

3634. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒŠƒ`ƒEƒ€•ž—pŠ³ŽÒ‚É‚¨‚¯‚éÌŒŒŽžŠÔ‚ÆŒŒ’†”Z“x‚Ì—\‘ª«. ’Å’C’|“எqC¡ˆäLŒbC¬—Ñ—TŽqCŠ‹ˆä^‹|CL£”ü‹IC¼‰€”ü˜aŽqC–îŒã˜a•vi–òÜjC²ŒÃŒ“ˆêCŽÂèŒöˆêi–òŠw•”jCŽá“c•””Ž•¶i¸j: “ú–{–òŠw‰ï‘æ119”N‰ï i99.03.30j, “¿“‡, —\eW, p.123.

3635. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆâ“`«˜ËŽòÇ/bó‘B‹@”\’ቺǃ‰ƒbƒgrdw‚É‚¨‚¯‚éƒyƒ“ƒgƒoƒ‹ƒrƒ^[ƒ‹–ƒŒŠoÁ’x‰„‚Ɗ̃~ƒNƒƒ\[ƒ€p450–ò•¨‘ãŽÓŠˆ«‚̒ቺ. ‘•ªG–çC–Ø‘º—˜”üC‘º£¨’ÃŽqC“‡“cŽœ•Fi–òÜjC›–ìKŽqiŠÅŒìjC“n•Ó“”ü”Ti¶‰»jCŒÃŠÚêˆêiŽÀ“®j: “ú–{–òŠw‰ï‘æ119”N‰ï i99.03.30j, “¿“‡, —vŽ|W, p.31, 1999.

3636. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚éCRC‹Æ–±‚ÌŒ»ó‚Æ‚»‚Ì•]‰¿. ’íŽqŠÛ‹IŽqCL£”ü‹IC–ì’†”ü˜aC‰¡“cTˆêC‘ò“cŽÀ‰ÔC•ŽR­ˆêC–îŒã˜a•vi–òÜj: “ú–{–òŠw‰ï‘æ119”N‰ï i99.03.31j, “¿“‡.

3637. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚P‚©ŒŽ•a‰@ŽÀK‚ÉŠÖ‚·‚é•]‰¿‚Ɖۑè. ”ö’¹Ÿ–çCX“c‰ë”VC–ؖõ•vC¬¼‡ŽqC‰|–{—TŽqC‚”ö—Ç—mC–îŒã˜a•vCŽðˆäG—mC¬—Ñ‹P–¾i–òÜj: “ú–{–òŠw‰ï‘æ119”N‰ï i99.03.31j, “¿“‡.

3638. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚é‚P‚©ŒŽŠw¶ŽÀK‚ÌŒ»ó‚Æ‚»‚Ì•]‰¿. “ï”gº—YC•ŽR­ˆêC”ö’¹Ÿ–çCóˆä”ü—R‹ICŽO‘ºˆê•½C–ì’†”ü˜aC’|“எqC–îŒã˜a•vi–òÜjC‹g“c‚ ‚âŽqi–òŠw•”j: “ú–{–òŠw‰ï‘æ119”N‰ï i99.03.31j, “¿“‡, ƒtƒ@ƒ‹ƒ}ƒVƒA, 35(2•t˜^): 126, 1999.

3639. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠO—ˆŠ³ŽÒƒg[ƒ^ƒ‹ƒPƒA‚Ì‘ÌŒn‰»|‘Þ‰@ŒãŽw“±‚Æ•ž–ò‰‡•‚ÌŽÀ‘H|. ‚‹´Œ«¬C›Œ´[LC“c‘º˜aŒhC–ìa—TŽqC‰ªè”ü‘ãŽqCÔ£•üGC²‹vŠÔ­•FC‰Á‰ê’J”£C“‡“cŽœ•Fi–òÜjC‰z‘OGri–¾Ž¡–ò‰È‘åj: “ú–{–òŠw‰ï‘æ119”N‰ï i99.03.31j, “¿“‡, —\eW, 4: 190, 1999.

3640. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰–Ž_ƒZƒtƒHƒ]ƒvƒ‰ƒ“‚É‚æ‚éƒGƒ“ƒhƒgƒLƒVƒ“—V—£‚ɂ‚¢‚Ä. ’¬“c[i–òÜjC˜@À—LjêCŒF‘ò‹`—Yi—ŠwjC“‡“cŽœ•Fi–òÜj: “ú–{–òŠw‰ï‘æ119”N‰ï i99.03.31j, “¿“‡, —\eW, p.95, 1999.

3641. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j _“Þ쌧•a‰@–òÜŽt‰ï‚É‚¨‚¯‚é‚­‚·‚èGet the Answers‚©‚È‚ª‚튈“®. ²“¡NMCŠâ“c—zŽqC‘å“à•¶LC÷ˆä–¯—YC²ŠÑ”ü’q—¯CŽOa˜a’jCª’×ÇKC’¬“c[i–òÜjCŽR“c‰p‹IC•ŽR­ˆêi–òÜjC‹e’n—L“¹C•½—Ñ“N˜YC¬—Ñ‹P–¾ i–òÜj: “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ28‰ñŠwp‘å‰ï i98.08.29j, b•{.

3642. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “«‚¤‚•a‚ɑ΂·‚éƒuƒƒ‚ƒNƒŠƒvƒ`ƒ““Š—^‚Æ–òÜŽt‚ÌŠÖ‚í‚è. ’|“எqC¬—Ñ—TŽqC¼‰€”ü˜aŽqC–îŒã˜a•vi–òÜj: ‘æ2‰ñL“‡Œ§¸_•a‰@‹¦‰ï–òÜŽt•”‰ïŠwp‘å‰ï i98.10.31j, L“‡.

3643. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒZƒtƒFƒ€ŒnR¶Ü‚ÌpŒã–òÜ«ŠÌáŠQ‚ÉŠÖ‚·‚é–ò܉uŠw“IŒ¤‹†. “uLKC•ŽR­ˆêC”ö’¹Ÿ–çC‰¡“cTˆêC‘ò“cŽÀ‰ÔCˆÉ“¡’¼ŽqC–îŒã˜a•vi–òÜjC“¡“c•üŒbCŒF’J—YŽ¡i–ò—j: ‘æ45‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï i99.02.06j, ‰¡•l.

3644. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —X‘—–@‚É‚æ‚éÁ‰»«’×ᇊ³ŽÒ‚Ö‚Ì•ž–òŽw“±. ˆÉ“¡’¼ŽqC•ŽR­ˆêCŠ™“cŸ‹vC“ï”gº—YC–îŒã˜a•vi–òÜj: _“Þ쌧•a‰@–òÜŽt‰ï‘æ6‰ñŠwp‘å‰ï i99.02.07j, ‰¡•l.

3645. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j ƒIƒ“ƒ‰ƒCƒ“ƒVƒXƒeƒ€‚Ì–ò—ðî•ñ‚ðŠˆ—p‚µ‚½‰æ‘œ•t‚«•ž–òŽw“±—pŽ†‚Ìì¬. ’íŽqŠÛ‹IŽqC¬ìK—YC“ï”gº—YC‰¡ˆäMŽqCóˆä”ü—R‹IC–îŒã˜a•vi–òÜjC”~“cN—YC¼–{½ŽŸiî•ñˆ—•”jCrˆäN•vi•a—ðj: “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ28‰ñŠwp‘å‰ï i98.08.30j, b•{.

3646. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j ˆã–ò•i“K³Žg—p‚ւ̃Aƒvƒ[ƒ`‡V|ƒgƒƒOƒŠƒ^ƒ]ƒ“iƒmƒXƒJ[ƒ‹j‚Ì“–‰@‚Å‚Ì‹Ù‹}ˆÀ‘S«î•ñ‚ւ̑Ήž|. ‚‹´—¢“ÞC’¬“c[C˜Iè_ŽqC²ìŒ«ˆêC‰Á‰ê’J”£C‘º£¨’ÃŽqCŠ‹ŽR°ŽqC–îŒã˜a•vC“‡“cŽœ•Fi–òÜj: “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ28‰ñŠwp‘å‰ï i98.08.30j, b•{.

3647. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j TPN—A‰t’²»Žž‚É‚¨‚¯‚éƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒW‚Ì—L—p«. •xŠ~“ÖŽqC¼Œ´”£C²ìŒ«ˆêC“‡“cŽœ•Fi–òÜj: ‘æ13‰ñÝ‘îÖ¬‰h—{(HPN)Œ¤‹†‰ï i98.09.12j, ‰¡•l, —\eW, p.1, 1998.

3648. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j _“Þ쌧•a‰@–òÜŽt‰ï‚É‚¨‚¯‚é‚­‚·‚èGet the Answers‚©‚È‚ª‚튈“®. ²“¡NMCŠâ“c—zŽqC‘å“à•¶LC÷ˆä–¯—YC²ŠÑ”ü’q—¯CŽOa˜a’jCª’×ÇKC’¬“c[i–òÜjCŽR“c‰p‹IC•ŽR­ˆêi–òÜjC‹e’n—L“¹C•½—Ñ“N˜YC¬—Ñ‹P–¾ i–òÜj: _“Þ쌧•a‰@–òÜŽt‰ï‘æ6‰ñŠwp‘å‰ï i99.02.07j, ‰¡•l.


<<35 ˆãŠwŒ´˜_@>>

3649. m’Z•ñ¥‘¬•ñn ŠÅŒì•w‚Ì—Ï—Šˆ“®‚ÉŠú‘Ò‚·‚é‚à‚Ì. ‰Æ‰i“oiˆãŠwŒ´˜_j: ŠÅŒìŠwŽGŽ, 62(8): 780`781, 1998.

3650. mÇ—á•ñn ƒGƒCƒY‹³ˆç‚̈êŠÂ‚Æ‚µ‚ÄŒö—§ŠwZ‚̶“k‚ɑ΂µ‚Ä—¼e‚ÌŠÖ—^‚È‚µ‚ɃRƒ“ƒh[ƒ€‚ð”z•z‚·‚邱‚Ƃ̉”ۂª‘ˆ‚í‚ꂽŽ–—á. ‰Æ‰i“oiˆãŠwŒ´˜_j: ƒAƒƒŠƒJ–@, 1998”N(2): 295`299, 1998.

3651. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ”»—á‘ÌŒne‘°¥‘Š‘±–@(Ž‘—¿W); ’ǘ^, 102`103†, Îì–«iã’q‘åjC‰Æ‰i“oiˆãŠwŒ´˜_j. •ÒW ‰Á“¡ˆê˜YC”\Œ©‘P‹vi“Œ‘åjC‰SFˆêi“s—§‘åjC•ÒC ‘æˆê–@‹K, “Œ‹žC98.08.05”­s.

3652. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ”»—á‘ÌŒne‘°¥‘Š‘±–@(Ž‘—¿W); ’ǘ^, 104`107†, Îì–«iã’q‘åjC‰Æ‰i“oiˆãŠwŒ´˜_j. •ÒW ‰Á“¡ˆê˜YC”\Œ©‘P‹vi“Œ‘åjC‰SFˆêi“s—§‘åjC•ÒC ‘æˆê–@‹K, “Œ‹žC99.02.25”­s.

3653. mŒ¤‹†‰ïi’n•ûjn ih‘è•ñj Alfonso‘ÎFernandezŽ–Œ. ‰Æ‰i“oiˆãŠwŒ´˜_j: ‰p•Ä‰Æ‘°–@”»—ጤ‹†‰ï‘æ126‰ñ—á‰ï i98.04.25j, “Œ‹ž.

3654. mŒ¤‹†‰ïi’n•ûjn ih‘è•ñj Curtis‘ÎSchool Committee of FalmonthŽ–Œ. F싈êi‘‘åjC‰Æ‰i“oiˆãŠwŒ´˜_j: ‰p•Ä‰Æ‘°–@”»—ጤ‹†‰ï‘æ127‰ñ—á‰ï i98.05.23j, “Œ‹ž.

3655. mŒ¤‹†‰ïi’n•ûjn ih‘è•ñj –¯Ž––@‚É‚¨‚¯‚鎀–S‚Ì–@“IŒø‰Ê. ‰Æ‰i“oiˆãŠwŒ´˜_j: ‰Æ‘°‚Æ–@Œ¤‹†‰ï‘æ144‰ñ—á‰ï i98.09.26j, “Œ‹ž.


<<36 ˆã—pî•ñŠw>>

3656. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚•p“xS–[ƒy[ƒVƒ“ƒOŽž‚Ì–[Žº“`“±“Á«|”Šwƒ‚ƒfƒ‹‚É‚æ‚錟“¢|. ’r“cŒ›ºC’|“ດŽC‹{Œ´‰p•viˆã—pî•ñjC”¯N—YiŽÀ“®jC“ޗljÀ—mi¶•¨•¨—ŒnjC‚–öŠ°iàÕ‹¦ˆã‘åj: ‘æ15‰ñ“ú–{S“dŠw‰ïŠwpW‰ï i98.10.02j, Ž­Ž™“‡, ´˜^W¥S“d}, 18(5): 735, 1998.


<<38 •¨—Šw>>

3657. mŒ´’˜n Off-the-energy-shell effect in HD+ dissociative recombination. ‚–ØGˆêi•¨—j: Atomic Collision Research in Japan, 24: 3`6, 1998.

3658. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j HD+‰ð—£«ÄŒ‹‡‚ÌŽU—–â‘è‚Æ‚µ‚Ä‚Ì“Á«‚Æ‚•ª‰ð”\ƒXƒyƒNƒgƒ‹‚̉ðÍ. ‚–ØGˆêi•¨—j: “ú–{•¨—Šw‰ï i98.09.27j, ‰«“ê, “ú–{•¨—Šw‰ïu‰‰ŠT—vW, 53(4): 884`884, 1998.

3659. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j …‘f•ªŽqƒCƒIƒ“¥“dŽqÕ“Ë‚É‚æ‚éU“®‰ñ“]‘JˆÚ. ‚–ØGˆêi•¨—j: “ú–{•¨—Šw‰ï i99.03.30j, L“‡, “ú–{•¨—Šw‰ïu‰‰ŠT—vW, 54(4): 759`759, 1999.


<<39 ‰»Šw>>

3660. mŒ´’˜n Properties of cattle bone powder-coated composite particles as high-performance and open column liquid chromatographic column packings. –{“c“ñ—tiPHD Inc.jC–{“cG—²C¬Î^ƒi“Œ—‘åjC¼–ìVŽmi‰»j: J. Chromatogr. A, (813): 21`33, 1998.

3661. mŒ´’˜n Preparation of laminated hydroxyapatite/zirconia sintered composite with the gradient composition. ¼–ìVŽmi‰»ŠwjC“n•ÓŒ’ˆêC¬–쌛ŽŸi“Þ—Ç‹@ŠBjC¬Î^ƒi“Œ—‘åj: J. Mater. Sci. Lett., (17): 1349`1351, 1998.

3662. m€Œ´’˜n Sintering of zirconia coated hydroxyapatite particles. “n•ÓŒ’ˆêC¬–쌛ŽŸi“Þ—Ç‹@ŠBjC¬Î^ƒi“Œ—‘åjC¼–ìVŽmi‰»Šwj: Proceedings of World Congress on Advanced Technologies for Particle Prosessing, 1: 386`391, 1998.

3663. m€Œ´’˜n Packing structure of monolayer particle coated powder prepared by the dry impact blending process utilizing mechanochemical treatment. –{“cG—²C¬Î^ƒi“Œ—‘åjC–{“c“ñ—tiPHD Inc.jC¼–ìVŽmi‰»j: Proceedings of World Congress on Particle Technology, (371): 1`6, 1998.

3664. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Packing structure of monolayer particle coated powder prepared by the dry impact blending process utilizing mechanochemical treatment. –{“cG—²C¬Î^ƒi“Œ—‘åjC–{“c“ñ—tiPHD Inc.jC¼–ìVŽmi‰»Šwj: World Congress on Particle Technology 3 i98.07.07j, ƒuƒ‰ƒCƒgƒ“iƒCƒMƒŠƒXj, —vŽ|W, p.194, 1998.

3665. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Sintering of zirconia coated hydroxyapatite particles. “n•ÓŒ’ˆêC¬–쌛ŽŸi“Þ—Ç‹@ŠBjC¬Î^ƒi“Œ—‘åjC¼–ìVŽmi‰»Šwj: World Congress on Advanced Technologies for Particle Processing i98.11.17j, ƒ}ƒCƒAƒ~i•Ä‘j, Online Technical Program (Abstracts), 1998.

3666. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j …Ž_ƒAƒpƒ^ƒCƒg‚Æ•”•ªˆÀ’艻ƒWƒ‹ƒRƒjƒA‚©‚ç‚È‚é‚ŽŸ\‘¢d‘gD‘ã‘ÖÞ—¿‚Ì’²»‚Æ«Ž¿. ¼–ìVŽmi‰»ŠwjCX“c^Žjiˆã—Éq¶jC“n•ÓŒ’ˆêC¬–쌛ŽŸi“Þ—Ç‹@ŠBjC¬Î^ƒi“Œ—‘åj: “ú–{ƒZƒ‰ƒ~ƒbƒNƒX‹¦‰ï‘æ11‰ñH‹GƒVƒ“ƒ|ƒWƒEƒ€ i98.10.02j, –¼ŒÃ‰®, —vŽ|W, p.342, 1998.

3667. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒhƒƒLƒVƒAƒpƒ^ƒCƒg/ƒWƒ‹ƒRƒjƒA•¡‡”÷—±ŽqÄŒ‹‘̶̂‘Ì“K‡«‚Æœ“`“±«. “n•ÓŒ’ˆêi“Þ—Ç‹@ŠBjC¼–ìVŽmi‰»ŠwjCX“c^Žjiˆã—Éq¶jC¬–쌛ŽŸi“Þ—Ç‹@ŠBjC¬Î^ƒi“Œ—‘åj: 1998”NÞ—¿‹ZpŒ¤‹†‹¦‰ï“¢˜_‰ï i98.12.04j, “Œ‹ž, —vŽ|W, p.13`14, 1998.

3668. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒhƒƒLƒVƒAƒpƒ^ƒCƒg^•”•ªˆÀ’艻ƒWƒ‹ƒRƒjƒA•¡‡”÷—±ŽqÄŒ‹‘̂̉»Šw‘g¬‚Æ×–E“Å«. ¼–ìVŽmi‰»ŠwjC“n•ÓŒ’ˆêC¬–쌛ŽŸi“Þ—Ç‹@ŠBjC“c’†Œ›•äC“n•Ó”üiH•i–ò•iˆÀ‘SƒZƒ“ƒ^[jC¬Î^ƒi“Œ—‘åj: ‘æ51‰ñƒRƒƒCƒh‚¨‚æ‚ÑŠE–ʉ»Šw“¢˜_‰ï i98.09.26j, ç—t, —vŽ|W, p.329, 1998.

3669. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒWƒ‹ƒRƒjƒA”í•¢…Ž_ƒAƒpƒ^ƒCƒg”÷—±ŽqÄŒ‹‘Ì‚Ì‹@ŠB“I‹­“x. ¼–ìVŽmi‰»ŠwjC“n•ÓŒ’ˆêC¬–쌛ŽŸi“Þ—Ç‹@ŠBjC¬Î^ƒi“Œ—‘åj: ‘æ14‰ñ“ú–{ƒAƒpƒ^ƒCƒgŒ¤‹†‰ï i98.06.05j, ŽD–y, —vŽ|W, p.8, 1998.


<<41 ¶•¨Šw>>

3670. mŒ´’˜n Evidence for heteromorphic sex chromosomes in males of Rana tagoi and Rana sakuraii in Nishitama district of Tokyo (Anura: Ranidae). —´è³Žmi¶•¨jCHanada, H.COkumoto, H.iL‘åjC‘ê‘ò’¼’èi¶—jCNishioka, M.iL‘åj: Chromosome Research, 6: 1`12, 1999.

3671. mŒ¤‹†‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Evidence for heteromorphic sex chromosomes in males of Rana tagoi and Rana sakuraii in Nishitama district of Tokyo (Anura: Ranidae). —´è³Žmi¶•¨jC‘ê‘ò’¼’èi¶—jCHanada, H.COkumoto, H.CNishioka, M.iL‘åj: International Symposium; The Frontiers of the Biology of Amphibia i99.03.22`24j, L“‡, —\eW, p.76, 1999.


<<42 ?? >>

3672. mŒ´’˜n ’°ŠÇoŒŒ«‘å’°‹Û‚É‚æ‚éƒ}ƒEƒX’°ŠÇŠ´õƒ‚ƒfƒ‹‚ɑ΂·‚éR‹Û–ò‚̉e‹¿; ‘æ2•ñ|Fosfomycin‚—p—Ê“Š—^ŒQ‚É‚¨‚¯‚鎡—ÃŒø‰Ê. ¬—ѓЋgC‘º‰ªG]C¼èŒOCŽG‰êˆÐC¼“cŽÀCH“c”ŽLCŠâ“c•qC²“¡‹g‘sC»ìŒc‰îiŠ´õÇj: “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 46(11): 445`449, 1998.

3673. m‘àn V¢‘ã‚̃jƒ…[ƒLƒmƒƒ“¥¬Ž™‰È—̈抴õÇ. »ìŒc‰îiŠ´õÇj: ‰»Šw—Ö@‚̗̈æ, 14(10): 1799`1804, 1998.

3674. m‘àn Ž¡—ÃgƒsƒbƒNƒX100, PRSPŠ´õÇ|Å‹ß‚Ì“®Œü‚ÆŽ¡—Ã. »ìŒc‰îiŠ´õÇjC¶•ûŒöŽq: Ž¡—Ã, 81(‘Š§): 383`386, 1999.

3675. m‘àn ŠeŽí•a‘Ô‚É‚¨‚¯‚éR‹Û–ò‚ÌŽg‚¢•û|¬Ž™. Šâ“c•qC»ìŒc‰îiŠ´õÇj: Ž¡—Êw, 32(10): 1309`1314, 1998.

3676. m‘àn V¶Ž™R‹Û–ò—Ö@‚ÌŽwj. »ìŒc‰îiŠ´õÇjC²“¡‹g‘s: ŽüŽYŠúˆãŠw, 28(10): 1270`1274, 1998.

3677. m‘àn “à‰Èˆã‚ª¬Ž™Š´õÇ‚Ìf’f‚ÆŽ¡—Âɂ¨‚¢‚Ä’ˆÓ‚·‚ׂ«“_. »ìŒc‰îiŠ´õÇj: “Œ‹ž“à‰Èˆã‰ï‰ïŽ, 14(2): 105`107, 1998.

3678. m‘àn Žè‘«Œû•a. »ìŒc‰îiŠ´õÇj: “ú–{—Õ°, 25(•Êû): 173`174, 1999.

3679. m‘àn àÍg”M. »ìŒc‰îiŠ´õÇj: “ú–{—Õ°, 25(•Êû): 97`98, 1999.

3680. m‘àn ƒŠƒXƒeƒŠƒAÇ. ˆî‘º—zŽqiŠ´õÇj: •Êû“ú–{—Õ°Š´õÇÇŒóŒQ‡T, ‡X.׋ۊ´õÇ, p.354`356, 1999.

3681. mŠwp‘n i•ª’SŽ·•Mj V–ò—Õ°•]‰¿‚̃KƒCƒhƒ‰ƒCƒ“1999; R‹Û–ò—Õ°•]‰¿‚̃KƒCƒhƒ‰ƒCƒ“, p.514`552, »ìŒc‰îiŠ´õÇj. •ÒW “ú–{Œö’è‘‹¦‰ïC•ÒC –òŽ–“ú•ñŽÐ, “Œ‹žC99.02.01”­s.

3682. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj Ž¾Š³•ÊÅVˆ•û; “`õ«g”Á, p.756`757, »ìŒc‰îiŠ´õÇj. ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹žC98.12.10”­s.

3683. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj Ž¾Š³•ÊÅVˆ•û; “Ë”­«”­], p.754`755, »ìŒc‰îiŠ´õÇj. ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹žC98.12.10”­s.

3684. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj Ž¾Š³•ÊÅVˆ•û; —¬s«Ž¨‰º‘B‰Š, p.758`759, »ìŒc‰îiŠ´õÇj. ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹žC98.12.10”­s.

3685. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; —¬s«Ž¨‰º‘B‰Š, 41: 150, »ìŒc‰îiŠ´õÇj. •ÒW ‘½‰ê{K’ji‘½‰ê{ƒNƒŠƒjƒbƒNjC”öŒ`‰x˜YiŠàŒ¤jC•ÒC ˆãŠw‘‰@, “Œ‹žC99.01.01”­s.

3686. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹îž•a‰@‚É‚¨‚¯‚éƒjƒ…[ƒ‚ƒVƒXƒ`ƒk¥ƒJƒŠƒj”x‰Š‚Ì—Õ°“IŒŸ“¢. ¡‘ºŒ°ŽjCˆäŒË“cˆê˜NCˆî‘º—zŽqiŠ´õÇjC–¡àV“ÄCªŠÝ¹Œ÷C‘“c„‘¾: ‘æ12‰ñ“ú–{ƒGƒCƒYŠw‰ï‘‰ï i98.12.02j, “Œ‹ž.

3687. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j HIV—z«ŽÒ‚ɇ•¹‚µ‚½’°ŠÇŒnŒ´’ŽÇ‚Ì—Õ°“IŒŸ“¢. ˆî‘º—zŽqiŠ´õÇjC–¡àV“ÄCˆäŒË“cˆê˜NC¡‘ºŒ°ŽjCªŠÝ¹Œ÷C‘“c„‘¾: ‘æ12‰ñ“ú–{ƒGƒCƒYŠw‰ï‘‰ï i98.12.02j, “Œ‹ž.

3688. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Bifidobacterium»Ü‚ÌEscherichia coli O157:H7‘B‚¨‚æ‚ÑVerotoxinŽY¶«‚ɑ΂·‚éì—p. ‘º‰ªG]C’·’Jì”üKCŽG‰êˆÐC¬—ѓЋgCŠâ“c•qC²“¡‹g‘sCH“c”ŽLC»ìŒc‰îiŠ´õÇj: ‘æ73‰ñ“ú–{Š´õÇŠw‰ï‘‰ï i99.03.30`31j, “Œ‹ž.

3689. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‡¬ƒyƒvƒ^ƒCƒh‚ðRŒ´‚Æ‚µ‚½EIA–@‚É‚æ‚茟o‚³‚ê‚é’჌ƒxƒ‹Rchlamydia trachomatis IgAR‘Ì‚Ì“ÁˆÙ«. â“à‹vˆêCŒÔ“cÆŽqCH“c”ŽLCŠâ“c•qC²“¡‹g‘sC‰¡“c—²•vC»ìŒc‰îiŠ´õÇj: ‘æ73‰ñ“ú–{Š´õÇŠw‰ï‘‰ï i99.03.30`31j, “Œ‹ž.

3690. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “Œ‹ž“s—§‹îž•a‰@Š´õljȂ̕s–¾”MÇ—á‚ÌŒŸ“¢. ˆî‘º—zŽqiŠ´õÇjC‘“c„‘¾C¡‘ºŒ°ŽjC–¡àV“ÄCªŠÝ¹Œ÷: ‘æ73‰ñ“ú–{Š´õÇŠw‰ï‘‰ï i99.03.30j, “Œ‹ž, Š´õÇŠw‰ïŽGŽ, 73(—Õ‘): 183, 1999.

3691. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j AIDS‚ɇ•¹‚µ‚½‘½”­«‹Ø‰Š‚Ì1—á. ˆî‘º—zŽqiŠ´õÇjC–¡àV“ÄCŠÝ“cC“ñi“s—§‹îž•a‰@j: ‘æ145‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i98.06.06j, “Œ‹ž.

3692. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j AIDS‚ɇ•¹‚µ‚½ƒCƒ\ƒXƒ|[ƒ‰Ç‚Ì1—á. ˆî‘º—zŽqiŠ´õÇjC–¡àV“ÄC¡‘ºŒ°ŽjCªŠÝ¹Œ÷C‘“c„‘¾CŽR“c‹`–çi“s—§‹îž•a‰@j: —Õ°Šñ¶’ŽŠw‰ï i98.06.13j, “Œ‹ž.

3693. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j VCM‚ª–³Œø‚Å‚ ‚Á‚½dÇMRSAŠ´õÇ‚ÉABK+RFP‚ª’˜Œø‚ðŽ¦‚µ‚½1—á. ˆî‘º—zŽqiŠ´õÇjC‘“c„‘¾C¡‘ºŒ°ŽjC–¡àV“ÄCªŠÝ¹Œ÷i“s—§‹îž•a‰@j: ‘æ45‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï i98.11.26j, “Œ‹ž.

3694. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’°ŠÇoŒŒ«‘å’°‹ÛŠ´õ’è’…ƒ}ƒEƒX‚ɑ΂·‚éFosfomycin‚—p—Ê“Š—^ŒQ‚É‚¨‚¯‚鎡—ÃŒø‰Ê. Šâ“c•qCH“c”ŽLC²“¡‹g‘sC»ìŒc‰îiŠ´õÇjC¬—ѓЋgC‘º‰ªG]: ‘æ47‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï¥‘æ45‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï‡“¯Šw‰ï i98.11.26`27j, “Œ‹ž.

3695. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¬Ž™×‹Û«‘–Œ‰Š‚ÌÅ‹ß‚ÌŽ¡—ìÑ. ˆé׉hˆêC²“¡‹g‘sCó‘ºM“ñCŠâ“c•qC“í–{—TCH“c”ŽLC»ìŒc‰îiŠ´õÇj: ‘æ47‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï i98.11.26`27j, “Œ‹ž.

3696. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Chlamydid pneumonideŠ´õÇ‚É‚¨‚¯‚錌´f’f–@‚Ì”äŠr. Šâ“c•qCH“c”ŽLC²“¡‹g‘sC»ìŒc‰îiŠ´õÇjCŒÔ“cÆŽqCâ“à‹vˆêC”‹Œ´•qŠŽ: ‘æ47‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï i98.11.26`27j, “Œ‹ž.

3697. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’°ŠÇoŒŒ«‘å’°‹ÛEscherichia coli O157:H7‚Ì‘B‹y‚ÑVerotoxinŽY¶«‚É‹y‚Ú‚·Bifidobacterium‚̉e‹¿. ¬—ѓЋgC‘º‰ªG]C¼èŒOC¼“cŽÀCŠâ“c•qCH“c”ŽLC²“¡‹g‘sC»ìŒc‰îiŠ´õÇj: ‘æ47‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï i98.11.26`27j, “Œ‹ž.

3698. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j V¶Ž™‚É‚¨‚¯‚éceftazidime‚Ì’`”’Œ‹‡—¦‹y‚Ñ—V—£ƒrƒŠƒ‹ƒrƒ“‚É—^‚¦‚é‰e‹¿. ²“¡‹g‘sCˆé”¨‰hˆêCŠâ“c•qCH“c”ŽLC»ìŒc‰îiŠ´õÇj: ‘æ47‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï i98.11.26`27j, “Œ‹ž.

3699. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™”A˜HŠ´õÇ‚Ì—Õ°“IŒŸ“¢. Šâ“c•qC²“¡‹g‘sCH“c”ŽLC»ìŒc‰îiŠ´õÇj: ‘æ9‰ñ”A˜HŠ´õÇŒ¤‹†‰ï i98.10.17j, “Œ‹ž.

3700. mŠw‰ïŽåÃi’n•û‰ïjn ‘æ47‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ïi98.11.26`27j, “Œ‹žC »ìŒc‰îiŠ´õÇj.

3701. mŠw‰ïŽåÃi‚»‚Ì‘¼jn ‘æ9‰ñ”A˜HŠ´õÇŒ¤‹†‰ïi98.10.17j, “Œ‹žC »ìŒc‰îiŠ´õÇj.